<SEC-DOCUMENT>0000021076-23-000015.txt : 20230502
<SEC-HEADER>0000021076-23-000015.hdr.sgml : 20230502
<ACCEPTANCE-DATETIME>20230502164506
ACCESSION NUMBER:		0000021076-23-000015
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		71
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230502
DATE AS OF CHANGE:		20230502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CLOROX CO /DE/
		CENTRAL INDEX KEY:			0000021076
		STANDARD INDUSTRIAL CLASSIFICATION:	SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842]
		IRS NUMBER:				310595760
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07151
		FILM NUMBER:		23879905

	BUSINESS ADDRESS:	
		STREET 1:		THE CLOROX COMPANY
		STREET 2:		1221 BROADWAY
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94612-1888
		BUSINESS PHONE:		5102717000

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 24305
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94612-1305
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>clx-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:0b973b79-9411-462a-9048-a4468bf442a9,g:effc8b7f-c824-4f09-9fb9-ffb97c19c826,d:35f8305358714061a46930a84f00a8d0--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:clx="http://www.clorox.com/20230331" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>clx-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80L2ZyYWc6YmUxMzUzNjlhNDYwNDIxMWIwZDYwMzg1NmU1OWYxM2UvdGFibGU6OWU2NjU1Y2Q1YjgyNDg2MWJkOTdmMGM5YzVlYTdhZDEvdGFibGVyYW5nZTo5ZTY2NTVjZDViODI0ODYxYmQ5N2YwYzljNWVhN2FkMV8zLTEtMS0xLTE0MjY4MA_cec62ae2-451c-49c7-bb73-2175e16b7c84">0000021076</ix:nonNumeric><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80L2ZyYWc6YmUxMzUzNjlhNDYwNDIxMWIwZDYwMzg1NmU1OWYxM2UvdGFibGU6OWU2NjU1Y2Q1YjgyNDg2MWJkOTdmMGM5YzVlYTdhZDEvdGFibGVyYW5nZTo5ZTY2NTVjZDViODI0ODYxYmQ5N2YwYzljNWVhN2FkMV80LTEtMS0xLTE0MjY4MA_50e22c04-a559-48f6-948d-846ad6f04547">false</ix:nonNumeric><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80L2ZyYWc6YmUxMzUzNjlhNDYwNDIxMWIwZDYwMzg1NmU1OWYxM2UvdGFibGU6OWU2NjU1Y2Q1YjgyNDg2MWJkOTdmMGM5YzVlYTdhZDEvdGFibGVyYW5nZTo5ZTY2NTVjZDViODI0ODYxYmQ5N2YwYzljNWVhN2FkMV81LTEtMS0xLTE0MjY4MA_e5df5593-b3de-41ed-aa2d-dd36e323c4a6">6/30</ix:nonNumeric><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80L2ZyYWc6YmUxMzUzNjlhNDYwNDIxMWIwZDYwMzg1NmU1OWYxM2UvdGFibGU6OWU2NjU1Y2Q1YjgyNDg2MWJkOTdmMGM5YzVlYTdhZDEvdGFibGVyYW5nZTo5ZTY2NTVjZDViODI0ODYxYmQ5N2YwYzljNWVhN2FkMV82LTEtMS0xLTE0MjY4MA_87d5f482-e04a-406d-8773-10b5ab1070bd">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80L2ZyYWc6YmUxMzUzNjlhNDYwNDIxMWIwZDYwMzg1NmU1OWYxM2UvdGFibGU6OWU2NjU1Y2Q1YjgyNDg2MWJkOTdmMGM5YzVlYTdhZDEvdGFibGVyYW5nZTo5ZTY2NTVjZDViODI0ODYxYmQ5N2YwYzljNWVhN2FkMV83LTEtMS0xLTE0MjY4MA_533623b1-0ed7-457c-ac62-6f21cb077ce2">2023</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="clx-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38686ba1b880423d945d44ba0aa0dc33_I20230418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8436d472730424da132f275fca3c42a_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38db454957ae42d1a879575c446b836f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf74c279d583412eaba0df33f84a8dd7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7a142fe888d4dbf8b9d78f7d4a764bd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icca7cfce0fa141dea44cb9ce7a326899_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06d000a1aa834bbfac4282e34d583a60_I20230630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2c8765c01654490b2b1c05a7f10e95c_I20230630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3aa3d22372b64584acb9882537a6dd42_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">clx:CostOfGoodsAndServicesSoldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba59125bcc944eaab44b48bc55a3dc85_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">clx:CostOfGoodsAndServicesSoldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ded3b682518451f87217f49e6d97925_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f615042f4614c5ca2aa6f2698e2ecdc_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36e02fa510054f06be615621c9bd2ecd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">clx:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad19817ded2e45cb9d95810868eafeea_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">clx:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id690da8b06c34b2db6496eb0743cd318_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb802f1785e94392ab45e3ccd217a284_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i058a79b88ddf43df8b916f862dfc5bf7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ae0d275a3c3490d8d3fad6bff44ecc3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a1d7d8632bd40d6918c50fe8c44ac85_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37c8da2bf20c490596a15b4866b80871_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i597c023bc1a04a0b99911d165820e8b0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51a13a9df4a44b17b6fe45952facdb9a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia25937b8293b44c98ede6be445bfbd4f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f92c48a282547ff99ddf8f3b5d7f2f5_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dd70a15f7a94b8baa949563effef687_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id94ba9c2186c47749a192c36f50af6e2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">clx:VitaminsMineralsAndSupplementsReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if866eca78fc44cb985650980c0effb9e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">clx:InternationalReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14a182d0cd5c4d15965a7e7a7bfdc653_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">clx:VitaminsMineralsAndSupplementsReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1963ee82a44d46ffa8708d4e456f329c_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">clx:InternationalReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f45254db7c44fd7baa3242ec875ed30_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30dd390ea6b04c08a6b35540c0fd90d5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if51281e120fb4c9aa9d0c0f419704d3e_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc9854de4e3c4c0985eef6728fd978cf_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2cff198bfe644e0a8fb1825c00677d3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie62ad774357041f9ae5c145530854b8e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e18cafffa494d9cb9daca6284175f4f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72eb4644e3f447fe8259fdad6f8dde47_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d6d75e5aa7b47e588ee1b82de531670_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i791d5f02e170464bb461195b53387d4d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i614e96f28f6b441c978c88983621bfff_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic42f71e1a2c44eb8bfbfca5078fdca23_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a5483738f5a46b9a4300446be65ea03_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8d385e83a0148869431bc29b025489b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i521e232ee0064169882cd1c6588b7510_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85730fdfbb9c48a58317696007eac6f3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i660f20ab0c1946359ba21c70908a1443_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf58e03903bd40ebbfded435df15b857_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ff79fb466cf4f528c2057c39855c6fc_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61861cccc66e4af39cd5f905d2e6e973_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2260b79bc57d4a56a8a43db5b050892e_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia81dc710789a4279b293057273b0585e_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ec0696cfea245148b8cb3ed95489d83_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e028c529aca4fe2a5bc96136e9b1d3d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3db36ab2a08e4e5e9acec297698a1d58_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c4931a784644dbc9654624dc6378c3d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i974dd2e411d44a7387a3a78f3494eff1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa6881da3a99458c8448602633dde541_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a5033b4e8dd41c2a30bdc0f5f38c4d7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b73e43b25f6458dbd1f98100fb99374_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90ccd04fdd2047da9e06c4f3f203df6e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i553b47cda5624d2b9e5b9b4464cbf54b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97da66cd682045d0a6cf64a53511a50f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i491dec08e3a04e15884928a98985d9ed_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i152e3a4caade4045835fdf23b4333786_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8437cff6d6ba45528bcf1bb542174783_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia20a96df8ee1438397ac0e1012769f4a_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88cfb390480c455eb1a2978c32713180_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38e791e368ab43409f15ba5e5f5cd67b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0463f04d5ee3451b946c7af6a61845ef_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia26f11b6660a4abcb09094cf9a8a25c1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clx:GladBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="icc15044a51144f99b1b95c3d077cfd0a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clx:GladBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48ad1cc1bb794a76b3dd0815532c06b3_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id06bee842a75404dac41877bdd92d1ef_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8a40de0484b4eeb80b4fe9c2b92525f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf2ca00060704f22aa28947a2c33bf44_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">clx:PurchasesofInventoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2159f0fecc5b4470982d356c86f23bf9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">clx:PurchasesofInventoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd98f18f73954c73b67fcb63121d3a6a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5e38353ad8c45ebbbeeb1760836023e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i267e13abd2ac4080863d5a4b5a5a1008_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia50e5e1f44b94908af2b9b0f33a06f5d_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib90adbece5bb496490f8e0ada42889bf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53d784e371024289a6bb1733a0bfeceb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06467bddcdcd40afaf9fc6a5d8f585b6_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59a5dd038e5d4dc8a7529d286f2503b1_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84aeaaa8c3d24da2a83bccbe80c40d7c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7569e47c817545e8b392a1799c23bb90_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62117e14e9614a8b8aae02999044878f_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66b892c371534620b3587d9e0450ac51_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66b2684d698e4766b9ae15f0597d7fdf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f46aa97434e48e89c802561e09aac43_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9edfde63c0c497e88e10ce6f5c5636f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77a4addd4aa1435083c94a016faebc92_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc0a6e589f2b483990fd8b1228aa3c8a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbea6dcd3f5647a9bf12d9d534a6ca9c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d413ac1c4d04865a4e5fe3b340023a7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i992290ad5dc147a89b2dc02782ff64ef_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i287e76237d8c427fa8b74226bacd7498_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa9b879156664a4cabe4b0c19b072452_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if09b23e716734285ad99334813cdd1c7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73735ddebada41feb165c246aab6ce4a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f6555be7a9e4d239338043a0facd422_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f7ebc1c469348ed885bc1105f8fc3df_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a68f814db4a4c5c95ed1bd0205e0034_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb497008d82d4021908269a98083af08_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03ee318c0e494e0981bcc1c4c86ac0c3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f23483af02142ff962e0bc8a46b198f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia680265241d34120bcbc6e5b1c032c3a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib949b42e3d64447f9f9da32d8fe053fc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b1b18d9575c4fe181987e3bdf974c55_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib19d64991cb241db9d152df2af96652c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a98cb40f89c4f6cb3174cc2385cfdc3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec4aaa03ddf14edab361fbdbd7af4a28_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd50e0a93db949dc86a0a76dea201d7e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdc22c41b65b44f5910fb2bd6e7aa7ef_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id77511cc08ae4fada9800a2edf805e8d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i699f3ca3c5db4d5bba548627af449cf4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80dda40f54024046ade281e97268afde_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb50e89eb9054e9497f1a6390acb66df_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a4b9990a76749d7b5b429e19b132705_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7abd7c745142489ba717edbad8ecc1b6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if177937c7cde476eace985e08c46bb5a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86811defe6884c9b8f1c17dcfaada1ff_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b50460a1b234ac3b19dc457a1b696e6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e23b9c3471546129e5eb560eabed6b9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37e76d4ac9234a0186486ff3b55d6a18_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaff929c5c7ef4f728e2ba0db462af797_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09e3af3669ef426badcf844049084f14_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd45a75514c24c568a56042ccd0c84da_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05ffbff4ac6b4a4b91ae2e1f6beaafa4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifae1e2814de34b5eb8043ef76cff06a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i575dfed5180b41c380550a620ea3e540_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4e77e9c323c43acad3d23fd72036b5f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i565b4c1e42f94eb2b2d7e89045b94abc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fb985ea42574447abbdeb651a94e290_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a8f4562f03f485b9222b7cce528e697_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ab076bc30324400b05fae96ad5d777d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i790c9340393b4fb0b02a7296fadf9609_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa3654eea4d143be9e65477225892c33_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bca9d2ecd9e481aa1ead4b270214e56_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56725ff0d43240d19e4b0e41d908614a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95257d576dfd45148c1997c326e7020b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93ed62d82fff40e495d855e264b32bc4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e4a56d9d98a4157b2c6e3bb88276c9b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1998332848f548599b1f44f8389dcf4c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe250680c3cb4a2d9422e47ecfbb9232_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i349984d984ac4a6dbf6cfa7d1779d9c9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0578ecbdca4a4b0683cb8154b35f6aea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71a1dcd718bb44bfb1a91f3a99cb0ad7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf167b776ade4df7b590155e62a3f0fa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic441f564bc3e4f1fa09858858b3e6ba6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e561b7b255d422cbcdac071c1398d6a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6170471920d746bcb25579e59b005902_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia33168f0db0843d685d4b21fe4e5edda_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i428de1acdef7408cacf083e495bd1acc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8ebbe87a5b44f8e86adb6c537baa365_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice2dbf9b838649879e0d1331a95d0191_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i382bd8dd06684d658f4f850a93ab45ab_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc1249e856e0404fa74fe81e86ac37b5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d7a9d9e6abc4064872b7d412c2a4ff8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3b6333e92ce42d7ab3cda6056f7c98a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62c0fe22bbdb4fb083de7d9a1d7d1f45_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd6ece4973e949d08182806d9a323160_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacc1e22ac19d48209ceace90c3d5b926_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73dbb3c50d1647ceb59c25ac8d3093fb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fef3da8c9d340c6996ac9bd4e846ef1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38dd7f792041456cbe661ea31eb94219_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5409859b1d8845f0aff788c9db7c4c79_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6228167648a4c80885f8515c358e74c_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cb19050263443049c6a5d3e0839f6cc_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if811f809413d4a6bb8691c5fcaa43e23_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d8d459930ee4918898527d3560df45e_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0606e8ef65d840a58c50419adf1e8e08_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cbd00ee054d4a0ea683f3e69c3f144c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21ccc62d5ccc400ca14bf9ef81476443_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82ec983182ab42d7bee00f12f996858a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie20aff337cf646b68d54fb6090aa44eb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i789c01c0eea04f1d858ad3fba90164ed_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5da3d885a8845f889db9160bcd4730c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i372b14b520094c4382db02e9bc4689f9_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefab848d9a3b4ce984a98c0628e4cabb_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9e6c3f82aac456096e02558c7413ecd_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7296f62c815b4fb88cc0fabc30e4a5f3_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cd390a11523485798e09a245d293c38_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id54b8127809f4f009450878e1f47eab0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec972b6c609643939ebb658b21202380_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10105acceec642bab440c62b4e41da18_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7e58ebc3d00448981b37243d360d5b8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cd10304fb1c43b798f36d9855e3a674_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i639e65a448654d5d87000a3caa18af16_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie85c1700bb824cf3a99834757ca0345d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d7840b6eb44467d910474da7f5cf458_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7941953b83146c2b4fd8a2efddca131_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd5d1bb8964841e785fdf870e1cd9c1f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0ed5f67bc8e489fbf38eea7a87acb42_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb003230a88c4000aac4e5c07d393cd2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20cdde6a918646608cafb482b69c1374_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b260ed4689a4167aedbbe4c6e8d5aed_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e2a1cf474674d64b709b61efc4388c7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a904ed9259247ed803bd9c4575c448b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8624504988204f299f5466845c6db945_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i991ef5bf9ed442ca8531f36420575a16_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bb0aa974c214b5e853f0cc3ae70a268_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia520dd3f71774e2b89b0bbe17d6294b9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0158083bc55c4728ad23a8bd5fdf8b21_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7d813979e3847bf94273f4ad7b0ec5c_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a0052b2ab86487f95d0cc11ca0882df_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbbbb87becc84b54bf3ad91efbb9dc00_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70b0eab852154e4abb63bef64c0c9253_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99ba1c772ca743cab239215ff58256f1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic03507f6901a459cbfc9f1686e275800_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74cca342e02946e285f57be15d303376_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b245889d00f4e2eb4062bb56ecd5f01_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6f7d0c924ce46a4a0fab6f32137e185_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25f320caf7334b4da9436fd1f08de3df_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i584c8b4ed6394f1d93786bbc0dc674af_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1af7dfaca4b4bb4939e8512479b3d34_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa6abb84427f42ceb43e887b2e70e3aa_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b73d8a1cfaf475cb132b48a9922e0b3_D20220517-20220517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-17</xbrli:startDate><xbrli:endDate>2022-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72e948a45d844caaa808077789bc9946_D20220517-20220517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-17</xbrli:startDate><xbrli:endDate>2022-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if97497268cb046da9dca9748a32e4bbb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i246ce3736a7a4184875d648605151755_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69b9322d04104475b3bd0b3239f85400_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i925a3774c2804469a6e6a80652cf53fb_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c9faa6e294049b0b02b4ca616aef8d4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5018154f07a6473082b19c7019bb5815_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i559a56b3ed7f4dad8b0eb215d3b4d96e_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb1bd9ce8db14db8b42305bf898b2988_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1215ef2fd713408c9543e79c8cf060d0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7407b536aaac44c9a0ef22436412b35c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac8c0a67be954e91bf9ca146dc56b8af_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fc0efb36d7e490a8d10a178a4f95683_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic71f7f98850c425cb50e81ac8cee6715_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9807c06a76d40c0ae21df8a99a25033_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reportablesegment"><xbrli:measure>clx:reportableSegment</xbrli:measure></xbrli:unit><xbrli:context id="iffcf3e3d97fe478ba53f98097b7768d3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3033698cc9d446b98ebb51f2cc6a8fc7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8b819629ac7412c9fa594839a2ca9ee_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8d519a96f9042bc8dcb0510d40a1b4e_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b20ce7569f946f996cfe02a046120e8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37775bc712c546ebbc80496c37c9b997_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c9d7f9d14d24f99895d7cf206821b4b_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4031a9dd94ae4d12aae506d6f2f1db96_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief9575da4e024669a982592f716c50d9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dc7ce1afe424640808a9e7de9aa36a0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie71b9480776e436f9c519240052f7677_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d021f6c3597425098add480ff912297_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icce3534c232c40299861e02393f34ae2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8021e9a77dd946919cfb390e149fbf16_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5de8a3a44dc424bbd78630823dbc605_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifca9fa030b7e4d4d857d843d0538b755_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icedf8ca64b12469f8b334ea1c52ce44f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic113bbab87514834aeff65f9dcd2d9ea_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib82d343ec2d2457491346026e4a1384b_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i008bd39b3c1441d28f56d156aa4e0e13_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06b7961dd4ab4d08b1f59fd5cecff3e8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8cd31d1d39a4a1dad35192d8a05943e_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae7e934f7d3345e38420a6419068a3d5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4827a5147dae403184de103cfa7cb609_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea0e1ddc7df0436291cc964f291d7156_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c370fc073ec40fc9f41fba7ceb625bf_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51a5efc4b1ce48669aeefd4046d6b146_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc836f2559f64ad48298463711e54cef_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d7befdad82d4d418a5d6f0c05a4d46a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f58e61108af4223b214e3fe0d5d2094_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e525b30dbd84ad096b5a005cb6c06b7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ed91cca97714a74bfef07a13999207e_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i376f067722d54b38b9d07d5df655a930_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7a17140503d4ae99e2c3110f5493890_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i534b552133ab458393a04aa68bb98837_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bcfd545b0374fbdb3542e9d143d4386_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ff574e3aa2743caabd5efe4f9812b66_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib002fea2011949d68a0bf85c0cd5f82f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ca63fe7639d421784a23dec0aad3de2_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f0cd8998a3d48ed956c2195a10e4a96_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cdb483b522a49da8b6e69c8bfb68e8b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48472411ffc14234a19c3b450fcd82c8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3eb238ad2564e2fb6be808234d4fb8a_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i629e3b1f030e4ce897713db4360a2347_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9db2e760489b4c11a3d33f81189967c9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39223577acf644679357f58a1290bd2a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie881bce8f5334f7aab4e543c319a5926_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbae45119cfa4a5c8b13e22928f50489_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice64939ca72241c09ec2b7d83c993371_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50673219f145422f8c076edc553d124d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id28fe0fdacae42b3a9ca317dc63e5d74_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1beaeabc59b0460b9b16920dc20b95a4_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95fdb90c917e4246b77256a7203284f4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63cbaccfe8b441e0b139019ea3e13e72_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i113699d3252e4e2d9ff0cd35976a5b8c_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fbb109938324676a455905b3813090f_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57adcb1929154f35951a65c97a1a9eec_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i787f1a9b3f7a4dc8b0d448fa0c26e975_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i989a32ba4f8d4a9d8454b53f177bf23d_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72213a90a16e4a55bf5162ceee1ad06b_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecbb9ee292dc40f8a27a70a208e98f03_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i503ca72ebec94846ab018289383f13fa_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieda62ebce8934fb09ef0adb92b5f7803_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i055b0b22709c429cbd64d4daebac1297_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a65275769d74bf48e3a461bc2e6a39d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb5c1ab1b82640178fbbc21e8512a431_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2436443839a40d6b25b269f3515ff1c_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie58eaa3597cd43668b6d4a0be6618155_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec1abcd1af04423ca693619b5556f630_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9de0a48a571549d3b006153987874a47_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63c6253b79704765be3a2886b72dc7ca_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib18537f4ac7f4342b5c6624f2b7bf768_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a97ed3b14274b9b830776063e4410c8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2f5fb7871c7436b900d2cd3d8311c5f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f41877e3cc24d2ab82f800b4e54b330_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i114f5fcb844c4cd48afc6773bae7de68_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic47b0bf2f6b74406ae63df384f0f2170_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b2275a8baa74a81974673ca3c98e934_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63be3d36820c4c14aeb977054b7bd9ef_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9c4181e447f4561894f05c7189939a9_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fcc63cd4e714eeeb040154124f4230f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaa89fb3550f4a919ddc0549b774313a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i141a04ca2b22429d966e6c25a5ba5b9f_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0aa39c9b9204bc7812195ead8b31158_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i964cbc2a36904c2c953e83d44d0db963_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90c7b45b7f53405ea50b2def6902b7ec_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80debe7af7c04b0d8001e647ecf24389_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if63670b5302b4743b3c30e0b8aadda12_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i788105bef8f040c3abaaec1851973630_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i119fc41a359743d585ccf388679848e8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib082af343f52451fb96251c408730857_D20220701-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d29d27dc57146a59614c80c2341fa42_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i35f8305358714061a46930a84f00a8d0_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">FORM <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV84NA_3bb67e73-d193-4daf-8999-8563d9f10c1f">10-Q</ix:nonNumeric> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.768%"><tr><td style="width:0.1%"></td><td style="width:2.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.230%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Mark One)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6MzhiNWJkNGZmMjgxNDNlNTgyOTQ5MzhkYzBhYWMwZDUvdGFibGVyYW5nZTozOGI1YmQ0ZmYyODE0M2U1ODI5NDkzOGRjMGFhYzBkNV8xLTAtMS0xLTE0MjY4MA_e0e20342-b7cf-405d-88b6-c572c20363f5">&#9745;</ix:nonNumeric></span></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8yMTk5MDIzMjU1NzU1MQ_a07db57d-df5d-454a-806c-e6c0ff1d2dc0">March 31, 2023</ix:nonNumeric>. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OR</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.623%"><tr><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.959%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6MDJjMjQ0YmZiNjY4NDBmNTg4YmI0YzViNTRhYzc4YmYvdGFibGVyYW5nZTowMmMyNDRiZmI2Njg0MGY1ODhiYjRjNWI1NGFjNzhiZl8wLTAtMS0xLTE0MjY4MA_4950cf6c-b2d8-423a-8222-f95b3c21e48b">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8yMDI_efc57e1b-4e56-458d-98c7-3c165b856de7">1-07151</ix:nonNumeric> </span></div><div style="text-align:center"><img src="clx-20230331_g1.jpg" alt="CLX logo.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:518px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8yMDg_ce5e2774-274a-4b1d-8da1-217dd5126023">THE CLOROX COMPANY</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.855%"><tr><td style="width:1.0%"></td><td style="width:48.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6NDg3MTgzZTM5MjQzNDdmMDkzZGYwNDE2MjJiZTM5NjAvdGFibGVyYW5nZTo0ODcxODNlMzkyNDM0N2YwOTNkZjA0MTYyMmJlMzk2MF8wLTAtMS0xLTE0MjY4MA_37423020-86a4-4564-8c99-df4295a5dc5a">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6NDg3MTgzZTM5MjQzNDdmMDkzZGYwNDE2MjJiZTM5NjAvdGFibGVyYW5nZTo0ODcxODNlMzkyNDM0N2YwOTNkZjA0MTYyMmJlMzk2MF8wLTEtMS0xLTE0MjY4MA_695f7de0-fa15-4f6f-850e-922ff4990f05">31-0595760</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8yNjk_ac297d08-302d-4b3e-aa16-c364ed8649ed">1221 Broadway</ix:nonNumeric>, <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8yNzM_f9f681bd-3eb3-4573-877b-ab9239a0deb1">Oakland</ix:nonNumeric>, <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8yNzc_7c99b330-8bb5-4c9c-862b-eceee53dfb32">California</ix:nonNumeric>, <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8yODE_94af2184-1fa8-4294-ba12-591df43e9c78">94612-1888</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip code)</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8zMzg_972cd325-1ef8-45d0-aa31-181566feff52">510</ix:nonNumeric>) <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8zNDI_1de67e0d-1cef-417f-96bb-874e094a6e9e">271-7000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.420%"><tr><td style="width:1.0%"></td><td style="width:36.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.635%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Former name, former address and former fiscal year, if changed since last report)</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">___________________</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6NDBjMjlhODdmYTY5NGJmYWExMDZjNjU5NWFmNzg5MzAvdGFibGVyYW5nZTo0MGMyOWE4N2ZhNjk0YmZhYTEwNmM2NTk1YWY3ODkzMF81LTAtMS0xLTE0MjY4MA_5aa16a85-2b21-4cfa-9d5e-17e06a80e5ff">Common Stock - $1.00 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6NDBjMjlhODdmYTY5NGJmYWExMDZjNjU5NWFmNzg5MzAvdGFibGVyYW5nZTo0MGMyOWE4N2ZhNjk0YmZhYTEwNmM2NTk1YWY3ODkzMF81LTEtMS0xLTE0MjY4MA_4fead223-315f-4022-8e2f-7257f1fa60dd">CLX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6NDBjMjlhODdmYTY5NGJmYWExMDZjNjU5NWFmNzg5MzAvdGFibGVyYW5nZTo0MGMyOWE4N2ZhNjk0YmZhYTEwNmM2NTk1YWY3ODkzMF81LTItMS0xLTE0MjY4MA_16b39641-11c2-4f42-88ee-50f891ffd674">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV83NDc_76249ce5-c8d6-42c5-b5ff-e74636956cf6">Yes</ix:nonNumeric>&#160;</span><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8xMDY4_bd823ff4-0b0c-40cd-b4ce-45f179b72343">Yes</ix:nonNumeric>&#160;</span><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. &#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.942%"><tr><td style="width:1.0%"></td><td style="width:15.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.552%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6ZWIwYjIzOGNmYmQ4NDg4NGI3M2JmMTc3NDE0OWNlMTIvdGFibGVyYW5nZTplYjBiMjM4Y2ZiZDg0ODg0YjczYmYxNzc0MTQ5Y2UxMl8wLTAtMS0xLTE0MjY4MA_0398536f-1094-4f3e-b31d-6661fa6895d1">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6ZWIwYjIzOGNmYmQ4NDg4NGI3M2JmMTc3NDE0OWNlMTIvdGFibGVyYW5nZTplYjBiMjM4Y2ZiZDg0ODg0YjczYmYxNzc0MTQ5Y2UxMl8wLTctMS0xLTE0MjY4MA_27aae552-64d1-4b63-bfed-b82e1af030cd">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6ZWIwYjIzOGNmYmQ4NDg4NGI3M2JmMTc3NDE0OWNlMTIvdGFibGVyYW5nZTplYjBiMjM4Y2ZiZDg0ODg0YjczYmYxNzc0MTQ5Y2UxMl8wLTktMS0xLTE0MjY4MA_6861e6a1-cb16-4d02-81eb-c4611c8fe8b3">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8xODAx_4bb00374-628b-482d-a553-d5bb9dd38a3b">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;18, 2023, there were <ix:nonFraction unitRef="shares" contextRef="i38686ba1b880423d945d44ba0aa0dc33_I20230418" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8xODMy_2e8eacf9-6394-4779-add1-83841325ff30">123,623,524</ix:nonFraction> shares outstanding of the registrant&#8217;s common stock ($1.00 par value).</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.985%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION</span></div><div id="i35f8305358714061a46930a84f00a8d0_10"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in millions, except per share data)</span></div><div style="margin-bottom:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.104%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMi0zLTEtMS0xNDI2ODA_2663da20-bc75-4e03-bc4b-db1e09f2ba31">1,915</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMi02LTEtMS0xNDI2ODA_a7040c8e-01e0-4a63-98f9-95c18078e1af">1,809</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMi05LTEtMS0xNDI2ODA_e5d2ab5f-5581-41ff-886d-1ee8a8685093">5,370</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMi0xMi0xLTEtMTQyNjgw_cb039485-7b7b-41b5-af9b-d2932d1cf6cd">5,306</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMy0zLTEtMS0xNDI2ODA_f5294bf3-181c-46b0-9f55-2fae62bdb4e7">1,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMy02LTEtMS0xNDI2ODA_fb7378d5-fe01-4a07-ba68-11995b6745ac">1,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMy05LTEtMS0xNDI2ODA_f4d1f447-f987-44c0-91a4-f4ce6dd3c9e5">3,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMy0xMi0xLTEtMTQyNjgw_e934a444-8ab7-48b1-b1fe-3284253dadba">3,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNC0zLTEtMS0xNDI2ODA_26d54b0c-b82e-4fc4-8d80-f39a372a370c">800</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNC02LTEtMS0xNDI2ODA_a90c73fc-7eec-488f-96ef-d8c6864541f7">649</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNC05LTEtMS0xNDI2ODA_37a536a4-6097-4cf0-be0d-6586cb4bc4b3">2,046</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNC0xMi0xLTEtMTQyNjgw_fde4f610-c1a9-4490-baff-b6dfe0bcde54">1,877</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNS0zLTEtMS0xNDI2ODA_5bd2a5a2-973e-42dd-aba4-067c404a97d7">311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNS02LTEtMS0xNDI2ODA_282bcf1d-5d31-418f-9627-1edbbcb5b41c">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNS05LTEtMS0xNDI2ODA_3d4bb974-bea7-48d2-9e9f-7dbf586e475b">854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNS0xMi0xLTEtMTQyNjgw_066523dd-a066-4d2a-9345-1d4ed8eaef6a">710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising costs</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNi0zLTEtMS0xNDI2ODA_0f425961-7219-4a56-afc9-6a764e444930">206</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNi02LTEtMS0xNDI2ODA_ba3b8795-ced0-4576-869b-ed9ce750b53f">153</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNi05LTEtMS0xNDI2ODA_28f202ca-d605-41e4-bd11-d1a29475972d">523</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNi0xMi0xLTEtMTQyNjgw_a83f72e1-2a89-4a38-95d8-46a908467e23">502</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNy0zLTEtMS0xNDI2ODA_d7c02b9d-8de5-4922-ab09-76a3f9e2d414">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNy02LTEtMS0xNDI2ODA_9d4143be-da13-41f3-8d96-dc80515195ef">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNy05LTEtMS0xNDI2ODA_6b6ddda5-cb5d-4a01-a0d9-baa3d31b39a2">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNy0xMi0xLTEtMTQyNjgw_d3bdf46b-fbca-4c25-a8de-ce84d6f45119">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, trademark and other asset impairments</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOC0zLTEtMS0xNDI2ODA_33405080-c6ca-4bb9-ae29-eac60f84ca8e">445</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOC02LTEtMS0xNDI2ODA_a811ad2c-943f-4f41-9fd8-31eaddce3eb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOC05LTEtMS0xNDI2ODA_edda9ec8-081f-4654-9ada-17c9cfef05ca">445</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOC0xMi0xLTEtMTQyNjgw_368c9c96-98b3-4cf8-8a43-a0e5cc48a1f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOS0zLTEtMS0xNDI2ODA_9d1e292f-f160-4a74-b26a-17bc97664385">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOS02LTEtMS0xNDI2ODA_7495537e-5003-480e-b47d-b8d48cca6d67">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOS05LTEtMS0xNDI2ODA_c235b178-3263-4b45-a4f4-c466826560ee">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOS0xMi0xLTEtMTQyNjgw_9a4378c8-48ef-4008-a005-a664274ce1f3">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="clx:OtherExpenseIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTAtMy0xLTEtMTQyNjgw_5b13ffbb-0f3a-43a3-909c-8373e7e791ca">24</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="clx:OtherExpenseIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTAtNi0xLTEtMTQyNjgw_b593f785-3fea-4792-87c8-2da727f41a0f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="clx:OtherExpenseIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTAtOS0xLTEtMTQyNjgw_1a2a93fd-9d83-4e18-8c72-77b3db8f15a7">54</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="clx:OtherExpenseIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTAtMTItMS0xLTE0MjY4MA_8b930c50-b87a-4b9c-a512-c2fcd14dcc52">20</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTEtMy0xLTEtMTQyNjgw_0b640dcd-aaca-46ea-9153-6b9bc11b1a32">245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTEtNi0xLTEtMTQyNjgw_ad1ef383-9af7-4f4a-9294-9ae088d97d5c">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTEtOS0xLTEtMTQyNjgw_7276b1d0-16f5-4c5a-85ee-597934580ae0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTEtMTItMS0xLTE0MjY4MA_8cc6c20c-f0a1-4d33-8dc3-d3fb788ccb65">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) </span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTItMy0xLTEtMTQyNjgw_56185977-9223-4a30-afa9-34cd005c9be3">36</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTItNi0xLTEtMTQyNjgw_150bbee3-682a-440f-884d-4c4ee3482818">48</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTItOS0xLTEtMTQyNjgw_7c6586bd-73e8-4946-bdba-9223eab55d60">21</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTItMTItMS0xLTE0MjY4MA_9cee9a95-4d0a-4ded-bac3-e32fb19db824">111</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTMtMy0xLTEtMTQyNjgw_582d6b3c-4fc2-437a-aaf8-61bc8fd7bb62">209</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTMtNi0xLTEtMTQyNjgw_5f837a09-5f3c-4d05-91cb-6592530b0fc7">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTMtOS0xLTEtMTQyNjgw_f1d321b6-7045-439d-958b-4d19d0c3a9d7">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTMtMTItMS0xLTE0MjY4MA_547c2518-626a-4135-b06e-1e29c2db413a">367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTQtMy0xLTEtMTQyNjgw_ef977f2c-c92d-4a90-85c4-8a6da4a18b9f">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTQtNi0xLTEtMTQyNjgw_ea0046c7-d18c-4a31-802d-503b1e2d81b2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTQtOS0xLTEtMTQyNjgw_24fbfae4-576c-474a-b54b-c2a68a7a1d5f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTQtMTItMS0xLTE0MjY4MA_24ac2d3a-fb6f-4d3f-a877-d2110e1921f9">6</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) attributable to Clorox</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTUtMy0xLTEtMTQyNjgw_5714ec4c-0472-4209-af33-63ac1a9f045d">211</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTUtNi0xLTEtMTQyNjgw_535dfaf7-f6ce-4574-930f-1ad0e172e3f4">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTUtOS0xLTEtMTQyNjgw_b3f77947-26b0-4a24-9390-d5d58e92f405">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTUtMTItMS0xLTE0MjY4MA_18b4ab98-0d66-4c9f-8bb8-0f14aaa04b74">361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) per share attributable to Clorox</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net earnings (losses) per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTctMy0xLTEtMTQyNjgw_4bb0c2c3-33ce-4167-a2cb-a54061095821">1.71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTctNi0xLTEtMTQyNjgw_5f6ec7b2-1904-43d2-a453-22b3222d9fa5">1.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTctOS0xLTEtMTQyNjgw_88e2bebe-a445-4e8b-b16b-edeef91188d6">0.22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTctMTItMS0xLTE0MjY4MA_e5279fdb-9ba8-4644-8908-226aa28d2057">2.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net earnings (losses) per share</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTgtMy0xLTEtMTQyNjgw_3c6de07e-6f93-464f-b8f0-a1e2c93a7431">1.71</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTgtNi0xLTEtMTQyNjgw_0bb370cd-994b-4394-bf49-d796d44213b1">1.21</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTgtOS0xLTEtMTQyNjgw_ef3a14dc-79d6-4aa4-9439-d2884e8dc2ab">0.22</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTgtMTItMS0xLTE0MjY4MA_5adcfe53-db6d-459a-98e5-7d3d8e70a25a">2.91</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding (in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjAtMy0xLTEtMTQyNjgw_859f37bd-4802-445d-83d9-9be044bae2e0">123,649</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjAtNi0xLTEtMTQyNjgw_171cf7a7-ccbc-437c-bcb6-374df10266ef">123,177</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjAtOS0xLTEtMTQyNjgw_b8602f9f-fb12-47e5-8e9d-bd4b77258dc0">123,512</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjAtMTItMS0xLTE0MjY4MA_ad255775-82bb-4c46-afe5-da9a984999db">123,074</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjEtMy0xLTEtMTQyNjgw_77b7e649-59eb-493e-8dfe-3a2cedfc9f52">123,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjEtNi0xLTEtMTQyNjgw_ec824e7c-0d62-4548-81ea-a987c7a109fd">123,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjEtOS0xLTEtMTQyNjgw_16342cf4-2a5a-4665-8681-23392e055ed9">123,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjEtMTItMS0xLTE0MjY4MA_80335ab7-c493-4492-93f6-815815b885af">123,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjMtMy0xLTEtMTQyNjgw_99f10b3d-e6cf-467f-91ef-ecaeda99f8d8">205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjMtNi0xLTEtMTQyNjgw_dafc7e5b-f40a-45e9-863a-2f84db6a57f1">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjMtOS0xLTEtMTQyNjgw_e5b1b280-5bd8-4427-a937-35c5dfcefd52">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjMtMTItMS0xLTE0MjY4MA_b48f8ced-e2aa-4c1e-b7db-fde8a2e4158c">394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjQtMy0xLTEtMTQyNjgw_81dcf2e9-d2e3-40b3-933e-824fff98da4a">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjQtNi0xLTEtMTQyNjgw_76e595c1-adfc-4a24-9bd5-02172c41eb80">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjQtOS0xLTEtMTQyNjgw_6bbd3e23-c667-4ffb-b799-175017d5135e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjQtMTItMS0xLTE0MjY4MA_77b91181-292e-446f-ad7e-43d9b08aa6aa">6</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income (loss) attributable to Clorox</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjUtMy0xLTEtMTQyNjgw_95b112e2-0fcf-4620-989d-299d460f4ed2">207</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjUtNi0xLTEtMTQyNjgw_75e6abb8-e9e9-4d16-b40c-649b04e972ec">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjUtOS0xLTEtMTQyNjgw_0a095bd8-8f1a-4b19-b0ca-bd73d2261256">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjUtMTItMS0xLTE0MjY4MA_3e6abbd2-525c-44af-a584-e3cbd518d5a9">388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_13"></div><hr style="page-break-after:always"/><div style="min-height:28.8pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in millions, except per share data)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.106%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="6" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNC0yLTEtMS0xNDI2ODA_566e50c1-fbc1-41b8-998f-91324864fd0d">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNC01LTEtMS0xNDI2ODA_77b9806e-81bc-41d3-84c5-cd0f22e38d15">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNS0yLTEtMS0xNDI2ODA_3021dbcb-0a13-454f-bda0-60a0b2602cee">678</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNS01LTEtMS0xNDI2ODA_d5d21afc-ea5e-4803-8543-85c5c5912dca">681</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNi0yLTEtMS0xNDI2ODA_e2cd8f33-8b06-40ad-9e6d-2c5092d295e1">735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNi01LTEtMS0xNDI2ODA_60c18384-d85b-4303-b664-06dee8f4dd7c">755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNy0yLTEtMS0xNDI2ODA_fd7dd9d8-ce96-4f10-9e86-d3870f4484ca">90</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNy01LTEtMS0xNDI2ODA_ea138035-6be9-4f52-8864-8bd7e8966eb2">106</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfOC0yLTEtMS0xNDI2ODA_b6fd295b-71bf-490f-8174-e1e1d5e45128">1,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfOC01LTEtMS0xNDI2ODA_3c439050-7e21-44b3-8b36-59403c822d8d">1,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net of accumulated depreciation and amortization </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;of $<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfOS0wLTEtMS0xNDI2ODAvdGV4dHJlZ2lvbjo0YjkxYmM2MmZlNGU0YzUyYjE5ZWZkNGYyOTkzYzI0Zl85Ng_b10213e6-8117-45d3-b08d-4a46b6c6f9f9">2,672</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfOS0wLTEtMS0xNDI2ODAvdGV4dHJlZ2lvbjo0YjkxYmM2MmZlNGU0YzUyYjE5ZWZkNGYyOTkzYzI0Zl8xMDM_6a0d7d28-02e4-4d33-9209-e74cb46f1d8d">2,530</ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfOS0yLTEtMS0xNDI2ODA_c1a582aa-3f21-4f8d-8e30-5142b9e21e0b">1,315</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfOS01LTEtMS0xNDI2ODA_f603a343-470b-4033-b020-cb4959772057">1,334</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTAtMi0xLTEtMTQyNjgw_e1ecd2de-7114-47cc-a04d-9c86fef8a577">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTAtNS0xLTEtMTQyNjgw_8aa1303d-fe1d-4307-91c6-56c6a75cbb61">342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTEtMi0xLTEtMTQyNjgw_07a18a06-0776-49a0-a2d6-370e9ceb585e">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTEtNS0xLTEtMTQyNjgw_c0959847-77fe-4d24-a1ea-0153b47be887">1,558</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="clx:TrademarksNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTItMi0xLTEtMTQyNjgw_19a7ffb9-64a5-4802-9066-9a74d1d5804a">546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="clx:TrademarksNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTItNS0xLTEtMTQyNjgw_651d7970-471c-4c52-8826-04f3187c0804">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:OtherIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTMtMi0xLTEtMTQyNjgw_4c366571-422c-426c-bf9b-65496ecaf480">176</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:OtherIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTMtNS0xLTEtMTQyNjgw_d8d6fcaf-ad32-4674-8e4b-d2d95deb77f1">197</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTQtMi0xLTEtMTQyNjgw_d00b8e9d-305d-4469-8046-7082e71c69e1">427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTQtNS0xLTEtMTQyNjgw_e3475eba-5f48-4d5e-bb80-bc32a248fc7a">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTUtMi0xLTEtMTQyNjgw_355aa200-f06e-4d3c-979e-feb97f9baf43">5,818</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTUtNS0xLTEtMTQyNjgw_efe11aad-0df5-4594-81d3-a21c39acb838">6,158</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTgtMi0xLTEtMTQyNjgw_8aea3e23-7690-470f-83df-c6d50a6c1e40">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTgtNS0xLTEtMTQyNjgw_95edf352-4c83-457c-a916-d6177dda368d">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjAtMi0xLTEtMTQyNjgw_66ad6059-c993-4000-90a2-9188cd67d004">88</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjAtNS0xLTEtMTQyNjgw_521d5ddf-a353-4e01-9506-695fb91188c3">78</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjEtMi0xLTEtMTQyNjgw_792acaaa-7b17-4194-b61d-455a434fc1d6">1,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjEtNS0xLTEtMTQyNjgw_00885c8f-7af5-43fc-a71d-cdcbc4648b3e">1,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjItMi0xLTEtMTQyNjgw_71c05e0f-6100-4fb0-9b0e-7ad0b4866e13">48</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjItNS0xLTEtMTQyNjgw_be8b190f-0725-4955-8933-f45314693cc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjMtMi0xLTEtMTQyNjgw_fb40dae1-e9fe-4323-ade5-1084c69f88f2">1,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjMtNS0xLTEtMTQyNjgw_30462315-4e73-4021-886c-0ab282f87736">1,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjQtMi0xLTEtMTQyNjgw_beeb7016-19c7-457f-8409-cf3d909b218b">2,476</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjQtNS0xLTEtMTQyNjgw_1b952cde-2d1a-4717-ad1f-44b2102d9f33">2,474</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjUtMi0xLTEtMTQyNjgw_9fc22526-d8a3-458a-9bb0-4b94d1a4b21e">323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjUtNS0xLTEtMTQyNjgw_a024e29e-c660-4659-b397-ff21ac345585">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjYtMi0xLTEtMTQyNjgw_94c6a4b7-3a6e-47c5-a0ca-5837635605a2">824</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjYtNS0xLTEtMTQyNjgw_14ec9b9d-27eb-4779-a242-7a37c005c665">791</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjctMi0xLTEtMTQyNjgw_9acdf69d-31aa-44e7-802d-d318b2bb105c">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjctNS0xLTEtMTQyNjgw_9d0b7c6c-deea-4652-a612-264ecc62442f">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjgtMi0xLTEtMTQyNjgw_ecf49820-28cc-4f5e-9b46-0238f2e18b43">5,646</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjgtNS0xLTEtMTQyNjgw_ae846e02-939d-49b6-8fe5-05d664e68e3e">5,429</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjktMi0xLTEtMTQyNjgw_6210d95f-dfaa-4d23-bbf7-c3ba05759c0f"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjktNS0xLTEtMTQyNjgw_1fc72a39-2400-4330-864d-d9d2698c02a3"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock: $<ix:nonFraction unitRef="usdPerShare" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfMjE_9eaf36c4-819b-461e-9b4c-1ba4076a164e"><ix:nonFraction unitRef="usdPerShare" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfMjE_abeaacaf-6979-42dc-8755-7da775c0b1d3">1.00</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfMzU_b3cf3ea9-dc91-43b0-ac9d-17990385ddac"><ix:nonFraction unitRef="shares" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfMzU_ea006905-cdd0-42a3-af88-1055f9c4c205">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfNTc_19884dc5-ada4-4f60-a41a-ee129168e90e"><ix:nonFraction unitRef="shares" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfNTc_869aebc3-6ecf-45be-9102-5724698c9c1e"><ix:nonFraction unitRef="shares" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfNTc_92f735a8-8054-4e85-a26e-f9d9108fa78c"><ix:nonFraction unitRef="shares" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfNTc_de4be583-9e80-405b-ad10-8ed9fc0a2ca7">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued or outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMi0xLTEtMTQyNjgw_3043cc3f-b6eb-4218-914a-268bc13ed9b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtNS0xLTEtMTQyNjgw_9605dd9b-bc19-4227-85ec-f0a99e1072ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock: $<ix:nonFraction unitRef="usdPerShare" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMC0xLTEtMTQyNjgwL3RleHRyZWdpb246Mzg1ZGE1YjFkODAyNDhmY2E4YTM4NWFmY2EyZmE5N2VfMTk_2e4d6422-2d4f-4f63-ad9a-8b7d3b87894a"><ix:nonFraction unitRef="usdPerShare" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMC0xLTEtMTQyNjgwL3RleHRyZWdpb246Mzg1ZGE1YjFkODAyNDhmY2E4YTM4NWFmY2EyZmE5N2VfMTk_e75b1039-3876-4b4c-838e-68c951fd5fa4">1.00</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMC0xLTEtMTQyNjgwL3RleHRyZWdpb246Mzg1ZGE1YjFkODAyNDhmY2E4YTM4NWFmY2EyZmE5N2VfMzM_84eff5d5-91cf-44a2-9373-551812a5c0a3"><ix:nonFraction unitRef="shares" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMC0xLTEtMTQyNjgwL3RleHRyZWdpb246Mzg1ZGE1YjFkODAyNDhmY2E4YTM4NWFmY2EyZmE5N2VfMzM_bcfe1819-ac2d-4c90-8bc7-96d237ec3701">750,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMC0xLTEtMTQyNjgwL3RleHRyZWdpb246Mzg1ZGE1YjFkODAyNDhmY2E4YTM4NWFmY2EyZmE5N2VfMjE5OTAyMzI1NTU3MDg_3ef0f892-4f70-4c2f-9459-90258ea9436c">130,741,461</ix:nonFraction> shares issued as of March&#160;31, 2023 and June&#160;30, 2022; and <ix:nonFraction unitRef="shares" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMC0xLTEtMTQyNjgwL3RleHRyZWdpb246Mzg1ZGE1YjFkODAyNDhmY2E4YTM4NWFmY2EyZmE5N2VfOTM_b6016922-275f-4803-8fc6-dc589171c542">123,611,466</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMC0xLTEtMTQyNjgwL3RleHRyZWdpb246Mzg1ZGE1YjFkODAyNDhmY2E4YTM4NWFmY2EyZmE5N2VfMTAw_21aa05d1-f9f8-403c-adc1-01684ebb9cc2">123,152,132</ix:nonFraction> shares outstanding as of March&#160;31, 2023 and June&#160;30, 2022, respectively</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMi0xLTEtMTQyNjgw_13277a6f-53e6-4475-9d04-afaab8d8ccf9">131</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItNS0xLTEtMTQyNjgw_e27e9189-8667-4009-a676-4d530d6e014a">131</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzMtMi0xLTEtMTQyNjgw_4d0c9f39-ae1a-4eae-860c-3d129e3d0fb7">1,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzMtNS0xLTEtMTQyNjgw_79f82477-0ac4-4290-811d-7d341da3550c">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzQtMi0xLTEtMTQyNjgw_1a681aef-560d-4a7e-b5a7-ef404d5069e6">415</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzQtNS0xLTEtMTQyNjgw_cd7ce281-41b0-4d1c-b0cf-bccfd86588d4">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost: <ix:nonFraction unitRef="shares" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzUtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZjE2ZDAxZDdiZDEyNGRiNWJjNmUxNTgxZWI0YjlhYTlfMjk_de3947b9-947e-43b4-9156-80a77f4b4b84">7,129,995</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzUtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZjE2ZDAxZDdiZDEyNGRiNWJjNmUxNTgxZWI0YjlhYTlfMzY_031f9d34-6b7c-40b5-8f46-fa0c4c86eded">7,589,329</ix:nonFraction> shares as of March&#160;31, 2023 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and June&#160;30, 2022, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzUtMi0xLTEtMTQyNjgw_f12d2f2c-a433-4aca-b2e3-38709b9e0de5">1,277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzUtNS0xLTEtMTQyNjgw_db4ade20-1db6-4c17-a2b3-93db33578478">1,346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive net (loss) income</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzYtMi0xLTEtMTQyNjgw_2bf661fe-f368-425c-936c-dd3755dad5fb">498</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzYtNS0xLTEtMTQyNjgw_c3fb2c14-7267-40aa-a572-90ffbcd2b314">479</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Clorox stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzctMi0xLTEtMTQyNjgw_ad39702a-ba23-4b06-b40d-851b414cd338">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzctNS0xLTEtMTQyNjgw_382213e2-b5b8-4edb-9706-7cf3022699dd">556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzgtMi0xLTEtMTQyNjgw_c69e75eb-20f1-4a1e-8177-2de73642b476">169</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzgtNS0xLTEtMTQyNjgw_261308c5-a82c-4ceb-9edb-5956bf8c063b">173</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzktMi0xLTEtMTQyNjgw_d314f11d-66fd-4ccf-b0db-d87424e05d98">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzktNS0xLTEtMTQyNjgw_f15878b6-083e-4d0d-9466-1f6971af5a2e">729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNDAtMi0xLTEtMTQyNjgw_79b21131-09ea-497c-9700-38b3c2c6088b">5,818</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNDAtNS0xLTEtMTQyNjgw_f4fa03c8-c290-4288-a32b-0a8e03df5123">6,158</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span><br/></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Cash Flows (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in millions)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:67.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMy0yLTEtMS0xNDI2ODA_938beac9-e990-430b-b97c-2f25dde3bb1d">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMy01LTEtMS0xNDI2ODA_16d9559b-c86a-40e1-82f7-fd28dcd60e21">367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings (losses) to net cash provided by operations:</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfNS0yLTEtMS0xNDI2ODA_39095dae-c63d-4006-a3f3-45c1d6ceb40f">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfNS01LTEtMS0xNDI2ODA_5d0436ed-fe2f-478d-b568-69680cb2c5a5">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfNi0yLTEtMS0xNDI2ODA_36fe5a93-998f-467b-8f56-ce73570c642f">60</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfNi01LTEtMS0xNDI2ODA_69d49bfc-c348-44cf-b1ec-9af46253466a">44</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfNy0yLTEtMS0xNDI2ODA_084c95e2-9c07-40d1-9d11-6b406ec9dd54">122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfNy01LTEtMS0xNDI2ODA_60d991d1-2ec2-43ff-950f-7109086939f5">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, trademark and other asset impairments</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfOC0yLTEtMS0xNDI2ODA_f5ffc73b-cc8a-4aed-91de-cf39eda598db">445</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfOC01LTEtMS0xNDI2ODA_46ac45be-5e4c-4bc7-a9a0-45619f4559d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfOS0yLTEtMS0xNDI2ODA_91614697-6347-4c3b-9a57-112988d3eddf">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfOS01LTEtMS0xNDI2ODA_b7e23196-cdcc-4eb9-8b19-15702b8d9858">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in:</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTEtMi0xLTEtMTQyNjgw_270ccc53-9757-4516-9ae6-a15c91438b5d">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTEtNS0xLTEtMTQyNjgw_6939e7a8-2951-419a-9066-e6e2f9e5c956">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTItMi0xLTEtMTQyNjgw_92bd558e-c340-4565-9c58-d7d5b3ec8f86">13</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTItNS0xLTEtMTQyNjgw_9d493104-e935-4840-b044-0dbfe96ebcdb">53</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTMtMi0xLTEtMTQyNjgw_c04a52cd-11f8-4d54-ac22-8e9852f3131c">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTMtNS0xLTEtMTQyNjgw_0e530741-2377-4f39-a1f3-f417de02de30">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTQtMi0xLTEtMTQyNjgw_40628124-b7ea-44a9-b06a-17d03dbd0c50">78</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTQtNS0xLTEtMTQyNjgw_36951136-0fd8-4d44-be07-0ec1bab272d0">93</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets and liabilities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="clx:OperatingLeaseRightofUseAssetAndLiabilityNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTUtMi0xLTEtMTQyNjgw_1896a9a0-2a57-4557-b5f3-5383fa448ff3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="clx:OperatingLeaseRightofUseAssetAndLiabilityNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTUtNS0xLTEtMTQyNjgw_ab903e7d-825c-407f-9629-12b64d0883ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable / prepaid</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTYtMi0xLTEtMTQyNjgw_99c0e013-bd78-482f-9b62-2e285f2ab1a0">80</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTYtNS0xLTEtMTQyNjgw_e6f12ca8-f8c0-4257-8df1-358c644babab">55</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operations</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTctMi0xLTEtMTQyNjgw_201a0989-57b3-4683-8f5b-ef2abb0c20f2">728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTctNS0xLTEtMTQyNjgw_9c16011c-9d1b-40b2-8417-b3a32ba5e16e">451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTktMi0xLTEtMTQyNjgw_82ec436f-13d5-46cb-978e-38ad44394874">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTktNS0xLTEtMTQyNjgw_2d513022-d637-4312-a9bb-25c2db8c0f90">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjEtMi0xLTEtMTQyNjgw_d7bad51a-c0cc-4860-aa37-150e91a8bf81">2</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjEtNS0xLTEtMTQyNjgw_db24219a-b5d8-4350-9f1b-fd9ac2266cd7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjItMi0xLTEtMTQyNjgw_78b29ee8-ea95-4cc6-a094-c533d5177868">142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjItNS0xLTEtMTQyNjgw_c7ff23bf-e752-425c-9013-201bffbff795">167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjQtMi0xLTEtMTQyNjgw_071a3c1c-5fcb-40da-99d5-fcd05c00dd42">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjQtNS0xLTEtMTQyNjgw_19c537d7-091b-493e-bafa-3aba1ba08ebb">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt repayments</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjUtMi0xLTEtMTQyNjgw_beacd2ed-54c4-4d2a-99f5-dabf3813ae21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjUtNS0xLTEtMTQyNjgw_8e0706e1-d5c9-4cfa-96fd-56493f8c7956">300</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjYtMi0xLTEtMTQyNjgw_f8f9a99b-ce3d-47e8-9710-d0af011ef6aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjYtNS0xLTEtMTQyNjgw_2b186575-c8ab-4959-b0a0-a020fca958f8">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends paid to Clorox stockholders</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjctMi0xLTEtMTQyNjgw_9490a31a-edab-45c3-9492-58154a689f24">437</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjctNS0xLTEtMTQyNjgw_cccd4950-e719-4f5b-ad03-cc3a59e48017">428</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends paid to noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjgtMi0xLTEtMTQyNjgw_25aa674b-af63-4b8a-b32b-b9e5b81f1d11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjgtNS0xLTEtMTQyNjgw_34276372-1fba-42e6-a58d-c7573b6b2adf">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock for employee stock plans and other</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjktMi0xLTEtMTQyNjgw_5d3ea8d2-5bb5-4cd3-8204-fd847e80f4f1">10</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjktNS0xLTEtMTQyNjgw_2f180f55-797e-4996-b5b6-e063dfcac9f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzAtMi0xLTEtMTQyNjgw_4478b70b-3796-4aa8-baa2-f50ba51d2570">526</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzAtNS0xLTEtMTQyNjgw_198df0d3-6219-4b09-a4d0-391544e50d5e">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzEtMi0xLTEtMTQyNjgw_53fb538c-dc40-4527-8c8f-6a85e72ba99b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzEtNS0xLTEtMTQyNjgw_26804a4d-3658-4863-ab53-a4e100374766">2</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzItMi0xLTEtMTQyNjgw_b3d526ba-80aa-4652-a760-bdf9b3d8d30f">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzItNS0xLTEtMTQyNjgw_eeb16198-88e7-4d20-a3e9-35588371e0cc">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash:</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzQtMi0xLTEtMTQyNjgw_f1c37126-23d2-44c6-8e41-1aa961b0a951">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38db454957ae42d1a879575c446b836f_I20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzQtNS0xLTEtMTQyNjgw_9db9b1e3-f4aa-475c-abf1-bea8f4cb79a8">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period</span></td><td colspan="3" style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzUtMi0xLTEtMTQyNjgw_52105ac4-14ed-48e8-bc9a-a80336c64182">246</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf74c279d583412eaba0df33f84a8dd7_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzUtNS0xLTEtMTQyNjgw_eea36ce5-2807-4553-b1f0-fe6cc063fd9a">243</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in millions, except per share data) </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xOS9mcmFnOjNiOGYwYTNmZDgwMTQ5NmZiMDA4YWJkNTQ0MDcyNTM3L3RleHRyZWdpb246M2I4ZjBhM2ZkODAxNDk2ZmIwMDhhYmQ1NDQwNzI1MzdfMzQ4Ng_cb9aab05-a505-4d8a-bbd9-4931f6545f41" continuedAt="ibfebf564251543b09b5823cd601d7c03" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="ibfebf564251543b09b5823cd601d7c03" continuedAt="i6fc929cf61f14183a73980500e5b8116"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xOS9mcmFnOjNiOGYwYTNmZDgwMTQ5NmZiMDA4YWJkNTQ0MDcyNTM3L3RleHRyZWdpb246M2I4ZjBhM2ZkODAxNDk2ZmIwMDhhYmQ1NDQwNzI1MzdfMzQ4Nw_def32fc4-1b1f-455a-9d40-6ee13c738780" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements for the three and nine months ended March 31, 2023 and 2022, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2022, which includes a complete set of footnote disclosures, including the Company&#8217;s significant accounting policies.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xOS9mcmFnOjNiOGYwYTNmZDgwMTQ5NmZiMDA4YWJkNTQ0MDcyNTM3L3RleHRyZWdpb246M2I4ZjBhM2ZkODAxNDk2ZmIwMDhhYmQ1NDQwNzI1MzdfMzQ4OQ_8094cc76-a897-44de-a063-cb033992c097" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Liabilities</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurs restructuring costs in connection with workforce reductions; consolidation or closure of a facility; sale or termination of a line of business; and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records employee termination liabilities once they are both probable and estimable for severance provided under the Company&#8217;s existing severance policy. Employee termination liabilities outside of the Company&#8217;s existing severance policy are recognized at the time relevant employees are notified, unless the employees will be retained to render service beyond a minimum retention period for transition purposes, in which case the liability is recognized ratably over the future service period. Other costs associated with a restructuring plan or exit or disposal activities, such as consulting and professional fees, facility exit costs, employee relocation, outplacement costs, accelerated depreciation or asset impairments associated with a restructuring plan, are recognized in the period in which the liability is incurred or the asset is impaired.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xOS9mcmFnOjNiOGYwYTNmZDgwMTQ5NmZiMDA4YWJkNTQ0MDcyNTM3L3RleHRyZWdpb246M2I4ZjBhM2ZkODAxNDk2ZmIwMDhhYmQ1NDQwNzI1MzdfMzEzMzYwODE0MTA5ODQ_5e7ea81c-08a2-48df-b5e4-8c20d2531510" continuedAt="ie1261902e5bc4476ba8afa8d4ca1451a" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment Review of Goodwill and Indefinite-Lived Intangible Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests its goodwill, trademarks with indefinite lives and other indefinite-lived intangible assets annually for impairment in the fiscal fourth quarter unless there are indications during a different interim period that these assets may have become impaired.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to goodwill, the Company has the option to first assess qualitative factors, such as the maturity and stability of the reporting unit, the magnitude of the excess fair value over carrying value from a previous period&#8217;s impairment testing, other reporting unit specific operating results, microeconomic and macroeconomic factors, as well as new events and circumstances impacting the operations at the reporting unit level. The Company operates through strategic business units (SBUs) that are organized into the Company&#8217;s operating segments. Reporting units for goodwill impairment testing purposes were identified as the Company&#8217;s individual operating segments. If the result of a qualitative test indicates a potential for impairment of a reporting unit, a quantitative test is performed. In the quantitative test, the Company compares the estimated fair value of the reporting unit to its carrying value. If the estimated fair value of any reporting unit is less than its carrying value, an impairment charge is recorded for the difference between the carrying value and the fair value of the reporting unit. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the fair value of a reporting unit as part of its quantitative test, the Company uses the discounted cash flow (DCF) method under the income approach, as it believes that this approach is the most reliable indicator of the fair value of its businesses and the fair value of its future earnings and cash flows. Under this approach, which requires significant judgments, the Company estimates the future cash flows of each reporting unit and discounts these cash flows at a rate of return that reflects their relative risk. The cash flows used in the DCF method are consistent with those the Company uses in its internal planning, which gives consideration to actual business trends experienced, and the broader business strategy for the long term. The other key estimates and factors used in the DCF method include, but are not limited to, net sales and expense growth rates, commodity prices, foreign exchange rates, inflation and a terminal growth rate. Changes in such estimates or the application of alternative assumptions could produce different results. </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6fc929cf61f14183a73980500e5b8116"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie1261902e5bc4476ba8afa8d4ca1451a">For trademarks and other intangible assets with indefinite lives, the Company has the option to first assess qualitative factors, such as the maturity and stability of the trademark or other intangible asset, the magnitude of the excess fair value over carrying value from a previous period&#8217;s impairment testing, other specific operating results as well as new events and circumstances impacting the significant inputs used to determine the fair value of the intangible asset. If the result of a qualitative test indicates that it is more likely than not that the asset is impaired, a quantitative test is performed. When a quantitative test is performed, the estimated fair value of an asset is compared to its carrying value. If the carrying value of such asset exceeds its estimated fair value, an impairment charge is recorded for the difference between the carrying value and the estimated fair value. The Company uses the DCF method under the relief from royalty income approach to estimate the fair value of its trademarks and other intangible assets with indefinite lives. This approach requires significant judgments in determining the royalty rates and the assets&#8217; estimated cash flows, as well as the appropriate discount and foreign exchange rates applied to those cash flows to determine fair value. Changes in such estimates or the use of alternative assumptions could produce different results.</ix:continuation></span></div><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xOS9mcmFnOjNiOGYwYTNmZDgwMTQ5NmZiMDA4YWJkNTQ0MDcyNTM3L3RleHRyZWdpb246M2I4ZjBhM2ZkODAxNDk2ZmIwMDhhYmQ1NDQwNzI1MzdfMzQ5Nw_0f586d3b-c7b3-43b8-8df9-40693fb68521" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#8221; These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations.&#160;These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. As these amendments relate to disclosures only, there are no impacts expected to the Company&#8217;s consolidated results of operations, financial position and cash flows.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div id="i35f8305358714061a46930a84f00a8d0_22"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfMjM0Ng_f1927191-0a16-45fd-984c-596d65c185e6" continuedAt="i470fd44e518341e4a8010b1e18b6ee72" escape="true">RESTRUCTURING AND RELATED COSTS</ix:nonNumeric></span></div><ix:continuation id="i470fd44e518341e4a8010b1e18b6ee72" continuedAt="ia47fc67a2cf74dc6905270d374b501b2"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2023, the Company began recognizing costs related to a plan that involves streamlining its operating model to meet its objectives of driving growth and productivity. The streamlined operating model is expected to enhance the Company&#8217;s ability to respond more quickly to changing consumer behaviors and innovate faster. The Company anticipates the implementation of this new model will be completed in fiscal year 2024, with different phases occurring throughout the implementation period.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company anticipates incurring approximately $<ix:nonFraction unitRef="usd" contextRef="id7a142fe888d4dbf8b9d78f7d4a764bd_I20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfNjE4_e390c283-34f7-4206-a18c-31b65728fcaf">75</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="icca7cfce0fa141dea44cb9ce7a326899_I20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfNjI0_db29fb23-40de-4eb7-8163-ca4dd8c1fd51">100</ix:nonFraction> of costs in fiscal years 2023 and 2024 related to this initiative. Of this total amount, the higher-end of the range of approximately $<ix:nonFraction unitRef="usd" contextRef="i06d000a1aa834bbfac4282e34d583a60_I20230630" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfNzE3_9830c241-ef15-4a37-b38b-fa2f11601f45">40</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="ib2c8765c01654490b2b1c05a7f10e95c_I20230630" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfNzIz_7d97b1c6-9e2c-4786-a74a-378a6bf62bbc">60</ix:nonFraction> is expected to be incurred in fiscal year 2023. Related costs are primarily expected to include employee-related costs to reduce certain staffing levels such as severance payments, as well as for consulting and other costs. Costs incurred are expected to be settled primarily in cash.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related implementation costs, net were $<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfMTA2OA_dcc9dc52-31b7-4f54-80fa-c7bf33bc21a5">21</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfMTA3NQ_89c59f32-75ca-4079-ba38-598d891611f8">44</ix:nonFraction> for the three and nine months ended March&#160;31, 2023, respectively. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfMjM0Mg_7d6afba9-520d-4c10-bf6a-0ba78d6664c3" continuedAt="i9c208080d0b24e66a04011a575fb7c1e" escape="true">The following table summarizes the total restructuring and related implementation costs, net associated with the Company&#8217;s streamlined operating model plan as reflected in the Consolidated Statements of Earnings and Comprehensive Income.</ix:nonNumeric></span></div><div><ix:continuation id="i9c208080d0b24e66a04011a575fb7c1e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.615%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">3/31/2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Costs of products sold</span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i3aa3d22372b64584acb9882537a6dd42_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfMi0xLTEtMS0xNDI2ODA_14b19232-e3ca-4ce8-852e-5144b8af26a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(<ix:nonFraction unitRef="usd" contextRef="iba59125bcc944eaab44b48bc55a3dc85_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfMi01LTEtMS0xNDI2ODA_2e563ad2-d8b7-4adb-8c28-d20ed0648378">1</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Selling and administrative expenses</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i9ded3b682518451f87217f49e6d97925_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfMy0xLTEtMS0xNDI2ODA_c5fd0d30-2a6e-4787-b750-9d948d648c83">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i6f615042f4614c5ca2aa6f2698e2ecdc_D20220701-20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfMy01LTEtMS0xNDI2ODA_03f8a72e-8a50-498f-a226-32ba53224a8c">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Other (income) expense, net:</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Employee-related costs</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i36e02fa510054f06be615621c9bd2ecd_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfNS0xLTEtMS0xNDI2ODA_bebe88a6-2660-49ae-aa06-f2ecce7c041b">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="iad19817ded2e45cb9d95810868eafeea_D20220701-20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfNS01LTEtMS0xNDI2ODA_b4bdbe72-0195-4e57-af54-3b5a1838148f">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Total, net</span></div></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfOC0xLTEtMS0xNDI2ODA_f9208291-4f59-4c6f-a70c-03c032d63159">21</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfOC01LTEtMS0xNDI2ODA_255c10b2-6230-41bc-8f20-300f8997474e">44</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee-related costs primarily include severance and other termination benefits calculated based on salary levels, prior service and statutory requirements. Other costs primarily include consulting fees incurred for the organizational design and implementation of the future streamlined operating model, related processes and other professional fees incurred. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges for restructuring and related implementation costs are recorded in the Corporate segment as these initiatives are centrally directed and controlled and are not included in internal measures of segment operating performance.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia47fc67a2cf74dc6905270d374b501b2"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, from time to time, decide to pursue additional restructuring-related initiatives that involve costs in future periods. </span></div><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfMjM0NQ_ccc986cd-0f95-4bbe-a7b4-c0ebad69fd96" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reconcile the accrual for the streamlined operating model restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the Consolidated Balance Sheets:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Employee-Related Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of December 31, 2022</span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="id690da8b06c34b2db6496eb0743cd318_I20221231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMi0xLTEtMS0xNDI2ODA_0919dffc-019d-4076-a656-cc690758ece8">13</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="idb802f1785e94392ab45e3ccd217a284_I20221231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMi0zLTEtMS0xNDI2ODA_d5a1c2a3-01c1-4372-b3d0-d0bf36c8cbe4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i058a79b88ddf43df8b916f862dfc5bf7_I20221231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMi01LTEtMS0xNDI2ODA_f4f60267-8cee-4d58-8018-fb3ff27e7271">15</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Charges</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i0ae0d275a3c3490d8d3fad6bff44ecc3_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMy0xLTEtMS0xNDI2ODA_67812f8d-8136-48bb-a239-95a3a4e9e890">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i7a1d7d8632bd40d6918c50fe8c44ac85_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMy0zLTEtMS0xNDI2ODA_6d34e38b-d5e1-40be-8a43-9b6d8a8be5fe">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMy01LTEtMS0xNDI2ODA_f51f11cd-792c-4ca9-8463-8acc1eb07b43">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Cash payments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(<ix:nonFraction unitRef="usd" contextRef="i0ae0d275a3c3490d8d3fad6bff44ecc3_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfNC0xLTEtMS0xNDI2ODA_c7f5ea67-ebf7-45ed-900d-167df0483a0e">10</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(<ix:nonFraction unitRef="usd" contextRef="i7a1d7d8632bd40d6918c50fe8c44ac85_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfNC0zLTEtMS0xNDI2ODA_288ddec4-50b4-442b-b2a9-697e131c7945">4</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfNC01LTEtMS0xNDI2ODA_51139bdb-00ac-40bc-a755-fbdbd71fa7dd">14</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of March 31, 2023</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c8da2bf20c490596a15b4866b80871_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfNi0xLTEtMS0xNDI2ODA_5588b4f8-aa5d-4026-8fe3-d3fdaacbce71">18</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i597c023bc1a04a0b99911d165820e8b0_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfNi0zLTEtMS0xNDI2ODA_833fd517-e3c5-45b4-aa04-6f3db32eec3a">5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfNi01LTEtMS0xNDI2ODA_50cf6536-c9fc-4747-a3b8-cc8aa6b26e5b">23</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Employee-Related Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of June 30, 2022</span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i51a13a9df4a44b17b6fe45952facdb9a_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTAtMS0xLTEtMTQyNjgw_36ad54b9-fce7-4c78-8cdc-081828c5722c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="ia25937b8293b44c98ede6be445bfbd4f_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTAtMy0xLTEtMTQyNjgw_2118681b-105d-44af-9aee-8eaeef91aa6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTAtNS0xLTEtMTQyNjgw_e75c4b21-fd90-4fb3-8710-3a249d5da961">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Charges</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i8f92c48a282547ff99ddf8f3b5d7f2f5_D20220701-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTEtMS0xLTEtMTQyNjgw_2c8b3af2-9916-45df-be85-278f4566f134">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i4dd70a15f7a94b8baa949563effef687_D20220701-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTEtMy0xLTEtMTQyNjgw_f69a11b2-c468-4cf5-bb20-930e495219e3">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTEtNS0xLTEtMTQyNjgw_81d3e507-cc46-4f74-b5f6-ba2bf808a19a">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Cash payments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(<ix:nonFraction unitRef="usd" contextRef="i8f92c48a282547ff99ddf8f3b5d7f2f5_D20220701-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTItMS0xLTEtMTQyNjgw_11ed2067-bf61-4047-b0c5-d7b1a376b904">16</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(<ix:nonFraction unitRef="usd" contextRef="i4dd70a15f7a94b8baa949563effef687_D20220701-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTItMy0xLTEtMTQyNjgw_27567169-680b-4b3b-93eb-a9caafbe3b48">9</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTItNS0xLTEtMTQyNjgw_7408b261-6b57-4c32-87ad-4e925c31525f">25</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of March 31, 2023</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c8da2bf20c490596a15b4866b80871_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTQtMS0xLTEtMTQyNjgw_e41a752e-ef87-4939-a99e-0f1adcfe6f3f">18</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i597c023bc1a04a0b99911d165820e8b0_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTQtMy0xLTEtMTQyNjgw_d5ce65ae-ba0a-4520-9b2e-22921ddc2db0">5</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTQtNS0xLTEtMTQyNjgw_b1c60135-1f54-4209-8777-c4259f77df37">23</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div id="i35f8305358714061a46930a84f00a8d0_25"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RleHRyZWdpb246MjA2NDhjMjNjYTk1NGFmYjg2ZmMxYzM0Zjc2MjA2YWFfMTQ4_a66041d1-1b20-45d6-be22-5aa962346a94" continuedAt="ie4f0161012f24eeab7b95a3bb36e8bfb" escape="true">INVENTORIES, NET</ix:nonNumeric></span></div><ix:continuation id="ie4f0161012f24eeab7b95a3bb36e8bfb"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RleHRyZWdpb246MjA2NDhjMjNjYTk1NGFmYjg2ZmMxYzM0Zjc2MjA2YWFfMTQz_47241666-4b07-45bc-8bc2-6ef83f5752fd" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net, consisted of the following as of:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfMS0xLTEtMS0xNDI2ODA_646f7124-0ecb-440b-bdf0-e45d4620d5ec">638</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfMS0zLTEtMS0xNDI2ODA_edb78187-5c56-4d4c-8429-ab9d4dc0cc88">593</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and packaging</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfMi0xLTEtMS0xNDI2ODA_4a31f428-7eac-4e29-bbda-84072d2cd690">185</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfMi0zLTEtMS0xNDI2ODA_33f7fd44-1398-469f-b8dd-55b6cea31df0">191</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfMy0xLTEtMS0xNDI2ODA_0617f197-17cf-401b-9e2f-37d260aa6643">13</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfMy0zLTEtMS0xNDI2ODA_047edb07-4817-4e5a-83c9-10243b3496d1">16</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIFO allowances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:InventoryLIFOReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNC0xLTEtMS0xNDI2ODA_51a4ac96-a939-40c0-a51e-12ed697cdc91">94</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:InventoryLIFOReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNC0zLTEtMS0xNDI2ODA_d85ac09e-17aa-4941-90cc-35e7e65ded3e">40</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="clx:InventoryCurrentAndNoncurrentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNS0xLTEtMS0xNDI2ODA_9d0ad178-6383-4ab7-93f2-0f09c504a022">742</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="clx:InventoryCurrentAndNoncurrentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNS0zLTEtMS0xNDI2ODA_6232126e-a9eb-4dd4-8a68-174b5ddcf0e3">760</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncurrent inventories, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNi0xLTEtMS0xNDI2ODA_1fca02fe-6333-4f67-9d61-cd5031f98025">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNi0zLTEtMS0xNDI2ODA_0c7c95f2-9531-4852-9118-6782ffb932f2">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current inventories, net</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNy0xLTEtMS0xNDI2ODA_f02ea26a-256c-4416-a98f-e9f58c386e40">735</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNy0zLTEtMS0xNDI2ODA_9de7b607-fd32-4f3a-a9c3-f41e0f46fc57">755</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Noncurrent inventories, net is recorded in Other assets.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_1026"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8zMTMzNjA4MTQxMzc2MA_86133c3d-8091-4d10-a13c-7c8b38f30e51" continuedAt="i58f5dfe78baa4b8788e9455fe5f254a0" escape="true">GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS</ix:nonNumeric></span></div><ix:continuation id="i58f5dfe78baa4b8788e9455fe5f254a0" continuedAt="ide6de336c0d843c281d32095e78a71dc"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal year 2023, management made a decision to narrow the focus on core brands and streamline investment levels in the Vitamins, Minerals and Supplements (VMS) business. As a result, revisions were made to the internal financial projections and operational plans of the VMS business reflecting the Company&#8217;s current estimates regarding the future financial performance of these operations and macroeconomic factors. The revised estimated future cash flows reflect lower sales growth expectations and lower investment levels. These revisions were considered a triggering event requiring interim impairment assessments to be performed as part of the preparation of the quar</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">terly financial statements on the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">global indefinite-lived trademarks, other long-term assets and the VMS reporting unit.</span></div><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8zMTMzNjA4MTQxMzc2MQ_206736c8-442a-48c1-a128-3606bfdd6db6" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the outcome of these assessments, the following pre-tax, non-cash impairment charges were recorded:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impairment Charges</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VMS reporting unit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International reporting unit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id94ba9c2186c47749a192c36f50af6e2_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl8xLTEtMS0xLTE1NjYwNg_3845dc39-1bfd-48ca-a85d-c2b5d89132ee">306</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if866eca78fc44cb985650980c0effb9e_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl8yLTItMS0xLTE1NzY5OQ_f65cca5a-596d-4a5c-a5b5-1862818785a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl8yLTMtMS0xLTE1NzcwNw_508ad3e5-27e0-4a9d-93c3-c77f0f2ec8fc">306</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id94ba9c2186c47749a192c36f50af6e2_D20230101-20230331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl8yLTEtMS0xLTE1NjYwNg_454227ff-b504-476f-a3cd-5d381baf4853">127</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if866eca78fc44cb985650980c0effb9e_D20230101-20230331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl8zLTItMS0xLTE1NzY5OQ_14b64992-2760-4032-aaa1-833b7c0459f0">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl8zLTMtMS0xLTE1NzcwNw_9ffb9866-4a06-4a3b-9607-7ed49e671c27">139</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id94ba9c2186c47749a192c36f50af6e2_D20230101-20230331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl81LTEtMS0xLTE1NjYwNg_6dd17bf2-568e-44fa-b5d4-fda0ca4db47d"><ix:nonFraction unitRef="usd" contextRef="i14a182d0cd5c4d15965a7e7a7bfdc653_D20220701-20230331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl81LTEtMS0xLTE1NjYwNg_6fd3cc3e-103e-4b62-8c50-8dc7bd860468">433</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if866eca78fc44cb985650980c0effb9e_D20230101-20230331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl82LTItMS0xLTE1NzY5OQ_0480a602-616f-4c59-88d9-3d687e0ba797"><ix:nonFraction unitRef="usd" contextRef="i1963ee82a44d46ffa8708d4e456f329c_D20220701-20230331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl82LTItMS0xLTE1NzY5OQ_437d4512-7080-4ae5-8322-4e1cfeaaea89">12</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl82LTMtMS0xLTE1NzcwNw_81a1d7a9-124b-431c-9584-c244e13453f3">445</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with recognizing these impairment charges, the Company recognized tax benefits related to the impairments of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="clx:ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV81NDk3NTU4MzU3NDg_2ac47263-dbd6-469e-be59-8a28f67eb66f">83</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> due to the partial tax deductibility of these charges. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the estimated fair values of the global indefinite-lived trademarks related to the VMS business, the Company used the DCF method under the relief from royalty income approach. This approach requires significant judgments in determining the royalty rates and the assets&#8217; estimated cash flows as well as the appropriate discount rates applied to those cash flows to determine fair value. As a result of the interim impairment test, the Company concluded that the carrying value of the global indefinite-lived trademarks exceeded their estimated fair value, and recorded impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i2f45254db7c44fd7baa3242ec875ed30_D20220701-20230331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV81NDk3NTU4MzU3ODM_224a14ea-cc36-4c22-b1a2-9c87e1c02e3b">139</ix:nonFraction>. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the useful lives of the impaired trademarks, with a remaining net carrying value of $<ix:nonFraction unitRef="usd" contextRef="i30dd390ea6b04c08a6b35540c0fd90d5_I20230331" decimals="-6" name="clx:IndefiniteLivedIntangibleAssetsRemainingCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV81NDk3NTU4MzU3OTA_62fc8e6d-1ecf-420b-8c87-dfdf2cf4fc9b">28</ix:nonFraction> as of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> March 31, 2023, were changed from indefinite to definite beginning on April 1, 2023, which reflects the remaining expected useful lives of the trademarks based on the most recent financial and operational plans. The weighted-average estimated useful life of these trademarks is <ix:nonNumeric contextRef="if51281e120fb4c9aa9d0c0f419704d3e_D20220701-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV80Mzk4MDQ2NTQyNzQ4_f77cd5d9-7404-4b1f-a385-ef0422543a51">20</ix:nonNumeric> years.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After adjusting the carrying</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">values of the global indefinite-lived trademarks and concluding that the carrying amounts of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the other long-lived assets were recoverable, the Company completed a quantitative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impairment test for goodwill and recorded a goodwill impairment charge of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="id94ba9c2186c47749a192c36f50af6e2_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV81NDk3NTU4MzU3NzM_cf4f2ffe-c614-4b08-a5fd-f0e30625ad4d">306</ix:nonFraction> i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n the VMS reporting unit. To determine the fair value of the VMS reporting unit, the Company used a DCF method under the income approach. In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accordance with this approach, the Company estimated the future cash flows of the VMS reporting unit and discounted these cash flows at a rate of return that reflects its relative risk. The other key estimates and factors used in the DCF method include,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">but are not limited to, net sales and expense growth rates and a terminal growth rate. The decrease in projected cash flows due to the revisions adversely impacted key assumptions used</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in determining the fair value of the VMS reporting unit and assets contained therein, primarily projected net sales</span><span style="background-color:#ffffff;color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no remaining goodwill associated with the impaired reporting unit.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No triggering events were identified in the fiscal quarter ended March&#160;31, 2023 that would more likely than not reduce the fair value of the International reporting unit below its carrying value through March&#160;31, 2023. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ide6de336c0d843c281d32095e78a71dc" continuedAt="i25fc6f320ac2417ca4eabf8a8d6b42fc"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8zMTMzNjA4MTQxMzc2Mg_1343eab0-3f2e-44ae-8797-ffa0ca17ca20" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of Goodwill as of March&#160;31, 2023 from June&#160;30, 2022, were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Goodwill</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc9854de4e3c4c0985eef6728fd978cf_I20220630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18yLTEtMS0xLTE1NjY0Mg_9c216648-7bf2-4816-b518-e1f631f123fb">629</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2cff198bfe644e0a8fb1825c00677d3_I20220630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18yLTMtMS0xLTE1NjY0Mg_f07f9deb-5e6b-4ab9-8d5b-89187c8c3f23">85</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie62ad774357041f9ae5c145530854b8e_I20220630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18yLTUtMS0xLTE1NjY0Mg_2dd47839-c530-4d0b-a017-e81d423089f7">244</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e18cafffa494d9cb9daca6284175f4f_I20220630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18yLTctMS0xLTE1NjY0Mg_12a0132b-6ddf-4d13-ac5a-a036111f6951">600</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18yLTktMS0xLTE1NjY0Mg_f000501e-2301-4fe1-a027-c9ecfb619e91">1,558</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72eb4644e3f447fe8259fdad6f8dde47_D20220701-20220930" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY180LTEtMS0xLTE1NjY0Mg_edf8bded-71a4-4f46-870d-fc1f4ebe9adc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6d75e5aa7b47e588ee1b82de531670_D20220701-20220930" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY180LTMtMS0xLTE1NjY0Mg_aa0fd859-0f4b-4bba-a93e-e0149fd5b11f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791d5f02e170464bb461195b53387d4d_D20220701-20220930" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY180LTUtMS0xLTE1NjY0Mg_563b7f95-33f2-4ae9-914c-7affb3500b9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i614e96f28f6b441c978c88983621bfff_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY180LTctMS0xLTE1NjY0Mg_99d775d5-6040-4380-b30f-7705d91b65f4">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic42f71e1a2c44eb8bfbfca5078fdca23_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY180LTktMS0xLTE1NjY0Mg_4a61c1b9-c9c9-4902-9323-46340fcbdfbe">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a5483738f5a46b9a4300446be65ea03_I20220930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY181LTEtMS0xLTE1NjY0Mg_15071db5-15f5-4ade-b26f-9a54b36696fa">629</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8d385e83a0148869431bc29b025489b_I20220930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY181LTMtMS0xLTE1NjY0Mg_4f874c92-5e8e-4a3a-92cf-74fcda48daf0">85</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521e232ee0064169882cd1c6588b7510_I20220930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY181LTUtMS0xLTE1NjY0Mg_7a1ca5e4-16af-4891-b26d-2519410b6981">244</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85730fdfbb9c48a58317696007eac6f3_I20220930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY181LTctMS0xLTE1NjY0Mg_71e223c1-7df8-4ed9-875f-6c257f57a0c8">589</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i660f20ab0c1946359ba21c70908a1443_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY181LTktMS0xLTE1NjY0Mg_6524aba2-f149-47b9-b6ae-c68e0d6a2d5b">1,547</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf58e03903bd40ebbfded435df15b857_D20221001-20221231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY182LTEtMS0xLTE1NjY0Mg_a9f94e56-9b03-4a9d-886c-9614f898207d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ff79fb466cf4f528c2057c39855c6fc_D20221001-20221231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY182LTMtMS0xLTE1NjY0Mg_67298882-0ed3-4f2a-b145-fa88eb54e5b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61861cccc66e4af39cd5f905d2e6e973_D20221001-20221231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY182LTUtMS0xLTE1NjY0Mg_eec9ff58-c4b6-4663-9035-d0c79ad060ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2260b79bc57d4a56a8a43db5b050892e_D20221001-20221231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY182LTctMS0xLTE1NjY0Mg_e79fb0a9-c100-488b-a5f1-61cc451d9049">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81dc710789a4279b293057273b0585e_D20221001-20221231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY182LTktMS0xLTE1NjY0Mg_5df1bea3-1338-4158-a2f5-ccc8e493fbef">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec0696cfea245148b8cb3ed95489d83_I20221231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY183LTEtMS0xLTE1NjY0Mg_bd43d1c6-71f4-46c8-bb4b-3d9be9030a6e">629</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e028c529aca4fe2a5bc96136e9b1d3d_I20221231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY183LTMtMS0xLTE1NjY0Mg_c33b273a-a087-48b6-841f-465238eb8975">85</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db36ab2a08e4e5e9acec297698a1d58_I20221231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY183LTUtMS0xLTE1NjY0Mg_1afbef21-3c20-48cc-aad4-0d93c164ea31">244</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4931a784644dbc9654624dc6378c3d_I20221231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY183LTctMS0xLTE1NjY0Mg_76a02de0-12b7-4f96-8a6b-3c9dd55d978c">595</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i058a79b88ddf43df8b916f862dfc5bf7_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY183LTktMS0xLTE1NjY0Mg_4cdf971e-acc8-407f-ade7-8989a24f61bd">1,553</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i974dd2e411d44a7387a3a78f3494eff1_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY184LTEtMS0xLTE1NjY0Mg_c75a5e53-0c6e-49bc-bcd5-269e379e30c1">306</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6881da3a99458c8448602633dde541_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY184LTMtMS0xLTE1NjY0Mg_6ab8ee50-1f73-47e4-9b16-462994791bf5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a5033b4e8dd41c2a30bdc0f5f38c4d7_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY184LTUtMS0xLTE1NjY0Mg_af033dce-5018-4800-a916-1881f18b2dae">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b73e43b25f6458dbd1f98100fb99374_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY184LTctMS0xLTE1NjY0Mg_5dca7142-f374-4039-af50-46da58b93b36">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY184LTktMS0xLTE1NjY0Mg_dd8f08f3-1cf6-45e5-b7f6-5b711c119ec3">306</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i974dd2e411d44a7387a3a78f3494eff1_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY185LTEtMS0xLTE1NjY0Mg_7ddec035-9065-4039-9da5-e5188ec687ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6881da3a99458c8448602633dde541_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY185LTMtMS0xLTE1NjY0Mg_ef67ccaf-369a-476d-9f3e-aa9c379e13a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a5033b4e8dd41c2a30bdc0f5f38c4d7_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY185LTUtMS0xLTE1NjY0Mg_45754bcb-a7a0-46fc-a721-5728ecf65849">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b73e43b25f6458dbd1f98100fb99374_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY185LTctMS0xLTE1NjY0Mg_aa13974e-e825-43f3-9ede-37c724af0d72">3</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY185LTktMS0xLTE1NjY0Mg_92c5b84c-c74e-419c-b6ff-79c9e1718856">3</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ccd04fdd2047da9e06c4f3f203df6e_I20230331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18xMC0xLTEtMS0xNTY2NDI_b58c39c8-42df-44b9-a67c-55efa77c11bc">323</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553b47cda5624d2b9e5b9b4464cbf54b_I20230331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18xMC0zLTEtMS0xNTY2NDI_c4db89fc-ebac-48e0-8f16-0d3bef289d24">85</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97da66cd682045d0a6cf64a53511a50f_I20230331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18xMC01LTEtMS0xNTY2NDI_1d48b947-e0db-4460-8183-1141e6208400">244</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491dec08e3a04e15884928a98985d9ed_I20230331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18xMC03LTEtMS0xNTY2NDI_51cec9eb-ca49-49e9-b941-063cf805fcdb">598</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18xMC05LTEtMS0xNTY2NDI_aa6f4a67-8553-4b51-8c22-18835d04a300">1,250</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8zMTMzNjA4MTQxMzc2Mw_1a0e711d-e3f5-4b1f-bf01-cfeb934a5b1b" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the carrying amount of trademarks and other intangible assets as of March&#160;31, 2023 and as of June&#160;30, 2022:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.702%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization / Impairments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization / Impairments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks not subject to amortization</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152e3a4caade4045835fdf23b4333786_I20230331" decimals="-6" name="clx:IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8yLTEtMS0xLTE1NjgxMg_25758375-3859-4fb9-9ea8-a30c922d873a">666</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f45254db7c44fd7baa3242ec875ed30_D20220701-20230331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8yLTMtMS0xLTE1NjgxMg_f977cb86-d0c0-4176-a1d9-6eb1f2ed7d45">139</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152e3a4caade4045835fdf23b4333786_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8yLTUtMS0xLTE1NjgxMg_dc82f3df-907d-4e99-b5f5-07cc8ec5c8bf">527</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8437cff6d6ba45528bcf1bb542174783_I20220630" decimals="-6" name="clx:IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8yLTctMS0xLTE1NjgxMg_c8cdbc51-b431-427e-be50-bee4e8a25e65">668</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia20a96df8ee1438397ac0e1012769f4a_D20210701-20220331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8yLTktMS0xLTE1NjgxMg_98ad2a09-4a54-4ce4-b197-1ec717d0d2e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8437cff6d6ba45528bcf1bb542174783_I20220630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8yLTExLTEtMS0xNTY4MTI_6e104966-3c34-4d73-9f20-3ee3e217247b">668</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks subject to amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30dd390ea6b04c08a6b35540c0fd90d5_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8zLTEtMS0xLTE1NjgxMg_d31d224e-8ab7-4653-879f-f0ca34b4e172">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30dd390ea6b04c08a6b35540c0fd90d5_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8zLTMtMS0xLTE1NjgxMg_451f4d9d-4624-4d07-b5cf-17d0fda6e56a">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30dd390ea6b04c08a6b35540c0fd90d5_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8zLTUtMS0xLTE1NjgxMg_cb3f227a-7015-42c6-b210-bb60809cf27c">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88cfb390480c455eb1a2978c32713180_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8zLTctMS0xLTE1NjgxMg_b60682a4-4948-4d66-8677-6ccca3b4def9">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88cfb390480c455eb1a2978c32713180_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8zLTktMS0xLTE1NjgxMg_37298f28-b67c-47b2-8c28-0b7a07de76b7">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88cfb390480c455eb1a2978c32713180_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8zLTExLTEtMS0xNTY4MTI_3c1b48e9-e20f-41ac-8641-3582869f8986">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38e791e368ab43409f15ba5e5f5cd67b_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl80LTEtMS0xLTE1NjgxMg_6ee344ae-d14e-4a66-abb3-0afabf3551d6">578</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38e791e368ab43409f15ba5e5f5cd67b_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl80LTMtMS0xLTE1NjgxMg_8ca5ac9f-f0cd-4843-8e1a-e77761fd49d0">402</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38e791e368ab43409f15ba5e5f5cd67b_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl80LTUtMS0xLTE1NjgxMg_5a63e890-6276-4bfc-9259-79ae36b1ba71">176</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0463f04d5ee3451b946c7af6a61845ef_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl80LTctMS0xLTE1NjgxMg_43a85aee-c454-4e5e-b94e-1fda5e4017cd">577</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0463f04d5ee3451b946c7af6a61845ef_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl80LTktMS0xLTE1NjgxMg_3f23b6af-0d5e-4ea1-b227-73cb55e2e83b">380</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0463f04d5ee3451b946c7af6a61845ef_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl80LTExLTEtMS0xNTY4MTI_df632b09-3995-4180-9ee9-d6a9b9f6fd47">197</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl81LTEtMS0xLTE1NjgxMg_86a9dc1f-2f69-444d-97b5-dd70f5541147">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl81LTMtMS0xLTE1NjgxMg_d8dc1fc8-2e43-46ca-a680-2297787fc518">578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl81LTUtMS0xLTE1NjgxMg_b7c2d69a-ade0-4dd0-9d14-0e23509277d9">722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl81LTctMS0xLTE1NjgxMg_b3f4102d-00b9-4efc-b6b6-fe78fe5f8312">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl81LTktMS0xLTE1NjgxMg_815c8bac-8e84-4f84-9c28-6bde695cd079">418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl81LTExLTEtMS0xNTY4MTI_9518be1b-b09f-4793-936e-2c32b1c1505b">884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i25fc6f320ac2417ca4eabf8a8d6b42fc">Amortization expense relating to the Company&#8217;s intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5MjY1_50097ed3-ec58-4fc3-b9f2-4c8e4bee3ec2">7</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5Mjcx_80b8c12e-b4f0-4dba-89fa-c3ca467c02df">22</ix:nonFraction> for the three and nine months ended March&#160;31, 2023, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5Mjc2_1832aa02-ae07-409b-884c-a4ca48f7ebc8">8</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5Mjgy_689f0fb9-ab1d-43dc-82c1-dc2122fcb4e8">24</ix:nonFraction> for the three and nine months ended March&#160;31, 2022, respectively. Estimated amortization expense for these intangible assets is $<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5MzIx_914ad836-1087-42d7-925b-e9b2c22776ee">8</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5MzI3_1f9a14c3-1459-49a8-b081-6fc8fa1da189">29</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5MzMz_a2c4d179-cd21-4af1-a298-633d116598e5">28</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5MzM5_87d2f786-1094-43d6-b2bf-087d851fb26b">28</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5MzQ1_091115b1-2095-4cc2-b3bc-b426e4d0a0ac">28</ix:nonFraction> for the remainder of fiscal year 2023 and fiscal years 2024, 2025, 2026 and 2027, respectively.</ix:continuation> </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div id="i35f8305358714061a46930a84f00a8d0_28"></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMTg5Mg_4c0db923-5b12-4607-97ed-1f46bcbf18f2" continuedAt="ib22458702db9425db7f0239307048042" escape="true">OTHER LIABILITIES</ix:nonNumeric></span></div><ix:continuation id="ib22458702db9425db7f0239307048042"><div style="margin-bottom:8pt;margin-top:8pt"><span id="i5f09d63c9cd64157bb33befdd9640676_1908"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Venture Agreement</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an agreement with The Procter &amp; Gamble Company (P&amp;G) for the Company&#8217;s Glad bags and wraps business. In connection with this agreement, P&amp;G provides research and development (R&amp;D) support to the Glad business. As of March&#160;31, 2023 and June&#160;30, 2022, P&amp;G had a <ix:nonFraction unitRef="number" contextRef="ia26f11b6660a4abcb09094cf9a8a25c1_I20220630" decimals="2" name="clx:PercentageofOwnershipbyVenturePartner" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMzAy_0bc48b26-0e6d-4246-98c2-a9cc9b4d36e4"><ix:nonFraction unitRef="number" contextRef="icc15044a51144f99b1b95c3d077cfd0a_I20230331" decimals="2" name="clx:PercentageofOwnershipbyVenturePartner" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMzAy_f4f7e3c6-9a66-4d6a-8f1a-f1483f462d17">20</ix:nonFraction></ix:nonFraction>% interest in the venture. The Company pays a royalty to P&amp;G for its interest in the profits, losses and cash flows, as contractually defined, of the Glad business, which is included in Cost of products sold. In December 2017, the Company and P&amp;G extended the term of the agreement and the related R&amp;D support provided by P&amp;G. The term will expire in January 2026, unless the parties agree, on or prior to January 31, 2025, to further extend the term of the agreement for another <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="clx:VentureAgreementOptiontoExtendAgreementTermPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfNzgz_3c8cbe48-8b03-4acf-a723-5194f2ed1d5c">seven years</ix:nonNumeric> or agree to take some other relevant action. The agreement can be terminated earlier under certain circumstances, including at P&amp;G&#8217;s option upon a change in control of the Company or, at either party&#8217;s option, upon the sale of the Glad business by the Company.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon termination of the agreement, the Company is required to purchase P&amp;G&#8217;s <ix:nonFraction unitRef="number" contextRef="ia26f11b6660a4abcb09094cf9a8a25c1_I20220630" decimals="2" name="clx:PercentageofOwnershipbyVenturePartner" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMTEyNA_0bc48b26-0e6d-4246-98c2-a9cc9b4d36e4"><ix:nonFraction unitRef="number" contextRef="icc15044a51144f99b1b95c3d077cfd0a_I20230331" decimals="2" name="clx:PercentageofOwnershipbyVenturePartner" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMTEyNA_f4f7e3c6-9a66-4d6a-8f1a-f1483f462d17">20</ix:nonFraction></ix:nonFraction>% interest for cash at fair value as established by predetermined valuation procedures. As of March&#160;31, 2023 and June&#160;30, 2022, the estimated fair value of P&amp;G&#8217;s interest in the venture was $<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="clx:VentureAgreement.TerminalObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMTI5Mg_cf9c94ae-8b3e-4b55-b0ad-16cc8e50e331">527</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="clx:VentureAgreement.TerminalObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMTI5OQ_0141cce3-3739-46b7-8265-838ad2f6a0d8">635</ix:nonFraction>, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="clx:VentureAgreementTerminalObligationNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMTM0Ng_53142084-1b29-46a6-b035-5b2033fea33b">492</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="clx:VentureAgreementTerminalObligationNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMTM1Mw_2bcf66f4-26d4-4dce-8c95-cdfc130b8caf">468</ix:nonFraction>, respectively, has been recognized and is reflected in Other liabilities. The difference between the estimated fair value and the amount recognized, and any future changes in the fair value of P&amp;G&#8217;s interest, is charged to Cost of products sold in accordance with the effective interest method over the remaining life of the agreement. Following termination, the Glad business will retain the exclusive core intellectual property licenses contributed by P&amp;G on a royalty-free basis for the licensed products marketed.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfNzgwOQ_b12dbf5c-3deb-41b9-a437-ec196b2ae443" continuedAt="iaa6fbd4940424a23b512c6a0e5d51318" escape="true">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="iaa6fbd4940424a23b512c6a0e5d51318" continuedAt="i9d37e94779624e5899a5d4cf741eb526"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Risk Management and Derivative Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain commodity, foreign currency and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity Price Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may use commodity futures, options and swap contracts to limit the impact of price volatility on a portion of its forecasted raw material requirements. These commodity derivatives may be exchange traded or over-the-counter contracts and generally have original contractual maturities of less than <ix:nonNumeric contextRef="i48ad1cc1bb794a76b3dd0815532c06b3_D20220701-20230331" name="us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfNjYw_10b2aca2-bf93-48cf-80c0-14ce461ecea6">two years</ix:nonNumeric>. Commodity purchase and options contracts are measured at fair value using market quotations obtained from the Chicago Board of Trade commodity futures exchange and commodity derivative dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, and June&#160;30, 2022, the notional amount of commodity derivatives was $<ix:nonFraction unitRef="usd" contextRef="id06bee842a75404dac41877bdd92d1ef_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMjE5OTAyMzI2OTQwMg_8a4035da-e836-4b2a-afd7-f95697cc42ac">55</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia8a40de0484b4eeb80b4fe9c2b92525f_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTY0OTI2NzQ0OTU1Nw_2d658edb-b3ad-4057-b6f5-f68b7276109e">27</ix:nonFraction>, respectively, which related primarily to exposures in soybean oil used for the Food products business and jet fuel used for the Grilling business.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also enter into certain over-the-counter derivative contracts to manage a portion of the Company&#8217;s forecasted foreign currency exposure associated with the purchase of inventory. These foreign currency contracts generally have original contractual maturities of less than <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTM4OA_ef74affb-fef8-44fd-9261-1d6fca99e198">two years</ix:nonNumeric>. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of outstanding foreign currency forward contracts used by the Company&#8217;s subsidiaries to hedge forecasted purchases of inventory were $<ix:nonFraction unitRef="usd" contextRef="icf2ca00060704f22aa28947a2c33bf44_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMjE5OTAyMzI2OTQwOQ_e2c954fe-d397-4174-816c-6ade7e9ef574">55</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2159f0fecc5b4470982d356c86f23bf9_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTY2NQ_537a9b93-7c69-4756-8238-9230c99a234e">31</ix:nonFraction> as of March&#160;31, 2023 and June&#160;30, 2022, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may enter into over-the-counter interest rate contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt. These interest rate contracts generally have original contractual maturities of less than <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTk4OQ_52783ffd-e52f-4aad-adfc-d4cb87a9840a">three years</ix:nonNumeric>. The interest rate contracts are measured at fair value using information quoted by bond dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held no interest rate contracts as of both March&#160;31, 2023 and June&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity, Foreign Exchange and Interest Rate Derivatives </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designates its commodity forward, futures and options contracts for forecasted purchases of raw materials, foreign currency forward contracts for forecasted purchases of inventory and interest rate contracts for forecasted interest payments as cash flow hedges.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)</span></div></div><ix:continuation id="i9d37e94779624e5899a5d4cf741eb526" continuedAt="i7987ce245b5e4b18b48f63f78273517f"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfNzgxMQ_48f0c984-8a26-4ee1-8f63-de1e48b23437" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings (losses) were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) recognized in Other comprehensive (loss) income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd98f18f73954c73b67fcb63121d3a6a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfMy0xLTEtMS0xNDI2ODA_3256dc4f-b134-4366-bfdc-a98e11cb7d1f">4</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e38353ad8c45ebbbeeb1760836023e_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfMy0zLTEtMS0xNDI2ODA_513ed888-720a-4d4d-9b4d-88830f3ce00a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i267e13abd2ac4080863d5a4b5a5a1008_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfMy01LTEtMS0xNDI2ODA_0b93a965-f6eb-4655-a136-707607c429f0">6</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia50e5e1f44b94908af2b9b0f33a06f5d_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfMy03LTEtMS0xNDI2ODA_ac343129-b340-4123-9731-8ff74b63c6ad">12</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib90adbece5bb496490f8e0ada42889bf_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNC0xLTEtMS0xNDI2ODA_408736ad-48a8-4224-a7d0-5dfbe453c2fa">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53d784e371024289a6bb1733a0bfeceb_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNC0zLTEtMS0xNDI2ODA_d7c31687-e964-43e0-ba30-78ecaec52481">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06467bddcdcd40afaf9fc6a5d8f585b6_D20220701-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNC01LTEtMS0xNDI2ODA_e7d5a2de-7c99-4be8-92e7-2e53996025c7">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59a5dd038e5d4dc8a7529d286f2503b1_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNC03LTEtMS0xNDI2ODA_e3c89d7e-6353-45bd-8ed1-2f1856ca338e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84aeaaa8c3d24da2a83bccbe80c40d7c_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNS0xLTEtMS0xNDI2ODA_42343933-0533-454b-8229-e041921bcf51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7569e47c817545e8b392a1799c23bb90_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNS0zLTEtMS0xNDI2ODA_124b791b-bd55-48f1-81e9-708f5188eda0">39</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62117e14e9614a8b8aae02999044878f_D20220701-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNS01LTEtMS0xNDI2ODA_5db56404-8d0d-4088-afab-52ec6660ea80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66b892c371534620b3587d9e0450ac51_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNS03LTEtMS0xNDI2ODA_41b95f82-44c4-4653-86e7-4dc67bfc5c01">39</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNi0xLTEtMS0xNDI2ODA_215cfb2d-ee3f-4530-aca3-65e354d26b44">3</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNi0zLTEtMS0xNDI2ODA_354a8c5e-b1ff-446a-ae78-f105a8c141e3">48</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNi01LTEtMS0xNDI2ODA_fb09d6fa-a04a-4eb4-8ee0-8eaa655f7e65">5</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNi03LTEtMS0xNDI2ODA_ed55bdec-814d-4a75-86bf-c3c1f63d397b">51</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfNzgyMw_1e0fd681-ea4a-4019-b19d-a08135ee90cb" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings (losses)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd98f18f73954c73b67fcb63121d3a6a_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfMy0yLTEtMS0xNDI2ODA_c170e389-b59e-4a92-90f6-7e3a293008e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e38353ad8c45ebbbeeb1760836023e_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfMy00LTEtMS0xNDI2ODA_2b56ba74-79bb-4633-aceb-02bb3c178ce0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i267e13abd2ac4080863d5a4b5a5a1008_D20220701-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfMy02LTEtMS0xNDI2ODA_a0796092-074b-4b7b-bdd6-81db0b7210b5">7</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia50e5e1f44b94908af2b9b0f33a06f5d_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfMy04LTEtMS0xNDI2ODA_d6f6884a-4f65-491a-a7f4-2c54e2266037">13</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib90adbece5bb496490f8e0ada42889bf_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNC0yLTEtMS0xNDI2ODA_8995c603-e45e-4be5-ad48-f69b93d98365">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53d784e371024289a6bb1733a0bfeceb_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNC00LTEtMS0xNDI2ODA_3a1c4324-9144-4298-a2c3-376f5f3e52b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06467bddcdcd40afaf9fc6a5d8f585b6_D20220701-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNC02LTEtMS0xNDI2ODA_669b473b-89fe-4353-bbf8-58f2d60bd13c">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59a5dd038e5d4dc8a7529d286f2503b1_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNC04LTEtMS0xNDI2ODA_9335fc38-cad1-409a-9364-a0575009a376">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84aeaaa8c3d24da2a83bccbe80c40d7c_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNS0yLTEtMS0xNDI2ODA_d8029365-d158-4d15-9c2b-95c2ac318a1b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7569e47c817545e8b392a1799c23bb90_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNS00LTEtMS0xNDI2ODA_ab68ee66-fc75-42e0-a1d9-60307cea2253">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62117e14e9614a8b8aae02999044878f_D20220701-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNS02LTEtMS0xNDI2ODA_7e679ee8-ecf5-4d7d-aae0-15931e669abd">10</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66b892c371534620b3587d9e0450ac51_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNS04LTEtMS0xNDI2ODA_7a3b7ec4-64d5-4ef6-a7ce-6369aebfe525">3</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNi0yLTEtMS0xNDI2ODA_97d85454-9b6a-49bb-b3a7-725adf409fd4">4</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNi00LTEtMS0xNDI2ODA_0eb862e9-c4fb-4efc-860e-d589ae7b3641">3</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNi02LTEtMS0xNDI2ODA_a609f8d7-4362-4463-a6e5-95a147f5e7f1">18</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNi04LTEtMS0xNDI2ODA_031617f7-7858-42a6-9fa0-7a5d87dddf1e">10</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amount of the existing net gain (loss) in Accumulated other comprehensive net (loss) income as of March&#160;31, 2023 that is expected to be reclassified into Net earnings (losses) within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMjE5OTAyMzI2OTQxNw_ce1549ab-4f8b-4521-a4f1-0cbc58646e0c">9</ix:nonFraction>. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Risk Management and Derivative Contract Requirements</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes a variety of financial institutions as counterparties for over-the-counter derivative instruments. The Company enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually-defined counterparty liability position limits. Of the over-the-counter derivative instruments in liability positions, $<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTY0OTI2NzQ1NTc1NA_cc9f0b3c-6478-4d6f-a954-1866c9e89c12">1</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTY0OTI2NzQ1NTc1OQ_6a60a0b8-7a7c-43f7-859d-207ea377ae92">0</ix:nonFraction> contained such terms as of March&#160;31, 2023 and June&#160;30, 2022, respectively. As of both March&#160;31, 2023 and June&#160;30, 2022, neither the Company nor any counterparty was required to post any collateral as no counterparty liability position limits were exceeded.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain terms of the agreements governing the Company&#8217;s over-the-counter derivative instruments require the Company&#8217;s credit ratings, as assigned by Standard &amp; Poor&#8217;s and Moody&#8217;s to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If the Company&#8217;s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of both March&#160;31, 2023 and June&#160;30, 2022, the Company and each of its counterparties had been assigned investment grade ratings by both Standard &amp; Poor&#8217;s and Moody&#8217;s.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s exchange traded futures and options contracts used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account held by the Company&#8217;s broker for trades conducted on that exchange. As of March&#160;31, 2023 and June&#160;30, 2022, the Company maintained cash margin balances related to exchange traded futures and options contracts of $<ix:nonFraction unitRef="usd" contextRef="i66b2684d698e4766b9ae15f0597d7fdf_I20230331" decimals="-6" name="us-gaap:MarginDepositAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMjE5OTAyMzI2OTQyMg_a68ed9d2-8a95-4baf-9a8a-ca469f07e998">3</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i8f46aa97434e48e89c802561e09aac43_I20220630" decimals="-6" name="us-gaap:MarginDepositAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfNDgwNw_916b3c34-05eb-4f73-b392-c4fc2c4866e8">1</ix:nonFraction>, respectively, which are classified as Prepaid expenses and other current assets on the condensed consolidated balance sheets.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)</span></div></div><ix:continuation id="i7987ce245b5e4b18b48f63f78273517f" continuedAt="i95f662e2d0664848bb8796597a9cb0db"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trust Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in mutual funds and cash equivalents as part of trust assets related to its nonqualified deferred compensation plans. The participants in the nonqualified deferred compensation plans, who are the Company&#8217;s current and former employees, may select among certain mutual funds in which their compensation deferrals are invested in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and therefore, trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The interests in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable securities as trading investments.</span></div><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfNzgyMg_36f56dde-b89e-49fc-bb94-2e4e8cb989a6" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of both March&#160;31, 2023 and June&#160;30, 2022, the Company&#8217;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#8217;s nonqualified deferred compensation plans, which were classified as Level 1.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s derivative instruments qualify for hedge accounting. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfNzgyOA_2a16e405-2187-45d4-8a5b-e04e67d71dd3" continuedAt="i78bc9f23df2b433286b6efd37584c376" escape="true">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s derivative instruments:</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:continuation id="i78bc9f23df2b433286b6efd37584c376" continuedAt="iaa83dd65b7e84a9fa805fb49a4e7d865"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase options contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9edfde63c0c497e88e10ce6f5c5636f_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMy01LTEtMS0xNDI2ODA_e8823ef8-fe6d-443f-bbf4-c28ef9534ac5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a4addd4aa1435083c94a016faebc92_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMy03LTEtMS0xNDI2ODA_20c71aec-25d1-47cb-b3dd-9538073ff2a2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0a6e589f2b483990fd8b1228aa3c8a_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMy05LTEtMS0xNDI2ODA_b1b4b4c3-6375-4670-b9df-e13c983117a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbea6dcd3f5647a9bf12d9d534a6ca9c_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMy0xMS0xLTEtMTQyNjgw_1765ff37-1790-4e0a-9c6e-473d7db0c26c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d413ac1c4d04865a4e5fe3b340023a7_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNC01LTEtMS0xNDI2ODA_1a788297-a5a4-4865-a839-bda62e25b45e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i992290ad5dc147a89b2dc02782ff64ef_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNC03LTEtMS0xNDI2ODA_99d5ec1e-fcd3-4782-b02f-6372202b8d58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i287e76237d8c427fa8b74226bacd7498_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNC05LTEtMS0xNDI2ODA_73a3aa0b-4840-49c7-b9cb-b0deed932fa9">6</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa9b879156664a4cabe4b0c19b072452_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNC0xMS0xLTEtMTQyNjgw_e72ade8e-f49c-4cdb-bbf9-3af4a14e850f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09b23e716734285ad99334813cdd1c7_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNi01LTEtMS0xNDI2ODA_0d4775b2-35d1-4ad2-9dcd-58527f6c41db">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73735ddebada41feb165c246aab6ce4a_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNi03LTEtMS0xNDI2ODA_21d57e5d-8429-440c-aee8-770fb0913d52">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f6555be7a9e4d239338043a0facd422_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNi05LTEtMS0xNDI2ODA_c42599c5-3d0b-48b0-ba18-a3d7459e4edb">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7ebc1c469348ed885bc1105f8fc3df_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNi0xMS0xLTEtMTQyNjgw_0429e327-42c2-437a-9a71-10fa45b55b63">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a68f814db4a4c5c95ed1bd0205e0034_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfOC01LTEtMS0xNDI2ODA_253314ab-7b00-45e9-af65-debb79573685">2</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb497008d82d4021908269a98083af08_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfOC03LTEtMS0xNDI2ODA_b0eab1f2-93d5-4403-bd1f-788c0143dfdd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03ee318c0e494e0981bcc1c4c86ac0c3_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfOC05LTEtMS0xNDI2ODA_fb3dbb13-61fe-4179-92e6-c42552d40364">7</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f23483af02142ff962e0bc8a46b198f_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfOC0xMS0xLTEtMTQyNjgw_737ba693-f790-42f0-bcb8-790907e92604">7</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase futures contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9edfde63c0c497e88e10ce6f5c5636f_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTAtNS0xLTEtMTQyNjgw_adcf831d-211d-41a8-86a3-5a4e3b9d19d1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a4addd4aa1435083c94a016faebc92_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTAtNy0xLTEtMTQyNjgw_2cbcc406-4c87-4767-8bec-cac2beb27920">2</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0a6e589f2b483990fd8b1228aa3c8a_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTAtOS0xLTEtMTQyNjgw_ccfd86e8-235e-4641-99ab-82f5cb52107c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbea6dcd3f5647a9bf12d9d534a6ca9c_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTAtMTEtMS0xLTE0MjY4MA_d5156565-5ff5-44cc-bd68-37c5de07a07e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d413ac1c4d04865a4e5fe3b340023a7_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTEtNS0xLTEtMTQyNjgw_f8cd37fd-73c9-42a9-9b9d-27bce5b34e24">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i992290ad5dc147a89b2dc02782ff64ef_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTEtNy0xLTEtMTQyNjgw_63a5097a-37b1-484a-ad72-ddfc73a186dc">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i287e76237d8c427fa8b74226bacd7498_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTEtOS0xLTEtMTQyNjgw_64a39c8b-c845-450d-9898-49502459a7e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa9b879156664a4cabe4b0c19b072452_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTEtMTEtMS0xLTE0MjY4MA_07127be5-2bfb-41aa-acc9-10a5b88d591c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a68f814db4a4c5c95ed1bd0205e0034_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTMtNS0xLTEtMTQyNjgw_cbe2029b-5f1c-434d-847c-351ff9ac334e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb497008d82d4021908269a98083af08_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTMtNy0xLTEtMTQyNjgw_169606bd-f529-4479-a546-2bf5ef1fe6c6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03ee318c0e494e0981bcc1c4c86ac0c3_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTMtOS0xLTEtMTQyNjgw_d162f3d5-3e98-473e-ae74-dd692782ca69">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f23483af02142ff962e0bc8a46b198f_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTMtMTEtMS0xLTE0MjY4MA_d1144346-6f27-4b7c-8e64-f7602d00fa1a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)</span></div></div><ix:continuation id="i95f662e2d0664848bb8796597a9cb0db"><ix:continuation id="iaa83dd65b7e84a9fa805fb49a4e7d865"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s other assets and liabilities for which disclosure of fair value is required:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-bearing investments, including money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia680265241d34120bcbc6e5b1c032c3a_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMy01LTEtMS0xNDI2ODA_5162c062-6518-4962-ac23-2475944f9c13">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib949b42e3d64447f9f9da32d8fe053fc_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMy03LTEtMS0xNDI2ODA_d510ea12-fea4-48c6-bd53-3b7c62d51eb5">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1b18d9575c4fe181987e3bdf974c55_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMy05LTEtMS0xNDI2ODA_b16259fa-d5d3-4f06-be30-3a9e3270d585">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19d64991cb241db9d152df2af96652c_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMy0xMS0xLTEtMTQyNjgw_21750e7f-1b1f-4af1-a035-d2f12b5dcb69">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposits</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a98cb40f89c4f6cb3174cc2385cfdc3_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNC01LTEtMS0xNDI2ODA_859d6b35-7e44-475d-9d1e-d9b297ae1b56">7</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec4aaa03ddf14edab361fbdbd7af4a28_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNC03LTEtMS0xNDI2ODA_65291ab7-2bcb-4e1e-9441-775c57b11e86">7</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd50e0a93db949dc86a0a76dea201d7e_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNC05LTEtMS0xNDI2ODA_647acf91-d711-42b7-baac-a66684224545">4</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdc22c41b65b44f5910fb2bd6e7aa7ef_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNC0xMS0xLTEtMTQyNjgw_0dfc3d93-07be-4f0e-966d-710c1189837a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trust assets for nonqualified deferred compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id77511cc08ae4fada9800a2edf805e8d_I20230331" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNy01LTEtMS0xNDI2ODA_67a77805-5aaa-4888-9298-a72f5661fb31">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i699f3ca3c5db4d5bba548627af449cf4_I20230331" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNy03LTEtMS0xNDI2ODA_22b7627d-eee5-459c-bc9b-29cfb8d17376">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80dda40f54024046ade281e97268afde_I20220630" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNy05LTEtMS0xNDI2ODA_354eddef-f7b1-4b22-9c6c-df4e8d4ca1e8">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb50e89eb9054e9497f1a6390acb66df_I20220630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNy0xMS0xLTEtMTQyNjgw_d95d0020-9909-43e7-8195-6b7f84abb487">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a68f814db4a4c5c95ed1bd0205e0034_I20230331" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfOC01LTEtMS0xNDI2ODA_d3232fdf-1f70-4d2e-af4d-08ad6ff0352b">194</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb497008d82d4021908269a98083af08_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfOC03LTEtMS0xNDI2ODA_ab63bb63-aab0-4953-b765-3d5b978bd144">194</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03ee318c0e494e0981bcc1c4c86ac0c3_I20220630" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfOC05LTEtMS0xNDI2ODA_14f293ad-563a-4de6-9aa6-4489fad61964">209</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f23483af02142ff962e0bc8a46b198f_I20220630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfOC0xMS0xLTEtMTQyNjgw_4bb6f356-9bba-4b51-a6b5-6ba7b652119d">209</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a4b9990a76749d7b5b429e19b132705_I20230331" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTAtNS0xLTEtMTQyNjgw_30d141df-8448-49db-bd7b-43e7c270f11b">138</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7abd7c745142489ba717edbad8ecc1b6_I20230331" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTAtNy0xLTEtMTQyNjgw_7e079ef5-b08a-46a2-b914-696f53e77c3d">138</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if177937c7cde476eace985e08c46bb5a_I20220630" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTAtOS0xLTEtMTQyNjgw_bb7cff02-e337-409f-b94f-8b53dbf27ea9">237</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86811defe6884c9b8f1c17dcfaada1ff_I20220630" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTAtMTEtMS0xLTE0MjY4MA_524bc9a2-d912-410d-bbfb-672e0f5b60eb">237</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">term debt and Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b50460a1b234ac3b19dc457a1b696e6_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTItNS0xLTEtMTQyNjgw_0362abc5-44c4-448f-b7af-a7ea10a8205b">2,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e23b9c3471546129e5eb560eabed6b9_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTItNy0xLTEtMTQyNjgw_3cbf2c02-1307-407c-90ce-e5c750849190">2,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37e76d4ac9234a0186486ff3b55d6a18_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTItOS0xLTEtMTQyNjgw_0ba88069-1dd8-4cd1-a0c2-a0b3332b2d20">2,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaff929c5c7ef4f728e2ba0db462af797_I20220630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTItMTEtMS0xLTE0MjY4MA_f4dd5497-e744-42d3-8492-1fd9541a473b">2,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a68f814db4a4c5c95ed1bd0205e0034_I20230331" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTMtNS0xLTEtMTQyNjgw_138b572f-9c29-4cb6-8897-d36857b64ade">2,614</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb497008d82d4021908269a98083af08_I20230331" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTMtNy0xLTEtMTQyNjgw_ff344cc8-6fb4-4fee-9806-7a13ef70bf1e">2,514</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03ee318c0e494e0981bcc1c4c86ac0c3_I20220630" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTMtOS0xLTEtMTQyNjgw_b58614f1-eb0b-4aab-bf80-24e3891abc28">2,711</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f23483af02142ff962e0bc8a46b198f_I20220630" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTMtMTEtMS0xLTE0MjY4MA_23f8558f-10d5-45f0-a952-02c901b74be6">2,623</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company&#8217;s credit agreements, all of which are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTA5OTUxMTY0MTcwMQ_81a1d7a9-124b-431c-9584-c244e13453f3">445</ix:nonFraction> were recorded during the third quarter of fiscal 2023, of which $<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTA5OTUxMTY0MTcwOQ_508ad3e5-27e0-4a9d-93c3-c77f0f2ec8fc">306</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTA5OTUxMTY0MTcxNQ_9ffb9866-4a06-4a3b-9607-7ed49e671c27">139</ix:nonFraction> related to the goodwill of the VMS reporting unit and certain related indefinite-lived trademarks, respectively. These adjustments were included as Goodwill, trademark and other asset impairments in the condensed consolidated statement of earnings. The non-recurring fair values utilized included unobservable Level 3 inputs based on management&#8217;s best estimates and assumptions. For additional information, refer to Note 4.</span></div></ix:continuation><div><span><br/></span></div><div id="i35f8305358714061a46930a84f00a8d0_34"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNC9mcmFnOjI3OTFjMjJlYzMyNDQ3Y2I5YTZkYmExZWQ1MjBlN2Q3L3RleHRyZWdpb246Mjc5MWMyMmVjMzI0NDdjYjlhNmRiYTFlZDUyMGU3ZDdfMTEyNA_3382f0d8-939a-4e38-9760-fe2687c39bfa" continuedAt="i2655ec6c0f764921aa7e724b80a74163" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2655ec6c0f764921aa7e724b80a74163" continuedAt="i581cdf4669b145a0986ec53873668bec">In determining its quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The effective tax rate on losses was <ix:nonFraction unitRef="number" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNC9mcmFnOjI3OTFjMjJlYzMyNDQ3Y2I5YTZkYmExZWQ1MjBlN2Q3L3RleHRyZWdpb246Mjc5MWMyMmVjMzI0NDdjYjlhNmRiYTFlZDUyMGU3ZDdfNTI3_922160d9-743f-4679-b80b-21757110570b">14.7</ix:nonFraction>% and the effective tax rate on earnings was <ix:nonFraction unitRef="number" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNC9mcmFnOjI3OTFjMjJlYzMyNDQ3Y2I5YTZkYmExZWQ1MjBlN2Q3L3RleHRyZWdpb246Mjc5MWMyMmVjMzI0NDdjYjlhNmRiYTFlZDUyMGU3ZDdfNTM0_c31ff3d8-2475-4397-b8c6-b97b7f540cf6">1,813.5</ix:nonFraction>% for the three and nine months ended March&#160;31, 2023, respectively. The effective tax rate on earnings was <ix:nonFraction unitRef="number" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNC9mcmFnOjI3OTFjMjJlYzMyNDQ3Y2I5YTZkYmExZWQ1MjBlN2Q3L3RleHRyZWdpb246Mjc5MWMyMmVjMzI0NDdjYjlhNmRiYTFlZDUyMGU3ZDdfNTcw_312eeefe-6249-40e4-97f1-5b5dca6064ea">23.9</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNC9mcmFnOjI3OTFjMjJlYzMyNDQ3Y2I5YTZkYmExZWQ1MjBlN2Q3L3RleHRyZWdpb246Mjc5MWMyMmVjMzI0NDdjYjlhNmRiYTFlZDUyMGU3ZDdfNTc3_674f305b-258d-4677-8d3f-32344830a594">23.3</ix:nonFraction>% for the three and nine months ended March&#160;31, 2022, respectively. The lower tax rate on losses before income taxes in the current three month period was driven by the partial non-deductibility of impaired VMS goodwill. The substantially higher tax rate on earnings before income taxes in the current nine month period was driven by lower pre-tax income due to the VMS impairment charges and the non-deductibility of a portion of those charges.</ix:continuation></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i581cdf4669b145a0986ec53873668bec">The Inflation Reduction Act (the &#8220;Act&#8221;) was signed into law on August 16, 2022. The Act introduces a new 15% corporate minimum tax for certain large corporations that becomes effective at the beginning of the Company&#8217;s fiscal 2024 and it imposes a 1% excise tax on the value of share repurchases, net of new share issuances, after December 31, 2022. These provisions, as well as the other corporate tax changes included in the Act, are not expected to have a material impact on the Company&#8217;s financial statements.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RleHRyZWdpb246MDUwY2EzYjAyZmUyNGRkY2IxZWNiMTNkMjdmNmMzZjlfMzQ1_1f1a8154-3364-4dd8-9b67-0aff8e159352" continuedAt="i00fa6c79250744d3ab04767b689401f8" escape="true">NET EARNINGS (LOSSES) PER SHARE (EPS)</ix:nonNumeric></span></div><ix:continuation id="i00fa6c79250744d3ab04767b689401f8"><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RleHRyZWdpb246MDUwY2EzYjAyZmUyNGRkY2IxZWNiMTNkMjdmNmMzZjlfMzUw_b7b817ad-a137-4a26-8254-24b66e620a8d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMi0xLTEtMS0xNDI2ODA_045e08e3-befa-4b7f-b43e-f50fa1131ba3">123,649</ix:nonFraction></span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMi0zLTEtMS0xNDI2ODA_29ede725-02b1-4e68-a243-4b24233bf9b5">123,177</ix:nonFraction></span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMi01LTEtMS0xNDI2ODA_b20af0c1-e01b-4b33-b418-d8fc9c6e6703">123,512</ix:nonFraction></span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMi03LTEtMS0xNDI2ODA_579cf6f6-a9da-413a-bcb7-09b7c8e5afe6">123,074</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMy0xLTEtMS0xNDI2ODA_2e180a21-1627-4c7f-968a-e28d895fc63e">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMy0zLTEtMS0xNDI2ODA_a30b6d2e-5568-412f-9a46-8780753c9ca8">700</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMy01LTEtMS0xNDI2ODA_ec7183aa-4f19-4b10-81df-4c8184e6f330">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMy03LTEtMS0xNDI2ODA_5b4b528f-14bc-46b8-b889-d61443b6aa77">869</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNC0xLTEtMS0xNDI2ODA_d5330061-4b74-4f34-8972-b73ffbe03eb8">123,649</ix:nonFraction></span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNC0zLTEtMS0xNDI2ODA_df87c46f-00d8-4d64-b2ef-1f4e0fd78d33">123,877</ix:nonFraction></span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNC01LTEtMS0xNDI2ODA_103438e0-3860-4719-996e-34bc85e9f9b8">123,512</ix:nonFraction></span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNC03LTEtMS0xNDI2ODA_d107bb45-f50f-4855-bb27-a5843ac136ba">123,943</ix:nonFraction></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive stock options and other</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNi0xLTEtMS0xNDI2ODA_2a961da7-ff4d-41d2-946c-04076442bd7d">4,953</ix:nonFraction></span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNi0zLTEtMS0xNDI2ODA_887d5a7a-8285-4276-9d1d-d6c015eda0ac">2,489</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNi01LTEtMS0xNDI2ODA_32860a61-1cec-4ff2-92ed-e359267ae07f">4,953</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNi03LTEtMS0xNDI2ODA_af5a4dbe-70a2-4ee2-af8b-1f3783474b26">2,489</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net earnings (losses) per share and Diluted net earnings (losses) per share are calculated on Net earnings (losses) attributable to Clorox.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the Company generated net losses attributable to Clorox for the three and nine months ended March&#160;31, 2023, there was no dilutive effect of stock options and other instruments because their impacts would be antidilutive.</span></div></ix:continuation><div><span><br/></span></div><div id="i35f8305358714061a46930a84f00a8d0_40"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RleHRyZWdpb246YjNmNDFlMWQxMjMxNDBmNjk5NTM1YWIwZDRjMWEzMjJfMTQz_73113bd0-6510-4e7f-ac7e-6561cc6592a4" continuedAt="i2cf7b535c8454a9e88e53e905c315001" escape="true">COMPREHENSIVE INCOME (LOSS)</ix:nonNumeric></span></div><ix:continuation id="i2cf7b535c8454a9e88e53e905c315001"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RleHRyZWdpb246YjNmNDFlMWQxMjMxNDBmNjk5NTM1YWIwZDRjMWEzMjJfMTQ2_8bd3bd8f-6fd4-4d24-b8b4-9e3841580068" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of Comprehensive income (loss) for the periods indicated:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMi0xLTEtMS0xNDI2ODA_08e11cf6-c7dc-4e0b-ab8d-af9b87a5a836">209</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMi0zLTEtMS0xNDI2ODA_122c3073-d792-4548-8351-05f3a1e5c6c1">152</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMi01LTEtMS0xNDI2ODA_ab28204e-3b6c-4f29-9f4b-6b1181ed7267">20</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMi03LTEtMS0xNDI2ODA_5ce7b781-1753-40da-b61d-ded11c29c64a">367</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNC0xLTEtMS0xNDI2ODA_7bf735e4-2ea2-4222-8568-ec46e5e267cc">10</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNC0zLTEtMS0xNDI2ODA_e9bfbeb9-e4cd-4934-ade7-857e72fce19e">19</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNC01LTEtMS0xNDI2ODA_b1c74843-8a1a-4ed6-bc68-30d9413bbea8">1</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNC03LTEtMS0xNDI2ODA_61180221-7d27-43d9-8671-038eede7526d">9</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNS0xLTEtMS0xNDI2ODA_96b3d670-5ee5-4d1f-b12b-8e2997eda1d8">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNS0zLTEtMS0xNDI2ODA_f2cc5f5d-a3bd-4cda-b001-7f0efbaf65da">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNS01LTEtMS0xNDI2ODA_92bad9db-ac2f-46f3-81b4-77514a6dcc0e">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNS03LTEtMS0xNDI2ODA_c274f82a-5e16-4ca8-a490-4ed8c653e53f">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNi0xLTEtMS0xNDI2ODA_eb6ec565-e72b-4de6-94a9-97467f0916a3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNi0zLTEtMS0xNDI2ODA_0065a0c2-5812-44d6-b6bb-bb58203a5c42">2</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNi01LTEtMS0xNDI2ODA_c26e69a1-bf53-4bc6-bced-4b846470ec58">3</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNi03LTEtMS0xNDI2ODA_dc554a50-47d1-4c5f-8790-b29fdf11d423">5</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNy0xLTEtMS0xNDI2ODA_87fcec40-248a-4eb6-b910-8417953f6a7b">4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNy0zLTEtMS0xNDI2ODA_262eef87-d07f-4c3b-a0ff-4f1d392602df">55</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNy01LTEtMS0xNDI2ODA_ef5c71af-6c00-4dee-938f-f602065c98be">19</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNy03LTEtMS0xNDI2ODA_5aa79f24-ebbb-4c0e-9ded-f769f8bc865e">27</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOC0xLTEtMS0xNDI2ODA_dcbb55cd-8628-471c-b830-c71d4d265f15">205</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOC0zLTEtMS0xNDI2ODA_7fa7027d-9c2a-4ee9-a551-4fefc07c8bfc">207</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOC01LTEtMS0xNDI2ODA_0fc192f2-a342-4c3b-a653-9ef111b1c1db">39</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOC03LTEtMS0xNDI2ODA_bd0355e5-1e07-4100-a99b-828aba56be3c">394</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOS0xLTEtMS0xNDI2ODA_2d072de0-8fe7-43ae-993a-ee321fd3b372">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOS0zLTEtMS0xNDI2ODA_6dbe010f-9cae-4347-a5a5-5d4c4d03b217">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOS01LTEtMS0xNDI2ODA_0361d396-b80d-48fe-8f1c-8433261688ac">7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOS03LTEtMS0xNDI2ODA_b7a7911b-0961-4796-9031-626f4c4ee041">6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income (loss) attributable to Clorox</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMTAtMS0xLTEtMTQyNjgw_366d401e-2af2-409d-bd7c-3d47147151d7">207</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMTAtMy0xLTEtMTQyNjgw_78b90f18-38dc-42e8-bfae-8254088c3474">205</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMTAtNS0xLTEtMTQyNjgw_1ea8924e-ca91-43e2-884b-4e92ca194200">46</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMTAtNy0xLTEtMTQyNjgw_f3223fe7-f5a7-4975-b9a5-4417cd416b77">388</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RleHRyZWdpb246Y2Q2YmVhMDExYWZmNDg5ZTliYTM3MzQwYWJlMmVjOTJfNjAz_f588a724-db0a-422a-a90e-169d3964bf6f" continuedAt="ib0d75d0c77e7449bb5b8d3a6d55465fa" escape="true">STOCKHOLDERS</ix:nonNumeric></span><ix:continuation id="ib0d75d0c77e7449bb5b8d3a6d55465fa" continuedAt="i32baeb8d39ea4ac7930cce84b47eec6a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> EQUITY </span></ix:continuation></div><ix:continuation id="i32baeb8d39ea4ac7930cce84b47eec6a" continuedAt="ifad453895c6d4394a679c1e43958de93"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RleHRyZWdpb246Y2Q2YmVhMDExYWZmNDg5ZTliYTM3MzQwYWJlMmVjOTJfNjAw_e295a3a7-3210-4f38-8a38-27dcb09b5597" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the components of Stockholders&#8217; equity were as follows for the periods indicated: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e3af3669ef426badcf844049084f14_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy0xLTEtMS0xNDI2ODA_83d29086-63cb-4127-9827-05a10bc2599c">131</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09e3af3669ef426badcf844049084f14_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy0zLTEtMS0xNDI2ODA_e61a6cae-022b-4b96-a481-5efacbb083fb">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd45a75514c24c568a56042ccd0c84da_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy01LTEtMS0xNDI2ODA_5fa8e070-aa2c-475c-b2a1-a8f14b4d9c01">1,180</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ffbff4ac6b4a4b91ae2e1f6beaafa4_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy03LTEtMS0xNDI2ODA_e90af6c7-ecfd-4fcc-8205-529f9da3f16d">949</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifae1e2814de34b5eb8043ef76cff06a1_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy05LTEtMS0xNDI2ODA_73f4fc30-6ad8-4d31-bad9-8031c3335b15">1,373</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifae1e2814de34b5eb8043ef76cff06a1_I20211231" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy0xMS0xLTEtMTQyNjgw_96ff53a4-e6cc-4f2d-ab06-bc7780333b76">7,777</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i575dfed5180b41c380550a620ea3e540_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy0xMy0xLTEtMTQyNjgw_fa631860-d8a5-48ff-8a5b-08c48f1e51ee">574</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e77e9c323c43acad3d23fd72036b5f_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy0xNS0xLTEtMTQyNjgw_a4e11ada-d0f2-4cae-ac75-eb183b9729d4">178</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565b4c1e42f94eb2b2d7e89045b94abc_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy0xNy0xLTEtMTQyNjgw_47561c80-7a5f-4e79-b9b0-021ee819b430">491</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb985ea42574447abbdeb651a94e290_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNC03LTEtMS0xNDI2ODA_477a4d7b-a92a-486c-b5e8-913bb2b1d4ca">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a8f4562f03f485b9222b7cce528e697_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNC0xNS0xLTEtMTQyNjgw_8bdf3fd1-303e-4d7b-8ee3-821cae17d3e5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNC0xNy0xLTEtMTQyNjgw_74cff457-d49a-4f27-a870-21e9782ce9f9">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab076bc30324400b05fae96ad5d777d_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNS0xMy0xLTEtMTQyNjgw_eb216888-09db-4dfb-9eb0-771861a6c853">55</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNS0xNy0xLTEtMTQyNjgw_731be27c-ef10-4132-b0f6-1b12a9b17b38">55</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNi0wLTEtMS0xNDI2ODAvdGV4dHJlZ2lvbjo4N2ZmOTVkOGRhZjM0YWU4YjdmZTQyMmExOGZjMjVlM18zOA_ab94a41e-cdbb-4f95-96a5-088c1a59acb7">1.16</ix:nonFraction> per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fb985ea42574447abbdeb651a94e290_D20220101-20220331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNi03LTEtMS0xNDI2ODA_63e696f8-b49d-4143-b954-a37e85462f4a">143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNi0xNy0xLTEtMTQyNjgw_d1a373fd-9a35-4c73-8200-c84206c2f1c2">143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a8f4562f03f485b9222b7cce528e697_D20220101-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNy0xNS0xLTEtMTQyNjgw_b1b1c894-ff5d-4039-ac5e-93837596444d">4</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNy0xNy0xLTEtMTQyNjgw_876905e4-fe78-4810-b3f5-6ef97c08449e">4</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i790c9340393b4fb0b02a7296fadf9609_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfOS01LTEtMS0xNDI2ODA_a21971cd-a34b-4ec6-908c-2e08e14804a9">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfOS0xNy0xLTEtMTQyNjgw_cfc75be3-65e2-4990-a395-8fc9c229ae83">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i790c9340393b4fb0b02a7296fadf9609_D20220101-20220331" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTAtNS0xLTEtMTQyNjgw_69647377-b1c5-40c3-b6d1-6a26cbffcbdf">4</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fb985ea42574447abbdeb651a94e290_D20220101-20220331" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTAtNy0xLTEtMTQyNjgw_ee1df0bf-d0ff-4c51-8735-d5af21a659ad">5</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3654eea4d143be9e65477225892c33_D20220101-20220331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTAtOS0xLTEtMTQyNjgw_ec71ed9d-9a63-4930-9cb7-aabb6a291fe1">15</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa3654eea4d143be9e65477225892c33_D20220101-20220331" decimals="-3" name="clx:OtherEmployeeStockPlanActivitiesShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTAtMTEtMS0xLTE0MjY4MA_c4218b23-8558-4619-99bb-9e02018bf15b">107</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTAtMTctMS0xLTE0MjY4MA_c3cbd414-8a3c-4eed-9b4c-f0f72ecde7ba">6</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bca9d2ecd9e481aa1ead4b270214e56_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtMS0xLTEtMTQyNjgw_947516df-16f3-4986-a51e-2090cde8bad8">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bca9d2ecd9e481aa1ead4b270214e56_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtMy0xLTEtMTQyNjgw_435f6b3b-4b91-496d-aadd-8e9c45c56a4f">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56725ff0d43240d19e4b0e41d908614a_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtNS0xLTEtMTQyNjgw_87e0816d-76eb-4ca8-8fbb-c385a2460a0c">1,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95257d576dfd45148c1997c326e7020b_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtNy0xLTEtMTQyNjgw_c5469467-cbcf-4eea-b7af-3dcd33beda0d">951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed62d82fff40e495d855e264b32bc4_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtOS0xLTEtMTQyNjgw_1c6cf3af-e753-4838-8a9d-1f67744938d1">1,358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i93ed62d82fff40e495d855e264b32bc4_I20220331" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtMTEtMS0xLTE0MjY4MA_9ca3fd74-1e99-4e8e-af19-8baf8387c048">7,670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e4a56d9d98a4157b2c6e3bb88276c9b_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtMTMtMS0xLTE0MjY4MA_db0a3323-0887-4b0e-a435-74cae4087c9f">519</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1998332848f548599b1f44f8389dcf4c_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtMTUtMS0xLTE0MjY4MA_4fe222fa-da2d-4aa2-9553-9a8d627f4f49">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf74c279d583412eaba0df33f84a8dd7_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtMTctMS0xLTE0MjY4MA_abcc0c5a-80b6-4ec3-8ca9-4ee3ad6ff9b0">576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe250680c3cb4a2d9422e47ecfbb9232_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtMS0xLTEtMTQyNjgw_be896e47-499a-415a-a470-2654b2b813be">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe250680c3cb4a2d9422e47ecfbb9232_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtMy0xLTEtMTQyNjgw_6ac35a62-6450-4321-a74a-233788b29812">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i349984d984ac4a6dbf6cfa7d1779d9c9_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtNS0xLTEtMTQyNjgw_a167e340-c596-45f4-9dcd-2bf000225fff">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0578ecbdca4a4b0683cb8154b35f6aea_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtNy0xLTEtMTQyNjgw_02d79927-27bd-4b45-a5cc-99f6e38d2fa7">782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71a1dcd718bb44bfb1a91f3a99cb0ad7_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtOS0xLTEtMTQyNjgw_7366c63c-d3e3-4db4-977c-80989438ce0d">1,297</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i71a1dcd718bb44bfb1a91f3a99cb0ad7_I20221231" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtMTEtMS0xLTE0MjY4MA_e0263219-fd32-4821-9776-1cbdd7d95d48">7,263</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf167b776ade4df7b590155e62a3f0fa_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtMTMtMS0xLTE0MjY4MA_51241d58-3376-400e-9bfc-1db25ec4b6c6">502</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic441f564bc3e4f1fa09858858b3e6ba6_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtMTUtMS0xLTE0MjY4MA_d1cfe363-a377-4ab7-bf31-a46fa344f1fc">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i058a79b88ddf43df8b916f862dfc5bf7_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtMTctMS0xLTE0MjY4MA_fca0f3f5-7fe4-4460-a831-e074800f4df9">491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e561b7b255d422cbcdac071c1398d6a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTYtNy0xLTEtMTQyNjgw_9b534d52-1d5d-470a-9372-bff6d19342b4">211</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170471920d746bcb25579e59b005902_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTYtMTUtMS0xLTE0MjY4MA_340ce479-3d5a-4efd-b26f-e7ea90428129">2</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTYtMTctMS0xLTE0MjY4MA_ffe7b573-7793-4e20-98b2-7434d6ddb375">209</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33168f0db0843d685d4b21fe4e5edda_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTctMTMtMS0xLTE0MjY4MA_eb403910-928e-4c7e-a67f-15649f678f4c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTctMTctMS0xLTE0MjY4MA_5f9fc631-e266-456a-96ef-b959e4800d11">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTgtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246NjYyMGFiMjA3YTY3NDAzYmI5MjM4OGJmMTU2ZTlkYThfMzg_c318fe6a-8e9f-43cd-9d2a-9c3003cbf485">1.18</ix:nonFraction> per share declared)</span></div></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e561b7b255d422cbcdac071c1398d6a_D20230101-20230331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTgtNy0xLTEtMTQyNjgw_eb207b54-0c06-44e0-8196-44f9eb3d77a3">147</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTgtMTctMS0xLTE0MjY4MA_6eababe0-3ead-42a4-800e-415e33a30b37">147</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6170471920d746bcb25579e59b005902_D20230101-20230331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTktMTUtMS0xLTE0MjY4MA_aa52757e-09f5-437e-987d-29b5e31dfe62">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTktMTctMS0xLTE0MjY4MA_7797ead8-2c84-42e4-bc0c-326e49ecb796">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i428de1acdef7408cacf083e495bd1acc_D20230101-20230331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjEtNS0xLTEtMTQyNjgw_1cca5fa6-ad1a-4f2a-ad56-3bcf6877c283">29</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjEtMTctMS0xLTE0MjY4MA_bbbfcdec-1057-49a4-8f1c-9f7a2065af83">29</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i428de1acdef7408cacf083e495bd1acc_D20230101-20230331" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjItNS0xLTEtMTQyNjgw_edc3d515-7351-4103-bda7-60017237086f">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e561b7b255d422cbcdac071c1398d6a_D20230101-20230331" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjItNy0xLTEtMTQyNjgw_a59b4861-1637-4e11-bfb5-9da061f57026">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ebbe87a5b44f8e86adb6c537baa365_D20230101-20230331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjItOS0xLTEtMTQyNjgw_1dba0711-9bce-47e9-adcb-f1516b636875">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8ebbe87a5b44f8e86adb6c537baa365_D20230101-20230331" decimals="-3" name="clx:OtherEmployeeStockPlanActivitiesShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjItMTEtMS0xLTE0MjY4MA_11bedfe9-b88d-4260-ad3e-409ed47da9de">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjItMTctMS0xLTE0MjY4MA_34ee31ed-c68b-4a59-b1b3-074b38fc8873">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2dbf9b838649879e0d1331a95d0191_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtMS0xLTEtMTQyNjgw_e0acad6d-b339-40d0-9ad6-0a5f1824ca63">131</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice2dbf9b838649879e0d1331a95d0191_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtMy0xLTEtMTQyNjgw_3f14bbfe-4633-48e7-ba3c-091f4cb2e99a">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i382bd8dd06684d658f4f850a93ab45ab_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtNS0xLTEtMTQyNjgw_08a87075-b94b-4fbf-84cc-c98228af68bf">1,232</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc1249e856e0404fa74fe81e86ac37b5_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtNy0xLTEtMTQyNjgw_e8c516f7-b6de-42b2-93da-881d223936ae">415</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d7a9d9e6abc4064872b7d412c2a4ff8_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtOS0xLTEtMTQyNjgw_e900231a-f213-4bed-a8e8-7f18447b0da9">1,277</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9d7a9d9e6abc4064872b7d412c2a4ff8_I20230331" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtMTEtMS0xLTE0MjY4MA_5f143ef5-24e5-422a-bc52-5f88795b9fc1">7,130</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b6333e92ce42d7ab3cda6056f7c98a_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtMTMtMS0xLTE0MjY4MA_76cc7188-290c-47ea-b6c7-fe2d9b26f186">498</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c0fe22bbdb4fb083de7d9a1d7d1f45_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtMTUtMS0xLTE0MjY4MA_1c21a6d6-15eb-4d1d-9cc5-90bd426ad20a">169</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtMTctMS0xLTE0MjY4MA_1daacde1-0b7f-4120-aa26-04453d2508fa">172</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd6ece4973e949d08182806d9a323160_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtMS0xLTEtMTQyNjgw_4da8bf7b-e309-445e-9deb-f02be3b18f76">131</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifd6ece4973e949d08182806d9a323160_I20210630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtMy0xLTEtMTQyNjgw_4143f1a4-e84d-481a-a276-3d40d37fe947">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacc1e22ac19d48209ceace90c3d5b926_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtNS0xLTEtMTQyNjgw_8c0981f1-6d83-4e1c-aa89-ca6b101ac43f">1,186</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73dbb3c50d1647ceb59c25ac8d3093fb_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtNy0xLTEtMTQyNjgw_eb472e9f-9d49-41e8-9322-22666e1705e2">1,036</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fef3da8c9d340c6996ac9bd4e846ef1_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtOS0xLTEtMTQyNjgw_8b833f31-ba43-4511-b381-d079c207e1ad">1,396</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6fef3da8c9d340c6996ac9bd4e846ef1_I20210630" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtMTEtMS0xLTE0MjY4MA_2234ad1c-8103-4813-b400-e865518e8e41">7,961</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38dd7f792041456cbe661ea31eb94219_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtMTMtMS0xLTE0MjY4MA_cb217a81-af41-4e56-8428-6b0872126b7d">546</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5409859b1d8845f0aff788c9db7c4c79_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtMTUtMS0xLTE0MjY4MA_c783fe1f-e1ab-49fc-b3a2-7895dfdab6b0">181</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38db454957ae42d1a879575c446b836f_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtMTctMS0xLTE0MjY4MA_48bbcee0-836d-4307-a781-4f0b0b73d359">592</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6228167648a4c80885f8515c358e74c_D20210701-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzMtNy0xLTEtMTQyNjgw_53df904f-079f-4fe5-bb52-57d0a08a49ff">361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb19050263443049c6a5d3e0839f6cc_D20210701-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzMtMTUtMS0xLTE0MjY4MA_7d4fcc50-e6e2-48aa-b553-28aab0eeebb2">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzMtMTctMS0xLTE0MjY4MA_2d5d0988-9bfc-4888-a1b4-2413bef755b4">367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if811f809413d4a6bb8691c5fcaa43e23_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzQtMTMtMS0xLTE0MjY4MA_f7b7919d-5eb6-4efa-9be8-6d7c0a7a5c14">27</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzQtMTctMS0xLTE0MjY4MA_03a3ff13-0d5e-49ec-a793-4d986ef2ad7f">27</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzUtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246MTczYThhMGQyODczNDM3MjgzZWI3ZjYwZWU3NTExYTZfMzg_bb346733-86bc-492a-a2a4-0494f37e5f6d">3.48</ix:nonFraction> per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6228167648a4c80885f8515c358e74c_D20210701-20220331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzUtNy0xLTEtMTQyNjgw_e4bfd664-d603-455c-9cd5-2aed73d335e5">430</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzUtMTctMS0xLTE0MjY4MA_e4e26f4b-8050-4234-8b94-a5f19931436e">430</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb19050263443049c6a5d3e0839f6cc_D20210701-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzYtMTUtMS0xLTE0MjY4MA_5a14ebcf-3c71-41cb-8b21-6f4587788341">11</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzYtMTctMS0xLTE0MjY4MA_a2fe3bf2-958a-4866-9e1b-452fc67ecb9c">11</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d8d459930ee4918898527d3560df45e_D20210701-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzgtNS0xLTEtMTQyNjgw_d52f7f94-ee14-4ad3-b5df-25bfa0a7d5ae">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzgtMTctMS0xLTE0MjY4MA_727d7d23-e937-4370-a953-0f282f2ac485">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d8d459930ee4918898527d3560df45e_D20210701-20220331" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzktNS0xLTEtMTQyNjgw_5e17a829-9a16-4788-b664-4f840f1658cc">35</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6228167648a4c80885f8515c358e74c_D20210701-20220331" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzktNy0xLTEtMTQyNjgw_c99a2f37-7665-4a91-9f10-6068ea00fcac">16</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0606e8ef65d840a58c50419adf1e8e08_D20210701-20220331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzktOS0xLTEtMTQyNjgw_7f7a9657-b98e-4783-b552-8614cd4fe530">63</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0606e8ef65d840a58c50419adf1e8e08_D20210701-20220331" decimals="-3" name="clx:OtherEmployeeStockPlanActivitiesShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzktMTEtMS0xLTE0MjY4MA_b24c38e0-6e68-41d5-94b2-b2cc3178111b">443</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzktMTctMS0xLTE0MjY4MA_c14d552a-d129-4958-bf21-ae2a2d13a558">12</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0606e8ef65d840a58c50419adf1e8e08_D20210701-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDAtOS0xLTEtMTQyNjgw_5f88e46c-a515-4662-91e8-82ed56c6b276">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0606e8ef65d840a58c50419adf1e8e08_D20210701-20220331" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDAtMTEtMS0xLTE0MjY4MA_f70d5cd4-cec0-4495-9ab7-a6855f28d0b9">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDAtMTctMS0xLTE0MjY4MA_f136e038-2110-497e-9462-d38906593c0e">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bca9d2ecd9e481aa1ead4b270214e56_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItMS0xLTEtMTQyNjgw_6f9e60de-e5fe-449b-a48d-86d6a8b5dd53">131</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bca9d2ecd9e481aa1ead4b270214e56_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItMy0xLTEtMTQyNjgw_642e8f73-d5ce-463e-b8e8-e183bbe00aa3">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56725ff0d43240d19e4b0e41d908614a_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItNS0xLTEtMTQyNjgw_5fdbc46f-3ba8-4256-a1d0-0e4b39429048">1,195</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95257d576dfd45148c1997c326e7020b_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItNy0xLTEtMTQyNjgw_fbd7b6b3-47bf-4ed0-9f1e-83280c18d837">951</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed62d82fff40e495d855e264b32bc4_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItOS0xLTEtMTQyNjgw_f25fdda8-a079-42ff-835c-2de946674a0a">1,358</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i93ed62d82fff40e495d855e264b32bc4_I20220331" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItMTEtMS0xLTE0MjY4MA_366cc1dc-dbb6-40a6-8825-b8ce832769b6">7,670</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e4a56d9d98a4157b2c6e3bb88276c9b_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItMTMtMS0xLTE0MjY4MA_2ad1a22f-d2ad-450d-8e9b-09923c49d8fa">519</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1998332848f548599b1f44f8389dcf4c_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItMTUtMS0xLTE0MjY4MA_18a7a873-13e0-43f6-8eb9-56bd8e376ff2">176</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf74c279d583412eaba0df33f84a8dd7_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItMTctMS0xLTE0MjY4MA_975c7741-eafb-4920-896a-142a61cca814">576</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cbd00ee054d4a0ea683f3e69c3f144c_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtMS0xLTEtMTQyNjgw_5b785a34-1e58-413b-b71d-f206da537b0d">131</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2cbd00ee054d4a0ea683f3e69c3f144c_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtMy0xLTEtMTQyNjgw_e2d539d9-9c29-404c-9b25-1be3d124ff67">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21ccc62d5ccc400ca14bf9ef81476443_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtNS0xLTEtMTQyNjgw_536c1f55-d428-4ca7-aee9-48cdf99361b1">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ec983182ab42d7bee00f12f996858a_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtNy0xLTEtMTQyNjgw_3f8c758f-a6a4-41b7-b42e-912ba81adb62">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie20aff337cf646b68d54fb6090aa44eb_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtOS0xLTEtMTQyNjgw_f0e18486-08d5-4b3d-8d63-6f9cdb57193c">1,346</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie20aff337cf646b68d54fb6090aa44eb_I20220630" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtMTEtMS0xLTE0MjY4MA_e1d64800-dec2-4787-ab5a-958f1116038a">7,589</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i789c01c0eea04f1d858ad3fba90164ed_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtMTMtMS0xLTE0MjY4MA_6ec571a2-05f9-497d-8168-425c0b519d95">479</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5da3d885a8845f889db9160bcd4730c_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtMTUtMS0xLTE0MjY4MA_b39b5be7-dd1a-4b78-90d3-24b6a8e888d8">173</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtMTctMS0xLTE0MjY4MA_b6fd40c4-6253-461d-837d-2cc5879eab31">729</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i372b14b520094c4382db02e9bc4689f9_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDUtNy0xLTEtMTQyNjgw_19946cf1-089a-43d6-9a2e-cd606e2b63ea">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefab848d9a3b4ce984a98c0628e4cabb_D20220701-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDUtMTUtMS0xLTE0MjY4MA_7a9088cc-8b17-46c7-a5ec-b7d2eeadce10">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDUtMTctMS0xLTE0MjY4MA_43d9e335-17d7-40d7-90a1-7f520fcc3794">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6c3f82aac456096e02558c7413ecd_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDYtMTMtMS0xLTE0MjY4MA_2b81ac1d-90ac-495d-88b4-3b52a3bcb5c6">19</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDYtMTctMS0xLTE0MjY4MA_f6fcf685-23bf-42fb-bb77-d993efd7fd82">19</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDctMC0xLTEtMTQyNjgwL3RleHRyZWdpb246NjM3M2MxODNmOWJkNDc0NjliNGJiYTViZTZmZjcxZjFfMzg_5e6e25eb-add6-4282-88fc-e6c0acca12dd">4.72</ix:nonFraction> per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i372b14b520094c4382db02e9bc4689f9_D20220701-20230331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDctNy0xLTEtMTQyNjgw_ce5bbbdb-2737-425a-b5e3-864e3bff8e58">587</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDctMTctMS0xLTE0MjY4MA_13898f01-1e91-496d-b620-e25de36c79e3">587</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefab848d9a3b4ce984a98c0628e4cabb_D20220701-20230331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDgtMTUtMS0xLTE0MjY4MA_ace301d1-9bbf-4d05-9b5e-4d292927edd9">11</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDgtMTctMS0xLTE0MjY4MA_c08dcedc-5ea1-4895-953a-291f59f13869">11</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7296f62c815b4fb88cc0fabc30e4a5f3_D20220701-20230331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTAtNS0xLTEtMTQyNjgw_6ba89b49-c8cf-4c74-9dde-3cc59579d385">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTAtMTctMS0xLTE0MjY4MA_2e00f92e-5b92-4e54-a035-7b85407b27dd">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7296f62c815b4fb88cc0fabc30e4a5f3_D20220701-20230331" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTEtNS0xLTEtMTQyNjgw_a0530be3-120b-470e-8ff2-ea441aa689ac">30</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i372b14b520094c4382db02e9bc4689f9_D20220701-20230331" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTEtNy0xLTEtMTQyNjgw_0d008245-d988-4b54-bc04-c52349439d05">19</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd390a11523485798e09a245d293c38_D20220701-20230331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTEtOS0xLTEtMTQyNjgw_4eae1479-b263-4351-a2d2-e8a264ce5387">69</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2cd390a11523485798e09a245d293c38_D20220701-20230331" decimals="-3" name="clx:OtherEmployeeStockPlanActivitiesShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTEtMTEtMS0xLTE0MjY4MA_134f8e32-d457-4204-b888-bab07e52bae4">459</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTEtMTctMS0xLTE0MjY4MA_ce90b77e-6d1b-4afd-8b9e-63b22f01caf8">20</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2dbf9b838649879e0d1331a95d0191_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtMS0xLTEtMTQyNjgw_f6c36b8f-b2ab-44b2-bf5e-e1d559586a8e">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice2dbf9b838649879e0d1331a95d0191_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtMy0xLTEtMTQyNjgw_d84a6bd3-60af-460a-b835-4778e72072e8">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i382bd8dd06684d658f4f850a93ab45ab_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtNS0xLTEtMTQyNjgw_786bf40a-6ae4-4927-a876-6da7d3b6dc06">1,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc1249e856e0404fa74fe81e86ac37b5_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtNy0xLTEtMTQyNjgw_80cf93b0-e7b2-43d6-a11c-387d379057ef">415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d7a9d9e6abc4064872b7d412c2a4ff8_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtOS0xLTEtMTQyNjgw_9ae7434f-aa80-4786-ad8a-bca3d785c3cf">1,277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9d7a9d9e6abc4064872b7d412c2a4ff8_I20230331" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtMTEtMS0xLTE0MjY4MA_788875ac-5af5-48d5-8625-10250d80a4a8">7,130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b6333e92ce42d7ab3cda6056f7c98a_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtMTMtMS0xLTE0MjY4MA_4af9a4c9-239f-426d-a53e-f4b0a920a5bb">498</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c0fe22bbdb4fb083de7d9a1d7d1f45_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtMTUtMS0xLTE0MjY4MA_1b04f5c6-585f-44bc-af51-f250fb4543b3">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtMTctMS0xLTE0MjY4MA_a688cef4-8113-428c-b4a0-e2fa6657916f">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:2pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10. STOCKHOLDERS&#8217; EQUITY (Continued)</span></div></div><ix:continuation id="ifad453895c6d4394a679c1e43958de93"><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RleHRyZWdpb246Y2Q2YmVhMDExYWZmNDg5ZTliYTM3MzQwYWJlMmVjOTJfNjAx_26151582-f608-4dcc-93d1-91dc6bd47955" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id54b8127809f4f009450878e1f47eab0_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMi0xLTEtMS0xNDI2ODA_180afe4f-a4dd-4cae-a384-28f84e70b9ac">431</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec972b6c609643939ebb658b21202380_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMi0zLTEtMS0xNDI2ODA_6e23c00f-4b63-41fc-9823-783137bc2097">18</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10105acceec642bab440c62b4e41da18_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMi01LTEtMS0xNDI2ODA_8563886e-8a96-4959-9c2e-41b4e1de0990">161</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i575dfed5180b41c380550a620ea3e540_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMi03LTEtMS0xNDI2ODA_122e3985-861b-4348-867d-058d29c5ca7f">574</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e58ebc3d00448981b37243d360d5b8_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMy0xLTEtMS0xNDI2ODA_e6dd6b41-d3d6-45cb-a66d-4e39bbe98479">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd10304fb1c43b798f36d9855e3a674_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMy0zLTEtMS0xNDI2ODA_8bc02dd2-faa9-4bb1-89ef-cf36bd85fdde">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i639e65a448654d5d87000a3caa18af16_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMy01LTEtMS0xNDI2ODA_cb30182d-596a-4b7e-9baa-0b10ab7d7836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab076bc30324400b05fae96ad5d777d_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMy03LTEtMS0xNDI2ODA_a5ecf2ee-b1ca-401a-95d4-624fdf317ccd">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e58ebc3d00448981b37243d360d5b8_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNC0xLTEtMS0xNDI2ODA_c510cf4c-c486-4d09-a394-282b305fbdd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cd10304fb1c43b798f36d9855e3a674_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNC0zLTEtMS0xNDI2ODA_ee921237-53cc-484d-bbc4-a99356cbbae2">3</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i639e65a448654d5d87000a3caa18af16_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNC01LTEtMS0xNDI2ODA_29d3c992-9681-40a2-9284-31a23a06bd9f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab076bc30324400b05fae96ad5d777d_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNC03LTEtMS0xNDI2ODA_a4501c8a-39c0-441c-b468-8b88aa7c5fe5">1</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e58ebc3d00448981b37243d360d5b8_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNS0xLTEtMS0xNDI2ODA_cf62aaf5-e849-4e51-b401-21b66cf06786">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cd10304fb1c43b798f36d9855e3a674_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNS0zLTEtMS0xNDI2ODA_90a6a7e5-3a11-4849-8403-cf60ae600786">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i639e65a448654d5d87000a3caa18af16_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNS01LTEtMS0xNDI2ODA_48703f39-22cf-4d0b-9799-ea50d3b1e4f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab076bc30324400b05fae96ad5d777d_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNS03LTEtMS0xNDI2ODA_18372f1a-1305-4e4f-ae24-a0230899844d">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e58ebc3d00448981b37243d360d5b8_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNi0xLTEtMS0xNDI2ODA_6c0543a3-2aa5-4a9d-b654-7aaeb52a0a36">19</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd10304fb1c43b798f36d9855e3a674_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNi0zLTEtMS0xNDI2ODA_7a8e2327-75e5-46ec-b46d-891c18ddbc67">34</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i639e65a448654d5d87000a3caa18af16_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNi01LTEtMS0xNDI2ODA_2756f301-83a9-4f19-b76e-039fd1684892">2</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab076bc30324400b05fae96ad5d777d_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNi03LTEtMS0xNDI2ODA_d821fbfe-1f35-43c1-9835-bf411333662a">55</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie85c1700bb824cf3a99834757ca0345d_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNy0xLTEtMS0xNDI2ODA_ab9e3264-14e2-4bd2-a7f3-d24d584aedee">412</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d7840b6eb44467d910474da7f5cf458_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNy0zLTEtMS0xNDI2ODA_f0fb907a-0fc8-488c-ac2f-3c6518e03603">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7941953b83146c2b4fd8a2efddca131_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNy01LTEtMS0xNDI2ODA_729233ee-a782-4b11-9152-ff4145c57400">159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e4a56d9d98a4157b2c6e3bb88276c9b_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNy03LTEtMS0xNDI2ODA_b0258d57-7c64-4eb7-9eb3-1ecbe3d68f47">519</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd5d1bb8964841e785fdf870e1cd9c1f_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfOS0xLTEtMS0xNDI2ODA_bde6996d-9f2e-4878-a056-cf6e653a5096">459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ed5f67bc8e489fbf38eea7a87acb42_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfOS0zLTEtMS0xNDI2ODA_f5b62124-3eb0-468b-beca-e42e17952efc">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb003230a88c4000aac4e5c07d393cd2_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfOS01LTEtMS0xNDI2ODA_d8076c9d-8689-43a8-b817-b66e50c67a82">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf167b776ade4df7b590155e62a3f0fa_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfOS03LTEtMS0xNDI2ODA_6f2ae82a-081f-47f1-8ee4-b58aadfd5f7c">502</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20cdde6a918646608cafb482b69c1374_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTAtMS0xLTEtMTQyNjgw_7f87bbb3-8a39-4a76-85e2-b1f45ed5cc76">9</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b260ed4689a4167aedbbe4c6e8d5aed_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTAtMy0xLTEtMTQyNjgw_6966176d-862d-4317-909a-557ef5138232">3</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e2a1cf474674d64b709b61efc4388c7_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTAtNS0xLTEtMTQyNjgw_61aa8520-5ee5-43ac-89eb-62156fb3cd54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33168f0db0843d685d4b21fe4e5edda_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTAtNy0xLTEtMTQyNjgw_5fe9b147-2a16-47f9-96a2-9204cfe0d793">6</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20cdde6a918646608cafb482b69c1374_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTEtMS0xLTEtMTQyNjgw_3994b478-9b94-43ae-98e7-32d15149ef9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b260ed4689a4167aedbbe4c6e8d5aed_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTEtMy0xLTEtMTQyNjgw_b0b44a1a-f317-4ad3-92ea-2509fe53d812">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e2a1cf474674d64b709b61efc4388c7_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTEtNS0xLTEtMTQyNjgw_f60d94fa-ce2c-44e0-a459-7dbec9223f72">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33168f0db0843d685d4b21fe4e5edda_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTEtNy0xLTEtMTQyNjgw_e6483554-0688-4691-8878-ef51dff60cbc">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20cdde6a918646608cafb482b69c1374_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTItMS0xLTEtMTQyNjgw_e70ac310-5892-4d98-a6b8-d7d47a17cf29">1</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b260ed4689a4167aedbbe4c6e8d5aed_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTItMy0xLTEtMTQyNjgw_b6f058ef-223f-4c4a-95f2-404ad6e7f053">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e2a1cf474674d64b709b61efc4388c7_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTItNS0xLTEtMTQyNjgw_4e99a536-9c0e-4874-8f27-dc4b5a722f2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33168f0db0843d685d4b21fe4e5edda_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTItNy0xLTEtMTQyNjgw_a0376bdb-0b5e-4dda-808c-735ca2484445">1</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20cdde6a918646608cafb482b69c1374_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTMtMS0xLTEtMTQyNjgw_eeba45d6-f328-4a29-8616-95d69ef72775">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b260ed4689a4167aedbbe4c6e8d5aed_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTMtMy0xLTEtMTQyNjgw_6c7451cf-56ed-4dcf-94c3-5df29724da3b">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e2a1cf474674d64b709b61efc4388c7_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTMtNS0xLTEtMTQyNjgw_cc71f6c0-70a1-4bd7-80a5-bc03861a592d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33168f0db0843d685d4b21fe4e5edda_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTMtNy0xLTEtMTQyNjgw_1ac1d290-4a16-4fb2-a008-fdbc878a659c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a904ed9259247ed803bd9c4575c448b_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTQtMS0xLTEtMTQyNjgw_eb8896d9-6513-4658-b26e-f4670e11d1c9">449</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8624504988204f299f5466845c6db945_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTQtMy0xLTEtMTQyNjgw_4f9c75d5-cd8c-4a88-bcdb-2013ba279ce5">100</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i991ef5bf9ed442ca8531f36420575a16_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTQtNS0xLTEtMTQyNjgw_fb3d3b13-40bf-48c4-8ed1-0d903d5ff690">149</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b6333e92ce42d7ab3cda6056f7c98a_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTQtNy0xLTEtMTQyNjgw_6a71a992-419d-44a6-be96-aa200eb822c4">498</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bb0aa974c214b5e853f0cc3ae70a268_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTgtMS0xLTEtMTQyNjgw_78d2fd1b-c691-4edc-be92-dc02ba64b1b3">403</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia520dd3f71774e2b89b0bbe17d6294b9_I20210630" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTgtMy0xLTEtMTQyNjgw_7cbd6fcc-8c4c-48cc-bebc-0f3369cb8e92">21</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0158083bc55c4728ad23a8bd5fdf8b21_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTgtNS0xLTEtMTQyNjgw_24fd0ccd-b57c-4b69-9565-50aced7ac53d">164</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38dd7f792041456cbe661ea31eb94219_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTgtNy0xLTEtMTQyNjgw_3febde36-bd2c-41a8-8709-6f5acbaf1bb0">546</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d813979e3847bf94273f4ad7b0ec5c_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTktMS0xLTEtMTQyNjgw_9a8742cd-0b58-4256-b947-d6a0c732906c">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a0052b2ab86487f95d0cc11ca0882df_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTktMy0xLTEtMTQyNjgw_c87b2a75-d9cd-408e-b875-88fec588153e">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbbbb87becc84b54bf3ad91efbb9dc00_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTktNS0xLTEtMTQyNjgw_3c4b4cf7-e805-4c43-a2b7-35db6d25d846">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if811f809413d4a6bb8691c5fcaa43e23_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTktNy0xLTEtMTQyNjgw_45de7577-381c-4592-9700-a1d16e3d407a">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d813979e3847bf94273f4ad7b0ec5c_D20210701-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjAtMS0xLTEtMTQyNjgw_b1cc364c-2c7c-4df5-9257-751d6e1b1748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a0052b2ab86487f95d0cc11ca0882df_D20210701-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjAtMy0xLTEtMTQyNjgw_2c13daa2-d280-48de-9cd1-361245f88f27">10</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbbbb87becc84b54bf3ad91efbb9dc00_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjAtNS0xLTEtMTQyNjgw_4706ff13-e49b-49a9-94ff-a64cbb8ff7a2">6</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if811f809413d4a6bb8691c5fcaa43e23_D20210701-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjAtNy0xLTEtMTQyNjgw_596034c7-d2c1-497c-af85-a0cb60ffdae4">4</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d813979e3847bf94273f4ad7b0ec5c_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjEtMS0xLTEtMTQyNjgw_adebd1cc-9b68-4285-bf39-7fa15538d813">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a0052b2ab86487f95d0cc11ca0882df_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjEtMy0xLTEtMTQyNjgw_153fc7ea-cdf7-4a86-bfd7-6b1708b23c66">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbbbb87becc84b54bf3ad91efbb9dc00_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjEtNS0xLTEtMTQyNjgw_3cee5cbf-0efe-454b-938a-feaec8315137">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if811f809413d4a6bb8691c5fcaa43e23_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjEtNy0xLTEtMTQyNjgw_834fb3dc-e625-4e5d-8546-ab0c6ef44587">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d813979e3847bf94273f4ad7b0ec5c_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjItMS0xLTEtMTQyNjgw_91f548a1-0096-4f45-9707-1f6ae2f31c75">9</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a0052b2ab86487f95d0cc11ca0882df_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjItMy0xLTEtMTQyNjgw_f4755fb8-2f37-48df-94c5-b00be80d835a">31</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbbbb87becc84b54bf3ad91efbb9dc00_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjItNS0xLTEtMTQyNjgw_b88a424e-b1c5-4e2c-88aa-c9d93631d8ea">5</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if811f809413d4a6bb8691c5fcaa43e23_D20210701-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjItNy0xLTEtMTQyNjgw_b18a64ff-f274-4e59-a615-3fedcc2cc67e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie85c1700bb824cf3a99834757ca0345d_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjMtMS0xLTEtMTQyNjgw_8884c3e1-a413-465d-965d-0be4579567dc">412</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d7840b6eb44467d910474da7f5cf458_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjMtMy0xLTEtMTQyNjgw_c2cdf596-345b-41c0-a023-9b5b4b428bcd">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7941953b83146c2b4fd8a2efddca131_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjMtNS0xLTEtMTQyNjgw_6ee8a477-284e-4520-9c64-493372a74057">159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e4a56d9d98a4157b2c6e3bb88276c9b_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjMtNy0xLTEtMTQyNjgw_df169f6a-9f6f-4164-8e25-a46fa055e322">519</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70b0eab852154e4abb63bef64c0c9253_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjUtMS0xLTEtMTQyNjgw_a5fe87ad-bc06-4c95-881b-1480ca2ed87d">448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ba1c772ca743cab239215ff58256f1_I20220630" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjUtMy0xLTEtMTQyNjgw_c05030bf-6e7c-44e3-9a66-2c96ada9af55">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03507f6901a459cbfc9f1686e275800_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjUtNS0xLTEtMTQyNjgw_473767c1-d5d8-4e9d-906a-5aded9e5a2b3">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i789c01c0eea04f1d858ad3fba90164ed_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjUtNy0xLTEtMTQyNjgw_58afdf61-5094-4a03-9689-f63451ca8399">479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74cca342e02946e285f57be15d303376_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjYtMS0xLTEtMTQyNjgw_95c97fcb-ba5f-458b-b92f-ac32eecb469f">2</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b245889d00f4e2eb4062bb56ecd5f01_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjYtMy0xLTEtMTQyNjgw_cf88bd46-afb2-4d83-bf8c-0edc9dac9099">5</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f7d0c924ce46a4a0fab6f32137e185_D20220701-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjYtNS0xLTEtMTQyNjgw_83139125-1597-4f41-b04e-39ff7fd57bca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6c3f82aac456096e02558c7413ecd_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjYtNy0xLTEtMTQyNjgw_3aec182b-93fc-48ae-bfa4-f772a5a3bf03">7</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74cca342e02946e285f57be15d303376_D20220701-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjctMS0xLTEtMTQyNjgw_4bde2dd5-f562-43b3-9b60-7898c986f2f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b245889d00f4e2eb4062bb56ecd5f01_D20220701-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjctMy0xLTEtMTQyNjgw_55cf0ed9-f8e0-451d-b86f-150ae600e1ee">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f7d0c924ce46a4a0fab6f32137e185_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjctNS0xLTEtMTQyNjgw_abe8317e-06b2-4bba-9848-ccff6e552ea9">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6c3f82aac456096e02558c7413ecd_D20220701-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjctNy0xLTEtMTQyNjgw_b058bf7c-7949-434b-9ea3-851374d7ec17">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74cca342e02946e285f57be15d303376_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjgtMS0xLTEtMTQyNjgw_dbbaab1c-8ce5-4790-b1ea-6f251f58fc1a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b245889d00f4e2eb4062bb56ecd5f01_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjgtMy0xLTEtMTQyNjgw_84aa26af-e66c-4ea0-af9f-da88221c82d6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f7d0c924ce46a4a0fab6f32137e185_D20220701-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjgtNS0xLTEtMTQyNjgw_3a35899d-b1ce-4c60-9ef1-dc8411527afa">1</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6c3f82aac456096e02558c7413ecd_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjgtNy0xLTEtMTQyNjgw_90095090-4bcb-4ae5-bfb1-972ee4fc7b48">2</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74cca342e02946e285f57be15d303376_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjktMS0xLTEtMTQyNjgw_ef9d3803-1407-4c94-a141-1ae78ad495a9">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b245889d00f4e2eb4062bb56ecd5f01_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjktMy0xLTEtMTQyNjgw_e6b54cf1-1e5e-47e6-a922-7d9fbbfa3bfc">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f7d0c924ce46a4a0fab6f32137e185_D20220701-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjktNS0xLTEtMTQyNjgw_80f6f190-8c09-4280-87f8-bad46a908af3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6c3f82aac456096e02558c7413ecd_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjktNy0xLTEtMTQyNjgw_bd510f81-8422-4d2d-9f91-3afe53e9d21a">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a904ed9259247ed803bd9c4575c448b_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMzAtMS0xLTEtMTQyNjgw_2b076786-96d3-4880-a088-71734492c8ee">449</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8624504988204f299f5466845c6db945_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMzAtMy0xLTEtMTQyNjgw_063a3dfb-b160-47ee-b796-d3e8bc5c6957">100</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i991ef5bf9ed442ca8531f36420575a16_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMzAtNS0xLTEtMTQyNjgw_bcaa0519-ee85-4e7e-a4b3-03d6f6c8ce3a">149</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b6333e92ce42d7ab3cda6056f7c98a_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMzAtNy0xLTEtMTQyNjgw_19fdc4b3-1ced-4df2-b631-03c4dda496c1">498</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in foreign currency translation adjustments are remeasurement losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future. There were <ix:nonFraction unitRef="usd" contextRef="i25f320caf7334b4da9436fd1f08de3df_D20220701-20230331" decimals="INF" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RleHRyZWdpb246Y2Q2YmVhMDExYWZmNDg5ZTliYTM3MzQwYWJlMmVjOTJfNDY4_1e900cce-4b2f-45b6-af5f-e5e56bd9b79b"><ix:nonFraction unitRef="usd" contextRef="i584c8b4ed6394f1d93786bbc0dc674af_D20210701-20220331" decimals="INF" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RleHRyZWdpb246Y2Q2YmVhMDExYWZmNDg5ZTliYTM3MzQwYWJlMmVjOTJfNDY4_2f201506-2c17-478c-ad11-379b5bf37aba"><ix:nonFraction unitRef="usd" contextRef="ie1af7dfaca4b4bb4939e8512479b3d34_D20230101-20230331" decimals="INF" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RleHRyZWdpb246Y2Q2YmVhMDExYWZmNDg5ZTliYTM3MzQwYWJlMmVjOTJfNDY4_5d755a88-89cb-4ea3-aa2e-41e4c60a1da3"><ix:nonFraction unitRef="usd" contextRef="ifa6abb84427f42ceb43e887b2e70e3aa_D20220101-20220331" decimals="INF" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RleHRyZWdpb246Y2Q2YmVhMDExYWZmNDg5ZTliYTM3MzQwYWJlMmVjOTJfNDY4_84d4b27e-a9af-4153-8742-57eb1c4db80b">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> amounts associated with these loans reclassified from Accumulated other comprehensive net (loss) income for the periods presented.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTk0OA_e1e09edb-8875-44ff-b587-77a95184d060" continuedAt="i1d785232d45f4390854d6b887ae48f47" escape="true">EMPLOYEE BENEFIT PLANS</ix:nonNumeric></span></div><ix:continuation id="i1d785232d45f4390854d6b887ae48f47" continuedAt="i1a9e71cdff0a4b688f0aa95634aecde0"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a domestic qualified pension plan (the Plan). The Plan is frozen for all participants. The Plan generally was frozen effective June 30, 2011 for all employees, except for certain collectively bargained employees, whose Plan freeze was effective January 1, 2019. As a result of the Plan freeze, no employees are eligible to commence participation in the Plan or accrue any additional benefits under the Plan.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2022, the Company&#8217;s Board of Directors approved a resolution to terminate the Plan. The amendment will allow the settlement of the pension obligation with either a lump sum payout or a purchased annuity. It is expected to take <ix:nonNumeric contextRef="i1b73d8a1cfaf475cb132b48a9922e0b3_D20220517-20220517" name="clx:DefinedBenefitPlanPlanTerminationPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfNjk5_09e61889-e31e-4d59-9561-6266fd8aea48">18</ix:nonNumeric> to <ix:nonNumeric contextRef="i72e948a45d844caaa808077789bc9946_D20220517-20220517" name="clx:DefinedBenefitPlanPlanTerminationPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfNzA1_b74b3f91-cc57-43fa-80e2-c8187003ddcf">24</ix:nonNumeric> months to complete the termination from the date of the approved resolution to terminate the Plan. The completion of the process of offering and accepting lump sum elections are dependent on when certain regulatory approvals are obtained. Currently, there is not enough information available to determine the ultimate charge of the termination. The Plan is fully funded under specified Employee Retirement Income Security Act (ERISA) funding rules as of March&#160;31, 2023.</span></div><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTk0NQ_18d51198-04e1-464a-992f-c56d3c7aae8b" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of net periodic benefit cost for the Company&#8217;s retirement income plans:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if97497268cb046da9dca9748a32e4bbb_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfMy0xLTEtMS0xNDI2ODA_5e1f6144-5d8a-4a90-b3de-ba257a14bb1a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i246ce3736a7a4184875d648605151755_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfMy0zLTEtMS0xNDI2ODA_c749890c-254f-4abc-99e6-614f37dbf937">3</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69b9322d04104475b3bd0b3239f85400_D20220701-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfMy01LTEtMS0xNDI2ODA_d2876cd2-c73e-4007-872b-7fafdfce90ee">13</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a3774c2804469a6e6a80652cf53fb_D20210701-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfMy03LTEtMS0xNDI2ODA_5e904df3-5c71-4b0e-a9c6-f516ac2cd59e">11</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if97497268cb046da9dca9748a32e4bbb_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNC0xLTEtMS0xNDI2ODA_27d373c4-4c4a-46cd-8b0d-e7fbf381f383">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i246ce3736a7a4184875d648605151755_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNC0zLTEtMS0xNDI2ODA_3aeae124-a277-4326-a51a-0b63ecee09f4">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69b9322d04104475b3bd0b3239f85400_D20220701-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNC01LTEtMS0xNDI2ODA_9c431643-2ad3-43dc-8cff-afefb934825e">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a3774c2804469a6e6a80652cf53fb_D20210701-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNC03LTEtMS0xNDI2ODA_d54a34c1-c467-4f52-8ca3-458f0e2f3f9f">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss recognized</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if97497268cb046da9dca9748a32e4bbb_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNS0xLTEtMS0xNDI2ODA_6d0bfc09-125e-445e-b9a8-8e54db133783">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i246ce3736a7a4184875d648605151755_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNS0zLTEtMS0xNDI2ODA_014fcd08-9355-4c30-a884-77e9834b4001">1</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69b9322d04104475b3bd0b3239f85400_D20220701-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNS01LTEtMS0xNDI2ODA_4709b360-2b57-4782-916d-9ee9e0752215">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a3774c2804469a6e6a80652cf53fb_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNS03LTEtMS0xNDI2ODA_3cc3d4bf-bb07-40a0-85d5-837f8dd54fbd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized items</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if97497268cb046da9dca9748a32e4bbb_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNi0xLTEtMS0xNDI2ODA_6e5f65f8-c99b-4d71-b04f-619ab4cee395">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i246ce3736a7a4184875d648605151755_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNi0zLTEtMS0xNDI2ODA_536773f9-a071-4ceb-ae56-4b0f745318d4">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69b9322d04104475b3bd0b3239f85400_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNi01LTEtMS0xNDI2ODA_33e3493c-41b1-4eca-b60c-501158b6f6b3">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a3774c2804469a6e6a80652cf53fb_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNi03LTEtMS0xNDI2ODA_ca2b7f01-4fdc-4800-b77d-17284651e744">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if97497268cb046da9dca9748a32e4bbb_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNy0xLTEtMS0xNDI2ODA_15d6a0f9-da64-4778-875e-75119978295a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i246ce3736a7a4184875d648605151755_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNy0zLTEtMS0xNDI2ODA_4603dbfe-f73c-4afa-bc3e-74fef176f8d9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69b9322d04104475b3bd0b3239f85400_D20220701-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNy01LTEtMS0xNDI2ODA_e5b4de16-8a07-46f7-b1a2-ebb587d720a4">12</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a3774c2804469a6e6a80652cf53fb_D20210701-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNy03LTEtMS0xNDI2ODA_a90c3a7c-c957-4557-9191-b6f26bc6e5cb">8</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2023 net periodic benefit cost is <ix:nonFraction unitRef="number" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTQyNQ_5d20e239-cf0a-47b5-b889-c9bbe3cb76ed">2.7</ix:nonFraction>%.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic benefit cost for the Company&#8217;s retirement health care plans was $(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTUxMA_3653d1ec-48d5-4795-a4d2-82eb946c8b99"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTUxMA_65dd646e-b8b1-47e2-97fd-314b04a30717">1</ix:nonFraction></ix:nonFraction>) for both the three and nine months ended March&#160;31, 2023, and $<ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTA0NDUzNjA0NjYzMzM_a51d63b2-c0d1-4410-96bc-fe764f00f700"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTA0NDUzNjA0NjYzMzM_e36362b4-a4f6-4509-9136-cce43fff983f">0</ix:nonFraction></ix:nonFraction> for both the three and nine months ended March&#160;31, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During both the three months ended March&#160;31, 2023 and 2022, the Company made $<ix:nonFraction unitRef="usd" contextRef="i6c9faa6e294049b0b02b4ca616aef8d4_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTY0OTI2NzQ0MzYxOQ_7593b000-22c9-48bf-95a5-2345294562d3"><ix:nonFraction unitRef="usd" contextRef="i5018154f07a6473082b19c7019bb5815_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTY0OTI2NzQ0MzYxOQ_b18e9b5c-c2e4-480a-8a98-9f697f9d5c20">8</ix:nonFraction></ix:nonFraction> in contributions to its domestic retirement income plans. During the nine months ended March&#160;31, 2023 and 2022, the Company made $<ix:nonFraction unitRef="usd" contextRef="i559a56b3ed7f4dad8b0eb215d3b4d96e_D20220701-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTY5MA_401fdb89-4ce9-45f0-9078-1f03c8949410">12</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="icb1bd9ce8db14db8b42305bf898b2988_D20210701-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTY5Nw_a358944f-209f-4848-950c-dc8a4aa63f31">13</ix:nonFraction> in contributions to its domestic retirement income plans, respectively.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1a9e71cdff0a4b688f0aa95634aecde0">Service cost component of the net periodic benefit cost, if any, is reflected in employee benefit costs, all other components are reflected in Other (income) expense, net.</ix:continuation> </span></div><div><span><br/></span></div><div id="i35f8305358714061a46930a84f00a8d0_49"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfNDg1Mw_da13b9ae-64ca-46b9-9a48-cd48a64c5def" continuedAt="iecb01c8747eb408b8a9afc32f402d016" escape="true">OTHER CONTINGENCIES AND GUARANTEES</ix:nonNumeric></span></div><ix:continuation id="iecb01c8747eb408b8a9afc32f402d016" continuedAt="i677978c50ab94842b458ba64db24395a"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in certain environmental matters, including response actions at various locations. The Company had recorded liabilities totaling $<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfMjE2_f178be75-4f16-437e-9661-afcd4580551b">26</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfMjIz_e7b0c983-c14f-4a2c-ad50-b3dba0b4a73a">28</ix:nonFraction> as of March&#160;31, 2023 and June&#160;30, 2022, respectively, for its share of aggregate future remediation costs related to these matters. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One matter, which accounted fo</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="i1215ef2fd713408c9543e79c8cf060d0_I20230331" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfMzY4_c8d0234d-5ee3-4863-8a7c-63d651b96ccb">12</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="i7407b536aaac44c9a0ef22436412b35c_I20220630" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfMzc1_f2661df8-4529-402e-bdbe-b53da748bd14">14</ix:nonFraction> of the recorded liability as of March&#160;31, 2023 and June&#160;30, 2022, respectively, relates to environmental costs associated with one of the Company&#8217;s former operations at a site located in Alameda County, California. In November 2016, at the request of regulators and with the assistance of environmental consultants, the Company submitted a Feasibility Study that evaluated various options for managing the site and included estimates of the related costs. Following further discussions with the regulators in 2017, the Company recorded an undiscounted liability for costs estimated to be incurred over a <ix:nonNumeric contextRef="iac8c0a67be954e91bf9ca146dc56b8af_D20220701-20230331" name="clx:RemediationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfNDg1Nw_66fab8a3-e412-4207-bb28-ad0d22f34780">30-year</ix:nonNumeric> period, based on one of the options in the Feasibility Study. In September 2021, as a result of an additional study and further discussions with regulators, the Company submitted a Soil Vapor Intrusion Report to the regulators, which has not resulted in a change to the recorded liability. While the Company believes its latest estimates of remediation costs are reasonable, the ultimate remediation requirements are not yet finalized and the regulators could require the Company to implement remediation actions for a longer period or take additional actions, which could include estimated undiscounted costs of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i1215ef2fd713408c9543e79c8cf060d0_I20230331" decimals="-6" name="clx:MaximumExposureUndiscountedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfMTYwMA_df170f78-af5f-4b19-9487-e52216e76848">28</ix:nonFraction> over an estimated <ix:nonNumeric contextRef="iac8c0a67be954e91bf9ca146dc56b8af_D20220701-20230331" name="clx:RemediationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfNDg1MQ_9465b633-6c4e-4a03-a354-7126b22c8551">30-year</ix:nonNumeric> period, or require the Company to take different actions and incur additional costs. </span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12: OTHER CONTINGENCIES AND GUARANTEES (continued)</span></div></div><ix:continuation id="i677978c50ab94842b458ba64db24395a"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another matter in Dickinson County, Michigan, at the site of one of the Company&#8217;s former operations for which the Company is jointly and severally liable, accounted for $<ix:nonFraction unitRef="usd" contextRef="i5fc0efb36d7e490a8d10a178a4f95683_I20230331" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfMTg4NA_416db166-4235-48f1-812c-1ded31ba7dbd">10</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic71f7f98850c425cb50e81ac8cee6715_I20220630" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfNjU5NzA2OTc3MTU3NQ_8e9f306c-277e-43e0-845f-82c4cf595f76">9</ix:nonFraction> of the recorded liability as of both March&#160;31, 2023 and June&#160;30, 2022, respectively. This amount reflects the Company&#8217;s agreement to be liable for <ix:nonFraction unitRef="number" contextRef="if9807c06a76d40c0ae21df8a99a25033_D20220701-20230331" decimals="3" name="clx:SiteContingencyAgreedPercentageOfCostSharing" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfMTk5Nw_46286991-de83-4355-b8c6-4c2f8c427586">24.3</ix:nonFraction>% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing agreement with a third party. If the third party is unable to pay its share of the response and remediation obligations, the Company may be responsible for such obligations. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance and other costs that may be incurred over an estimated <ix:nonNumeric contextRef="if9807c06a76d40c0ae21df8a99a25033_D20220701-20230331" name="clx:RemediationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfNDg1Mg_f7bb2632-59c9-4cc6-9442-a3dbbec0308c">30-year</ix:nonNumeric> remediation period. Although it is reasonably possible that the Company&#8217;s exposure may exceed the amount recorded for the Dickinson County matter, any amount of such additional exposures, or range of exposures, is not estimable at this time. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated losses related to these matters are sensitive to a variety of uncertain factors, including the efficacy of any remediation efforts, changes in any remediation requirements and the future availability of alternative clean-up technologies. The Company is subject to various legal proceedings, claims and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements (including costs connected to the transition and unwinding of certain supply and manufacturing relationships), product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, either individually or in the aggregate, on the Company&#8217;s condensed consolidated financial statements taken as a whole.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make, any material payments relating to its indemnifications, and believes that any reasonably possible payments would not have a material adverse effect, either individually or in the aggregate, on the Company&#8217;s condensed consolidated financial statements taken as a whole.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had not recorded any material liabilities on the aforementioned guarantees as of both March&#160;31, 2023 and June&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was a party to letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="clx:LetterOfCreditBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfNDc2MA_04365ad2-f008-4c97-98ff-90f94adc7f90">14</ix:nonFraction> as of March&#160;31, 2023, primarily related to its insurance carriers, of which $<ix:nonFraction unitRef="usd" contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfNDgyNw_ded08958-1404-4864-96ac-820edb072cc2">0</ix:nonFraction> had been drawn upon.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13. <ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTgzMA_5748fc24-d740-44f4-984e-eea66c672ac0" continuedAt="i1490258abe8a403499787453ff4da966" escape="true">SEGMENT RESULTS</ix:nonNumeric></span></div><ix:continuation id="i1490258abe8a403499787453ff4da966" continuedAt="i2c29e4ed15994b6698663b7e3986b629"><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTgyNw_5e7e9f7c-c7d5-4d19-af31-b0b32927f695" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates through strategic business units (SBUs) that are organized into the Company&#8217;s operating segments. The operating segments are then aggregated into <ix:nonFraction unitRef="reportablesegment" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTk3_1b6fc735-dee8-49df-b30c-cea373521621">four</ix:nonFraction> reportable segments: Health and Wellness, Household, Lifestyle and International. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTgzOA_92c57a45-9407-4724-928e-7ee9cb8d582f" continuedAt="ia05a8a97eb25481f8f3c8fe72f55e931" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present reportable segment information and a reconciliation of the segment information to the Company&#8217;s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.133%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffcf3e3d97fe478ba53f98097b7768d3_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMy0yLTEtMS0xNDI2ODA_254e1a74-a0e1-42fc-bdba-0702be3892d0">707</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3033698cc9d446b98ebb51f2cc6a8fc7_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMy00LTEtMS0xNDI2ODA_f5968441-4342-4f00-af68-48b63d98be90">662</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8b819629ac7412c9fa594839a2ca9ee_D20220701-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMy02LTEtMS0xNDI2ODA_84635877-56e7-4139-8d27-00f84ed5e17a">2,054</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8d519a96f9042bc8dcb0510d40a1b4e_D20210701-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMy04LTEtMS0xNDI2ODA_01588b7b-a8a8-475a-afc8-03a5e7d9c16a">2,055</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b20ce7569f946f996cfe02a046120e8_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNC0yLTEtMS0xNDI2ODA_0ff02cff-9ba8-4088-bedb-10ff95150e0f">550</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37775bc712c546ebbc80496c37c9b997_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNC00LTEtMS0xNDI2ODA_64a0c8e9-6c50-456a-9375-6fa300e25bed">539</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c9d7f9d14d24f99895d7cf206821b4b_D20220701-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNC02LTEtMS0xNDI2ODA_5b51c882-e7fd-4828-a223-041d1e910262">1,435</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4031a9dd94ae4d12aae506d6f2f1db96_D20210701-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNC04LTEtMS0xNDI2ODA_6850a4da-5408-4ab0-9981-f5ac001f4f71">1,404</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9575da4e024669a982592f716c50d9_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNS0yLTEtMS0xNDI2ODA_2628c1d5-891a-4746-8bb7-efb0a775c929">353</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dc7ce1afe424640808a9e7de9aa36a0_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNS00LTEtMS0xNDI2ODA_c4c92d2c-8fba-491f-ba2b-d0597a240101">306</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71b9480776e436f9c519240052f7677_D20220701-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNS02LTEtMS0xNDI2ODA_48c61146-b062-46f2-ac31-1e4cbadb06b2">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d021f6c3597425098add480ff912297_D20210701-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNS04LTEtMS0xNDI2ODA_fd1536e5-17e4-4ce4-8be1-8b96cc019f29">961</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce3534c232c40299861e02393f34ae2_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNi0yLTEtMS0xNDI2ODA_4cf377ea-9dfd-4f20-8594-00ce19cd3a3d">305</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8021e9a77dd946919cfb390e149fbf16_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNi00LTEtMS0xNDI2ODA_dada02f1-4af4-4f0d-859c-d2c142b350be">302</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5de8a3a44dc424bbd78630823dbc605_D20220701-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNi02LTEtMS0xNDI2ODA_f39eaf57-1ead-4f2a-906e-f075d3d4e89d">876</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca9fa030b7e4d4d857d843d0538b755_D20210701-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNi04LTEtMS0xNDI2ODA_b34187ca-01bf-493b-99f2-0fcb6632a25f">886</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfOC0yLTEtMS0xNDI2ODA_dadabeba-2001-4e58-b0c4-0c1424f04bac">1,915</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfOC00LTEtMS0xNDI2ODA_23d49e61-c5f7-495c-a374-0522c81d276b">1,809</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfOC02LTEtMS0xNDI2ODA_15c66fa8-2149-4711-ae9d-74076dcbf8ee">5,370</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfOC04LTEtMS0xNDI2ODA_5271d44d-c41b-449b-a937-d1c4a3277643">5,306</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (losses) before income taxes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffcf3e3d97fe478ba53f98097b7768d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTMtMi0xLTEtMTQyNjgw_170a0c28-d231-4d1a-bcf1-1a8798970baf">290</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3033698cc9d446b98ebb51f2cc6a8fc7_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTMtNC0xLTEtMTQyNjgw_ae4a78fc-531e-4147-9555-cfc56e8966a2">84</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8b819629ac7412c9fa594839a2ca9ee_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTMtNi0xLTEtMTQyNjgw_c1f06046-3f75-4faa-855f-d074b16d765a">72</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8d519a96f9042bc8dcb0510d40a1b4e_D20210701-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTMtOC0xLTEtMTQyNjgw_77f7b125-7c30-43c9-a1ee-66b6bc89d7af">245</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b20ce7569f946f996cfe02a046120e8_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTQtMi0xLTEtMTQyNjgw_96446760-2f1b-4b9c-9869-af32bcdc1514">99</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37775bc712c546ebbc80496c37c9b997_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTQtNC0xLTEtMTQyNjgw_c09f4e04-c631-4c5a-9775-c280f422fa98">92</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c9d7f9d14d24f99895d7cf206821b4b_D20220701-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTQtNi0xLTEtMTQyNjgw_22315567-5224-47d7-835b-210f481076e4">165</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4031a9dd94ae4d12aae506d6f2f1db96_D20210701-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTQtOC0xLTEtMTQyNjgw_6d372fe7-e052-41de-8f87-171d46e0095c">138</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9575da4e024669a982592f716c50d9_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTUtMi0xLTEtMTQyNjgw_607b3287-d26f-42bc-85f8-8ac87515e965">83</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dc7ce1afe424640808a9e7de9aa36a0_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTUtNC0xLTEtMTQyNjgw_8e8404da-0ea2-4175-8758-f1db7905fd34">66</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71b9480776e436f9c519240052f7677_D20220701-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTUtNi0xLTEtMTQyNjgw_985a1f7b-5abb-4dd5-b1a9-5540579cf8a2">217</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d021f6c3597425098add480ff912297_D20210701-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTUtOC0xLTEtMTQyNjgw_0694d9e5-2357-4309-9ad9-105e9c7a3817">239</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce3534c232c40299861e02393f34ae2_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTYtMi0xLTEtMTQyNjgw_cc4bdbeb-cff9-4722-a839-de4cb9c88896">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8021e9a77dd946919cfb390e149fbf16_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTYtNC0xLTEtMTQyNjgw_7498a15d-af07-40b2-a099-b42cd5ed582b">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5de8a3a44dc424bbd78630823dbc605_D20220701-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTYtNi0xLTEtMTQyNjgw_20cabbc5-cd2e-4165-a2ab-e631f7fbb558">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca9fa030b7e4d4d857d843d0538b755_D20210701-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTYtOC0xLTEtMTQyNjgw_fb3a45ef-4ad4-4a5b-98e9-6982ff8463f7">80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icedf8ca64b12469f8b334ea1c52ce44f_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTctMi0xLTEtMTQyNjgw_cbb280fc-cd61-4e3b-9854-f1c9624e7d3c">152</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic113bbab87514834aeff65f9dcd2d9ea_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTctNC0xLTEtMTQyNjgw_e71758e6-7df5-40c8-9376-dd3dd35275e0">73</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib82d343ec2d2457491346026e4a1384b_D20220701-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTctNi0xLTEtMTQyNjgw_c8fa3f3d-6c08-4a73-84a8-75ef91e57daf">371</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i008bd39b3c1441d28f56d156aa4e0e13_D20210701-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTctOC0xLTEtMTQyNjgw_ff2c22ad-6694-4650-b2d7-7a96651c2377">224</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTgtMi0xLTEtMTQyNjgw_5c82bd23-82bb-4d46-aa57-246a2e677999">245</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTgtNC0xLTEtMTQyNjgw_a47d7d46-c6b2-4e02-b846-54d1ea78df63">200</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTgtNi0xLTEtMTQyNjgw_58e3b75b-c4e9-44f3-9957-84599af118b1">1</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTgtOC0xLTEtMTQyNjgw_36c0ebde-1ed7-48f9-9e4d-a2c9d509b29b">478</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">The earnings (losses) before income taxes for the Health and Wellness segment includes $<ix:nonFraction unitRef="usd" contextRef="id94ba9c2186c47749a192c36f50af6e2_D20230101-20230331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTA5OTUxMTYzMDgzMg_6dd17bf2-568e-44fa-b5d4-fda0ca4db47d"><ix:nonFraction unitRef="usd" contextRef="i14a182d0cd5c4d15965a7e7a7bfdc653_D20220701-20230331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTA5OTUxMTYzMDgzMg_6fd3cc3e-103e-4b62-8c50-8dc7bd860468">433</ix:nonFraction></ix:nonFraction> of non-cash impairment charges related to the VMS business for the three and nine months ended March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">The earnings (losses) before income taxes for the International segment include $<ix:nonFraction unitRef="usd" contextRef="if866eca78fc44cb985650980c0effb9e_D20230101-20230331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTA5OTUxMTYzMDg0OA_0480a602-616f-4c59-88d9-3d687e0ba797"><ix:nonFraction unitRef="usd" contextRef="i1963ee82a44d46ffa8708d4e456f329c_D20220701-20230331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTA5OTUxMTYzMDg0OA_437d4512-7080-4ae5-8322-4e1cfeaaea89">12</ix:nonFraction></ix:nonFraction> of non-cash impairment charges related to the VMS business for the three and nine months ended March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">The losses before income taxes for Corporate includes restructuring and related implementation costs, net for the streamlined operating model of $<ix:nonFraction unitRef="usd" contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTA3Ng_dcc9dc52-31b7-4f54-80fa-c7bf33bc21a5">21</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTA4Mw_89c59f32-75ca-4079-ba38-598d891611f8">44</ix:nonFraction> for the three and nine months ended March&#160;31, 2023, respectively. While recorded within the Corporate segment, for informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company&#8217;s reportable segments as a percentage of the total costs: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"></td><td style="width:5.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.421%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.451%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.192%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i06b7961dd4ab4d08b1f59fd5cecff3e8_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfMi0zLTEtMS0xNDI2ODA_bc0b098d-125a-4b89-88ab-59be342f6dbc">7</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8cd31d1d39a4a1dad35192d8a05943e_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfMi01LTEtMS0xNDI2ODA_634f4356-8976-4882-b5bb-9b8ca1d22e8a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iae7e934f7d3345e38420a6419068a3d5_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfMy0zLTEtMS0xNDI2ODA_83a550b6-af80-4548-97eb-d385e9bfa137">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4827a5147dae403184de103cfa7cb609_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfMy01LTEtMS0xNDI2ODA_a49b1ddb-f81d-480f-9fb3-bfbe80b64464">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iea0e1ddc7df0436291cc964f291d7156_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNC0zLTEtMS0xNDI2ODA_56a21bca-3ee9-461a-9a2a-173c6bdf4af1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c370fc073ec40fc9f41fba7ceb625bf_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNC01LTEtMS0xNDI2ODA_7e275be4-c3c0-4cb9-87fe-60309e3c05fb">3</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i51a5efc4b1ce48669aeefd4046d6b146_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNS0zLTEtMS0xNDI2ODA_3ccea1ed-63ba-4382-8160-1666d96dece2">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibc836f2559f64ad48298463711e54cef_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNS01LTEtMS0xNDI2ODA_b9f7b675-3a2c-4e4e-9017-d1f6799d10cf">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d7befdad82d4d418a5d6f0c05a4d46a_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNi0zLTEtMS0xNDI2ODA_b960e75a-bbd3-470e-81a0-a98f0418d7e0">66</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5f58e61108af4223b214e3fe0d5d2094_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNi01LTEtMS0xNDI2ODA_84302287-3b86-4ffb-9f17-b0eb75851e30">70</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e525b30dbd84ad096b5a005cb6c06b7_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNy0zLTEtMS0xNDI2ODA_cd714d0d-6041-40ac-8ff6-fe5a1debfffd">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ed91cca97714a74bfef07a13999207e_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNy01LTEtMS0xNDI2ODA_069ca93f-b31e-47b2-9432-44363e44200f">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intersegment sales are eliminated and are not included in the Company&#8217;s reportable segments&#8217; net sales.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales to the Company&#8217;s largest customer, Walmart Inc. and its affiliates, as a percentage of consolidated net sales, were <ix:nonFraction unitRef="number" contextRef="i376f067722d54b38b9d07d5df655a930_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTYwOA_3c99f90c-45ea-4936-bdb4-7a9951c0ad35"><ix:nonFraction unitRef="number" contextRef="ie7a17140503d4ae99e2c3110f5493890_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTYwOA_5ae4e646-8a88-47f6-aafc-df6e9b187924">26</ix:nonFraction></ix:nonFraction>% for the three and nine months ended March&#160;31, 2023 and <ix:nonFraction unitRef="number" contextRef="i534b552133ab458393a04aa68bb98837_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTY1MQ_436e1699-82c4-44d9-8b49-6748249e8dad"><ix:nonFraction unitRef="number" contextRef="i2bcfd545b0374fbdb3542e9d143d4386_D20210701-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTY1MQ_70b6d632-f54a-4e7e-bc8b-4798fe5e9de1">25</ix:nonFraction></ix:nonFraction>% for the three and nine months ended March 31, 2022.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13. SEGMENT RESULTS (Continued)</span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:continuation id="i2c29e4ed15994b6698663b7e3986b629"><ix:continuation id="ia05a8a97eb25481f8f3c8fe72f55e931"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides Net sales as a percentage of the Company&#8217;s consolidated net sales, disaggregated by operating segment, for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.586%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cleaning</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ff574e3aa2743caabd5efe4f9812b66_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMy0yLTEtMS0xNDI2ODA_3e23cd12-a9cf-4c13-8cc2-bcecfd2359a2">30</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib002fea2011949d68a0bf85c0cd5f82f_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMy01LTEtMS0xNDI2ODA_8f44c19e-b0dc-4f5e-8814-3fa32ebec85e">28</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ca63fe7639d421784a23dec0aad3de2_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMy04LTEtMS0xNDI2ODA_da499b68-53ac-4295-b8a1-00c27656aa18">30</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5f0cd8998a3d48ed956c2195a10e4a96_D20210701-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMy0xMS0xLTEtMTQyNjgw_4ed4a0d1-c596-44c4-838e-1f4e43ecb195">30</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3cdb483b522a49da8b6e69c8bfb68e8b_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNC0yLTEtMS0xNDI2ODA_032707d3-323f-4326-9eb5-cf9092639e7b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48472411ffc14234a19c3b450fcd82c8_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNC01LTEtMS0xNDI2ODA_cd324069-b704-4366-9f5c-d3b8d5e76ae2">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if3eb238ad2564e2fb6be808234d4fb8a_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNC04LTEtMS0xNDI2ODA_90e22706-6d4f-4a96-927d-f6d2a413689b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i629e3b1f030e4ce897713db4360a2347_D20210701-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNC0xMS0xLTEtMTQyNjgw_588bc2e7-75db-48e8-9e87-e4dc7782af45">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitamins, Minerals and Supplements</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9db2e760489b4c11a3d33f81189967c9_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNS0yLTEtMS0xNDI2ODA_d2ce016e-5729-4a9e-9fa1-59eeec7f5e01">3</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39223577acf644679357f58a1290bd2a_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNS01LTEtMS0xNDI2ODA_d9dca5c2-8c11-4448-a00b-7b8e01726653">4</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie881bce8f5334f7aab4e543c319a5926_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNS04LTEtMS0xNDI2ODA_091859b1-566c-4f8d-b629-0831f20c1923">3</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idbae45119cfa4a5c8b13e22928f50489_D20210701-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNS0xMS0xLTEtMTQyNjgw_67a99b80-d594-4d4b-8bb4-771100f2ae3b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ice64939ca72241c09ec2b7d83c993371_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNi0yLTEtMS0xNDI2ODA_7d5faf6a-611e-41b9-992c-428219172c7f">37</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i50673219f145422f8c076edc553d124d_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNi01LTEtMS0xNDI2ODA_9a7972b3-7cd7-402c-8b19-41de46ef7893">36</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id28fe0fdacae42b3a9ca317dc63e5d74_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNi04LTEtMS0xNDI2ODA_fd205005-2f58-4e2b-877a-f61d7e5f238d">38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1beaeabc59b0460b9b16920dc20b95a4_D20210701-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNi0xMS0xLTEtMTQyNjgw_b57ee0e9-06b8-47a6-b9ce-542ff99c038c">39</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bags and Wraps</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95fdb90c917e4246b77256a7203284f4_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNy0yLTEtMS0xNDI2ODA_40e2b19e-09e3-4ff0-bce9-0f77c388bcad">12</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63cbaccfe8b441e0b139019ea3e13e72_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNy01LTEtMS0xNDI2ODA_98b08317-e45e-4320-a23a-b3efdd260bc9">12</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i113699d3252e4e2d9ff0cd35976a5b8c_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNy04LTEtMS0xNDI2ODA_f262f1f7-fd51-482a-81de-714315ac9638">12</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2fbb109938324676a455905b3813090f_D20210701-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNy0xMS0xLTEtMTQyNjgw_0f559a78-35f1-40de-a37c-e4537b1e2388">12</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grilling</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i57adcb1929154f35951a65c97a1a9eec_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOC0yLTEtMS0xNDI2ODA_7a767fad-0110-4785-a05d-6c89eda1224c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i787f1a9b3f7a4dc8b0d448fa0c26e975_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOC01LTEtMS0xNDI2ODA_26109a06-773b-4abc-b47a-f3cdafe01dec">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i989a32ba4f8d4a9d8454b53f177bf23d_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOC04LTEtMS0xNDI2ODA_6d66837b-8e4c-4938-a710-b6c0bad6d8e6">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i72213a90a16e4a55bf5162ceee1ad06b_D20210701-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOC0xMS0xLTEtMTQyNjgw_38d7b416-f0a8-4478-98ed-10359ef13492">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cat Litter</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iecbb9ee292dc40f8a27a70a208e98f03_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOS0yLTEtMS0xNDI2ODA_50052fde-cf34-4a3c-99da-3fdd9aa1ba3a">9</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i503ca72ebec94846ab018289383f13fa_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOS01LTEtMS0xNDI2ODA_d662fdb9-cc79-4450-bd88-1da0d5e97a23">8</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieda62ebce8934fb09ef0adb92b5f7803_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOS04LTEtMS0xNDI2ODA_4b9b6735-cb4a-4380-ac7e-b42c7a3d7d62">9</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i055b0b22709c429cbd64d4daebac1297_D20210701-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOS0xMS0xLTEtMTQyNjgw_a8eedd41-efa9-4aab-bbf2-618db01208ff">8</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8a65275769d74bf48e3a461bc2e6a39d_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTAtMi0xLTEtMTQyNjgw_8627f17e-b58a-42f5-b515-5ac527584e07">29</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb5c1ab1b82640178fbbc21e8512a431_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTAtNS0xLTEtMTQyNjgw_afe603f6-b304-44be-b5cc-c8711e70891b">30</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id2436443839a40d6b25b269f3515ff1c_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTAtOC0xLTEtMTQyNjgw_8b25233b-4714-4006-a1dd-df92f44ce68d">27</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie58eaa3597cd43668b6d4a0be6618155_D20210701-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTAtMTEtMS0xLTE0MjY4MA_796f7c42-82c1-4556-9a5c-89678f86c6b5">26</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iec1abcd1af04423ca693619b5556f630_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTEtMi0xLTEtMTQyNjgw_97244089-0751-4736-9b06-9602e46c133f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9de0a48a571549d3b006153987874a47_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTEtNS0xLTEtMTQyNjgw_e2f194bd-de39-485a-9ebf-9a882241ed6b">10</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63c6253b79704765be3a2886b72dc7ca_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTEtOC0xLTEtMTQyNjgw_593ceca1-ca79-4f27-8970-f7192741fe65">11</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib18537f4ac7f4342b5c6624f2b7bf768_D20210701-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTEtMTEtMS0xLTE0MjY4MA_36c7d781-d884-4ab2-8670-4ac0f473b9ea">10</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natural Personal Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a97ed3b14274b9b830776063e4410c8_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTItMi0xLTEtMTQyNjgw_6d0f5c39-8d55-4211-8c1a-6b75fa5c1982">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2f5fb7871c7436b900d2cd3d8311c5f_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTItNS0xLTEtMTQyNjgw_2ebfe798-f096-48fe-a6d8-a0b8fa70b0d9">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f41877e3cc24d2ab82f800b4e54b330_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTItOC0xLTEtMTQyNjgw_c252e3a8-d21c-4978-8fca-4fa095947c3d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i114f5fcb844c4cd48afc6773bae7de68_D20210701-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTItMTEtMS0xLTE0MjY4MA_7e32be6b-162a-4e06-9c51-46400c2f01f6">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Water Filtration</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic47b0bf2f6b74406ae63df384f0f2170_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTMtMi0xLTEtMTQyNjgw_01bed872-8cf8-4652-9da6-b3ccb65cf82c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8b2275a8baa74a81974673ca3c98e934_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTMtNS0xLTEtMTQyNjgw_e15958d9-946d-4e9a-854b-7394b985d3d6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63be3d36820c4c14aeb977054b7bd9ef_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTMtOC0xLTEtMTQyNjgw_46d18a8e-fcf5-435c-ba8f-c20b09ba2460">4</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic9c4181e447f4561894f05c7189939a9_D20210701-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTMtMTEtMS0xLTE0MjY4MA_798956c9-15b4-414c-bc78-d012b8459687">4</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2fcc63cd4e714eeeb040154124f4230f_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTQtMi0xLTEtMTQyNjgw_853776a4-7e4a-42d7-8663-68b5cfa487bf">18</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icaa89fb3550f4a919ddc0549b774313a_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTQtNS0xLTEtMTQyNjgw_fd820dc3-834b-47fe-9ac5-2285b737ca24">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i141a04ca2b22429d966e6c25a5ba5b9f_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTQtOC0xLTEtMTQyNjgw_1ffc2527-36ec-4f3a-9f73-e4f56691b94a">19</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib0aa39c9b9204bc7812195ead8b31158_D20210701-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTQtMTEtMS0xLTE0MjY4MA_12c0268e-ef45-410e-b919-fb6f7b5c4cc2">18</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i964cbc2a36904c2c953e83d44d0db963_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTUtMi0xLTEtMTQyNjgw_2485217f-8b5f-4d8a-bc3e-9dcde877170d">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i90c7b45b7f53405ea50b2def6902b7ec_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTUtNS0xLTEtMTQyNjgw_700bc739-6ca0-4d8c-a16d-d44d3e47cbfc">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80debe7af7c04b0d8001e647ecf24389_D20220701-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTUtOC0xLTEtMTQyNjgw_c575dcda-91ca-4e13-9afc-d85b9fef1c46">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if63670b5302b4743b3c30e0b8aadda12_D20210701-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTUtMTEtMS0xLTE0MjY4MA_d1b90fc6-dcb1-4c89-93b9-33887761ff70">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i788105bef8f040c3abaaec1851973630_D20230101-20230331" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTYtMi0xLTEtMTQyNjgw_ef141c63-1604-4ea7-8962-73060a43d009">100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i119fc41a359743d585ccf388679848e8_D20220101-20220331" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTYtNS0xLTEtMTQyNjgw_f9cc5434-8c14-4387-9758-fbf23d6f4331">100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib082af343f52451fb96251c408730857_D20220701-20230331" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTYtOC0xLTEtMTQyNjgw_f6e3f0a5-b750-4f29-8d06-c43d388bf3fb">100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d29d27dc57146a59614c80c2341fa42_D20210701-20220331" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTYtMTEtMS0xLTE0MjY4MA_44d5c26d-d917-41aa-93d5-b24b386363b2">100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></ix:continuation></ix:continuation></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company<br/>(Dollars in millions, except per share data)</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (MD&amp;A) is designed to provide a reader of The Clorox Company&#8217;s (the Company or Clorox) financial statements with a narrative from the perspective of management on the Company&#8217;s financial condition, results of operations, liquidity and certain other factors that may affect future results. The following discussion of the Company&#8217;s financial condition and results of operations should be read in conjunction with MD&amp;A and the consolidated financial statements and related notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022, which was filed with the SEC on August 10, 2022, and the unaudited condensed consolidated financial statements and related notes contained in this Quarterly Report on Form 10-Q (this Report). Unless otherwise noted, MD&amp;A compares the three and nine month periods ended March&#160;31, 2023 (the current period) to the three and nine month periods ended March&#160;31, 2022 (the prior period), with percentage and basis point calculations based on rounded numbers, except for per share data and the effective tax rate.</span></div><div style="margin-top:8pt"><span><br/></span></div><div id="i35f8305358714061a46930a84f00a8d0_58"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OVERVIEW</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clorox is a leading multinational manufacturer and marketer of consumer and professional products with approximately 9,000 employees worldwide. Clorox sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, drug, pet and military stores, third-party and owned e-commerce channels, and distributors. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach and cleaning products, Pine-Sol</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cleaners; Liquid-Plumr</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> clog removers; Poett</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> home care products; Fresh Step</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cat litter; Glad</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> bags and wraps; Kingsford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> grilling products; Hidden Valley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dressings, dips, seasonings and sauces; Brita</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> water-filtration products; Burt&#8217;s Bees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> natural personal care products; and RenewLife</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Rainbow Light</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Natural Vitality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and NeoCell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vitamins, minerals and supplements. The Company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro</span><span style="color:#0a0a0a;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Clorox Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand names. The Company has operations in more than 25 countries or territories and sells its products in more than 100 markets.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company primarily markets its leading brands in midsized categories considered to be financially attractive. Most of the Company&#8217;s products compete with other nationally advertised brands within each category and with &#8220;private label&#8221; brands.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates through strategic business units (SBUs) that are organized into the Company&#8217;s operating segments. These operating segments are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. These four reportable segments consist of the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Health and Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the U.S. Products within this segment include cleaning products such as laundry additives and home care products, primarily under the Clorox</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Clorox2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Scentiva</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Pine-Sol, Liquid-Plumr, Tilex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Formula 409</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplements under the RenewLife, Natural Vitality, NeoCell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Rainbow Light brands.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Household</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of bags and wraps, grilling products and cat litter marketed and sold in the U.S. Products within this segment include bags and wraps under the Glad brand; grilling products under the Kingsford brand; and cat litter primarily under the Fresh Step</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Scoop Away</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Lifestyle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of food, natural personal care products and water-filtration products marketed and sold in the U.S. Products within this segment include dressings, dips, seasonings and sauces, primarily under the Hidden Valley brand; natural personal care products under the Burt&#8217;s Bees brand; and water-filtration products under the Brita brand.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of products sold outside the U.S. Products within this segment include laundry additives, home care products, water-filtration products, digestive health products; grilling products; cat litter; food; bags and wraps; natural personal care products; and professional cleaning and disinfecting products marketed primarily under the Clorox, Ayudin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Clorinda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Burt&#8217;s Bees brands.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECENT EVENTS AFFECTING THE COMPANY</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal quarter ended March&#160;31, 2023, the Company continued to experience supply chain disruptions including the impacts of cost inflation resulting in persistently high manufacturing and logistics costs as well as higher commodity costs. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to these evolving challenges, ongoing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">uncertainties and economic and social disruptions remained present due to the continued effects of the coronavirus (COVID-19) pandemic, which were further heightened by the conflict in Ukraine that began in the previous fiscal year.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While demand for many of the products across the Company's portfolio remained strong compared to pre-pandemic levels, it has moderated versus the initial periods of the COVID-19 pandemic. An</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> inflationary environment marked by supply chain disruptions, higher manufacturing and logistics costs and higher commodity costs is expected to continue through fiscal year 2023. While we have not experienced significant disruptions in our operations during fiscal year 2023 to date, the risks of future negative impacts due to transportation, logistical or supply constraints and higher commodity costs for certain raw materials remain present, and the Company continues to experience corresponding incremental costs and gross margin pressures. For fiscal year 2023, the Company&#8217;s focus will be on addressing supply chain disruptions and volatility in commodity costs and foreign exchange markets and countering inflationary pressures through pricing actions and cost-cutting measures. In order to enhance the Company&#8217;s ability to respond more quickly to changing consumer behaviors and innovate faster, the Company has announced a streamlined operating model to be implemented over the course of fiscal years 2023 and 2024.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of continued inflationary pressures and geopolitical events, specifically the conflict in Ukraine, have increased global economic and political uncertainty due to the uncertainty around the duration and resolution of the conflict and potential economic and global supply chain disruptions. Additionally, the extent of COVID-19&#8217;s effect on the Company&#8217;s operational and financial performance in the future will depend on future developments, including the duration, spread, intensity and phase of the pandemic in different countries, the emergence of COVID-19 variants and the effectiveness of vaccines against these variants, the Company&#8217;s continued ability to manufacture and distribute its products, any future government actions affecting consumers, our business operations, including any vaccine mandates, or the economy in general, and effectiveness of global vaccines. All of these factors are difficult to predict considering the rapidly evolving landscape as the Company continues to expect a variable operating environment going forward. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on the impacts and our response to the coronavirus pandemic, refer to &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in Exhibit 99.1 of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022.</span></div><div style="margin-top:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONSOLIDATED RESULTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,915&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,370&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,306&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.455%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage change versus the year-ago period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported (GAAP) Net Sales Growth / (Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Volume</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Acquisitions &amp; Divestitures</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Exchange Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Price/Mix/ Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Organic Sales Growth / (Decrease) (Non-GAAP)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Organic Volume </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage change versus the year-ago period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported (GAAP) Net Sales Growth / (Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Volume</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Acquisitions &amp; Divestitures</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Exchange Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Price/Mix/Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Organic Sales Growth / (Decrease) (Non-GAAP) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Organic Volume </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#b6b6b6;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#b6b6b6;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">This represents the net impact on net sales growth / (decrease) from pricing actions, mix and other factors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Organic sales growth / (decrease) is defined as net sales growth / (decrease) excluding the effect of any acquisitions and divestitures and foreign exchange rate changes. See &#8220;Non-GAAP Financial Measures&#8221; below for reconciliation of organic sales growth / (decrease) to net sales growth / (decrease), the most directly comparable GAAP financial measure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Organic volume represents volume excluding the effect of any acquisitions and divestitures.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the current three month period increased by 6%, primarily driven by sales growth across all reportable segments. Volume decreased by 11% versus the prior period primarily due to pricing actions. The variance between volume and net sales was primarily due to the impact of favorable price mix.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the current nine month period increased by 1%, primarily driven by sales growth in the Lifestyle and Household reportable segments. Volume decreased by 12%, reflecting lower shipments across all reportable segments primarily due to pricing actions. The variance between volume and net sales was primarily due to the impact of favorable price mix.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,877&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased by 590 basis points in the current three month period from 35.9% to 41.8%. The increase was primarily driven by the benefit of price increases as well as cost savings, partially offset by unfavorable commodity costs and higher manufacturing and logistics costs. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by 270 basis points in the current nine month period from 35.4% to 38.1%. The increase was primarily driven by the benefit of price increases as well as cost savings, partially offset by unfavorable commodity costs and higher manufacturing and logistics costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expenses</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.335%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expenses</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expenses</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as a percentage of net sales, increased by 330 basis points and 250 basis points in current three and nine month periods, respectively. The dollar increase in selling and administrative expenses in both the current three and nine month periods was primarily due to higher incentive compensation expense and the Company&#8217;s digital capabilities and productivity enhancements investments. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as a percentage of net sales, increased by 230 basis points and 20 basis points in the current three and nine month periods versus the prior periods, respectively. The increase in advertising costs reflects the Company&#8217;s continued support behind its brands. The Company&#8217;s U.S. retail advertising spend as a percentage of net sales was 12% and 9% in the current and prior three month periods, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a percentage of net sales, were essentially flat in both the current three and nine month periods as compared to the prior periods. The Company continues to invest behind product innovation and cost savings.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill, trademark and other asset impairments, Interest expense, Other (income) expense, net and the effective tax rate on earnings (losses)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, trademark and other asset impairments</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate on earnings (losses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill, trademark and other asset impairments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $445 in both the current three and nine month periods reflect non-cash impairment charges to goodwill and certain indefinite-lived trademarks related to the VMS business. See Notes to Condensed Consolidated Financial Statements for further information. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $24 and $11 in the current and prior three month periods, respectively, and $54 and $20 in the current and prior nine month periods, respectively. The variance was primarily due to restructuring and related implementation costs associated with the streamlined operating model incurred in both the current three and nine month periods. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring and related costs</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2023, the Company began recognizing costs related to a plan that involves streamlining its operating model to meet its objectives of driving growth and productivity. The streamlined operating model is expected to enhance the Company&#8217;s ability to respond more quickly to changing consumer behaviors and innovate faster. The Company anticipates the implementation of this new model will be completed in fiscal year 2024, with different phases occurring throughout the implementation period.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once fully implemented, the Company expects annual cost savings to be approximately $75 to $100 annually, with benefits of approximately $35 anticipated in fiscal year 2023. The benefits of the streamlined operating model are currently expected to increase future cash flows as a result of cost savings that will be generated primarily in the areas of selling and administration, supply chain, marketing and research and development.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company anticipates incurring approximately $75 to $100 of costs in fiscal years 2023 and 2024 related to this initiative. Of this total amount, the higher-end of the range of approximately $40 to $60 is expected to be incurred in fiscal year 2023. Related costs are primarily expected to include employee-related costs to reduce certain staffing levels such as severance payments, as well as for consulting and other costs. Costs incurred are expected to be settled primarily in cash.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related implementation costs, net were $21 for the three months ended March&#160;31, 2023, of which $14 was related to employee-related costs and $7 was related to other costs. Restructuring and related implementation costs, net were $44 for the nine months ended March&#160;31, 2023,of which $30 was related to employee-related costs and $14 was related to other costs. For further details on the streamlined operating model and restructuring, refer to the Notes to Consolidated Financial Statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The effective tax rate on earnings (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was 14.7% and 1,813.5% for the current three and nine month periods, respectively, and 23.9% and 23.3% for the prior three and nine month periods, respectively. The lower tax rate on losses before income taxes in the current three month period was driven by the partial non-deductibility of impaired VMS goodwill. The substantially higher tax rate on earnings before income taxes in the current nine month period was driven by lower pre-tax income due to the VMS impairment charges and the non-deductibility of a portion of those charges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diluted net earnings (losses) per share</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net earnings (losses) per share</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.71)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.91&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diluted net earnings (losses) per share (EPS)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased by $2.92, or 241%, in the current three month period, primarily due to the noncash impairment charges on assets related to the VMS business, higher selling and administrative expenses, advertising investments and unfavorable commodity costs, partially offset by higher net sales primarily behind pricing as well as the benefit of cost savings.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased by $3.13, or 108%, in the current nine month period, primarily due to the noncash impairment charges on assets related to the VMS business, higher selling and administrative expenses, unfavorable commodity costs, higher manufacturing and logistics costs and the impact of unfavorable foreign currency exchange rates, partially offset by net sales growth as well as the benefit of cost savings.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEGMENT RESULTS </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the results of the Company&#8217;s reportable segments and certain unallocated costs reflected in Corporate (see Notes to Condensed Consolidated Financial Statements for a reconciliation of segment results to consolidated results):</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health and Wellness</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,055&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Volume and earnings (losses) before income taxes decreased by 16% and 445% respectively, and net sales increased by 7% during the current three month period. The volume decrease was primarily due to pricing actions, partially offset by strong consumption, primarily in Cleaning. The variance between volume and net sales was primarily due to the benefit of price increases. The decrease in earnings (losses) before income taxes in the current period was primarily due to the noncash impairment charges on assets related to the VMS business, unfavorable commodity costs and advertising investments, partially offset by net sales growth primarily behind pricing as well as the benefit of cost savings.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume and earnings (losses) before income taxes decreased by 19% and 129% respectively, and net sales were essentially flat during the current nine month period. The volume decrease was primarily due to pricing actions and lower shipments from the ongoing normalization of consumer demand in Cleaning in the current period. The variance between volume and net sales was primarily due to the benefit of price increases. The decrease in earnings (losses) before income taxes in the current period was primarily due to the noncash impairment charges on assets related to the VMS business and unfavorable commodity costs, partially offset by the benefit of price increases as well as cost savings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Household</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales and earnings before income taxes increased by 2% and 8%, respectively, and volume decreased by 12% during the current three month period. The volume decrease was primarily driven by lower shipments across all SBUs due to pricing actions and in Grilling due to increased competitive activity, partially offset by strong consumption in Litter and Bags and Wraps. The variance between volume and net sales was primarily due to the benefit of price increases. The increase in earnings before income taxes was mainly due to net sales growth primarily behind pricing as well as the benefit of cost savings, partially offset by advertising investments and unfavorable commodity costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales and earnings before income taxes increased by 2% and 20%, respectively, and volume decreased by 8% during the current nine month period. The volume decrease was primarily driven by lower shipments across all SBUs due to pricing actions, as well as lower shipments in Grilling due to increased competitive activity in the current period. The variance between volume and net sales was primarily due to the benefit of price increases. The increase in earnings before income taxes was mainly due to net sales growth primarily behind pricing as well as the benefit of cost savings, partially offset by unfavorable commodity costs, higher manufacturing and logistics costs and advertising investments.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lifestyle</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales and earnings before income taxes increased by 15% and 26% respectively, and volume was essentially flat during the current three month period. The variance between volume and net sales was mainly due to the benefit of pricing and strong consumption supported by merchandising activities in Brita and Food. The increase in earnings before income taxes was due to net sales growth primarily behind pricing as well as the benefit of cost savings, partially offset by advertising investments and unfavorable commodity costs. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume and earnings before income taxes decreased by 6% and 9% respectively, and net sales increased by 5% during the current nine month period. The volume decrease was primarily driven by lower shipments across all SBUs due to pricing actions. The variance between volume and net sales was mainly due to the benefit of price increases. The decrease in earnings before income taxes was primarily due to unfavorable commodity costs, advertising investments and higher manufacturing and logistics costs, partially offset by net sales growth primarily behind pricing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume and earnings before income taxes decreased by 7% and 52% respectively, and net sales increased by 1% during the current three month period. The volume decrease was primarily due to pricing actions. The variance between volume and net sales was mainly due to the benefit of price increases, partially offset by unfavorable foreign currency exchange rates. The decrease in earnings before income taxes was primarily due to unfavorable foreign currency exchange rates, a noncash impairment charge related to the VMS business and higher manufacturing and logistics costs, partially offset by net sales growth primarily behind pricing and the benefit of cost savings. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume, net sales and earnings before income taxes decreased by 6%, 1% and 23%, respectively, in the current nine month period. The volume decrease was primarily due to pricing actions. The variance between volume and net sales was mainly due to the benefit of price increases, partially offset by the impact of unfavorable foreign currency exchange rates. The decrease in earnings before income taxes was primarily due to unfavorable foreign currency exchange rates, higher manufacturing and logistics costs, unfavorable commodity costs, lower volume and higher selling and administrative expenses, partially offset by the net impact of pricing.</span></div><div id="i35f8305358714061a46930a84f00a8d0_998"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Argentina</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective July 1, 2018, under the requirements of U.S. GAAP, Argentina was designated as a highly inflationary economy, and as a result the U.S. dollar replaced the Argentine peso as the functional currency of the Company&#8217;s subsidiaries in Argentina. Consequently, gains and losses from non-U.S. dollar denominated monetary assets and liabilities of Clorox Argentina are recognized in Other (income) expense, net in the condensed consolidated statement of earnings. The business environment in Argentina continues to be challenging due to significant volatility in Argentina&#8217;s currency, high inflation, economic recession, impacts of COVID-19 and temporary price controls. As of March&#160;31, 2023 and June&#160;30, 2022, the net asset position, excluding goodwill, of Clorox Argentina was $49 and $45, respectively. Of these net assets, cash balances were approximately $24 and $15 as of March&#160;31, 2023 and June&#160;30, 2022, respectively. Net sales from Clorox Argentina represented approximately 2% of the Company&#8217;s consolidated net sales for both the nine months ended March&#160;31, 2023 and the fiscal year ended June&#160;30, 2022. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on the impacts of, and our response to, the business environment in Argentina, refer to &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022.</span></div><div id="i35f8305358714061a46930a84f00a8d0_1003"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate includes certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses before income taxes</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Losses before income taxes increased by $79 in the current three month period primarily due to higher incentive compensation expense, restructuring charges associated with the implementation of the Company&#8217;s new operating model and the Company&#8217;s digital capabilities and productivity enhancement investments.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Losses before income taxes increased by $147 in the current nine month period primarily due to higher incentive compensation expense, the Company&#8217;s digital capabilities and productivity enhancement investments, and restructuring charges associated with the implementation of the Company&#8217;s new operating model.&#160;</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL POSITION AND LIQUIDITY</span></div><div id="i35f8305358714061a46930a84f00a8d0_1063"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial condition and liquidity remained strong as of March&#160;31, 2023. The following table summarizes cash activities:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operations</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for financing activities</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(526)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operations was $728 in the current nine month period, compared with $451 in the prior nine month period. The increase was primarily driven by a decrease in working capital and lower incentive compensation paid in the current nine month period. The decrease in working capital was primarily driven by higher Accounts payable and accrued liabilities due to timing of payments, lower inventory balances mostly driven by optimization of inventory levels in the current nine month period and decrease in Accounts receivable due to timing of sales in the prior nine month period.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Payment Terms Extension and Supply Chain Financing </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company initiated the extension of its payment terms with its suppliers in the second half of fiscal year 2020 in order to improve working capital as part of and to fund the IGNITE strategy and in keeping with evolving market practices. The Company&#8217;s current payment terms do not exceed 120 days in keeping with industry standards. The Company&#8217;s operating cash flows are directly impacted as a result of the extension of the payment terms with the suppliers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of those ongoing efforts, the Company has arranged for a global financial institution to offer a voluntary supply chain finance (SCF) program for the benefit of the Company&#8217;s suppliers. Leveraging the Company&#8217;s credit rating, the SCF program enables suppliers to directly contract with the financial institution to receive payment from the financial institution prior to the payment terms between the Company and the supplier by selling the Company&#8217;s payables to the financial institution. Participation in the program is at the sole discretion of the supplier and the Company has no economic interest in a supplier's decision to enter into the agreement and has no direct financial relationship with the financial institution, as it relates to the SCF program. Once a supplier elects to participate in the SCF program and reaches an agreement with the financial institution, the supplier elects which individual Company invoices to sell to the financial institution. The terms of the Company&#8217;s payment obligations are not impacted by a supplier&#8217;s participation in the program and as such, the SCF program has no direct impact on the Company&#8217;s balance sheets, cash flows or liquidity. No guarantees are provided by the Company or any of our subsidiaries under the SCF program. There would not be an expected material impact to the Company&#8217;s liquidity or capital resources if the financial institution or a supplier terminated the SCF arrangement.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All outstanding amounts related to suppliers participating in SCF are recorded within Accounts payable and accrued liabilities in the Consolidated Balance Sheets and the associated payments are included in operating activities within the Consolidated Statements of Cash Flows. As of March&#160;31, 2023 and June&#160;30, 2022, the amount due to suppliers participating in SCF and included in Accounts payable and accrued liabilities was $212 and $211, respectively. While the Company does not have direct access to information on, or influence over, which invoices a participating supplier elects to sell to the financial institution, the Company expects that the majority of these amounts have been sold to the financial institution.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used for investing activities was $142 in the current nine month period, compared with $167 in the prior nine month period. The year-over-year decrease was mainly due to lower capital spending in the current nine month period.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used for financing activities was $526 in the current nine month period, compared with $363 in the prior nine month period. The year-over-year increase was mainly due to net cash used against borrowings, partially offset by lower treasury stock purchases in the current nine month period.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_1048"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Resources and Liquidity</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's current liabilities may periodically exceed current assets as a result of the Company's debt management policies, including the Company's use of commercial paper borrowings which fluctuates depending on the amount and timing of operating and investing cash flows and payments for shareholder transactions such as dividends. In addition, the Company&#8217;s cash generated from operations has decreased from historical levels primarily due to higher manufacturing and logistics costs and unfavorable commodity costs. The Company continues to take actions to address some of the effects of such cost increases, which include implementing price increases, driving cost savings and optimizing the Company&#8217;s supply chain.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global financial markets have experienced a significant increase in volatility due to heightened uncertainty, the impacts of cost inflation and continued economic and social disruptions caused by the COVID-19 outbreak and other geopolitical circumstances. Notwithstanding potential unforeseen adverse market conditions and as part of the Company&#8217;s regular assessment of its cash needs, the Company believes it will have the funds necessary to support our short- and long-term liquidity and operating needs, including the costs related to the announced streamlined operating model and its digital capabilities and productivity enhancements investments, based on our anticipated ability to generate positive cash flows from operations in the future, access to capital markets enabled by our strong short-term and long-term credit ratings and current borrowing availability.</span></div><div id="i35f8305358714061a46930a84f00a8d0_1041"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Arrangements</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company maintained a $1,200 revolving credit agreement that matures in March 2027 (the Credit Agreement). There were no borrowings under the Credit Agreement as of March&#160;31, 2023 and June&#160;30, 2022, and the Company believes that borrowings under the Credit Agreement are and will continue to be available for general corporate purposes. The Credit Agreement includes certain restrictive covenants and limitations. The primary restrictive covenant is a minimum ratio of 4.0, calculated as total earnings before interest, taxes, depreciation and amortization and other similar non-cash charges and certain other items (Consolidated EBITDA) to total interest expense for the trailing four quarters (Interest Coverage ratio), as defined and described in the Credit Agreement.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was in compliance with all restrictive covenants and limitations in the Credit Agreement as of March&#160;31, 2023, and anticipates being in compliance with all restrictive covenants for the foreseeable future.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company maintained $31 of foreign and other credit lines, of which $5 was outstanding.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchases and Dividend Payments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had two stock repurchase programs: an open-market purchase program with an authorized aggregate purchase amount of up to $2,000, which has no expiration date, and a program to offset the anticipated impact of dilution related to stock-based awards (the Evergreen Program), which has no authorization limit on the dollar amount and no expiration date. There were no share repurchases of common stock during the three months ended March&#160;31, 2023 and 2022. During the nine months ended March&#160;31, 2023 and 2022, the Company repurchased 0 and 152 thousand shares of common stock at a cost of $0 and $25, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends per share declared and total dividends paid to Clorox stockholders were as follows for the periods indicated: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends per share declared</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.18&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.72&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.48&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_1035"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Venture Agreement</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a venture agreement with The Procter &amp; Gamble Company (P&amp;G) for the Company&#8217;s Glad bags and wraps business. As of March&#160;31, 2023 and June&#160;30, 2022, P&amp;G had a 20% interest in the venture. Upon termination of the agreement, the Company is required to purchase P&amp;G&#8217;s 20% interest for cash at fair value as established by predetermined valuation procedures.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performed a valuation of the Glad bags and wraps business as of December 31, 2022 in connection with an update of the Company&#8217;s financial projections in the second quarter of fiscal year 2023. As of March 31, 2023 and June 30, 2022, the estimated fair value of P&amp;G&#8217;s interest in the venture was $527 and $635, respectively, of which $492 and $468, respectively, has been recognized and is reflected in Other liabilities in the Company&#8217;s Condensed Consolidated Balance Sheet. The $108 decrease in the estimated fair value of P&amp;G&#8217;s interest since June&#160;30, 2022 was attributable to an increase in the discount rate and a decrease in the estimated future cash flows since the prior valuation. Changes in the judgments, assumptions and market factors used could result in significantly different estimates of fair value. The difference between the estimated fair value and the amount recognized, and any future changes in the fair value of P&amp;G&#8217;s interest, is charged to Cost of products sold in accordance over the remaining life of the agreement.</span></div><div><span><br/></span></div><div id="i35f8305358714061a46930a84f00a8d0_73"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTINGENCIES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements for information on the Company&#8217;s contingencies.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECENTLY ISSUED ACCOUNTING STANDARDS</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements for a summary of recently issued accounting standards relevant to the Company. </span></div><div><span><br/></span></div><div id="i35f8305358714061a46930a84f00a8d0_79"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING ESTIMATES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The methods, estimates and judgments the Company uses in applying its most critical accounting policies have a significant impact on the results the Company reports in its consolidated financial statements. Accordingly, a different financial presentation could result depending on the judgments, estimates or assumptions that are used. The most critical accounting estimates are those that are most important to the portrayal of the Company&#8217;s financial condition and results, and require the Company to make the most difficult and subjective judgments, often estimating the outcome of future events that are inherently uncertain. As of March&#160;31, 2023, there have been no significant changes to the Company&#8217;s critical accounting estimates since the preparation of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022, except as noted below:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Goodwill and Other Intangible Assets</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal year 2023, management made a decision to narrow the focus on core brands and streamline investment levels in the Vitamins, Minerals and Supplements (VMS) business. As a result, revisions were made to the internal financial projections and operational plans of the VMS business reflecting the Company&#8217;s current estimates regarding the future financial performance of these operations and macroeconomic factors. The revised estimated future cash flows reflect lower sales growth expectations and lower investment levels. These revisions were considered a triggering event requiring interim impairment assessments to be performed as part of the preparation of the quar</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">terly financial statements on the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">global indefinite-lived trademarks, other long-term assets and the VMS reporting unit. Based on the outcome of these assessments, a $306 goodwill impairment charge was recorded during the third quarter of fiscal year 2023. There is no remaining goodwill associated with the impaired reporting unit.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, impairment charges of $139 were recorded in the third quarter of fiscal year 2023 related to indefinite-lived intangible assets associated with the VMS business. The useful lives of the impaired trademarks, with a remaining net carrying value of $28 as of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> March 31, 2023, were changed from indefinite to definite beginning on April 1, 2023.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Venture Agreement Terminal Obligation</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performed a valuation of the Glad bags and wraps business as of December 31, 2022 in connection with an update of the Company&#8217;s financial projections in the second quarter of fiscal year 2023. As of March 31, 2023 and June 30, 2022, the estimated fair value of P&amp;G&#8217;s interest in the venture was $527 and $635, respectively, of which $492 and $468, respectively, has been recognized and is reflected in Other liabilities. See Notes to Condensed Consolidated Financial Statements for additional information on the Venture Agreement.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value determination requires significant judgment, assumptions and market factors which are uncertain and subject to change. Changes in the judgments, assumptions and market factors used could result in significantly different estimates of fair value. For perspective, if the discount rate as of December 31, 2022, the date of the most recent valuation performed, were to increase or decrease by 100 basis points, the estimated fair value of P&amp;G&#8217;s interest would decrease by approximately $54 or increase by approximately $69, respectively. Such changes would affect the amount of future charges to Cost of products sold.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NON-GAAP FINANCIAL MEASURES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The non-GAAP financial measures that are included in this MD&amp;A and the reasons management believes they are useful to investors are described below. These measures should be considered supplemental in nature and are not intended to be a substitute for the related financial information prepared in accordance with U.S. GAAP. In addition, these measures may not be the same as similarly named measures presented by other companies.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organic sales growth / (decrease)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is defined as net sales growth / (decrease) excluding the effect of foreign exchange rate changes and any acquisitions and divestitures.&#160;Management believes that the presentation of organic sales growth / (decrease) is useful to investors because it excludes sales from any acquisitions and divestitures, which results in a comparison of sales only from the businesses that the Company was operating and expects to continue to operate throughout the relevant periods, and the Company&#8217;s estimate of the impact of foreign exchange rate changes, which are difficult to predict and out of the control of the Company and management.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of organic sales growth / (decrease) (non-GAAP) to net sales growth / (decrease) (GAAP), the most comparable GAAP measure:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.335%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage change versus the year-ago period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales growth / (decrease) (GAAP)</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Foreign Exchange</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add/(Subtract): Divestitures / Acquisitions</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic sales growth / (decrease) (non-GAAP)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage change versus the year-ago period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales growth / (decrease) (GAAP)</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Foreign Exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add/(Subtract): Divestitures / Acquisitions</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic sales growth / (decrease) (non-GAAP)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cautionary Statement</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Report, including the exhibits hereto and the information incorporated by reference herein, contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the novel coronavirus (COVID-19) pandemic, and the related responses of governments, consumers, customers, suppliers, employees and the Company, on our business, operations, employees, financial condition and results of operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise, involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management&#8217;s estimates, beliefs, assumptions and projections. Words such as &#8220;could,&#8221; &#8220;may,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;targets,&#8221; &#8220;goals,&#8221; &#8220;projects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;will,&#8221; &#8220;predicts,&#8221; and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management&#8217;s expectations, are described in the sections entitled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022, and in this Report, as updated from time to time in the Company&#8217;s Securities and Exchange Commission filings. These factors include, but are not limited to:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">volatility and increases in the costs of raw materials, energy, transportation, labor and other necessary supplies or services;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the Company to drive sales growth, increase prices and market share, grow its product categories and manage favorable product and geographic mix;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to supply chain issues, product shortages and disruptions to the business, as a result of increased supply chain dependencies due to an expanded supplier network and a reliance on certain single-source suppliers;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ongoing COVID-19 pandemic and related impacts, including on the availability of, and efficiency of the supply, manufacturing and distribution systems for, the Company&#8217;s products, including any significant disruption to such systems; on the demand for and sales of the Company&#8217;s products; and on worldwide, regional and local adverse economic conditions;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">intense competition in the Company&#8217;s markets;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unfavorable general economic and political conditions beyond our control, including recent supply chain disruptions, labor shortages, wage pressures, rising inflation, the interest rate environment, fuel and energy costs, foreign currency exchange rate fluctuations, weather events or natural disasters, disease outbreaks or pandemics, such as COVID-19, terrorism, and unstable geopolitical conditions, including the conflict in Ukraine;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to the Company&#8217;s use of and reliance on information technology systems, including potential security breaches, cyber-attacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or Company information, or service interruptions, especially at a time when a large number of the Company&#8217;s employees are working remotely and accessing its technology infrastructure remotely;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the ability of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company to implement and generate cost savings and efficiencies, and successfully implement its business strategies, including achieving anticipated results and cost savings from the implementation of the streamlined operating model;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">dependence on key customers and risks related to customer consolidation and ordering patterns;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s ability to attract and retain key personnel, which may continue to be impacted by challenges in the labor market, such as wage inflation and sustained labor shortages;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s ability to maintain its business reputation and the reputation of its brands and products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lower revenue, increased costs or reputational harm resulting from government actions and compliance with regulations, or any material costs imposed by changes in regulation;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the Company to successfully manage global political, legal, tax and regulatory risks, including changes in regulatory or administrative activity;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to international operations and international trade, including changing macroeconomic conditions as a result of inflation, volatile commodity prices and increases in raw and packaging materials prices, labor, energy and logistics; global economic or political instability; foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls; changes in governmental policies, including trade, travel or immigration restrictions, new or additional tariffs, and price or other controls; labor claims and civil unrest; continued high levels of inflation in Argentina; potential disruption from wars and military conflicts, including the conflict in Ukraine; impact of the United Kingdom&#8217;s exit from the European Union; potential negative impact and liabilities from the use, storage and transportation of chlorine in certain international markets where chlorine is used in the production of bleach; widespread health emergencies, such as COVID-19; and the possibility of nationalization, expropriation of assets or other government action;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of Environmental, Social, and Governance (ESG) issues, including those related to climate change and sustainability on our sales, operating costs or reputation;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the Company to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of product liability claims, labor claims and other legal, governmental or tax proceedings, including in foreign jurisdictions and in connection with any product recalls;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks relating to acquisitions, new ventures and divestitures, and associated costs, including for asset impairment charges related to, among others, intangible assets, including trademarks and goodwill, in particular the impairment charges related to the carrying value of the Company&#8217;s VMS business; and the ability to complete announced transactions and, if completed, integration costs and potential contingent liabilities related to those transactions;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the accuracy of the Company&#8217;s estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to additional increases in the estimated fair value of P&amp;G&#8217;s interest in the Glad business;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s ability to effectively utilize, assert and defend its intellectual property rights, and any infringement or claimed infringement by the Company of third-party intellectual property rights;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the performance of strategic alliances and other business relationships;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of the Company&#8217;s indebtedness and credit rating on its business operations and financial results and the Company&#8217;s ability to access capital markets and other funding sources, as well as the cost of capital to the Company;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s ability to pay and declare dividends or repurchase its stock in the future;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impacts of potential stockholder activism; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to any litigation associated with the exclusive forum provision in the Company&#8217;s bylaws. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s forward-looking statements in this Report are based on management&#8217;s current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this Report. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Report, unless the context requires otherwise, the terms &#8220;the Company,&#8221; &#8220;Clorox,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to The Clorox Company and its subsidiaries. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have not been any material changes to the Company&#8217;s market risk since June&#160;30, 2022. For additional information, refer to &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in Exhibit 99.1 of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div id="i35f8305358714061a46930a84f00a8d0_91"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management, with the participation of the Company&#8217;s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures as of the end of the period covered by this Report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company&#8217;s disclosure controls and procedures, as of the end of the period covered by this Report, were effective such that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and (ii) accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No change in the Company&#8217;s internal control over financial reporting occurred during the third fiscal quarter of the fiscal year ending June&#160;30, 2023, that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div id="i35f8305358714061a46930a84f00a8d0_97"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.A. Risk Factors</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding Risk Factors, please refer to Item 1.A. in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022 and the information in &#8220;Cautionary Statement&#8221; included in this Report.</span></div><div><span><br/></span></div><div id="i35f8305358714061a46930a84f00a8d0_100"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, the Board of Directors authorized the Company to repurchase up to $2,000 million in shares of common stock on the open market (the 2018 Open-Market Program), which has no expiration date.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 1999, the Board of Directors authorized a stock repurchase program to reduce or eliminate dilution upon the issuance of common stock pursuant to the Company&#8217;s stock compensation plans (the Evergreen Program). In November 2005, the Board of Directors authorized the extension of the Evergreen Program to reduce or eliminate dilution in connection with issuances of common stock pursuant to the Company&#8217;s 2005 Stock Incentive Plan. The Evergreen Program has no expiration date and has no specified limit as to dollar amount and therefore is not included in column [d] below.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the purchases of the Company&#8217;s securities by the Company and any affiliated purchasers within the meaning of Rule 10b-18(a)(3) (17 CFR 240.10b-18(a)(3)) during the third quarter of fiscal year 2023. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.057%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">[a]</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">[b]</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">[c]</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">[d]</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Price Paid</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">per Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased as<br/>Part of Publicly<br/>Announced Plans or<br/>Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maximum Number (or<br/>Approximate Dollar<br/>Value) of Shares that<br/>May Yet Be Purchased<br/>Under the Plans or<br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1 to 31, 2023</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$993 million</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1 to 28, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$993 million</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1 to 31, 2023</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$993 million</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Average price paid per share in the period includes commission.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Exhibit Index below, which is incorporated by reference herein.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit No.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.197%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy23ex101amendedannua.htm">The Clorox Company Annual Incentive Plan, amended and restated as of February 14, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy23ex311ceocertifica.htm">Certification by the Chief Executive Officer of the Company Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy23ex312cfocertifica.htm">Certification by the Chief Financial Officer of the Company Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy23ex32ceocfocertifi.htm">Certification by the Chief Executive Officer and Chief Financial Officer of the Company Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i35f8305358714061a46930a84f00a8d0_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.924%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THE CLOROX COMPANY</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DATE: May 2, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BY</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Laura Peck</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laura Peck<br/>Vice President &#8211; Chief Accounting Officer and Corporate Controller</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>clxq3fy23ex101amendedannua.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib16a277d25504a508e5daf97c8daddcd_33"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:180pt;padding-right:180pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE CLOROX COMPANY ANNUAL INCENTIVE PLAN</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:180pt;padding-right:180pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Amended and Restated Effective as of February 14, 2023</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Purpose.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of The Clorox Company Annual Incentive Plan (the &#8220;Plan&#8221;) is to attract and retain the best available personnel for positions of substantial responsibility and to provide an incentive for employees of The Clorox Company, a Delaware corporation (the &#8220;Company&#8221;) and its subsidiaries and to recognize and reward those employees.  The Company&#8217;s executives are eligible to earn short-term cash incentive awards under this Plan.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Definitions.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms will have the following meaning for purposes of the Plan&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a bonus paid in cash under the Plan.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the chief executive officer of the Company.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief People Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the officer of the Company responsible for the Company&#8217;s human resources matters, which position is presently held by the Executive Vice President - Chief People and Corporate Affairs Officer of the Company.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Management Development and Compensation Committee of the Board, or such other Committee designated by the Board to administer the Plan.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person employed by the Company or any Subsidiary.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the executives who are members of the Company&#8217;s management executive committee.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mid-Year Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i) an individual who becomes an Employee on or following the 90-day period after the beginning of a Year and who is selected by the Committee to participate in the Plan during such Year or (ii) an Employee previously selected by the Committee to participate in the Plan for the Year who is subsequently promoted during such Year.   For avoidance of doubt, this shall include an Employee who is promoted to a position which is eligible for participation in the Plan.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Employee selected by the Committee to participate in the Plan (including, for the avoidance of doubt, a Mid-Year Participant).</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Company, other than by reason of death or disability, of a Participant after (1) attaining age 65, (2) attaining age 55 with at least ten years of vesting service, which solely for purposes of this Plan, shall be calculated under Article III of The Clorox Company 401(k) Plan (the &#8220;401(k) Plan&#8221;) entitled &#8220;Service&#8221; along with any other relevant provisions of the 401(k) Plan necessary or desirable to give full effect thereto, or any successor provisions, regardless of the status of the Participant with respect to the 401(k) Plan (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or (3) 20 or more years of Vesting Service.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Section 409A of the Code and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any corporation in which the Company, directly or indirectly, controls 50 percent or more of the total combined voting power of all classes of stock.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vice President</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a regular salaried Employee scheduled to work more than 20 hours per week who is in salary grade 30 or above and who is not a member of the Executive Committee, but is a Vice President.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a fiscal year of the Company.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Awards.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Within 90 days after the beginning of each Year, the Committee will select Participants for the Year and establish in writing the method by which the Awards will be calculated for that Year&#59; provided, that, with respect to Participants who are Mid-Year Participants, the Committee shall determine the method by which the Awards to such individuals will be calculated for the Year during which they are hired or promoted, as applicable, as soon as administratively practicable following their commencement of employment or promotion, as applicable, including whether or not the Award for such Year will be prorated.  The Committee may provide for payment of all or part of the Award in the case of Retirement, death, disability or change of ownership of control of the Company or a Subsidiary during the Year in accordance with Section 409A.  In addition, the Committee may provide for payment of all or part of the Award, including a prorated payment of the Award, in the event of (1) all other terminations of employment during the Year, (2) placement on medical or other leave of absence from the Company or (3) hiring or promotions during the Year in accordance with Section 409A.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the Chief Executive Officer and the Executive Committee, the Committee shall determine and certify the amount of the Award, if any, to be made.  The Committee may decrease or eliminate any Award calculated under the methodology established in accordance with paragraph (a) in order to reflect additional considerations relating to performance.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">For Vice Presidents and all other participants, the Chief Executive Officer shall determine and certify the amount of the Award, if any, to be made.  The Chief Executive Officer may increase, decrease or eliminate, any Award calculated under the methodology established in accordance with paragraph (a) in order to reflect additional considerations relating to performance.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Awards will be paid to the Participants following certification and no later than ninety (90) days following the close of the Year with respect to which the Awards are made, unless all or a portion of a Participant&#8217;s Award is deferred pursuant to the Participant&#8217;s timely and validly made election made in accordance with such terms as the Company, the Board , Committee (or other committee of the Board) may determine.  A timely election is one that satisfies the requirements of Section 409A and typically for performance-based compensation must be made at least six months before the end of the performance period, provided that the Participant performs services continuously from the later of the beginning of the performance period or the date the performance criteria are established through the date an election is made and provided further that in no event may a deferral be made after such compensation has become readily ascertainable as set forth in Section 409A.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The Company shall withhold from the payment of any Award hereunder any amount required to be withheld for taxes.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt">In the event of a restatement of the Company&#8217;s financial results to correct a material error resulting from fraud or intentional misconduct, as determined by the Board or the Committee, the Board, or the Committee, will review all compensation that was made pursuant to this Plan on the basis of having met or exceeded specific performance targets for performance periods beginning after June 30, 2008 which occur during the years for which financial statements are restated.  If a lower payment of performance-based compensation would have been made to the Participants based upon the restated financial results, the Board or the Committee, as applicable, will, to the extent permitted by governing law and subject to the following sentence, seek to recoup for the benefit of the Company the amount by which the individual Participant&#8217;s Award(s) for the restated years exceeded the lower payment that would have been made based on the restated financial results, plus a reasonable rate of interest&#59; provided, however, that neither the Board nor the Committee will seek to recoup Awards paid more than three years prior to the date on which the Company announces the need for the applicable financial statements to be restated.  The Board, or the Committee, will only seek to recoup Awards paid to Participants whose fraud or intentional misconduct was a significant contributing factor to the need for such restatement, as determined by the Board or the Committee, as applicable. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notwithstanding the foregoing, this Section 3(f) shall not apply to Participants who are &#8220;Covered Employees&#8221; (as defined in the Company&#8217;s Policy Regarding Clawback of Incentive Compensation, the &#8220;Policy&#8221;), and Awards made to such Covered Employee shall be subject instead to the clawback provisions contained in the Policy, as provided in Section 7 hereof.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Termination of Employment.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as may be specifically provided in an Award pursuant to Section 3(a), a Participant shall have no right to an Award under the Plan for any Year in which the Participant is not actively employed by the Company or its Subsidiaries on June 30 of such Year.  When establishing Awards each Year, the Committee may also provide that in the event a Participant is not employed by the Company or its Subsidiaries on the date on which the Award is paid, the Participant may forfeit such Participant&#8217;s right to the Award paid under the Plan.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Administration.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan will be administered by the Committee.  The Committee will have the authority to interpret the Plan, to prescribe rules relating to the Plan and to make all determinations necessary or advisable in administering the Plan.  Decisions of the Committee with respect to the Plan will be final and conclusive.  The Committee may delegate some or all of its authority as identified herein to the Chief Executive Officer or the Chief People Officer, including the power and authority to make Awards with respect to Participants who are not members of the Clorox Executive Committee or an &#8220;officer&#8221; of the Company for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, pursuant to such conditions and limitations as the Committee may establish. References to the Committee in this Plan shall refer to the Chief Executive Officer or the Chief People Officer with respect to any action of such officer within the scope of the authority delegated to such officer by the Committee.  The Chief Executive Officer may delegate some or all of its authority under Section 3(c) to the Chief People Officer.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Unfunded Plan.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards under the Plan will be paid from the general assets of the Company, and the rights of Participants under the Plan will be only those of general unsecured creditors of the Company.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Clawback. </font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards under the Plan granted to Participants who are &#8220;Covered Employees&#8221; (as defined in the Policy) are subject to clawback in accordance with the terms of the Policy, as amended from time to time, and pursuant to any other policy the Company may adopt as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.  No recovery of any Award granted hereunder pursuant to such a clawback policy shall be treated as an event giving rise to a Participant&#8217;s right to terminate employment for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or any similar term) under any agreement with the Company.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Amendment or Termination of the Plan. </font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee may from time to time suspend, revise, amend or terminate the Plan.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Applicable Law.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent not preempted by federal law, the Plan shall be construed in accordance with and governed by the laws of the State of California, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Plan to the substantive law of another jurisdiction.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">No Rights to Employment.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nothing contained in the Plan shall give any person the right to be retained in the employment of the Company or any of its Subsidiaries.  The Company reserves the right to terminate any Participant at any time for any reason notwithstanding the existence of the Plan.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">No Assignment.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise required by applicable law, any interest, benefit, payment, claim or right of any Participant under the Plan shall not be sold, transferred, assigned, pledged, encumbered or hypothecated by any Participant and shall not be subject in any manner to any claims of any creditor of any Participant or beneficiary, and any attempt to take any such action shall be null and void.  During the lifetime of any Participant, payment of an Award shall only be made to such Participant.  Notwithstanding the foregoing, the Committee may establish such procedures as it deems necessary for a Participant to designate a beneficiary to whom any amounts would be payable in the event of any Participant&#8217;s death.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Number and References.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except where otherwise indicated by the context, the plural shall include the singular and the singular shall include the plural.  Any reference in the Plan to a Section of the Plan either in the Plan or to an act or code or to any section thereof or rule or regulation thereunder shall be deemed to refer to such Section of the Plan, act, code, section, rule or regulation, as may be amended from time to time, or to any successor Section of the Plan, act, code, section, rule or regulation.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Severability.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any one or more of the provisions contained in this Plan, or any application thereof, shall be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and all other applications thereof shall not in any way be affected or impaired thereby.  This Plan shall be construed and enforced as if such invalid, illegal or unenforceable provision has never comprised a part hereof, and the remaining provisions hereof shall remain in full force and effect and shall not be affected by the invalid, illegal or unenforceable provision or by its severance from the Plan.  In lieu of such invalid, illegal or unenforceable provisions there shall be added automatically as a part hereof a provision as similar in terms and economic effect to such invalid, illegal or unenforceable provision as may be possible and be valid, legal and enforceable.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Requirements of Law.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of cash under the Plan shall be subject to all applicable laws and to such approvals by any governmental agencies or national securities exchanges as may be required.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Non</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exclusive Plan.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of the Plan by the Board shall not be construed as creating any limitations on the power of the Board or a committee thereof to adopt such other incentive arrangements as it may deem desirable.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Section 409A Compliance.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent applicable, it is intended that this Plan and any Awards granted hereunder comply with the requirements of Section 409A.  Any provision that would cause the Plan or any Award granted hereunder to fail to satisfy Section 409A shall have no force or effect until amended to comply with Section 409A, which amendment may be retroactive to the extent permitted by Section 409A.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">END OF DOCUMENT</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>clxq3fy23ex311ceocertifica.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i5d241c4706e348da9c3fe258be369b25_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Linda Rendle, certify that&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of The Clorox Company&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May 2, 2023</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Linda Rendle</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Linda Rendle</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>clxq3fy23ex312cfocertifica.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i716779aad8754116aec976776be9c8fd_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kevin B. Jacobsen, certify that&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of The Clorox Company&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.497%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May 2, 2023</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kevin B. Jacobsen</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin B. Jacobsen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President - Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>5
<FILENAME>clxq3fy23ex32ceocfocertifi.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib826866c135e4222856b6d5a9b04df9f_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the periodic report of The Clorox Company (the &#8220;Company&#8221;) on Form 10-Q for the period ended March&#160;31, 2023,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;), we, Linda Rendle, Chief Executive Officer of the Company, and Kevin B. Jacobsen, Executive Vice President - Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to our knowledge&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Certification has not been, and shall not be deemed, &#8220;filed&#8221; with the Securities and Exchange Commission.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May 2, 2023</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.497%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Linda Rendle</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Linda Rendle</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kevin B. Jacobsen</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin B. Jacobsen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President - Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>clx-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0b973b79-9411-462a-9048-a4468bf442a9,g:effc8b7f-c824-4f09-9fb9-ffb97c19c826-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:clx="http://www.clorox.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.clorox.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clx-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clx-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clx-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clx-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.clorox.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited">
        <link:definition>0000002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGANDRELATEDCOSTS" roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS">
        <link:definition>0000007 - Disclosure - RESTRUCTURING AND RELATED COSTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESNET" roleURI="http://www.clorox.com/role/INVENTORIESNET">
        <link:definition>0000008 - Disclosure - INVENTORIES, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTS" roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTS">
        <link:definition>0000009 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERLIABILITIES" roleURI="http://www.clorox.com/role/OTHERLIABILITIES">
        <link:definition>0000010 - Disclosure - OTHER LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS">
        <link:definition>0000011 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.clorox.com/role/INCOMETAXES">
        <link:definition>0000012 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETEARNINGSLOSSESPERSHAREEPS" roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS">
        <link:definition>0000013 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPREHENSIVEINCOMELOSS" roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS">
        <link:definition>0000014 - Disclosure - COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITY">
        <link:definition>0000015 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANS" roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANS">
        <link:definition>0000016 - Disclosure - EMPLOYEE BENEFIT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONTINGENCIESANDGUARANTEES" roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES">
        <link:definition>0000017 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTRESULTS" roleURI="http://www.clorox.com/role/SEGMENTRESULTS">
        <link:definition>0000018 - Disclosure - SEGMENT RESULTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGANDRELATEDCOSTSTables" roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables">
        <link:definition>0000020 - Disclosure - RESTRUCTURING AND RELATED COSTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESNETTables" roleURI="http://www.clorox.com/role/INVENTORIESNETTables">
        <link:definition>0000021 - Disclosure - INVENTORIES, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSTables" roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSTables">
        <link:definition>0000022 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables">
        <link:definition>0000023 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETEARNINGSLOSSESPERSHAREEPSTables" roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables">
        <link:definition>0000024 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPREHENSIVEINCOMELOSSTables" roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables">
        <link:definition>0000025 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>0000026 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSTables" roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables">
        <link:definition>0000027 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTRESULTSTables" roleURI="http://www.clorox.com/role/SEGMENTRESULTSTables">
        <link:definition>0000028 - Disclosure - SEGMENT RESULTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails">
        <link:definition>0000029 - Disclosure - RESTRUCTURING AND RELATED COSTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails">
        <link:definition>0000030 - Disclosure - RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails">
        <link:definition>0000031 - Disclosure - RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESNETDetails" roleURI="http://www.clorox.com/role/INVENTORIESNETDetails">
        <link:definition>0000032 - Disclosure - INVENTORIES, NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESNETDetails_1" roleURI="http://www.clorox.com/role/INVENTORIESNETDetails_1">
        <link:definition>0000032 - Disclosure - INVENTORIES, NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails" roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails">
        <link:definition>0000033 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Schedule of Impairment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails" roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails">
        <link:definition>0000034 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails" roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails">
        <link:definition>0000035 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Schedule of Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails" roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails">
        <link:definition>0000036 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails_1" roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails_1">
        <link:definition>0000036 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERLIABILITIESNarrativeDetails" roleURI="http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails">
        <link:definition>0000037 - Disclosure - OTHER LIABILITIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>0000038 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails">
        <link:definition>0000039 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails">
        <link:definition>0000040 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails">
        <link:definition>0000041 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://www.clorox.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>0000042 - Disclosure - INCOME TAXES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails">
        <link:definition>0000043 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails">
        <link:definition>0000044 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofEquityDetails" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails">
        <link:definition>0000045 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails">
        <link:definition>0000046 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeDetails" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails">
        <link:definition>0000047 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSNarrativeDetails" roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails">
        <link:definition>0000048 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails">
        <link:definition>0000049 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONTINGENCIESANDGUARANTEESDetails" roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails">
        <link:definition>0000050 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTRESULTSNarrativeDetails" roleURI="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails">
        <link:definition>0000051 - Disclosure - SEGMENT RESULTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTRESULTSReportableSegmentInformationDetails" roleURI="http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails">
        <link:definition>0000052 - Disclosure - SEGMENT RESULTS (Reportable Segment Information ) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTRESULTSNetSalesPercentagesDetails" roleURI="http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails">
        <link:definition>0000053 - Disclosure - SEGMENT RESULTS (Net Sales Percentages) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="clx_OtherExpenseIncomeNet" abstract="false" name="OtherExpenseIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_MaximumExposureUndiscountedCost" abstract="false" name="MaximumExposureUndiscountedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_TrademarksNet" abstract="false" name="TrademarksNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_LifestyleMember" abstract="false" name="LifestyleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_InventoryCurrentAndNoncurrentNet" abstract="false" name="InventoryCurrentAndNoncurrentNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_GrillingMember" abstract="true" name="GrillingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" abstract="true" name="FinancialInstrumentsAndFairValueMeasurementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="clx_WaterFiltrationMember" abstract="true" name="WaterFiltrationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue" abstract="false" name="IndefiniteLivedIntangibleAssetsRemainingCarryingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_RetirementIncomeMember" abstract="false" name="RetirementIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_RemediationPeriod" abstract="false" name="RemediationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clx_ProfessionalProductsMember" abstract="true" name="ProfessionalProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_NotesAndLoansPayableMember" abstract="true" name="NotesAndLoansPayableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_CleaningMember" abstract="false" name="CleaningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_DefinedBenefitPlanPlanTerminationPeriod" abstract="false" name="DefinedBenefitPlanPlanTerminationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clx_FoodProductsMember" abstract="true" name="FoodProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_HealthAndWellnessMember" abstract="true" name="HealthAndWellnessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_VitaminsMineralsAndSupplementsMember" abstract="true" name="VitaminsMineralsAndSupplementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_NaturalPersonalCareMember" abstract="true" name="NaturalPersonalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_TotalCommodityPurchaseDerivativeContractsMember" abstract="true" name="TotalCommodityPurchaseDerivativeContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_CommodityPurchaseDerivativeContractsAxis" abstract="true" name="CommodityPurchaseDerivativeContractsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="clx_PurchasesofInventoryMember" abstract="true" name="PurchasesofInventoryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_GladBusinessMember" abstract="true" name="GladBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" abstract="false" name="ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_BagsWrapsAndContainersMember" abstract="true" name="BagsWrapsAndContainersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_OtherIncomeExpenseNetMember" abstract="true" name="OtherIncomeExpenseNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_RestructuringAndRelatedCostsBenchmarkMember" abstract="true" name="RestructuringAndRelatedCostsBenchmarkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" abstract="false" name="TrustAssetsForNonqualifiedDeferredCompensationPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" abstract="false" name="IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_SiteContingencyAgreedPercentageOfCostSharing" abstract="false" name="SiteContingencyAgreedPercentageOfCostSharing" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="clx_CostOfGoodsAndServicesSoldMember" abstract="true" name="CostOfGoodsAndServicesSoldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_LongTermInterCompanyLoansMember" abstract="false" name="LongTermInterCompanyLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount" abstract="false" name="DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_HouseholdMember" abstract="false" name="HouseholdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_VitaminsMineralsAndSupplementsReportingUnitMember" abstract="true" name="VitaminsMineralsAndSupplementsReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_VentureAgreementTerminalObligationNet" abstract="false" name="VentureAgreementTerminalObligationNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_PercentageofOwnershipbyVenturePartner" abstract="false" name="PercentageofOwnershipbyVenturePartner" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" abstract="false" name="IssuanceOfCommonStockForEmployeeStockPlansAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_CatLitterMember" abstract="true" name="CatLitterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_LetterOfCreditBorrowingCapacity" abstract="false" name="LetterOfCreditBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_CommodityPurchaseDerivativeContractsDomain" abstract="true" name="CommodityPurchaseDerivativeContractsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_OperatingLeaseRightofUseAssetAndLiabilityNet" abstract="false" name="OperatingLeaseRightofUseAssetAndLiabilityNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_VentureAgreement.TerminalObligation" abstract="false" name="VentureAgreement.TerminalObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_VentureAgreementOptiontoExtendAgreementTermPeriod" abstract="false" name="VentureAgreementOptiontoExtendAgreementTermPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" abstract="false" name="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="clx_OtherEmployeeStockPlanActivitiesShares" abstract="false" name="OtherEmployeeStockPlanActivitiesShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clx_InternationalReportingUnitMember" abstract="true" name="InternationalReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_WalmartStoresIncMember" abstract="false" name="WalmartStoresIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_DickinsonCountyMichiganMatterMember" abstract="true" name="DickinsonCountyMichiganMatterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_OtherEmployeeStockPlanActivitiesAmount" abstract="false" name="OtherEmployeeStockPlanActivitiesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_AlamedaCountyCaliforniaMatterMember" abstract="true" name="AlamedaCountyCaliforniaMatterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_InternationalMember" abstract="false" name="InternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>clx-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0b973b79-9411-462a-9048-a4468bf442a9,g:effc8b7f-c824-4f09-9fb9-ffb97c19c826-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="clx-20230331.xsd#CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9a9be573-17c7-4b7c-b9db-24b59c9b0c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_22295fef-b2aa-40b6-8b35-78f6fc788277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_9a9be573-17c7-4b7c-b9db-24b59c9b0c0a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_22295fef-b2aa-40b6-8b35-78f6fc788277" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_fc4ad073-18ed-40c5-9432-6dfdf1b09f74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_9a9be573-17c7-4b7c-b9db-24b59c9b0c0a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_fc4ad073-18ed-40c5-9432-6dfdf1b09f74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2b0c2a8d-e214-4d5b-8529-cbbf55a7df17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_38c70fed-7dae-4612-aa02-d708e68ce676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2b0c2a8d-e214-4d5b-8529-cbbf55a7df17" xlink:to="loc_us-gaap_ProfitLoss_38c70fed-7dae-4612-aa02-d708e68ce676" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b5518049-a5a4-4646-af60-cf495711111c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2b0c2a8d-e214-4d5b-8529-cbbf55a7df17" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b5518049-a5a4-4646-af60-cf495711111c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_59253abc-c86b-4be1-a8bd-60d5fdedbcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dbd6c01a-4826-42b5-b29c-b499d137d816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_59253abc-c86b-4be1-a8bd-60d5fdedbcc1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dbd6c01a-4826-42b5-b29c-b499d137d816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_34c960d3-6955-4f8e-a91c-d0b4a42b2e51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_59253abc-c86b-4be1-a8bd-60d5fdedbcc1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_34c960d3-6955-4f8e-a91c-d0b4a42b2e51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_527fb284-41d6-49e4-a9a3-3b931dadd747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherExpenseIncomeNet_8e1db346-3285-4028-9cd0-a3382612264d" xlink:href="clx-20230331.xsd#clx_OtherExpenseIncomeNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_527fb284-41d6-49e4-a9a3-3b931dadd747" xlink:to="loc_clx_OtherExpenseIncomeNet_8e1db346-3285-4028-9cd0-a3382612264d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3b2feeb1-46dc-4f2b-bd30-7b8e5ddf9e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_527fb284-41d6-49e4-a9a3-3b931dadd747" xlink:to="loc_us-gaap_InterestExpense_3b2feeb1-46dc-4f2b-bd30-7b8e5ddf9e42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4b029471-72aa-4d2c-a5fc-eee0d9c40cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_527fb284-41d6-49e4-a9a3-3b931dadd747" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4b029471-72aa-4d2c-a5fc-eee0d9c40cb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7caabf32-bb89-45ec-bdc7-5e10ba5305d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_527fb284-41d6-49e4-a9a3-3b931dadd747" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7caabf32-bb89-45ec-bdc7-5e10ba5305d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_fa49bf18-a1e6-4f42-828e-d44cc9a4cd83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_527fb284-41d6-49e4-a9a3-3b931dadd747" xlink:to="loc_us-gaap_GrossProfit_fa49bf18-a1e6-4f42-828e-d44cc9a4cd83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_909889bf-3885-476f-8ae3-594ee42385dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_527fb284-41d6-49e4-a9a3-3b931dadd747" xlink:to="loc_us-gaap_AdvertisingExpense_909889bf-3885-476f-8ae3-594ee42385dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_a1d3c784-4268-4925-8dcc-d52ace8facc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_527fb284-41d6-49e4-a9a3-3b931dadd747" xlink:to="loc_us-gaap_AssetImpairmentCharges_a1d3c784-4268-4925-8dcc-d52ace8facc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_bd610e10-db79-40bb-b7bc-38ad3e38bcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_522877da-2f3c-437e-91ff-d8e92aa460b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_bd610e10-db79-40bb-b7bc-38ad3e38bcfd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_522877da-2f3c-437e-91ff-d8e92aa460b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d94e747f-aedc-4dc9-bd72-c8cccfa91c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_bd610e10-db79-40bb-b7bc-38ad3e38bcfd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d94e747f-aedc-4dc9-bd72-c8cccfa91c36" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="clx-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_369d2d52-0ba0-4d5c-ad80-d1f6e05a5131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d2142470-a06d-4dfa-8476-d352ef8ee535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_369d2d52-0ba0-4d5c-ad80-d1f6e05a5131" xlink:to="loc_us-gaap_AssetsCurrent_d2142470-a06d-4dfa-8476-d352ef8ee535" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3dfd7c05-ce0e-4445-aeb0-ca5f89e0cadd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_369d2d52-0ba0-4d5c-ad80-d1f6e05a5131" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3dfd7c05-ce0e-4445-aeb0-ca5f89e0cadd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1494ddf9-4847-43c3-be19-736282875718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_369d2d52-0ba0-4d5c-ad80-d1f6e05a5131" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1494ddf9-4847-43c3-be19-736282875718" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_679bd207-861f-4a86-a116-7d5808aa7a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_369d2d52-0ba0-4d5c-ad80-d1f6e05a5131" xlink:to="loc_us-gaap_Goodwill_679bd207-861f-4a86-a116-7d5808aa7a54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrademarksNet_e0ea9cab-1cb2-45a4-a1f9-cd3add21cd51" xlink:href="clx-20230331.xsd#clx_TrademarksNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_369d2d52-0ba0-4d5c-ad80-d1f6e05a5131" xlink:to="loc_clx_TrademarksNet_e0ea9cab-1cb2-45a4-a1f9-cd3add21cd51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_677e2015-8251-4da2-9418-bd502162cb34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_369d2d52-0ba0-4d5c-ad80-d1f6e05a5131" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_677e2015-8251-4da2-9418-bd502162cb34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b022ced5-d1c3-4833-bf55-943b48ce61da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_369d2d52-0ba0-4d5c-ad80-d1f6e05a5131" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b022ced5-d1c3-4833-bf55-943b48ce61da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_711dc163-6360-48a8-8121-4b5c690029e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9db1dcba-c7d2-444d-95cf-0a8eed2a3c56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_711dc163-6360-48a8-8121-4b5c690029e5" xlink:to="loc_us-gaap_Liabilities_9db1dcba-c7d2-444d-95cf-0a8eed2a3c56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7be2a7b4-af1e-443e-9d2b-99f01a61a01c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_711dc163-6360-48a8-8121-4b5c690029e5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7be2a7b4-af1e-443e-9d2b-99f01a61a01c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_429d23f4-d280-47f1-be5b-09498cdcd646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_711dc163-6360-48a8-8121-4b5c690029e5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_429d23f4-d280-47f1-be5b-09498cdcd646" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2aeeeda1-c996-4ec2-b454-3dbec2ee2608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_312491b5-8a9c-489b-ade9-06bb8dfdbc07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2aeeeda1-c996-4ec2-b454-3dbec2ee2608" xlink:to="loc_us-gaap_LiabilitiesCurrent_312491b5-8a9c-489b-ade9-06bb8dfdbc07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_fa302997-fe50-4e69-bc42-a66127785935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2aeeeda1-c996-4ec2-b454-3dbec2ee2608" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_fa302997-fe50-4e69-bc42-a66127785935" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d19e019b-e245-41bd-871f-500a22ec5007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2aeeeda1-c996-4ec2-b454-3dbec2ee2608" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d19e019b-e245-41bd-871f-500a22ec5007" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_0deedc38-a68a-43b0-85b8-94ffe51532da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2aeeeda1-c996-4ec2-b454-3dbec2ee2608" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_0deedc38-a68a-43b0-85b8-94ffe51532da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_32cb136d-2061-437d-94fb-4937312f8f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2aeeeda1-c996-4ec2-b454-3dbec2ee2608" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_32cb136d-2061-437d-94fb-4937312f8f8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_472ac037-880a-45ba-8f24-61ecf8673e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_71789440-0bac-4016-a7a8-4f4b9a326863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_472ac037-880a-45ba-8f24-61ecf8673e73" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_71789440-0bac-4016-a7a8-4f4b9a326863" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_ec921ddd-18e5-4f09-8a9f-e5d602bef29f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_472ac037-880a-45ba-8f24-61ecf8673e73" xlink:to="loc_us-gaap_ReceivablesNetCurrent_ec921ddd-18e5-4f09-8a9f-e5d602bef29f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_acd15313-b47c-4c49-a827-05f5c39db636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_472ac037-880a-45ba-8f24-61ecf8673e73" xlink:to="loc_us-gaap_InventoryNet_acd15313-b47c-4c49-a827-05f5c39db636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_76e1f583-7f80-4bc3-9611-30b30332b5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_472ac037-880a-45ba-8f24-61ecf8673e73" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_76e1f583-7f80-4bc3-9611-30b30332b5b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3fd572b2-1a85-493c-8ca9-72aff2892727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b286b6cf-4e5b-44da-9fb7-101a5038efdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3fd572b2-1a85-493c-8ca9-72aff2892727" xlink:to="loc_us-gaap_StockholdersEquity_b286b6cf-4e5b-44da-9fb7-101a5038efdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_86eccfa7-15d2-4d29-aebd-7db5202a0eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3fd572b2-1a85-493c-8ca9-72aff2892727" xlink:to="loc_us-gaap_MinorityInterest_86eccfa7-15d2-4d29-aebd-7db5202a0eaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7474b7e6-7ef0-4dd2-8a6c-ae8881b2d7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a0683249-73a4-4bba-bb83-f0782b4641ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7474b7e6-7ef0-4dd2-8a6c-ae8881b2d7f6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a0683249-73a4-4bba-bb83-f0782b4641ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6ee19eca-8e20-4f7b-b6db-c0ab5dbdf3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7474b7e6-7ef0-4dd2-8a6c-ae8881b2d7f6" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6ee19eca-8e20-4f7b-b6db-c0ab5dbdf3ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_131d9bee-2d6a-4a77-a63d-35be6250e8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7474b7e6-7ef0-4dd2-8a6c-ae8881b2d7f6" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_131d9bee-2d6a-4a77-a63d-35be6250e8cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_883dd4b5-405c-4c9d-ab3e-bdec3bfbaaf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7474b7e6-7ef0-4dd2-8a6c-ae8881b2d7f6" xlink:to="loc_us-gaap_CommercialPaper_883dd4b5-405c-4c9d-ab3e-bdec3bfbaaf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b7451ef9-e219-4aba-bfcf-e783b111c739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_73c09e6d-8670-42cd-bf89-a4d867095236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b7451ef9-e219-4aba-bfcf-e783b111c739" xlink:to="loc_us-gaap_PreferredStockValue_73c09e6d-8670-42cd-bf89-a4d867095236" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a793bde6-c80b-4a64-bd4b-047cf6cc7e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b7451ef9-e219-4aba-bfcf-e783b111c739" xlink:to="loc_us-gaap_CommonStockValue_a793bde6-c80b-4a64-bd4b-047cf6cc7e5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_24c7248c-be9d-4b3c-8dbf-32b9d137a7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b7451ef9-e219-4aba-bfcf-e783b111c739" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_24c7248c-be9d-4b3c-8dbf-32b9d137a7dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_818d7e9d-7340-4070-b310-92de3148b0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b7451ef9-e219-4aba-bfcf-e783b111c739" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_818d7e9d-7340-4070-b310-92de3148b0ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_69b4b5e9-af6f-4f42-a085-77682a28c4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b7451ef9-e219-4aba-bfcf-e783b111c739" xlink:to="loc_us-gaap_TreasuryStockValue_69b4b5e9-af6f-4f42-a085-77682a28c4fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_be591d40-beae-42fc-8d32-3e2c916392df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b7451ef9-e219-4aba-bfcf-e783b111c739" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_be591d40-beae-42fc-8d32-3e2c916392df" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="clx-20230331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f80b612d-51c3-4832-9336-3cef35cd6918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5e174382-36a2-4632-8107-45e729ae776a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f80b612d-51c3-4832-9336-3cef35cd6918" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5e174382-36a2-4632-8107-45e729ae776a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_45953e50-6f94-4e73-aba2-67325eb70ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f80b612d-51c3-4832-9336-3cef35cd6918" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_45953e50-6f94-4e73-aba2-67325eb70ff6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0cd98426-ffb3-45ab-b7ce-fb2e2bef93fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_522f287b-400f-4ec1-b389-df78e63df39e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0cd98426-ffb3-45ab-b7ce-fb2e2bef93fb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_522f287b-400f-4ec1-b389-df78e63df39e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1e00577b-23f7-4497-845b-14adc72894d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0cd98426-ffb3-45ab-b7ce-fb2e2bef93fb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1e00577b-23f7-4497-845b-14adc72894d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01da1fb9-1a05-4e03-8daa-bb03322976bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0cd98426-ffb3-45ab-b7ce-fb2e2bef93fb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01da1fb9-1a05-4e03-8daa-bb03322976bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b2bed656-a4f7-421a-a1e2-0b62c6fb3bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0cd98426-ffb3-45ab-b7ce-fb2e2bef93fb" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b2bed656-a4f7-421a-a1e2-0b62c6fb3bb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_365cfc41-b6cb-4fdb-8b49-8794f248e83d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_de5b6412-2fd8-4728-b13c-daf65649b0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_365cfc41-b6cb-4fdb-8b49-8794f248e83d" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_de5b6412-2fd8-4728-b13c-daf65649b0d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_c57f49ba-d971-4653-b083-d2e9c1866cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_365cfc41-b6cb-4fdb-8b49-8794f248e83d" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_c57f49ba-d971-4653-b083-d2e9c1866cc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_569b5682-9510-40ec-a42a-a66318433d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_365cfc41-b6cb-4fdb-8b49-8794f248e83d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_569b5682-9510-40ec-a42a-a66318433d0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_1537aeaa-7ada-497f-a32a-f9af29386605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_365cfc41-b6cb-4fdb-8b49-8794f248e83d" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_1537aeaa-7ada-497f-a32a-f9af29386605" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_1ccbd20a-b9a5-4b76-8499-b1d2add208e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_365cfc41-b6cb-4fdb-8b49-8794f248e83d" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_1ccbd20a-b9a5-4b76-8499-b1d2add208e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_9d0ba4f2-8ff3-4dcd-a41e-6ea8260f5357" xlink:href="clx-20230331.xsd#clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_365cfc41-b6cb-4fdb-8b49-8794f248e83d" xlink:to="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_9d0ba4f2-8ff3-4dcd-a41e-6ea8260f5357" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef318f16-063e-40d3-ba1c-d7c71750c312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_77c1c83e-bfaa-42c4-a744-6ee5f5add4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef318f16-063e-40d3-ba1c-d7c71750c312" xlink:to="loc_us-gaap_ProfitLoss_77c1c83e-bfaa-42c4-a744-6ee5f5add4cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_70ea74d5-fe13-469d-a7c5-2754f8cdba4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef318f16-063e-40d3-ba1c-d7c71750c312" xlink:to="loc_us-gaap_AssetImpairmentCharges_70ea74d5-fe13-469d-a7c5-2754f8cdba4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b4e2102e-5987-4cd3-8a72-d5ab9a42d07a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef318f16-063e-40d3-ba1c-d7c71750c312" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b4e2102e-5987-4cd3-8a72-d5ab9a42d07a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3bb74561-e8df-48e9-93ab-2aaa8ad4ff17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef318f16-063e-40d3-ba1c-d7c71750c312" xlink:to="loc_us-gaap_ShareBasedCompensation_3bb74561-e8df-48e9-93ab-2aaa8ad4ff17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_273401f6-15de-423c-9d21-00c31c4f43bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef318f16-063e-40d3-ba1c-d7c71750c312" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_273401f6-15de-423c-9d21-00c31c4f43bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_842047c0-8347-48e9-a231-3df399dccf14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef318f16-063e-40d3-ba1c-d7c71750c312" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_842047c0-8347-48e9-a231-3df399dccf14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_5945b450-9a50-4018-96db-0e4eb826bbea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef318f16-063e-40d3-ba1c-d7c71750c312" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_5945b450-9a50-4018-96db-0e4eb826bbea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_32f90a53-8168-44b8-abe4-44c88c1c2cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef318f16-063e-40d3-ba1c-d7c71750c312" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_32f90a53-8168-44b8-abe4-44c88c1c2cdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fa077d90-9b39-48c1-b41c-5da9e01a52f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef318f16-063e-40d3-ba1c-d7c71750c312" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fa077d90-9b39-48c1-b41c-5da9e01a52f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_34abb59c-eb32-4582-8c19-b2740c161020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef318f16-063e-40d3-ba1c-d7c71750c312" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_34abb59c-eb32-4582-8c19-b2740c161020" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_fe13b37e-1ac2-4c89-8261-ccb70b2d7bd9" xlink:href="clx-20230331.xsd#clx_OperatingLeaseRightofUseAssetAndLiabilityNet"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef318f16-063e-40d3-ba1c-d7c71750c312" xlink:to="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_fe13b37e-1ac2-4c89-8261-ccb70b2d7bd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_85519f87-ac09-4aa5-bc52-0130aa6579da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef318f16-063e-40d3-ba1c-d7c71750c312" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_85519f87-ac09-4aa5-bc52-0130aa6579da" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#INVENTORIESNETDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/INVENTORIESNETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_InventoryCurrentAndNoncurrentNet_116f0396-19c5-447f-946d-b84e3af970be" xlink:href="clx-20230331.xsd#clx_InventoryCurrentAndNoncurrentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_f3fb47d6-ca2e-4377-8d42-8e13bbc8191a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_clx_InventoryCurrentAndNoncurrentNet_116f0396-19c5-447f-946d-b84e3af970be" xlink:to="loc_us-gaap_InventoryNoncurrent_f3fb47d6-ca2e-4377-8d42-8e13bbc8191a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6a9778c4-5cbf-45a7-8c84-d64b4e81351a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_clx_InventoryCurrentAndNoncurrentNet_116f0396-19c5-447f-946d-b84e3af970be" xlink:to="loc_us-gaap_InventoryNet_6a9778c4-5cbf-45a7-8c84-d64b4e81351a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETDetails_1" xlink:type="simple" xlink:href="clx-20230331.xsd#INVENTORIESNETDetails_1"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/INVENTORIESNETDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_InventoryCurrentAndNoncurrentNet_ec908039-54f0-4b0e-ae88-8c3a98f9d776" xlink:href="clx-20230331.xsd#clx_InventoryCurrentAndNoncurrentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_7639b35f-1c60-42b0-a738-9603363e9723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_clx_InventoryCurrentAndNoncurrentNet_ec908039-54f0-4b0e-ae88-8c3a98f9d776" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_7639b35f-1c60-42b0-a738-9603363e9723" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_180c9287-10eb-43c0-ba4f-e2800986eae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_clx_InventoryCurrentAndNoncurrentNet_ec908039-54f0-4b0e-ae88-8c3a98f9d776" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_180c9287-10eb-43c0-ba4f-e2800986eae3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ab3be964-eb53-42b6-a186-88bbc58d1c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_clx_InventoryCurrentAndNoncurrentNet_ec908039-54f0-4b0e-ae88-8c3a98f9d776" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ab3be964-eb53-42b6-a186-88bbc58d1c0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve_b47a4f02-75e8-4e65-b434-7985550d54bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_clx_InventoryCurrentAndNoncurrentNet_ec908039-54f0-4b0e-ae88-8c3a98f9d776" xlink:to="loc_us-gaap_InventoryLIFOReserve_b47a4f02-75e8-4e65-b434-7985550d54bc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_67d88e3b-d9ad-4e63-a8ba-854a3ab8a13d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_07426c34-4d0b-4e65-8dcb-d097063730a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetImpairmentCharges_67d88e3b-d9ad-4e63-a8ba-854a3ab8a13d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_07426c34-4d0b-4e65-8dcb-d097063730a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_770a3a39-b748-4e0c-90cd-544cf7c3eb99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetImpairmentCharges_67d88e3b-d9ad-4e63-a8ba-854a3ab8a13d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_770a3a39-b748-4e0c-90cd-544cf7c3eb99" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f3104100-d873-4008-a9b0-6f253c34d89c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f1c5f934-513b-497a-bef8-cf38d092f599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f3104100-d873-4008-a9b0-6f253c34d89c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f1c5f934-513b-497a-bef8-cf38d092f599" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_63f2dd35-3b8e-448d-85b3-d1d11f9f9373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f3104100-d873-4008-a9b0-6f253c34d89c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_63f2dd35-3b8e-448d-85b3-d1d11f9f9373" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0079546d-d574-4d46-a068-586c5683e5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e30663cf-ba77-496a-8c4e-a792243748d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0079546d-d574-4d46-a068-586c5683e5e4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e30663cf-ba77-496a-8c4e-a792243748d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a7cea9b0-7e83-4d89-b33f-7826102f7048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0079546d-d574-4d46-a068-586c5683e5e4" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a7cea9b0-7e83-4d89-b33f-7826102f7048" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_829bb282-cb75-4329-8961-d91a04c4db4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_401bf798-df46-4f80-aa6c-d9fe9d0ca60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_829bb282-cb75-4329-8961-d91a04c4db4b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_401bf798-df46-4f80-aa6c-d9fe9d0ca60e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_2d24aaa0-ebca-4420-8c41-73c607493b2f" xlink:href="clx-20230331.xsd#clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_829bb282-cb75-4329-8961-d91a04c4db4b" xlink:to="loc_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_2d24aaa0-ebca-4420-8c41-73c607493b2f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="clx-20230331.xsd#GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_aea944e5-ad94-4405-a078-939e2a392052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d4796590-633b-4af5-890a-050da9ea027d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_aea944e5-ad94-4405-a078-939e2a392052" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d4796590-633b-4af5-890a-050da9ea027d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_00ef1052-c5ff-4b20-bd4c-4a25e977945e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_aea944e5-ad94-4405-a078-939e2a392052" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_00ef1052-c5ff-4b20-bd4c-4a25e977945e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_90b51983-b176-409e-932c-9733aeff1f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_9a3b11c4-0fa7-4dcf-8082-43b34e57e49a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_90b51983-b176-409e-932c-9733aeff1f3c" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_9a3b11c4-0fa7-4dcf-8082-43b34e57e49a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e364f9a5-9c69-4b01-99fe-b392d981d244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_90b51983-b176-409e-932c-9733aeff1f3c" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e364f9a5-9c69-4b01-99fe-b392d981d244" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f93e414e-4aff-44d6-82f3-2a5bcb13badb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e5469315-67c2-4d23-a20d-2e4cc935d95d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f93e414e-4aff-44d6-82f3-2a5bcb13badb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e5469315-67c2-4d23-a20d-2e4cc935d95d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_01d75957-a505-421b-ac0c-61a704ecf64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f93e414e-4aff-44d6-82f3-2a5bcb13badb" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_01d75957-a505-421b-ac0c-61a704ecf64b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_16b00c1c-a2be-41bc-95a6-ae8c5289a89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5b21157b-fe8c-4efc-8b13-a9ce4421ddb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_16b00c1c-a2be-41bc-95a6-ae8c5289a89e" xlink:to="loc_us-gaap_LongTermDebt_5b21157b-fe8c-4efc-8b13-a9ce4421ddb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_f6ecf32e-8c43-41b9-b9ad-8aee5fa8b6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_16b00c1c-a2be-41bc-95a6-ae8c5289a89e" xlink:to="loc_us-gaap_CommercialPaper_f6ecf32e-8c43-41b9-b9ad-8aee5fa8b6c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_6ec79676-84b5-480a-a012-acaf13317dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue_f0b13f2b-6b67-47e7-891d-2af076e65529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_6ec79676-84b5-480a-a012-acaf13317dda" xlink:to="loc_us-gaap_ShorttermDebtFairValue_f0b13f2b-6b67-47e7-891d-2af076e65529" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_273fd2f3-5116-43ba-a29d-1a97c8b94ded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_6ec79676-84b5-480a-a012-acaf13317dda" xlink:to="loc_us-gaap_DebtInstrumentFairValue_273fd2f3-5116-43ba-a29d-1a97c8b94ded" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_026ec596-14db-4ce2-96b0-e9ec5f7dfeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1d8cdd00-9a20-4d82-b274-155f4e7cde9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_026ec596-14db-4ce2-96b0-e9ec5f7dfeb5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1d8cdd00-9a20-4d82-b274-155f4e7cde9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_44117358-ba40-4604-be05-572af1e47d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_026ec596-14db-4ce2-96b0-e9ec5f7dfeb5" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_44117358-ba40-4604-be05-572af1e47d5a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_901783b6-8490-4c59-8f7a-d1a3a69687b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8d495f3a-1f26-4418-ab35-ce615a61e202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_901783b6-8490-4c59-8f7a-d1a3a69687b7" xlink:to="loc_us-gaap_ProfitLoss_8d495f3a-1f26-4418-ab35-ce615a61e202" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8e4ec543-3a59-4224-b59e-68e1eb631a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_901783b6-8490-4c59-8f7a-d1a3a69687b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8e4ec543-3a59-4224-b59e-68e1eb631a8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2a73fdbe-331b-4ca8-8e27-b1704bcc6727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0112329d-7c1d-46c9-9e77-bf520dc39c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2a73fdbe-331b-4ca8-8e27-b1704bcc6727" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0112329d-7c1d-46c9-9e77-bf520dc39c5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7f10bb0e-41a5-4cc5-a50c-229df9e86a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2a73fdbe-331b-4ca8-8e27-b1704bcc6727" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7f10bb0e-41a5-4cc5-a50c-229df9e86a3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_deca3639-f042-4048-8d76-d753c0db5de0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2a73fdbe-331b-4ca8-8e27-b1704bcc6727" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_deca3639-f042-4048-8d76-d753c0db5de0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_14b9c8d1-0b34-49ff-b513-748e027aeba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_ae705c69-a5f2-4c20-b78a-a6bc7754a5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_14b9c8d1-0b34-49ff-b513-748e027aeba1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_ae705c69-a5f2-4c20-b78a-a6bc7754a5e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_701e8177-161b-4c09-a59e-646962bd1087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_14b9c8d1-0b34-49ff-b513-748e027aeba1" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_701e8177-161b-4c09-a59e-646962bd1087" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_ff3a1e0e-ac0f-4020-9568-47e47c9dba29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_14b9c8d1-0b34-49ff-b513-748e027aeba1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_ff3a1e0e-ac0f-4020-9568-47e47c9dba29" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f5c59d32-240a-46ee-b5b9-3c70efd22fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_d1e68653-112f-4a7c-aa3c-b04887952aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f5c59d32-240a-46ee-b5b9-3c70efd22fc5" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_d1e68653-112f-4a7c-aa3c-b04887952aed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_04c3a668-171f-401d-968b-dcc178c694c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f5c59d32-240a-46ee-b5b9-3c70efd22fc5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_04c3a668-171f-401d-968b-dcc178c694c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_c9e4d434-3e53-4579-bf8b-df73bb6c2115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f5c59d32-240a-46ee-b5b9-3c70efd22fc5" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_c9e4d434-3e53-4579-bf8b-df73bb6c2115" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a0de9120-c349-4280-a7d9-eaefb1a41a59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f5c59d32-240a-46ee-b5b9-3c70efd22fc5" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a0de9120-c349-4280-a7d9-eaefb1a41a59" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>clx-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0b973b79-9411-462a-9048-a4468bf442a9,g:effc8b7f-c824-4f09-9fb9-ffb97c19c826-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" xlink:type="extended" id="i6f4667e25b664cd984b64e66957c11f5_RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_83c62398-f006-436b-824f-1bb0a5a557bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_3916f464-a4a8-43e6-abf5-ee3462cb31c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_83c62398-f006-436b-824f-1bb0a5a557bd" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_3916f464-a4a8-43e6-abf5-ee3462cb31c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_bc6b2852-9f7f-4618-8b6d-2f60813c3099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_83c62398-f006-436b-824f-1bb0a5a557bd" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_bc6b2852-9f7f-4618-8b6d-2f60813c3099" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d601bea7-51f1-4671-ad2f-57e0e3bb2f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_83c62398-f006-436b-824f-1bb0a5a557bd" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d601bea7-51f1-4671-ad2f-57e0e3bb2f31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_462cff01-937e-402b-80bc-c715366719d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d601bea7-51f1-4671-ad2f-57e0e3bb2f31" xlink:to="loc_srt_RangeAxis_462cff01-937e-402b-80bc-c715366719d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_462cff01-937e-402b-80bc-c715366719d8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_462cff01-937e-402b-80bc-c715366719d8" xlink:to="loc_srt_RangeMember_462cff01-937e-402b-80bc-c715366719d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_df251483-b618-4663-ae2c-93b24fd947ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_462cff01-937e-402b-80bc-c715366719d8" xlink:to="loc_srt_RangeMember_df251483-b618-4663-ae2c-93b24fd947ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f5bf4c6c-4fff-4bf7-95ed-050738946a1f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_df251483-b618-4663-ae2c-93b24fd947ca" xlink:to="loc_srt_MinimumMember_f5bf4c6c-4fff-4bf7-95ed-050738946a1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2b04b193-2d43-403d-8f87-10474123d18a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_df251483-b618-4663-ae2c-93b24fd947ca" xlink:to="loc_srt_MaximumMember_2b04b193-2d43-403d-8f87-10474123d18a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c0d31f60-69b3-4162-afde-17df5a6f66b6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d601bea7-51f1-4671-ad2f-57e0e3bb2f31" xlink:to="loc_srt_StatementScenarioAxis_c0d31f60-69b3-4162-afde-17df5a6f66b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c0d31f60-69b3-4162-afde-17df5a6f66b6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_c0d31f60-69b3-4162-afde-17df5a6f66b6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c0d31f60-69b3-4162-afde-17df5a6f66b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_78ce573b-fb68-4086-8782-d8304467d5fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_c0d31f60-69b3-4162-afde-17df5a6f66b6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_78ce573b-fb68-4086-8782-d8304467d5fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_5bba0dda-0035-4323-a5e7-49a7b13ddde8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_78ce573b-fb68-4086-8782-d8304467d5fb" xlink:to="loc_srt_ScenarioForecastMember_5bba0dda-0035-4323-a5e7-49a7b13ddde8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" xlink:type="extended" id="if135f82101864eb88a43a24d78ee1d8b_RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a8794e37-8374-4713-9b45-bdf00fe54752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_26052ee0-e5f6-474e-b2b4-e2f2bd2b26b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a8794e37-8374-4713-9b45-bdf00fe54752" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_26052ee0-e5f6-474e-b2b4-e2f2bd2b26b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fd2bab05-6db3-4c90-a6c0-11c9acff2535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a8794e37-8374-4713-9b45-bdf00fe54752" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fd2bab05-6db3-4c90-a6c0-11c9acff2535" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_06d95539-f781-4d6d-9e0a-050ee3a81900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fd2bab05-6db3-4c90-a6c0-11c9acff2535" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_06d95539-f781-4d6d-9e0a-050ee3a81900" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_06d95539-f781-4d6d-9e0a-050ee3a81900_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_06d95539-f781-4d6d-9e0a-050ee3a81900" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_06d95539-f781-4d6d-9e0a-050ee3a81900_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c0eeaae4-8ee9-446f-b3f2-aa01fada7fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_06d95539-f781-4d6d-9e0a-050ee3a81900" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c0eeaae4-8ee9-446f-b3f2-aa01fada7fe8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CostOfGoodsAndServicesSoldMember_6a0abe29-7d86-4db2-88d4-f7725791b456" xlink:href="clx-20230331.xsd#clx_CostOfGoodsAndServicesSoldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c0eeaae4-8ee9-446f-b3f2-aa01fada7fe8" xlink:to="loc_clx_CostOfGoodsAndServicesSoldMember_6a0abe29-7d86-4db2-88d4-f7725791b456" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2f1c500e-0fc6-4c66-911a-5d6e1d88822f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c0eeaae4-8ee9-446f-b3f2-aa01fada7fe8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2f1c500e-0fc6-4c66-911a-5d6e1d88822f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherIncomeExpenseNetMember_fcf84920-99fa-4950-9b74-0b8d181bcd5e" xlink:href="clx-20230331.xsd#clx_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c0eeaae4-8ee9-446f-b3f2-aa01fada7fe8" xlink:to="loc_clx_OtherIncomeExpenseNetMember_fcf84920-99fa-4950-9b74-0b8d181bcd5e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" xlink:type="extended" id="i6787b525a1414b42b3500a62684db2c5_RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c644ba16-36d1-4c1f-9d97-967e99e8d0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_94b7f216-c82e-404c-b5a9-1066cb1243cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c644ba16-36d1-4c1f-9d97-967e99e8d0e9" xlink:to="loc_us-gaap_RestructuringReserveRollForward_94b7f216-c82e-404c-b5a9-1066cb1243cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_1d1f44b6-57b0-4718-a94d-688ab877b696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_94b7f216-c82e-404c-b5a9-1066cb1243cb" xlink:to="loc_us-gaap_RestructuringReserve_1d1f44b6-57b0-4718-a94d-688ab877b696" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6f14971c-753b-4d2d-be3d-4b0385a31bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_94b7f216-c82e-404c-b5a9-1066cb1243cb" xlink:to="loc_us-gaap_RestructuringCharges_6f14971c-753b-4d2d-be3d-4b0385a31bc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_234dd894-33d6-4183-bbf9-534efacadda5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_94b7f216-c82e-404c-b5a9-1066cb1243cb" xlink:to="loc_us-gaap_PaymentsForRestructuring_234dd894-33d6-4183-bbf9-534efacadda5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_ffb0b48d-a59b-4c3c-853e-f9db4d806dce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_bac69afa-fec8-4d2e-a3a3-447958173f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c644ba16-36d1-4c1f-9d97-967e99e8d0e9" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_bac69afa-fec8-4d2e-a3a3-447958173f94" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_d824df03-332e-4024-8c16-b5126a7e6895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_bac69afa-fec8-4d2e-a3a3-447958173f94" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_d824df03-332e-4024-8c16-b5126a7e6895" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_d824df03-332e-4024-8c16-b5126a7e6895_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_d824df03-332e-4024-8c16-b5126a7e6895" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_d824df03-332e-4024-8c16-b5126a7e6895_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_3aaa8274-2eb3-487c-8fef-11013a38e540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_d824df03-332e-4024-8c16-b5126a7e6895" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_3aaa8274-2eb3-487c-8fef-11013a38e540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_923a6306-ba68-46f8-b974-f2e6cf714a27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3aaa8274-2eb3-487c-8fef-11013a38e540" xlink:to="loc_us-gaap_EmployeeSeveranceMember_923a6306-ba68-46f8-b974-f2e6cf714a27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_439c471c-27d9-4bd9-af44-f1253ab87a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3aaa8274-2eb3-487c-8fef-11013a38e540" xlink:to="loc_us-gaap_OtherRestructuringMember_439c471c-27d9-4bd9-af44-f1253ab87a20" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails" xlink:type="extended" id="i685a8d428faa49a4b7b94ba3d44bba7d_GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_c7caa3a1-05a9-47f0-8faf-f759de14c26c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_c737a773-4e35-4c5b-9650-3c326dea5709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_c7caa3a1-05a9-47f0-8faf-f759de14c26c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_c737a773-4e35-4c5b-9650-3c326dea5709" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_0d656809-5236-4a76-b140-ba5a9eb18d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_c7caa3a1-05a9-47f0-8faf-f759de14c26c" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_0d656809-5236-4a76-b140-ba5a9eb18d32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_6cb33a0c-2076-4f89-aad2-ca0f62cf7b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_c7caa3a1-05a9-47f0-8faf-f759de14c26c" xlink:to="loc_us-gaap_AssetImpairmentCharges_6cb33a0c-2076-4f89-aad2-ca0f62cf7b88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3331815d-dd7b-45e8-9dca-c02017489edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_c7caa3a1-05a9-47f0-8faf-f759de14c26c" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3331815d-dd7b-45e8-9dca-c02017489edc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_bf162445-01b9-4e67-90da-c2de7527a573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3331815d-dd7b-45e8-9dca-c02017489edc" xlink:to="loc_us-gaap_ReportingUnitAxis_bf162445-01b9-4e67-90da-c2de7527a573" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_bf162445-01b9-4e67-90da-c2de7527a573_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_bf162445-01b9-4e67-90da-c2de7527a573" xlink:to="loc_us-gaap_ReportingUnitDomain_bf162445-01b9-4e67-90da-c2de7527a573_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_9c12555a-7864-41b9-a421-50557ea8ff17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_bf162445-01b9-4e67-90da-c2de7527a573" xlink:to="loc_us-gaap_ReportingUnitDomain_9c12555a-7864-41b9-a421-50557ea8ff17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsReportingUnitMember_00a1c8a2-2ef5-4f31-9281-0cde4334769c" xlink:href="clx-20230331.xsd#clx_VitaminsMineralsAndSupplementsReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_9c12555a-7864-41b9-a421-50557ea8ff17" xlink:to="loc_clx_VitaminsMineralsAndSupplementsReportingUnitMember_00a1c8a2-2ef5-4f31-9281-0cde4334769c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalReportingUnitMember_0ae5ec0d-0692-4fd6-9cd4-d23e6e6cc6b2" xlink:href="clx-20230331.xsd#clx_InternationalReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_9c12555a-7864-41b9-a421-50557ea8ff17" xlink:to="loc_clx_InternationalReportingUnitMember_0ae5ec0d-0692-4fd6-9cd4-d23e6e6cc6b2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails" xlink:type="extended" id="i770cc0e78b0f42d585e5e453800cf092_GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit_93a5e67d-1437-492b-86b2-4bcef872bff9" xlink:href="clx-20230331.xsd#clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit_93a5e67d-1437-492b-86b2-4bcef872bff9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_ed3a87fc-042d-4a74-94d7-1b97ac416e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_ed3a87fc-042d-4a74-94d7-1b97ac416e0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue_e1cf5d5a-43f6-4ac4-9e3c-a5878a283c3a" xlink:href="clx-20230331.xsd#clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue_e1cf5d5a-43f6-4ac4-9e3c-a5878a283c3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0ea26a7f-62cd-487c-a694-2aa6ab192cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0ea26a7f-62cd-487c-a694-2aa6ab192cfc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_354ac2b5-1d68-42e9-823f-8fbb56bd89f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_354ac2b5-1d68-42e9-823f-8fbb56bd89f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_93121201-0c91-40e1-a433-584a9b7e1106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_93121201-0c91-40e1-a433-584a9b7e1106" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_51fa69da-b243-4039-a9ad-fa94958f3b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_51fa69da-b243-4039-a9ad-fa94958f3b21" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5761d22b-8edc-4ad6-88e1-ee8903faac54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5761d22b-8edc-4ad6-88e1-ee8903faac54" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_863048c2-9955-45e1-b8a7-a4701b332302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_863048c2-9955-45e1-b8a7-a4701b332302" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_82a5e655-1258-429d-852b-efed9d71cab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_82a5e655-1258-429d-852b-efed9d71cab0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5be709b5-bd50-43b0-80cf-46a279955bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5be709b5-bd50-43b0-80cf-46a279955bc4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_0b776cf6-f14a-44fa-8664-87a261495062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_0b776cf6-f14a-44fa-8664-87a261495062" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2802875f-6f0c-4c1a-943c-6c8d4546364c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0b776cf6-f14a-44fa-8664-87a261495062" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2802875f-6f0c-4c1a-943c-6c8d4546364c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2802875f-6f0c-4c1a-943c-6c8d4546364c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2802875f-6f0c-4c1a-943c-6c8d4546364c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2802875f-6f0c-4c1a-943c-6c8d4546364c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f210f149-04c7-4ccc-b021-625da90f2576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2802875f-6f0c-4c1a-943c-6c8d4546364c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f210f149-04c7-4ccc-b021-625da90f2576" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_e5a340ed-6782-4aab-8878-94595252b2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f210f149-04c7-4ccc-b021-625da90f2576" xlink:to="loc_us-gaap_TrademarksMember_e5a340ed-6782-4aab-8878-94595252b2c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_2627609f-9a90-4793-8544-790d6e31eeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0b776cf6-f14a-44fa-8664-87a261495062" xlink:to="loc_us-gaap_ReportingUnitAxis_2627609f-9a90-4793-8544-790d6e31eeb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_2627609f-9a90-4793-8544-790d6e31eeb2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_2627609f-9a90-4793-8544-790d6e31eeb2" xlink:to="loc_us-gaap_ReportingUnitDomain_2627609f-9a90-4793-8544-790d6e31eeb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_f4a97e32-e7a5-4068-8d25-593b6d890346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_2627609f-9a90-4793-8544-790d6e31eeb2" xlink:to="loc_us-gaap_ReportingUnitDomain_f4a97e32-e7a5-4068-8d25-593b6d890346" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsReportingUnitMember_9712af4d-4759-43f3-92ba-d25ed66ae816" xlink:href="clx-20230331.xsd#clx_VitaminsMineralsAndSupplementsReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_f4a97e32-e7a5-4068-8d25-593b6d890346" xlink:to="loc_clx_VitaminsMineralsAndSupplementsReportingUnitMember_9712af4d-4759-43f3-92ba-d25ed66ae816" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b63634d2-db1f-4727-908d-edebbc773d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0b776cf6-f14a-44fa-8664-87a261495062" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b63634d2-db1f-4727-908d-edebbc773d25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b63634d2-db1f-4727-908d-edebbc773d25_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b63634d2-db1f-4727-908d-edebbc773d25" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b63634d2-db1f-4727-908d-edebbc773d25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a97f10e-ce33-42cd-a91a-7868a02be395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b63634d2-db1f-4727-908d-edebbc773d25" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a97f10e-ce33-42cd-a91a-7868a02be395" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_551ea2b2-c8a6-4b47-b751-8447df10bd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a97f10e-ce33-42cd-a91a-7868a02be395" xlink:to="loc_us-gaap_TrademarksMember_551ea2b2-c8a6-4b47-b751-8447df10bd4d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails" xlink:type="extended" id="i29b93ae2d17846fb81cbe1ee3199e3cc_GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_9e448b79-60ee-491d-83bc-b5a8fb37b941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_68cd2cb6-0bf5-48eb-a1e1-23a2cb228a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9e448b79-60ee-491d-83bc-b5a8fb37b941" xlink:to="loc_us-gaap_GoodwillRollForward_68cd2cb6-0bf5-48eb-a1e1-23a2cb228a92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b1d78900-8fe3-4fdd-900d-52c0765a916e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_68cd2cb6-0bf5-48eb-a1e1-23a2cb228a92" xlink:to="loc_us-gaap_Goodwill_b1d78900-8fe3-4fdd-900d-52c0765a916e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_a7fb2393-ff3e-45a7-a30a-730288d3402c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_68cd2cb6-0bf5-48eb-a1e1-23a2cb228a92" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_a7fb2393-ff3e-45a7-a30a-730288d3402c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_90f95578-ed81-4b9b-a968-85f7e6f70c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_68cd2cb6-0bf5-48eb-a1e1-23a2cb228a92" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_90f95578-ed81-4b9b-a968-85f7e6f70c35" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fd2de46d-a4cd-4282-89c2-b8ad15a53562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_84801f77-4872-45e5-ab27-eff6d2c8016a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_9e448b79-60ee-491d-83bc-b5a8fb37b941" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_84801f77-4872-45e5-ab27-eff6d2c8016a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4590f125-60b6-44d5-9192-0641618e1160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_84801f77-4872-45e5-ab27-eff6d2c8016a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4590f125-60b6-44d5-9192-0641618e1160" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4590f125-60b6-44d5-9192-0641618e1160_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4590f125-60b6-44d5-9192-0641618e1160" xlink:to="loc_us-gaap_SegmentDomain_4590f125-60b6-44d5-9192-0641618e1160_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f210a080-3b3b-4d46-b7cc-00ac7a3bc1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4590f125-60b6-44d5-9192-0641618e1160" xlink:to="loc_us-gaap_SegmentDomain_f210a080-3b3b-4d46-b7cc-00ac7a3bc1d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_0bfbe2b4-eaa0-4e9f-8be4-5ff2d9d50db1" xlink:href="clx-20230331.xsd#clx_HealthAndWellnessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f210a080-3b3b-4d46-b7cc-00ac7a3bc1d7" xlink:to="loc_clx_HealthAndWellnessMember_0bfbe2b4-eaa0-4e9f-8be4-5ff2d9d50db1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember_8aac5959-e2c3-4def-954c-003d242699e8" xlink:href="clx-20230331.xsd#clx_HouseholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f210a080-3b3b-4d46-b7cc-00ac7a3bc1d7" xlink:to="loc_clx_HouseholdMember_8aac5959-e2c3-4def-954c-003d242699e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember_c85c3f78-a8b6-4e3f-9bdb-a6a287025982" xlink:href="clx-20230331.xsd#clx_LifestyleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f210a080-3b3b-4d46-b7cc-00ac7a3bc1d7" xlink:to="loc_clx_LifestyleMember_c85c3f78-a8b6-4e3f-9bdb-a6a287025982" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember_331ff5d1-16bd-4df5-9282-8d2b0872f0c7" xlink:href="clx-20230331.xsd#clx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f210a080-3b3b-4d46-b7cc-00ac7a3bc1d7" xlink:to="loc_clx_InternationalMember_331ff5d1-16bd-4df5-9282-8d2b0872f0c7" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails" xlink:type="extended" id="i3d0956e8f374474a92918964a841815d_GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_14a51dd9-375d-4d05-8de2-c89169a5de45" xlink:href="clx-20230331.xsd#clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_14a51dd9-375d-4d05-8de2-c89169a5de45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_8bb079c8-bfdf-4efc-8ad8-b0c9d2108470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_8bb079c8-bfdf-4efc-8ad8-b0c9d2108470" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9393eab4-3ec1-4427-93f7-baf5c01524b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9393eab4-3ec1-4427-93f7-baf5c01524b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_290d7f20-b36c-4eeb-83d9-78ea06af6f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_290d7f20-b36c-4eeb-83d9-78ea06af6f12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_48f75516-f3fc-4167-8a80-7a2aa8c7a145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_48f75516-f3fc-4167-8a80-7a2aa8c7a145" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6a830be1-ae7b-4eb7-b9dd-b8a0df62e458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6a830be1-ae7b-4eb7-b9dd-b8a0df62e458" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_49a7b332-7847-46f8-a857-654af814e98f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_49a7b332-7847-46f8-a857-654af814e98f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_373a35bd-4448-4ed1-a373-5c1e5f59dc18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_373a35bd-4448-4ed1-a373-5c1e5f59dc18" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_830907f9-3a6e-4999-ab39-9cc851ebdbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_830907f9-3a6e-4999-ab39-9cc851ebdbcb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_736de8fd-1bd7-4c03-85e6-b879278629c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_830907f9-3a6e-4999-ab39-9cc851ebdbcb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_736de8fd-1bd7-4c03-85e6-b879278629c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_736de8fd-1bd7-4c03-85e6-b879278629c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_736de8fd-1bd7-4c03-85e6-b879278629c4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_736de8fd-1bd7-4c03-85e6-b879278629c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_66896abf-1f4d-4886-b09c-e9ffb5b18aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_736de8fd-1bd7-4c03-85e6-b879278629c4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_66896abf-1f4d-4886-b09c-e9ffb5b18aff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_cb413286-f558-497e-a28f-169445bdc87a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_66896abf-1f4d-4886-b09c-e9ffb5b18aff" xlink:to="loc_us-gaap_TrademarksMember_cb413286-f558-497e-a28f-169445bdc87a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_84024647-7e1d-4c1c-be39-54c71d20675f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_66896abf-1f4d-4886-b09c-e9ffb5b18aff" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_84024647-7e1d-4c1c-be39-54c71d20675f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9ccc713d-1c09-4259-9f80-144d6d041389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_830907f9-3a6e-4999-ab39-9cc851ebdbcb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9ccc713d-1c09-4259-9f80-144d6d041389" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9ccc713d-1c09-4259-9f80-144d6d041389_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9ccc713d-1c09-4259-9f80-144d6d041389" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9ccc713d-1c09-4259-9f80-144d6d041389_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_45cb0554-d44c-463a-adf9-51a46653be58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9ccc713d-1c09-4259-9f80-144d6d041389" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_45cb0554-d44c-463a-adf9-51a46653be58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_dbbd90c2-ebd1-4de0-b8bb-6c4485751ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_45cb0554-d44c-463a-adf9-51a46653be58" xlink:to="loc_us-gaap_TrademarksMember_dbbd90c2-ebd1-4de0-b8bb-6c4485751ce0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#OTHERLIABILITIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails" xlink:type="extended" id="ibeba7355dc1349c69bedab40a436471c_OTHERLIABILITIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_1afeaf00-5e0b-4e33-ab7e-85fa93273880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_PercentageofOwnershipbyVenturePartner_6184c8d1-835a-4b7d-a751-7d119de1faec" xlink:href="clx-20230331.xsd#clx_PercentageofOwnershipbyVenturePartner"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1afeaf00-5e0b-4e33-ab7e-85fa93273880" xlink:to="loc_clx_PercentageofOwnershipbyVenturePartner_6184c8d1-835a-4b7d-a751-7d119de1faec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VentureAgreementOptiontoExtendAgreementTermPeriod_e74f118b-4a58-449b-8891-d618f7bb50cf" xlink:href="clx-20230331.xsd#clx_VentureAgreementOptiontoExtendAgreementTermPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1afeaf00-5e0b-4e33-ab7e-85fa93273880" xlink:to="loc_clx_VentureAgreementOptiontoExtendAgreementTermPeriod_e74f118b-4a58-449b-8891-d618f7bb50cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VentureAgreement.TerminalObligation_3d64d821-1d73-4e3c-9fad-c96916c6027d" xlink:href="clx-20230331.xsd#clx_VentureAgreement.TerminalObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1afeaf00-5e0b-4e33-ab7e-85fa93273880" xlink:to="loc_clx_VentureAgreement.TerminalObligation_3d64d821-1d73-4e3c-9fad-c96916c6027d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VentureAgreementTerminalObligationNet_9280b075-df08-4fba-ac35-3ed75a82079e" xlink:href="clx-20230331.xsd#clx_VentureAgreementTerminalObligationNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1afeaf00-5e0b-4e33-ab7e-85fa93273880" xlink:to="loc_clx_VentureAgreementTerminalObligationNet_9280b075-df08-4fba-ac35-3ed75a82079e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_823fdc73-5ccc-4159-9286-65d7c37dbcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1afeaf00-5e0b-4e33-ab7e-85fa93273880" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_823fdc73-5ccc-4159-9286-65d7c37dbcc0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_46c97344-b49b-4944-810d-626688220d57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_823fdc73-5ccc-4159-9286-65d7c37dbcc0" xlink:to="loc_srt_CounterpartyNameAxis_46c97344-b49b-4944-810d-626688220d57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_46c97344-b49b-4944-810d-626688220d57_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_46c97344-b49b-4944-810d-626688220d57" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_46c97344-b49b-4944-810d-626688220d57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_30cefd12-6e4d-4994-9d46-ffd8e01e71c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_46c97344-b49b-4944-810d-626688220d57" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_30cefd12-6e4d-4994-9d46-ffd8e01e71c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_GladBusinessMember_7304fdeb-57ba-46af-a7fc-98428de68b73" xlink:href="clx-20230331.xsd#clx_GladBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_30cefd12-6e4d-4994-9d46-ffd8e01e71c7" xlink:to="loc_clx_GladBusinessMember_7304fdeb-57ba-46af-a7fc-98428de68b73" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended" id="i7cc43c2ff4914f6787316540ba796962_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_6b16af8f-bb62-4cf5-9f99-ef78dc3e38d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_6b16af8f-bb62-4cf5-9f99-ef78dc3e38d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_3cb991d2-c624-4986-9cdc-3a67f903fef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_DerivativeNotionalAmount_3cb991d2-c624-4986-9cdc-3a67f903fef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_e053463e-12c9-4832-bf9a-f6b21172db38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_e053463e-12c9-4832-bf9a-f6b21172db38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_54d3137c-adee-4e57-a4ca-c6c427277e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_54d3137c-adee-4e57-a4ca-c6c427277e47" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_9a731330-b02a-45f2-a803-4fbd21be36c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_9a731330-b02a-45f2-a803-4fbd21be36c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount_0dd8e6fe-2779-4761-86eb-f3cb810be459" xlink:href="clx-20230331.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount_0dd8e6fe-2779-4761-86eb-f3cb810be459" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarginDepositAssets_cb53ec61-18bc-42f3-bba5-3683e0ca525d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarginDepositAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_MarginDepositAssets_cb53ec61-18bc-42f3-bba5-3683e0ca525d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_a4ad8452-1701-4760-a6e8-2e33bb7da209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_AssetImpairmentCharges_a4ad8452-1701-4760-a6e8-2e33bb7da209" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_069b0c0e-ad5f-446a-a9ec-7ac6e20139de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_069b0c0e-ad5f-446a-a9ec-7ac6e20139de" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_25d92855-060b-4ef7-b17f-8e7309e1044a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_25d92855-060b-4ef7-b17f-8e7309e1044a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_5fd35da7-ac9e-4ae7-92df-eac99b2e8190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_DerivativeTable_5fd35da7-ac9e-4ae7-92df-eac99b2e8190" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsAxis_67ce5bea-ca9d-4c93-84c8-767750073803" xlink:href="clx-20230331.xsd#clx_CommodityPurchaseDerivativeContractsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5fd35da7-ac9e-4ae7-92df-eac99b2e8190" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsAxis_67ce5bea-ca9d-4c93-84c8-767750073803" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsDomain_67ce5bea-ca9d-4c93-84c8-767750073803_default" xlink:href="clx-20230331.xsd#clx_CommodityPurchaseDerivativeContractsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsAxis_67ce5bea-ca9d-4c93-84c8-767750073803" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsDomain_67ce5bea-ca9d-4c93-84c8-767750073803_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsDomain_8acfc93a-65b2-4b89-b732-c6f1b2fe8fe3" xlink:href="clx-20230331.xsd#clx_CommodityPurchaseDerivativeContractsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsAxis_67ce5bea-ca9d-4c93-84c8-767750073803" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsDomain_8acfc93a-65b2-4b89-b732-c6f1b2fe8fe3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TotalCommodityPurchaseDerivativeContractsMember_cfd313f5-2abe-47cf-8a49-76b29fbf4528" xlink:href="clx-20230331.xsd#clx_TotalCommodityPurchaseDerivativeContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsDomain_8acfc93a-65b2-4b89-b732-c6f1b2fe8fe3" xlink:to="loc_clx_TotalCommodityPurchaseDerivativeContractsMember_cfd313f5-2abe-47cf-8a49-76b29fbf4528" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_83453e97-e37c-4495-b395-9e98a936af3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5fd35da7-ac9e-4ae7-92df-eac99b2e8190" xlink:to="loc_us-gaap_TransactionTypeAxis_83453e97-e37c-4495-b395-9e98a936af3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_83453e97-e37c-4495-b395-9e98a936af3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TransactionTypeAxis_83453e97-e37c-4495-b395-9e98a936af3e" xlink:to="loc_us-gaap_TransactionDomain_83453e97-e37c-4495-b395-9e98a936af3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_d65d9e05-c9a8-4ef2-9f8e-4b2a838890fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TransactionTypeAxis_83453e97-e37c-4495-b395-9e98a936af3e" xlink:to="loc_us-gaap_TransactionDomain_d65d9e05-c9a8-4ef2-9f8e-4b2a838890fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_PurchasesofInventoryMember_4f97f68b-20c5-4216-9a6a-885e3809d60d" xlink:href="clx-20230331.xsd#clx_PurchasesofInventoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransactionDomain_d65d9e05-c9a8-4ef2-9f8e-4b2a838890fd" xlink:to="loc_clx_PurchasesofInventoryMember_4f97f68b-20c5-4216-9a6a-885e3809d60d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_913bfb67-8ce8-4805-952f-b3ff07933ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5fd35da7-ac9e-4ae7-92df-eac99b2e8190" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_913bfb67-8ce8-4805-952f-b3ff07933ac0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_913bfb67-8ce8-4805-952f-b3ff07933ac0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_913bfb67-8ce8-4805-952f-b3ff07933ac0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_913bfb67-8ce8-4805-952f-b3ff07933ac0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ac92a9d7-4153-4225-8591-d993edbdf89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_913bfb67-8ce8-4805-952f-b3ff07933ac0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ac92a9d7-4153-4225-8591-d993edbdf89e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_438ebe27-7800-4b8e-b65a-13352e46a847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac92a9d7-4153-4225-8591-d993edbdf89e" xlink:to="loc_us-gaap_ForeignExchangeContractMember_438ebe27-7800-4b8e-b65a-13352e46a847" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_8f907a4a-74e0-4ea2-b64b-7eb2ba987706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac92a9d7-4153-4225-8591-d993edbdf89e" xlink:to="loc_us-gaap_CommodityContractMember_8f907a4a-74e0-4ea2-b64b-7eb2ba987706" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="iee1c999ecd954966b730d35cf884dbca_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_07f0def8-da2a-458e-a447-1a28d2f1f15d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e6fb63c6-dfe4-4540-b01e-391790cefe69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_07f0def8-da2a-458e-a447-1a28d2f1f15d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e6fb63c6-dfe4-4540-b01e-391790cefe69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_74492f21-0b02-4c50-9ff2-551032786afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_07f0def8-da2a-458e-a447-1a28d2f1f15d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_74492f21-0b02-4c50-9ff2-551032786afb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5d5c4d32-4471-4ace-9763-4405df5e2274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_07f0def8-da2a-458e-a447-1a28d2f1f15d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5d5c4d32-4471-4ace-9763-4405df5e2274" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_713bfb05-7e1d-4394-9ff9-462ee2e032e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5d5c4d32-4471-4ace-9763-4405df5e2274" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_713bfb05-7e1d-4394-9ff9-462ee2e032e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_713bfb05-7e1d-4394-9ff9-462ee2e032e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_713bfb05-7e1d-4394-9ff9-462ee2e032e9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_713bfb05-7e1d-4394-9ff9-462ee2e032e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d143dc1c-5650-4dee-8ec4-a4311cce7a82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_713bfb05-7e1d-4394-9ff9-462ee2e032e9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d143dc1c-5650-4dee-8ec4-a4311cce7a82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_ea3991ed-2267-4883-ae54-29f0e7cb7596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d143dc1c-5650-4dee-8ec4-a4311cce7a82" xlink:to="loc_us-gaap_CommodityContractMember_ea3991ed-2267-4883-ae54-29f0e7cb7596" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_08f4feb6-c175-4bf6-8ea3-131b5eb6e41d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d143dc1c-5650-4dee-8ec4-a4311cce7a82" xlink:to="loc_us-gaap_ForeignExchangeContractMember_08f4feb6-c175-4bf6-8ea3-131b5eb6e41d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_7469c94f-8e30-4140-9955-af27a464ab33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d143dc1c-5650-4dee-8ec4-a4311cce7a82" xlink:to="loc_us-gaap_InterestRateContractMember_7469c94f-8e30-4140-9955-af27a464ab33" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" xlink:type="extended" id="id570d1a9b8c04cb9ba2c8ed9d072338b_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d4fbe4cd-e38d-48bc-9793-7c860c0c0b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_eba211f1-7aea-4a51-86c6-1241f15a5896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d4fbe4cd-e38d-48bc-9793-7c860c0c0b38" xlink:to="loc_us-gaap_DerivativeAssets_eba211f1-7aea-4a51-86c6-1241f15a5896" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_ceccaf56-79f2-4a48-b33e-c83020971551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d4fbe4cd-e38d-48bc-9793-7c860c0c0b38" xlink:to="loc_us-gaap_DerivativeLiabilities_ceccaf56-79f2-4a48-b33e-c83020971551" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_16a4c698-ea35-4291-83d9-2c00d9b18f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d4fbe4cd-e38d-48bc-9793-7c860c0c0b38" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_16a4c698-ea35-4291-83d9-2c00d9b18f5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3e72ef59-0af9-4331-9bad-1fa467642cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_16a4c698-ea35-4291-83d9-2c00d9b18f5b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3e72ef59-0af9-4331-9bad-1fa467642cf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3e72ef59-0af9-4331-9bad-1fa467642cf5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3e72ef59-0af9-4331-9bad-1fa467642cf5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3e72ef59-0af9-4331-9bad-1fa467642cf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_18eb024c-02f4-48ec-b9bd-bc89125dd179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3e72ef59-0af9-4331-9bad-1fa467642cf5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_18eb024c-02f4-48ec-b9bd-bc89125dd179" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_589c65c7-b6d9-4362-8078-d10d756f47c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_18eb024c-02f4-48ec-b9bd-bc89125dd179" xlink:to="loc_us-gaap_CommodityContractMember_589c65c7-b6d9-4362-8078-d10d756f47c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_d738769e-d9b0-4b91-aabc-81afc8de0bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_18eb024c-02f4-48ec-b9bd-bc89125dd179" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_d738769e-d9b0-4b91-aabc-81afc8de0bbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_193c47c4-03f6-4cc0-9855-409ef1d6c64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_16a4c698-ea35-4291-83d9-2c00d9b18f5b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_193c47c4-03f6-4cc0-9855-409ef1d6c64b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_193c47c4-03f6-4cc0-9855-409ef1d6c64b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_193c47c4-03f6-4cc0-9855-409ef1d6c64b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_193c47c4-03f6-4cc0-9855-409ef1d6c64b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eeb1096c-f5b1-47a3-8ae1-051366349193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_193c47c4-03f6-4cc0-9855-409ef1d6c64b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eeb1096c-f5b1-47a3-8ae1-051366349193" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c6e2d24c-3790-41eb-8e9b-f379255e7c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eeb1096c-f5b1-47a3-8ae1-051366349193" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c6e2d24c-3790-41eb-8e9b-f379255e7c38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f777a5d0-8baa-4028-b600-38358f7b0648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eeb1096c-f5b1-47a3-8ae1-051366349193" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f777a5d0-8baa-4028-b600-38358f7b0648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_c19f27bd-ef4d-4738-9d2a-7ea16891e3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_16a4c698-ea35-4291-83d9-2c00d9b18f5b" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_c19f27bd-ef4d-4738-9d2a-7ea16891e3e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_c19f27bd-ef4d-4738-9d2a-7ea16891e3e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_c19f27bd-ef4d-4738-9d2a-7ea16891e3e1" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_c19f27bd-ef4d-4738-9d2a-7ea16891e3e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3d817c92-fb4d-4c73-b799-95910678a0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_c19f27bd-ef4d-4738-9d2a-7ea16891e3e1" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3d817c92-fb4d-4c73-b799-95910678a0c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cedb93b2-b854-427b-b078-57b2ed8a99b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3d817c92-fb4d-4c73-b799-95910678a0c8" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cedb93b2-b854-427b-b078-57b2ed8a99b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_6b534d5c-f9e1-4872-b645-3f27e759a979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cedb93b2-b854-427b-b078-57b2ed8a99b3" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_6b534d5c-f9e1-4872-b645-3f27e759a979" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_ad358300-8db3-405e-b2a9-eb7c920a0458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cedb93b2-b854-427b-b078-57b2ed8a99b3" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_ad358300-8db3-405e-b2a9-eb7c920a0458" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="extended" id="ie10b01b6660c41549f9387a640b182f6_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4726553e-e179-48b2-bb8b-b42b31212aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4726553e-e179-48b2-bb8b-b42b31212aee" xlink:to="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f5a4a746-16ff-4000-9c65-1a5c83e6612c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f5a4a746-16ff-4000-9c65-1a5c83e6612c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_540296ca-a695-4f94-84e7-d117061b0e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_540296ca-a695-4f94-84e7-d117061b0e93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_f5003a73-ca31-4ab1-914d-06cb63dc7bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_f5003a73-ca31-4ab1-914d-06cb63dc7bd5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_f920ffed-4550-408c-9e71-b36b0570614d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_f920ffed-4550-408c-9e71-b36b0570614d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3a6e3383-4c08-4ad8-8a1f-0919e594ad08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:to="loc_us-gaap_Assets_3a6e3383-4c08-4ad8-8a1f-0919e594ad08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_381be3db-34b3-4dde-80a7-e8cb08182add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_381be3db-34b3-4dde-80a7-e8cb08182add" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4726553e-e179-48b2-bb8b-b42b31212aee" xlink:to="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_edd59e6f-0e13-473e-a5d6-e471a3863805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:to="loc_us-gaap_CommercialPaper_edd59e6f-0e13-473e-a5d6-e471a3863805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue_3ea10636-a0c5-4510-a31a-86ee4a6dacc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:to="loc_us-gaap_ShorttermDebtFairValue_3ea10636-a0c5-4510-a31a-86ee4a6dacc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_96bd43cf-bb44-4482-84a4-a960b1391587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:to="loc_us-gaap_LongTermDebt_96bd43cf-bb44-4482-84a4-a960b1391587" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_b6cfb0d0-2756-4dcb-a148-59e9f8f53251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:to="loc_us-gaap_DebtInstrumentFairValue_b6cfb0d0-2756-4dcb-a148-59e9f8f53251" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_02fe4ff1-e5ca-4dc0-b734-09d438a41546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:to="loc_us-gaap_Liabilities_02fe4ff1-e5ca-4dc0-b734-09d438a41546" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_bf62d65f-80e5-4657-9f42-d73e2889f7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_bf62d65f-80e5-4657-9f42-d73e2889f7e1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4726553e-e179-48b2-bb8b-b42b31212aee" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_ade3788b-a8ad-465b-855f-e3cdfc5274af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_ade3788b-a8ad-465b-855f-e3cdfc5274af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_ade3788b-a8ad-465b-855f-e3cdfc5274af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_ade3788b-a8ad-465b-855f-e3cdfc5274af" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_ade3788b-a8ad-465b-855f-e3cdfc5274af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6388c58-79c2-4152-9c75-aaf1ecbbab61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_ade3788b-a8ad-465b-855f-e3cdfc5274af" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6388c58-79c2-4152-9c75-aaf1ecbbab61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_2f4f9e81-9392-45f2-8d02-1f680b1cd709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6388c58-79c2-4152-9c75-aaf1ecbbab61" xlink:to="loc_us-gaap_MoneyMarketFundsMember_2f4f9e81-9392-45f2-8d02-1f680b1cd709" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_fb237906-98bb-48bc-bbce-f946d65e81ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6388c58-79c2-4152-9c75-aaf1ecbbab61" xlink:to="loc_us-gaap_BankTimeDepositsMember_fb237906-98bb-48bc-bbce-f946d65e81ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_32d4cb62-006b-4510-874d-c29867595ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_32d4cb62-006b-4510-874d-c29867595ae9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_32d4cb62-006b-4510-874d-c29867595ae9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_32d4cb62-006b-4510-874d-c29867595ae9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_32d4cb62-006b-4510-874d-c29867595ae9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f416504-b10e-4f50-96e0-95acd41d5371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_32d4cb62-006b-4510-874d-c29867595ae9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f416504-b10e-4f50-96e0-95acd41d5371" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d0ef8f50-7f5b-43ab-97f2-d772038da5af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f416504-b10e-4f50-96e0-95acd41d5371" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d0ef8f50-7f5b-43ab-97f2-d772038da5af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_dfe02d15-f905-4dec-aa1a-9e2a0fc4fb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f416504-b10e-4f50-96e0-95acd41d5371" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_dfe02d15-f905-4dec-aa1a-9e2a0fc4fb8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_5e655c6c-0823-497b-b8c5-61e6c1de0894" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_5e655c6c-0823-497b-b8c5-61e6c1de0894" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5e655c6c-0823-497b-b8c5-61e6c1de0894_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_5e655c6c-0823-497b-b8c5-61e6c1de0894" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5e655c6c-0823-497b-b8c5-61e6c1de0894_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_97dbaab6-0906-4cc4-bfa6-44f096e77b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_5e655c6c-0823-497b-b8c5-61e6c1de0894" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_97dbaab6-0906-4cc4-bfa6-44f096e77b98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e5a200e2-d407-4459-9eaf-b10b15cd8e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_97dbaab6-0906-4cc4-bfa6-44f096e77b98" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e5a200e2-d407-4459-9eaf-b10b15cd8e80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_3a20806b-8e95-4756-88f9-f61c61209881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e5a200e2-d407-4459-9eaf-b10b15cd8e80" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_3a20806b-8e95-4756-88f9-f61c61209881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_df1c0670-666f-4703-ba95-615ba6f512ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e5a200e2-d407-4459-9eaf-b10b15cd8e80" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_df1c0670-666f-4703-ba95-615ba6f512ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_08bb985c-14cd-453b-932f-bc43eac3729d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:to="loc_us-gaap_InvestmentTypeAxis_08bb985c-14cd-453b-932f-bc43eac3729d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_08bb985c-14cd-453b-932f-bc43eac3729d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_08bb985c-14cd-453b-932f-bc43eac3729d" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_08bb985c-14cd-453b-932f-bc43eac3729d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_146a8dbe-f72d-4108-9cd0-501b42a51d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_08bb985c-14cd-453b-932f-bc43eac3729d" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_146a8dbe-f72d-4108-9cd0-501b42a51d2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_7a6eadd8-d54b-4c81-99aa-feca57b699ad" xlink:href="clx-20230331.xsd#clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_146a8dbe-f72d-4108-9cd0-501b42a51d2a" xlink:to="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_7a6eadd8-d54b-4c81-99aa-feca57b699ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_1cf6759d-305c-4aba-b793-f057a74db51f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_1cf6759d-305c-4aba-b793-f057a74db51f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1cf6759d-305c-4aba-b793-f057a74db51f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1cf6759d-305c-4aba-b793-f057a74db51f" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1cf6759d-305c-4aba-b793-f057a74db51f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_6e441d57-7b07-4a6d-8ea8-153affdd2d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1cf6759d-305c-4aba-b793-f057a74db51f" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_6e441d57-7b07-4a6d-8ea8-153affdd2d78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NotesAndLoansPayableMember_b01f33d5-80c9-4e58-87c7-d273636e4865" xlink:href="clx-20230331.xsd#clx_NotesAndLoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_6e441d57-7b07-4a6d-8ea8-153affdd2d78" xlink:to="loc_clx_NotesAndLoansPayableMember_b01f33d5-80c9-4e58-87c7-d273636e4865" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c683bc93-8c8b-46c7-92b7-2992ba836c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c683bc93-8c8b-46c7-92b7-2992ba836c18" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c683bc93-8c8b-46c7-92b7-2992ba836c18_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c683bc93-8c8b-46c7-92b7-2992ba836c18" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c683bc93-8c8b-46c7-92b7-2992ba836c18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1081e94a-c3e5-4abb-8d97-eaeb6f774721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c683bc93-8c8b-46c7-92b7-2992ba836c18" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1081e94a-c3e5-4abb-8d97-eaeb6f774721" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_4fecd52a-7869-4688-b4cd-333e68df9b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1081e94a-c3e5-4abb-8d97-eaeb6f774721" xlink:to="loc_us-gaap_LongTermDebtMember_4fecd52a-7869-4688-b4cd-333e68df9b2e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#STOCKHOLDERSEQUITYScheduleofEquityDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" xlink:type="extended" id="ib2be5e165a55463dbee39a81f4bc3fb3_STOCKHOLDERSEQUITYScheduleofEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_2fe0783a-f485-4442-ab1b-7178efd6a98c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_9e0284e5-5a30-4fa7-95e9-3ed2dee8fffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_2fe0783a-f485-4442-ab1b-7178efd6a98c" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_9e0284e5-5a30-4fa7-95e9-3ed2dee8fffc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_2fe0783a-f485-4442-ab1b-7178efd6a98c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cff6f4f2-4486-4bd4-b9f6-f452b11ad539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cff6f4f2-4486-4bd4-b9f6-f452b11ad539" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_cd07fdd7-c451-4764-accc-40dee45f8298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_cd07fdd7-c451-4764-accc-40dee45f8298" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_04a75150-f872-43ab-bc71-708f3e2e5e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_TreasuryStockCommonShares_04a75150-f872-43ab-bc71-708f3e2e5e57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1968d5f7-01b3-470f-8b32-91a708daa3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_ProfitLoss_1968d5f7-01b3-470f-8b32-91a708daa3c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5d5d4a1a-7d25-46be-8d17-10611fab6009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5d5d4a1a-7d25-46be-8d17-10611fab6009" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_89c1aa14-150e-43ba-a6f1-e19bda509fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_Dividends_89c1aa14-150e-43ba-a6f1-e19bda509fcb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_eea223d1-3424-4875-a335-46a0504fc59b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_eea223d1-3424-4875-a335-46a0504fc59b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c8f53123-a839-4690-9210-a59e2d111fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c8f53123-a839-4690-9210-a59e2d111fba" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesAmount_fddf9389-ea16-47b4-86ed-a5fcb85b915d" xlink:href="clx-20230331.xsd#clx_OtherEmployeeStockPlanActivitiesAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_clx_OtherEmployeeStockPlanActivitiesAmount_fddf9389-ea16-47b4-86ed-a5fcb85b915d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesShares_e098308d-ba3c-4c4d-b3ab-8b35202866bd" xlink:href="clx-20230331.xsd#clx_OtherEmployeeStockPlanActivitiesShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_clx_OtherEmployeeStockPlanActivitiesShares_e098308d-ba3c-4c4d-b3ab-8b35202866bd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_a7a8fb5c-f23d-400e-bb79-05874cca743b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_a7a8fb5c-f23d-400e-bb79-05874cca743b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_2c03e903-b530-4fed-9871-ce1cf514c204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_2c03e903-b530-4fed-9871-ce1cf514c204" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f8c386f4-4438-4eec-b771-7cd235b80bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_db69ea15-9230-45ed-b511-cf7e5465902c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_3e37bd5e-9945-48cb-87fb-12b80a75b908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ad37f150-8ad5-4b0e-bd29-784a28967fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_2fe0783a-f485-4442-ab1b-7178efd6a98c" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ad37f150-8ad5-4b0e-bd29-784a28967fd3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7fa0ed83-367e-4f4e-bf14-23009827f6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ad37f150-8ad5-4b0e-bd29-784a28967fd3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7fa0ed83-367e-4f4e-bf14-23009827f6d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7fa0ed83-367e-4f4e-bf14-23009827f6d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7fa0ed83-367e-4f4e-bf14-23009827f6d9" xlink:to="loc_us-gaap_EquityComponentDomain_7fa0ed83-367e-4f4e-bf14-23009827f6d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7fa0ed83-367e-4f4e-bf14-23009827f6d9" xlink:to="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b2c985c0-253f-4b1a-9ff0-685a66b868ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:to="loc_us-gaap_CommonStockMember_b2c985c0-253f-4b1a-9ff0-685a66b868ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_28f794fe-23f2-420b-8356-02b8ac23d5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_28f794fe-23f2-420b-8356-02b8ac23d5c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_ba44e540-6668-4975-9caa-c7f612168781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:to="loc_us-gaap_RetainedEarningsMember_ba44e540-6668-4975-9caa-c7f612168781" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_5bae100f-50b5-476c-a4c9-63c7a56b81cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:to="loc_us-gaap_TreasuryStockCommonMember_5bae100f-50b5-476c-a4c9-63c7a56b81cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eaa9f099-401a-48e8-a5f4-77ac360442ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eaa9f099-401a-48e8-a5f4-77ac360442ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_6448deb7-78e7-4ca5-ac34-630314a46f24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:to="loc_us-gaap_NoncontrollingInterestMember_6448deb7-78e7-4ca5-ac34-630314a46f24" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="extended" id="id9b8f263b4274844a0d2167fb4fe0d13_STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3f048a4c-f902-465b-899a-0c53f4b293ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3f048a4c-f902-465b-899a-0c53f4b293ab" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_97f53a24-da91-43e3-b7a8-3f9fa78dfb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:to="loc_us-gaap_StockholdersEquity_97f53a24-da91-43e3-b7a8-3f9fa78dfb2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_5b35839f-d8e2-4147-a622-22a4ee077a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_5b35839f-d8e2-4147-a622-22a4ee077a53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_6b6805d5-4b99-4854-aee8-80476592e361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_6b6805d5-4b99-4854-aee8-80476592e361" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_42a0bc6e-aed7-4152-9aa1-2690f2e359bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_42a0bc6e-aed7-4152-9aa1-2690f2e359bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_52747f95-ab75-415c-a340-583d08fd5c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_52747f95-ab75-415c-a340-583d08fd5c3e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ab4152bb-c20f-4bf8-a696-275bd67add5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_86e6ed7d-ab1c-4657-a99e-172cbe27510b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3f048a4c-f902-465b-899a-0c53f4b293ab" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_86e6ed7d-ab1c-4657-a99e-172cbe27510b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_16f711c8-0b96-4433-9da3-e1bc0ab29164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_86e6ed7d-ab1c-4657-a99e-172cbe27510b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_16f711c8-0b96-4433-9da3-e1bc0ab29164" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_16f711c8-0b96-4433-9da3-e1bc0ab29164_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_16f711c8-0b96-4433-9da3-e1bc0ab29164" xlink:to="loc_us-gaap_EquityComponentDomain_16f711c8-0b96-4433-9da3-e1bc0ab29164_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8705d6c4-5cb1-4ba2-b41c-257f59ea5aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_16f711c8-0b96-4433-9da3-e1bc0ab29164" xlink:to="loc_us-gaap_EquityComponentDomain_8705d6c4-5cb1-4ba2-b41c-257f59ea5aaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c50a75b0-56ef-452c-99e3-f07c9a188b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8705d6c4-5cb1-4ba2-b41c-257f59ea5aaf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c50a75b0-56ef-452c-99e3-f07c9a188b9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f7b84186-a0ec-4f18-9673-4ee390eb6530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c50a75b0-56ef-452c-99e3-f07c9a188b9a" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f7b84186-a0ec-4f18-9673-4ee390eb6530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_1f43b1f9-3501-40b4-b7bf-a612b99c0721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c50a75b0-56ef-452c-99e3-f07c9a188b9a" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_1f43b1f9-3501-40b4-b7bf-a612b99c0721" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f38ffc5d-06df-4e16-9035-e0313ab18024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c50a75b0-56ef-452c-99e3-f07c9a188b9a" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f38ffc5d-06df-4e16-9035-e0313ab18024" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended" id="i2d323655a5b1401ea56204b34ba526d9_STOCKHOLDERSEQUITYNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_74c3ef55-d3c9-4c2d-b77a-95ebcba6dd21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_f2055f8e-419e-413b-ab23-5c0ce2ca4320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_74c3ef55-d3c9-4c2d-b77a-95ebcba6dd21" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_f2055f8e-419e-413b-ab23-5c0ce2ca4320" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7b45e4c6-c304-44a6-901f-30d8bcdaf24f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_74c3ef55-d3c9-4c2d-b77a-95ebcba6dd21" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7b45e4c6-c304-44a6-901f-30d8bcdaf24f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_ef904a33-3113-48af-8dc9-e4efa7b224b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7b45e4c6-c304-44a6-901f-30d8bcdaf24f" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_ef904a33-3113-48af-8dc9-e4efa7b224b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_ef904a33-3113-48af-8dc9-e4efa7b224b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_ef904a33-3113-48af-8dc9-e4efa7b224b2" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_ef904a33-3113-48af-8dc9-e4efa7b224b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_936c0781-02bb-44b3-bd94-585238b0eaba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_ef904a33-3113-48af-8dc9-e4efa7b224b2" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_936c0781-02bb-44b3-bd94-585238b0eaba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LongTermInterCompanyLoansMember_9ed5f3a5-a131-494e-96c8-90fdfeb3ff3b" xlink:href="clx-20230331.xsd#clx_LongTermInterCompanyLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_936c0781-02bb-44b3-bd94-585238b0eaba" xlink:to="loc_clx_LongTermInterCompanyLoansMember_9ed5f3a5-a131-494e-96c8-90fdfeb3ff3b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#EMPLOYEEBENEFITPLANSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="extended" id="ica569ae979294e04ad56ee7df1c85ff7_EMPLOYEEBENEFITPLANSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e11f9c4c-c961-44cd-9b38-65c4ba166dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DefinedBenefitPlanPlanTerminationPeriod_0a4f2b10-1d00-471b-82e9-dcbf83617f64" xlink:href="clx-20230331.xsd#clx_DefinedBenefitPlanPlanTerminationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e11f9c4c-c961-44cd-9b38-65c4ba166dc3" xlink:to="loc_clx_DefinedBenefitPlanPlanTerminationPeriod_0a4f2b10-1d00-471b-82e9-dcbf83617f64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_30f0c653-138b-4371-9258-93d7f77f54a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e11f9c4c-c961-44cd-9b38-65c4ba166dc3" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_30f0c653-138b-4371-9258-93d7f77f54a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_89d42fe1-569e-499d-b86e-4ec933a5c638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e11f9c4c-c961-44cd-9b38-65c4ba166dc3" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_89d42fe1-569e-499d-b86e-4ec933a5c638" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7ce6cf6f-a7cc-4089-8b2d-d24aebf36013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e11f9c4c-c961-44cd-9b38-65c4ba166dc3" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7ce6cf6f-a7cc-4089-8b2d-d24aebf36013" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_dc001127-a5ad-488d-bb8d-29909efdda54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7ce6cf6f-a7cc-4089-8b2d-d24aebf36013" xlink:to="loc_us-gaap_PlanNameAxis_dc001127-a5ad-488d-bb8d-29909efdda54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_dc001127-a5ad-488d-bb8d-29909efdda54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_dc001127-a5ad-488d-bb8d-29909efdda54" xlink:to="loc_us-gaap_PlanNameDomain_dc001127-a5ad-488d-bb8d-29909efdda54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4a400258-7dbf-48da-a29f-d8c53ddb2b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_dc001127-a5ad-488d-bb8d-29909efdda54" xlink:to="loc_us-gaap_PlanNameDomain_4a400258-7dbf-48da-a29f-d8c53ddb2b73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember_8a2d4eb8-d4e1-4fcd-874e-0784004a22a0" xlink:href="clx-20230331.xsd#clx_RetirementIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_4a400258-7dbf-48da-a29f-d8c53ddb2b73" xlink:to="loc_clx_RetirementIncomeMember_8a2d4eb8-d4e1-4fcd-874e-0784004a22a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_67af9d91-45a0-46f8-9880-2eb68a19add4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7ce6cf6f-a7cc-4089-8b2d-d24aebf36013" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_67af9d91-45a0-46f8-9880-2eb68a19add4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_67af9d91-45a0-46f8-9880-2eb68a19add4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_67af9d91-45a0-46f8-9880-2eb68a19add4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_67af9d91-45a0-46f8-9880-2eb68a19add4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_d1124e5a-1da8-47de-b702-a299c6c66a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_67af9d91-45a0-46f8-9880-2eb68a19add4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_d1124e5a-1da8-47de-b702-a299c6c66a54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_7af0b847-3776-44de-a15a-b028a6fd359a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_d1124e5a-1da8-47de-b702-a299c6c66a54" xlink:to="loc_us-gaap_DomesticPlanMember_7af0b847-3776-44de-a15a-b028a6fd359a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_66e23b74-78d8-4565-b7a2-19032c6cdd29" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_7af0b847-3776-44de-a15a-b028a6fd359a" xlink:to="loc_country_US_66e23b74-78d8-4565-b7a2-19032c6cdd29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e4171213-1b53-4c16-825c-485428b8c55a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7ce6cf6f-a7cc-4089-8b2d-d24aebf36013" xlink:to="loc_srt_RangeAxis_e4171213-1b53-4c16-825c-485428b8c55a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e4171213-1b53-4c16-825c-485428b8c55a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e4171213-1b53-4c16-825c-485428b8c55a" xlink:to="loc_srt_RangeMember_e4171213-1b53-4c16-825c-485428b8c55a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d086778c-865c-4435-9bf3-20d678df21a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e4171213-1b53-4c16-825c-485428b8c55a" xlink:to="loc_srt_RangeMember_d086778c-865c-4435-9bf3-20d678df21a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_360e7cc2-54c3-4756-b348-397d7c0a68b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d086778c-865c-4435-9bf3-20d678df21a2" xlink:to="loc_srt_MinimumMember_360e7cc2-54c3-4756-b348-397d7c0a68b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0e10a4c7-9f32-4197-9ceb-c6ec754d7eb0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d086778c-865c-4435-9bf3-20d678df21a2" xlink:to="loc_srt_MaximumMember_0e10a4c7-9f32-4197-9ceb-c6ec754d7eb0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="extended" id="i91a8cb075a9b49a6a016e1916d55084a_EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_806b2ffa-8d67-4a55-8a88-7269323f20f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_806b2ffa-8d67-4a55-8a88-7269323f20f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_707ad95a-62c1-4f93-acec-a2b0410a028f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_707ad95a-62c1-4f93-acec-a2b0410a028f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_59455a66-bb10-4f65-99d0-430a91c136f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_59455a66-bb10-4f65-99d0-430a91c136f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_b91404b2-97cf-4f7b-9534-3b4c247d157b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_b91404b2-97cf-4f7b-9534-3b4c247d157b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2fccf25b-f28a-492c-bfc0-9b4df7575546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2fccf25b-f28a-492c-bfc0-9b4df7575546" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_ac34b072-1713-4d2c-a9fd-fd71e347c38f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_ac34b072-1713-4d2c-a9fd-fd71e347c38f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e92c469b-a66e-46de-a675-351bf8c1a31c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e92c469b-a66e-46de-a675-351bf8c1a31c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_e7d340f5-b186-46e9-8ba2-0f6b0ea2c836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e92c469b-a66e-46de-a675-351bf8c1a31c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_e7d340f5-b186-46e9-8ba2-0f6b0ea2c836" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e7d340f5-b186-46e9-8ba2-0f6b0ea2c836_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e7d340f5-b186-46e9-8ba2-0f6b0ea2c836" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e7d340f5-b186-46e9-8ba2-0f6b0ea2c836_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a53811fa-ea4f-42f1-8198-b5bb831828a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e7d340f5-b186-46e9-8ba2-0f6b0ea2c836" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a53811fa-ea4f-42f1-8198-b5bb831828a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_98040a3e-8545-44e7-a6ed-7f98f881dba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a53811fa-ea4f-42f1-8198-b5bb831828a7" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_98040a3e-8545-44e7-a6ed-7f98f881dba8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_05196c22-ede0-49b0-bd60-53181eec50aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e92c469b-a66e-46de-a675-351bf8c1a31c" xlink:to="loc_us-gaap_PlanNameAxis_05196c22-ede0-49b0-bd60-53181eec50aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_05196c22-ede0-49b0-bd60-53181eec50aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_05196c22-ede0-49b0-bd60-53181eec50aa" xlink:to="loc_us-gaap_PlanNameDomain_05196c22-ede0-49b0-bd60-53181eec50aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8be9c460-53ff-4656-9c7e-6b4a579c232b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_05196c22-ede0-49b0-bd60-53181eec50aa" xlink:to="loc_us-gaap_PlanNameDomain_8be9c460-53ff-4656-9c7e-6b4a579c232b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember_348f9c69-814f-41a6-9924-7ddf6a578512" xlink:href="clx-20230331.xsd#clx_RetirementIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8be9c460-53ff-4656-9c7e-6b4a579c232b" xlink:to="loc_clx_RetirementIncomeMember_348f9c69-814f-41a6-9924-7ddf6a578512" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#OTHERCONTINGENCIESANDGUARANTEESDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" xlink:type="extended" id="i04b24d711a6942f7aab18583b56be625_OTHERCONTINGENCIESANDGUARANTEESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_576f05ba-fa2a-46d2-9e29-5603de18fd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_576f05ba-fa2a-46d2-9e29-5603de18fd75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RemediationPeriod_119fc0ba-3cf1-4770-ac91-1c7f94927267" xlink:href="clx-20230331.xsd#clx_RemediationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:to="loc_clx_RemediationPeriod_119fc0ba-3cf1-4770-ac91-1c7f94927267" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_MaximumExposureUndiscountedCost_9e47dbba-1509-4e66-8067-6584fe596eb9" xlink:href="clx-20230331.xsd#clx_MaximumExposureUndiscountedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:to="loc_clx_MaximumExposureUndiscountedCost_9e47dbba-1509-4e66-8067-6584fe596eb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_SiteContingencyAgreedPercentageOfCostSharing_fa88ef02-f4cd-4cf6-a5d6-3f0ad6ba0cc0" xlink:href="clx-20230331.xsd#clx_SiteContingencyAgreedPercentageOfCostSharing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:to="loc_clx_SiteContingencyAgreedPercentageOfCostSharing_fa88ef02-f4cd-4cf6-a5d6-3f0ad6ba0cc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LetterOfCreditBorrowingCapacity_443a8f96-9858-45c2-a690-b651a508fc4d" xlink:href="clx-20230331.xsd#clx_LetterOfCreditBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:to="loc_clx_LetterOfCreditBorrowingCapacity_443a8f96-9858-45c2-a690-b651a508fc4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_473ca7e7-557d-45a6-b57b-68022413db35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_473ca7e7-557d-45a6-b57b-68022413db35" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_228a619a-390e-46fc-9c45-3ea397b2b7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:to="loc_us-gaap_LossContingenciesTable_228a619a-390e-46fc-9c45-3ea397b2b7fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_14573e61-ceae-401d-a2a9-7457b8954149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_228a619a-390e-46fc-9c45-3ea397b2b7fb" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_14573e61-ceae-401d-a2a9-7457b8954149" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_14573e61-ceae-401d-a2a9-7457b8954149_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_14573e61-ceae-401d-a2a9-7457b8954149" xlink:to="loc_us-gaap_LossContingencyNatureDomain_14573e61-ceae-401d-a2a9-7457b8954149_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_397b62e5-26e7-445b-a40d-7f3b8c90545b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_14573e61-ceae-401d-a2a9-7457b8954149" xlink:to="loc_us-gaap_LossContingencyNatureDomain_397b62e5-26e7-445b-a40d-7f3b8c90545b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_AlamedaCountyCaliforniaMatterMember_8a153ce3-40fa-4b24-b538-8668ea485fd4" xlink:href="clx-20230331.xsd#clx_AlamedaCountyCaliforniaMatterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_397b62e5-26e7-445b-a40d-7f3b8c90545b" xlink:to="loc_clx_AlamedaCountyCaliforniaMatterMember_8a153ce3-40fa-4b24-b538-8668ea485fd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DickinsonCountyMichiganMatterMember_5964ad11-7625-4862-a3e7-c33771ce1b60" xlink:href="clx-20230331.xsd#clx_DickinsonCountyMichiganMatterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_397b62e5-26e7-445b-a40d-7f3b8c90545b" xlink:to="loc_clx_DickinsonCountyMichiganMatterMember_5964ad11-7625-4862-a3e7-c33771ce1b60" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#SEGMENTRESULTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" xlink:type="extended" id="i82ea23759f724a088cc8911388986e7e_SEGMENTRESULTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_f87e5ec6-a837-4eb0-a80e-e877aba3fb27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_06a859ad-39e5-4675-b374-c1d0d783b458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f87e5ec6-a837-4eb0-a80e-e877aba3fb27" xlink:to="loc_us-gaap_NumberOfReportableSegments_06a859ad-39e5-4675-b374-c1d0d783b458" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_a9a52dcc-57dc-4869-bd26-e7e18512e0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f87e5ec6-a837-4eb0-a80e-e877aba3fb27" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_a9a52dcc-57dc-4869-bd26-e7e18512e0b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_27ee6ad1-3386-4c60-aac2-4da32f261da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f87e5ec6-a837-4eb0-a80e-e877aba3fb27" xlink:to="loc_us-gaap_ConcentrationRiskTable_27ee6ad1-3386-4c60-aac2-4da32f261da9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1470a1e3-e7c5-472a-a9ba-3a752e2ffe18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_27ee6ad1-3386-4c60-aac2-4da32f261da9" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1470a1e3-e7c5-472a-a9ba-3a752e2ffe18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1470a1e3-e7c5-472a-a9ba-3a752e2ffe18_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1470a1e3-e7c5-472a-a9ba-3a752e2ffe18" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1470a1e3-e7c5-472a-a9ba-3a752e2ffe18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e971e3fb-fd09-4f0b-bd9c-bc8648a29741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1470a1e3-e7c5-472a-a9ba-3a752e2ffe18" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e971e3fb-fd09-4f0b-bd9c-bc8648a29741" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_1e374bde-606a-4ba8-a53e-c7740cdb52a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e971e3fb-fd09-4f0b-bd9c-bc8648a29741" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_1e374bde-606a-4ba8-a53e-c7740cdb52a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_01ada067-78e3-4b96-98b2-2f5adea24215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_27ee6ad1-3386-4c60-aac2-4da32f261da9" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_01ada067-78e3-4b96-98b2-2f5adea24215" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_01ada067-78e3-4b96-98b2-2f5adea24215_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_01ada067-78e3-4b96-98b2-2f5adea24215" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_01ada067-78e3-4b96-98b2-2f5adea24215_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_48e53288-c6c5-4658-85d9-2273ed43907f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_01ada067-78e3-4b96-98b2-2f5adea24215" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_48e53288-c6c5-4658-85d9-2273ed43907f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_0fd76674-b14f-4c23-9e24-56ab4002a0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_48e53288-c6c5-4658-85d9-2273ed43907f" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_0fd76674-b14f-4c23-9e24-56ab4002a0bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_c2a2da16-b161-4ff3-80be-0b9ddb457e0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_27ee6ad1-3386-4c60-aac2-4da32f261da9" xlink:to="loc_srt_MajorCustomersAxis_c2a2da16-b161-4ff3-80be-0b9ddb457e0d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_c2a2da16-b161-4ff3-80be-0b9ddb457e0d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_c2a2da16-b161-4ff3-80be-0b9ddb457e0d" xlink:to="loc_srt_NameOfMajorCustomerDomain_c2a2da16-b161-4ff3-80be-0b9ddb457e0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_183f3d22-cb7f-49a5-a92d-28df6a2669a8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_c2a2da16-b161-4ff3-80be-0b9ddb457e0d" xlink:to="loc_srt_NameOfMajorCustomerDomain_183f3d22-cb7f-49a5-a92d-28df6a2669a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WalmartStoresIncMember_4d9646b4-1723-444e-8743-609f23857b22" xlink:href="clx-20230331.xsd#clx_WalmartStoresIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_183f3d22-cb7f-49a5-a92d-28df6a2669a8" xlink:to="loc_clx_WalmartStoresIncMember_4d9646b4-1723-444e-8743-609f23857b22" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#SEGMENTRESULTSReportableSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" xlink:type="extended" id="i6a182d412e3e4b3091526a28612f8d47_SEGMENTRESULTSReportableSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3fe4a525-6c68-404f-ab7f-dc57d317f9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7b66061c-eea2-4ec7-b2f7-7137dde1e065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fe4a525-6c68-404f-ab7f-dc57d317f9db" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7b66061c-eea2-4ec7-b2f7-7137dde1e065" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_94a96432-8570-47ab-9c19-8d4add11a006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fe4a525-6c68-404f-ab7f-dc57d317f9db" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_94a96432-8570-47ab-9c19-8d4add11a006" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_11323bb4-70e1-40e9-ad2c-8f6caf5a3e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fe4a525-6c68-404f-ab7f-dc57d317f9db" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_11323bb4-70e1-40e9-ad2c-8f6caf5a3e99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_d62a680c-7006-4b7a-b3ad-ed6069f7b778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fe4a525-6c68-404f-ab7f-dc57d317f9db" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_d62a680c-7006-4b7a-b3ad-ed6069f7b778" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_4054b5d7-d2d2-4325-9d56-21f28e09caf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fe4a525-6c68-404f-ab7f-dc57d317f9db" xlink:to="loc_us-gaap_AssetImpairmentCharges_4054b5d7-d2d2-4325-9d56-21f28e09caf4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fe4a525-6c68-404f-ab7f-dc57d317f9db" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_2b1a3b58-a5c6-40e9-a55e-70bc612a17da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:to="loc_srt_ConsolidationItemsAxis_2b1a3b58-a5c6-40e9-a55e-70bc612a17da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2b1a3b58-a5c6-40e9-a55e-70bc612a17da_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_2b1a3b58-a5c6-40e9-a55e-70bc612a17da" xlink:to="loc_srt_ConsolidationItemsDomain_2b1a3b58-a5c6-40e9-a55e-70bc612a17da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c1d0a57a-b116-445f-b55d-d8e55a4368ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_2b1a3b58-a5c6-40e9-a55e-70bc612a17da" xlink:to="loc_srt_ConsolidationItemsDomain_c1d0a57a-b116-445f-b55d-d8e55a4368ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a3bef5b5-ecfb-4698-aac3-3d0ea8858dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c1d0a57a-b116-445f-b55d-d8e55a4368ca" xlink:to="loc_us-gaap_OperatingSegmentsMember_a3bef5b5-ecfb-4698-aac3-3d0ea8858dde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_0ce9dec4-ccd2-4121-a1ab-9aa38e066450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c1d0a57a-b116-445f-b55d-d8e55a4368ca" xlink:to="loc_us-gaap_CorporateNonSegmentMember_0ce9dec4-ccd2-4121-a1ab-9aa38e066450" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_473a29bf-bb7e-469b-86db-1d2e4d3198df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_473a29bf-bb7e-469b-86db-1d2e4d3198df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_473a29bf-bb7e-469b-86db-1d2e4d3198df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_473a29bf-bb7e-469b-86db-1d2e4d3198df" xlink:to="loc_us-gaap_SegmentDomain_473a29bf-bb7e-469b-86db-1d2e4d3198df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4e674fcb-1e71-4e8f-9a69-e2642a472ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_473a29bf-bb7e-469b-86db-1d2e4d3198df" xlink:to="loc_us-gaap_SegmentDomain_4e674fcb-1e71-4e8f-9a69-e2642a472ba1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_6efb235e-06f0-44c4-9568-e67cc4604b9d" xlink:href="clx-20230331.xsd#clx_HealthAndWellnessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4e674fcb-1e71-4e8f-9a69-e2642a472ba1" xlink:to="loc_clx_HealthAndWellnessMember_6efb235e-06f0-44c4-9568-e67cc4604b9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember_e30f98b4-ab25-4a7a-b5a5-02f8efff8f5e" xlink:href="clx-20230331.xsd#clx_HouseholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4e674fcb-1e71-4e8f-9a69-e2642a472ba1" xlink:to="loc_clx_HouseholdMember_e30f98b4-ab25-4a7a-b5a5-02f8efff8f5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember_15624fd8-aba1-480b-a41e-513d389fb7ec" xlink:href="clx-20230331.xsd#clx_LifestyleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4e674fcb-1e71-4e8f-9a69-e2642a472ba1" xlink:to="loc_clx_LifestyleMember_15624fd8-aba1-480b-a41e-513d389fb7ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember_82435cdd-c717-49b6-af7e-f132648bf491" xlink:href="clx-20230331.xsd#clx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4e674fcb-1e71-4e8f-9a69-e2642a472ba1" xlink:to="loc_clx_InternationalMember_82435cdd-c717-49b6-af7e-f132648bf491" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0d460a40-3410-4c95-97cd-4425b3eae0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0d460a40-3410-4c95-97cd-4425b3eae0c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0d460a40-3410-4c95-97cd-4425b3eae0c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0d460a40-3410-4c95-97cd-4425b3eae0c2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0d460a40-3410-4c95-97cd-4425b3eae0c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_495cfb78-7b31-4217-932a-67cfa9f550d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0d460a40-3410-4c95-97cd-4425b3eae0c2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_495cfb78-7b31-4217-932a-67cfa9f550d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RestructuringAndRelatedCostsBenchmarkMember_78a3e470-5eb8-4530-a076-af345afda766" xlink:href="clx-20230331.xsd#clx_RestructuringAndRelatedCostsBenchmarkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_495cfb78-7b31-4217-932a-67cfa9f550d0" xlink:to="loc_clx_RestructuringAndRelatedCostsBenchmarkMember_78a3e470-5eb8-4530-a076-af345afda766" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_fdb3045d-90b2-4eee-a694-b1c9182481b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_fdb3045d-90b2-4eee-a694-b1c9182481b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_fdb3045d-90b2-4eee-a694-b1c9182481b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_fdb3045d-90b2-4eee-a694-b1c9182481b8" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_fdb3045d-90b2-4eee-a694-b1c9182481b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ef2402f6-9842-4214-9e04-2e06d036c223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_fdb3045d-90b2-4eee-a694-b1c9182481b8" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ef2402f6-9842-4214-9e04-2e06d036c223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_b0bdcb01-c850-40fc-8fe8-e45554e3a102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ef2402f6-9842-4214-9e04-2e06d036c223" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_b0bdcb01-c850-40fc-8fe8-e45554e3a102" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_1b9cd11b-021a-468c-9580-225850a45c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:to="loc_us-gaap_ReportingUnitAxis_1b9cd11b-021a-468c-9580-225850a45c7e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_1b9cd11b-021a-468c-9580-225850a45c7e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_1b9cd11b-021a-468c-9580-225850a45c7e" xlink:to="loc_us-gaap_ReportingUnitDomain_1b9cd11b-021a-468c-9580-225850a45c7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_7657958b-6af2-4034-bb06-a8bbc6767bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_1b9cd11b-021a-468c-9580-225850a45c7e" xlink:to="loc_us-gaap_ReportingUnitDomain_7657958b-6af2-4034-bb06-a8bbc6767bd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsReportingUnitMember_a8281d18-0232-4e4a-b008-6be038a27855" xlink:href="clx-20230331.xsd#clx_VitaminsMineralsAndSupplementsReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_7657958b-6af2-4034-bb06-a8bbc6767bd5" xlink:to="loc_clx_VitaminsMineralsAndSupplementsReportingUnitMember_a8281d18-0232-4e4a-b008-6be038a27855" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalReportingUnitMember_318d35c2-6b31-4d76-b11f-1ce1de4b84b1" xlink:href="clx-20230331.xsd#clx_InternationalReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_7657958b-6af2-4034-bb06-a8bbc6767bd5" xlink:to="loc_clx_InternationalReportingUnitMember_318d35c2-6b31-4d76-b11f-1ce1de4b84b1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#SEGMENTRESULTSNetSalesPercentagesDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" xlink:type="extended" id="i4f9da8a24af1451e85d01c59f32b569f_SEGMENTRESULTSNetSalesPercentagesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5ad0ecf1-9851-48d3-998f-de383e06a5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_eeafeb34-10d6-4810-8d9b-9d40cf936bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5ad0ecf1-9851-48d3-998f-de383e06a5f2" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_eeafeb34-10d6-4810-8d9b-9d40cf936bc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_798652f4-f846-42cc-83f7-d4b12864f890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5ad0ecf1-9851-48d3-998f-de383e06a5f2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_798652f4-f846-42cc-83f7-d4b12864f890" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_04375e9b-7e9b-4385-ae32-594c596a8b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_798652f4-f846-42cc-83f7-d4b12864f890" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_04375e9b-7e9b-4385-ae32-594c596a8b72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_04375e9b-7e9b-4385-ae32-594c596a8b72_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_04375e9b-7e9b-4385-ae32-594c596a8b72" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_04375e9b-7e9b-4385-ae32-594c596a8b72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_11f836c3-6984-47aa-8a92-0acdecf1cfc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_04375e9b-7e9b-4385-ae32-594c596a8b72" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_11f836c3-6984-47aa-8a92-0acdecf1cfc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_815290d6-6e35-4768-a0b8-a4c3928377d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_11f836c3-6984-47aa-8a92-0acdecf1cfc7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_815290d6-6e35-4768-a0b8-a4c3928377d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_949211a1-999b-4e15-bd53-b324d967622b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_798652f4-f846-42cc-83f7-d4b12864f890" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_949211a1-999b-4e15-bd53-b324d967622b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_949211a1-999b-4e15-bd53-b324d967622b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_949211a1-999b-4e15-bd53-b324d967622b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_949211a1-999b-4e15-bd53-b324d967622b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_423b4ed6-7513-4df2-ab3b-78072aaa3600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_949211a1-999b-4e15-bd53-b324d967622b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_423b4ed6-7513-4df2-ab3b-78072aaa3600" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_3d400df6-c818-4e17-8e0e-05933d52159a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_423b4ed6-7513-4df2-ab3b-78072aaa3600" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_3d400df6-c818-4e17-8e0e-05933d52159a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_16a5a227-d119-4401-8fc2-1ba6861d0601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_798652f4-f846-42cc-83f7-d4b12864f890" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_16a5a227-d119-4401-8fc2-1ba6861d0601" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_16a5a227-d119-4401-8fc2-1ba6861d0601_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_16a5a227-d119-4401-8fc2-1ba6861d0601" xlink:to="loc_us-gaap_SegmentDomain_16a5a227-d119-4401-8fc2-1ba6861d0601_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_44730ae9-bf6f-4591-a40c-da73b3c6a852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_16a5a227-d119-4401-8fc2-1ba6861d0601" xlink:to="loc_us-gaap_SegmentDomain_44730ae9-bf6f-4591-a40c-da73b3c6a852" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_7d350af4-fd1b-4ef6-a3f1-b8cfeee93303" xlink:href="clx-20230331.xsd#clx_HealthAndWellnessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_44730ae9-bf6f-4591-a40c-da73b3c6a852" xlink:to="loc_clx_HealthAndWellnessMember_7d350af4-fd1b-4ef6-a3f1-b8cfeee93303" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember_fc230a00-dd53-4c93-ae27-b61b06d41d98" xlink:href="clx-20230331.xsd#clx_HouseholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_44730ae9-bf6f-4591-a40c-da73b3c6a852" xlink:to="loc_clx_HouseholdMember_fc230a00-dd53-4c93-ae27-b61b06d41d98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember_0de98370-0874-44aa-88df-bb2df013f0dd" xlink:href="clx-20230331.xsd#clx_LifestyleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_44730ae9-bf6f-4591-a40c-da73b3c6a852" xlink:to="loc_clx_LifestyleMember_0de98370-0874-44aa-88df-bb2df013f0dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember_e78e35a6-fd8f-4e03-96fe-f59d2c9a66fe" xlink:href="clx-20230331.xsd#clx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_44730ae9-bf6f-4591-a40c-da73b3c6a852" xlink:to="loc_clx_InternationalMember_e78e35a6-fd8f-4e03-96fe-f59d2c9a66fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_8e250cbb-f6b5-44d6-b868-06029341af49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_798652f4-f846-42cc-83f7-d4b12864f890" xlink:to="loc_us-gaap_SubsegmentsAxis_8e250cbb-f6b5-44d6-b868-06029341af49" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_8e250cbb-f6b5-44d6-b868-06029341af49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_8e250cbb-f6b5-44d6-b868-06029341af49" xlink:to="loc_us-gaap_SubsegmentsDomain_8e250cbb-f6b5-44d6-b868-06029341af49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_8e250cbb-f6b5-44d6-b868-06029341af49" xlink:to="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CleaningMember_65c484cc-5045-4147-b3ae-dc3cbe3a1980" xlink:href="clx-20230331.xsd#clx_CleaningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_CleaningMember_65c484cc-5045-4147-b3ae-dc3cbe3a1980" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ProfessionalProductsMember_395a8f95-35f7-414e-8bcb-d589465178a3" xlink:href="clx-20230331.xsd#clx_ProfessionalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_ProfessionalProductsMember_395a8f95-35f7-414e-8bcb-d589465178a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsMember_02763c3c-f1fd-41ca-b7dd-b9f936361983" xlink:href="clx-20230331.xsd#clx_VitaminsMineralsAndSupplementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_VitaminsMineralsAndSupplementsMember_02763c3c-f1fd-41ca-b7dd-b9f936361983" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BagsWrapsAndContainersMember_042a8b7e-41c6-47a6-b90f-cda821975c7a" xlink:href="clx-20230331.xsd#clx_BagsWrapsAndContainersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_BagsWrapsAndContainersMember_042a8b7e-41c6-47a6-b90f-cda821975c7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_GrillingMember_f1a37031-619c-449f-b705-76bfdbbbe26c" xlink:href="clx-20230331.xsd#clx_GrillingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_GrillingMember_f1a37031-619c-449f-b705-76bfdbbbe26c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CatLitterMember_d12b5670-2993-4a6f-9ddf-ec8b6f146ed2" xlink:href="clx-20230331.xsd#clx_CatLitterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_CatLitterMember_d12b5670-2993-4a6f-9ddf-ec8b6f146ed2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FoodProductsMember_c32bf26a-a461-4c86-a459-06f74d8a51a2" xlink:href="clx-20230331.xsd#clx_FoodProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_FoodProductsMember_c32bf26a-a461-4c86-a459-06f74d8a51a2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NaturalPersonalCareMember_360f8747-854e-4f28-bdca-7f60f88e1dc7" xlink:href="clx-20230331.xsd#clx_NaturalPersonalCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_NaturalPersonalCareMember_360f8747-854e-4f28-bdca-7f60f88e1dc7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WaterFiltrationMember_e52657a5-bb9e-41a8-aca0-7785b4bcc884" xlink:href="clx-20230331.xsd#clx_WaterFiltrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_WaterFiltrationMember_e52657a5-bb9e-41a8-aca0-7785b4bcc884" xlink:type="arc" order="8"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>clx-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0b973b79-9411-462a-9048-a4468bf442a9,g:effc8b7f-c824-4f09-9fb9-ffb97c19c826-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_clx_InternationalReportingUnitMember_243bbe64-db7d-4f7e-a88f-f67c8b802813_terseLabel_en-US" xlink:label="lab_clx_InternationalReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International reporting unit</link:label>
    <link:label id="lab_clx_InternationalReportingUnitMember_label_en-US" xlink:label="lab_clx_InternationalReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Reporting Unit [Member]</link:label>
    <link:label id="lab_clx_InternationalReportingUnitMember_documentation_en-US" xlink:label="lab_clx_InternationalReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Reporting Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalReportingUnitMember" xlink:href="clx-20230331.xsd#clx_InternationalReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_InternationalReportingUnitMember" xlink:to="lab_clx_InternationalReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11e59981-4961-4029-9766-a2fa99a5bd90_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_74bda1be-a013-4862-82bf-2892d38052e2_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_3ea76303-2a6a-4248-964f-84b99cbe7e26_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a523ed49-2522-4f61-90b3-dc332b316469_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_199325b2-22ad-409b-bb06-7b35cedecdbe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_924136fc-16d0-4991-aeec-f27172ced845_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_22a95e32-2459-451d-bb6a-77f77d0baea6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust assets for nonqualified deferred compensation plans, estimated fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_56b26e2e-d03f-42f1-bc3a-d345c4533c5b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid to Clorox stockholders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_0b067e37-3d14-4d93-abe9-541cd50903da_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_38ad739b-50c9-458e-bed8-22413525997f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and Long-term debt, estimated fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_f9ba96a2-3f67-47a7-890a-63ac6d8c58bd_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning accrual balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_8c201013-c2b3-4c9d-8446-38f7b453d154_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending accrual balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_22143f57-6e6d-4a75-af0e-f2db479139a5_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange derivative contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_d6c671df-8849-40a1-9a82-a4ed4033b859_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust assets for nonqualified deferred compensation plans</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_fb69e8bc-b2c1-4844-af39-447b326d97a3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ce2a3057-c3ee-424c-8594-124f05a43549_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_a621f37f-361c-4080-ac71-d01cab25a750_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c871d07f-8b83-48ba-a1bc-3b7cbcc5ba42_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_c29de700-a72f-45f7-9c8f-ab486790f5b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsAxis_31cf3d99-8a05-4e7e-aabf-cdb416e8bd11_terseLabel_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Axis]</link:label>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsAxis_label_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Axis]</link:label>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsAxis_documentation_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsAxis" xlink:href="clx-20230331.xsd#clx_CommodityPurchaseDerivativeContractsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsAxis" xlink:to="lab_clx_CommodityPurchaseDerivativeContractsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_e4cfc0e1-5228-45bb-8a3a-ef704a4c1dff_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_685e3566-106e-44f6-88b1-e2c4642b0263_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_353d4d3c-5e5d-4f60-98cf-79915f937d64_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost (benefit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_84d1f9b7-4c15-4024-b81d-e719d01f7ad9_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_283f8c2e-ac16-4c0c-ad60-3d5e39102ea1_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_875ea7b9-125f-40c1-a610-1ea435a8fcb0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock purchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_7e8b6fd4-c7cf-4dc6-b64d-cf91e906e9f6_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses) attributable to Clorox</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_860c1ceb-4f04-4443-b2ad-11ac24d315b9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive stock options and other (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_2ba5f7d1-42a5-49f1-8d6b-897740996095_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_GladBusinessMember_9f619828-4ddb-4360-a6cf-d2a93a5cf2e9_terseLabel_en-US" xlink:label="lab_clx_GladBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glad Business</link:label>
    <link:label id="lab_clx_GladBusinessMember_label_en-US" xlink:label="lab_clx_GladBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glad Business [Member]</link:label>
    <link:label id="lab_clx_GladBusinessMember_documentation_en-US" xlink:label="lab_clx_GladBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glad Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_GladBusinessMember" xlink:href="clx-20230331.xsd#clx_GladBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_GladBusinessMember" xlink:to="lab_clx_GladBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_efac3193-effc-4543-9269-68593d5192d0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_68898cda-a28c-471d-8f14-c4b78eca001d_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesShares_6a5027e8-24a1-40fb-b2b1-d59002f8b0b6_terseLabel_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other employee stock plan activities (in shares)</link:label>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesShares_label_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Employee Stock Plan Activities, Shares</link:label>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesShares_documentation_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued during the period as a result of exercises of employee stock options or the vesting of other share-based awards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesShares" xlink:href="clx-20230331.xsd#clx_OtherEmployeeStockPlanActivitiesShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OtherEmployeeStockPlanActivitiesShares" xlink:to="lab_clx_OtherEmployeeStockPlanActivitiesShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_0a340fb6-6701-43cc-a094-ec7475e9390a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets, estimated fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_0fe7ce18-aa57-4db5-94a8-12bc31f3629d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_158ff261-7c32-4b62-aeb7-3dd6d490e76f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_eceefe2f-ec5e-45f1-bb0c-4c72a4d9b8fa_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_LongTermInterCompanyLoansMember_3f02c172-c1a5-465f-975d-699fce4efad0_terseLabel_en-US" xlink:label="lab_clx_LongTermInterCompanyLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Inter-Company Loans</link:label>
    <link:label id="lab_clx_LongTermInterCompanyLoansMember_label_en-US" xlink:label="lab_clx_LongTermInterCompanyLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Inter-Company Loans [Member]</link:label>
    <link:label id="lab_clx_LongTermInterCompanyLoansMember_documentation_en-US" xlink:label="lab_clx_LongTermInterCompanyLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term inter-company loans included in foreign currency adjustments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LongTermInterCompanyLoansMember" xlink:href="clx-20230331.xsd#clx_LongTermInterCompanyLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_LongTermInterCompanyLoansMember" xlink:to="lab_clx_LongTermInterCompanyLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_c9124a57-6324-4878-8489-2908f1d20ef1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_e7272fac-1de8-48b0-a3d8-7fcb2a1d9296_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_28a8320d-2fab-44f5-ad23-5db6d4ffc7b4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_e4b55655-1d2c-4247-8464-6434b3e98255_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_bdb8a495-12ec-4fff-b86e-ba1475795c1d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_ProfessionalProductsMember_673617ac-8266-46a2-80bc-debd63f2c0ac_terseLabel_en-US" xlink:label="lab_clx_ProfessionalProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Products</link:label>
    <link:label id="lab_clx_ProfessionalProductsMember_label_en-US" xlink:label="lab_clx_ProfessionalProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Products [Member]</link:label>
    <link:label id="lab_clx_ProfessionalProductsMember_documentation_en-US" xlink:label="lab_clx_ProfessionalProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ProfessionalProductsMember" xlink:href="clx-20230331.xsd#clx_ProfessionalProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_ProfessionalProductsMember" xlink:to="lab_clx_ProfessionalProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_85eea2c0-70f0-4922-85a2-d1058877ee1f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_1d095b55-282e-4ed1-98a6-4478005ecf83_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_cb82b9ea-ed90-4599-a9d7-12966be567ad_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_5cf89478-f980-4d54-8260-9c7da6279279_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_8af466d9-f4e0-4f49-b2cc-1394e0e920e6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_3cc05e7c-ce56-45f7-93f6-a01c827d7637_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_6690f8a7-910c-4f81-9f8c-ed9b89c6f15a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_HouseholdMember_06d62167-3bcb-4e64-b267-16e82675872e_terseLabel_en-US" xlink:label="lab_clx_HouseholdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Household</link:label>
    <link:label id="lab_clx_HouseholdMember_label_en-US" xlink:label="lab_clx_HouseholdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Household [Member]</link:label>
    <link:label id="lab_clx_HouseholdMember_documentation_en-US" xlink:label="lab_clx_HouseholdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Household [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember" xlink:href="clx-20230331.xsd#clx_HouseholdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_HouseholdMember" xlink:to="lab_clx_HouseholdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_LetterOfCreditBorrowingCapacity_0027ee97-f7c6-4b0b-9b23-73dae9099676_terseLabel_en-US" xlink:label="lab_clx_LetterOfCreditBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit</link:label>
    <link:label id="lab_clx_LetterOfCreditBorrowingCapacity_label_en-US" xlink:label="lab_clx_LetterOfCreditBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit</link:label>
    <link:label id="lab_clx_LetterOfCreditBorrowingCapacity_documentation_en-US" xlink:label="lab_clx_LetterOfCreditBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LetterOfCreditBorrowingCapacity" xlink:href="clx-20230331.xsd#clx_LetterOfCreditBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_LetterOfCreditBorrowingCapacity" xlink:to="lab_clx_LetterOfCreditBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionDomain_3e2640de-5718-4c4f-97f1-1988d94a58fc_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_TransactionDomain_label_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionDomain" xlink:to="lab_us-gaap_TransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_242e010a-a0e0-4bef-8d48-865a1c4d8e90_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and related implementation, expected cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_d269e4e0-dc00-44c6-8bae-ae4009f0edef_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_f5870dee-5a24-44f4-914b-33d00428ba39_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_9a666238-208a-4d7e-abf0-55fc0d29e391_terseLabel_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time deposits</link:label>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_label_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Time Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankTimeDepositsMember" xlink:to="lab_us-gaap_BankTimeDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_04b012c0-b380-4a3c-b0e1-47693f9884a8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7df7032d-bad7-4771-9389-601d57288bc0_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_TotalCommodityPurchaseDerivativeContractsMember_fede6211-c9d1-4305-b784-17765305b2d8_terseLabel_en-US" xlink:label="lab_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Commodity Purchase Derivative Contracts</link:label>
    <link:label id="lab_clx_TotalCommodityPurchaseDerivativeContractsMember_label_en-US" xlink:label="lab_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Commodity Purchase Derivative Contracts [Member]</link:label>
    <link:label id="lab_clx_TotalCommodityPurchaseDerivativeContractsMember_documentation_en-US" xlink:label="lab_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Commodity Purchase Derivative Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:href="clx-20230331.xsd#clx_TotalCommodityPurchaseDerivativeContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:to="lab_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_82b6be24-19fd-483d-bea0-cf8607042cd9_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c02f7bb9-a492-4fd6-889c-054d46458441_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_23fb91ea-e445-4267-a812-5d64f03349ba_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_84a9d25a-6a83-4f05-9e3f-b3c96c9bdb19_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_2bf430fe-fd86-4562-b6ef-7be563ba0559_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b37beed-c394-422c-9bf6-71a61e6009d6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_e301a5b0-4342-44ab-84b3-87c10cc13612_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_78c68dbf-a908-493d-9ee8-d18873a604d9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_a62ca018-8c50-4156-9bb3-fa9eaee8533b_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_d1eb683c-93db-4366-9637-dd3fc01e4f11_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_AlamedaCountyCaliforniaMatterMember_f8b555cb-60b8-42ed-8e86-4ed730008b46_terseLabel_en-US" xlink:label="lab_clx_AlamedaCountyCaliforniaMatterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County, California Matter</link:label>
    <link:label id="lab_clx_AlamedaCountyCaliforniaMatterMember_label_en-US" xlink:label="lab_clx_AlamedaCountyCaliforniaMatterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County, California Matter [Member]</link:label>
    <link:label id="lab_clx_AlamedaCountyCaliforniaMatterMember_documentation_en-US" xlink:label="lab_clx_AlamedaCountyCaliforniaMatterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County, California Matter [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_AlamedaCountyCaliforniaMatterMember" xlink:href="clx-20230331.xsd#clx_AlamedaCountyCaliforniaMatterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_AlamedaCountyCaliforniaMatterMember" xlink:to="lab_clx_AlamedaCountyCaliforniaMatterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_BagsWrapsAndContainersMember_b7fd2bbf-312d-47ad-b489-a54ecc4bebea_terseLabel_en-US" xlink:label="lab_clx_BagsWrapsAndContainersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bags and Wraps</link:label>
    <link:label id="lab_clx_BagsWrapsAndContainersMember_label_en-US" xlink:label="lab_clx_BagsWrapsAndContainersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bags, Wraps, And Containers [Member]</link:label>
    <link:label id="lab_clx_BagsWrapsAndContainersMember_documentation_en-US" xlink:label="lab_clx_BagsWrapsAndContainersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bags, Wraps, And Containers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BagsWrapsAndContainersMember" xlink:href="clx-20230331.xsd#clx_BagsWrapsAndContainersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_BagsWrapsAndContainersMember" xlink:to="lab_clx_BagsWrapsAndContainersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_PercentageofOwnershipbyVenturePartner_d10ea671-210c-453e-a932-d3196a09335a_terseLabel_en-US" xlink:label="lab_clx_PercentageofOwnershipbyVenturePartner" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent ownership by venture partner</link:label>
    <link:label id="lab_clx_PercentageofOwnershipbyVenturePartner_label_en-US" xlink:label="lab_clx_PercentageofOwnershipbyVenturePartner" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Ownership by Venture Partner</link:label>
    <link:label id="lab_clx_PercentageofOwnershipbyVenturePartner_documentation_en-US" xlink:label="lab_clx_PercentageofOwnershipbyVenturePartner" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of ownership interest by the venture partner.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_PercentageofOwnershipbyVenturePartner" xlink:href="clx-20230331.xsd#clx_PercentageofOwnershipbyVenturePartner"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_PercentageofOwnershipbyVenturePartner" xlink:to="lab_clx_PercentageofOwnershipbyVenturePartner" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_a66db507-edba-46a3-8301-9f0b65cb8bc1_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_c8e90455-4c90-44c4-b2fa-58201c184802_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER LIABILITIES</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_020510bc-eb03-4aa4-857e-af37f3880623_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) recognized in Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_82d87919-1d5a-4d87-82b2-dde33b7d2956_terseLabel_en-US" xlink:label="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Foreign Currency Balance by Description [Axis]</link:label>
    <link:label id="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Foreign Currency Balance by Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:to="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_30ae2949-a3c7-4659-aa8f-0b15749fc475_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_78fd8bf1-164e-4803-9b10-df5cc2367efd_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_InventoryCurrentAndNoncurrentNet_232cda08-94c0-4cb6-8813-fb4e7e9877e2_totalLabel_en-US" xlink:label="lab_clx_InventoryCurrentAndNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories, net</link:label>
    <link:label id="lab_clx_InventoryCurrentAndNoncurrentNet_label_en-US" xlink:label="lab_clx_InventoryCurrentAndNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current And Noncurrent, Net</link:label>
    <link:label id="lab_clx_InventoryCurrentAndNoncurrentNet_documentation_en-US" xlink:label="lab_clx_InventoryCurrentAndNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current And Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InventoryCurrentAndNoncurrentNet" xlink:href="clx-20230331.xsd#clx_InventoryCurrentAndNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_InventoryCurrentAndNoncurrentNet" xlink:to="lab_clx_InventoryCurrentAndNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b8c6f350-4eb7-44f9-8218-e999b7008efc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_766be57c-f032-41c9-af77-073d9bacb657_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_f89857ab-8432-4294-b5a2-9fe601e4f542_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_DefinedBenefitPlanPlanTerminationPeriod_a793e87f-6f56-4084-870e-aa7914c6f970_terseLabel_en-US" xlink:label="lab_clx_DefinedBenefitPlanPlanTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan termination period</link:label>
    <link:label id="lab_clx_DefinedBenefitPlanPlanTerminationPeriod_label_en-US" xlink:label="lab_clx_DefinedBenefitPlanPlanTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Termination Period</link:label>
    <link:label id="lab_clx_DefinedBenefitPlanPlanTerminationPeriod_documentation_en-US" xlink:label="lab_clx_DefinedBenefitPlanPlanTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Termination Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DefinedBenefitPlanPlanTerminationPeriod" xlink:href="clx-20230331.xsd#clx_DefinedBenefitPlanPlanTerminationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_DefinedBenefitPlanPlanTerminationPeriod" xlink:to="lab_clx_DefinedBenefitPlanPlanTerminationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_9401580b-4e8b-4c41-826f-ee309a64c267_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses) per share attributable to Clorox</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_5122e4ca-a292-42bd-bb86-86b5e90a043a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_d0f53001-b6b1-438d-a147-8494e6a52e70_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discretionary contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarginDepositAssets_1e8f487c-7e34-4b74-903c-8ff052848c87_terseLabel_en-US" xlink:label="lab_us-gaap_MarginDepositAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash margin balances amount</link:label>
    <link:label id="lab_us-gaap_MarginDepositAssets_label_en-US" xlink:label="lab_us-gaap_MarginDepositAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Margin Deposit Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarginDepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarginDepositAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarginDepositAssets" xlink:to="lab_us-gaap_MarginDepositAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0aa04d1-3bd0-40eb-a02d-801eb40b0025_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_ad0c90d2-f065-457d-a833-5adc72ab25e2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used for financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_VentureAgreementTerminalObligationNet_8134fbb1-e507-4527-bd13-e829929e864a_terseLabel_en-US" xlink:label="lab_clx_VentureAgreementTerminalObligationNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Venture agreement terminal obligation, net</link:label>
    <link:label id="lab_clx_VentureAgreementTerminalObligationNet_label_en-US" xlink:label="lab_clx_VentureAgreementTerminalObligationNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Venture Agreement, Terminal Obligation, Net</link:label>
    <link:label id="lab_clx_VentureAgreementTerminalObligationNet_documentation_en-US" xlink:label="lab_clx_VentureAgreementTerminalObligationNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Venture Agreement, Terminal Obligation, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VentureAgreementTerminalObligationNet" xlink:href="clx-20230331.xsd#clx_VentureAgreementTerminalObligationNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_VentureAgreementTerminalObligationNet" xlink:to="lab_clx_VentureAgreementTerminalObligationNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_b3dad92d-da35-4a5c-acf5-9f186c8f5961_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_865b752f-d6bf-46f5-9cdb-598f5e0c1da9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_bc4aeed0-f81c-40e6-b1bb-78a300fe6061_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3c369054-9ab2-4cbb-93a0-c72052e44ba5_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a443874c-09c2-4222-a3e4-3e2da90cd3f5_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5445b45a-47c0-4819-b98a-96f53c90e7b7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_b9405119-b6cd-49dc-b8d1-8f1d9ce059bf_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_686b4b4e-680b-4706-91a7-11ed32b0448d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_99ee7caa-810c-45b4-b590-9053da293ce7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET EARNINGS (LOSSES) PER SHARE (EPS)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_3de6a1b8-89b4-455b-967a-02a43898745e_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_50d0b164-9d18-4efc-83b9-bc048ec95b09_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5cff638a-bf7e-4825-bc53-3cc771d0132a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_08bb8d71-b5ea-4ce2-bc3b-a3a51ea0826d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c878930d-a3bb-4dcd-8175-5fc5c0f9aaba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_9b52e0bb-7b94-43d0-aefa-971bc9c2a900_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_bcad2bfa-2bbe-4882-b4c4-f493f558ab2e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities for Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_76dc008c-b684-4787-ba53-c064386bdaee_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_9d21e2ce-4d59-40e1-bb28-eb86bcd27ad5_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_f61df22e-d732-4507-b012-3dbeab8b207b_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum duration, commodity contracts (in years)</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time Hedged in Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:to="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9beffc3f-77d5-45fa-985f-b4d7cc1abac0_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_eff1a7af-5a8f-49b1-9c0d-5d8fdd9bde18_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_6c97fc38-3531-4cba-b245-f39e2b2a57a2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount_59dcde67-7624-4025-82bd-a92de3d1bfd2_terseLabel_en-US" xlink:label="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of derivative instruments subject to contractually defined counterparty liability position limits</link:label>
    <link:label id="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount_label_en-US" xlink:label="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Subject To Contractually Defined Counterparty Liability Position Limits, Amount</link:label>
    <link:label id="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount_documentation_en-US" xlink:label="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments subject to contractually defined counterparty liability position limits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount" xlink:href="clx-20230331.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount" xlink:to="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f0bfb950-e131-455a-8f2b-614df9e893d3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_bd6c0163-5cb3-4f42-b045-46366df85994_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMPLOYEE BENEFIT PLANS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_39b0e96b-6316-4675-8fa0-c33926d5fb7a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains (losses) on derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_PurchasesofInventoryMember_6d71bd06-6f4b-455e-929f-70219d4c79fb_terseLabel_en-US" xlink:label="lab_clx_PurchasesofInventoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of Inventory</link:label>
    <link:label id="lab_clx_PurchasesofInventoryMember_label_en-US" xlink:label="lab_clx_PurchasesofInventoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of Inventory [Member]</link:label>
    <link:label id="lab_clx_PurchasesofInventoryMember_documentation_en-US" xlink:label="lab_clx_PurchasesofInventoryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of Inventory [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_PurchasesofInventoryMember" xlink:href="clx-20230331.xsd#clx_PurchasesofInventoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_PurchasesofInventoryMember" xlink:to="lab_clx_PurchasesofInventoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_4062047f-86b1-48c9-bd3d-8028fb39dd25_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_040ca65e-6236-4923-add4-883e5136a162_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_392da40b-5e8f-45f0-9720-2a82681590ce_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3a23d8af-a6ff-4524-8526-68e2c760be88_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_f729d58c-6f71-4194-a9e2-0539681d48f8_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_31dbb32a-7ab0-4741-816e-6408e9e4fed6_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_f19603c8-56a3-4a55-acdd-3b15b3fe00cb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_07423ef1-2319-4ad8-b3c3-5dfc14628571_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_349b03f1-cba8-43d7-9916-a2b84e56888b_terseLabel_en-US" xlink:label="lab_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not subject to amortization, before impairment</link:label>
    <link:label id="lab_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_label_en-US" xlink:label="lab_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill), Before Impairment</link:label>
    <link:label id="lab_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_documentation_en-US" xlink:label="lab_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill), Before Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" xlink:href="clx-20230331.xsd#clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" xlink:to="lab_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_DickinsonCountyMichiganMatterMember_495e97a6-f2d4-43b8-9cfb-797d0c2020bf_terseLabel_en-US" xlink:label="lab_clx_DickinsonCountyMichiganMatterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dickinson County, Michigan Matter</link:label>
    <link:label id="lab_clx_DickinsonCountyMichiganMatterMember_label_en-US" xlink:label="lab_clx_DickinsonCountyMichiganMatterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dickinson County, Michigan Matter [Member]</link:label>
    <link:label id="lab_clx_DickinsonCountyMichiganMatterMember_documentation_en-US" xlink:label="lab_clx_DickinsonCountyMichiganMatterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dickinson County, Michigan Matter [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DickinsonCountyMichiganMatterMember" xlink:href="clx-20230331.xsd#clx_DickinsonCountyMichiganMatterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_DickinsonCountyMichiganMatterMember" xlink:to="lab_clx_DickinsonCountyMichiganMatterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_f65733f4-d7a1-443e-9b9b-2c6da9a0c442_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_00ab96b0-fc43-4256-973f-f026088ffc7e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_b9ba7cc1-5e68-4a13-aa81-204619757dd4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_c6d0a06e-ddc6-4980-9835-b3c9a3cd4a24_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_a2ef9494-b94c-4637-99e2-7309f3af89dc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_ff907116-d15e-4449-8fca-f9d4010d0908_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a7226457-5d68-401c-aade-df84a2c24c23_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_c8c5410f-a15d-4b7b-b916-bce13ec2def2_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_fd45c432-8508-4c69-b146-78b21523a1c6_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_1b6f8472-b817-4a78-a709-daf7b055949a_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b7489eef-1903-4f72-a56b-861b6d2d3d37_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e72c830d-5173-4be7-a90b-8d9c17d3824c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, year four</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_76942571-3d87-4b78-985a-ad8043ee7f32_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionTypeAxis_29ccf363-11a0-47e0-95b6-b9ac2ad40a5c_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:label id="lab_us-gaap_TransactionTypeAxis_label_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionTypeAxis" xlink:to="lab_us-gaap_TransactionTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f16e8efb-25af-46e7-86e2-34df3bdc089a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Total comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_56073478-304c-4477-b320-929e411cda7b_verboseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Total comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_VitaminsMineralsAndSupplementsReportingUnitMember_1bf287dc-40a3-44f1-a505-d34f024f4cf8_terseLabel_en-US" xlink:label="lab_clx_VitaminsMineralsAndSupplementsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VMS reporting unit</link:label>
    <link:label id="lab_clx_VitaminsMineralsAndSupplementsReportingUnitMember_label_en-US" xlink:label="lab_clx_VitaminsMineralsAndSupplementsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals And Supplements Reporting Unit [Member]</link:label>
    <link:label id="lab_clx_VitaminsMineralsAndSupplementsReportingUnitMember_documentation_en-US" xlink:label="lab_clx_VitaminsMineralsAndSupplementsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals And Supplements Reporting Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsReportingUnitMember" xlink:href="clx-20230331.xsd#clx_VitaminsMineralsAndSupplementsReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_VitaminsMineralsAndSupplementsReportingUnitMember" xlink:to="lab_clx_VitaminsMineralsAndSupplementsReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_fcbf0807-da70-4b6c-b050-454ae8059c99_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate on earnings from continuing operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_36be50de-027b-487f-8a86-1587ff3846af_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0e3f3175-5529-4563-90d4-1c817dba448e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, estimated fair value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_25cc1361-6cfe-4b21-94b8-7f6176a0b79f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_e96a3d9b-7a68-40af-9358-702657bba52a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains (losses) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_99023f7f-41aa-4cff-bdff-10052bb3dad7_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_b263a6cd-461a-46c8-9cab-62b35791a764_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsDomain_63aaa677-2ed0-4135-86c8-e8bf09d54baa_terseLabel_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Domain]</link:label>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsDomain_label_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Domain]</link:label>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsDomain_documentation_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsDomain" xlink:href="clx-20230331.xsd#clx_CommodityPurchaseDerivativeContractsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsDomain" xlink:to="lab_clx_CommodityPurchaseDerivativeContractsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_04ee136f-9e74-4df0-a526-a3684e8c0982_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_6c87f537-e91f-456e-93ea-879598b8bbac_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_19c78c94-a1b7-405f-b1a8-80b1a7604de8_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_08631920-dc08-464d-a09a-dc340ddb6ec0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_6daef0b8-5a2c-4a01-a200-7c16887007db_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net earnings (losses) per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_e6f40396-84a5-41cb-8f30-e46fea9ec815_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_f71134b4-9e8e-48bb-9fc3-5c2d65f3d095_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from Accumulated other comprehensive net (loss) income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_1450d3d5-8f5a-4d44-b886-c3e5708b2cd2_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive net (loss) income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_f47463e6-91df-4bc9-872e-7bc278f78711_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f1e61652-7836-4755-8bbd-5550dc06f264_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefit adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_d601333a-7fd3-46a4-9891-d9b3a12818b7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_722f010f-fbba-4213-abe1-c8ff2d262887_terseLabel_en-US" xlink:label="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</link:label>
    <link:label id="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_label_en-US" xlink:label="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</link:label>
    <link:label id="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_documentation_en-US" xlink:label="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments and Fair Value Measurements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:href="clx-20230331.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_e3233d3e-0bbb-4d68-adc9-17807ea9f480_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_65f66321-aca3-4e1e-914b-ce6ae3cc8a6f_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_f6190304-534d-4b59-a323-0c40e8cf4dbf_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Clorox stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_93d43e18-83ca-4a2b-abc7-083af2fae79f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_8428ab70-bccd-436b-9711-566be2a74cdf_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, ending</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_MaximumExposureUndiscountedCost_07653c43-2a23-4b91-b70d-4d1ce247cb5d_terseLabel_en-US" xlink:label="lab_clx_MaximumExposureUndiscountedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum undiscounted costs</link:label>
    <link:label id="lab_clx_MaximumExposureUndiscountedCost_label_en-US" xlink:label="lab_clx_MaximumExposureUndiscountedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Exposure, Undiscounted Cost</link:label>
    <link:label id="lab_clx_MaximumExposureUndiscountedCost_documentation_en-US" xlink:label="lab_clx_MaximumExposureUndiscountedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum potential amount of future payments (undiscounted) that the Company could incur over an estimated remediation period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_MaximumExposureUndiscountedCost" xlink:href="clx-20230331.xsd#clx_MaximumExposureUndiscountedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_MaximumExposureUndiscountedCost" xlink:to="lab_clx_MaximumExposureUndiscountedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_14983ce8-d813-4e4c-8ad6-b12cb14646ab_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_f09787ca-bb62-4aa5-abff-e590c8ddc4cd_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_825e251d-cf7b-410d-a983-d0f5d92ac057_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject to amortization, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a329a7eb-d8a8-40b9-b4e7-7f7d21d4b91a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_84c66760-dffd-4fd8-b5a5-cb196ef042f2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, year three</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_8cb9d58d-de61-4c05-a43f-2f11167c1d00_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest-bearing investments, including money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_fb004a67-fc08-4279-81f3-b09a6e209973_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum duration, foreign exchange contracts (in years)</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time, Foreign Currency Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:to="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_240fdb36-40b6-4aec-9692-0d60482c0537_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_af30040a-983e-4602-8615-80c8b9adfd65_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_1ce2506d-3b5f-423b-98f5-53bbc5037445_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CostOfGoodsAndServicesSoldMember_36c77272-c7b8-4595-9e19-943ebdd77ef1_terseLabel_en-US" xlink:label="lab_clx_CostOfGoodsAndServicesSoldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs of products sold</link:label>
    <link:label id="lab_clx_CostOfGoodsAndServicesSoldMember_label_en-US" xlink:label="lab_clx_CostOfGoodsAndServicesSoldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold [Member]</link:label>
    <link:label id="lab_clx_CostOfGoodsAndServicesSoldMember_documentation_en-US" xlink:label="lab_clx_CostOfGoodsAndServicesSoldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CostOfGoodsAndServicesSoldMember" xlink:href="clx-20230331.xsd#clx_CostOfGoodsAndServicesSoldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CostOfGoodsAndServicesSoldMember" xlink:to="lab_clx_CostOfGoodsAndServicesSoldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_997d8cfb-8095-4884-8af5-60696e4e6a6d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_7e65ff4b-b253-4f9d-8085-d8a2d133de9e_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_2c3312e6-3845-47dd-a2f1-9f99df47d3d2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock purchased</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_a7d89c4e-7172-437a-9a66-48dfb4cf56cc_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and loans payable</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_90f13b53-5b20-4c78-9768-ee34f40ea717_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_8b4b2378-bdc9-4f78-8dae-17a618c2980d_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_08c7f2cd-c3e8-4c95-8d15-bddbd0f52a6d_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_2d9f37ba-0b23-4902-adab-56a8705e1297_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0e76463d-1ce9-4ba2-ae0f-6c16ff733572_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_7b8c3941-4cea-425b-a3f5-b1a0cb3a3d7d_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_64b3e8c0-ce30-4894-9b3e-2d15258b755b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock purchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_20c6adde-d3ed-425f-b539-d6e9c636dc0b_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not subject to amortization</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_9853e9c3-3fed-4186-8e28-8fe2f402d6b6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_32a56709-a286-4785-8dcb-3617c3d35a0c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement loss recognized</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6ee875ee-a953-436a-a91f-6b8627323189_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_7e2954ea-98e9-4c95-8641-30dc0b92606c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_6b2244e5-9352-4270-8f18-3d832d8dc2ca_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_5f133450-e546-4afa-a0c6-0575d59603a0_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_7a58bc84-104f-4875-a93a-baac6f80140b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Results</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_31602e51-91bb-4844-9a10-86f93361f980_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_be270095-6097-4a79-8754-703141c9be81_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_48666a51-0285-4ce2-98db-5e34c807e451_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_70c5c211-dc9a-4ae8-a1c6-b1ce887e7004_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_b6edda54-7544-4b5e-b4e8-ef68205367b4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject to amortization, gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_2927bcca-b57c-446f-b3d5-27aba65bb849_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_8c57a68f-fad3-47d3-96f7-ec77ed051fd3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_a9a52c1a-acfe-40e3-9c5c-e4d4dd82f26f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_77309214-afdf-4ace-9715-fa22365ee7bb_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Net (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ea70109b-5bdb-4474-ad22-65712fdbd97c_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive net (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_27addd30-8a2f-4423-a101-448465dc03c6_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_1f7f1d93-e69c-427f-821d-2dcee9c5835a_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_592ed943-1004-4795-843d-ffa8cfdb7135_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_NotesAndLoansPayableMember_ee98931f-b1f6-434a-984a-93f90fc985a0_terseLabel_en-US" xlink:label="lab_clx_NotesAndLoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and loans payable</link:label>
    <link:label id="lab_clx_NotesAndLoansPayableMember_label_en-US" xlink:label="lab_clx_NotesAndLoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes And Loans Payable [Member]</link:label>
    <link:label id="lab_clx_NotesAndLoansPayableMember_documentation_en-US" xlink:label="lab_clx_NotesAndLoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NotesAndLoansPayableMember" xlink:href="clx-20230331.xsd#clx_NotesAndLoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_NotesAndLoansPayableMember" xlink:to="lab_clx_NotesAndLoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b80b929b-9e78-4a1d-aed3-98b0e4a15b20_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_57dd1c2e-271c-4b0d-b018-0d8602256516_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6f660b5c-2e73-4459-b003-865dbb64c74d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OtherIncomeExpenseNetMember_afcb61e4-60cb-4add-a683-19788ce57c98_terseLabel_en-US" xlink:label="lab_clx_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_clx_OtherIncomeExpenseNetMember_label_en-US" xlink:label="lab_clx_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense), Net [Member]</link:label>
    <link:label id="lab_clx_OtherIncomeExpenseNetMember_documentation_en-US" xlink:label="lab_clx_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherIncomeExpenseNetMember" xlink:href="clx-20230331.xsd#clx_OtherIncomeExpenseNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OtherIncomeExpenseNetMember" xlink:to="lab_clx_OtherIncomeExpenseNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5f9b43dd-8a71-4a20-8537-cffd84086c9b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a70986c7-15fa-4e2a-b393-69fba2ad3276_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_50fa219b-8ff6-49bc-b546-7088810a6ad5_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_75809669-7671-4c26-9e81-2f4de794d390_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_91b02fbe-93a8-405c-8513-862f1f80d6ab_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_179108f6-eb73-48d1-8770-86a82d8976ba_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_6d7b8053-c1fd-471a-9e68-af37f233bf12_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7e6c36a7-5a13-4260-ab01-4e43685b71a2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings (losses) to net cash provided by operations:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_645d4b8c-36fe-4dab-a4a3-061659cdb1d7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b99bd520-60c9-4442-b9b2-8221bc027be0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_69c5036b-730a-4ca7-8f4c-be189a680c0a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_bf994332-33db-4e1a-8eb4-cc0e43e05558_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_8b1577e1-6dd0-41b6-80e3-eefd6dc1505d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_bc2e4946-685d-4e49-b89e-0f3324e185ef_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_e7ec43f0-0e91-4735-a859-2dabbf1058ab_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_6d715006-6ff4-447a-91b0-4622c2e8ae80_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_d0972598-a8b0-46bb-be68-cbd4d80dfa2e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7763da74-d174-4a16-9429-62b57f544fca_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_568c7eb1-18e9-4e5d-b307-daaf92b3f6e5_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_3f48714d-fd85-4f3d-a362-50bda2d17608_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_87af5479-9821-44c1-8a13-8ad7ec8cf88f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_aabe6ff8-3b6a-4cfc-93e3-c873bc103c4e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_ce066ad9-9ade-45bd-8f2e-fecbfb14f97c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_546ccfac-12a3-4bce-b106-1ecf73e20516_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_47097965-f81e-4639-be82-0624243ae628_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_c1cf9373-0b0f-43b3-8567-fbaabff40522_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of March&#160;31, 2023 and June&#160;30, 2022; and 123,611,466 and 123,152,132 shares outstanding as of March&#160;31, 2023 and June&#160;30, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_96c4be98-bee8-4dc5-bb16-7074c3c429c7_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_RemediationPeriod_f18a1dbf-fef9-43f0-a809-cb4c7b395bd8_terseLabel_en-US" xlink:label="lab_clx_RemediationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remediation period (in years)</link:label>
    <link:label id="lab_clx_RemediationPeriod_label_en-US" xlink:label="lab_clx_RemediationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remediation period</link:label>
    <link:label id="lab_clx_RemediationPeriod_documentation_en-US" xlink:label="lab_clx_RemediationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RemediationPeriod" xlink:href="clx-20230331.xsd#clx_RemediationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_RemediationPeriod" xlink:to="lab_clx_RemediationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CleaningMember_b0a66ba3-8b6c-474e-9e8b-86b264f075bf_terseLabel_en-US" xlink:label="lab_clx_CleaningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cleaning</link:label>
    <link:label id="lab_clx_CleaningMember_label_en-US" xlink:label="lab_clx_CleaningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cleaning [Member]</link:label>
    <link:label id="lab_clx_CleaningMember_documentation_en-US" xlink:label="lab_clx_CleaningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cleaning [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CleaningMember" xlink:href="clx-20230331.xsd#clx_CleaningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CleaningMember" xlink:to="lab_clx_CleaningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_LifestyleMember_eb0f5108-555e-4bdd-a71d-742971b8b876_terseLabel_en-US" xlink:label="lab_clx_LifestyleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lifestyle</link:label>
    <link:label id="lab_clx_LifestyleMember_label_en-US" xlink:label="lab_clx_LifestyleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lifestyle [Member]</link:label>
    <link:label id="lab_clx_LifestyleMember_documentation_en-US" xlink:label="lab_clx_LifestyleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lifestyle [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember" xlink:href="clx-20230331.xsd#clx_LifestyleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_LifestyleMember" xlink:to="lab_clx_LifestyleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b7300df0-2555-4830-ad8b-ab7f85a32600_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Derivative Instruments Designated as Hedging Instruments on OCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_afd72beb-4ce9-4d80-bd13-1a16ba86e951_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_5517c9d9-1149-4419-a746-ea139c503896_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_42982583-57cf-4f45-b4c5-cf92c941f3a0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_797961a6-f264-4002-b769-f6121969aafb_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ea111a62-781f-4431-b24f-b594349bd0c7_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b0f75c95-1641-49c0-8500-e000584c2042_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_89dd332a-037f-474f-9efd-8f7e95efe76a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_fd3ad88d-450a-4c4d-b029-ace8e433e94d_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net earnings attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c75acf17-f2d8-467e-bc53-9c9e62ce2b2b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER CONTINGENCIES AND GUARANTEES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_3a0275ad-8ad5-4c7d-8191-881dfce58534_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_c37667b8-7a43-489b-83fa-064420dccb7c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_e52e9d27-a062-431a-a16f-64dcd772b1e8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit_a3864f61-e8d2-48c8-9802-f5da60ccfa4d_negatedTerseLabel_en-US" xlink:label="lab_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, tax benefit</link:label>
    <link:label id="lab_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill), Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill), Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" xlink:href="clx-20230331.xsd#clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" xlink:to="lab_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_VitaminsMineralsAndSupplementsMember_bb2978e3-5437-4e08-be5a-02c456c5677f_terseLabel_en-US" xlink:label="lab_clx_VitaminsMineralsAndSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals and Supplements</link:label>
    <link:label id="lab_clx_VitaminsMineralsAndSupplementsMember_label_en-US" xlink:label="lab_clx_VitaminsMineralsAndSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals and Supplements [Member]</link:label>
    <link:label id="lab_clx_VitaminsMineralsAndSupplementsMember_documentation_en-US" xlink:label="lab_clx_VitaminsMineralsAndSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals and Supplements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsMember" xlink:href="clx-20230331.xsd#clx_VitaminsMineralsAndSupplementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_VitaminsMineralsAndSupplementsMember" xlink:to="lab_clx_VitaminsMineralsAndSupplementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_0d8e68ad-acf4-4461-a5d2-7d41214c038e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_83a349bb-070a-48e9-930f-54e6d2998d29_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_d599dbfc-4816-4a3a-93ae-f3db9a21cd3f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_47dbff8a-34bb-46b9-932c-b93102995052_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5b388502-ca18-4aa3-b343-66bab49ab68f_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_bdd418ec-0821-4f55-8f80-cedc9d707de5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_f48864f1-609f-40a3-9191-555a02ea7b31_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used for investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_9e2961ce-f569-4751-95ae-b4120ad43d9e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_334f833f-2e53-4774-8004-4f1f01b8ed6b_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive (loss) income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_95a1db7c-cd33-4456-9e61-b462284a0828_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_bc97e4a8-635d-48b8-98b0-7282754057cb_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss) attributable to Clorox</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_GrillingMember_c4def2dd-4ac0-47c8-bb0d-5023f7c50162_terseLabel_en-US" xlink:label="lab_clx_GrillingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grilling</link:label>
    <link:label id="lab_clx_GrillingMember_label_en-US" xlink:label="lab_clx_GrillingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grilling [Member]</link:label>
    <link:label id="lab_clx_GrillingMember_documentation_en-US" xlink:label="lab_clx_GrillingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grilling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_GrillingMember" xlink:href="clx-20230331.xsd#clx_GrillingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_GrillingMember" xlink:to="lab_clx_GrillingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_667147e0-91d2-48cc-b99a-9c7b3d02f879_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected Financial Information Relating to the Company's Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_RestructuringAndRelatedCostsBenchmarkMember_fe8d2ed8-0d18-4ac7-9038-dfc441736e9c_terseLabel_en-US" xlink:label="lab_clx_RestructuringAndRelatedCostsBenchmarkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_clx_RestructuringAndRelatedCostsBenchmarkMember_label_en-US" xlink:label="lab_clx_RestructuringAndRelatedCostsBenchmarkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs Benchmark [Member]</link:label>
    <link:label id="lab_clx_RestructuringAndRelatedCostsBenchmarkMember_documentation_en-US" xlink:label="lab_clx_RestructuringAndRelatedCostsBenchmarkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs Benchmark</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RestructuringAndRelatedCostsBenchmarkMember" xlink:href="clx-20230331.xsd#clx_RestructuringAndRelatedCostsBenchmarkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_RestructuringAndRelatedCostsBenchmarkMember" xlink:to="lab_clx_RestructuringAndRelatedCostsBenchmarkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_99559cd0-ea1a-4b89-8737-0a188338df46_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_ac8082e1-1a24-436c-8545-11800881d151_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_346e1887-c6b4-4104-860e-6b660702ddce_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Review of Goodwill and Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_1dfb4786-1232-4782-aef2-d2e8b2b6f191_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_6b54bf3a-f814-4e27-8653-2f1322224419_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_2e37229f-cb67-430e-b23b-e125dd9f5e71_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_b2b6793f-cb54-4e11-a4d2-e845c83c73aa_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-Related Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityContractMember_2fafd826-d6cc-45d1-afc4-c731d12c1576_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity purchase derivative contracts</link:label>
    <link:label id="lab_us-gaap_CommodityContractMember_0767f85e-90a7-4baa-bdb4-f133d2a355a0_verboseLabel_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity purchase options contracts</link:label>
    <link:label id="lab_us-gaap_CommodityContractMember_label_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityContractMember" xlink:to="lab_us-gaap_CommodityContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_01aaf857-cad3-49fc-9668-ddf3545d65b5_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_e3f444b6-5a5a-490e-b2b1-5cce054a0cce_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9c4d9c87-6451-4c10-ad47-34f16948e3c7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_3d6192b9-c48f-4fdb-8344-2d48ba9ad23e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_TrademarksNet_5ede5080-2cae-431d-9086-c4d12158589e_terseLabel_en-US" xlink:label="lab_clx_TrademarksNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, net</link:label>
    <link:label id="lab_clx_TrademarksNet_label_en-US" xlink:label="lab_clx_TrademarksNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, net</link:label>
    <link:label id="lab_clx_TrademarksNet_documentation_en-US" xlink:label="lab_clx_TrademarksNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrademarksNet" xlink:href="clx-20230331.xsd#clx_TrademarksNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_TrademarksNet" xlink:to="lab_clx_TrademarksNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_b0fbc4c8-08dc-4004-8cda-a3fdd21c261c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_92e774b9-90a9-48c5-b2c8-eabad3d48faa_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_beae054e-674b-449d-96d8-ae13fa357623_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b8baaa82-f1fd-48e4-a76f-2a627eb47189_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_be2e1cef-47f6-4715-8c92-f5ef79c905e8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1784b2e5-0e07-4849-8b23-43653eb254fc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net of accumulated depreciation and amortization of $2,672 and $2,530, respectively</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_VentureAgreement.TerminalObligation_533574e7-a6bf-4c6f-aaee-66e52a88586d_terseLabel_en-US" xlink:label="lab_clx_VentureAgreement.TerminalObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Venture agreement, terminal obligation</link:label>
    <link:label id="lab_clx_VentureAgreement.TerminalObligation_label_en-US" xlink:label="lab_clx_VentureAgreement.TerminalObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Venture Agreement. Terminal Obligation</link:label>
    <link:label id="lab_clx_VentureAgreement.TerminalObligation_documentation_en-US" xlink:label="lab_clx_VentureAgreement.TerminalObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Venture Agreement. Terminal Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VentureAgreement.TerminalObligation" xlink:href="clx-20230331.xsd#clx_VentureAgreement.TerminalObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_VentureAgreement.TerminalObligation" xlink:to="lab_clx_VentureAgreement.TerminalObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_3894dcaf-5ce3-4ff1-be32-855275b4f3f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt repayments</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_cf780c9b-eb2b-4acc-b756-2188bc5b6752_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_9cf9b5b2-0d1d-4b12-b2e0-3f393ee30670_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost: 7,129,995 and 7,589,329 shares as of March&#160;31, 2023 and June&#160;30, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b6be4d37-aca3-405e-8656-b9fd499ff343_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefit adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_c67c6904-db1c-49cb-8a21-4d182d602713_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_9b0b141b-4b6f-4e86-b616-eb77cc55c07c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to Clorox stockholders</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_ffe54264-0e8f-4c15-a378-a96beb580974_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_694380b6-88d8-4e3d-a9fc-b63ed4403623_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RESTRUCTURING AND RELATED COSTS</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_29c99a2e-aa7b-49f0-80b9-96fbc983b6dc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_5ba2b1e8-ded8-425b-a637-58b868d87a01_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ebbac169-81ac-4833-89af-96090229a364_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a4b8f5e2-49d4-4a37-a0fa-77f421328c83_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive net (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_68074ae1-2577-4b03-b77d-b5bce9b73e04_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average long-term expected rate or return on plan assets (percentage)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3afcc213-c937-4cfc-9ab7-4ffbb980a693_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_5c801cce-72fa-4ad2-8e7f-f1a6a3a286c0_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_RetirementIncomeMember_3e8ce360-2f23-475f-9a3b-4c7d10439827_terseLabel_en-US" xlink:label="lab_clx_RetirementIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Income Plans</link:label>
    <link:label id="lab_clx_RetirementIncomeMember_label_en-US" xlink:label="lab_clx_RetirementIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Income Plans [Member]</link:label>
    <link:label id="lab_clx_RetirementIncomeMember_documentation_en-US" xlink:label="lab_clx_RetirementIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember" xlink:href="clx-20230331.xsd#clx_RetirementIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_RetirementIncomeMember" xlink:to="lab_clx_RetirementIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_ce7c3b6e-b250-4d43-8660-defab810649c_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_df81b72a-54db-461b-bb50-60ef32e0dc39_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_593ec868-1491-4fb1-951c-6a5162f5e0c9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_c87aee7c-5813-4cb0-b068-8f1622836f46_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_e9cafed0-002e-4b75-88b4-7e8de56b30d2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_7b560fdc-558b-4eee-b119-fad0042726dc_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject to amortization, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3f3915f2-6916-422a-87ca-5d1fde9fe99f_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_0a8b47f7-7242-4709-821c-096f268c9f46_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Impaired Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Impaired Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:to="lab_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_cfb4a3e0-e837-4796-80f7-602984cd876d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ee1e0758-9d85-48fa-b490-7845f82192cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_36c7f65f-dd58-4221-aba3-bbc5bb17ee03_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_20697a0b-657c-4b35-b013-87575b972371_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_9cdaeea9-cbc1-4539-b407-27547b0447b3_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_8b98182c-3fe6-4434-9026-998e4baa2641_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_fc536c8f-0ef2-45e5-903e-556ed2469e75_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT RESULTS</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_a5ec06c4-bdcd-4ebc-a737-9c0959629f2f_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_78857b7f-31fb-4065-ae94-2b5c35a4de5c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, year two</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_48e8409d-186d-4349-9ddb-73d275a9c9e4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_7aaa7925-5638-4139-ad5b-e6d0ab366cd3_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_e9a5141b-8dee-44f0-8dd5-0a2dd2d16bd6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d432943d-a849-485b-bbd7-b0ab34d6ce61_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_9e95d14a-8bfe-4e5e-85e9-a3f9aacef7bd_terseLabel_en-US" xlink:label="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets and liabilities, net</link:label>
    <link:label id="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_label_en-US" xlink:label="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset And Liability, Net</link:label>
    <link:label id="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_documentation_en-US" xlink:label="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset And Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:href="clx-20230331.xsd#clx_OperatingLeaseRightofUseAssetAndLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:to="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5c2f70d0-9fb8-40d2-9323-bde66106ad7b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding (in thousands)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_23bf688e-a213-476d-9c48-4187df76bdea_terseLabel_en-US" xlink:label="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust assets for nonqualified deferred compensation plans</link:label>
    <link:label id="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_label_en-US" xlink:label="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust Assets for nonqualified deferred compensation plans [Member]</link:label>
    <link:label id="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_documentation_en-US" xlink:label="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust Assets For Nonqualified Deferred Compensation Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:href="clx-20230331.xsd#clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:to="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_13baa6bd-b187-4bf5-b3a7-42f9bb3819d4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_e7e06202-394e-41b2-966b-ae5406c3c39b_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_3d534c9f-b5e7-424e-b462-65f23a4e1046_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_7434d655-2ae5-4da3-ab6c-c0bd787abaa0_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for aggregate future remediation costs</link:label>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_label_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Environmental Loss Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:to="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c84af802-5209-4ca9-9830-6e525da56f62_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3523aec4-90ee-4954-b8f3-fa4b36bdd9a7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_cb12695a-5b9d-4e4a-a47e-469dda2b8dbd_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_SiteContingencyAgreedPercentageOfCostSharing_f05185a1-fa75-4968-9d02-54e2d34dc4ee_terseLabel_en-US" xlink:label="lab_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of liability for aggregate remediation and associated costs, other than legal fees</link:label>
    <link:label id="lab_clx_SiteContingencyAgreedPercentageOfCostSharing_label_en-US" xlink:label="lab_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of liability for aggregate remediation and associated costs, other than legal fees</link:label>
    <link:label id="lab_clx_SiteContingencyAgreedPercentageOfCostSharing_documentation_en-US" xlink:label="lab_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:href="clx-20230331.xsd#clx_SiteContingencyAgreedPercentageOfCostSharing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:to="lab_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_InternationalMember_1f20c2cf-b8d1-49e7-91cb-1ca52eb6a847_terseLabel_en-US" xlink:label="lab_clx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_clx_InternationalMember_label_en-US" xlink:label="lab_clx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_clx_InternationalMember_documentation_en-US" xlink:label="lab_clx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember" xlink:href="clx-20230331.xsd#clx_InternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_InternationalMember" xlink:to="lab_clx_InternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_8ad06271-fab8-423f-8b21-ad7f2340eb32_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_e029159a-91a9-4a76-9849-803785ad73c3_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_39830d42-2d4a-45ed-93ec-61e18db64544_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_63a26165-bb4c-41a7-8e08-9712e5382a71_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_ce096585-2c54-4d87-b241-b753843d1304_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_e2c4e01e-6ac8-470c-9b87-83021b8778b2_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit, amount outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_6b7c8603-dbfd-4eca-8224-3e240f680d3c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_491c0795-d024-426f-9f1f-53ea202e44cd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_FoodProductsMember_9d735bd9-5384-4dc9-aa62-6bd27c6bdc31_terseLabel_en-US" xlink:label="lab_clx_FoodProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food</link:label>
    <link:label id="lab_clx_FoodProductsMember_label_en-US" xlink:label="lab_clx_FoodProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food Products [Member]</link:label>
    <link:label id="lab_clx_FoodProductsMember_documentation_en-US" xlink:label="lab_clx_FoodProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FoodProductsMember" xlink:href="clx-20230331.xsd#clx_FoodProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_FoodProductsMember" xlink:to="lab_clx_FoodProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_f8cb83c7-c4e3-45a8-adfd-d389caeab6a8_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_2c7cb93b-0727-4b7b-bd62-766b9676cc9b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_525d46a9-de68-45c4-9858-28a65a5f0515_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_c9173244-a1ea-4440-99fc-69204032b356_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_ffb75715-9702-450a-9978-3d0eb5104d7a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_c519ecb6-a7f5-4874-a132-492797bb5c82_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_97373ca3-c3ab-46b6-8c93-928981081be6_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_353b0f2d-305f-49c4-9b3a-e74db9d06fc6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_2f7f78c0-0654-49ef-9a4b-8c34c2138ec3_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring and related implementation costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_33da1fba-8076-4ec2-b5ea-c3f13cd3571d_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, net</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_4da21e95-1469-42ee-816c-f80f21a28a0d_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_70ea3244-76bb-4c6b-b90d-b73dd49d7440_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of unrecognized items</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_28be2127-2724-461d-ac0c-a41e321b65e8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_ba4ebcae-48e9-47da-b608-555caae03c9f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials and packaging</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_e70bf062-1a27-42de-b2b4-53456741df27_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_7f868737-2e71-4452-9774-ff5b7b1a42ba_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_c7aa3f20-bbf9-4337-b327-22a5306816bb_terseLabel_en-US" xlink:label="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_label_en-US" xlink:label="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Text Block]</link:label>
    <link:label id="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_documentation_en-US" xlink:label="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for financial instruments and fair value measurements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:href="clx-20230331.xsd#clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:to="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_432886d5-8703-4a54-8d63-fee7f7be5a6e_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of stock options and other (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_8cb4418d-7775-4dce-b608-5c400b54d19b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_7c3eecef-b07a-4599-8eef-78cd504961d4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_ca9ce780-3ee4-4e99-924a-92bc7af2ca18_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum duration, interest rate contracts (in years)</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time Hedged in Interest Rate Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:to="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_bb792b8d-dfed-449b-aaec-564a11b18bf4_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_45cc16af-220b-4b3d-9c60-f52e5d3297eb_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_5c1b61b9-e6a0-4c48-a02e-851aef0d2645_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_dbabfabc-f9cb-47fa-9956-39d5dedd140d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net earnings (losses) per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a2d62591-1bb8-48f1-8f76-dc38538410df_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_00a54601-fff9-402d-a8d4-f02838fa41d5_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_e9cf6db7-5d17-4873-b87c-822e4eb0fab1_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_502d3049-ef6b-40bd-8112-ad76d490d5dc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_bbdcde7b-b19f-484e-8a94-05ac679c6c50_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_4bdd287a-7123-41da-b1dd-d93a9bfdcf34_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_fe0546fd-6d55-4923-aa30-4f9b955db7b7_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_2d4eb1d6-9985-4ccb-9b41-c7807ce3d268_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_6ad4d02f-6c37-4744-b274-f6bad0083e2e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_c2c4aba9-8a1f-43b7-9101-845b8ec3d40f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_d0e785b0-b662-47c6-90f4-1fcefe3f216f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable / prepaid</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesAmount_821eefee-5cc8-4d36-92d0-d774477a36fb_terseLabel_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other employee stock plan activities</link:label>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesAmount_label_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Employee Stock Plan Activities, Amount</link:label>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesAmount_documentation_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount includes the value of stock granted during the period as a result of exercises of employee stock options or vesting of other share-based awards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:href="clx-20230331.xsd#clx_OtherEmployeeStockPlanActivitiesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:to="lab_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_93aa581b-f0e4-465a-92c7-bc0b01c6184e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_fb811e13-487d-48fa-a706-84c519319bd5_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OtherExpenseIncomeNet_6feb941d-5801-4752-8318-d6eaef301aa9_terseLabel_en-US" xlink:label="lab_clx_OtherExpenseIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_clx_OtherExpenseIncomeNet_label_en-US" xlink:label="lab_clx_OtherExpenseIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income), Net</link:label>
    <link:label id="lab_clx_OtherExpenseIncomeNet_documentation_en-US" xlink:label="lab_clx_OtherExpenseIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherExpenseIncomeNet" xlink:href="clx-20230331.xsd#clx_OtherExpenseIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OtherExpenseIncomeNet" xlink:to="lab_clx_OtherExpenseIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_WaterFiltrationMember_65a86b84-c2a1-4212-94f8-4ec398d899af_terseLabel_en-US" xlink:label="lab_clx_WaterFiltrationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Water Filtration</link:label>
    <link:label id="lab_clx_WaterFiltrationMember_label_en-US" xlink:label="lab_clx_WaterFiltrationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Water Filtration [Member]</link:label>
    <link:label id="lab_clx_WaterFiltrationMember_documentation_en-US" xlink:label="lab_clx_WaterFiltrationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Water Filtration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WaterFiltrationMember" xlink:href="clx-20230331.xsd#clx_WaterFiltrationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_WaterFiltrationMember" xlink:to="lab_clx_WaterFiltrationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b57f72c3-4efc-4083-bef4-e4b2b9039fd2_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_0be2ac3b-a708-4329-8dbe-fda58bda65b5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and loans payable, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_NaturalPersonalCareMember_01093291-8c5e-4785-81a7-d6d8f08a4c8f_terseLabel_en-US" xlink:label="lab_clx_NaturalPersonalCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natural Personal Care</link:label>
    <link:label id="lab_clx_NaturalPersonalCareMember_label_en-US" xlink:label="lab_clx_NaturalPersonalCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natural Personal Care [Member]</link:label>
    <link:label id="lab_clx_NaturalPersonalCareMember_documentation_en-US" xlink:label="lab_clx_NaturalPersonalCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natural Personal Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NaturalPersonalCareMember" xlink:href="clx-20230331.xsd#clx_NaturalPersonalCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_NaturalPersonalCareMember" xlink:to="lab_clx_NaturalPersonalCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8e3d793f-a327-4fc7-b107-a5258b881e77_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShorttermDebtFairValue_9e8c5c32-e136-466e-b615-e22a4c6ba17b_terseLabel_en-US" xlink:label="lab_us-gaap_ShorttermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and loans payable, estimated fair value</link:label>
    <link:label id="lab_us-gaap_ShorttermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_ShorttermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShorttermDebtFairValue" xlink:to="lab_us-gaap_ShorttermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_3041bb01-575f-4d17-ad45-3f3314cf2bf6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_f8b96306-fbf9-463d-be71-3ac1685487a2_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNoncurrent_dcd2b8a4-85b2-4439-804c-0f47130d80dc_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Noncurrent inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNoncurrent_label_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNoncurrent" xlink:to="lab_us-gaap_InventoryNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_2e4d35a3-2ac7-49d9-918a-ab1bee1f438c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORIES, NET</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b67031af-54b9-4851-8223-6b2b41c49441_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bbccb035-2f87-4653-97dd-17546e7afd3d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_56438443-3600-49d7-b17f-ecc53c05e802_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_5acdcabb-5541-427b-9925-008d0177a8ff_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_0739c679-4450-4bce-864a-b71dcb6640c5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_3c86e144-0714-4231-a43a-9c3d08150587_negatedLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIFO allowances</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReserve" xlink:to="lab_us-gaap_InventoryLIFOReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_8004a231-b8ba-4141-ad73-2c8d60cebf2e_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Liabilities</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_VentureAgreementOptiontoExtendAgreementTermPeriod_278f6150-ac52-4114-8210-508c4f096823_terseLabel_en-US" xlink:label="lab_clx_VentureAgreementOptiontoExtendAgreementTermPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to extend agreement (in years)</link:label>
    <link:label id="lab_clx_VentureAgreementOptiontoExtendAgreementTermPeriod_label_en-US" xlink:label="lab_clx_VentureAgreementOptiontoExtendAgreementTermPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Venture Agreement, Option to Extend Agreement Term Period</link:label>
    <link:label id="lab_clx_VentureAgreementOptiontoExtendAgreementTermPeriod_documentation_en-US" xlink:label="lab_clx_VentureAgreementOptiontoExtendAgreementTermPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Venture Agreement, Option to Extend Agreement Term Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VentureAgreementOptiontoExtendAgreementTermPeriod" xlink:href="clx-20230331.xsd#clx_VentureAgreementOptiontoExtendAgreementTermPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_VentureAgreementOptiontoExtendAgreementTermPeriod" xlink:to="lab_clx_VentureAgreementOptiontoExtendAgreementTermPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_81dbdc2b-6999-4e96-8255-857786ad6bac_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_HealthAndWellnessMember_21fba862-ebe5-433d-b191-2a2ed57642f5_terseLabel_en-US" xlink:label="lab_clx_HealthAndWellnessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health and Wellness</link:label>
    <link:label id="lab_clx_HealthAndWellnessMember_label_en-US" xlink:label="lab_clx_HealthAndWellnessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health and Wellness [Member]</link:label>
    <link:label id="lab_clx_HealthAndWellnessMember_documentation_en-US" xlink:label="lab_clx_HealthAndWellnessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health and Wellness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember" xlink:href="clx-20230331.xsd#clx_HealthAndWellnessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_HealthAndWellnessMember" xlink:to="lab_clx_HealthAndWellnessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_8668499e-499e-4f57-b1c8-1fef14ab338f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, remainder of fiscal year</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_780f1e2e-9856-4891-b252-1ea5d3bd3ebd_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_1eba54f4-4ecd-4eed-bffa-3462f13e8720_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_64763242-f3e7-4933-8b7d-9696785ff037_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_4cbae253-ceaf-4ec3-8bbd-3bd73168209d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsNet" xlink:to="lab_us-gaap_OtherIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_49a6a9dc-0d38-42b6-9fec-98c1a41529fc_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e23653aa-5845-48aa-a545-1f1fc6d38455_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_9cd7caf8-8cfb-4c1f-bc72-5f2a2bf8dde9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue_e770c282-fc3a-4946-be8e-31eb0a6a6f73_verboseLabel_en-US" xlink:label="lab_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining net carrying value</link:label>
    <link:label id="lab_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue_label_en-US" xlink:label="lab_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Remaining Carrying Value</link:label>
    <link:label id="lab_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue_documentation_en-US" xlink:label="lab_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Remaining Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue" xlink:href="clx-20230331.xsd#clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue" xlink:to="lab_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_6b68ba32-84f1-445e-b004-bcc721b8708c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_18b39022-3439-497f-a316-cd60a616d37c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_6687ebeb-e732-48bc-b32e-ada0c80190c8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_5f67c4f6-5fda-4597-9e9d-8f7c84fc4801_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_beac4694-5278-4ae5-a70b-82f8bb10f038_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, net</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_cbcdb27b-db46-477e-b1e5-1d0cace23689_verboseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_808c5367-2980-4b8b-86b6-93a429b8b7d9_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_64c7550d-a748-4ed0-9549-99d5f524cf85_terseLabel_en-US" xlink:label="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for employee stock plans and other</link:label>
    <link:label id="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_label_en-US" xlink:label="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance Of Common Stock For Employee Stock Plans And Other</link:label>
    <link:label id="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_documentation_en-US" xlink:label="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow associated with the amount received from holders exercising their stock options. Also includes the net cash inflow (outflow) from other financing activities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:href="clx-20230331.xsd#clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:to="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CatLitterMember_a9c689ee-c5bd-4f9c-8ac0-374a1b598d65_terseLabel_en-US" xlink:label="lab_clx_CatLitterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cat Litter</link:label>
    <link:label id="lab_clx_CatLitterMember_label_en-US" xlink:label="lab_clx_CatLitterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cat Litter [Member]</link:label>
    <link:label id="lab_clx_CatLitterMember_documentation_en-US" xlink:label="lab_clx_CatLitterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cat Litter [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CatLitterMember" xlink:href="clx-20230331.xsd#clx_CatLitterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CatLitterMember" xlink:to="lab_clx_CatLitterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1aa28c67-d682-46d5-b454-325d9f7a3c84_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_434e549c-115b-4f47-a12e-5039b9330c10_totalLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, estimated fair value</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_2cd49c8a-91a6-445f-8154-d8c14ba2c8b5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_f4935d25-2936-4cfe-ab60-011fa515250d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_WalmartStoresIncMember_5c685746-7714-40f2-87b9-b4974ef324c8_terseLabel_en-US" xlink:label="lab_clx_WalmartStoresIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart Stores, Inc.</link:label>
    <link:label id="lab_clx_WalmartStoresIncMember_label_en-US" xlink:label="lab_clx_WalmartStoresIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart Stores, Inc. [Member]</link:label>
    <link:label id="lab_clx_WalmartStoresIncMember_documentation_en-US" xlink:label="lab_clx_WalmartStoresIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart Stores, Inc. and its affiliates [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WalmartStoresIncMember" xlink:href="clx-20230331.xsd#clx_WalmartStoresIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_WalmartStoresIncMember" xlink:to="lab_clx_WalmartStoresIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_71d95afc-54e0-4910-bf34-8443ca19a490_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate derivative contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_60802a2a-6091-4b1e-aa7e-0d6330379a39_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_ff66df8f-eb4f-4def-ad29-b9cd8a3797e8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, trademark and other asset impairments</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_96413b8a-705e-4d69-a409-e36204bcb313_totalLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_4d57e969-086a-47b9-80c0-86558633fb7a_terseLabel_en-US" xlink:label="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Foreign Currency Balance, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_label_en-US" xlink:label="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Foreign Currency Balance, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:to="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_aa78f841-ac0c-40b1-99a1-dd69bde52673_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, year one</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_5c60b065-86d0-4512-a199-bf5321699962_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b1157e69-2ce7-4fdc-ae1d-b877000c493b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>clx-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0b973b79-9411-462a-9048-a4468bf442a9,g:effc8b7f-c824-4f09-9fb9-ffb97c19c826-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.clorox.com/role/CoverPage" xlink:type="simple" xlink:href="clx-20230331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a3666370-c538-4610-ad89-05f2ee026da6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_DocumentType_a3666370-c538-4610-ad89-05f2ee026da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_fdca3223-4372-438c-b4e2-c6590ab1b61c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_DocumentQuarterlyReport_fdca3223-4372-438c-b4e2-c6590ab1b61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b21b5535-b1a0-42f3-8c0b-d866fae106fd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_DocumentPeriodEndDate_b21b5535-b1a0-42f3-8c0b-d866fae106fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a921db2d-7fb7-4ce2-bff1-14bbbaa14896" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_DocumentTransitionReport_a921db2d-7fb7-4ce2-bff1-14bbbaa14896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0298b160-258c-4a68-b255-72dd92e2b54a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityFileNumber_0298b160-258c-4a68-b255-72dd92e2b54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_75fcf492-3e41-45c0-8cef-3799cd90ad29" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityRegistrantName_75fcf492-3e41-45c0-8cef-3799cd90ad29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0bc4781c-db91-4b05-a177-692478264efc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0bc4781c-db91-4b05-a177-692478264efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6849ad08-d7de-4027-a70a-74780bccb5db" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityTaxIdentificationNumber_6849ad08-d7de-4027-a70a-74780bccb5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_4a4c68f5-3ab7-41c5-abfc-5bff0134b8f4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityAddressAddressLine1_4a4c68f5-3ab7-41c5-abfc-5bff0134b8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d67a91a6-d555-47b1-a987-b49f79be3b07" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityAddressCityOrTown_d67a91a6-d555-47b1-a987-b49f79be3b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_a1981c06-f516-401f-9017-1eb91bbdd313" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityAddressStateOrProvince_a1981c06-f516-401f-9017-1eb91bbdd313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_484144c5-f5d1-4146-a8b3-9bbe6113eb79" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityAddressPostalZipCode_484144c5-f5d1-4146-a8b3-9bbe6113eb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f91fa2f7-43f6-4c18-8103-0a9a0875f55c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_CityAreaCode_f91fa2f7-43f6-4c18-8103-0a9a0875f55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2d52acc8-5113-46c5-8f46-053eca9c4fb3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_LocalPhoneNumber_2d52acc8-5113-46c5-8f46-053eca9c4fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a72d1fed-f2a9-4653-ad49-99cee6e47668" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_Security12bTitle_a72d1fed-f2a9-4653-ad49-99cee6e47668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_fc8a3904-e7a1-4645-bdf8-865b134336e4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_TradingSymbol_fc8a3904-e7a1-4645-bdf8-865b134336e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_239d6eba-8351-4745-84da-d6818161bf13" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_SecurityExchangeName_239d6eba-8351-4745-84da-d6818161bf13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_439b441c-65c0-4598-b2e0-41165d961ca8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityCurrentReportingStatus_439b441c-65c0-4598-b2e0-41165d961ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_7c83e8be-b7ea-422e-9489-481abae4b6ee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityInteractiveDataCurrent_7c83e8be-b7ea-422e-9489-481abae4b6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_cf2e0f26-cf48-4f06-9858-d7b9aaf936ad" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityFilerCategory_cf2e0f26-cf48-4f06-9858-d7b9aaf936ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_9ae573d2-ac38-4ea3-96be-17ab17bb3c06" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntitySmallBusiness_9ae573d2-ac38-4ea3-96be-17ab17bb3c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_56673878-b28d-428a-a874-a7946fd1fa92" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityEmergingGrowthCompany_56673878-b28d-428a-a874-a7946fd1fa92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a31d0221-ee6f-4763-a036-8b27f0bf5339" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityShellCompany_a31d0221-ee6f-4763-a036-8b27f0bf5339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_6de69bc8-0035-4da5-8791-7234ccd0f1bb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_6de69bc8-0035-4da5-8791-7234ccd0f1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_bbc7d847-56e4-40bd-ac31-99f9bb157af1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_EntityCentralIndexKey_bbc7d847-56e4-40bd-ac31-99f9bb157af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a26ec879-75c9-4e54-ba00-9759e08dac74" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_AmendmentFlag_a26ec879-75c9-4e54-ba00-9759e08dac74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_66680d49-5549-4e2c-b7a8-d1e47a8c8104" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_CurrentFiscalYearEndDate_66680d49-5549-4e2c-b7a8-d1e47a8c8104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_392f0feb-36d5-4ee9-bb38-bc9293415d4e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_392f0feb-36d5-4ee9-bb38-bc9293415d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_53bb9fdc-3ba7-4895-a87c-d8760571e9af" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_540ca041-54ea-4096-bc71-6584d7d2ec8e" xlink:to="loc_dei_DocumentFiscalYearFocus_53bb9fdc-3ba7-4895-a87c-d8760571e9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="clx-20230331.xsd#CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1920c83f-e0b8-495c-a23b-ee1d80560ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1920c83f-e0b8-495c-a23b-ee1d80560ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_91984583-b072-48fa-a120-b11bea0d9258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_91984583-b072-48fa-a120-b11bea0d9258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_43cdf6ce-2678-4dd4-befc-359d9100ae25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_GrossProfit_43cdf6ce-2678-4dd4-befc-359d9100ae25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_95fc4718-9b22-4764-b3a2-a7c1e1795387" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_95fc4718-9b22-4764-b3a2-a7c1e1795387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_7f93ac65-6eb3-46e5-a841-4bf66c1b8e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_AdvertisingExpense_7f93ac65-6eb3-46e5-a841-4bf66c1b8e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_dc3dc743-a889-4e4f-b686-e93a0c0af8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_dc3dc743-a889-4e4f-b686-e93a0c0af8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_849fd06a-5ae6-4170-a230-98c0cfcd21e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_AssetImpairmentCharges_849fd06a-5ae6-4170-a230-98c0cfcd21e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_89ca2b12-6f25-444a-ace4-6ddbb8da8a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_InterestExpense_89ca2b12-6f25-444a-ace4-6ddbb8da8a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherExpenseIncomeNet_da335267-60ca-40d3-8bc2-722742acd2d9" xlink:href="clx-20230331.xsd#clx_OtherExpenseIncomeNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_clx_OtherExpenseIncomeNet_da335267-60ca-40d3-8bc2-722742acd2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_06e90cf1-b767-4a4a-896f-8f71fb9ec295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_06e90cf1-b767-4a4a-896f-8f71fb9ec295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_69527a64-2ef0-4f21-88e6-8a1825ad0623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_69527a64-2ef0-4f21-88e6-8a1825ad0623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6f9b7ffe-91f1-4336-bce8-46da53f25918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_ProfitLoss_6f9b7ffe-91f1-4336-bce8-46da53f25918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_bc9d53cf-bc61-41a3-8962-d888c1d6c552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_bc9d53cf-bc61-41a3-8962-d888c1d6c552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c23559f9-c751-42fe-b53f-a283be6bb9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_NetIncomeLoss_c23559f9-c751-42fe-b53f-a283be6bb9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0a03ea5f-c478-4970-bfa9-24e133b07cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_EarningsPerShareAbstract_0a03ea5f-c478-4970-bfa9-24e133b07cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_57fc9a9a-23ea-4751-a188-f8fa773d46a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0a03ea5f-c478-4970-bfa9-24e133b07cfb" xlink:to="loc_us-gaap_EarningsPerShareBasic_57fc9a9a-23ea-4751-a188-f8fa773d46a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7da33051-ee09-446e-b62d-3e33fff69c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0a03ea5f-c478-4970-bfa9-24e133b07cfb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7da33051-ee09-446e-b62d-3e33fff69c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cd9bfd65-ddb4-43e0-b656-761d3c3143e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cd9bfd65-ddb4-43e0-b656-761d3c3143e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_474907db-cdd2-4607-b24b-9db3a038ad11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cd9bfd65-ddb4-43e0-b656-761d3c3143e6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_474907db-cdd2-4607-b24b-9db3a038ad11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8db2229c-6f8e-4b66-9f07-4506012b38a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cd9bfd65-ddb4-43e0-b656-761d3c3143e6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8db2229c-6f8e-4b66-9f07-4506012b38a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_76fb6d0e-934a-46fb-befd-93838b37650c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_76fb6d0e-934a-46fb-befd-93838b37650c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_13a62fb8-5d46-4392-83a3-8fedb0cf7878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_13a62fb8-5d46-4392-83a3-8fedb0cf7878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3aba1f97-731a-4ebd-99d6-036f1bcecbce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_84dbda6f-382e-4961-8dd6-888df431af26" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3aba1f97-731a-4ebd-99d6-036f1bcecbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="clx-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_febea969-f807-4b69-8830-caf91ef04415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_80d87283-9633-4ccb-9644-b1e80987ffb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_febea969-f807-4b69-8830-caf91ef04415" xlink:to="loc_us-gaap_AssetsAbstract_80d87283-9633-4ccb-9644-b1e80987ffb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_43b81f45-6dee-4e2b-a0e2-82ffdbeac5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_80d87283-9633-4ccb-9644-b1e80987ffb7" xlink:to="loc_us-gaap_AssetsCurrentAbstract_43b81f45-6dee-4e2b-a0e2-82ffdbeac5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f821d657-a015-4e85-b970-cdea969330b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_43b81f45-6dee-4e2b-a0e2-82ffdbeac5a5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f821d657-a015-4e85-b970-cdea969330b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_da00dd91-cb66-4275-8842-ecb13f54092a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_43b81f45-6dee-4e2b-a0e2-82ffdbeac5a5" xlink:to="loc_us-gaap_ReceivablesNetCurrent_da00dd91-cb66-4275-8842-ecb13f54092a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_61b33543-b046-436f-bdfa-c73f153d9dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_43b81f45-6dee-4e2b-a0e2-82ffdbeac5a5" xlink:to="loc_us-gaap_InventoryNet_61b33543-b046-436f-bdfa-c73f153d9dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cc9a85db-3e3a-4012-83e3-ff6b27803a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_43b81f45-6dee-4e2b-a0e2-82ffdbeac5a5" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cc9a85db-3e3a-4012-83e3-ff6b27803a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_902f441c-1bd2-4dc3-a955-0d6a7de4f20e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_43b81f45-6dee-4e2b-a0e2-82ffdbeac5a5" xlink:to="loc_us-gaap_AssetsCurrent_902f441c-1bd2-4dc3-a955-0d6a7de4f20e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_28774091-63bb-403d-a4d9-60f353267bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_80d87283-9633-4ccb-9644-b1e80987ffb7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_28774091-63bb-403d-a4d9-60f353267bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9d4b8c79-3705-43ef-98e6-b35da79585d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_80d87283-9633-4ccb-9644-b1e80987ffb7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9d4b8c79-3705-43ef-98e6-b35da79585d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_58ccc876-3dec-400b-9380-6d215561916c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_80d87283-9633-4ccb-9644-b1e80987ffb7" xlink:to="loc_us-gaap_Goodwill_58ccc876-3dec-400b-9380-6d215561916c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrademarksNet_f64b4592-2dbe-4a56-9013-159c3fbf80fa" xlink:href="clx-20230331.xsd#clx_TrademarksNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_80d87283-9633-4ccb-9644-b1e80987ffb7" xlink:to="loc_clx_TrademarksNet_f64b4592-2dbe-4a56-9013-159c3fbf80fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_9ea454de-432b-4c07-a1cc-cba659af33c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_80d87283-9633-4ccb-9644-b1e80987ffb7" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_9ea454de-432b-4c07-a1cc-cba659af33c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0acd8667-c67f-469c-a51a-e94b144c5915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_80d87283-9633-4ccb-9644-b1e80987ffb7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_0acd8667-c67f-469c-a51a-e94b144c5915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3536a3fb-92db-404a-917c-083aa95b9148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_80d87283-9633-4ccb-9644-b1e80987ffb7" xlink:to="loc_us-gaap_Assets_3536a3fb-92db-404a-917c-083aa95b9148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78492287-7212-4b27-b589-ab741869f3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_febea969-f807-4b69-8830-caf91ef04415" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78492287-7212-4b27-b589-ab741869f3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_4b3e4c0e-189f-4767-bd88-24e39d72ccdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78492287-7212-4b27-b589-ab741869f3c1" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_4b3e4c0e-189f-4767-bd88-24e39d72ccdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_42885ade-f0f8-4547-806c-bde26abb2e52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4b3e4c0e-189f-4767-bd88-24e39d72ccdf" xlink:to="loc_us-gaap_CommercialPaper_42885ade-f0f8-4547-806c-bde26abb2e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c7c0bf15-b936-4e6d-b040-25df380ea19b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4b3e4c0e-189f-4767-bd88-24e39d72ccdf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c7c0bf15-b936-4e6d-b040-25df380ea19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_117d9e1a-d4ed-4487-be8e-c615241c6c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4b3e4c0e-189f-4767-bd88-24e39d72ccdf" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_117d9e1a-d4ed-4487-be8e-c615241c6c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_b629db63-43b3-4e49-82a9-7e24f8f77509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4b3e4c0e-189f-4767-bd88-24e39d72ccdf" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_b629db63-43b3-4e49-82a9-7e24f8f77509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7f974ddb-4f0b-4f5a-b060-87833a027eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4b3e4c0e-189f-4767-bd88-24e39d72ccdf" xlink:to="loc_us-gaap_LiabilitiesCurrent_7f974ddb-4f0b-4f5a-b060-87833a027eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e8ba65e4-e3ea-44fb-a38c-e10fda77ed42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78492287-7212-4b27-b589-ab741869f3c1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e8ba65e4-e3ea-44fb-a38c-e10fda77ed42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6106facc-1973-4981-a65c-9ab693abbb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78492287-7212-4b27-b589-ab741869f3c1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6106facc-1973-4981-a65c-9ab693abbb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_13d26df3-115a-4933-a68d-4b51631583ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78492287-7212-4b27-b589-ab741869f3c1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_13d26df3-115a-4933-a68d-4b51631583ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9a3806f6-4df8-48d9-a23f-01a64f561851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78492287-7212-4b27-b589-ab741869f3c1" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9a3806f6-4df8-48d9-a23f-01a64f561851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f11a375c-2670-4440-911b-4d1044d1adea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78492287-7212-4b27-b589-ab741869f3c1" xlink:to="loc_us-gaap_Liabilities_f11a375c-2670-4440-911b-4d1044d1adea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2d298cd2-6d1b-4cf3-84f7-28959807ed4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78492287-7212-4b27-b589-ab741869f3c1" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2d298cd2-6d1b-4cf3-84f7-28959807ed4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_fb26dc5d-73d5-4c9f-84e0-f2645f64127b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78492287-7212-4b27-b589-ab741869f3c1" xlink:to="loc_us-gaap_StockholdersEquityAbstract_fb26dc5d-73d5-4c9f-84e0-f2645f64127b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_fa33068d-e9e9-4f97-826f-03abe1911536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb26dc5d-73d5-4c9f-84e0-f2645f64127b" xlink:to="loc_us-gaap_PreferredStockValue_fa33068d-e9e9-4f97-826f-03abe1911536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f6be48e0-9d51-44a5-8284-ce019150c198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb26dc5d-73d5-4c9f-84e0-f2645f64127b" xlink:to="loc_us-gaap_CommonStockValue_f6be48e0-9d51-44a5-8284-ce019150c198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7c8ad81f-373c-4edf-b345-8c8686cd2385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb26dc5d-73d5-4c9f-84e0-f2645f64127b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7c8ad81f-373c-4edf-b345-8c8686cd2385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bc9a2b2c-d7a2-4c12-9b3f-ad4aec4aafba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb26dc5d-73d5-4c9f-84e0-f2645f64127b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bc9a2b2c-d7a2-4c12-9b3f-ad4aec4aafba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_f6244f4d-345d-43cc-8ade-908e8b2b972d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb26dc5d-73d5-4c9f-84e0-f2645f64127b" xlink:to="loc_us-gaap_TreasuryStockValue_f6244f4d-345d-43cc-8ade-908e8b2b972d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_00a557b1-78b2-4c66-a487-c3e918e71d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb26dc5d-73d5-4c9f-84e0-f2645f64127b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_00a557b1-78b2-4c66-a487-c3e918e71d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6c6428b8-ae07-4bdb-9e5d-076aadab92ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb26dc5d-73d5-4c9f-84e0-f2645f64127b" xlink:to="loc_us-gaap_StockholdersEquity_6c6428b8-ae07-4bdb-9e5d-076aadab92ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_c7e0752c-1bef-4375-b648-8a8e55e14efa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb26dc5d-73d5-4c9f-84e0-f2645f64127b" xlink:to="loc_us-gaap_MinorityInterest_c7e0752c-1bef-4375-b648-8a8e55e14efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2d8fc167-2473-456d-a470-ea69891a2660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb26dc5d-73d5-4c9f-84e0-f2645f64127b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2d8fc167-2473-456d-a470-ea69891a2660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a5fe8edc-7225-4c76-a132-0605bc90e69b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78492287-7212-4b27-b589-ab741869f3c1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_a5fe8edc-7225-4c76-a132-0605bc90e69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="clx-20230331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_42c3c75c-55c4-42c2-8349-4738d27ef2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_fce3f689-102c-4f36-a4f4-f1678cf0d012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42c3c75c-55c4-42c2-8349-4738d27ef2c6" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_fce3f689-102c-4f36-a4f4-f1678cf0d012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_48134bd5-6871-453a-a72c-c3cfa93221f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42c3c75c-55c4-42c2-8349-4738d27ef2c6" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_48134bd5-6871-453a-a72c-c3cfa93221f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_10d30721-e45f-47e0-8fdc-1b809ff94815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42c3c75c-55c4-42c2-8349-4738d27ef2c6" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_10d30721-e45f-47e0-8fdc-1b809ff94815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_f35c8a59-a6e5-4688-a06e-ecf20b08351f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42c3c75c-55c4-42c2-8349-4738d27ef2c6" xlink:to="loc_us-gaap_PreferredStockSharesIssued_f35c8a59-a6e5-4688-a06e-ecf20b08351f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_25e59067-f29f-484e-ab39-3e486f29989b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42c3c75c-55c4-42c2-8349-4738d27ef2c6" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_25e59067-f29f-484e-ab39-3e486f29989b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2fc8d39c-9eae-4735-b7a0-3df521727188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42c3c75c-55c4-42c2-8349-4738d27ef2c6" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2fc8d39c-9eae-4735-b7a0-3df521727188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5e53ea95-86fd-4289-8929-987773d35be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42c3c75c-55c4-42c2-8349-4738d27ef2c6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5e53ea95-86fd-4289-8929-987773d35be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_dc925803-391b-4080-ad24-a8f518721508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42c3c75c-55c4-42c2-8349-4738d27ef2c6" xlink:to="loc_us-gaap_CommonStockSharesIssued_dc925803-391b-4080-ad24-a8f518721508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1306e291-4876-4fec-96aa-93d62738a055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42c3c75c-55c4-42c2-8349-4738d27ef2c6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1306e291-4876-4fec-96aa-93d62738a055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_f9b80b17-213c-4f22-82df-de5f4e340f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42c3c75c-55c4-42c2-8349-4738d27ef2c6" xlink:to="loc_us-gaap_TreasuryStockCommonShares_f9b80b17-213c-4f22-82df-de5f4e340f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="clx-20230331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_58dd3a77-d429-4f1b-8ffa-f1780fd9b5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c1d4dd8f-d112-4fb1-84f1-de3a92c1628c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_58dd3a77-d429-4f1b-8ffa-f1780fd9b5a0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c1d4dd8f-d112-4fb1-84f1-de3a92c1628c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f2d3dbd6-62c9-4d5e-a4a2-275578c405ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c1d4dd8f-d112-4fb1-84f1-de3a92c1628c" xlink:to="loc_us-gaap_ProfitLoss_f2d3dbd6-62c9-4d5e-a4a2-275578c405ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7a89deaa-5e10-4d09-b595-daa55046991a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c1d4dd8f-d112-4fb1-84f1-de3a92c1628c" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7a89deaa-5e10-4d09-b595-daa55046991a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1cbb766e-42c9-42f0-9fbb-a530bb4ad177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7a89deaa-5e10-4d09-b595-daa55046991a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1cbb766e-42c9-42f0-9fbb-a530bb4ad177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6a500673-1d85-425c-8da1-4f7519c13a00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7a89deaa-5e10-4d09-b595-daa55046991a" xlink:to="loc_us-gaap_ShareBasedCompensation_6a500673-1d85-425c-8da1-4f7519c13a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bbca7cec-ea42-4be1-9940-0440e5d800ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7a89deaa-5e10-4d09-b595-daa55046991a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bbca7cec-ea42-4be1-9940-0440e5d800ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_ceda58f2-fa1c-4a69-9b39-1f304972c2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7a89deaa-5e10-4d09-b595-daa55046991a" xlink:to="loc_us-gaap_AssetImpairmentCharges_ceda58f2-fa1c-4a69-9b39-1f304972c2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_fa3c9aaa-96ca-4185-80a6-4936454e8dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7a89deaa-5e10-4d09-b595-daa55046991a" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_fa3c9aaa-96ca-4185-80a6-4936454e8dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3d4f1ee-526d-4544-a2af-89e59aec3b54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7a89deaa-5e10-4d09-b595-daa55046991a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3d4f1ee-526d-4544-a2af-89e59aec3b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_a5353981-7a86-4bc3-aebf-84c71ea01582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3d4f1ee-526d-4544-a2af-89e59aec3b54" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_a5353981-7a86-4bc3-aebf-84c71ea01582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_64978104-9c99-4aac-81e0-eed243fc6ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3d4f1ee-526d-4544-a2af-89e59aec3b54" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_64978104-9c99-4aac-81e0-eed243fc6ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d55ff9fd-fe42-4e5f-a2ff-ffd18fa6515a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3d4f1ee-526d-4544-a2af-89e59aec3b54" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d55ff9fd-fe42-4e5f-a2ff-ffd18fa6515a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1a61ad98-efd1-496a-a1cd-9f7d679b23bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3d4f1ee-526d-4544-a2af-89e59aec3b54" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1a61ad98-efd1-496a-a1cd-9f7d679b23bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_35bd02ba-3e05-46c2-bfef-bbe6d3f290ef" xlink:href="clx-20230331.xsd#clx_OperatingLeaseRightofUseAssetAndLiabilityNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3d4f1ee-526d-4544-a2af-89e59aec3b54" xlink:to="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_35bd02ba-3e05-46c2-bfef-bbe6d3f290ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_8ad67825-df3f-4d52-b19f-f82955a754a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3d4f1ee-526d-4544-a2af-89e59aec3b54" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_8ad67825-df3f-4d52-b19f-f82955a754a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fed4663c-2052-46e8-932b-8f1b8729e56f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c1d4dd8f-d112-4fb1-84f1-de3a92c1628c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fed4663c-2052-46e8-932b-8f1b8729e56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a4111d2f-bb4b-49d4-a249-f22b85d741f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_58dd3a77-d429-4f1b-8ffa-f1780fd9b5a0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a4111d2f-bb4b-49d4-a249-f22b85d741f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0512762a-00a0-4f71-948d-2e23793c5b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a4111d2f-bb4b-49d4-a249-f22b85d741f2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0512762a-00a0-4f71-948d-2e23793c5b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_173c96db-2a4e-403a-8f94-78de7f2873e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a4111d2f-bb4b-49d4-a249-f22b85d741f2" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_173c96db-2a4e-403a-8f94-78de7f2873e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6527aef7-c805-42c9-b224-a4d1872ed327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a4111d2f-bb4b-49d4-a249-f22b85d741f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6527aef7-c805-42c9-b224-a4d1872ed327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a6e1c6d9-5d56-4757-b599-9c488cee7987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_58dd3a77-d429-4f1b-8ffa-f1780fd9b5a0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a6e1c6d9-5d56-4757-b599-9c488cee7987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_f01c12ff-ee52-45f3-8da1-894783a3d78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a6e1c6d9-5d56-4757-b599-9c488cee7987" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_f01c12ff-ee52-45f3-8da1-894783a3d78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_264e0af6-0ef9-4e8a-ab9c-eec2a63d4a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a6e1c6d9-5d56-4757-b599-9c488cee7987" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_264e0af6-0ef9-4e8a-ab9c-eec2a63d4a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6c9e5342-bd90-4347-a123-295eb9288064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a6e1c6d9-5d56-4757-b599-9c488cee7987" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6c9e5342-bd90-4347-a123-295eb9288064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_d6d8a90a-5c93-454a-a702-f0d797a0b683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a6e1c6d9-5d56-4757-b599-9c488cee7987" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_d6d8a90a-5c93-454a-a702-f0d797a0b683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_f84b2c4e-73c4-42eb-bc69-45b7db6485d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a6e1c6d9-5d56-4757-b599-9c488cee7987" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_f84b2c4e-73c4-42eb-bc69-45b7db6485d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_3c61bf9c-1efa-45b1-a5c9-bab708cdf99e" xlink:href="clx-20230331.xsd#clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a6e1c6d9-5d56-4757-b599-9c488cee7987" xlink:to="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_3c61bf9c-1efa-45b1-a5c9-bab708cdf99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7b74aa06-6e61-4457-b30d-9cb5db9b7c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a6e1c6d9-5d56-4757-b599-9c488cee7987" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7b74aa06-6e61-4457-b30d-9cb5db9b7c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fade0dab-52ce-4629-9147-3c08d2f6d0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_58dd3a77-d429-4f1b-8ffa-f1780fd9b5a0" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fade0dab-52ce-4629-9147-3c08d2f6d0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2ec5fdf5-8f87-49aa-981a-08cafa394892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_58dd3a77-d429-4f1b-8ffa-f1780fd9b5a0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2ec5fdf5-8f87-49aa-981a-08cafa394892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_ac9fb84a-531f-4c27-9422-b56ed91ca513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_58dd3a77-d429-4f1b-8ffa-f1780fd9b5a0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_ac9fb84a-531f-4c27-9422-b56ed91ca513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_af0e0c32-32e7-4d3f-80a0-5f81e68fda8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_ac9fb84a-531f-4c27-9422-b56ed91ca513" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_af0e0c32-32e7-4d3f-80a0-5f81e68fda8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4f3da8ec-3227-452b-afd6-7742b99bf866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_ac9fb84a-531f-4c27-9422-b56ed91ca513" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4f3da8ec-3227-452b-afd6-7742b99bf866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="clx-20230331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ed2d15a5-d3c6-46ea-9ba3-3e7fffd1a7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_bc5bf5a1-c86c-42f2-8978-0f2128c2e785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed2d15a5-d3c6-46ea-9ba3-3e7fffd1a7d3" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_bc5bf5a1-c86c-42f2-8978-0f2128c2e785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS" xlink:type="simple" xlink:href="clx-20230331.xsd#RESTRUCTURINGANDRELATEDCOSTS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7cd770e5-fa32-4119-9e93-887f3189ccf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_0cbe9f54-d8d1-497b-ba5f-779921f6ce6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7cd770e5-fa32-4119-9e93-887f3189ccf9" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_0cbe9f54-d8d1-497b-ba5f-779921f6ce6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNET" xlink:type="simple" xlink:href="clx-20230331.xsd#INVENTORIESNET"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INVENTORIESNET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_66c693e3-cb5c-403a-a443-919e0d16e0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_30c819b8-a9a6-4a51-883a-917a9341f9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_66c693e3-cb5c-403a-a443-919e0d16e0ab" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_30c819b8-a9a6-4a51-883a-917a9341f9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTS" xlink:type="simple" xlink:href="clx-20230331.xsd#GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5443840c-d3d8-4522-b2f5-a91b2942247d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1b45cb92-93ad-4fe7-855c-f12a65167c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5443840c-d3d8-4522-b2f5-a91b2942247d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1b45cb92-93ad-4fe7-855c-f12a65167c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERLIABILITIES" xlink:type="simple" xlink:href="clx-20230331.xsd#OTHERLIABILITIES"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/OTHERLIABILITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_84be2663-c99d-4b94-962c-97c76a29b632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_cd8a7897-c0d5-4782-9d05-905b2423c03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_84be2663-c99d-4b94-962c-97c76a29b632" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_cd8a7897-c0d5-4782-9d05-905b2423c03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="clx-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_bdda41c4-5030-40a1-92df-cbe8425f942d" xlink:href="clx-20230331.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_3501f2fd-c2ca-41eb-b363-dafc0383056e" xlink:href="clx-20230331.xsd#clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_bdda41c4-5030-40a1-92df-cbe8425f942d" xlink:to="loc_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_3501f2fd-c2ca-41eb-b363-dafc0383056e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INCOMETAXES" xlink:type="simple" xlink:href="clx-20230331.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4c54bcc6-6fa5-4444-b959-e114a372f318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_ecb07e4d-656f-414c-88cf-13c41c1654cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4c54bcc6-6fa5-4444-b959-e114a372f318" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_ecb07e4d-656f-414c-88cf-13c41c1654cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS" xlink:type="simple" xlink:href="clx-20230331.xsd#NETEARNINGSLOSSESPERSHAREEPS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_51a44601-cda6-4709-a1f4-f77ace806b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_1d25350a-8bf6-4d42-a8d9-3a27fe41ecdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_51a44601-cda6-4709-a1f4-f77ace806b5d" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_1d25350a-8bf6-4d42-a8d9-3a27fe41ecdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="clx-20230331.xsd#COMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_5eb07b78-af62-4c27-b239-6ce661a1b3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_913d1931-f52f-4e64-9841-ffca8a805064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5eb07b78-af62-4c27-b239-6ce661a1b3a7" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_913d1931-f52f-4e64-9841-ffca8a805064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="clx-20230331.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_355ddb16-1e0c-4ba5-960f-2f48f7ea2cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3ecbeb2d-fa80-4b74-b582-f3e764dce055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_355ddb16-1e0c-4ba5-960f-2f48f7ea2cb1" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3ecbeb2d-fa80-4b74-b582-f3e764dce055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANS" xlink:type="simple" xlink:href="clx-20230331.xsd#EMPLOYEEBENEFITPLANS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_be00f648-11ce-445a-bf92-c8bb8fdd2b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_061b00d5-50fc-490e-b257-409e00f86842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_be00f648-11ce-445a-bf92-c8bb8fdd2b1e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_061b00d5-50fc-490e-b257-409e00f86842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES" xlink:type="simple" xlink:href="clx-20230331.xsd#OTHERCONTINGENCIESANDGUARANTEES"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4c4050e6-d1bf-4b61-b9a1-2daf21a4f316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3a383c97-0672-41bb-bd63-3c99f7b07766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4c4050e6-d1bf-4b61-b9a1-2daf21a4f316" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3a383c97-0672-41bb-bd63-3c99f7b07766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTS" xlink:type="simple" xlink:href="clx-20230331.xsd#SEGMENTRESULTS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7a8f55c7-411e-425d-9cd4-2d1c0d526882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_f294a5a8-6b4e-44f9-869f-4cab64f341a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7a8f55c7-411e-425d-9cd4-2d1c0d526882" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_f294a5a8-6b4e-44f9-869f-4cab64f341a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="clx-20230331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_da89e731-6a53-41ab-b9fa-7cd0bc8edf04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_66bdc00f-18d1-449f-9fcc-b1e56bae8352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_da89e731-6a53-41ab-b9fa-7cd0bc8edf04" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_66bdc00f-18d1-449f-9fcc-b1e56bae8352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_34ecff27-727d-4c95-9d6f-62b0345b75fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_da89e731-6a53-41ab-b9fa-7cd0bc8edf04" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_34ecff27-727d-4c95-9d6f-62b0345b75fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_747835ce-e152-4489-a1bf-324b0c8bb8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_da89e731-6a53-41ab-b9fa-7cd0bc8edf04" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_747835ce-e152-4489-a1bf-324b0c8bb8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d9b1b324-cac9-4cf0-9ca4-5010cc757499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_da89e731-6a53-41ab-b9fa-7cd0bc8edf04" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d9b1b324-cac9-4cf0-9ca4-5010cc757499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_5a4026f9-4edb-4867-a5cf-14f89536f531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_da89e731-6a53-41ab-b9fa-7cd0bc8edf04" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_5a4026f9-4edb-4867-a5cf-14f89536f531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_2c106cf7-8bec-4561-a038-c167cf7c6274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_da89e731-6a53-41ab-b9fa-7cd0bc8edf04" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_2c106cf7-8bec-4561-a038-c167cf7c6274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables" xlink:type="simple" xlink:href="clx-20230331.xsd#RESTRUCTURINGANDRELATEDCOSTSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d9f33403-e71c-4339-82a7-97549d8d3d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_816a35d1-27c6-4515-867a-da13fcc5c056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d9f33403-e71c-4339-82a7-97549d8d3d0b" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_816a35d1-27c6-4515-867a-da13fcc5c056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_cefbdbf0-c268-40da-8d67-ed6817f30ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d9f33403-e71c-4339-82a7-97549d8d3d0b" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_cefbdbf0-c268-40da-8d67-ed6817f30ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETTables" xlink:type="simple" xlink:href="clx-20230331.xsd#INVENTORIESNETTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INVENTORIESNETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_10722ba9-a4bf-4cd2-8267-9af30ceff1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2366dbdf-715b-4bb1-89ff-55a140dce885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_10722ba9-a4bf-4cd2-8267-9af30ceff1b2" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2366dbdf-715b-4bb1-89ff-55a140dce885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSTables" xlink:type="simple" xlink:href="clx-20230331.xsd#GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1d5c9e73-459d-4875-81e2-2b387d20c5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_4cc75fff-ffec-4ce3-a0fd-658da7fe72da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1d5c9e73-459d-4875-81e2-2b387d20c5a6" xlink:to="loc_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_4cc75fff-ffec-4ce3-a0fd-658da7fe72da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_1db4365c-e84d-4bb9-809a-c746672cda40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1d5c9e73-459d-4875-81e2-2b387d20c5a6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_1db4365c-e84d-4bb9-809a-c746672cda40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_d02db8a3-1ca3-4d54-9a93-9e25641dbe9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1d5c9e73-459d-4875-81e2-2b387d20c5a6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_d02db8a3-1ca3-4d54-9a93-9e25641dbe9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="clx-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_332fb0c2-a403-4fe1-b5a2-d0c713bbfc06" xlink:href="clx-20230331.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_116baea0-871b-47c9-8ca6-4da6eb42b8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_332fb0c2-a403-4fe1-b5a2-d0c713bbfc06" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_116baea0-871b-47c9-8ca6-4da6eb42b8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_a034af22-53ff-4a87-b8dd-f5dd55572fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_332fb0c2-a403-4fe1-b5a2-d0c713bbfc06" xlink:to="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_a034af22-53ff-4a87-b8dd-f5dd55572fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_2117b229-4879-46b8-8d0c-0cd14407ab41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_332fb0c2-a403-4fe1-b5a2-d0c713bbfc06" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_2117b229-4879-46b8-8d0c-0cd14407ab41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables" xlink:type="simple" xlink:href="clx-20230331.xsd#NETEARNINGSLOSSESPERSHAREEPSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_da7be41c-c176-4f44-925e-edbe7f9e3162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_cb600011-f4d3-4219-85c6-193b9636f45e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_da7be41c-c176-4f44-925e-edbe7f9e3162" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_cb600011-f4d3-4219-85c6-193b9636f45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables" xlink:type="simple" xlink:href="clx-20230331.xsd#COMPREHENSIVEINCOMELOSSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_d3cf4458-3cb5-4e07-8c96-a71957a53599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_9fe2b7e0-51dd-437b-8ec3-ff55d48bee1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d3cf4458-3cb5-4e07-8c96-a71957a53599" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_9fe2b7e0-51dd-437b-8ec3-ff55d48bee1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="clx-20230331.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_72fde726-3fd4-49a1-ae3e-db57fad2d656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_c3fd0d2e-e567-4a0b-b6d5-2659176f7f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_72fde726-3fd4-49a1-ae3e-db57fad2d656" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_c3fd0d2e-e567-4a0b-b6d5-2659176f7f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_90c0c64d-0bb5-4bae-b207-3b36d0036807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_72fde726-3fd4-49a1-ae3e-db57fad2d656" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_90c0c64d-0bb5-4bae-b207-3b36d0036807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables" xlink:type="simple" xlink:href="clx-20230331.xsd#EMPLOYEEBENEFITPLANSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1b331e42-23c2-40a4-a4fc-daf85f943563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_85eba0c1-dea2-4684-9bd9-c2e3dc19090a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1b331e42-23c2-40a4-a4fc-daf85f943563" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_85eba0c1-dea2-4684-9bd9-c2e3dc19090a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSTables" xlink:type="simple" xlink:href="clx-20230331.xsd#SEGMENTRESULTSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4b021b99-a243-4869-99bc-132386468169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ae762c8a-b7e2-429a-9f86-611106215a36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4b021b99-a243-4869-99bc-132386468169" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ae762c8a-b7e2-429a-9f86-611106215a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_db0a3e6e-5784-4a2e-b2d1-44ad5aa98022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d601bea7-51f1-4671-ad2f-57e0e3bb2f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_db0a3e6e-5784-4a2e-b2d1-44ad5aa98022" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d601bea7-51f1-4671-ad2f-57e0e3bb2f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_462cff01-937e-402b-80bc-c715366719d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d601bea7-51f1-4671-ad2f-57e0e3bb2f31" xlink:to="loc_srt_RangeAxis_462cff01-937e-402b-80bc-c715366719d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_df251483-b618-4663-ae2c-93b24fd947ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_462cff01-937e-402b-80bc-c715366719d8" xlink:to="loc_srt_RangeMember_df251483-b618-4663-ae2c-93b24fd947ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f5bf4c6c-4fff-4bf7-95ed-050738946a1f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_df251483-b618-4663-ae2c-93b24fd947ca" xlink:to="loc_srt_MinimumMember_f5bf4c6c-4fff-4bf7-95ed-050738946a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2b04b193-2d43-403d-8f87-10474123d18a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_df251483-b618-4663-ae2c-93b24fd947ca" xlink:to="loc_srt_MaximumMember_2b04b193-2d43-403d-8f87-10474123d18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c0d31f60-69b3-4162-afde-17df5a6f66b6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d601bea7-51f1-4671-ad2f-57e0e3bb2f31" xlink:to="loc_srt_StatementScenarioAxis_c0d31f60-69b3-4162-afde-17df5a6f66b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_78ce573b-fb68-4086-8782-d8304467d5fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_c0d31f60-69b3-4162-afde-17df5a6f66b6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_78ce573b-fb68-4086-8782-d8304467d5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_5bba0dda-0035-4323-a5e7-49a7b13ddde8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_78ce573b-fb68-4086-8782-d8304467d5fb" xlink:to="loc_srt_ScenarioForecastMember_5bba0dda-0035-4323-a5e7-49a7b13ddde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_83c62398-f006-436b-824f-1bb0a5a557bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d601bea7-51f1-4671-ad2f-57e0e3bb2f31" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_83c62398-f006-436b-824f-1bb0a5a557bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_3916f464-a4a8-43e6-abf5-ee3462cb31c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_83c62398-f006-436b-824f-1bb0a5a557bd" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_3916f464-a4a8-43e6-abf5-ee3462cb31c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_bc6b2852-9f7f-4618-8b6d-2f60813c3099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_83c62398-f006-436b-824f-1bb0a5a557bd" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_bc6b2852-9f7f-4618-8b6d-2f60813c3099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_82a2af39-d70e-4594-8850-b6e58ecc4bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fd2bab05-6db3-4c90-a6c0-11c9acff2535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_82a2af39-d70e-4594-8850-b6e58ecc4bb2" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fd2bab05-6db3-4c90-a6c0-11c9acff2535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_06d95539-f781-4d6d-9e0a-050ee3a81900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fd2bab05-6db3-4c90-a6c0-11c9acff2535" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_06d95539-f781-4d6d-9e0a-050ee3a81900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c0eeaae4-8ee9-446f-b3f2-aa01fada7fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_06d95539-f781-4d6d-9e0a-050ee3a81900" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c0eeaae4-8ee9-446f-b3f2-aa01fada7fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CostOfGoodsAndServicesSoldMember_6a0abe29-7d86-4db2-88d4-f7725791b456" xlink:href="clx-20230331.xsd#clx_CostOfGoodsAndServicesSoldMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c0eeaae4-8ee9-446f-b3f2-aa01fada7fe8" xlink:to="loc_clx_CostOfGoodsAndServicesSoldMember_6a0abe29-7d86-4db2-88d4-f7725791b456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2f1c500e-0fc6-4c66-911a-5d6e1d88822f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c0eeaae4-8ee9-446f-b3f2-aa01fada7fe8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2f1c500e-0fc6-4c66-911a-5d6e1d88822f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherIncomeExpenseNetMember_fcf84920-99fa-4950-9b74-0b8d181bcd5e" xlink:href="clx-20230331.xsd#clx_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c0eeaae4-8ee9-446f-b3f2-aa01fada7fe8" xlink:to="loc_clx_OtherIncomeExpenseNetMember_fcf84920-99fa-4950-9b74-0b8d181bcd5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a8794e37-8374-4713-9b45-bdf00fe54752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fd2bab05-6db3-4c90-a6c0-11c9acff2535" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_a8794e37-8374-4713-9b45-bdf00fe54752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_26052ee0-e5f6-474e-b2b4-e2f2bd2b26b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a8794e37-8374-4713-9b45-bdf00fe54752" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_26052ee0-e5f6-474e-b2b4-e2f2bd2b26b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0e0071c2-94ed-4a9b-ad1e-e6591ed0a934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_bac69afa-fec8-4d2e-a3a3-447958173f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0e0071c2-94ed-4a9b-ad1e-e6591ed0a934" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_bac69afa-fec8-4d2e-a3a3-447958173f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_d824df03-332e-4024-8c16-b5126a7e6895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_bac69afa-fec8-4d2e-a3a3-447958173f94" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_d824df03-332e-4024-8c16-b5126a7e6895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_3aaa8274-2eb3-487c-8fef-11013a38e540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_d824df03-332e-4024-8c16-b5126a7e6895" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_3aaa8274-2eb3-487c-8fef-11013a38e540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_923a6306-ba68-46f8-b974-f2e6cf714a27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3aaa8274-2eb3-487c-8fef-11013a38e540" xlink:to="loc_us-gaap_EmployeeSeveranceMember_923a6306-ba68-46f8-b974-f2e6cf714a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_439c471c-27d9-4bd9-af44-f1253ab87a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3aaa8274-2eb3-487c-8fef-11013a38e540" xlink:to="loc_us-gaap_OtherRestructuringMember_439c471c-27d9-4bd9-af44-f1253ab87a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c644ba16-36d1-4c1f-9d97-967e99e8d0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_bac69afa-fec8-4d2e-a3a3-447958173f94" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_c644ba16-36d1-4c1f-9d97-967e99e8d0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_94b7f216-c82e-404c-b5a9-1066cb1243cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c644ba16-36d1-4c1f-9d97-967e99e8d0e9" xlink:to="loc_us-gaap_RestructuringReserveRollForward_94b7f216-c82e-404c-b5a9-1066cb1243cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_1d1f44b6-57b0-4718-a94d-688ab877b696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_94b7f216-c82e-404c-b5a9-1066cb1243cb" xlink:to="loc_us-gaap_RestructuringReserve_1d1f44b6-57b0-4718-a94d-688ab877b696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6f14971c-753b-4d2d-be3d-4b0385a31bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_94b7f216-c82e-404c-b5a9-1066cb1243cb" xlink:to="loc_us-gaap_RestructuringCharges_6f14971c-753b-4d2d-be3d-4b0385a31bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_234dd894-33d6-4183-bbf9-534efacadda5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_94b7f216-c82e-404c-b5a9-1066cb1243cb" xlink:to="loc_us-gaap_PaymentsForRestructuring_234dd894-33d6-4183-bbf9-534efacadda5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_ffb0b48d-a59b-4c3c-853e-f9db4d806dce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_94b7f216-c82e-404c-b5a9-1066cb1243cb" xlink:to="loc_us-gaap_RestructuringReserve_ffb0b48d-a59b-4c3c-853e-f9db4d806dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#INVENTORIESNETDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INVENTORIESNETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_362ec507-142c-4bfd-8929-1516238105cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a3e238a9-8292-4531-a882-d95ca5d3f238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_362ec507-142c-4bfd-8929-1516238105cb" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a3e238a9-8292-4531-a882-d95ca5d3f238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_404868c5-bed1-4217-9c0f-6421bbf576e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_362ec507-142c-4bfd-8929-1516238105cb" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_404868c5-bed1-4217-9c0f-6421bbf576e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_5824d8ff-4144-4000-8e70-86798c45a8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_362ec507-142c-4bfd-8929-1516238105cb" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_5824d8ff-4144-4000-8e70-86798c45a8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve_801fa70b-e048-4c7a-9094-8bf5a7315ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_362ec507-142c-4bfd-8929-1516238105cb" xlink:to="loc_us-gaap_InventoryLIFOReserve_801fa70b-e048-4c7a-9094-8bf5a7315ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InventoryCurrentAndNoncurrentNet_894c3335-394f-4aeb-8d1b-7d987a172e05" xlink:href="clx-20230331.xsd#clx_InventoryCurrentAndNoncurrentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_362ec507-142c-4bfd-8929-1516238105cb" xlink:to="loc_clx_InventoryCurrentAndNoncurrentNet_894c3335-394f-4aeb-8d1b-7d987a172e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_12322ba0-a2cf-43fb-a61c-9a7a597f61a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_362ec507-142c-4bfd-8929-1516238105cb" xlink:to="loc_us-gaap_InventoryNoncurrent_12322ba0-a2cf-43fb-a61c-9a7a597f61a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4c2fa192-d500-4a1a-968c-ada722973650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_362ec507-142c-4bfd-8929-1516238105cb" xlink:to="loc_us-gaap_InventoryNet_4c2fa192-d500-4a1a-968c-ada722973650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETDetails_1" xlink:type="simple" xlink:href="clx-20230331.xsd#INVENTORIESNETDetails_1"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INVENTORIESNETDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f747dba-7cff-4a07-83e4-8dbc47b95d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3331815d-dd7b-45e8-9dca-c02017489edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f747dba-7cff-4a07-83e4-8dbc47b95d0b" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3331815d-dd7b-45e8-9dca-c02017489edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_bf162445-01b9-4e67-90da-c2de7527a573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3331815d-dd7b-45e8-9dca-c02017489edc" xlink:to="loc_us-gaap_ReportingUnitAxis_bf162445-01b9-4e67-90da-c2de7527a573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_9c12555a-7864-41b9-a421-50557ea8ff17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_bf162445-01b9-4e67-90da-c2de7527a573" xlink:to="loc_us-gaap_ReportingUnitDomain_9c12555a-7864-41b9-a421-50557ea8ff17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsReportingUnitMember_00a1c8a2-2ef5-4f31-9281-0cde4334769c" xlink:href="clx-20230331.xsd#clx_VitaminsMineralsAndSupplementsReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_9c12555a-7864-41b9-a421-50557ea8ff17" xlink:to="loc_clx_VitaminsMineralsAndSupplementsReportingUnitMember_00a1c8a2-2ef5-4f31-9281-0cde4334769c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalReportingUnitMember_0ae5ec0d-0692-4fd6-9cd4-d23e6e6cc6b2" xlink:href="clx-20230331.xsd#clx_InternationalReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_9c12555a-7864-41b9-a421-50557ea8ff17" xlink:to="loc_clx_InternationalReportingUnitMember_0ae5ec0d-0692-4fd6-9cd4-d23e6e6cc6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_c7caa3a1-05a9-47f0-8faf-f759de14c26c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3331815d-dd7b-45e8-9dca-c02017489edc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_c7caa3a1-05a9-47f0-8faf-f759de14c26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_c737a773-4e35-4c5b-9650-3c326dea5709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_c7caa3a1-05a9-47f0-8faf-f759de14c26c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_c737a773-4e35-4c5b-9650-3c326dea5709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_0d656809-5236-4a76-b140-ba5a9eb18d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_c7caa3a1-05a9-47f0-8faf-f759de14c26c" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_0d656809-5236-4a76-b140-ba5a9eb18d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_6cb33a0c-2076-4f89-aad2-ca0f62cf7b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_c7caa3a1-05a9-47f0-8faf-f759de14c26c" xlink:to="loc_us-gaap_AssetImpairmentCharges_6cb33a0c-2076-4f89-aad2-ca0f62cf7b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9ac774fe-e02b-4977-97a8-11e19231bc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_0b776cf6-f14a-44fa-8664-87a261495062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9ac774fe-e02b-4977-97a8-11e19231bc2b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_0b776cf6-f14a-44fa-8664-87a261495062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2802875f-6f0c-4c1a-943c-6c8d4546364c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0b776cf6-f14a-44fa-8664-87a261495062" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2802875f-6f0c-4c1a-943c-6c8d4546364c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f210f149-04c7-4ccc-b021-625da90f2576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2802875f-6f0c-4c1a-943c-6c8d4546364c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f210f149-04c7-4ccc-b021-625da90f2576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_e5a340ed-6782-4aab-8878-94595252b2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f210f149-04c7-4ccc-b021-625da90f2576" xlink:to="loc_us-gaap_TrademarksMember_e5a340ed-6782-4aab-8878-94595252b2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_2627609f-9a90-4793-8544-790d6e31eeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0b776cf6-f14a-44fa-8664-87a261495062" xlink:to="loc_us-gaap_ReportingUnitAxis_2627609f-9a90-4793-8544-790d6e31eeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_f4a97e32-e7a5-4068-8d25-593b6d890346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_2627609f-9a90-4793-8544-790d6e31eeb2" xlink:to="loc_us-gaap_ReportingUnitDomain_f4a97e32-e7a5-4068-8d25-593b6d890346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsReportingUnitMember_9712af4d-4759-43f3-92ba-d25ed66ae816" xlink:href="clx-20230331.xsd#clx_VitaminsMineralsAndSupplementsReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_f4a97e32-e7a5-4068-8d25-593b6d890346" xlink:to="loc_clx_VitaminsMineralsAndSupplementsReportingUnitMember_9712af4d-4759-43f3-92ba-d25ed66ae816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b63634d2-db1f-4727-908d-edebbc773d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0b776cf6-f14a-44fa-8664-87a261495062" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b63634d2-db1f-4727-908d-edebbc773d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a97f10e-ce33-42cd-a91a-7868a02be395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b63634d2-db1f-4727-908d-edebbc773d25" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a97f10e-ce33-42cd-a91a-7868a02be395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_551ea2b2-c8a6-4b47-b751-8447df10bd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a97f10e-ce33-42cd-a91a-7868a02be395" xlink:to="loc_us-gaap_TrademarksMember_551ea2b2-c8a6-4b47-b751-8447df10bd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0b776cf6-f14a-44fa-8664-87a261495062" xlink:to="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit_93a5e67d-1437-492b-86b2-4bcef872bff9" xlink:href="clx-20230331.xsd#clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit_93a5e67d-1437-492b-86b2-4bcef872bff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_ed3a87fc-042d-4a74-94d7-1b97ac416e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_ed3a87fc-042d-4a74-94d7-1b97ac416e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue_e1cf5d5a-43f6-4ac4-9e3c-a5878a283c3a" xlink:href="clx-20230331.xsd#clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue_e1cf5d5a-43f6-4ac4-9e3c-a5878a283c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0ea26a7f-62cd-487c-a694-2aa6ab192cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0ea26a7f-62cd-487c-a694-2aa6ab192cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_354ac2b5-1d68-42e9-823f-8fbb56bd89f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_354ac2b5-1d68-42e9-823f-8fbb56bd89f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_93121201-0c91-40e1-a433-584a9b7e1106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_93121201-0c91-40e1-a433-584a9b7e1106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_51fa69da-b243-4039-a9ad-fa94958f3b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_51fa69da-b243-4039-a9ad-fa94958f3b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5761d22b-8edc-4ad6-88e1-ee8903faac54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5761d22b-8edc-4ad6-88e1-ee8903faac54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_863048c2-9955-45e1-b8a7-a4701b332302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_863048c2-9955-45e1-b8a7-a4701b332302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_82a5e655-1258-429d-852b-efed9d71cab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_82a5e655-1258-429d-852b-efed9d71cab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5be709b5-bd50-43b0-80cf-46a279955bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_139a3c91-805c-48ac-a604-23005f232e05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5be709b5-bd50-43b0-80cf-46a279955bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f290e49b-cd2e-4ac5-a787-0caa9eba778f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_84801f77-4872-45e5-ab27-eff6d2c8016a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f290e49b-cd2e-4ac5-a787-0caa9eba778f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_84801f77-4872-45e5-ab27-eff6d2c8016a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4590f125-60b6-44d5-9192-0641618e1160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_84801f77-4872-45e5-ab27-eff6d2c8016a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4590f125-60b6-44d5-9192-0641618e1160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f210a080-3b3b-4d46-b7cc-00ac7a3bc1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4590f125-60b6-44d5-9192-0641618e1160" xlink:to="loc_us-gaap_SegmentDomain_f210a080-3b3b-4d46-b7cc-00ac7a3bc1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_0bfbe2b4-eaa0-4e9f-8be4-5ff2d9d50db1" xlink:href="clx-20230331.xsd#clx_HealthAndWellnessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f210a080-3b3b-4d46-b7cc-00ac7a3bc1d7" xlink:to="loc_clx_HealthAndWellnessMember_0bfbe2b4-eaa0-4e9f-8be4-5ff2d9d50db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember_8aac5959-e2c3-4def-954c-003d242699e8" xlink:href="clx-20230331.xsd#clx_HouseholdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f210a080-3b3b-4d46-b7cc-00ac7a3bc1d7" xlink:to="loc_clx_HouseholdMember_8aac5959-e2c3-4def-954c-003d242699e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember_c85c3f78-a8b6-4e3f-9bdb-a6a287025982" xlink:href="clx-20230331.xsd#clx_LifestyleMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f210a080-3b3b-4d46-b7cc-00ac7a3bc1d7" xlink:to="loc_clx_LifestyleMember_c85c3f78-a8b6-4e3f-9bdb-a6a287025982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember_331ff5d1-16bd-4df5-9282-8d2b0872f0c7" xlink:href="clx-20230331.xsd#clx_InternationalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f210a080-3b3b-4d46-b7cc-00ac7a3bc1d7" xlink:to="loc_clx_InternationalMember_331ff5d1-16bd-4df5-9282-8d2b0872f0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_9e448b79-60ee-491d-83bc-b5a8fb37b941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_84801f77-4872-45e5-ab27-eff6d2c8016a" xlink:to="loc_us-gaap_GoodwillLineItems_9e448b79-60ee-491d-83bc-b5a8fb37b941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_68cd2cb6-0bf5-48eb-a1e1-23a2cb228a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9e448b79-60ee-491d-83bc-b5a8fb37b941" xlink:to="loc_us-gaap_GoodwillRollForward_68cd2cb6-0bf5-48eb-a1e1-23a2cb228a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b1d78900-8fe3-4fdd-900d-52c0765a916e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_68cd2cb6-0bf5-48eb-a1e1-23a2cb228a92" xlink:to="loc_us-gaap_Goodwill_b1d78900-8fe3-4fdd-900d-52c0765a916e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_a7fb2393-ff3e-45a7-a30a-730288d3402c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_68cd2cb6-0bf5-48eb-a1e1-23a2cb228a92" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_a7fb2393-ff3e-45a7-a30a-730288d3402c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_90f95578-ed81-4b9b-a968-85f7e6f70c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_68cd2cb6-0bf5-48eb-a1e1-23a2cb228a92" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_90f95578-ed81-4b9b-a968-85f7e6f70c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fd2de46d-a4cd-4282-89c2-b8ad15a53562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_68cd2cb6-0bf5-48eb-a1e1-23a2cb228a92" xlink:to="loc_us-gaap_Goodwill_fd2de46d-a4cd-4282-89c2-b8ad15a53562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_97b5d756-c1d2-4b23-8b18-1e1f1d836246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_830907f9-3a6e-4999-ab39-9cc851ebdbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_97b5d756-c1d2-4b23-8b18-1e1f1d836246" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_830907f9-3a6e-4999-ab39-9cc851ebdbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_736de8fd-1bd7-4c03-85e6-b879278629c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_830907f9-3a6e-4999-ab39-9cc851ebdbcb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_736de8fd-1bd7-4c03-85e6-b879278629c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_66896abf-1f4d-4886-b09c-e9ffb5b18aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_736de8fd-1bd7-4c03-85e6-b879278629c4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_66896abf-1f4d-4886-b09c-e9ffb5b18aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_cb413286-f558-497e-a28f-169445bdc87a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_66896abf-1f4d-4886-b09c-e9ffb5b18aff" xlink:to="loc_us-gaap_TrademarksMember_cb413286-f558-497e-a28f-169445bdc87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_84024647-7e1d-4c1c-be39-54c71d20675f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_66896abf-1f4d-4886-b09c-e9ffb5b18aff" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_84024647-7e1d-4c1c-be39-54c71d20675f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9ccc713d-1c09-4259-9f80-144d6d041389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_830907f9-3a6e-4999-ab39-9cc851ebdbcb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9ccc713d-1c09-4259-9f80-144d6d041389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_45cb0554-d44c-463a-adf9-51a46653be58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9ccc713d-1c09-4259-9f80-144d6d041389" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_45cb0554-d44c-463a-adf9-51a46653be58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_dbbd90c2-ebd1-4de0-b8bb-6c4485751ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_45cb0554-d44c-463a-adf9-51a46653be58" xlink:to="loc_us-gaap_TrademarksMember_dbbd90c2-ebd1-4de0-b8bb-6c4485751ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_830907f9-3a6e-4999-ab39-9cc851ebdbcb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_14a51dd9-375d-4d05-8de2-c89169a5de45" xlink:href="clx-20230331.xsd#clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_14a51dd9-375d-4d05-8de2-c89169a5de45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_8bb079c8-bfdf-4efc-8ad8-b0c9d2108470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_8bb079c8-bfdf-4efc-8ad8-b0c9d2108470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9393eab4-3ec1-4427-93f7-baf5c01524b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9393eab4-3ec1-4427-93f7-baf5c01524b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_290d7f20-b36c-4eeb-83d9-78ea06af6f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_290d7f20-b36c-4eeb-83d9-78ea06af6f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_48f75516-f3fc-4167-8a80-7a2aa8c7a145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_48f75516-f3fc-4167-8a80-7a2aa8c7a145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6a830be1-ae7b-4eb7-b9dd-b8a0df62e458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6a830be1-ae7b-4eb7-b9dd-b8a0df62e458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_49a7b332-7847-46f8-a857-654af814e98f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_49a7b332-7847-46f8-a857-654af814e98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_373a35bd-4448-4ed1-a373-5c1e5f59dc18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7b763833-6194-4c29-ae60-6f12c8d57710" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_373a35bd-4448-4ed1-a373-5c1e5f59dc18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="clx-20230331.xsd#GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails_1"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#OTHERLIABILITIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_f867a1ea-992c-4631-91dc-7f3fcaf38ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_823fdc73-5ccc-4159-9286-65d7c37dbcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_f867a1ea-992c-4631-91dc-7f3fcaf38ce5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_823fdc73-5ccc-4159-9286-65d7c37dbcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_46c97344-b49b-4944-810d-626688220d57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_823fdc73-5ccc-4159-9286-65d7c37dbcc0" xlink:to="loc_srt_CounterpartyNameAxis_46c97344-b49b-4944-810d-626688220d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_30cefd12-6e4d-4994-9d46-ffd8e01e71c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_46c97344-b49b-4944-810d-626688220d57" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_30cefd12-6e4d-4994-9d46-ffd8e01e71c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_GladBusinessMember_7304fdeb-57ba-46af-a7fc-98428de68b73" xlink:href="clx-20230331.xsd#clx_GladBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_30cefd12-6e4d-4994-9d46-ffd8e01e71c7" xlink:to="loc_clx_GladBusinessMember_7304fdeb-57ba-46af-a7fc-98428de68b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_1afeaf00-5e0b-4e33-ab7e-85fa93273880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_823fdc73-5ccc-4159-9286-65d7c37dbcc0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_1afeaf00-5e0b-4e33-ab7e-85fa93273880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_PercentageofOwnershipbyVenturePartner_6184c8d1-835a-4b7d-a751-7d119de1faec" xlink:href="clx-20230331.xsd#clx_PercentageofOwnershipbyVenturePartner"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1afeaf00-5e0b-4e33-ab7e-85fa93273880" xlink:to="loc_clx_PercentageofOwnershipbyVenturePartner_6184c8d1-835a-4b7d-a751-7d119de1faec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VentureAgreementOptiontoExtendAgreementTermPeriod_e74f118b-4a58-449b-8891-d618f7bb50cf" xlink:href="clx-20230331.xsd#clx_VentureAgreementOptiontoExtendAgreementTermPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1afeaf00-5e0b-4e33-ab7e-85fa93273880" xlink:to="loc_clx_VentureAgreementOptiontoExtendAgreementTermPeriod_e74f118b-4a58-449b-8891-d618f7bb50cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VentureAgreement.TerminalObligation_3d64d821-1d73-4e3c-9fad-c96916c6027d" xlink:href="clx-20230331.xsd#clx_VentureAgreement.TerminalObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1afeaf00-5e0b-4e33-ab7e-85fa93273880" xlink:to="loc_clx_VentureAgreement.TerminalObligation_3d64d821-1d73-4e3c-9fad-c96916c6027d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VentureAgreementTerminalObligationNet_9280b075-df08-4fba-ac35-3ed75a82079e" xlink:href="clx-20230331.xsd#clx_VentureAgreementTerminalObligationNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1afeaf00-5e0b-4e33-ab7e-85fa93273880" xlink:to="loc_clx_VentureAgreementTerminalObligationNet_9280b075-df08-4fba-ac35-3ed75a82079e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_594d3a2b-c614-4824-b9fc-bf8c3fe8e838" xlink:href="clx-20230331.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_5fd35da7-ac9e-4ae7-92df-eac99b2e8190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_594d3a2b-c614-4824-b9fc-bf8c3fe8e838" xlink:to="loc_us-gaap_DerivativeTable_5fd35da7-ac9e-4ae7-92df-eac99b2e8190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsAxis_67ce5bea-ca9d-4c93-84c8-767750073803" xlink:href="clx-20230331.xsd#clx_CommodityPurchaseDerivativeContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5fd35da7-ac9e-4ae7-92df-eac99b2e8190" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsAxis_67ce5bea-ca9d-4c93-84c8-767750073803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsDomain_8acfc93a-65b2-4b89-b732-c6f1b2fe8fe3" xlink:href="clx-20230331.xsd#clx_CommodityPurchaseDerivativeContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsAxis_67ce5bea-ca9d-4c93-84c8-767750073803" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsDomain_8acfc93a-65b2-4b89-b732-c6f1b2fe8fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TotalCommodityPurchaseDerivativeContractsMember_cfd313f5-2abe-47cf-8a49-76b29fbf4528" xlink:href="clx-20230331.xsd#clx_TotalCommodityPurchaseDerivativeContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsDomain_8acfc93a-65b2-4b89-b732-c6f1b2fe8fe3" xlink:to="loc_clx_TotalCommodityPurchaseDerivativeContractsMember_cfd313f5-2abe-47cf-8a49-76b29fbf4528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_83453e97-e37c-4495-b395-9e98a936af3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5fd35da7-ac9e-4ae7-92df-eac99b2e8190" xlink:to="loc_us-gaap_TransactionTypeAxis_83453e97-e37c-4495-b395-9e98a936af3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_d65d9e05-c9a8-4ef2-9f8e-4b2a838890fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionTypeAxis_83453e97-e37c-4495-b395-9e98a936af3e" xlink:to="loc_us-gaap_TransactionDomain_d65d9e05-c9a8-4ef2-9f8e-4b2a838890fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_PurchasesofInventoryMember_4f97f68b-20c5-4216-9a6a-885e3809d60d" xlink:href="clx-20230331.xsd#clx_PurchasesofInventoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionDomain_d65d9e05-c9a8-4ef2-9f8e-4b2a838890fd" xlink:to="loc_clx_PurchasesofInventoryMember_4f97f68b-20c5-4216-9a6a-885e3809d60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_913bfb67-8ce8-4805-952f-b3ff07933ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5fd35da7-ac9e-4ae7-92df-eac99b2e8190" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_913bfb67-8ce8-4805-952f-b3ff07933ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ac92a9d7-4153-4225-8591-d993edbdf89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_913bfb67-8ce8-4805-952f-b3ff07933ac0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ac92a9d7-4153-4225-8591-d993edbdf89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_438ebe27-7800-4b8e-b65a-13352e46a847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac92a9d7-4153-4225-8591-d993edbdf89e" xlink:to="loc_us-gaap_ForeignExchangeContractMember_438ebe27-7800-4b8e-b65a-13352e46a847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_8f907a4a-74e0-4ea2-b64b-7eb2ba987706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac92a9d7-4153-4225-8591-d993edbdf89e" xlink:to="loc_us-gaap_CommodityContractMember_8f907a4a-74e0-4ea2-b64b-7eb2ba987706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5fd35da7-ac9e-4ae7-92df-eac99b2e8190" xlink:to="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_6b16af8f-bb62-4cf5-9f99-ef78dc3e38d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_6b16af8f-bb62-4cf5-9f99-ef78dc3e38d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_3cb991d2-c624-4986-9cdc-3a67f903fef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_DerivativeNotionalAmount_3cb991d2-c624-4986-9cdc-3a67f903fef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_e053463e-12c9-4832-bf9a-f6b21172db38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_e053463e-12c9-4832-bf9a-f6b21172db38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_54d3137c-adee-4e57-a4ca-c6c427277e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_54d3137c-adee-4e57-a4ca-c6c427277e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_9a731330-b02a-45f2-a803-4fbd21be36c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_9a731330-b02a-45f2-a803-4fbd21be36c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount_0dd8e6fe-2779-4761-86eb-f3cb810be459" xlink:href="clx-20230331.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount_0dd8e6fe-2779-4761-86eb-f3cb810be459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarginDepositAssets_cb53ec61-18bc-42f3-bba5-3683e0ca525d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarginDepositAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_MarginDepositAssets_cb53ec61-18bc-42f3-bba5-3683e0ca525d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_a4ad8452-1701-4760-a6e8-2e33bb7da209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_AssetImpairmentCharges_a4ad8452-1701-4760-a6e8-2e33bb7da209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_069b0c0e-ad5f-446a-a9ec-7ac6e20139de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_069b0c0e-ad5f-446a-a9ec-7ac6e20139de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_25d92855-060b-4ef7-b17f-8e7309e1044a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_40d44cd3-95b3-4e68-9114-71a4b27d0052" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_25d92855-060b-4ef7-b17f-8e7309e1044a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_0b97b25a-5249-4319-82a9-b1aa6e1c7a05" xlink:href="clx-20230331.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5d5c4d32-4471-4ace-9763-4405df5e2274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_0b97b25a-5249-4319-82a9-b1aa6e1c7a05" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5d5c4d32-4471-4ace-9763-4405df5e2274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_713bfb05-7e1d-4394-9ff9-462ee2e032e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5d5c4d32-4471-4ace-9763-4405df5e2274" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_713bfb05-7e1d-4394-9ff9-462ee2e032e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d143dc1c-5650-4dee-8ec4-a4311cce7a82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_713bfb05-7e1d-4394-9ff9-462ee2e032e9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d143dc1c-5650-4dee-8ec4-a4311cce7a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_ea3991ed-2267-4883-ae54-29f0e7cb7596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d143dc1c-5650-4dee-8ec4-a4311cce7a82" xlink:to="loc_us-gaap_CommodityContractMember_ea3991ed-2267-4883-ae54-29f0e7cb7596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_08f4feb6-c175-4bf6-8ea3-131b5eb6e41d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d143dc1c-5650-4dee-8ec4-a4311cce7a82" xlink:to="loc_us-gaap_ForeignExchangeContractMember_08f4feb6-c175-4bf6-8ea3-131b5eb6e41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_7469c94f-8e30-4140-9955-af27a464ab33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d143dc1c-5650-4dee-8ec4-a4311cce7a82" xlink:to="loc_us-gaap_InterestRateContractMember_7469c94f-8e30-4140-9955-af27a464ab33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_07f0def8-da2a-458e-a447-1a28d2f1f15d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5d5c4d32-4471-4ace-9763-4405df5e2274" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_07f0def8-da2a-458e-a447-1a28d2f1f15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e6fb63c6-dfe4-4540-b01e-391790cefe69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_07f0def8-da2a-458e-a447-1a28d2f1f15d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e6fb63c6-dfe4-4540-b01e-391790cefe69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_74492f21-0b02-4c50-9ff2-551032786afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_07f0def8-da2a-458e-a447-1a28d2f1f15d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_74492f21-0b02-4c50-9ff2-551032786afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_b363d3e8-24cb-45a5-b3d8-8bd1678e018a" xlink:href="clx-20230331.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_16a4c698-ea35-4291-83d9-2c00d9b18f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_b363d3e8-24cb-45a5-b3d8-8bd1678e018a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_16a4c698-ea35-4291-83d9-2c00d9b18f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3e72ef59-0af9-4331-9bad-1fa467642cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_16a4c698-ea35-4291-83d9-2c00d9b18f5b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3e72ef59-0af9-4331-9bad-1fa467642cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_18eb024c-02f4-48ec-b9bd-bc89125dd179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3e72ef59-0af9-4331-9bad-1fa467642cf5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_18eb024c-02f4-48ec-b9bd-bc89125dd179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_589c65c7-b6d9-4362-8078-d10d756f47c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_18eb024c-02f4-48ec-b9bd-bc89125dd179" xlink:to="loc_us-gaap_CommodityContractMember_589c65c7-b6d9-4362-8078-d10d756f47c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_d738769e-d9b0-4b91-aabc-81afc8de0bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_18eb024c-02f4-48ec-b9bd-bc89125dd179" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_d738769e-d9b0-4b91-aabc-81afc8de0bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_193c47c4-03f6-4cc0-9855-409ef1d6c64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_16a4c698-ea35-4291-83d9-2c00d9b18f5b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_193c47c4-03f6-4cc0-9855-409ef1d6c64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eeb1096c-f5b1-47a3-8ae1-051366349193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_193c47c4-03f6-4cc0-9855-409ef1d6c64b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eeb1096c-f5b1-47a3-8ae1-051366349193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c6e2d24c-3790-41eb-8e9b-f379255e7c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eeb1096c-f5b1-47a3-8ae1-051366349193" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c6e2d24c-3790-41eb-8e9b-f379255e7c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f777a5d0-8baa-4028-b600-38358f7b0648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eeb1096c-f5b1-47a3-8ae1-051366349193" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f777a5d0-8baa-4028-b600-38358f7b0648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_c19f27bd-ef4d-4738-9d2a-7ea16891e3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_16a4c698-ea35-4291-83d9-2c00d9b18f5b" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_c19f27bd-ef4d-4738-9d2a-7ea16891e3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3d817c92-fb4d-4c73-b799-95910678a0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_c19f27bd-ef4d-4738-9d2a-7ea16891e3e1" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3d817c92-fb4d-4c73-b799-95910678a0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cedb93b2-b854-427b-b078-57b2ed8a99b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3d817c92-fb4d-4c73-b799-95910678a0c8" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cedb93b2-b854-427b-b078-57b2ed8a99b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_6b534d5c-f9e1-4872-b645-3f27e759a979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cedb93b2-b854-427b-b078-57b2ed8a99b3" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_6b534d5c-f9e1-4872-b645-3f27e759a979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_ad358300-8db3-405e-b2a9-eb7c920a0458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cedb93b2-b854-427b-b078-57b2ed8a99b3" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_ad358300-8db3-405e-b2a9-eb7c920a0458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d4fbe4cd-e38d-48bc-9793-7c860c0c0b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_16a4c698-ea35-4291-83d9-2c00d9b18f5b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d4fbe4cd-e38d-48bc-9793-7c860c0c0b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_eba211f1-7aea-4a51-86c6-1241f15a5896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d4fbe4cd-e38d-48bc-9793-7c860c0c0b38" xlink:to="loc_us-gaap_DerivativeAssets_eba211f1-7aea-4a51-86c6-1241f15a5896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_ceccaf56-79f2-4a48-b33e-c83020971551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d4fbe4cd-e38d-48bc-9793-7c860c0c0b38" xlink:to="loc_us-gaap_DerivativeLiabilities_ceccaf56-79f2-4a48-b33e-c83020971551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_99929d8b-4854-48f7-8b08-0b48441c0335" xlink:href="clx-20230331.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_99929d8b-4854-48f7-8b08-0b48441c0335" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_ade3788b-a8ad-465b-855f-e3cdfc5274af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_ade3788b-a8ad-465b-855f-e3cdfc5274af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6388c58-79c2-4152-9c75-aaf1ecbbab61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_ade3788b-a8ad-465b-855f-e3cdfc5274af" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6388c58-79c2-4152-9c75-aaf1ecbbab61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_2f4f9e81-9392-45f2-8d02-1f680b1cd709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6388c58-79c2-4152-9c75-aaf1ecbbab61" xlink:to="loc_us-gaap_MoneyMarketFundsMember_2f4f9e81-9392-45f2-8d02-1f680b1cd709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_fb237906-98bb-48bc-bbce-f946d65e81ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6388c58-79c2-4152-9c75-aaf1ecbbab61" xlink:to="loc_us-gaap_BankTimeDepositsMember_fb237906-98bb-48bc-bbce-f946d65e81ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_32d4cb62-006b-4510-874d-c29867595ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_32d4cb62-006b-4510-874d-c29867595ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f416504-b10e-4f50-96e0-95acd41d5371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_32d4cb62-006b-4510-874d-c29867595ae9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f416504-b10e-4f50-96e0-95acd41d5371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d0ef8f50-7f5b-43ab-97f2-d772038da5af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f416504-b10e-4f50-96e0-95acd41d5371" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d0ef8f50-7f5b-43ab-97f2-d772038da5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_dfe02d15-f905-4dec-aa1a-9e2a0fc4fb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f416504-b10e-4f50-96e0-95acd41d5371" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_dfe02d15-f905-4dec-aa1a-9e2a0fc4fb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_5e655c6c-0823-497b-b8c5-61e6c1de0894" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_5e655c6c-0823-497b-b8c5-61e6c1de0894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_97dbaab6-0906-4cc4-bfa6-44f096e77b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_5e655c6c-0823-497b-b8c5-61e6c1de0894" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_97dbaab6-0906-4cc4-bfa6-44f096e77b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e5a200e2-d407-4459-9eaf-b10b15cd8e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_97dbaab6-0906-4cc4-bfa6-44f096e77b98" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e5a200e2-d407-4459-9eaf-b10b15cd8e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_3a20806b-8e95-4756-88f9-f61c61209881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e5a200e2-d407-4459-9eaf-b10b15cd8e80" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_3a20806b-8e95-4756-88f9-f61c61209881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_df1c0670-666f-4703-ba95-615ba6f512ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e5a200e2-d407-4459-9eaf-b10b15cd8e80" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_df1c0670-666f-4703-ba95-615ba6f512ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_08bb985c-14cd-453b-932f-bc43eac3729d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:to="loc_us-gaap_InvestmentTypeAxis_08bb985c-14cd-453b-932f-bc43eac3729d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_146a8dbe-f72d-4108-9cd0-501b42a51d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_08bb985c-14cd-453b-932f-bc43eac3729d" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_146a8dbe-f72d-4108-9cd0-501b42a51d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_7a6eadd8-d54b-4c81-99aa-feca57b699ad" xlink:href="clx-20230331.xsd#clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_146a8dbe-f72d-4108-9cd0-501b42a51d2a" xlink:to="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_7a6eadd8-d54b-4c81-99aa-feca57b699ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_1cf6759d-305c-4aba-b793-f057a74db51f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_1cf6759d-305c-4aba-b793-f057a74db51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_6e441d57-7b07-4a6d-8ea8-153affdd2d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1cf6759d-305c-4aba-b793-f057a74db51f" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_6e441d57-7b07-4a6d-8ea8-153affdd2d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NotesAndLoansPayableMember_b01f33d5-80c9-4e58-87c7-d273636e4865" xlink:href="clx-20230331.xsd#clx_NotesAndLoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_6e441d57-7b07-4a6d-8ea8-153affdd2d78" xlink:to="loc_clx_NotesAndLoansPayableMember_b01f33d5-80c9-4e58-87c7-d273636e4865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c683bc93-8c8b-46c7-92b7-2992ba836c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c683bc93-8c8b-46c7-92b7-2992ba836c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1081e94a-c3e5-4abb-8d97-eaeb6f774721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c683bc93-8c8b-46c7-92b7-2992ba836c18" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1081e94a-c3e5-4abb-8d97-eaeb6f774721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_4fecd52a-7869-4688-b4cd-333e68df9b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1081e94a-c3e5-4abb-8d97-eaeb6f774721" xlink:to="loc_us-gaap_LongTermDebtMember_4fecd52a-7869-4688-b4cd-333e68df9b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4726553e-e179-48b2-bb8b-b42b31212aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_708f8d62-f5fb-4ba5-add6-979448a6f5db" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4726553e-e179-48b2-bb8b-b42b31212aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4726553e-e179-48b2-bb8b-b42b31212aee" xlink:to="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f5a4a746-16ff-4000-9c65-1a5c83e6612c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f5a4a746-16ff-4000-9c65-1a5c83e6612c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_540296ca-a695-4f94-84e7-d117061b0e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_540296ca-a695-4f94-84e7-d117061b0e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_f5003a73-ca31-4ab1-914d-06cb63dc7bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_f5003a73-ca31-4ab1-914d-06cb63dc7bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_f920ffed-4550-408c-9e71-b36b0570614d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_f920ffed-4550-408c-9e71-b36b0570614d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3a6e3383-4c08-4ad8-8a1f-0919e594ad08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:to="loc_us-gaap_Assets_3a6e3383-4c08-4ad8-8a1f-0919e594ad08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_381be3db-34b3-4dde-80a7-e8cb08182add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99dd3a70-85ab-4aa9-b4dc-526d4a9cbece" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_381be3db-34b3-4dde-80a7-e8cb08182add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4726553e-e179-48b2-bb8b-b42b31212aee" xlink:to="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_edd59e6f-0e13-473e-a5d6-e471a3863805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:to="loc_us-gaap_CommercialPaper_edd59e6f-0e13-473e-a5d6-e471a3863805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue_3ea10636-a0c5-4510-a31a-86ee4a6dacc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:to="loc_us-gaap_ShorttermDebtFairValue_3ea10636-a0c5-4510-a31a-86ee4a6dacc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_96bd43cf-bb44-4482-84a4-a960b1391587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:to="loc_us-gaap_LongTermDebt_96bd43cf-bb44-4482-84a4-a960b1391587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_b6cfb0d0-2756-4dcb-a148-59e9f8f53251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:to="loc_us-gaap_DebtInstrumentFairValue_b6cfb0d0-2756-4dcb-a148-59e9f8f53251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_02fe4ff1-e5ca-4dc0-b734-09d438a41546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:to="loc_us-gaap_Liabilities_02fe4ff1-e5ca-4dc0-b734-09d438a41546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_bf62d65f-80e5-4657-9f42-d73e2889f7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6d8f063c-d55d-406d-adbc-c441c4c3eee2" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_bf62d65f-80e5-4657-9f42-d73e2889f7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f192835d-ddb7-4759-aec2-8e33d2f4aad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ac751488-4aec-45e0-b02b-a0f69cec3186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f192835d-ddb7-4759-aec2-8e33d2f4aad3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ac751488-4aec-45e0-b02b-a0f69cec3186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5458c665-78af-4af4-861b-e64f5a4f638c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3ccfa09b-01a5-439d-94bd-a5b6e4830fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5458c665-78af-4af4-861b-e64f5a4f638c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3ccfa09b-01a5-439d-94bd-a5b6e4830fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_332dd3b1-2eae-4000-8397-fcf63dc5b3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5458c665-78af-4af4-861b-e64f5a4f638c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_332dd3b1-2eae-4000-8397-fcf63dc5b3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cd7edb19-e369-4f76-90c1-ea0f4202b6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5458c665-78af-4af4-861b-e64f5a4f638c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cd7edb19-e369-4f76-90c1-ea0f4202b6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2ef354d0-63ca-4226-9087-1bf3f3b298df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5458c665-78af-4af4-861b-e64f5a4f638c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2ef354d0-63ca-4226-9087-1bf3f3b298df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_9f8d82c5-98b9-4faf-8fe1-2a1fe3c7c4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f68ab650-30c0-470c-9a13-fa2445bd08ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_9f8d82c5-98b9-4faf-8fe1-2a1fe3c7c4af" xlink:to="loc_us-gaap_ProfitLoss_f68ab650-30c0-470c-9a13-fa2445bd08ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bcc51caa-1e18-43ce-b978-7bb09a91a28d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_9f8d82c5-98b9-4faf-8fe1-2a1fe3c7c4af" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bcc51caa-1e18-43ce-b978-7bb09a91a28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_25305731-7894-48f1-8088-5ffff9e8845a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bcc51caa-1e18-43ce-b978-7bb09a91a28d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_25305731-7894-48f1-8088-5ffff9e8845a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_de95ae09-0907-4cd1-abc0-376ae9826bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bcc51caa-1e18-43ce-b978-7bb09a91a28d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_de95ae09-0907-4cd1-abc0-376ae9826bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_cf55bbb1-e9e4-4f28-a310-bebb448e376f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bcc51caa-1e18-43ce-b978-7bb09a91a28d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_cf55bbb1-e9e4-4f28-a310-bebb448e376f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3f39e893-0560-4fa4-aece-26fb45ffe2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bcc51caa-1e18-43ce-b978-7bb09a91a28d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3f39e893-0560-4fa4-aece-26fb45ffe2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9d66b0bf-72c6-41c3-ac8c-b0a6dc201841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_9f8d82c5-98b9-4faf-8fe1-2a1fe3c7c4af" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9d66b0bf-72c6-41c3-ac8c-b0a6dc201841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8aba946a-52b1-4959-84c7-29b157133c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_9f8d82c5-98b9-4faf-8fe1-2a1fe3c7c4af" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8aba946a-52b1-4959-84c7-29b157133c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f4f1e20d-d08c-4657-9397-c0cffe876185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_9f8d82c5-98b9-4faf-8fe1-2a1fe3c7c4af" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_f4f1e20d-d08c-4657-9397-c0cffe876185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#STOCKHOLDERSEQUITYScheduleofEquityDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e0f9478e-f16d-4ddb-9372-01900d120214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ad37f150-8ad5-4b0e-bd29-784a28967fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e0f9478e-f16d-4ddb-9372-01900d120214" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ad37f150-8ad5-4b0e-bd29-784a28967fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7fa0ed83-367e-4f4e-bf14-23009827f6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ad37f150-8ad5-4b0e-bd29-784a28967fd3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7fa0ed83-367e-4f4e-bf14-23009827f6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7fa0ed83-367e-4f4e-bf14-23009827f6d9" xlink:to="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b2c985c0-253f-4b1a-9ff0-685a66b868ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:to="loc_us-gaap_CommonStockMember_b2c985c0-253f-4b1a-9ff0-685a66b868ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_28f794fe-23f2-420b-8356-02b8ac23d5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_28f794fe-23f2-420b-8356-02b8ac23d5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_ba44e540-6668-4975-9caa-c7f612168781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:to="loc_us-gaap_RetainedEarningsMember_ba44e540-6668-4975-9caa-c7f612168781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_5bae100f-50b5-476c-a4c9-63c7a56b81cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:to="loc_us-gaap_TreasuryStockCommonMember_5bae100f-50b5-476c-a4c9-63c7a56b81cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eaa9f099-401a-48e8-a5f4-77ac360442ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eaa9f099-401a-48e8-a5f4-77ac360442ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_6448deb7-78e7-4ca5-ac34-630314a46f24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ceee7da8-5fa9-4349-b7d7-8aa700a1b772" xlink:to="loc_us-gaap_NoncontrollingInterestMember_6448deb7-78e7-4ca5-ac34-630314a46f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_2fe0783a-f485-4442-ab1b-7178efd6a98c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ad37f150-8ad5-4b0e-bd29-784a28967fd3" xlink:to="loc_us-gaap_ClassOfStockLineItems_2fe0783a-f485-4442-ab1b-7178efd6a98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_9e0284e5-5a30-4fa7-95e9-3ed2dee8fffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_2fe0783a-f485-4442-ab1b-7178efd6a98c" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_9e0284e5-5a30-4fa7-95e9-3ed2dee8fffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_2fe0783a-f485-4442-ab1b-7178efd6a98c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cff6f4f2-4486-4bd4-b9f6-f452b11ad539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cff6f4f2-4486-4bd4-b9f6-f452b11ad539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_cd07fdd7-c451-4764-accc-40dee45f8298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_cd07fdd7-c451-4764-accc-40dee45f8298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_04a75150-f872-43ab-bc71-708f3e2e5e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_TreasuryStockCommonShares_04a75150-f872-43ab-bc71-708f3e2e5e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1968d5f7-01b3-470f-8b32-91a708daa3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_ProfitLoss_1968d5f7-01b3-470f-8b32-91a708daa3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5d5d4a1a-7d25-46be-8d17-10611fab6009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5d5d4a1a-7d25-46be-8d17-10611fab6009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_89c1aa14-150e-43ba-a6f1-e19bda509fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_Dividends_89c1aa14-150e-43ba-a6f1-e19bda509fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_eea223d1-3424-4875-a335-46a0504fc59b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_eea223d1-3424-4875-a335-46a0504fc59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c8f53123-a839-4690-9210-a59e2d111fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c8f53123-a839-4690-9210-a59e2d111fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesAmount_fddf9389-ea16-47b4-86ed-a5fcb85b915d" xlink:href="clx-20230331.xsd#clx_OtherEmployeeStockPlanActivitiesAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_clx_OtherEmployeeStockPlanActivitiesAmount_fddf9389-ea16-47b4-86ed-a5fcb85b915d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesShares_e098308d-ba3c-4c4d-b3ab-8b35202866bd" xlink:href="clx-20230331.xsd#clx_OtherEmployeeStockPlanActivitiesShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_clx_OtherEmployeeStockPlanActivitiesShares_e098308d-ba3c-4c4d-b3ab-8b35202866bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_a7a8fb5c-f23d-400e-bb79-05874cca743b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_a7a8fb5c-f23d-400e-bb79-05874cca743b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_2c03e903-b530-4fed-9871-ce1cf514c204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_2c03e903-b530-4fed-9871-ce1cf514c204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f8c386f4-4438-4eec-b771-7cd235b80bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f8c386f4-4438-4eec-b771-7cd235b80bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_db69ea15-9230-45ed-b511-cf7e5465902c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_db69ea15-9230-45ed-b511-cf7e5465902c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_3e37bd5e-9945-48cb-87fb-12b80a75b908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34de17b7-813e-4c15-9261-e195230c2d7d" xlink:to="loc_us-gaap_TreasuryStockCommonShares_3e37bd5e-9945-48cb-87fb-12b80a75b908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_27b653d9-2fc8-4fd7-824c-61fa8931ed05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_86e6ed7d-ab1c-4657-a99e-172cbe27510b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_27b653d9-2fc8-4fd7-824c-61fa8931ed05" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_86e6ed7d-ab1c-4657-a99e-172cbe27510b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_16f711c8-0b96-4433-9da3-e1bc0ab29164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_86e6ed7d-ab1c-4657-a99e-172cbe27510b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_16f711c8-0b96-4433-9da3-e1bc0ab29164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8705d6c4-5cb1-4ba2-b41c-257f59ea5aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_16f711c8-0b96-4433-9da3-e1bc0ab29164" xlink:to="loc_us-gaap_EquityComponentDomain_8705d6c4-5cb1-4ba2-b41c-257f59ea5aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c50a75b0-56ef-452c-99e3-f07c9a188b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8705d6c4-5cb1-4ba2-b41c-257f59ea5aaf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c50a75b0-56ef-452c-99e3-f07c9a188b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f7b84186-a0ec-4f18-9673-4ee390eb6530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c50a75b0-56ef-452c-99e3-f07c9a188b9a" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f7b84186-a0ec-4f18-9673-4ee390eb6530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_1f43b1f9-3501-40b4-b7bf-a612b99c0721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c50a75b0-56ef-452c-99e3-f07c9a188b9a" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_1f43b1f9-3501-40b4-b7bf-a612b99c0721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f38ffc5d-06df-4e16-9035-e0313ab18024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c50a75b0-56ef-452c-99e3-f07c9a188b9a" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f38ffc5d-06df-4e16-9035-e0313ab18024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3f048a4c-f902-465b-899a-0c53f4b293ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_86e6ed7d-ab1c-4657-a99e-172cbe27510b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3f048a4c-f902-465b-899a-0c53f4b293ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3f048a4c-f902-465b-899a-0c53f4b293ab" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_97f53a24-da91-43e3-b7a8-3f9fa78dfb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:to="loc_us-gaap_StockholdersEquity_97f53a24-da91-43e3-b7a8-3f9fa78dfb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_5b35839f-d8e2-4147-a622-22a4ee077a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_5b35839f-d8e2-4147-a622-22a4ee077a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_6b6805d5-4b99-4854-aee8-80476592e361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_6b6805d5-4b99-4854-aee8-80476592e361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_42a0bc6e-aed7-4152-9aa1-2690f2e359bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_42a0bc6e-aed7-4152-9aa1-2690f2e359bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_52747f95-ab75-415c-a340-583d08fd5c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_52747f95-ab75-415c-a340-583d08fd5c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ab4152bb-c20f-4bf8-a696-275bd67add5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9b22a459-5dbc-43c0-adb3-9898e9ddf5ca" xlink:to="loc_us-gaap_StockholdersEquity_ab4152bb-c20f-4bf8-a696-275bd67add5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_21c1a0d6-5f9e-40dc-ae40-afd6ff7ed81f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7b45e4c6-c304-44a6-901f-30d8bcdaf24f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_21c1a0d6-5f9e-40dc-ae40-afd6ff7ed81f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7b45e4c6-c304-44a6-901f-30d8bcdaf24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_ef904a33-3113-48af-8dc9-e4efa7b224b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7b45e4c6-c304-44a6-901f-30d8bcdaf24f" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_ef904a33-3113-48af-8dc9-e4efa7b224b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_936c0781-02bb-44b3-bd94-585238b0eaba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_ef904a33-3113-48af-8dc9-e4efa7b224b2" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_936c0781-02bb-44b3-bd94-585238b0eaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LongTermInterCompanyLoansMember_9ed5f3a5-a131-494e-96c8-90fdfeb3ff3b" xlink:href="clx-20230331.xsd#clx_LongTermInterCompanyLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_936c0781-02bb-44b3-bd94-585238b0eaba" xlink:to="loc_clx_LongTermInterCompanyLoansMember_9ed5f3a5-a131-494e-96c8-90fdfeb3ff3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_74c3ef55-d3c9-4c2d-b77a-95ebcba6dd21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7b45e4c6-c304-44a6-901f-30d8bcdaf24f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_74c3ef55-d3c9-4c2d-b77a-95ebcba6dd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_f2055f8e-419e-413b-ab23-5c0ce2ca4320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_74c3ef55-d3c9-4c2d-b77a-95ebcba6dd21" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_f2055f8e-419e-413b-ab23-5c0ce2ca4320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#EMPLOYEEBENEFITPLANSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_63e135c4-6381-4d4c-aac9-797c643ec278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7ce6cf6f-a7cc-4089-8b2d-d24aebf36013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_63e135c4-6381-4d4c-aac9-797c643ec278" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7ce6cf6f-a7cc-4089-8b2d-d24aebf36013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_dc001127-a5ad-488d-bb8d-29909efdda54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7ce6cf6f-a7cc-4089-8b2d-d24aebf36013" xlink:to="loc_us-gaap_PlanNameAxis_dc001127-a5ad-488d-bb8d-29909efdda54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4a400258-7dbf-48da-a29f-d8c53ddb2b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_dc001127-a5ad-488d-bb8d-29909efdda54" xlink:to="loc_us-gaap_PlanNameDomain_4a400258-7dbf-48da-a29f-d8c53ddb2b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember_8a2d4eb8-d4e1-4fcd-874e-0784004a22a0" xlink:href="clx-20230331.xsd#clx_RetirementIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_4a400258-7dbf-48da-a29f-d8c53ddb2b73" xlink:to="loc_clx_RetirementIncomeMember_8a2d4eb8-d4e1-4fcd-874e-0784004a22a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_67af9d91-45a0-46f8-9880-2eb68a19add4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7ce6cf6f-a7cc-4089-8b2d-d24aebf36013" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_67af9d91-45a0-46f8-9880-2eb68a19add4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_d1124e5a-1da8-47de-b702-a299c6c66a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_67af9d91-45a0-46f8-9880-2eb68a19add4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_d1124e5a-1da8-47de-b702-a299c6c66a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_7af0b847-3776-44de-a15a-b028a6fd359a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_d1124e5a-1da8-47de-b702-a299c6c66a54" xlink:to="loc_us-gaap_DomesticPlanMember_7af0b847-3776-44de-a15a-b028a6fd359a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_66e23b74-78d8-4565-b7a2-19032c6cdd29" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_7af0b847-3776-44de-a15a-b028a6fd359a" xlink:to="loc_country_US_66e23b74-78d8-4565-b7a2-19032c6cdd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e4171213-1b53-4c16-825c-485428b8c55a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7ce6cf6f-a7cc-4089-8b2d-d24aebf36013" xlink:to="loc_srt_RangeAxis_e4171213-1b53-4c16-825c-485428b8c55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d086778c-865c-4435-9bf3-20d678df21a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e4171213-1b53-4c16-825c-485428b8c55a" xlink:to="loc_srt_RangeMember_d086778c-865c-4435-9bf3-20d678df21a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_360e7cc2-54c3-4756-b348-397d7c0a68b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d086778c-865c-4435-9bf3-20d678df21a2" xlink:to="loc_srt_MinimumMember_360e7cc2-54c3-4756-b348-397d7c0a68b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0e10a4c7-9f32-4197-9ceb-c6ec754d7eb0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d086778c-865c-4435-9bf3-20d678df21a2" xlink:to="loc_srt_MaximumMember_0e10a4c7-9f32-4197-9ceb-c6ec754d7eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e11f9c4c-c961-44cd-9b38-65c4ba166dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7ce6cf6f-a7cc-4089-8b2d-d24aebf36013" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e11f9c4c-c961-44cd-9b38-65c4ba166dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DefinedBenefitPlanPlanTerminationPeriod_0a4f2b10-1d00-471b-82e9-dcbf83617f64" xlink:href="clx-20230331.xsd#clx_DefinedBenefitPlanPlanTerminationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e11f9c4c-c961-44cd-9b38-65c4ba166dc3" xlink:to="loc_clx_DefinedBenefitPlanPlanTerminationPeriod_0a4f2b10-1d00-471b-82e9-dcbf83617f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_30f0c653-138b-4371-9258-93d7f77f54a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e11f9c4c-c961-44cd-9b38-65c4ba166dc3" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_30f0c653-138b-4371-9258-93d7f77f54a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_89d42fe1-569e-499d-b86e-4ec933a5c638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e11f9c4c-c961-44cd-9b38-65c4ba166dc3" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_89d42fe1-569e-499d-b86e-4ec933a5c638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_01cfc04d-46e1-41e3-a0e6-48a53560c634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e92c469b-a66e-46de-a675-351bf8c1a31c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_01cfc04d-46e1-41e3-a0e6-48a53560c634" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e92c469b-a66e-46de-a675-351bf8c1a31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_e7d340f5-b186-46e9-8ba2-0f6b0ea2c836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e92c469b-a66e-46de-a675-351bf8c1a31c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_e7d340f5-b186-46e9-8ba2-0f6b0ea2c836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a53811fa-ea4f-42f1-8198-b5bb831828a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e7d340f5-b186-46e9-8ba2-0f6b0ea2c836" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a53811fa-ea4f-42f1-8198-b5bb831828a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_98040a3e-8545-44e7-a6ed-7f98f881dba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a53811fa-ea4f-42f1-8198-b5bb831828a7" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_98040a3e-8545-44e7-a6ed-7f98f881dba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_05196c22-ede0-49b0-bd60-53181eec50aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e92c469b-a66e-46de-a675-351bf8c1a31c" xlink:to="loc_us-gaap_PlanNameAxis_05196c22-ede0-49b0-bd60-53181eec50aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8be9c460-53ff-4656-9c7e-6b4a579c232b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_05196c22-ede0-49b0-bd60-53181eec50aa" xlink:to="loc_us-gaap_PlanNameDomain_8be9c460-53ff-4656-9c7e-6b4a579c232b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember_348f9c69-814f-41a6-9924-7ddf6a578512" xlink:href="clx-20230331.xsd#clx_RetirementIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8be9c460-53ff-4656-9c7e-6b4a579c232b" xlink:to="loc_clx_RetirementIncomeMember_348f9c69-814f-41a6-9924-7ddf6a578512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e92c469b-a66e-46de-a675-351bf8c1a31c" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_806b2ffa-8d67-4a55-8a88-7269323f20f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_806b2ffa-8d67-4a55-8a88-7269323f20f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_707ad95a-62c1-4f93-acec-a2b0410a028f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_707ad95a-62c1-4f93-acec-a2b0410a028f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_59455a66-bb10-4f65-99d0-430a91c136f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_59455a66-bb10-4f65-99d0-430a91c136f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_b91404b2-97cf-4f7b-9534-3b4c247d157b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_b91404b2-97cf-4f7b-9534-3b4c247d157b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2fccf25b-f28a-492c-bfc0-9b4df7575546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2fccf25b-f28a-492c-bfc0-9b4df7575546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_ac34b072-1713-4d2c-a9fd-fd71e347c38f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3404521e-7921-4b6a-83b8-fb07e8072889" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_ac34b072-1713-4d2c-a9fd-fd71e347c38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#OTHERCONTINGENCIESANDGUARANTEESDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_622f8e58-3176-44f1-b0a4-ede0eaf1da8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_228a619a-390e-46fc-9c45-3ea397b2b7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_622f8e58-3176-44f1-b0a4-ede0eaf1da8c" xlink:to="loc_us-gaap_LossContingenciesTable_228a619a-390e-46fc-9c45-3ea397b2b7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_14573e61-ceae-401d-a2a9-7457b8954149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_228a619a-390e-46fc-9c45-3ea397b2b7fb" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_14573e61-ceae-401d-a2a9-7457b8954149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_397b62e5-26e7-445b-a40d-7f3b8c90545b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_14573e61-ceae-401d-a2a9-7457b8954149" xlink:to="loc_us-gaap_LossContingencyNatureDomain_397b62e5-26e7-445b-a40d-7f3b8c90545b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_AlamedaCountyCaliforniaMatterMember_8a153ce3-40fa-4b24-b538-8668ea485fd4" xlink:href="clx-20230331.xsd#clx_AlamedaCountyCaliforniaMatterMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_397b62e5-26e7-445b-a40d-7f3b8c90545b" xlink:to="loc_clx_AlamedaCountyCaliforniaMatterMember_8a153ce3-40fa-4b24-b538-8668ea485fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DickinsonCountyMichiganMatterMember_5964ad11-7625-4862-a3e7-c33771ce1b60" xlink:href="clx-20230331.xsd#clx_DickinsonCountyMichiganMatterMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_397b62e5-26e7-445b-a40d-7f3b8c90545b" xlink:to="loc_clx_DickinsonCountyMichiganMatterMember_5964ad11-7625-4862-a3e7-c33771ce1b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_228a619a-390e-46fc-9c45-3ea397b2b7fb" xlink:to="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_576f05ba-fa2a-46d2-9e29-5603de18fd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_576f05ba-fa2a-46d2-9e29-5603de18fd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RemediationPeriod_119fc0ba-3cf1-4770-ac91-1c7f94927267" xlink:href="clx-20230331.xsd#clx_RemediationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:to="loc_clx_RemediationPeriod_119fc0ba-3cf1-4770-ac91-1c7f94927267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_MaximumExposureUndiscountedCost_9e47dbba-1509-4e66-8067-6584fe596eb9" xlink:href="clx-20230331.xsd#clx_MaximumExposureUndiscountedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:to="loc_clx_MaximumExposureUndiscountedCost_9e47dbba-1509-4e66-8067-6584fe596eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_SiteContingencyAgreedPercentageOfCostSharing_fa88ef02-f4cd-4cf6-a5d6-3f0ad6ba0cc0" xlink:href="clx-20230331.xsd#clx_SiteContingencyAgreedPercentageOfCostSharing"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:to="loc_clx_SiteContingencyAgreedPercentageOfCostSharing_fa88ef02-f4cd-4cf6-a5d6-3f0ad6ba0cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LetterOfCreditBorrowingCapacity_443a8f96-9858-45c2-a690-b651a508fc4d" xlink:href="clx-20230331.xsd#clx_LetterOfCreditBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:to="loc_clx_LetterOfCreditBorrowingCapacity_443a8f96-9858-45c2-a690-b651a508fc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_473ca7e7-557d-45a6-b57b-68022413db35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e8c8de6-c967-46c2-b433-deb592165b4d" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_473ca7e7-557d-45a6-b57b-68022413db35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#SEGMENTRESULTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e8ccbbc7-7e2c-4b03-86ae-9b6abe0b66cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_27ee6ad1-3386-4c60-aac2-4da32f261da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e8ccbbc7-7e2c-4b03-86ae-9b6abe0b66cd" xlink:to="loc_us-gaap_ConcentrationRiskTable_27ee6ad1-3386-4c60-aac2-4da32f261da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1470a1e3-e7c5-472a-a9ba-3a752e2ffe18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_27ee6ad1-3386-4c60-aac2-4da32f261da9" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1470a1e3-e7c5-472a-a9ba-3a752e2ffe18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e971e3fb-fd09-4f0b-bd9c-bc8648a29741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1470a1e3-e7c5-472a-a9ba-3a752e2ffe18" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e971e3fb-fd09-4f0b-bd9c-bc8648a29741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_1e374bde-606a-4ba8-a53e-c7740cdb52a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e971e3fb-fd09-4f0b-bd9c-bc8648a29741" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_1e374bde-606a-4ba8-a53e-c7740cdb52a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_01ada067-78e3-4b96-98b2-2f5adea24215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_27ee6ad1-3386-4c60-aac2-4da32f261da9" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_01ada067-78e3-4b96-98b2-2f5adea24215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_48e53288-c6c5-4658-85d9-2273ed43907f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_01ada067-78e3-4b96-98b2-2f5adea24215" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_48e53288-c6c5-4658-85d9-2273ed43907f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_0fd76674-b14f-4c23-9e24-56ab4002a0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_48e53288-c6c5-4658-85d9-2273ed43907f" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_0fd76674-b14f-4c23-9e24-56ab4002a0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_c2a2da16-b161-4ff3-80be-0b9ddb457e0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_27ee6ad1-3386-4c60-aac2-4da32f261da9" xlink:to="loc_srt_MajorCustomersAxis_c2a2da16-b161-4ff3-80be-0b9ddb457e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_183f3d22-cb7f-49a5-a92d-28df6a2669a8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_c2a2da16-b161-4ff3-80be-0b9ddb457e0d" xlink:to="loc_srt_NameOfMajorCustomerDomain_183f3d22-cb7f-49a5-a92d-28df6a2669a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WalmartStoresIncMember_4d9646b4-1723-444e-8743-609f23857b22" xlink:href="clx-20230331.xsd#clx_WalmartStoresIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_183f3d22-cb7f-49a5-a92d-28df6a2669a8" xlink:to="loc_clx_WalmartStoresIncMember_4d9646b4-1723-444e-8743-609f23857b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_f87e5ec6-a837-4eb0-a80e-e877aba3fb27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_27ee6ad1-3386-4c60-aac2-4da32f261da9" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_f87e5ec6-a837-4eb0-a80e-e877aba3fb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_06a859ad-39e5-4675-b374-c1d0d783b458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f87e5ec6-a837-4eb0-a80e-e877aba3fb27" xlink:to="loc_us-gaap_NumberOfReportableSegments_06a859ad-39e5-4675-b374-c1d0d783b458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_a9a52dcc-57dc-4869-bd26-e7e18512e0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f87e5ec6-a837-4eb0-a80e-e877aba3fb27" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_a9a52dcc-57dc-4869-bd26-e7e18512e0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#SEGMENTRESULTSReportableSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cf453d05-20cf-48e2-a457-dd3bc3120216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cf453d05-20cf-48e2-a457-dd3bc3120216" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_2b1a3b58-a5c6-40e9-a55e-70bc612a17da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:to="loc_srt_ConsolidationItemsAxis_2b1a3b58-a5c6-40e9-a55e-70bc612a17da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c1d0a57a-b116-445f-b55d-d8e55a4368ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_2b1a3b58-a5c6-40e9-a55e-70bc612a17da" xlink:to="loc_srt_ConsolidationItemsDomain_c1d0a57a-b116-445f-b55d-d8e55a4368ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a3bef5b5-ecfb-4698-aac3-3d0ea8858dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c1d0a57a-b116-445f-b55d-d8e55a4368ca" xlink:to="loc_us-gaap_OperatingSegmentsMember_a3bef5b5-ecfb-4698-aac3-3d0ea8858dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_0ce9dec4-ccd2-4121-a1ab-9aa38e066450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c1d0a57a-b116-445f-b55d-d8e55a4368ca" xlink:to="loc_us-gaap_CorporateNonSegmentMember_0ce9dec4-ccd2-4121-a1ab-9aa38e066450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_473a29bf-bb7e-469b-86db-1d2e4d3198df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_473a29bf-bb7e-469b-86db-1d2e4d3198df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4e674fcb-1e71-4e8f-9a69-e2642a472ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_473a29bf-bb7e-469b-86db-1d2e4d3198df" xlink:to="loc_us-gaap_SegmentDomain_4e674fcb-1e71-4e8f-9a69-e2642a472ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_6efb235e-06f0-44c4-9568-e67cc4604b9d" xlink:href="clx-20230331.xsd#clx_HealthAndWellnessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4e674fcb-1e71-4e8f-9a69-e2642a472ba1" xlink:to="loc_clx_HealthAndWellnessMember_6efb235e-06f0-44c4-9568-e67cc4604b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember_e30f98b4-ab25-4a7a-b5a5-02f8efff8f5e" xlink:href="clx-20230331.xsd#clx_HouseholdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4e674fcb-1e71-4e8f-9a69-e2642a472ba1" xlink:to="loc_clx_HouseholdMember_e30f98b4-ab25-4a7a-b5a5-02f8efff8f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember_15624fd8-aba1-480b-a41e-513d389fb7ec" xlink:href="clx-20230331.xsd#clx_LifestyleMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4e674fcb-1e71-4e8f-9a69-e2642a472ba1" xlink:to="loc_clx_LifestyleMember_15624fd8-aba1-480b-a41e-513d389fb7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember_82435cdd-c717-49b6-af7e-f132648bf491" xlink:href="clx-20230331.xsd#clx_InternationalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4e674fcb-1e71-4e8f-9a69-e2642a472ba1" xlink:to="loc_clx_InternationalMember_82435cdd-c717-49b6-af7e-f132648bf491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0d460a40-3410-4c95-97cd-4425b3eae0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0d460a40-3410-4c95-97cd-4425b3eae0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_495cfb78-7b31-4217-932a-67cfa9f550d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0d460a40-3410-4c95-97cd-4425b3eae0c2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_495cfb78-7b31-4217-932a-67cfa9f550d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RestructuringAndRelatedCostsBenchmarkMember_78a3e470-5eb8-4530-a076-af345afda766" xlink:href="clx-20230331.xsd#clx_RestructuringAndRelatedCostsBenchmarkMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_495cfb78-7b31-4217-932a-67cfa9f550d0" xlink:to="loc_clx_RestructuringAndRelatedCostsBenchmarkMember_78a3e470-5eb8-4530-a076-af345afda766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_fdb3045d-90b2-4eee-a694-b1c9182481b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_fdb3045d-90b2-4eee-a694-b1c9182481b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ef2402f6-9842-4214-9e04-2e06d036c223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_fdb3045d-90b2-4eee-a694-b1c9182481b8" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ef2402f6-9842-4214-9e04-2e06d036c223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_b0bdcb01-c850-40fc-8fe8-e45554e3a102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ef2402f6-9842-4214-9e04-2e06d036c223" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_b0bdcb01-c850-40fc-8fe8-e45554e3a102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_1b9cd11b-021a-468c-9580-225850a45c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:to="loc_us-gaap_ReportingUnitAxis_1b9cd11b-021a-468c-9580-225850a45c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_7657958b-6af2-4034-bb06-a8bbc6767bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_1b9cd11b-021a-468c-9580-225850a45c7e" xlink:to="loc_us-gaap_ReportingUnitDomain_7657958b-6af2-4034-bb06-a8bbc6767bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsReportingUnitMember_a8281d18-0232-4e4a-b008-6be038a27855" xlink:href="clx-20230331.xsd#clx_VitaminsMineralsAndSupplementsReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_7657958b-6af2-4034-bb06-a8bbc6767bd5" xlink:to="loc_clx_VitaminsMineralsAndSupplementsReportingUnitMember_a8281d18-0232-4e4a-b008-6be038a27855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalReportingUnitMember_318d35c2-6b31-4d76-b11f-1ce1de4b84b1" xlink:href="clx-20230331.xsd#clx_InternationalReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_7657958b-6af2-4034-bb06-a8bbc6767bd5" xlink:to="loc_clx_InternationalReportingUnitMember_318d35c2-6b31-4d76-b11f-1ce1de4b84b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3fe4a525-6c68-404f-ab7f-dc57d317f9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_37c9c265-031c-4d20-9a17-78a55bdd7876" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_3fe4a525-6c68-404f-ab7f-dc57d317f9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7b66061c-eea2-4ec7-b2f7-7137dde1e065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fe4a525-6c68-404f-ab7f-dc57d317f9db" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7b66061c-eea2-4ec7-b2f7-7137dde1e065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_94a96432-8570-47ab-9c19-8d4add11a006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fe4a525-6c68-404f-ab7f-dc57d317f9db" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_94a96432-8570-47ab-9c19-8d4add11a006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_11323bb4-70e1-40e9-ad2c-8f6caf5a3e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fe4a525-6c68-404f-ab7f-dc57d317f9db" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_11323bb4-70e1-40e9-ad2c-8f6caf5a3e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_d62a680c-7006-4b7a-b3ad-ed6069f7b778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fe4a525-6c68-404f-ab7f-dc57d317f9db" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_d62a680c-7006-4b7a-b3ad-ed6069f7b778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_4054b5d7-d2d2-4325-9d56-21f28e09caf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fe4a525-6c68-404f-ab7f-dc57d317f9db" xlink:to="loc_us-gaap_AssetImpairmentCharges_4054b5d7-d2d2-4325-9d56-21f28e09caf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" xlink:type="simple" xlink:href="clx-20230331.xsd#SEGMENTRESULTSNetSalesPercentagesDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cfbf5c5e-1d8f-4ba4-ad21-a802f051406b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_798652f4-f846-42cc-83f7-d4b12864f890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cfbf5c5e-1d8f-4ba4-ad21-a802f051406b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_798652f4-f846-42cc-83f7-d4b12864f890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_04375e9b-7e9b-4385-ae32-594c596a8b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_798652f4-f846-42cc-83f7-d4b12864f890" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_04375e9b-7e9b-4385-ae32-594c596a8b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_11f836c3-6984-47aa-8a92-0acdecf1cfc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_04375e9b-7e9b-4385-ae32-594c596a8b72" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_11f836c3-6984-47aa-8a92-0acdecf1cfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_815290d6-6e35-4768-a0b8-a4c3928377d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_11f836c3-6984-47aa-8a92-0acdecf1cfc7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_815290d6-6e35-4768-a0b8-a4c3928377d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_949211a1-999b-4e15-bd53-b324d967622b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_798652f4-f846-42cc-83f7-d4b12864f890" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_949211a1-999b-4e15-bd53-b324d967622b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_423b4ed6-7513-4df2-ab3b-78072aaa3600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_949211a1-999b-4e15-bd53-b324d967622b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_423b4ed6-7513-4df2-ab3b-78072aaa3600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_3d400df6-c818-4e17-8e0e-05933d52159a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_423b4ed6-7513-4df2-ab3b-78072aaa3600" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_3d400df6-c818-4e17-8e0e-05933d52159a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_16a5a227-d119-4401-8fc2-1ba6861d0601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_798652f4-f846-42cc-83f7-d4b12864f890" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_16a5a227-d119-4401-8fc2-1ba6861d0601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_44730ae9-bf6f-4591-a40c-da73b3c6a852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_16a5a227-d119-4401-8fc2-1ba6861d0601" xlink:to="loc_us-gaap_SegmentDomain_44730ae9-bf6f-4591-a40c-da73b3c6a852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_7d350af4-fd1b-4ef6-a3f1-b8cfeee93303" xlink:href="clx-20230331.xsd#clx_HealthAndWellnessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_44730ae9-bf6f-4591-a40c-da73b3c6a852" xlink:to="loc_clx_HealthAndWellnessMember_7d350af4-fd1b-4ef6-a3f1-b8cfeee93303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember_fc230a00-dd53-4c93-ae27-b61b06d41d98" xlink:href="clx-20230331.xsd#clx_HouseholdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_44730ae9-bf6f-4591-a40c-da73b3c6a852" xlink:to="loc_clx_HouseholdMember_fc230a00-dd53-4c93-ae27-b61b06d41d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember_0de98370-0874-44aa-88df-bb2df013f0dd" xlink:href="clx-20230331.xsd#clx_LifestyleMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_44730ae9-bf6f-4591-a40c-da73b3c6a852" xlink:to="loc_clx_LifestyleMember_0de98370-0874-44aa-88df-bb2df013f0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember_e78e35a6-fd8f-4e03-96fe-f59d2c9a66fe" xlink:href="clx-20230331.xsd#clx_InternationalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_44730ae9-bf6f-4591-a40c-da73b3c6a852" xlink:to="loc_clx_InternationalMember_e78e35a6-fd8f-4e03-96fe-f59d2c9a66fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_8e250cbb-f6b5-44d6-b868-06029341af49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_798652f4-f846-42cc-83f7-d4b12864f890" xlink:to="loc_us-gaap_SubsegmentsAxis_8e250cbb-f6b5-44d6-b868-06029341af49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_8e250cbb-f6b5-44d6-b868-06029341af49" xlink:to="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CleaningMember_65c484cc-5045-4147-b3ae-dc3cbe3a1980" xlink:href="clx-20230331.xsd#clx_CleaningMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_CleaningMember_65c484cc-5045-4147-b3ae-dc3cbe3a1980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ProfessionalProductsMember_395a8f95-35f7-414e-8bcb-d589465178a3" xlink:href="clx-20230331.xsd#clx_ProfessionalProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_ProfessionalProductsMember_395a8f95-35f7-414e-8bcb-d589465178a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsMember_02763c3c-f1fd-41ca-b7dd-b9f936361983" xlink:href="clx-20230331.xsd#clx_VitaminsMineralsAndSupplementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_VitaminsMineralsAndSupplementsMember_02763c3c-f1fd-41ca-b7dd-b9f936361983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BagsWrapsAndContainersMember_042a8b7e-41c6-47a6-b90f-cda821975c7a" xlink:href="clx-20230331.xsd#clx_BagsWrapsAndContainersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_BagsWrapsAndContainersMember_042a8b7e-41c6-47a6-b90f-cda821975c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_GrillingMember_f1a37031-619c-449f-b705-76bfdbbbe26c" xlink:href="clx-20230331.xsd#clx_GrillingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_GrillingMember_f1a37031-619c-449f-b705-76bfdbbbe26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CatLitterMember_d12b5670-2993-4a6f-9ddf-ec8b6f146ed2" xlink:href="clx-20230331.xsd#clx_CatLitterMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_CatLitterMember_d12b5670-2993-4a6f-9ddf-ec8b6f146ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FoodProductsMember_c32bf26a-a461-4c86-a459-06f74d8a51a2" xlink:href="clx-20230331.xsd#clx_FoodProductsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_FoodProductsMember_c32bf26a-a461-4c86-a459-06f74d8a51a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NaturalPersonalCareMember_360f8747-854e-4f28-bdca-7f60f88e1dc7" xlink:href="clx-20230331.xsd#clx_NaturalPersonalCareMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_NaturalPersonalCareMember_360f8747-854e-4f28-bdca-7f60f88e1dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WaterFiltrationMember_e52657a5-bb9e-41a8-aca0-7785b4bcc884" xlink:href="clx-20230331.xsd#clx_WaterFiltrationMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_631eccd0-f5d5-4f3a-9a5d-13f72e070923" xlink:to="loc_clx_WaterFiltrationMember_e52657a5-bb9e-41a8-aca0-7785b4bcc884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5ad0ecf1-9851-48d3-998f-de383e06a5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_798652f4-f846-42cc-83f7-d4b12864f890" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_5ad0ecf1-9851-48d3-998f-de383e06a5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_eeafeb34-10d6-4810-8d9b-9d40cf936bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5ad0ecf1-9851-48d3-998f-de383e06a5f2" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_eeafeb34-10d6-4810-8d9b-9d40cf936bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>clx-20230331_g1.jpg
<TEXT>
begin 644 clx-20230331_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0 Z17AI9@  34T *@    @  U$0  $
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M(&@VXN=5\*:G*LDZ0E@OVBWE7 N( Q"E@JLI90R+N4M]L4 %%?F3_P %2/\
M@YY^$_[ WQ*O/AMX(T&_^,WQ2LYOLEWINE7(@T_2[G.W[/-<A7+SAL Q0QN0
M<JS(PQ7RW=_\'._[8OP\T]?%'C#]B36[+P.H\Z2Y;3-9L?+AZ[C<R0M&O'\1
M0"@#]VJ*^,?^"4/_  7+^#?_  5HT2YM?"<U[X8\>Z5!]IU+PEK#(+R*+(4S
MP.IVW$(8@%EPRY7>B;ES]G4 %%%?EC_P=;_\%,-5_8?_ &'=/\!^#]2DTWQO
M\:)I]+6[MY"EQI^E1(OVV6-ARKOYL4(/! ED((90: .,_P""HW_!U;X?_9^^
M*MU\)_V<?"D7QD^(T-T=.FU(>;-H]O=?=,%O'!^]OI0W!$;(@/1WY \"TSXC
M_P#!;#]H&V'B/2]%'@VQD_>PZ=-8>'=+8 \[?)O,W ],2'-?:7_!NI_P12\,
M_P#!._\ 9GT#X@>*=%M;SXW>.=.CO]1O[J(--X<MIU#IIUOG_5E4*^<R_,\A
M8$E545^EF* /Y_\ P]_P<6_MI?\ !,GX@Z;HG[9/P/FU3P[J$HB75K?3DTN]
MDQG<;>XA+6%RP'/EJ%)QRZYS7[5?L9?MK?#C]OSX$Z9\1/A?X@@U_P .ZCF-
MQCR[K3YP 7MKB(_-%,F1E3U!#*65E8])\?OV??!G[4GPEUCP+\0/#NF^*/"N
MO0&"]T^]BWQR CAE/5'4_,KH0RL 001FOSW_ .",'_!!3QA_P2:_:V^*7BBS
M^+3ZA\+_ !([6>C^%8K<R/?VP8/;W%](VU4N8-SQ@Q*=X+DLH;8 #Y+_ .#Y
M! ?"_P"S:V!N%WXB&<=MFFU^ZGPW&/AWH/\ V#K?_P!%+7X6?\'Q_P#R*O[-
MO_7WXA_] TVOW3^''_)/-!_[!UO_ .BEH VJ*^*_^"KW_!=;X,_\$FM+AT_Q
M5<7GBKXA:E;BYL/"6CNAO&B)(6:XD8[+:$D$!FRS8.U'P<?F]!_P=??M3>-K
M$^*/"_['MS>>!6_>I>+::O>QF+U^UQPK%T_BV8H _?6BOS1_X)2?\'./P?\
M^"COCNQ^'_B/2KSX2_$_4&\FRTK4[M;C3]8FZ>3;76U/WQ.<12(C-P%+GBOT
MNH **_+33?\ @YK\,>$/VZ_V@/A?\1O!5OX/\&? :SU6ZN/$T6L&[N=8>TO;
M>TAMXK0PH/.N'G4*OFG!ZG&6'RAXR_X/*?B=>ZE/KWA/]E]Y/A]'-MAO=1U&
M[:69,X!::*#R8V/]T;P"<9:@#]^J*\\T3X^V_AK]F*P^)'Q,@L?AG##H,.M^
M(;;4K]7A\.%H5DEAEG(4-Y9)0L%&XC@<@5^1'[1G_!X2/$_Q3N/"'[,?P/\
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MS^TYX?\ V<?^"07Q3M=6NH%U7X@6:^%-%LV8>9>W%RP$FT>D<"S2$]M@[D4
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M]@!C<<.G[^>%O#&G^"?#6GZ-I-G;:;I.DVT=G96EO&(X;2"- D<:*.%554
M= !5^B@#\2O^"8G[&7Q:^&?_  <Y_M!_$SQ%\-_&FB?#WQ"WB4:9XBO=*EAT
MV_\ .OK=X?+G(V-O569<'D U^VM%% 'S+_P5>_X)A>#?^"K?[*M]\//%$S:3
MJEK+_:/AW78H1)-HE\JE5DVDC?$RDI)'D;E/!5E5E_&GX/\ Q2_X*5?\$ K2
M3X=R?#.Y^-GPETF1H](DM].NM=TZVB))S;7%KBXMD)R?*G4*ISA!DD_T844
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M%,I0*'@D(.Y%>,[^!^W'_!Q'_P H6?V@/^P#%_Z6V]>0_P#!I+_RA?\ "/\
MV,.L_P#I6U 'QYJG_!R!^WYH6GMX7O/V-[F/QU&OV?[1_P (EKIB:7&W>+8$
MD\\\2[?PJA^QQ_P0V_:7_P""LW[7>G_'C]N:YU#2O#.FRQR6_A6^V0WNIPHY
M=+)+6/Y;&SW??#8E?+<;G,H_H"HH CM+*'3[2*W@ACA@@01QQQJ%2-0,  #@
M #@ =*_"_P#X*D?\$"_C?^RS^V3=?M1_L0W]Q9ZW=7<NIZEX6T^:."[LKB4D
MW!M4D_<W%K,2Q>U?D%B%5U*JG[J44 ?@3X;_ .#CC]O_ ,.6D?A36OV.K[5O
M'$7^C?:!X1URW\Z0<;FMUR#SUVNJ^F!7#_M*_P#!)C]LW_@I9\ /B/\ M!?M
M/PZU=>+O#_A]XOAQ\+]"AS<Q7$LT2E_LD)<0HJ;G*$M/*57S" @#?T744 ?G
MW_P;(? 7QM^S9_P2?\-^%/B!X4U[P7XEM==U6:;3-8LGL[J-)+DLC&-P&"L#
MD''(KY'\)_L8?%RT_P"#O?4/BY)\-?&B?"^:>;9XJ.DRC26!\,?9P?M&-F#-
M^[Z_>XK]O** "OE?_@MO\,?$7QG_ ."4GQP\+>$M#U3Q)XDUKP\;>PTS3K=K
MBZO)/.B.R.-068X!.!Z5]444 ?G/_P &N/[/7CK]F+_@EI;>%_B)X1\0^"?$
M<?BO4[DZ;K5B]G=")_)V2;' .UL'!QS@U]P?M,? OP[^TU^SYXT^'WBZ-)/#
M7C#1[G2M0W8'E12QE3(">%9"0ZMV90>U=Q7Y\_\ !S#^WO\ \,-?\$O_ !5#
MI=]]E\9?%$GP?HFQ\2Q+.C?:[@8Y'EVPD 8?=>6+U% 'XS_\&O7_  3S7]I+
M_@JC=>(M0O(?$O@']GF:75(;Z,,UEJ%^9I(]/,0;[H9TDNAT/^CC/6OZGAP*
M_/\ _P"#:O\ 8%_X82_X)@>$_P"U;+[+XS^)F/&&N[TQ+#]H1?LMNV>1Y=L(
MLJ?NR/+ZFOT H *P_B'\.-#^+'@[4?#WB32K'6]#U:$P75E=Q"2&93Z@]QP0
M1R" 0016Y15TZDZ<U.FVFG=-:--;-/N3.$9Q<9JZ>Z9^2W[9?_! KQ!X5U"Z
MUSX,WRZ]I+$R'P[J,XCOK4==L$[8251V$A5N@W,:^!/B7\)O%7P8UF33_%_A
MO7/#-Y&<&/4K*2WS]&8;6'NI(K^F)^M>;_M5_P#)%-5_W#_(U_0/"'CYG6%]
MG@\R@L0M$I-\L^VLDFI?.-WU;/R?B'PKRZLI8G!S=%[V2YH_)-IK[[=D?SAI
M*LHRK*P]0<T^PC;5[U;6SCDO+J0[5A@0RR.3V"KDGZ8KU/\ : _Y*Q=?]=S_
M .A5^H'_  1Y_P"0"W^X?Y5_0W%_B#_8F3PS54/:<R^'FM;;KRN^_9'X_P .
M\+O,\P>!=7EMUY;[/M='YI_ [_@@3\7OVJ=>M=1M](7X9^'+EPUW?>((&B8H
M>2]O:C$K,1T#!$Z?,.E?L=_P3Y_X)@?#/_@G/X)EL_!]C)J/B/4HU35_$FHA
M7U'4<<[ 0,10@\B),+T)W'YJ^BF^\:D'2OXMXM\0,QSZI+G2I4F_@A=+YMMM
M_E?5)'].Y'D-++J$:?.ZDE]J5K_A_P %]VPHHHKX<]T**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#@_VG?V;?"?[7_P&\2?#7QU8W&I>$O%ENMKJ5M#=26LDT:R+( )(R&7YD4Y
M!'2L3]B_]BOX?_L _ JS^&_PQTNZT?PG874]Y!:W%]+>.DDS[Y#YDK,Y!8]"
M>*]7HH **** "BBB@ HHHH **** "BBB@ KYM_;D_P""3?P3_P""CGC7PCKG
MQ=\/ZIXFF\#AQI%L-8N;6SAWR(\A:&-U1RYCC#%@<J@'05])44 -AA6WA6.-
15C2,!551A5 Z "G444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032209688352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 18, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-07151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">THE CLOROX COMPANY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-0595760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1221 Broadway<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Oakland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94612-1888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">271-7000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock - $1.00 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CLX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,623,524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000021076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032208829952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,915<span></span>
</td>
<td class="nump">$ 1,809<span></span>
</td>
<td class="nump">$ 5,370<span></span>
</td>
<td class="nump">$ 5,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">1,115<span></span>
</td>
<td class="nump">1,160<span></span>
</td>
<td class="nump">3,324<span></span>
</td>
<td class="nump">3,429<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">649<span></span>
</td>
<td class="nump">2,046<span></span>
</td>
<td class="nump">1,877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expenses</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">233<span></span>
</td>
<td class="nump">854<span></span>
</td>
<td class="nump">710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="nump">502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development costs</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill, trademark and other asset impairments</a></td>
<td class="nump">445<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">445<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_OtherExpenseIncomeNet', window );">Other (income) expense, net</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="num">(245)<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">(36)<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="num">(209)<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="nump">367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to noncontrolling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (losses) attributable to Clorox</a></td>
<td class="num">$ (211)<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="num">$ (27)<span></span>
</td>
<td class="nump">$ 361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net earnings (losses) per share attributable to Clorox</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings (losses) per share (in dollars per share)</a></td>
<td class="num">$ (1.71)<span></span>
</td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="nump">$ 2.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings (losses) per share (in dollars per share)</a></td>
<td class="num">$ (1.71)<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="nump">$ 2.91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding (in thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">123,649<span></span>
</td>
<td class="nump">123,177<span></span>
</td>
<td class="nump">123,512<span></span>
</td>
<td class="nump">123,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">123,649<span></span>
</td>
<td class="nump">123,877<span></span>
</td>
<td class="nump">123,512<span></span>
</td>
<td class="nump">123,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="num">$ (205)<span></span>
</td>
<td class="nump">$ 207<span></span>
</td>
<td class="num">$ (39)<span></span>
</td>
<td class="nump">$ 394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Total comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income (loss) attributable to Clorox</a></td>
<td class="num">$ (207)<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
<td class="nump">$ 388<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherExpenseIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherExpenseIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032204509680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 242<span></span>
</td>
<td class="nump">$ 183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">678<span></span>
</td>
<td class="nump">681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">735<span></span>
</td>
<td class="nump">755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,745<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net of accumulated depreciation and amortization of $2,672 and $2,530, respectively</a></td>
<td class="nump">1,315<span></span>
</td>
<td class="nump">1,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">1,558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_TrademarksNet', window );">Trademarks, net</a></td>
<td class="nump">546<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">427<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">5,818<span></span>
</td>
<td class="nump">6,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Notes and loans payable</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,722<span></span>
</td>
<td class="nump">1,469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,996<span></span>
</td>
<td class="nump">1,784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">2,476<span></span>
</td>
<td class="nump">2,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">824<span></span>
</td>
<td class="nump">791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,646<span></span>
</td>
<td class="nump">5,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of March&#160;31, 2023 and June&#160;30, 2022; and 123,611,466 and 123,152,132 shares outstanding as of March&#160;31, 2023 and June&#160;30, 2022, respectively</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,232<span></span>
</td>
<td class="nump">1,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">415<span></span>
</td>
<td class="nump">1,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost: 7,129,995 and 7,589,329 shares as of March&#160;31, 2023 and June&#160;30, 2022, respectively</a></td>
<td class="num">(1,277)<span></span>
</td>
<td class="num">(1,346)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive net (loss) income</a></td>
<td class="num">(498)<span></span>
</td>
<td class="num">(479)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Clorox stockholders&#8217; equity</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">169<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">729<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 5,818<span></span>
</td>
<td class="nump">$ 6,158<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_TrademarksNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_TrademarksNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032204487760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property, plant and equipment, accumulated depreciation and amortization</a></td>
<td class="nump">$ 2,672<span></span>
</td>
<td class="nump">$ 2,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">130,741,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">123,611,466<span></span>
</td>
<td class="nump">123,152,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">7,129,995<span></span>
</td>
<td class="nump">7,589,329<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032209568560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="num">$ (20)<span></span>
</td>
<td class="nump">$ 367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings (losses) to net cash provided by operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(122)<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill, trademark and other asset impairments</a></td>
<td class="nump">445<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories, net</a></td>
<td class="nump">13<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">78<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_OperatingLeaseRightofUseAssetAndLiabilityNet', window );">Operating lease right-of-use assets and liabilities, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable', window );">Income taxes payable / prepaid</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operations</a></td>
<td class="nump">728<span></span>
</td>
<td class="nump">451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(144)<span></span>
</td>
<td class="num">(172)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used for investing activities</a></td>
<td class="num">(142)<span></span>
</td>
<td class="num">(167)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Notes and loans payable, net</a></td>
<td class="num">(99)<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repayments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Treasury stock purchased</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends paid to Clorox stockholders</a></td>
<td class="num">(437)<span></span>
</td>
<td class="num">(428)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Cash dividends paid to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther', window );">Issuance of common stock for employee stock plans and other</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used for financing activities</a></td>
<td class="num">(526)<span></span>
</td>
<td class="num">(363)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="nump">60<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, cash equivalents, and restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of period</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of period</a></td>
<td class="nump">$ 246<span></span>
</td>
<td class="nump">$ 243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock options. Also includes the net cash inflow (outflow) from other financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OperatingLeaseRightofUseAssetAndLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-of-Use Asset And Liability, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OperatingLeaseRightofUseAssetAndLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032214122320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements for the three and nine months ended March 31, 2023 and 2022, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2022, which includes a complete set of footnote disclosures, including the Company&#8217;s significant accounting policies.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Liabilities</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurs restructuring costs in connection with workforce reductions; consolidation or closure of a facility; sale or termination of a line of business; and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records employee termination liabilities once they are both probable and estimable for severance provided under the Company&#8217;s existing severance policy. Employee termination liabilities outside of the Company&#8217;s existing severance policy are recognized at the time relevant employees are notified, unless the employees will be retained to render service beyond a minimum retention period for transition purposes, in which case the liability is recognized ratably over the future service period. Other costs associated with a restructuring plan or exit or disposal activities, such as consulting and professional fees, facility exit costs, employee relocation, outplacement costs, accelerated depreciation or asset impairments associated with a restructuring plan, are recognized in the period in which the liability is incurred or the asset is impaired.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment Review of Goodwill and Indefinite-Lived Intangible Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests its goodwill, trademarks with indefinite lives and other indefinite-lived intangible assets annually for impairment in the fiscal fourth quarter unless there are indications during a different interim period that these assets may have become impaired.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to goodwill, the Company has the option to first assess qualitative factors, such as the maturity and stability of the reporting unit, the magnitude of the excess fair value over carrying value from a previous period&#8217;s impairment testing, other reporting unit specific operating results, microeconomic and macroeconomic factors, as well as new events and circumstances impacting the operations at the reporting unit level. The Company operates through strategic business units (SBUs) that are organized into the Company&#8217;s operating segments. Reporting units for goodwill impairment testing purposes were identified as the Company&#8217;s individual operating segments. If the result of a qualitative test indicates a potential for impairment of a reporting unit, a quantitative test is performed. In the quantitative test, the Company compares the estimated fair value of the reporting unit to its carrying value. If the estimated fair value of any reporting unit is less than its carrying value, an impairment charge is recorded for the difference between the carrying value and the fair value of the reporting unit. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the fair value of a reporting unit as part of its quantitative test, the Company uses the discounted cash flow (DCF) method under the income approach, as it believes that this approach is the most reliable indicator of the fair value of its businesses and the fair value of its future earnings and cash flows. Under this approach, which requires significant judgments, the Company estimates the future cash flows of each reporting unit and discounts these cash flows at a rate of return that reflects their relative risk. The cash flows used in the DCF method are consistent with those the Company uses in its internal planning, which gives consideration to actual business trends experienced, and the broader business strategy for the long term. The other key estimates and factors used in the DCF method include, but are not limited to, net sales and expense growth rates, commodity prices, foreign exchange rates, inflation and a terminal growth rate. Changes in such estimates or the application of alternative assumptions could produce different results. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For trademarks and other intangible assets with indefinite lives, the Company has the option to first assess qualitative factors, such as the maturity and stability of the trademark or other intangible asset, the magnitude of the excess fair value over carrying value from a previous period&#8217;s impairment testing, other specific operating results as well as new events and circumstances impacting the significant inputs used to determine the fair value of the intangible asset. If the result of a qualitative test indicates that it is more likely than not that the asset is impaired, a quantitative test is performed. When a quantitative test is performed, the estimated fair value of an asset is compared to its carrying value. If the carrying value of such asset exceeds its estimated fair value, an impairment charge is recorded for the difference between the carrying value and the estimated fair value. The Company uses the DCF method under the relief from royalty income approach to estimate the fair value of its trademarks and other intangible assets with indefinite lives. This approach requires significant judgments in determining the royalty rates and the assets&#8217; estimated cash flows, as well as the appropriate discount and foreign exchange rates applied to those cash flows to determine fair value. Changes in such estimates or the use of alternative assumptions could produce different results.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#8221; These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations.&#160;These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. As these amendments relate to disclosures only, there are no impacts expected to the Company&#8217;s consolidated results of operations, financial position and cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032204489280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING AND RELATED COSTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">RESTRUCTURING AND RELATED COSTS</a></td>
<td class="text">RESTRUCTURING AND RELATED COSTS<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2023, the Company began recognizing costs related to a plan that involves streamlining its operating model to meet its objectives of driving growth and productivity. The streamlined operating model is expected to enhance the Company&#8217;s ability to respond more quickly to changing consumer behaviors and innovate faster. The Company anticipates the implementation of this new model will be completed in fiscal year 2024, with different phases occurring throughout the implementation period.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company anticipates incurring approximately $75 to $100 of costs in fiscal years 2023 and 2024 related to this initiative. Of this total amount, the higher-end of the range of approximately $40 to $60 is expected to be incurred in fiscal year 2023. Related costs are primarily expected to include employee-related costs to reduce certain staffing levels such as severance payments, as well as for consulting and other costs. Costs incurred are expected to be settled primarily in cash.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related implementation costs, net were $21 and $44 for the three and nine months ended March&#160;31, 2023, respectively. The following table summarizes the total restructuring and related implementation costs, net associated with the Company&#8217;s streamlined operating model plan as reflected in the Consolidated Statements of Earnings and Comprehensive Income.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.615%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">3/31/2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Costs of products sold</span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(1)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Selling and administrative expenses</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Other (income) expense, net:</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Employee-related costs</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Total, net</span></div></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee-related costs primarily include severance and other termination benefits calculated based on salary levels, prior service and statutory requirements. Other costs primarily include consulting fees incurred for the organizational design and implementation of the future streamlined operating model, related processes and other professional fees incurred. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges for restructuring and related implementation costs are recorded in the Corporate segment as these initiatives are centrally directed and controlled and are not included in internal measures of segment operating performance.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, from time to time, decide to pursue additional restructuring-related initiatives that involve costs in future periods. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reconcile the accrual for the streamlined operating model restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the Consolidated Balance Sheets:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Employee-Related Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of December 31, 2022</span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">13&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">2&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">15&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Charges</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Cash payments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(10)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(4)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(14)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of March 31, 2023</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Employee-Related Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of June 30, 2022</span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Charges</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Cash payments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(16)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(9)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(25)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of March 31, 2023</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032291826336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES, NET<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES, NET</a></td>
<td class="text">INVENTORIES, NET<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net, consisted of the following as of:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and packaging</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIFO allowances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncurrent inventories, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current inventories, net</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Noncurrent inventories, net is recorded in Other assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032209739936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS</a></td>
<td class="text">GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal year 2023, management made a decision to narrow the focus on core brands and streamline investment levels in the Vitamins, Minerals and Supplements (VMS) business. As a result, revisions were made to the internal financial projections and operational plans of the VMS business reflecting the Company&#8217;s current estimates regarding the future financial performance of these operations and macroeconomic factors. The revised estimated future cash flows reflect lower sales growth expectations and lower investment levels. These revisions were considered a triggering event requiring interim impairment assessments to be performed as part of the preparation of the quar</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">terly financial statements on the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">global indefinite-lived trademarks, other long-term assets and the VMS reporting unit.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the outcome of these assessments, the following pre-tax, non-cash impairment charges were recorded:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impairment Charges</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VMS reporting unit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International reporting unit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with recognizing these impairment charges, the Company recognized tax benefits related to the impairments of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$83</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> due to the partial tax deductibility of these charges. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the estimated fair values of the global indefinite-lived trademarks related to the VMS business, the Company used the DCF method under the relief from royalty income approach. This approach requires significant judgments in determining the royalty rates and the assets&#8217; estimated cash flows as well as the appropriate discount rates applied to those cash flows to determine fair value. As a result of the interim impairment test, the Company concluded that the carrying value of the global indefinite-lived trademarks exceeded their estimated fair value, and recorded impairment charges of $139. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the useful lives of the impaired trademarks, with a remaining net carrying value of $28 as of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> March 31, 2023, were changed from indefinite to definite beginning on April 1, 2023, which reflects the remaining expected useful lives of the trademarks based on the most recent financial and operational plans. The weighted-average estimated useful life of these trademarks is 20 years.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After adjusting the carrying</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">values of the global indefinite-lived trademarks and concluding that the carrying amounts of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the other long-lived assets were recoverable, the Company completed a quantitative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impairment test for goodwill and recorded a goodwill impairment charge of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $306 i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n the VMS reporting unit. To determine the fair value of the VMS reporting unit, the Company used a DCF method under the income approach. In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accordance with this approach, the Company estimated the future cash flows of the VMS reporting unit and discounted these cash flows at a rate of return that reflects its relative risk. The other key estimates and factors used in the DCF method include,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">but are not limited to, net sales and expense growth rates and a terminal growth rate. The decrease in projected cash flows due to the revisions adversely impacted key assumptions used</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in determining the fair value of the VMS reporting unit and assets contained therein, primarily projected net sales</span><span style="background-color:#ffffff;color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no remaining goodwill associated with the impaired reporting unit.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No triggering events were identified in the fiscal quarter ended March&#160;31, 2023 that would more likely than not reduce the fair value of the International reporting unit below its carrying value through March&#160;31, 2023. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of Goodwill as of March&#160;31, 2023 from June&#160;30, 2022, were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Goodwill</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,547&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,553&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the carrying amount of trademarks and other intangible assets as of March&#160;31, 2023 and as of June&#160;30, 2022:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.702%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization / Impairments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization / Impairments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks not subject to amortization</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks subject to amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Amortization expense relating to the Company&#8217;s intangible assets was $7 and $22 for the three and nine months ended March&#160;31, 2023, respectively, and $8 and $24 for the three and nine months ended March&#160;31, 2022, respectively. Estimated amortization expense for these intangible assets is $8, $29, $28, $28 and $28 for the remainder of fiscal year 2023 and fiscal years 2024, 2025, 2026 and 2027, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032215040496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">OTHER LIABILITIES</a></td>
<td class="text">OTHER LIABILITIES<div style="margin-bottom:8pt;margin-top:8pt"><span id="i5f09d63c9cd64157bb33befdd9640676_1908"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Venture Agreement</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an agreement with The Procter &amp; Gamble Company (P&amp;G) for the Company&#8217;s Glad bags and wraps business. In connection with this agreement, P&amp;G provides research and development (R&amp;D) support to the Glad business. As of March&#160;31, 2023 and June&#160;30, 2022, P&amp;G had a 20% interest in the venture. The Company pays a royalty to P&amp;G for its interest in the profits, losses and cash flows, as contractually defined, of the Glad business, which is included in Cost of products sold. In December 2017, the Company and P&amp;G extended the term of the agreement and the related R&amp;D support provided by P&amp;G. The term will expire in January 2026, unless the parties agree, on or prior to January 31, 2025, to further extend the term of the agreement for another seven years or agree to take some other relevant action. The agreement can be terminated earlier under certain circumstances, including at P&amp;G&#8217;s option upon a change in control of the Company or, at either party&#8217;s option, upon the sale of the Glad business by the Company.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon termination of the agreement, the Company is required to purchase P&amp;G&#8217;s 20% interest for cash at fair value as established by predetermined valuation procedures. As of March&#160;31, 2023 and June&#160;30, 2022, the estimated fair value of P&amp;G&#8217;s interest in the venture was $527 and $635, respectively, of which $492 and $468, respectively, has been recognized and is reflected in Other liabilities. The difference between the estimated fair value and the amount recognized, and any future changes in the fair value of P&amp;G&#8217;s interest, is charged to Cost of products sold in accordance with the effective interest method over the remaining life of the agreement. Following termination, the Glad business will retain the exclusive core intellectual property licenses contributed by P&amp;G on a royalty-free basis for the licensed products marketed.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032209739936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract', window );"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock', window );">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Risk Management and Derivative Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain commodity, foreign currency and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity Price Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may use commodity futures, options and swap contracts to limit the impact of price volatility on a portion of its forecasted raw material requirements. These commodity derivatives may be exchange traded or over-the-counter contracts and generally have original contractual maturities of less than two years. Commodity purchase and options contracts are measured at fair value using market quotations obtained from the Chicago Board of Trade commodity futures exchange and commodity derivative dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, and June&#160;30, 2022, the notional amount of commodity derivatives was $55 and $27, respectively, which related primarily to exposures in soybean oil used for the Food products business and jet fuel used for the Grilling business.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also enter into certain over-the-counter derivative contracts to manage a portion of the Company&#8217;s forecasted foreign currency exposure associated with the purchase of inventory. These foreign currency contracts generally have original contractual maturities of less than two years. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of outstanding foreign currency forward contracts used by the Company&#8217;s subsidiaries to hedge forecasted purchases of inventory were $55 and $31 as of March&#160;31, 2023 and June&#160;30, 2022, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may enter into over-the-counter interest rate contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt. These interest rate contracts generally have original contractual maturities of less than three years. The interest rate contracts are measured at fair value using information quoted by bond dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held no interest rate contracts as of both March&#160;31, 2023 and June&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity, Foreign Exchange and Interest Rate Derivatives </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designates its commodity forward, futures and options contracts for forecasted purchases of raw materials, foreign currency forward contracts for forecasted purchases of inventory and interest rate contracts for forecasted interest payments as cash flow hedges.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings (losses) were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) recognized in Other comprehensive (loss) income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings (losses)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amount of the existing net gain (loss) in Accumulated other comprehensive net (loss) income as of March&#160;31, 2023 that is expected to be reclassified into Net earnings (losses) within the next twelve months is $9. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Risk Management and Derivative Contract Requirements</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes a variety of financial institutions as counterparties for over-the-counter derivative instruments. The Company enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually-defined counterparty liability position limits. Of the over-the-counter derivative instruments in liability positions, $1 and $0 contained such terms as of March&#160;31, 2023 and June&#160;30, 2022, respectively. As of both March&#160;31, 2023 and June&#160;30, 2022, neither the Company nor any counterparty was required to post any collateral as no counterparty liability position limits were exceeded.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain terms of the agreements governing the Company&#8217;s over-the-counter derivative instruments require the Company&#8217;s credit ratings, as assigned by Standard &amp; Poor&#8217;s and Moody&#8217;s to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If the Company&#8217;s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of both March&#160;31, 2023 and June&#160;30, 2022, the Company and each of its counterparties had been assigned investment grade ratings by both Standard &amp; Poor&#8217;s and Moody&#8217;s.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s exchange traded futures and options contracts used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account held by the Company&#8217;s broker for trades conducted on that exchange. As of March&#160;31, 2023 and June&#160;30, 2022, the Company maintained cash margin balances related to exchange traded futures and options contracts of $3 and $1, respectively, which are classified as Prepaid expenses and other current assets on the condensed consolidated balance sheets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trust Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in mutual funds and cash equivalents as part of trust assets related to its nonqualified deferred compensation plans. The participants in the nonqualified deferred compensation plans, who are the Company&#8217;s current and former employees, may select among certain mutual funds in which their compensation deferrals are invested in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and therefore, trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The interests in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable securities as trading investments.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of both March&#160;31, 2023 and June&#160;30, 2022, the Company&#8217;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#8217;s nonqualified deferred compensation plans, which were classified as Level 1.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s derivative instruments qualify for hedge accounting. The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s derivative instruments:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase options contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase futures contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s other assets and liabilities for which disclosure of fair value is required:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.707%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-bearing investments, including money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposits</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trust assets for nonqualified deferred compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">term debt and Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,514&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,711&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,623&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company&#8217;s credit agreements, all of which are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, impairment charges of $445 were recorded during the third quarter of fiscal 2023, of which $306 and $139 related to the goodwill of the VMS reporting unit and certain related indefinite-lived trademarks, respectively. These adjustments were included as Goodwill, trademark and other asset impairments in the condensed consolidated statement of earnings. The non-recurring fair values utilized included unobservable Level 3 inputs based on management&#8217;s best estimates and assumptions. For additional information, refer to Note 4.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments and fair value measurements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments and Fair Value Measurements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FinancialInstrumentsAndFairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032214260128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXESIn determining its quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The effective tax rate on losses was 14.7% and the effective tax rate on earnings was 1,813.5% for the three and nine months ended March&#160;31, 2023, respectively. The effective tax rate on earnings was 23.9% and 23.3% for the three and nine months ended March&#160;31, 2022, respectively. The lower tax rate on losses before income taxes in the current three month period was driven by the partial non-deductibility of impaired VMS goodwill. The substantially higher tax rate on earnings before income taxes in the current nine month period was driven by lower pre-tax income due to the VMS impairment charges and the non-deductibility of a portion of those charges.The Inflation Reduction Act (the &#8220;Act&#8221;) was signed into law on August 16, 2022. The Act introduces a new 15% corporate minimum tax for certain large corporations that becomes effective at the beginning of the Company&#8217;s fiscal 2024 and it imposes a 1% excise tax on the value of share repurchases, net of new share issuances, after December 31, 2022. These provisions, as well as the other corporate tax changes included in the Act, are not expected to have a material impact on the Company&#8217;s financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032214312928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS (LOSSES) PER SHARE (EPS)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET EARNINGS (LOSSES) PER SHARE (EPS)</a></td>
<td class="text">NET EARNINGS (LOSSES) PER SHARE (EPS)<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,649</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,177</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,512</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,074</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,649</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,877</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,512</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,943</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive stock options and other</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,953</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,953&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net earnings (losses) per share and Diluted net earnings (losses) per share are calculated on Net earnings (losses) attributable to Clorox.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the Company generated net losses attributable to Clorox for the three and nine months ended March&#160;31, 2023, there was no dilutive effect of stock options and other instruments because their impacts would be antidilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032214249632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (LOSS)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text">COMPREHENSIVE INCOME (LOSS)<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of Comprehensive income (loss) for the periods indicated:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.015%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income (loss) attributable to Clorox</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032214185360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> EQUITY </span><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the components of Stockholders&#8217; equity were as follows for the periods indicated: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,373)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,777)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($1.16 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,358)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,670)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($1.18 per share declared)</span></div></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,232&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,277)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,130)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(498)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,396)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,961)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(546)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($3.48 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(430)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(430)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,358)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,670)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,346)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,589)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($4.72 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,232&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,277)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,130)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(498)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(459)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(498)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(546)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(498)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in foreign currency translation adjustments are remeasurement losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future. There were no amounts associated with these loans reclassified from Accumulated other comprehensive net (loss) income for the periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032214090368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">EMPLOYEE BENEFIT PLANS</a></td>
<td class="text">EMPLOYEE BENEFIT PLANS<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a domestic qualified pension plan (the Plan). The Plan is frozen for all participants. The Plan generally was frozen effective June 30, 2011 for all employees, except for certain collectively bargained employees, whose Plan freeze was effective January 1, 2019. As a result of the Plan freeze, no employees are eligible to commence participation in the Plan or accrue any additional benefits under the Plan.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2022, the Company&#8217;s Board of Directors approved a resolution to terminate the Plan. The amendment will allow the settlement of the pension obligation with either a lump sum payout or a purchased annuity. It is expected to take 18 to 24 months to complete the termination from the date of the approved resolution to terminate the Plan. The completion of the process of offering and accepting lump sum elections are dependent on when certain regulatory approvals are obtained. Currently, there is not enough information available to determine the ultimate charge of the termination. The Plan is fully funded under specified Employee Retirement Income Security Act (ERISA) funding rules as of March&#160;31, 2023.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of net periodic benefit cost for the Company&#8217;s retirement income plans:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss recognized</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized items</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2023 net periodic benefit cost is 2.7%.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic benefit cost for the Company&#8217;s retirement health care plans was $(1) for both the three and nine months ended March&#160;31, 2023, and $0 for both the three and nine months ended March&#160;31, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During both the three months ended March&#160;31, 2023 and 2022, the Company made $8 in contributions to its domestic retirement income plans. During the nine months ended March&#160;31, 2023 and 2022, the Company made $12 and $13 in contributions to its domestic retirement income plans, respectively.</span></div>Service cost component of the net periodic benefit cost, if any, is reflected in employee benefit costs, all other components are reflected in Other (income) expense, net.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032214250448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONTINGENCIES AND GUARANTEES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">OTHER CONTINGENCIES AND GUARANTEES</a></td>
<td class="text">OTHER CONTINGENCIES AND GUARANTEES<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in certain environmental matters, including response actions at various locations. The Company had recorded liabilities totaling $26 and $28 as of March&#160;31, 2023 and June&#160;30, 2022, respectively, for its share of aggregate future remediation costs related to these matters. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One matter, which accounted fo</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $12</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $14 of the recorded liability as of March&#160;31, 2023 and June&#160;30, 2022, respectively, relates to environmental costs associated with one of the Company&#8217;s former operations at a site located in Alameda County, California. In November 2016, at the request of regulators and with the assistance of environmental consultants, the Company submitted a Feasibility Study that evaluated various options for managing the site and included estimates of the related costs. Following further discussions with the regulators in 2017, the Company recorded an undiscounted liability for costs estimated to be incurred over a 30-year period, based on one of the options in the Feasibility Study. In September 2021, as a result of an additional study and further discussions with regulators, the Company submitted a Soil Vapor Intrusion Report to the regulators, which has not resulted in a change to the recorded liability. While the Company believes its latest estimates of remediation costs are reasonable, the ultimate remediation requirements are not yet finalized and the regulators could require the Company to implement remediation actions for a longer period or take additional actions, which could include estimated undiscounted costs of up to approximately $28 over an estimated 30-year period, or require the Company to take different actions and incur additional costs. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another matter in Dickinson County, Michigan, at the site of one of the Company&#8217;s former operations for which the Company is jointly and severally liable, accounted for $10 and $9 of the recorded liability as of both March&#160;31, 2023 and June&#160;30, 2022, respectively. This amount reflects the Company&#8217;s agreement to be liable for 24.3% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing agreement with a third party. If the third party is unable to pay its share of the response and remediation obligations, the Company may be responsible for such obligations. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Although it is reasonably possible that the Company&#8217;s exposure may exceed the amount recorded for the Dickinson County matter, any amount of such additional exposures, or range of exposures, is not estimable at this time. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated losses related to these matters are sensitive to a variety of uncertain factors, including the efficacy of any remediation efforts, changes in any remediation requirements and the future availability of alternative clean-up technologies. The Company is subject to various legal proceedings, claims and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements (including costs connected to the transition and unwinding of certain supply and manufacturing relationships), product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, either individually or in the aggregate, on the Company&#8217;s condensed consolidated financial statements taken as a whole.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make, any material payments relating to its indemnifications, and believes that any reasonably possible payments would not have a material adverse effect, either individually or in the aggregate, on the Company&#8217;s condensed consolidated financial statements taken as a whole.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had not recorded any material liabilities on the aforementioned guarantees as of both March&#160;31, 2023 and June&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was a party to letters of credit of $14 as of March&#160;31, 2023, primarily related to its insurance carriers, of which $0 had been drawn upon.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032209641728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT RESULTS</a></td>
<td class="text">SEGMENT RESULTS<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates through strategic business units (SBUs) that are organized into the Company&#8217;s operating segments. The operating segments are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present reportable segment information and a reconciliation of the segment information to the Company&#8217;s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.133%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,055&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,915&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,370&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,306&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (losses) before income taxes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">The earnings (losses) before income taxes for the Health and Wellness segment includes $433 of non-cash impairment charges related to the VMS business for the three and nine months ended March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">The earnings (losses) before income taxes for the International segment include $12 of non-cash impairment charges related to the VMS business for the three and nine months ended March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">The losses before income taxes for Corporate includes restructuring and related implementation costs, net for the streamlined operating model of $21 and $44 for the three and nine months ended March&#160;31, 2023, respectively. While recorded within the Corporate segment, for informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company&#8217;s reportable segments as a percentage of the total costs: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"/><td style="width:5.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.192%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intersegment sales are eliminated and are not included in the Company&#8217;s reportable segments&#8217; net sales.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales to the Company&#8217;s largest customer, Walmart Inc. and its affiliates, as a percentage of consolidated net sales, were 26% for the three and nine months ended March&#160;31, 2023 and 25% for the three and nine months ended March 31, 2022.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides Net sales as a percentage of the Company&#8217;s consolidated net sales, disaggregated by operating segment, for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cleaning</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitamins, Minerals and Supplements</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bags and Wraps</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grilling</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cat Litter</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natural Personal Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Water Filtration</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032209561296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements for the three and nine months ended March 31, 2023 and 2022, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2022, which includes a complete set of footnote disclosures, including the Company&#8217;s significant accounting policies.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Restructuring Liabilities</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Liabilities</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurs restructuring costs in connection with workforce reductions; consolidation or closure of a facility; sale or termination of a line of business; and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records employee termination liabilities once they are both probable and estimable for severance provided under the Company&#8217;s existing severance policy. Employee termination liabilities outside of the Company&#8217;s existing severance policy are recognized at the time relevant employees are notified, unless the employees will be retained to render service beyond a minimum retention period for transition purposes, in which case the liability is recognized ratably over the future service period. Other costs associated with a restructuring plan or exit or disposal activities, such as consulting and professional fees, facility exit costs, employee relocation, outplacement costs, accelerated depreciation or asset impairments associated with a restructuring plan, are recognized in the period in which the liability is incurred or the asset is impaired.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Impairment Review of Goodwill and Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment Review of Goodwill and Indefinite-Lived Intangible Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests its goodwill, trademarks with indefinite lives and other indefinite-lived intangible assets annually for impairment in the fiscal fourth quarter unless there are indications during a different interim period that these assets may have become impaired.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to goodwill, the Company has the option to first assess qualitative factors, such as the maturity and stability of the reporting unit, the magnitude of the excess fair value over carrying value from a previous period&#8217;s impairment testing, other reporting unit specific operating results, microeconomic and macroeconomic factors, as well as new events and circumstances impacting the operations at the reporting unit level. The Company operates through strategic business units (SBUs) that are organized into the Company&#8217;s operating segments. Reporting units for goodwill impairment testing purposes were identified as the Company&#8217;s individual operating segments. If the result of a qualitative test indicates a potential for impairment of a reporting unit, a quantitative test is performed. In the quantitative test, the Company compares the estimated fair value of the reporting unit to its carrying value. If the estimated fair value of any reporting unit is less than its carrying value, an impairment charge is recorded for the difference between the carrying value and the fair value of the reporting unit. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the fair value of a reporting unit as part of its quantitative test, the Company uses the discounted cash flow (DCF) method under the income approach, as it believes that this approach is the most reliable indicator of the fair value of its businesses and the fair value of its future earnings and cash flows. Under this approach, which requires significant judgments, the Company estimates the future cash flows of each reporting unit and discounts these cash flows at a rate of return that reflects their relative risk. The cash flows used in the DCF method are consistent with those the Company uses in its internal planning, which gives consideration to actual business trends experienced, and the broader business strategy for the long term. The other key estimates and factors used in the DCF method include, but are not limited to, net sales and expense growth rates, commodity prices, foreign exchange rates, inflation and a terminal growth rate. Changes in such estimates or the application of alternative assumptions could produce different results. </span></div>For trademarks and other intangible assets with indefinite lives, the Company has the option to first assess qualitative factors, such as the maturity and stability of the trademark or other intangible asset, the magnitude of the excess fair value over carrying value from a previous period&#8217;s impairment testing, other specific operating results as well as new events and circumstances impacting the significant inputs used to determine the fair value of the intangible asset. If the result of a qualitative test indicates that it is more likely than not that the asset is impaired, a quantitative test is performed. When a quantitative test is performed, the estimated fair value of an asset is compared to its carrying value. If the carrying value of such asset exceeds its estimated fair value, an impairment charge is recorded for the difference between the carrying value and the estimated fair value. The Company uses the DCF method under the relief from royalty income approach to estimate the fair value of its trademarks and other intangible assets with indefinite lives. This approach requires significant judgments in determining the royalty rates and the assets&#8217; estimated cash flows, as well as the appropriate discount and foreign exchange rates applied to those cash flows to determine fair value. Changes in such estimates or the use of alternative assumptions could produce different results.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#8221; These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations.&#160;These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. As these amendments relate to disclosures only, there are no impacts expected to the Company&#8217;s consolidated results of operations, financial position and cash flows.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of both March&#160;31, 2023 and June&#160;30, 2022, the Company&#8217;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#8217;s nonqualified deferred compensation plans, which were classified as Level 1.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Results</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates through strategic business units (SBUs) that are organized into the Company&#8217;s operating segments. The operating segments are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032214270000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING AND RELATED COSTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs</a></td>
<td class="text">The following table summarizes the total restructuring and related implementation costs, net associated with the Company&#8217;s streamlined operating model plan as reflected in the Consolidated Statements of Earnings and Comprehensive Income.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.615%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">3/31/2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Costs of products sold</span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(1)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Selling and administrative expenses</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Other (income) expense, net:</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Employee-related costs</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Total, net</span></div></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reconcile the accrual for the streamlined operating model restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the Consolidated Balance Sheets:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Employee-Related Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of December 31, 2022</span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">13&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">2&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">15&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Charges</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Cash payments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(10)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(4)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(14)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of March 31, 2023</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Employee-Related Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of June 30, 2022</span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Charges</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Cash payments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(16)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(9)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(25)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of March 31, 2023</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032214250448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories, Net</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net, consisted of the following as of:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and packaging</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIFO allowances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncurrent inventories, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current inventories, net</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Noncurrent inventories, net is recorded in Other assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032213386192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock', window );">Schedule of Impaired Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the outcome of these assessments, the following pre-tax, non-cash impairment charges were recorded:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impairment Charges</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VMS reporting unit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International reporting unit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of Goodwill as of March&#160;31, 2023 from June&#160;30, 2022, were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Goodwill</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,547&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,553&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the carrying amount of trademarks and other intangible assets as of March&#160;31, 2023 and as of June&#160;30, 2022:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.702%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization / Impairments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization / Impairments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks not subject to amortization</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks subject to amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of impaired intangible assets excluding goodwill. This may include a description of the facts and circumstances leading to the recording of impairment charges of intangible assets in the period, the amount of the impairment charges, the methods of determining fair value of the associated assets, the caption in the income statement in which the impairment losses are aggregated, and the segment in which the impaired intangible assets are reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032204703840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract', window );"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Effects of Derivative Instruments Designated as Hedging Instruments on OCI</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings (losses) were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) recognized in Other comprehensive (loss) income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings (losses)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Assets and Liabilities for Fair Value Disclosure</a></td>
<td class="text">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s derivative instruments:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase options contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase futures contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s other assets and liabilities for which disclosure of fair value is required:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.707%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-bearing investments, including money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposits</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trust assets for nonqualified deferred compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">term debt and Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,514&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,711&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,623&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company&#8217;s credit agreements, all of which are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments and Fair Value Measurements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FinancialInstrumentsAndFairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032214169424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS (LOSSES) PER SHARE (EPS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,649</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,177</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,512</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,074</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,649</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,877</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,512</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,943</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive stock options and other</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,953</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,953&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032214063184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (LOSS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Comprehensive Income</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of Comprehensive income (loss) for the periods indicated:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.015%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income (loss) attributable to Clorox</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032214152144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Stockholders Equity</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the components of Stockholders&#8217; equity were as follows for the periods indicated: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,373)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,777)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($1.16 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,358)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,670)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($1.18 per share declared)</span></div></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,232&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,277)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,130)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(498)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,396)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,961)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(546)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($3.48 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(430)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(430)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,358)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,670)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,346)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,589)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($4.72 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,232&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,277)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,130)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(498)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(459)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(498)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(546)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(498)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032214133680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Components of Net Periodic Benefit Cost</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of net periodic benefit cost for the Company&#8217;s retirement income plans:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss recognized</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized items</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2023 net periodic benefit cost is 2.7%.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032214131680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Selected Financial Information Relating to the Company's Segments</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present reportable segment information and a reconciliation of the segment information to the Company&#8217;s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.133%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,055&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,915&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,370&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,306&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (losses) before income taxes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">The earnings (losses) before income taxes for the Health and Wellness segment includes $433 of non-cash impairment charges related to the VMS business for the three and nine months ended March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">The earnings (losses) before income taxes for the International segment include $12 of non-cash impairment charges related to the VMS business for the three and nine months ended March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">The losses before income taxes for Corporate includes restructuring and related implementation costs, net for the streamlined operating model of $21 and $44 for the three and nine months ended March&#160;31, 2023, respectively. While recorded within the Corporate segment, for informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company&#8217;s reportable segments as a percentage of the total costs: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"/><td style="width:5.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.192%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides Net sales as a percentage of the Company&#8217;s consolidated net sales, disaggregated by operating segment, for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cleaning</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitamins, Minerals and Supplements</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bags and Wraps</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grilling</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cat Litter</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natural Personal Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Water Filtration</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032208428064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING AND RELATED COSTS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total restructuring and related implementation costs</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and related implementation, expected cost</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and related implementation, expected cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and related implementation, expected cost</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and related implementation, expected cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032209781376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total, net</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=clx_CostOfGoodsAndServicesSoldMember', window );">Costs of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total, net</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=clx_OtherIncomeExpenseNetMember', window );">Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total, net</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=clx_CostOfGoodsAndServicesSoldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=clx_CostOfGoodsAndServicesSoldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=clx_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=clx_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032208855488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning accrual balance</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending accrual balance</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee-Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning accrual balance</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending accrual balance</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning accrual balance</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending accrual balance</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032209661200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES, NET (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 638<span></span>
</td>
<td class="nump">$ 593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw materials and packaging</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLIFOReserve', window );">LIFO allowances</a></td>
<td class="num">(94)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_InventoryCurrentAndNoncurrentNet', window );">Total inventories, net</a></td>
<td class="nump">742<span></span>
</td>
<td class="nump">760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Less: Noncurrent inventories, net</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total current inventories, net</a></td>
<td class="nump">$ 735<span></span>
</td>
<td class="nump">$ 755<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_InventoryCurrentAndNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory, Current And Noncurrent, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_InventoryCurrentAndNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032204740704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Schedule of Impairment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill</a></td>
<td class="nump">$ 306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Trademarks, net</a></td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Total</a></td>
<td class="nump">445<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 445<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=clx_VitaminsMineralsAndSupplementsReportingUnitMember', window );">VMS reporting unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill</a></td>
<td class="nump">306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Trademarks, net</a></td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Total</a></td>
<td class="nump">433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=clx_InternationalReportingUnitMember', window );">International reporting unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Trademarks, net</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Total</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=clx_VitaminsMineralsAndSupplementsReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=clx_VitaminsMineralsAndSupplementsReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=clx_InternationalReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=clx_InternationalReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032204656464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit', window );">Impairment, tax benefit</a></td>
<td class="nump">$ 83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Amortization, remainder of fiscal year</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization, year one</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization, year two</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization, year three</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization, year four</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue', window );">Remaining net carrying value</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=clx_VitaminsMineralsAndSupplementsReportingUnitMember', window );">VMS reporting unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">$ 306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 139<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment of Intangible Assets (Excluding Goodwill), Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indefinite-Lived Intangible Assets, Remaining Carrying Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=clx_VitaminsMineralsAndSupplementsReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=clx_VitaminsMineralsAndSupplementsReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032207496624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Schedule of Goodwill) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 1,553<span></span>
</td>
<td class="nump">$ 1,547<span></span>
</td>
<td class="nump">$ 1,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="num">(306)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Translation adjustments and other</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">1,553<span></span>
</td>
<td class="nump">1,547<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember', window );">Health and Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">629<span></span>
</td>
<td class="nump">629<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="num">(306)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Translation adjustments and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">629<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember', window );">Household</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Translation adjustments and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember', window );">Lifestyle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Translation adjustments and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">595<span></span>
</td>
<td class="nump">589<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Translation adjustments and other</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 598<span></span>
</td>
<td class="nump">$ 595<span></span>
</td>
<td class="nump">$ 589<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032209764080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Subject to amortization, accumulated amortization</a></td>
<td class="nump">$ 578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 418<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">884<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment', window );">Not subject to amortization, before impairment</a></td>
<td class="nump">666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset impairment</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Not subject to amortization</a></td>
<td class="nump">527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Subject to amortization, gross</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Subject to amortization, accumulated amortization</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Subject to amortization, net</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Subject to amortization, gross</a></td>
<td class="nump">578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Subject to amortization, accumulated amortization</a></td>
<td class="nump">402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Subject to amortization, net</a></td>
<td class="nump">$ 176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indefinite-lived Intangible Assets (Excluding Goodwill), Before Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032201490688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER LIABILITIES (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_VentureAgreementOptiontoExtendAgreementTermPeriod', window );">Option to extend agreement (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_VentureAgreement.TerminalObligation', window );">Venture agreement, terminal obligation</a></td>
<td class="nump">$ 527<span></span>
</td>
<td class="nump">$ 635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_VentureAgreementTerminalObligationNet', window );">Venture agreement terminal obligation, net</a></td>
<td class="nump">$ 492<span></span>
</td>
<td class="nump">$ 468<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=clx_GladBusinessMember', window );">Glad Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_PercentageofOwnershipbyVenturePartner', window );">Percent ownership by venture partner</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_PercentageofOwnershipbyVenturePartner">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership interest by the venture partner.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_PercentageofOwnershipbyVenturePartner</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_VentureAgreement.TerminalObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Venture Agreement. Terminal Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_VentureAgreement.TerminalObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_VentureAgreementOptiontoExtendAgreementTermPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Venture Agreement, Option to Extend Agreement Term Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_VentureAgreementOptiontoExtendAgreementTermPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_VentureAgreementTerminalObligationNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Venture Agreement, Terminal Obligation, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_VentureAgreementTerminalObligationNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=clx_GladBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=clx_GladBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032208233328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge', window );">Maximum duration, foreign exchange contracts (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1', window );">Maximum duration, interest rate contracts (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount', window );">Amount of derivative instruments subject to contractually defined counterparty liability position limits</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill, trademark and other asset impairments</a></td>
<td class="nump">445<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">445<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase derivative contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarginDepositAssets', window );">Cash margin balances amount</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=clx_PurchasesofInventoryMember', window );">Purchases of Inventory | Foreign exchange derivative contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_CommodityPurchaseDerivativeContractsAxis=clx_TotalCommodityPurchaseDerivativeContractsMember', window );">Total Commodity Purchase Derivative Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1', window );">Maximum duration, commodity contracts (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative instruments subject to contractually defined counterparty liability position limits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarginDepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash or securities placed with a broker or counterparty as security for a trading or derivatives securities position which was partially obtained with funds provided by the broker dealer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarginDepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum period the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=clx_PurchasesofInventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=clx_PurchasesofInventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_CommodityPurchaseDerivativeContractsAxis=clx_TotalCommodityPurchaseDerivativeContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_CommodityPurchaseDerivativeContractsAxis=clx_TotalCommodityPurchaseDerivativeContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032201730080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (losses) recognized in Other comprehensive (loss) income</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings (losses)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase derivative contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (losses) recognized in Other comprehensive (loss) income</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings (losses)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange derivative contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (losses) recognized in Other comprehensive (loss) income</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings (losses)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate derivative contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (losses) recognized in Other comprehensive (loss) income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings (losses)</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032208230672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liabilities</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liabilities</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase options contracts | Fair Value, Inputs, Level 1 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liabilities</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase options contracts | Fair Value, Inputs, Level 1 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liabilities</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase options contracts | Fair Value, Inputs, Level 2 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liabilities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase options contracts | Fair Value, Inputs, Level 2 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liabilities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign exchange forward contracts | Fair Value, Inputs, Level 2 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign exchange forward contracts | Fair Value, Inputs, Level 2 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032201603520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 242<span></span>
</td>
<td class="nump">$ 183<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">5,818<span></span>
</td>
<td class="nump">6,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Notes and loans payable</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,646<span></span>
</td>
<td class="nump">5,429<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,614<span></span>
</td>
<td class="nump">2,711<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets, estimated fair value</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities, estimated fair value</a></td>
<td class="nump">2,514<span></span>
</td>
<td class="nump">2,623<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | Carrying Amount | Trust assets for nonqualified deferred compensation plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Trust assets for nonqualified deferred compensation plans</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | Estimated Fair Value | Trust assets for nonqualified deferred compensation plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Trust assets for nonqualified deferred compensation plans, estimated fair value</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Carrying Amount | Current maturities of long-term debt and Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Current maturities of long-term debt and Long-term debt</a></td>
<td class="nump">2,476<span></span>
</td>
<td class="nump">2,474<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Carrying Amount | Notes and loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Notes and loans payable</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Estimated Fair Value | Current maturities of long-term debt and Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Current maturities of long-term debt and Long-term debt, estimated fair value</a></td>
<td class="nump">2,376<span></span>
</td>
<td class="nump">2,386<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Estimated Fair Value | Notes and loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Notes and loans payable, estimated fair value</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Interest-bearing investments, including money market funds | Fair Value, Inputs, Level 1 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Interest-bearing investments, including money market funds | Fair Value, Inputs, Level 1 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents, estimated fair value</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember', window );">Time deposits | Fair Value, Inputs, Level 2 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember', window );">Time deposits | Fair Value, Inputs, Level 2 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents, estimated fair value</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShorttermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShorttermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=clx_NotesAndLoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=clx_NotesAndLoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032213378976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate on earnings from continuing operations</a></td>
<td class="nump">14.70%<span></span>
</td>
<td class="nump">23.90%<span></span>
</td>
<td class="nump">1813.50%<span></span>
</td>
<td class="nump">23.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032201491936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS (LOSSES) PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">123,649<span></span>
</td>
<td class="nump">123,177<span></span>
</td>
<td class="nump">123,512<span></span>
</td>
<td class="nump">123,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of stock options and other (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">869<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">123,649<span></span>
</td>
<td class="nump">123,877<span></span>
</td>
<td class="nump">123,512<span></span>
</td>
<td class="nump">123,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive stock options and other (in shares)</a></td>
<td class="nump">4,953<span></span>
</td>
<td class="nump">2,489<span></span>
</td>
<td class="nump">4,953<span></span>
</td>
<td class="nump">2,489<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032204657536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="num">$ (209)<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
<td class="num">$ (20)<span></span>
</td>
<td class="nump">$ 367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net unrealized gains (losses) on derivatives</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and postretirement benefit adjustments</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="num">(205)<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="nump">394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Total comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income (loss) attributable to Clorox</a></td>
<td class="num">$ (207)<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
<td class="nump">$ 388<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032204816240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Schedule of Equity) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 1.18<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="nump">$ 4.72<span></span>
</td>
<td class="nump">$ 3.48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 491<span></span>
</td>
<td class="nump">$ 491<span></span>
</td>
<td class="nump">$ 729<span></span>
</td>
<td class="nump">$ 592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,152,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance, treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,589,329)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="num">(209)<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="num">$ (20)<span></span>
</td>
<td class="nump">367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends to Clorox stockholders</a></td>
<td class="num">(147)<span></span>
</td>
<td class="num">(143)<span></span>
</td>
<td class="num">(587)<span></span>
</td>
<td class="num">(430)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Dividends to noncontrolling interests</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesAmount', window );">Other employee stock plan activities</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 172<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="nump">$ 172<span></span>
</td>
<td class="nump">576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, common stock (in shares)</a></td>
<td class="nump">123,611,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,611,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance, treasury stock (in shares)</a></td>
<td class="num">(7,129,995)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,129,995)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, common stock (in shares)</a></td>
<td class="nump">130,741,000<span></span>
</td>
<td class="nump">130,741,000<span></span>
</td>
<td class="nump">130,741,000<span></span>
</td>
<td class="nump">130,741,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, common stock (in shares)</a></td>
<td class="nump">130,741,000<span></span>
</td>
<td class="nump">130,741,000<span></span>
</td>
<td class="nump">130,741,000<span></span>
</td>
<td class="nump">130,741,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 1,207<span></span>
</td>
<td class="nump">$ 1,180<span></span>
</td>
<td class="nump">$ 1,202<span></span>
</td>
<td class="nump">$ 1,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesAmount', window );">Other employee stock plan activities</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">1,232<span></span>
</td>
<td class="nump">1,195<span></span>
</td>
<td class="nump">1,232<span></span>
</td>
<td class="nump">1,195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">782<span></span>
</td>
<td class="nump">949<span></span>
</td>
<td class="nump">1,048<span></span>
</td>
<td class="nump">1,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="num">(211)<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="nump">361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends to Clorox stockholders</a></td>
<td class="num">(147)<span></span>
</td>
<td class="num">(143)<span></span>
</td>
<td class="num">(587)<span></span>
</td>
<td class="num">(430)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesAmount', window );">Other employee stock plan activities</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">415<span></span>
</td>
<td class="nump">951<span></span>
</td>
<td class="nump">415<span></span>
</td>
<td class="nump">951<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">$ (1,297)<span></span>
</td>
<td class="num">$ (1,373)<span></span>
</td>
<td class="num">$ (1,346)<span></span>
</td>
<td class="num">$ (1,396)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance, treasury stock (in shares)</a></td>
<td class="num">(7,263,000)<span></span>
</td>
<td class="num">(7,777,000)<span></span>
</td>
<td class="num">(7,589,000)<span></span>
</td>
<td class="num">(7,961,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesAmount', window );">Other employee stock plan activities</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesShares', window );">Other employee stock plan activities (in shares)</a></td>
<td class="nump">133,000<span></span>
</td>
<td class="nump">107,000<span></span>
</td>
<td class="nump">459,000<span></span>
</td>
<td class="nump">443,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(152,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (1,277)<span></span>
</td>
<td class="num">$ (1,358)<span></span>
</td>
<td class="num">$ (1,277)<span></span>
</td>
<td class="num">$ (1,358)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance, treasury stock (in shares)</a></td>
<td class="num">(7,130,000)<span></span>
</td>
<td class="num">(7,670,000)<span></span>
</td>
<td class="num">(7,130,000)<span></span>
</td>
<td class="num">(7,670,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Net (Loss) Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">$ (502)<span></span>
</td>
<td class="num">$ (574)<span></span>
</td>
<td class="num">$ (479)<span></span>
</td>
<td class="num">$ (546)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(498)<span></span>
</td>
<td class="num">(519)<span></span>
</td>
<td class="num">(498)<span></span>
</td>
<td class="num">(519)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Dividends to noncontrolling interests</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 169<span></span>
</td>
<td class="nump">$ 176<span></span>
</td>
<td class="nump">$ 169<span></span>
</td>
<td class="nump">$ 176<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherEmployeeStockPlanActivitiesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount includes the value of stock granted during the period as a result of exercises of employee stock options or vesting of other share-based awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherEmployeeStockPlanActivitiesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherEmployeeStockPlanActivitiesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of exercises of employee stock options or the vesting of other share-based awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherEmployeeStockPlanActivitiesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032201078608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive net (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="num">(502)<span></span>
</td>
<td class="num">(574)<span></span>
</td>
<td class="num">(479)<span></span>
</td>
<td class="num">(546)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from Accumulated other comprehensive net (loss) income</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax benefit (expense)</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="num">(498)<span></span>
</td>
<td class="num">(519)<span></span>
</td>
<td class="num">(498)<span></span>
</td>
<td class="num">(519)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="num">(459)<span></span>
</td>
<td class="num">(431)<span></span>
</td>
<td class="num">(448)<span></span>
</td>
<td class="num">(403)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from Accumulated other comprehensive net (loss) income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax benefit (expense)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="num">(449)<span></span>
</td>
<td class="num">(412)<span></span>
</td>
<td class="num">(449)<span></span>
</td>
<td class="num">(412)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Net unrealized gains (losses) on derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from Accumulated other comprehensive net (loss) income</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax benefit (expense)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension and postretirement benefit adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(161)<span></span>
</td>
<td class="num">(152)<span></span>
</td>
<td class="num">(164)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from Accumulated other comprehensive net (loss) income</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax benefit (expense)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="num">$ (149)<span></span>
</td>
<td class="num">$ (159)<span></span>
</td>
<td class="num">$ (149)<span></span>
</td>
<td class="num">$ (159)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032209991424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermInterCompanyLoansMember', window );">Long-Term Inter-Company Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from accumulated other comprehensive net (loss) income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermInterCompanyLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermInterCompanyLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032204630144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 17, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clx_RetirementIncomeMember', window );">Retirement Income Plans | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_DefinedBenefitPlanPlanTerminationPeriod', window );">Plan termination period</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clx_RetirementIncomeMember', window );">Retirement Income Plans | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_DefinedBenefitPlanPlanTerminationPeriod', window );">Plan termination period</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clx_RetirementIncomeMember', window );">Retirement Income Plans | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Discretionary contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DefinedBenefitPlanPlanTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Termination Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DefinedBenefitPlanPlanTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=clx_RetirementIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=clx_RetirementIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032208858160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Weighted average long-term expected rate or return on plan assets (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan | Retirement Income Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlement loss recognized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of unrecognized items</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=clx_RetirementIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=clx_RetirementIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032201459968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONTINGENCIES AND GUARANTEES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Liability for aggregate future remediation costs</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_LetterOfCreditBorrowingCapacity', window );">Letter of credit</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letter of credit, amount outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_AlamedaCountyCaliforniaMatterMember', window );">Alameda County, California Matter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Liability for aggregate future remediation costs</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_RemediationPeriod', window );">Remediation period (in years)</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_MaximumExposureUndiscountedCost', window );">Maximum undiscounted costs</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_DickinsonCountyMichiganMatterMember', window );">Dickinson County, Michigan Matter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Liability for aggregate future remediation costs</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_RemediationPeriod', window );">Remediation period (in years)</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_SiteContingencyAgreedPercentageOfCostSharing', window );">Percentage of liability for aggregate remediation and associated costs, other than legal fees</a></td>
<td class="nump">24.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_LetterOfCreditBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_LetterOfCreditBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_MaximumExposureUndiscountedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) that the Company could incur over an estimated remediation period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_MaximumExposureUndiscountedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_RemediationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_RemediationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_SiteContingencyAgreedPercentageOfCostSharing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_SiteContingencyAgreedPercentageOfCostSharing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForEnvironmentalLossContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs accrued as of the balance sheet date for environmental loss contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13237-110859<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13207-110859<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 5: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13237-110859<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 55<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=6571209&amp;loc=d3e13703-110860<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForEnvironmentalLossContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_AlamedaCountyCaliforniaMatterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_AlamedaCountyCaliforniaMatterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_DickinsonCountyMichiganMatterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_DickinsonCountyMichiganMatterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032208449296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS (Narrative) (Details) - reportableSegment<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer | Customer Concentration Risk | Walmart Stores, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=clx_WalmartStoresIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=clx_WalmartStoresIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032206471600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS (Reportable Segment Information ) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,915<span></span>
</td>
<td class="nump">$ 1,809<span></span>
</td>
<td class="nump">$ 5,370<span></span>
</td>
<td class="nump">$ 5,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="num">(245)<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total restructuring and related implementation costs</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill, trademark and other asset impairments</a></td>
<td class="nump">445<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">445<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=clx_VitaminsMineralsAndSupplementsReportingUnitMember', window );">VMS reporting unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill, trademark and other asset impairments</a></td>
<td class="nump">433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=clx_InternationalReportingUnitMember', window );">International reporting unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill, trademark and other asset impairments</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=clx_RestructuringAndRelatedCostsBenchmarkMember', window );">Restructuring and Related Costs | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health and Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 707<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="nump">$ 2,054<span></span>
</td>
<td class="nump">2,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="num">$ (290)<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="num">$ (72)<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health and Wellness | Restructuring and Related Costs | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Household</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 550<span></span>
</td>
<td class="nump">539<span></span>
</td>
<td class="nump">$ 1,435<span></span>
</td>
<td class="nump">1,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="nump">$ 165<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Household | Restructuring and Related Costs | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Lifestyle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 353<span></span>
</td>
<td class="nump">306<span></span>
</td>
<td class="nump">$ 1,005<span></span>
</td>
<td class="nump">961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
<td class="nump">239<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Lifestyle | Restructuring and Related Costs | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 305<span></span>
</td>
<td class="nump">302<span></span>
</td>
<td class="nump">$ 876<span></span>
</td>
<td class="nump">886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International | Restructuring and Related Costs | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="num">$ (152)<span></span>
</td>
<td class="num">$ (73)<span></span>
</td>
<td class="num">$ (371)<span></span>
</td>
<td class="num">$ (224)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate | Restructuring and Related Costs | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">66.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=clx_VitaminsMineralsAndSupplementsReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=clx_VitaminsMineralsAndSupplementsReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=clx_InternationalReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=clx_InternationalReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=clx_RestructuringAndRelatedCostsBenchmarkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=clx_RestructuringAndRelatedCostsBenchmarkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140032201427504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS (Net Sales Percentages) (Details) - Revenue from Contract with Customer - Product Concentration Risk<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Health and Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Health and Wellness | Cleaning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Health and Wellness | Professional Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Health and Wellness | Vitamins, Minerals and Supplements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Household</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Household | Bags and Wraps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Household | Grilling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Household | Cat Litter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Lifestyle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Lifestyle | Food</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Lifestyle | Natural Personal Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Lifestyle | Water Filtration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_CleaningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_CleaningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_ProfessionalProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_ProfessionalProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_VitaminsMineralsAndSupplementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_VitaminsMineralsAndSupplementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_BagsWrapsAndContainersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_BagsWrapsAndContainersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_GrillingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_GrillingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_CatLitterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_CatLitterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_FoodProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_FoodProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_NaturalPersonalCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_NaturalPersonalCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_WaterFiltrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_WaterFiltrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>clx-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:clx="http://www.clorox.com/20230331"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="clx-20230331.xsd" xlink:type="simple"/>
    <context id="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i38686ba1b880423d945d44ba0aa0dc33_I20230418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2023-04-18</instant>
        </period>
    </context>
    <context id="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if8436d472730424da132f275fca3c42a_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i85cd7ba9934b45cfb7d15022292a50e0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i38db454957ae42d1a879575c446b836f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icf74c279d583412eaba0df33f84a8dd7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id7a142fe888d4dbf8b9d78f7d4a764bd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icca7cfce0fa141dea44cb9ce7a326899_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i06d000a1aa834bbfac4282e34d583a60_I20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="ib2c8765c01654490b2b1c05a7f10e95c_I20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="i3aa3d22372b64584acb9882537a6dd42_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">clx:CostOfGoodsAndServicesSoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iba59125bcc944eaab44b48bc55a3dc85_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">clx:CostOfGoodsAndServicesSoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9ded3b682518451f87217f49e6d97925_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6f615042f4614c5ca2aa6f2698e2ecdc_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i36e02fa510054f06be615621c9bd2ecd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">clx:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iad19817ded2e45cb9d95810868eafeea_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">clx:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id690da8b06c34b2db6496eb0743cd318_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb802f1785e94392ab45e3ccd217a284_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i058a79b88ddf43df8b916f862dfc5bf7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0ae0d275a3c3490d8d3fad6bff44ecc3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7a1d7d8632bd40d6918c50fe8c44ac85_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i37c8da2bf20c490596a15b4866b80871_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i597c023bc1a04a0b99911d165820e8b0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i51a13a9df4a44b17b6fe45952facdb9a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia25937b8293b44c98ede6be445bfbd4f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8f92c48a282547ff99ddf8f3b5d7f2f5_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4dd70a15f7a94b8baa949563effef687_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id94ba9c2186c47749a192c36f50af6e2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">clx:VitaminsMineralsAndSupplementsReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if866eca78fc44cb985650980c0effb9e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">clx:InternationalReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i14a182d0cd5c4d15965a7e7a7bfdc653_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">clx:VitaminsMineralsAndSupplementsReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1963ee82a44d46ffa8708d4e456f329c_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">clx:InternationalReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2f45254db7c44fd7baa3242ec875ed30_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i30dd390ea6b04c08a6b35540c0fd90d5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if51281e120fb4c9aa9d0c0f419704d3e_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifc9854de4e3c4c0985eef6728fd978cf_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia2cff198bfe644e0a8fb1825c00677d3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie62ad774357041f9ae5c145530854b8e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8e18cafffa494d9cb9daca6284175f4f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i72eb4644e3f447fe8259fdad6f8dde47_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0d6d75e5aa7b47e588ee1b82de531670_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i791d5f02e170464bb461195b53387d4d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i614e96f28f6b441c978c88983621bfff_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic42f71e1a2c44eb8bfbfca5078fdca23_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0a5483738f5a46b9a4300446be65ea03_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie8d385e83a0148869431bc29b025489b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i521e232ee0064169882cd1c6588b7510_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i85730fdfbb9c48a58317696007eac6f3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i660f20ab0c1946359ba21c70908a1443_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibf58e03903bd40ebbfded435df15b857_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5ff79fb466cf4f528c2057c39855c6fc_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i61861cccc66e4af39cd5f905d2e6e973_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2260b79bc57d4a56a8a43db5b050892e_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia81dc710789a4279b293057273b0585e_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0ec0696cfea245148b8cb3ed95489d83_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e028c529aca4fe2a5bc96136e9b1d3d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3db36ab2a08e4e5e9acec297698a1d58_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4c4931a784644dbc9654624dc6378c3d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i974dd2e411d44a7387a3a78f3494eff1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaa6881da3a99458c8448602633dde541_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1a5033b4e8dd41c2a30bdc0f5f38c4d7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5b73e43b25f6458dbd1f98100fb99374_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i90ccd04fdd2047da9e06c4f3f203df6e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i553b47cda5624d2b9e5b9b4464cbf54b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i97da66cd682045d0a6cf64a53511a50f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i491dec08e3a04e15884928a98985d9ed_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i152e3a4caade4045835fdf23b4333786_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8437cff6d6ba45528bcf1bb542174783_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia20a96df8ee1438397ac0e1012769f4a_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i88cfb390480c455eb1a2978c32713180_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i38e791e368ab43409f15ba5e5f5cd67b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0463f04d5ee3451b946c7af6a61845ef_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia26f11b6660a4abcb09094cf9a8a25c1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clx:GladBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icc15044a51144f99b1b95c3d077cfd0a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clx:GladBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i48ad1cc1bb794a76b3dd0815532c06b3_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id06bee842a75404dac41877bdd92d1ef_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia8a40de0484b4eeb80b4fe9c2b92525f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icf2ca00060704f22aa28947a2c33bf44_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">clx:PurchasesofInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2159f0fecc5b4470982d356c86f23bf9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">clx:PurchasesofInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifd98f18f73954c73b67fcb63121d3a6a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie5e38353ad8c45ebbbeeb1760836023e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i267e13abd2ac4080863d5a4b5a5a1008_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia50e5e1f44b94908af2b9b0f33a06f5d_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib90adbece5bb496490f8e0ada42889bf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i53d784e371024289a6bb1733a0bfeceb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i06467bddcdcd40afaf9fc6a5d8f585b6_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i59a5dd038e5d4dc8a7529d286f2503b1_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i84aeaaa8c3d24da2a83bccbe80c40d7c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7569e47c817545e8b392a1799c23bb90_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i62117e14e9614a8b8aae02999044878f_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i66b892c371534620b3587d9e0450ac51_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i66b2684d698e4766b9ae15f0597d7fdf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8f46aa97434e48e89c802561e09aac43_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic9edfde63c0c497e88e10ce6f5c5636f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i77a4addd4aa1435083c94a016faebc92_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icc0a6e589f2b483990fd8b1228aa3c8a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icbea6dcd3f5647a9bf12d9d534a6ca9c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8d413ac1c4d04865a4e5fe3b340023a7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i992290ad5dc147a89b2dc02782ff64ef_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i287e76237d8c427fa8b74226bacd7498_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iaa9b879156664a4cabe4b0c19b072452_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if09b23e716734285ad99334813cdd1c7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i73735ddebada41feb165c246aab6ce4a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2f6555be7a9e4d239338043a0facd422_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6f7ebc1c469348ed885bc1105f8fc3df_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6a68f814db4a4c5c95ed1bd0205e0034_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idb497008d82d4021908269a98083af08_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i03ee318c0e494e0981bcc1c4c86ac0c3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5f23483af02142ff962e0bc8a46b198f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia680265241d34120bcbc6e5b1c032c3a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib949b42e3d64447f9f9da32d8fe053fc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6b1b18d9575c4fe181987e3bdf974c55_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib19d64991cb241db9d152df2af96652c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7a98cb40f89c4f6cb3174cc2385cfdc3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iec4aaa03ddf14edab361fbdbd7af4a28_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idd50e0a93db949dc86a0a76dea201d7e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icdc22c41b65b44f5910fb2bd6e7aa7ef_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id77511cc08ae4fada9800a2edf805e8d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i699f3ca3c5db4d5bba548627af449cf4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i80dda40f54024046ade281e97268afde_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icb50e89eb9054e9497f1a6390acb66df_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9a4b9990a76749d7b5b429e19b132705_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7abd7c745142489ba717edbad8ecc1b6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if177937c7cde476eace985e08c46bb5a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i86811defe6884c9b8f1c17dcfaada1ff_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3b50460a1b234ac3b19dc457a1b696e6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2e23b9c3471546129e5eb560eabed6b9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i37e76d4ac9234a0186486ff3b55d6a18_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iaff929c5c7ef4f728e2ba0db462af797_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i09e3af3669ef426badcf844049084f14_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd45a75514c24c568a56042ccd0c84da_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i05ffbff4ac6b4a4b91ae2e1f6beaafa4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifae1e2814de34b5eb8043ef76cff06a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i575dfed5180b41c380550a620ea3e540_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic4e77e9c323c43acad3d23fd72036b5f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i565b4c1e42f94eb2b2d7e89045b94abc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9fb985ea42574447abbdeb651a94e290_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1a8f4562f03f485b9222b7cce528e697_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0ab076bc30324400b05fae96ad5d777d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i790c9340393b4fb0b02a7296fadf9609_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifa3654eea4d143be9e65477225892c33_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9bca9d2ecd9e481aa1ead4b270214e56_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i56725ff0d43240d19e4b0e41d908614a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i95257d576dfd45148c1997c326e7020b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i93ed62d82fff40e495d855e264b32bc4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0e4a56d9d98a4157b2c6e3bb88276c9b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1998332848f548599b1f44f8389dcf4c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibe250680c3cb4a2d9422e47ecfbb9232_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i349984d984ac4a6dbf6cfa7d1779d9c9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0578ecbdca4a4b0683cb8154b35f6aea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i71a1dcd718bb44bfb1a91f3a99cb0ad7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibf167b776ade4df7b590155e62a3f0fa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic441f564bc3e4f1fa09858858b3e6ba6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e561b7b255d422cbcdac071c1398d6a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6170471920d746bcb25579e59b005902_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia33168f0db0843d685d4b21fe4e5edda_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i428de1acdef7408cacf083e495bd1acc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib8ebbe87a5b44f8e86adb6c537baa365_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ice2dbf9b838649879e0d1331a95d0191_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i382bd8dd06684d658f4f850a93ab45ab_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idc1249e856e0404fa74fe81e86ac37b5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9d7a9d9e6abc4064872b7d412c2a4ff8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if3b6333e92ce42d7ab3cda6056f7c98a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i62c0fe22bbdb4fb083de7d9a1d7d1f45_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifd6ece4973e949d08182806d9a323160_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iacc1e22ac19d48209ceace90c3d5b926_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i73dbb3c50d1647ceb59c25ac8d3093fb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6fef3da8c9d340c6996ac9bd4e846ef1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i38dd7f792041456cbe661ea31eb94219_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5409859b1d8845f0aff788c9db7c4c79_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id6228167648a4c80885f8515c358e74c_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5cb19050263443049c6a5d3e0839f6cc_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if811f809413d4a6bb8691c5fcaa43e23_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8d8d459930ee4918898527d3560df45e_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0606e8ef65d840a58c50419adf1e8e08_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2cbd00ee054d4a0ea683f3e69c3f144c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i21ccc62d5ccc400ca14bf9ef81476443_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i82ec983182ab42d7bee00f12f996858a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie20aff337cf646b68d54fb6090aa44eb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i789c01c0eea04f1d858ad3fba90164ed_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if5da3d885a8845f889db9160bcd4730c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i372b14b520094c4382db02e9bc4689f9_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iefab848d9a3b4ce984a98c0628e4cabb_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia9e6c3f82aac456096e02558c7413ecd_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7296f62c815b4fb88cc0fabc30e4a5f3_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2cd390a11523485798e09a245d293c38_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id54b8127809f4f009450878e1f47eab0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec972b6c609643939ebb658b21202380_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i10105acceec642bab440c62b4e41da18_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7e58ebc3d00448981b37243d360d5b8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6cd10304fb1c43b798f36d9855e3a674_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i639e65a448654d5d87000a3caa18af16_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie85c1700bb824cf3a99834757ca0345d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8d7840b6eb44467d910474da7f5cf458_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib7941953b83146c2b4fd8a2efddca131_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifd5d1bb8964841e785fdf870e1cd9c1f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia0ed5f67bc8e489fbf38eea7a87acb42_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icb003230a88c4000aac4e5c07d393cd2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i20cdde6a918646608cafb482b69c1374_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5b260ed4689a4167aedbbe4c6e8d5aed_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7e2a1cf474674d64b709b61efc4388c7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9a904ed9259247ed803bd9c4575c448b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8624504988204f299f5466845c6db945_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i991ef5bf9ed442ca8531f36420575a16_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7bb0aa974c214b5e853f0cc3ae70a268_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia520dd3f71774e2b89b0bbe17d6294b9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0158083bc55c4728ad23a8bd5fdf8b21_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia7d813979e3847bf94273f4ad7b0ec5c_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3a0052b2ab86487f95d0cc11ca0882df_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idbbbb87becc84b54bf3ad91efbb9dc00_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i70b0eab852154e4abb63bef64c0c9253_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i99ba1c772ca743cab239215ff58256f1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic03507f6901a459cbfc9f1686e275800_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i74cca342e02946e285f57be15d303376_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3b245889d00f4e2eb4062bb56ecd5f01_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib6f7d0c924ce46a4a0fab6f32137e185_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i25f320caf7334b4da9436fd1f08de3df_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i584c8b4ed6394f1d93786bbc0dc674af_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie1af7dfaca4b4bb4939e8512479b3d34_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifa6abb84427f42ceb43e887b2e70e3aa_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1b73d8a1cfaf475cb132b48a9922e0b3_D20220517-20220517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-17</startDate>
            <endDate>2022-05-17</endDate>
        </period>
    </context>
    <context id="i72e948a45d844caaa808077789bc9946_D20220517-20220517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-17</startDate>
            <endDate>2022-05-17</endDate>
        </period>
    </context>
    <context id="if97497268cb046da9dca9748a32e4bbb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i246ce3736a7a4184875d648605151755_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i69b9322d04104475b3bd0b3239f85400_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i925a3774c2804469a6e6a80652cf53fb_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6c9faa6e294049b0b02b4ca616aef8d4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5018154f07a6473082b19c7019bb5815_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i559a56b3ed7f4dad8b0eb215d3b4d96e_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icb1bd9ce8db14db8b42305bf898b2988_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1215ef2fd713408c9543e79c8cf060d0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7407b536aaac44c9a0ef22436412b35c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iac8c0a67be954e91bf9ca146dc56b8af_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5fc0efb36d7e490a8d10a178a4f95683_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic71f7f98850c425cb50e81ac8cee6715_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if9807c06a76d40c0ae21df8a99a25033_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iffcf3e3d97fe478ba53f98097b7768d3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3033698cc9d446b98ebb51f2cc6a8fc7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id8b819629ac7412c9fa594839a2ca9ee_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib8d519a96f9042bc8dcb0510d40a1b4e_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7b20ce7569f946f996cfe02a046120e8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i37775bc712c546ebbc80496c37c9b997_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7c9d7f9d14d24f99895d7cf206821b4b_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4031a9dd94ae4d12aae506d6f2f1db96_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ief9575da4e024669a982592f716c50d9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7dc7ce1afe424640808a9e7de9aa36a0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie71b9480776e436f9c519240052f7677_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5d021f6c3597425098add480ff912297_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icce3534c232c40299861e02393f34ae2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8021e9a77dd946919cfb390e149fbf16_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic5de8a3a44dc424bbd78630823dbc605_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifca9fa030b7e4d4d857d843d0538b755_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icedf8ca64b12469f8b334ea1c52ce44f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic113bbab87514834aeff65f9dcd2d9ea_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib82d343ec2d2457491346026e4a1384b_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i008bd39b3c1441d28f56d156aa4e0e13_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i06b7961dd4ab4d08b1f59fd5cecff3e8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if8cd31d1d39a4a1dad35192d8a05943e_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iae7e934f7d3345e38420a6419068a3d5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4827a5147dae403184de103cfa7cb609_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iea0e1ddc7df0436291cc964f291d7156_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2c370fc073ec40fc9f41fba7ceb625bf_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i51a5efc4b1ce48669aeefd4046d6b146_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibc836f2559f64ad48298463711e54cef_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2d7befdad82d4d418a5d6f0c05a4d46a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5f58e61108af4223b214e3fe0d5d2094_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4e525b30dbd84ad096b5a005cb6c06b7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6ed91cca97714a74bfef07a13999207e_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i376f067722d54b38b9d07d5df655a930_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie7a17140503d4ae99e2c3110f5493890_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i534b552133ab458393a04aa68bb98837_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2bcfd545b0374fbdb3542e9d143d4386_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4ff574e3aa2743caabd5efe4f9812b66_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib002fea2011949d68a0bf85c0cd5f82f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6ca63fe7639d421784a23dec0aad3de2_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5f0cd8998a3d48ed956c2195a10e4a96_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3cdb483b522a49da8b6e69c8bfb68e8b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i48472411ffc14234a19c3b450fcd82c8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if3eb238ad2564e2fb6be808234d4fb8a_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i629e3b1f030e4ce897713db4360a2347_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9db2e760489b4c11a3d33f81189967c9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i39223577acf644679357f58a1290bd2a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie881bce8f5334f7aab4e543c319a5926_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idbae45119cfa4a5c8b13e22928f50489_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ice64939ca72241c09ec2b7d83c993371_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i50673219f145422f8c076edc553d124d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id28fe0fdacae42b3a9ca317dc63e5d74_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1beaeabc59b0460b9b16920dc20b95a4_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i95fdb90c917e4246b77256a7203284f4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i63cbaccfe8b441e0b139019ea3e13e72_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i113699d3252e4e2d9ff0cd35976a5b8c_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2fbb109938324676a455905b3813090f_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i57adcb1929154f35951a65c97a1a9eec_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i787f1a9b3f7a4dc8b0d448fa0c26e975_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i989a32ba4f8d4a9d8454b53f177bf23d_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i72213a90a16e4a55bf5162ceee1ad06b_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iecbb9ee292dc40f8a27a70a208e98f03_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i503ca72ebec94846ab018289383f13fa_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ieda62ebce8934fb09ef0adb92b5f7803_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i055b0b22709c429cbd64d4daebac1297_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8a65275769d74bf48e3a461bc2e6a39d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icb5c1ab1b82640178fbbc21e8512a431_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id2436443839a40d6b25b269f3515ff1c_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie58eaa3597cd43668b6d4a0be6618155_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iec1abcd1af04423ca693619b5556f630_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9de0a48a571549d3b006153987874a47_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i63c6253b79704765be3a2886b72dc7ca_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib18537f4ac7f4342b5c6624f2b7bf768_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4a97ed3b14274b9b830776063e4410c8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if2f5fb7871c7436b900d2cd3d8311c5f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0f41877e3cc24d2ab82f800b4e54b330_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i114f5fcb844c4cd48afc6773bae7de68_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic47b0bf2f6b74406ae63df384f0f2170_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8b2275a8baa74a81974673ca3c98e934_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i63be3d36820c4c14aeb977054b7bd9ef_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic9c4181e447f4561894f05c7189939a9_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2fcc63cd4e714eeeb040154124f4230f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icaa89fb3550f4a919ddc0549b774313a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i141a04ca2b22429d966e6c25a5ba5b9f_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib0aa39c9b9204bc7812195ead8b31158_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i964cbc2a36904c2c953e83d44d0db963_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i90c7b45b7f53405ea50b2def6902b7ec_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i80debe7af7c04b0d8001e647ecf24389_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if63670b5302b4743b3c30e0b8aadda12_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i788105bef8f040c3abaaec1851973630_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i119fc41a359743d585ccf388679848e8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib082af343f52451fb96251c408730857_D20220701-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2d29d27dc57146a59614c80c2341fa42_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="reportablesegment">
        <measure>clx:reportableSegment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80L2ZyYWc6YmUxMzUzNjlhNDYwNDIxMWIwZDYwMzg1NmU1OWYxM2UvdGFibGU6OWU2NjU1Y2Q1YjgyNDg2MWJkOTdmMGM5YzVlYTdhZDEvdGFibGVyYW5nZTo5ZTY2NTVjZDViODI0ODYxYmQ5N2YwYzljNWVhN2FkMV8zLTEtMS0xLTE0MjY4MA_cec62ae2-451c-49c7-bb73-2175e16b7c84">0000021076</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80L2ZyYWc6YmUxMzUzNjlhNDYwNDIxMWIwZDYwMzg1NmU1OWYxM2UvdGFibGU6OWU2NjU1Y2Q1YjgyNDg2MWJkOTdmMGM5YzVlYTdhZDEvdGFibGVyYW5nZTo5ZTY2NTVjZDViODI0ODYxYmQ5N2YwYzljNWVhN2FkMV80LTEtMS0xLTE0MjY4MA_50e22c04-a559-48f6-948d-846ad6f04547">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80L2ZyYWc6YmUxMzUzNjlhNDYwNDIxMWIwZDYwMzg1NmU1OWYxM2UvdGFibGU6OWU2NjU1Y2Q1YjgyNDg2MWJkOTdmMGM5YzVlYTdhZDEvdGFibGVyYW5nZTo5ZTY2NTVjZDViODI0ODYxYmQ5N2YwYzljNWVhN2FkMV81LTEtMS0xLTE0MjY4MA_e5df5593-b3de-41ed-aa2d-dd36e323c4a6">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80L2ZyYWc6YmUxMzUzNjlhNDYwNDIxMWIwZDYwMzg1NmU1OWYxM2UvdGFibGU6OWU2NjU1Y2Q1YjgyNDg2MWJkOTdmMGM5YzVlYTdhZDEvdGFibGVyYW5nZTo5ZTY2NTVjZDViODI0ODYxYmQ5N2YwYzljNWVhN2FkMV82LTEtMS0xLTE0MjY4MA_87d5f482-e04a-406d-8773-10b5ab1070bd">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80L2ZyYWc6YmUxMzUzNjlhNDYwNDIxMWIwZDYwMzg1NmU1OWYxM2UvdGFibGU6OWU2NjU1Y2Q1YjgyNDg2MWJkOTdmMGM5YzVlYTdhZDEvdGFibGVyYW5nZTo5ZTY2NTVjZDViODI0ODYxYmQ5N2YwYzljNWVhN2FkMV83LTEtMS0xLTE0MjY4MA_533623b1-0ed7-457c-ac62-6f21cb077ce2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentType
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV84NA_3bb67e73-d193-4daf-8999-8563d9f10c1f">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6MzhiNWJkNGZmMjgxNDNlNTgyOTQ5MzhkYzBhYWMwZDUvdGFibGVyYW5nZTozOGI1YmQ0ZmYyODE0M2U1ODI5NDkzOGRjMGFhYzBkNV8xLTAtMS0xLTE0MjY4MA_e0e20342-b7cf-405d-88b6-c572c20363f5">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8yMTk5MDIzMjU1NzU1MQ_a07db57d-df5d-454a-806c-e6c0ff1d2dc0">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6MDJjMjQ0YmZiNjY4NDBmNTg4YmI0YzViNTRhYzc4YmYvdGFibGVyYW5nZTowMmMyNDRiZmI2Njg0MGY1ODhiYjRjNWI1NGFjNzhiZl8wLTAtMS0xLTE0MjY4MA_4950cf6c-b2d8-423a-8222-f95b3c21e48b">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8yMDI_efc57e1b-4e56-458d-98c7-3c165b856de7">1-07151</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8yMDg_ce5e2774-274a-4b1d-8da1-217dd5126023">THE CLOROX COMPANY</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6NDg3MTgzZTM5MjQzNDdmMDkzZGYwNDE2MjJiZTM5NjAvdGFibGVyYW5nZTo0ODcxODNlMzkyNDM0N2YwOTNkZjA0MTYyMmJlMzk2MF8wLTAtMS0xLTE0MjY4MA_37423020-86a4-4564-8c99-df4295a5dc5a">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6NDg3MTgzZTM5MjQzNDdmMDkzZGYwNDE2MjJiZTM5NjAvdGFibGVyYW5nZTo0ODcxODNlMzkyNDM0N2YwOTNkZjA0MTYyMmJlMzk2MF8wLTEtMS0xLTE0MjY4MA_695f7de0-fa15-4f6f-850e-922ff4990f05">31-0595760</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8yNjk_ac297d08-302d-4b3e-aa16-c364ed8649ed">1221 Broadway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8yNzM_f9f681bd-3eb3-4573-877b-ab9239a0deb1">Oakland</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8yNzc_7c99b330-8bb5-4c9c-862b-eceee53dfb32">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8yODE_94af2184-1fa8-4294-ba12-591df43e9c78">94612-1888</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8zMzg_972cd325-1ef8-45d0-aa31-181566feff52">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8zNDI_1de67e0d-1cef-417f-96bb-874e094a6e9e">271-7000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6NDBjMjlhODdmYTY5NGJmYWExMDZjNjU5NWFmNzg5MzAvdGFibGVyYW5nZTo0MGMyOWE4N2ZhNjk0YmZhYTEwNmM2NTk1YWY3ODkzMF81LTAtMS0xLTE0MjY4MA_5aa16a85-2b21-4cfa-9d5e-17e06a80e5ff">Common Stock - $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6NDBjMjlhODdmYTY5NGJmYWExMDZjNjU5NWFmNzg5MzAvdGFibGVyYW5nZTo0MGMyOWE4N2ZhNjk0YmZhYTEwNmM2NTk1YWY3ODkzMF81LTEtMS0xLTE0MjY4MA_4fead223-315f-4022-8e2f-7257f1fa60dd">CLX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6NDBjMjlhODdmYTY5NGJmYWExMDZjNjU5NWFmNzg5MzAvdGFibGVyYW5nZTo0MGMyOWE4N2ZhNjk0YmZhYTEwNmM2NTk1YWY3ODkzMF81LTItMS0xLTE0MjY4MA_16b39641-11c2-4f42-88ee-50f891ffd674">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV83NDc_76249ce5-c8d6-42c5-b5ff-e74636956cf6">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8xMDY4_bd823ff4-0b0c-40cd-b4ce-45f179b72343">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6ZWIwYjIzOGNmYmQ4NDg4NGI3M2JmMTc3NDE0OWNlMTIvdGFibGVyYW5nZTplYjBiMjM4Y2ZiZDg0ODg0YjczYmYxNzc0MTQ5Y2UxMl8wLTAtMS0xLTE0MjY4MA_0398536f-1094-4f3e-b31d-6661fa6895d1">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6ZWIwYjIzOGNmYmQ4NDg4NGI3M2JmMTc3NDE0OWNlMTIvdGFibGVyYW5nZTplYjBiMjM4Y2ZiZDg0ODg0YjczYmYxNzc0MTQ5Y2UxMl8wLTctMS0xLTE0MjY4MA_27aae552-64d1-4b63-bfed-b82e1af030cd">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGFibGU6ZWIwYjIzOGNmYmQ4NDg4NGI3M2JmMTc3NDE0OWNlMTIvdGFibGVyYW5nZTplYjBiMjM4Y2ZiZDg0ODg0YjczYmYxNzc0MTQ5Y2UxMl8wLTktMS0xLTE0MjY4MA_6861e6a1-cb16-4d02-81eb-c4611c8fe8b3">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8xODAx_4bb00374-628b-482d-a553-d5bb9dd38a3b">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i38686ba1b880423d945d44ba0aa0dc33_I20230418"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xL2ZyYWc6MmYxZTVjYzZiYjA1NDI3Njg0ZDQ3N2ZiYmFjMWQyN2UvdGV4dHJlZ2lvbjoyZjFlNWNjNmJiMDU0Mjc2ODRkNDc3ZmJiYWMxZDI3ZV8xODMy_2e8eacf9-6394-4779-add1-83841325ff30"
      unitRef="shares">123623524</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMi0zLTEtMS0xNDI2ODA_2663da20-bc75-4e03-bc4b-db1e09f2ba31"
      unitRef="usd">1915000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMi02LTEtMS0xNDI2ODA_a7040c8e-01e0-4a63-98f9-95c18078e1af"
      unitRef="usd">1809000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMi05LTEtMS0xNDI2ODA_e5d2ab5f-5581-41ff-886d-1ee8a8685093"
      unitRef="usd">5370000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMi0xMi0xLTEtMTQyNjgw_cb039485-7b7b-41b5-af9b-d2932d1cf6cd"
      unitRef="usd">5306000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMy0zLTEtMS0xNDI2ODA_f5294bf3-181c-46b0-9f55-2fae62bdb4e7"
      unitRef="usd">1115000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMy02LTEtMS0xNDI2ODA_fb7378d5-fe01-4a07-ba68-11995b6745ac"
      unitRef="usd">1160000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMy05LTEtMS0xNDI2ODA_f4d1f447-f987-44c0-91a4-f4ce6dd3c9e5"
      unitRef="usd">3324000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMy0xMi0xLTEtMTQyNjgw_e934a444-8ab7-48b1-b1fe-3284253dadba"
      unitRef="usd">3429000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNC0zLTEtMS0xNDI2ODA_26d54b0c-b82e-4fc4-8d80-f39a372a370c"
      unitRef="usd">800000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNC02LTEtMS0xNDI2ODA_a90c73fc-7eec-488f-96ef-d8c6864541f7"
      unitRef="usd">649000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNC05LTEtMS0xNDI2ODA_37a536a4-6097-4cf0-be0d-6586cb4bc4b3"
      unitRef="usd">2046000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNC0xMi0xLTEtMTQyNjgw_fde4f610-c1a9-4490-baff-b6dfe0bcde54"
      unitRef="usd">1877000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNS0zLTEtMS0xNDI2ODA_5bd2a5a2-973e-42dd-aba4-067c404a97d7"
      unitRef="usd">311000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNS02LTEtMS0xNDI2ODA_282bcf1d-5d31-418f-9627-1edbbcb5b41c"
      unitRef="usd">233000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNS05LTEtMS0xNDI2ODA_3d4bb974-bea7-48d2-9e9f-7dbf586e475b"
      unitRef="usd">854000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNS0xMi0xLTEtMTQyNjgw_066523dd-a066-4d2a-9345-1d4ed8eaef6a"
      unitRef="usd">710000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNi0zLTEtMS0xNDI2ODA_0f425961-7219-4a56-afc9-6a764e444930"
      unitRef="usd">206000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNi02LTEtMS0xNDI2ODA_ba3b8795-ced0-4576-869b-ed9ce750b53f"
      unitRef="usd">153000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNi05LTEtMS0xNDI2ODA_28f202ca-d605-41e4-bd11-d1a29475972d"
      unitRef="usd">523000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNi0xMi0xLTEtMTQyNjgw_a83f72e1-2a89-4a38-95d8-46a908467e23"
      unitRef="usd">502000000</us-gaap:AdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNy0zLTEtMS0xNDI2ODA_d7c02b9d-8de5-4922-ab09-76a3f9e2d414"
      unitRef="usd">35000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNy02LTEtMS0xNDI2ODA_9d4143be-da13-41f3-8d96-dc80515195ef"
      unitRef="usd">31000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNy05LTEtMS0xNDI2ODA_6b6ddda5-cb5d-4a01-a0d9-baa3d31b39a2"
      unitRef="usd">100000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfNy0xMi0xLTEtMTQyNjgw_d3bdf46b-fbca-4c25-a8de-ce84d6f45119"
      unitRef="usd">98000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AssetImpairmentCharges
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOC0zLTEtMS0xNDI2ODA_33405080-c6ca-4bb9-ae29-eac60f84ca8e"
      unitRef="usd">445000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOC02LTEtMS0xNDI2ODA_a811ad2c-943f-4f41-9fd8-31eaddce3eb8"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOC05LTEtMS0xNDI2ODA_edda9ec8-081f-4654-9ada-17c9cfef05ca"
      unitRef="usd">445000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOC0xMi0xLTEtMTQyNjgw_368c9c96-98b3-4cf8-8a43-a0e5cc48a1f4"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:InterestExpense
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOS0zLTEtMS0xNDI2ODA_9d1e292f-f160-4a74-b26a-17bc97664385"
      unitRef="usd">24000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOS02LTEtMS0xNDI2ODA_7495537e-5003-480e-b47d-b8d48cca6d67"
      unitRef="usd">21000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOS05LTEtMS0xNDI2ODA_c235b178-3263-4b45-a4f4-c466826560ee"
      unitRef="usd">69000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfOS0xMi0xLTEtMTQyNjgw_9a4378c8-48ef-4008-a005-a664274ce1f3"
      unitRef="usd">69000000</us-gaap:InterestExpense>
    <clx:OtherExpenseIncomeNet
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTAtMy0xLTEtMTQyNjgw_5b13ffbb-0f3a-43a3-909c-8373e7e791ca"
      unitRef="usd">24000000</clx:OtherExpenseIncomeNet>
    <clx:OtherExpenseIncomeNet
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTAtNi0xLTEtMTQyNjgw_b593f785-3fea-4792-87c8-2da727f41a0f"
      unitRef="usd">11000000</clx:OtherExpenseIncomeNet>
    <clx:OtherExpenseIncomeNet
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTAtOS0xLTEtMTQyNjgw_1a2a93fd-9d83-4e18-8c72-77b3db8f15a7"
      unitRef="usd">54000000</clx:OtherExpenseIncomeNet>
    <clx:OtherExpenseIncomeNet
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTAtMTItMS0xLTE0MjY4MA_8b930c50-b87a-4b9c-a512-c2fcd14dcc52"
      unitRef="usd">20000000</clx:OtherExpenseIncomeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTEtMy0xLTEtMTQyNjgw_0b640dcd-aaca-46ea-9153-6b9bc11b1a32"
      unitRef="usd">-245000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTEtNi0xLTEtMTQyNjgw_ad1ef383-9af7-4f4a-9294-9ae088d97d5c"
      unitRef="usd">200000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTEtOS0xLTEtMTQyNjgw_7276b1d0-16f5-4c5a-85ee-597934580ae0"
      unitRef="usd">1000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTEtMTItMS0xLTE0MjY4MA_8cc6c20c-f0a1-4d33-8dc3-d3fb788ccb65"
      unitRef="usd">478000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTItMy0xLTEtMTQyNjgw_56185977-9223-4a30-afa9-34cd005c9be3"
      unitRef="usd">-36000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTItNi0xLTEtMTQyNjgw_150bbee3-682a-440f-884d-4c4ee3482818"
      unitRef="usd">48000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTItOS0xLTEtMTQyNjgw_7c6586bd-73e8-4946-bdba-9223eab55d60"
      unitRef="usd">21000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTItMTItMS0xLTE0MjY4MA_9cee9a95-4d0a-4ded-bac3-e32fb19db824"
      unitRef="usd">111000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTMtMy0xLTEtMTQyNjgw_582d6b3c-4fc2-437a-aaf8-61bc8fd7bb62"
      unitRef="usd">-209000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTMtNi0xLTEtMTQyNjgw_5f837a09-5f3c-4d05-91cb-6592530b0fc7"
      unitRef="usd">152000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTMtOS0xLTEtMTQyNjgw_f1d321b6-7045-439d-958b-4d19d0c3a9d7"
      unitRef="usd">-20000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTMtMTItMS0xLTE0MjY4MA_547c2518-626a-4135-b06e-1e29c2db413a"
      unitRef="usd">367000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTQtMy0xLTEtMTQyNjgw_ef977f2c-c92d-4a90-85c4-8a6da4a18b9f"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTQtNi0xLTEtMTQyNjgw_ea0046c7-d18c-4a31-802d-503b1e2d81b2"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTQtOS0xLTEtMTQyNjgw_24fbfae4-576c-474a-b54b-c2a68a7a1d5f"
      unitRef="usd">7000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTQtMTItMS0xLTE0MjY4MA_24ac2d3a-fb6f-4d3f-a877-d2110e1921f9"
      unitRef="usd">6000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTUtMy0xLTEtMTQyNjgw_5714ec4c-0472-4209-af33-63ac1a9f045d"
      unitRef="usd">-211000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTUtNi0xLTEtMTQyNjgw_535dfaf7-f6ce-4574-930f-1ad0e172e3f4"
      unitRef="usd">150000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTUtOS0xLTEtMTQyNjgw_b3f77947-26b0-4a24-9390-d5d58e92f405"
      unitRef="usd">-27000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTUtMTItMS0xLTE0MjY4MA_18b4ab98-0d66-4c9f-8bb8-0f14aaa04b74"
      unitRef="usd">361000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTctMy0xLTEtMTQyNjgw_4bb0c2c3-33ce-4167-a2cb-a54061095821"
      unitRef="usdPerShare">-1.71</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTctNi0xLTEtMTQyNjgw_5f6ec7b2-1904-43d2-a453-22b3222d9fa5"
      unitRef="usdPerShare">1.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTctOS0xLTEtMTQyNjgw_88e2bebe-a445-4e8b-b16b-edeef91188d6"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTctMTItMS0xLTE0MjY4MA_e5279fdb-9ba8-4644-8908-226aa28d2057"
      unitRef="usdPerShare">2.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTgtMy0xLTEtMTQyNjgw_3c6de07e-6f93-464f-b8f0-a1e2c93a7431"
      unitRef="usdPerShare">-1.71</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTgtNi0xLTEtMTQyNjgw_0bb370cd-994b-4394-bf49-d796d44213b1"
      unitRef="usdPerShare">1.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTgtOS0xLTEtMTQyNjgw_ef3a14dc-79d6-4aa4-9439-d2884e8dc2ab"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMTgtMTItMS0xLTE0MjY4MA_5adcfe53-db6d-459a-98e5-7d3d8e70a25a"
      unitRef="usdPerShare">2.91</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjAtMy0xLTEtMTQyNjgw_859f37bd-4802-445d-83d9-9be044bae2e0"
      unitRef="shares">123649000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjAtNi0xLTEtMTQyNjgw_171cf7a7-ccbc-437c-bcb6-374df10266ef"
      unitRef="shares">123177000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjAtOS0xLTEtMTQyNjgw_b8602f9f-fb12-47e5-8e9d-bd4b77258dc0"
      unitRef="shares">123512000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjAtMTItMS0xLTE0MjY4MA_ad255775-82bb-4c46-afe5-da9a984999db"
      unitRef="shares">123074000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjEtMy0xLTEtMTQyNjgw_77b7e649-59eb-493e-8dfe-3a2cedfc9f52"
      unitRef="shares">123649000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjEtNi0xLTEtMTQyNjgw_ec824e7c-0d62-4548-81ea-a987c7a109fd"
      unitRef="shares">123877000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjEtOS0xLTEtMTQyNjgw_16342cf4-2a5a-4665-8681-23392e055ed9"
      unitRef="shares">123512000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjEtMTItMS0xLTE0MjY4MA_80335ab7-c493-4492-93f6-815815b885af"
      unitRef="shares">123943000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjMtMy0xLTEtMTQyNjgw_99f10b3d-e6cf-467f-91ef-ecaeda99f8d8"
      unitRef="usd">-205000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjMtNi0xLTEtMTQyNjgw_dafc7e5b-f40a-45e9-863a-2f84db6a57f1"
      unitRef="usd">207000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjMtOS0xLTEtMTQyNjgw_e5b1b280-5bd8-4427-a937-35c5dfcefd52"
      unitRef="usd">-39000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjMtMTItMS0xLTE0MjY4MA_b48f8ced-e2aa-4c1e-b7db-fde8a2e4158c"
      unitRef="usd">394000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjQtMy0xLTEtMTQyNjgw_81dcf2e9-d2e3-40b3-933e-824fff98da4a"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjQtNi0xLTEtMTQyNjgw_76e595c1-adfc-4a24-9bd5-02172c41eb80"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjQtOS0xLTEtMTQyNjgw_6bbd3e23-c667-4ffb-b799-175017d5135e"
      unitRef="usd">7000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjQtMTItMS0xLTE0MjY4MA_77b91181-292e-446f-ad7e-43d9b08aa6aa"
      unitRef="usd">6000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjUtMy0xLTEtMTQyNjgw_95b112e2-0fcf-4620-989d-299d460f4ed2"
      unitRef="usd">-207000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjUtNi0xLTEtMTQyNjgw_75e6abb8-e9e9-4d16-b40c-649b04e972ec"
      unitRef="usd">205000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjUtOS0xLTEtMTQyNjgw_0a095bd8-8f1a-4b19-b0ca-bd73d2261256"
      unitRef="usd">-46000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMC9mcmFnOjc3MmRiYjY5ZGNiMDQ2MWU4NDRlMDE2YmE1OTU5MTBiL3RhYmxlOjRiYzgyOGUzMWM4ODQ4ZWM4OGIxMGJkOWI3NjA2MWUxL3RhYmxlcmFuZ2U6NGJjODI4ZTMxYzg4NDhlYzg4YjEwYmQ5Yjc2MDYxZTFfMjUtMTItMS0xLTE0MjY4MA_3e6abbd2-525c-44af-a584-e3cbd518d5a9"
      unitRef="usd">388000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNC0yLTEtMS0xNDI2ODA_566e50c1-fbc1-41b8-998f-91324864fd0d"
      unitRef="usd">242000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNC01LTEtMS0xNDI2ODA_77b9806e-81bc-41d3-84c5-cd0f22e38d15"
      unitRef="usd">183000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNS0yLTEtMS0xNDI2ODA_3021dbcb-0a13-454f-bda0-60a0b2602cee"
      unitRef="usd">678000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNS01LTEtMS0xNDI2ODA_d5d21afc-ea5e-4803-8543-85c5c5912dca"
      unitRef="usd">681000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNi0yLTEtMS0xNDI2ODA_e2cd8f33-8b06-40ad-9e6d-2c5092d295e1"
      unitRef="usd">735000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNi01LTEtMS0xNDI2ODA_60c18384-d85b-4303-b664-06dee8f4dd7c"
      unitRef="usd">755000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNy0yLTEtMS0xNDI2ODA_fd7dd9d8-ce96-4f10-9e86-d3870f4484ca"
      unitRef="usd">90000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNy01LTEtMS0xNDI2ODA_ea138035-6be9-4f52-8864-8bd7e8966eb2"
      unitRef="usd">106000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfOC0yLTEtMS0xNDI2ODA_b6fd295b-71bf-490f-8174-e1e1d5e45128"
      unitRef="usd">1745000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfOC01LTEtMS0xNDI2ODA_3c439050-7e21-44b3-8b36-59403c822d8d"
      unitRef="usd">1725000000</us-gaap:AssetsCurrent>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfOS0wLTEtMS0xNDI2ODAvdGV4dHJlZ2lvbjo0YjkxYmM2MmZlNGU0YzUyYjE5ZWZkNGYyOTkzYzI0Zl85Ng_b10213e6-8117-45d3-b08d-4a46b6c6f9f9"
      unitRef="usd">2672000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfOS0wLTEtMS0xNDI2ODAvdGV4dHJlZ2lvbjo0YjkxYmM2MmZlNGU0YzUyYjE5ZWZkNGYyOTkzYzI0Zl8xMDM_6a0d7d28-02e4-4d33-9209-e74cb46f1d8d"
      unitRef="usd">2530000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfOS0yLTEtMS0xNDI2ODA_c1a582aa-3f21-4f8d-8e30-5142b9e21e0b"
      unitRef="usd">1315000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfOS01LTEtMS0xNDI2ODA_f603a343-470b-4033-b020-cb4959772057"
      unitRef="usd">1334000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTAtMi0xLTEtMTQyNjgw_e1ecd2de-7114-47cc-a04d-9c86fef8a577"
      unitRef="usd">359000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTAtNS0xLTEtMTQyNjgw_8aa1303d-fe1d-4307-91c6-56c6a75cbb61"
      unitRef="usd">342000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTEtMi0xLTEtMTQyNjgw_07a18a06-0776-49a0-a2d6-370e9ceb585e"
      unitRef="usd">1250000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTEtNS0xLTEtMTQyNjgw_c0959847-77fe-4d24-a1ea-0153b47be887"
      unitRef="usd">1558000000</us-gaap:Goodwill>
    <clx:TrademarksNet
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTItMi0xLTEtMTQyNjgw_19a7ffb9-64a5-4802-9066-9a74d1d5804a"
      unitRef="usd">546000000</clx:TrademarksNet>
    <clx:TrademarksNet
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTItNS0xLTEtMTQyNjgw_651d7970-471c-4c52-8826-04f3187c0804"
      unitRef="usd">687000000</clx:TrademarksNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTMtMi0xLTEtMTQyNjgw_4c366571-422c-426c-bf9b-65496ecaf480"
      unitRef="usd">176000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTMtNS0xLTEtMTQyNjgw_d8d6fcaf-ad32-4674-8e4b-d2d95deb77f1"
      unitRef="usd">197000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTQtMi0xLTEtMTQyNjgw_d00b8e9d-305d-4469-8046-7082e71c69e1"
      unitRef="usd">427000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTQtNS0xLTEtMTQyNjgw_e3475eba-5f48-4d5e-bb80-bc32a248fc7a"
      unitRef="usd">315000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTUtMi0xLTEtMTQyNjgw_355aa200-f06e-4d3c-979e-feb97f9baf43"
      unitRef="usd">5818000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTUtNS0xLTEtMTQyNjgw_efe11aad-0df5-4594-81d3-a21c39acb838"
      unitRef="usd">6158000000</us-gaap:Assets>
    <us-gaap:CommercialPaper
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTgtMi0xLTEtMTQyNjgw_8aea3e23-7690-470f-83df-c6d50a6c1e40"
      unitRef="usd">138000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMTgtNS0xLTEtMTQyNjgw_95edf352-4c83-457c-a916-d6177dda368d"
      unitRef="usd">237000000</us-gaap:CommercialPaper>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjAtMi0xLTEtMTQyNjgw_66ad6059-c993-4000-90a2-9188cd67d004"
      unitRef="usd">88000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjAtNS0xLTEtMTQyNjgw_521d5ddf-a353-4e01-9506-695fb91188c3"
      unitRef="usd">78000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjEtMi0xLTEtMTQyNjgw_792acaaa-7b17-4194-b61d-455a434fc1d6"
      unitRef="usd">1722000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjEtNS0xLTEtMTQyNjgw_00885c8f-7af5-43fc-a71d-cdcbc4648b3e"
      unitRef="usd">1469000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjItMi0xLTEtMTQyNjgw_71c05e0f-6100-4fb0-9b0e-7ad0b4866e13"
      unitRef="usd">48000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjItNS0xLTEtMTQyNjgw_be8b190f-0725-4955-8933-f45314693cc7"
      unitRef="usd">0</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjMtMi0xLTEtMTQyNjgw_fb40dae1-e9fe-4323-ade5-1084c69f88f2"
      unitRef="usd">1996000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjMtNS0xLTEtMTQyNjgw_30462315-4e73-4021-886c-0ab282f87736"
      unitRef="usd">1784000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjQtMi0xLTEtMTQyNjgw_beeb7016-19c7-457f-8409-cf3d909b218b"
      unitRef="usd">2476000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjQtNS0xLTEtMTQyNjgw_1b952cde-2d1a-4717-ad1f-44b2102d9f33"
      unitRef="usd">2474000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjUtMi0xLTEtMTQyNjgw_9fc22526-d8a3-458a-9bb0-4b94d1a4b21e"
      unitRef="usd">323000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjUtNS0xLTEtMTQyNjgw_a024e29e-c660-4659-b397-ff21ac345585"
      unitRef="usd">314000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjYtMi0xLTEtMTQyNjgw_94c6a4b7-3a6e-47c5-a0ca-5837635605a2"
      unitRef="usd">824000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjYtNS0xLTEtMTQyNjgw_14ec9b9d-27eb-4779-a242-7a37c005c665"
      unitRef="usd">791000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjctMi0xLTEtMTQyNjgw_9acdf69d-31aa-44e7-802d-d318b2bb105c"
      unitRef="usd">27000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjctNS0xLTEtMTQyNjgw_9d0b7c6c-deea-4652-a612-264ecc62442f"
      unitRef="usd">66000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjgtMi0xLTEtMTQyNjgw_ecf49820-28cc-4f5e-9b46-0238f2e18b43"
      unitRef="usd">5646000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjgtNS0xLTEtMTQyNjgw_ae846e02-939d-49b6-8fe5-05d664e68e3e"
      unitRef="usd">5429000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjktMi0xLTEtMTQyNjgw_6210d95f-dfaa-4d23-bbf7-c3ba05759c0f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMjktNS0xLTEtMTQyNjgw_1fc72a39-2400-4330-864d-d9d2698c02a3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfMjE_9eaf36c4-819b-461e-9b4c-1ba4076a164e"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfMjE_abeaacaf-6979-42dc-8755-7da775c0b1d3"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfMzU_b3cf3ea9-dc91-43b0-ac9d-17990385ddac"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfMzU_ea006905-cdd0-42a3-af88-1055f9c4c205"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfNTc_19884dc5-ada4-4f60-a41a-ee129168e90e"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfNTc_869aebc3-6ecf-45be-9102-5724698c9c1e"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfNTc_92f735a8-8054-4e85-a26e-f9d9108fa78c"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZmYzOGVkYzRjNTBkNDQyMGEzNzBkZmYxNDgzNmZiOGZfNTc_de4be583-9e80-405b-ad10-8ed9fc0a2ca7"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtMi0xLTEtMTQyNjgw_3043cc3f-b6eb-4218-914a-268bc13ed9b4"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzEtNS0xLTEtMTQyNjgw_9605dd9b-bc19-4227-85ec-f0a99e1072ef"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMC0xLTEtMTQyNjgwL3RleHRyZWdpb246Mzg1ZGE1YjFkODAyNDhmY2E4YTM4NWFmY2EyZmE5N2VfMTk_2e4d6422-2d4f-4f63-ad9a-8b7d3b87894a"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMC0xLTEtMTQyNjgwL3RleHRyZWdpb246Mzg1ZGE1YjFkODAyNDhmY2E4YTM4NWFmY2EyZmE5N2VfMTk_e75b1039-3876-4b4c-838e-68c951fd5fa4"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMC0xLTEtMTQyNjgwL3RleHRyZWdpb246Mzg1ZGE1YjFkODAyNDhmY2E4YTM4NWFmY2EyZmE5N2VfMzM_84eff5d5-91cf-44a2-9373-551812a5c0a3"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMC0xLTEtMTQyNjgwL3RleHRyZWdpb246Mzg1ZGE1YjFkODAyNDhmY2E4YTM4NWFmY2EyZmE5N2VfMzM_bcfe1819-ac2d-4c90-8bc7-96d237ec3701"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMC0xLTEtMTQyNjgwL3RleHRyZWdpb246Mzg1ZGE1YjFkODAyNDhmY2E4YTM4NWFmY2EyZmE5N2VfMjE5OTAyMzI1NTU3MDg_3ef0f892-4f70-4c2f-9459-90258ea9436c"
      unitRef="shares">130741461</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMC0xLTEtMTQyNjgwL3RleHRyZWdpb246Mzg1ZGE1YjFkODAyNDhmY2E4YTM4NWFmY2EyZmE5N2VfOTM_b6016922-275f-4803-8fc6-dc589171c542"
      unitRef="shares">123611466</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMC0xLTEtMTQyNjgwL3RleHRyZWdpb246Mzg1ZGE1YjFkODAyNDhmY2E4YTM4NWFmY2EyZmE5N2VfMTAw_21aa05d1-f9f8-403c-adc1-01684ebb9cc2"
      unitRef="shares">123152132</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItMi0xLTEtMTQyNjgw_13277a6f-53e6-4475-9d04-afaab8d8ccf9"
      unitRef="usd">131000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzItNS0xLTEtMTQyNjgw_e27e9189-8667-4009-a676-4d530d6e014a"
      unitRef="usd">131000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzMtMi0xLTEtMTQyNjgw_4d0c9f39-ae1a-4eae-860c-3d129e3d0fb7"
      unitRef="usd">1232000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzMtNS0xLTEtMTQyNjgw_79f82477-0ac4-4290-811d-7d341da3550c"
      unitRef="usd">1202000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzQtMi0xLTEtMTQyNjgw_1a681aef-560d-4a7e-b5a7-ef404d5069e6"
      unitRef="usd">415000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzQtNS0xLTEtMTQyNjgw_cd7ce281-41b0-4d1c-b0cf-bccfd86588d4"
      unitRef="usd">1048000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzUtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZjE2ZDAxZDdiZDEyNGRiNWJjNmUxNTgxZWI0YjlhYTlfMjk_de3947b9-947e-43b4-9156-80a77f4b4b84"
      unitRef="shares">7129995</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzUtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246ZjE2ZDAxZDdiZDEyNGRiNWJjNmUxNTgxZWI0YjlhYTlfMzY_031f9d34-6b7c-40b5-8f46-fa0c4c86eded"
      unitRef="shares">7589329</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzUtMi0xLTEtMTQyNjgw_f12d2f2c-a433-4aca-b2e3-38709b9e0de5"
      unitRef="usd">1277000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzUtNS0xLTEtMTQyNjgw_db4ade20-1db6-4c17-a2b3-93db33578478"
      unitRef="usd">1346000000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzYtMi0xLTEtMTQyNjgw_2bf661fe-f368-425c-936c-dd3755dad5fb"
      unitRef="usd">-498000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzYtNS0xLTEtMTQyNjgw_c3fb2c14-7267-40aa-a572-90ffbcd2b314"
      unitRef="usd">-479000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzctMi0xLTEtMTQyNjgw_ad39702a-ba23-4b06-b40d-851b414cd338"
      unitRef="usd">3000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzctNS0xLTEtMTQyNjgw_382213e2-b5b8-4edb-9706-7cf3022699dd"
      unitRef="usd">556000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzgtMi0xLTEtMTQyNjgw_c69e75eb-20f1-4a1e-8177-2de73642b476"
      unitRef="usd">169000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzgtNS0xLTEtMTQyNjgw_261308c5-a82c-4ceb-9edb-5956bf8c063b"
      unitRef="usd">173000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzktMi0xLTEtMTQyNjgw_d314f11d-66fd-4ccf-b0db-d87424e05d98"
      unitRef="usd">172000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfMzktNS0xLTEtMTQyNjgw_f15878b6-083e-4d0d-9466-1f6971af5a2e"
      unitRef="usd">729000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNDAtMi0xLTEtMTQyNjgw_79b21131-09ea-497c-9700-38b3c2c6088b"
      unitRef="usd">5818000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMy9mcmFnOjM1NThiOTFmZmViYjQyMzk4Y2NjNTZjNmQ5YTE0M2ZkL3RhYmxlOjUxNzExNTk0MWM4ZDQ1N2M4ZDM4MzdiY2JhYmY1YWFhL3RhYmxlcmFuZ2U6NTE3MTE1OTQxYzhkNDU3YzhkMzgzN2JjYmFiZjVhYWFfNDAtNS0xLTEtMTQyNjgw_f4fa03c8-c290-4288-a32b-0a8e03df5123"
      unitRef="usd">6158000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMy0yLTEtMS0xNDI2ODA_938beac9-e990-430b-b97c-2f25dde3bb1d"
      unitRef="usd">-20000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMy01LTEtMS0xNDI2ODA_16d9559b-c86a-40e1-82f7-fd28dcd60e21"
      unitRef="usd">367000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfNS0yLTEtMS0xNDI2ODA_39095dae-c63d-4006-a3f3-45c1d6ceb40f"
      unitRef="usd">174000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfNS01LTEtMS0xNDI2ODA_5d0436ed-fe2f-478d-b568-69680cb2c5a5"
      unitRef="usd">167000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfNi0yLTEtMS0xNDI2ODA_36fe5a93-998f-467b-8f56-ce73570c642f"
      unitRef="usd">60000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfNi01LTEtMS0xNDI2ODA_69d49bfc-c348-44cf-b1ec-9af46253466a"
      unitRef="usd">44000000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfNy0yLTEtMS0xNDI2ODA_084c95e2-9c07-40d1-9d11-6b406ec9dd54"
      unitRef="usd">-122000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfNy01LTEtMS0xNDI2ODA_60d991d1-2ec2-43ff-950f-7109086939f5"
      unitRef="usd">11000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:AssetImpairmentCharges
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfOC0yLTEtMS0xNDI2ODA_f5ffc73b-cc8a-4aed-91de-cf39eda598db"
      unitRef="usd">445000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfOC01LTEtMS0xNDI2ODA_46ac45be-5e4c-4bc7-a9a0-45619f4559d4"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfOS0yLTEtMS0xNDI2ODA_91614697-6347-4c3b-9a57-112988d3eddf"
      unitRef="usd">-34000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfOS01LTEtMS0xNDI2ODA_b7e23196-cdcc-4eb9-8b19-15702b8d9858"
      unitRef="usd">-7000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTEtMi0xLTEtMTQyNjgw_270ccc53-9757-4516-9ae6-a15c91438b5d"
      unitRef="usd">1000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTEtNS0xLTEtMTQyNjgw_6939e7a8-2951-419a-9066-e6e2f9e5c956"
      unitRef="usd">56000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTItMi0xLTEtMTQyNjgw_92bd558e-c340-4565-9c58-d7d5b3ec8f86"
      unitRef="usd">-13000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTItNS0xLTEtMTQyNjgw_9d493104-e935-4840-b044-0dbfe96ebcdb"
      unitRef="usd">53000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTMtMi0xLTEtMTQyNjgw_c04a52cd-11f8-4d54-ac22-8e9852f3131c"
      unitRef="usd">15000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTMtNS0xLTEtMTQyNjgw_0e530741-2377-4f39-a1f3-f417de02de30"
      unitRef="usd">-2000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTQtMi0xLTEtMTQyNjgw_40628124-b7ea-44a9-b06a-17d03dbd0c50"
      unitRef="usd">78000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTQtNS0xLTEtMTQyNjgw_36951136-0fd8-4d44-be07-0ec1bab272d0"
      unitRef="usd">-93000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <clx:OperatingLeaseRightofUseAssetAndLiabilityNet
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTUtMi0xLTEtMTQyNjgw_1896a9a0-2a57-4557-b5f3-5383fa448ff3"
      unitRef="usd">2000000</clx:OperatingLeaseRightofUseAssetAndLiabilityNet>
    <clx:OperatingLeaseRightofUseAssetAndLiabilityNet
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTUtNS0xLTEtMTQyNjgw_ab903e7d-825c-407f-9629-12b64d0883ca"
      unitRef="usd">0</clx:OperatingLeaseRightofUseAssetAndLiabilityNet>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTYtMi0xLTEtMTQyNjgw_99c0e013-bd78-482f-9b62-2e285f2ab1a0"
      unitRef="usd">80000000</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTYtNS0xLTEtMTQyNjgw_e6f12ca8-f8c0-4257-8df1-358c644babab"
      unitRef="usd">55000000</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTctMi0xLTEtMTQyNjgw_201a0989-57b3-4683-8f5b-ef2abb0c20f2"
      unitRef="usd">728000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTctNS0xLTEtMTQyNjgw_9c16011c-9d1b-40b2-8417-b3a32ba5e16e"
      unitRef="usd">451000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTktMi0xLTEtMTQyNjgw_82ec436f-13d5-46cb-978e-38ad44394874"
      unitRef="usd">144000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMTktNS0xLTEtMTQyNjgw_2d513022-d637-4312-a9bb-25c2db8c0f90"
      unitRef="usd">172000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjEtMi0xLTEtMTQyNjgw_d7bad51a-c0cc-4860-aa37-150e91a8bf81"
      unitRef="usd">-2000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjEtNS0xLTEtMTQyNjgw_db24219a-b5d8-4350-9f1b-fd9ac2266cd7"
      unitRef="usd">-5000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjItMi0xLTEtMTQyNjgw_78b29ee8-ea95-4cc6-a094-c533d5177868"
      unitRef="usd">-142000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjItNS0xLTEtMTQyNjgw_c7ff23bf-e752-425c-9013-201bffbff795"
      unitRef="usd">-167000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjQtMi0xLTEtMTQyNjgw_071a3c1c-5fcb-40da-99d5-fcd05c00dd42"
      unitRef="usd">-99000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjQtNS0xLTEtMTQyNjgw_19c537d7-091b-493e-bafa-3aba1ba08ebb"
      unitRef="usd">395000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjUtMi0xLTEtMTQyNjgw_beacd2ed-54c4-4d2a-99f5-dabf3813ae21"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjUtNS0xLTEtMTQyNjgw_8e0706e1-d5c9-4cfa-96fd-56493f8c7956"
      unitRef="usd">300000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjYtMi0xLTEtMTQyNjgw_f8f9a99b-ce3d-47e8-9710-d0af011ef6aa"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjYtNS0xLTEtMTQyNjgw_2b186575-c8ab-4959-b0a0-a020fca958f8"
      unitRef="usd">25000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjctMi0xLTEtMTQyNjgw_9490a31a-edab-45c3-9492-58154a689f24"
      unitRef="usd">437000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjctNS0xLTEtMTQyNjgw_cccd4950-e719-4f5b-ad03-cc3a59e48017"
      unitRef="usd">428000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjgtMi0xLTEtMTQyNjgw_25aa674b-af63-4b8a-b32b-b9e5b81f1d11"
      unitRef="usd">0</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjgtNS0xLTEtMTQyNjgw_34276372-1fba-42e6-a58d-c7573b6b2adf"
      unitRef="usd">5000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjktMi0xLTEtMTQyNjgw_5d3ea8d2-5bb5-4cd3-8204-fd847e80f4f1"
      unitRef="usd">10000000</clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther>
    <clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMjktNS0xLTEtMTQyNjgw_2f180f55-797e-4996-b5b6-e063dfcac9f1"
      unitRef="usd">0</clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzAtMi0xLTEtMTQyNjgw_4478b70b-3796-4aa8-baa2-f50ba51d2570"
      unitRef="usd">-526000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzAtNS0xLTEtMTQyNjgw_198df0d3-6219-4b09-a4d0-391544e50d5e"
      unitRef="usd">-363000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzEtMi0xLTEtMTQyNjgw_53fb538c-dc40-4527-8c8f-6a85e72ba99b"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzEtNS0xLTEtMTQyNjgw_26804a4d-3658-4863-ab53-a4e100374766"
      unitRef="usd">-2000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzItMi0xLTEtMTQyNjgw_b3d526ba-80aa-4652-a760-bdf9b3d8d30f"
      unitRef="usd">60000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzItNS0xLTEtMTQyNjgw_eeb16198-88e7-4d20-a3e9-35588371e0cc"
      unitRef="usd">-81000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzQtMi0xLTEtMTQyNjgw_f1c37126-23d2-44c6-8e41-1aa961b0a951"
      unitRef="usd">186000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i38db454957ae42d1a879575c446b836f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzQtNS0xLTEtMTQyNjgw_9db9b1e3-f4aa-475c-abf1-bea8f4cb79a8"
      unitRef="usd">324000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzUtMi0xLTEtMTQyNjgw_52105ac4-14ed-48e8-bc9a-a80336c64182"
      unitRef="usd">246000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icf74c279d583412eaba0df33f84a8dd7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xNi9mcmFnOjdjYWYxNjk3NzBkOTRlYWViNWJmM2IxOWYxNGI1YTRhL3RhYmxlOjY4NzZiNDc0YzQ2MzRlMDI5ZDAyYTVmOTFkMjYyNjNmL3RhYmxlcmFuZ2U6Njg3NmI0NzRjNDYzNGUwMjlkMDJhNWY5MWQyNjI2M2ZfMzUtNS0xLTEtMTQyNjgw_eea36ce5-2807-4553-b1f0-fe6cc063fd9a"
      unitRef="usd">243000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xOS9mcmFnOjNiOGYwYTNmZDgwMTQ5NmZiMDA4YWJkNTQ0MDcyNTM3L3RleHRyZWdpb246M2I4ZjBhM2ZkODAxNDk2ZmIwMDhhYmQ1NDQwNzI1MzdfMzQ4Ng_cb9aab05-a505-4d8a-bbd9-4931f6545f41">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim condensed consolidated financial statements for the three and nine months ended March 31, 2023 and 2022, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2022, which includes a complete set of footnote disclosures, including the Company&#x2019;s significant accounting policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurs restructuring costs in connection with workforce reductions; consolidation or closure of a facility; sale or termination of a line of business; and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records employee termination liabilities once they are both probable and estimable for severance provided under the Company&#x2019;s existing severance policy. Employee termination liabilities outside of the Company&#x2019;s existing severance policy are recognized at the time relevant employees are notified, unless the employees will be retained to render service beyond a minimum retention period for transition purposes, in which case the liability is recognized ratably over the future service period. Other costs associated with a restructuring plan or exit or disposal activities, such as consulting and professional fees, facility exit costs, employee relocation, outplacement costs, accelerated depreciation or asset impairments associated with a restructuring plan, are recognized in the period in which the liability is incurred or the asset is impaired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment Review of Goodwill and Indefinite-Lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests its goodwill, trademarks with indefinite lives and other indefinite-lived intangible assets annually for impairment in the fiscal fourth quarter unless there are indications during a different interim period that these assets may have become impaired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to goodwill, the Company has the option to first assess qualitative factors, such as the maturity and stability of the reporting unit, the magnitude of the excess fair value over carrying value from a previous period&#x2019;s impairment testing, other reporting unit specific operating results, microeconomic and macroeconomic factors, as well as new events and circumstances impacting the operations at the reporting unit level. The Company operates through strategic business units (SBUs) that are organized into the Company&#x2019;s operating segments. Reporting units for goodwill impairment testing purposes were identified as the Company&#x2019;s individual operating segments. If the result of a qualitative test indicates a potential for impairment of a reporting unit, a quantitative test is performed. In the quantitative test, the Company compares the estimated fair value of the reporting unit to its carrying value. If the estimated fair value of any reporting unit is less than its carrying value, an impairment charge is recorded for the difference between the carrying value and the fair value of the reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine the fair value of a reporting unit as part of its quantitative test, the Company uses the discounted cash flow (DCF) method under the income approach, as it believes that this approach is the most reliable indicator of the fair value of its businesses and the fair value of its future earnings and cash flows. Under this approach, which requires significant judgments, the Company estimates the future cash flows of each reporting unit and discounts these cash flows at a rate of return that reflects their relative risk. The cash flows used in the DCF method are consistent with those the Company uses in its internal planning, which gives consideration to actual business trends experienced, and the broader business strategy for the long term. The other key estimates and factors used in the DCF method include, but are not limited to, net sales and expense growth rates, commodity prices, foreign exchange rates, inflation and a terminal growth rate. Changes in such estimates or the application of alternative assumptions could produce different results. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For trademarks and other intangible assets with indefinite lives, the Company has the option to first assess qualitative factors, such as the maturity and stability of the trademark or other intangible asset, the magnitude of the excess fair value over carrying value from a previous period&#x2019;s impairment testing, other specific operating results as well as new events and circumstances impacting the significant inputs used to determine the fair value of the intangible asset. If the result of a qualitative test indicates that it is more likely than not that the asset is impaired, a quantitative test is performed. When a quantitative test is performed, the estimated fair value of an asset is compared to its carrying value. If the carrying value of such asset exceeds its estimated fair value, an impairment charge is recorded for the difference between the carrying value and the estimated fair value. The Company uses the DCF method under the relief from royalty income approach to estimate the fair value of its trademarks and other intangible assets with indefinite lives. This approach requires significant judgments in determining the royalty rates and the assets&#x2019; estimated cash flows, as well as the appropriate discount and foreign exchange rates applied to those cash flows to determine fair value. Changes in such estimates or the use of alternative assumptions could produce different results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#x201d; These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations.&#160;These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. As these amendments relate to disclosures only, there are no impacts expected to the Company&#x2019;s consolidated results of operations, financial position and cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xOS9mcmFnOjNiOGYwYTNmZDgwMTQ5NmZiMDA4YWJkNTQ0MDcyNTM3L3RleHRyZWdpb246M2I4ZjBhM2ZkODAxNDk2ZmIwMDhhYmQ1NDQwNzI1MzdfMzQ4Nw_def32fc4-1b1f-455a-9d40-6ee13c738780">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim condensed consolidated financial statements for the three and nine months ended March 31, 2023 and 2022, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2022, which includes a complete set of footnote disclosures, including the Company&#x2019;s significant accounting policies.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xOS9mcmFnOjNiOGYwYTNmZDgwMTQ5NmZiMDA4YWJkNTQ0MDcyNTM3L3RleHRyZWdpb246M2I4ZjBhM2ZkODAxNDk2ZmIwMDhhYmQ1NDQwNzI1MzdfMzQ4OQ_8094cc76-a897-44de-a063-cb033992c097">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurs restructuring costs in connection with workforce reductions; consolidation or closure of a facility; sale or termination of a line of business; and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records employee termination liabilities once they are both probable and estimable for severance provided under the Company&#x2019;s existing severance policy. Employee termination liabilities outside of the Company&#x2019;s existing severance policy are recognized at the time relevant employees are notified, unless the employees will be retained to render service beyond a minimum retention period for transition purposes, in which case the liability is recognized ratably over the future service period. Other costs associated with a restructuring plan or exit or disposal activities, such as consulting and professional fees, facility exit costs, employee relocation, outplacement costs, accelerated depreciation or asset impairments associated with a restructuring plan, are recognized in the period in which the liability is incurred or the asset is impaired.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xOS9mcmFnOjNiOGYwYTNmZDgwMTQ5NmZiMDA4YWJkNTQ0MDcyNTM3L3RleHRyZWdpb246M2I4ZjBhM2ZkODAxNDk2ZmIwMDhhYmQ1NDQwNzI1MzdfMzEzMzYwODE0MTA5ODQ_5e7ea81c-08a2-48df-b5e4-8c20d2531510">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment Review of Goodwill and Indefinite-Lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests its goodwill, trademarks with indefinite lives and other indefinite-lived intangible assets annually for impairment in the fiscal fourth quarter unless there are indications during a different interim period that these assets may have become impaired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to goodwill, the Company has the option to first assess qualitative factors, such as the maturity and stability of the reporting unit, the magnitude of the excess fair value over carrying value from a previous period&#x2019;s impairment testing, other reporting unit specific operating results, microeconomic and macroeconomic factors, as well as new events and circumstances impacting the operations at the reporting unit level. The Company operates through strategic business units (SBUs) that are organized into the Company&#x2019;s operating segments. Reporting units for goodwill impairment testing purposes were identified as the Company&#x2019;s individual operating segments. If the result of a qualitative test indicates a potential for impairment of a reporting unit, a quantitative test is performed. In the quantitative test, the Company compares the estimated fair value of the reporting unit to its carrying value. If the estimated fair value of any reporting unit is less than its carrying value, an impairment charge is recorded for the difference between the carrying value and the fair value of the reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine the fair value of a reporting unit as part of its quantitative test, the Company uses the discounted cash flow (DCF) method under the income approach, as it believes that this approach is the most reliable indicator of the fair value of its businesses and the fair value of its future earnings and cash flows. Under this approach, which requires significant judgments, the Company estimates the future cash flows of each reporting unit and discounts these cash flows at a rate of return that reflects their relative risk. The cash flows used in the DCF method are consistent with those the Company uses in its internal planning, which gives consideration to actual business trends experienced, and the broader business strategy for the long term. The other key estimates and factors used in the DCF method include, but are not limited to, net sales and expense growth rates, commodity prices, foreign exchange rates, inflation and a terminal growth rate. Changes in such estimates or the application of alternative assumptions could produce different results. &lt;/span&gt;&lt;/div&gt;For trademarks and other intangible assets with indefinite lives, the Company has the option to first assess qualitative factors, such as the maturity and stability of the trademark or other intangible asset, the magnitude of the excess fair value over carrying value from a previous period&#x2019;s impairment testing, other specific operating results as well as new events and circumstances impacting the significant inputs used to determine the fair value of the intangible asset. If the result of a qualitative test indicates that it is more likely than not that the asset is impaired, a quantitative test is performed. When a quantitative test is performed, the estimated fair value of an asset is compared to its carrying value. If the carrying value of such asset exceeds its estimated fair value, an impairment charge is recorded for the difference between the carrying value and the estimated fair value. The Company uses the DCF method under the relief from royalty income approach to estimate the fair value of its trademarks and other intangible assets with indefinite lives. This approach requires significant judgments in determining the royalty rates and the assets&#x2019; estimated cash flows, as well as the appropriate discount and foreign exchange rates applied to those cash flows to determine fair value. Changes in such estimates or the use of alternative assumptions could produce different results.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xOS9mcmFnOjNiOGYwYTNmZDgwMTQ5NmZiMDA4YWJkNTQ0MDcyNTM3L3RleHRyZWdpb246M2I4ZjBhM2ZkODAxNDk2ZmIwMDhhYmQ1NDQwNzI1MzdfMzQ5Nw_0f586d3b-c7b3-43b8-8df9-40693fb68521">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#x201d; These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations.&#160;These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. As these amendments relate to disclosures only, there are no impacts expected to the Company&#x2019;s consolidated results of operations, financial position and cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfMjM0Ng_f1927191-0a16-45fd-984c-596d65c185e6">RESTRUCTURING AND RELATED COSTS&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of fiscal year 2023, the Company began recognizing costs related to a plan that involves streamlining its operating model to meet its objectives of driving growth and productivity. The streamlined operating model is expected to enhance the Company&#x2019;s ability to respond more quickly to changing consumer behaviors and innovate faster. The Company anticipates the implementation of this new model will be completed in fiscal year 2024, with different phases occurring throughout the implementation period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company anticipates incurring approximately $75 to $100 of costs in fiscal years 2023 and 2024 related to this initiative. Of this total amount, the higher-end of the range of approximately $40 to $60 is expected to be incurred in fiscal year 2023. Related costs are primarily expected to include employee-related costs to reduce certain staffing levels such as severance payments, as well as for consulting and other costs. Costs incurred are expected to be settled primarily in cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring and related implementation costs, net were $21 and $44 for the three and nine months ended March&#160;31, 2023, respectively. The following table summarizes the total restructuring and related implementation costs, net associated with the Company&#x2019;s streamlined operating model plan as reflected in the Consolidated Statements of Earnings and Comprehensive Income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Costs of products sold&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Selling and administrative expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Other (income) expense, net:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Employee-related costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Total, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee-related costs primarily include severance and other termination benefits calculated based on salary levels, prior service and statutory requirements. Other costs primarily include consulting fees incurred for the organizational design and implementation of the future streamlined operating model, related processes and other professional fees incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Charges for restructuring and related implementation costs are recorded in the Corporate segment as these initiatives are centrally directed and controlled and are not included in internal measures of segment operating performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may, from time to time, decide to pursue additional restructuring-related initiatives that involve costs in future periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables reconcile the accrual for the streamlined operating model restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the Consolidated Balance Sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;Employee-Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Accrual Balance as of December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Charges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Accrual Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;Employee-Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Accrual Balance as of June 30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Charges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Accrual Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="id7a142fe888d4dbf8b9d78f7d4a764bd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfNjE4_e390c283-34f7-4206-a18c-31b65728fcaf"
      unitRef="usd">75000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="icca7cfce0fa141dea44cb9ce7a326899_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfNjI0_db29fb23-40de-4eb7-8163-ca4dd8c1fd51"
      unitRef="usd">100000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i06d000a1aa834bbfac4282e34d583a60_I20230630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfNzE3_9830c241-ef15-4a37-b38b-fa2f11601f45"
      unitRef="usd">40000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="ib2c8765c01654490b2b1c05a7f10e95c_I20230630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfNzIz_7d97b1c6-9e2c-4786-a74a-378a6bf62bbc"
      unitRef="usd">60000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfMTA2OA_dcc9dc52-31b7-4f54-80fa-c7bf33bc21a5"
      unitRef="usd">21000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfMTA3NQ_89c59f32-75ca-4079-ba38-598d891611f8"
      unitRef="usd">44000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfMjM0Mg_7d6afba9-520d-4c10-bf6a-0ba78d6664c3">The following table summarizes the total restructuring and related implementation costs, net associated with the Company&#x2019;s streamlined operating model plan as reflected in the Consolidated Statements of Earnings and Comprehensive Income.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Costs of products sold&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Selling and administrative expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Other (income) expense, net:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Employee-related costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Total, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i3aa3d22372b64584acb9882537a6dd42_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfMi0xLTEtMS0xNDI2ODA_14b19232-e3ca-4ce8-852e-5144b8af26a8"
      unitRef="usd">0</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="iba59125bcc944eaab44b48bc55a3dc85_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfMi01LTEtMS0xNDI2ODA_2e563ad2-d8b7-4adb-8c28-d20ed0648378"
      unitRef="usd">-1000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i9ded3b682518451f87217f49e6d97925_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfMy0xLTEtMS0xNDI2ODA_c5fd0d30-2a6e-4787-b750-9d948d648c83"
      unitRef="usd">6000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i6f615042f4614c5ca2aa6f2698e2ecdc_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfMy01LTEtMS0xNDI2ODA_03f8a72e-8a50-498f-a226-32ba53224a8c"
      unitRef="usd">11000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i36e02fa510054f06be615621c9bd2ecd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfNS0xLTEtMS0xNDI2ODA_bebe88a6-2660-49ae-aa06-f2ecce7c041b"
      unitRef="usd">15000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="iad19817ded2e45cb9d95810868eafeea_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfNS01LTEtMS0xNDI2ODA_b4bdbe72-0195-4e57-af54-3b5a1838148f"
      unitRef="usd">34000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfOC0xLTEtMS0xNDI2ODA_f9208291-4f59-4c6f-a70c-03c032d63159"
      unitRef="usd">21000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjU1N2RlMzQ5NWY3YzQxMjU4NmE1MjYwMzZmYjdkZGZjL3RhYmxlcmFuZ2U6NTU3ZGUzNDk1ZjdjNDEyNTg2YTUyNjAzNmZiN2RkZmNfOC01LTEtMS0xNDI2ODA_255c10b2-6230-41bc-8f20-300f8997474e"
      unitRef="usd">44000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RleHRyZWdpb246OGU5ZTgwYzdmOGNiNDgxNzgyMGNmMTUxOWRkYzk1YjRfMjM0NQ_ccc986cd-0f95-4bbe-a7b4-c0ebad69fd96">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables reconcile the accrual for the streamlined operating model restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the Consolidated Balance Sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;Employee-Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Accrual Balance as of December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Charges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Accrual Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;Employee-Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Accrual Balance as of June 30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Charges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Accrual Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="id690da8b06c34b2db6496eb0743cd318_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMi0xLTEtMS0xNDI2ODA_0919dffc-019d-4076-a656-cc690758ece8"
      unitRef="usd">13000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="idb802f1785e94392ab45e3ccd217a284_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMi0zLTEtMS0xNDI2ODA_d5a1c2a3-01c1-4372-b3d0-d0bf36c8cbe4"
      unitRef="usd">2000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i058a79b88ddf43df8b916f862dfc5bf7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMi01LTEtMS0xNDI2ODA_f4f60267-8cee-4d58-8018-fb3ff27e7271"
      unitRef="usd">15000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i0ae0d275a3c3490d8d3fad6bff44ecc3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMy0xLTEtMS0xNDI2ODA_67812f8d-8136-48bb-a239-95a3a4e9e890"
      unitRef="usd">15000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7a1d7d8632bd40d6918c50fe8c44ac85_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMy0zLTEtMS0xNDI2ODA_6d34e38b-d5e1-40be-8a43-9b6d8a8be5fe"
      unitRef="usd">7000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMy01LTEtMS0xNDI2ODA_f51f11cd-792c-4ca9-8463-8acc1eb07b43"
      unitRef="usd">22000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i0ae0d275a3c3490d8d3fad6bff44ecc3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfNC0xLTEtMS0xNDI2ODA_c7f5ea67-ebf7-45ed-900d-167df0483a0e"
      unitRef="usd">10000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i7a1d7d8632bd40d6918c50fe8c44ac85_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfNC0zLTEtMS0xNDI2ODA_288ddec4-50b4-442b-b2a9-697e131c7945"
      unitRef="usd">4000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfNC01LTEtMS0xNDI2ODA_51139bdb-00ac-40bc-a755-fbdbd71fa7dd"
      unitRef="usd">14000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i37c8da2bf20c490596a15b4866b80871_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfNi0xLTEtMS0xNDI2ODA_5588b4f8-aa5d-4026-8fe3-d3fdaacbce71"
      unitRef="usd">18000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i597c023bc1a04a0b99911d165820e8b0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfNi0zLTEtMS0xNDI2ODA_833fd517-e3c5-45b4-aa04-6f3db32eec3a"
      unitRef="usd">5000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfNi01LTEtMS0xNDI2ODA_50cf6536-c9fc-4747-a3b8-cc8aa6b26e5b"
      unitRef="usd">23000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i51a13a9df4a44b17b6fe45952facdb9a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTAtMS0xLTEtMTQyNjgw_36ad54b9-fce7-4c78-8cdc-081828c5722c"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia25937b8293b44c98ede6be445bfbd4f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTAtMy0xLTEtMTQyNjgw_2118681b-105d-44af-9aee-8eaeef91aa6b"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTAtNS0xLTEtMTQyNjgw_e75c4b21-fd90-4fb3-8710-3a249d5da961"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i8f92c48a282547ff99ddf8f3b5d7f2f5_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTEtMS0xLTEtMTQyNjgw_2c8b3af2-9916-45df-be85-278f4566f134"
      unitRef="usd">34000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4dd70a15f7a94b8baa949563effef687_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTEtMy0xLTEtMTQyNjgw_f69a11b2-c468-4cf5-bb20-930e495219e3"
      unitRef="usd">14000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTEtNS0xLTEtMTQyNjgw_81d3e507-cc46-4f74-b5f6-ba2bf808a19a"
      unitRef="usd">48000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i8f92c48a282547ff99ddf8f3b5d7f2f5_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTItMS0xLTEtMTQyNjgw_11ed2067-bf61-4047-b0c5-d7b1a376b904"
      unitRef="usd">16000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i4dd70a15f7a94b8baa949563effef687_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTItMy0xLTEtMTQyNjgw_27567169-680b-4b3b-93eb-a9caafbe3b48"
      unitRef="usd">9000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTItNS0xLTEtMTQyNjgw_7408b261-6b57-4c32-87ad-4e925c31525f"
      unitRef="usd">25000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i37c8da2bf20c490596a15b4866b80871_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTQtMS0xLTEtMTQyNjgw_e41a752e-ef87-4939-a99e-0f1adcfe6f3f"
      unitRef="usd">18000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i597c023bc1a04a0b99911d165820e8b0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTQtMy0xLTEtMTQyNjgw_d5ce65ae-ba0a-4520-9b2e-22921ddc2db0"
      unitRef="usd">5000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yMi9mcmFnOjhlOWU4MGM3ZjhjYjQ4MTc4MjBjZjE1MTlkZGM5NWI0L3RhYmxlOjVmZDRmZmIzNDAwMjRlZWJhYjBhODcwZDBkNWFlOTM5L3RhYmxlcmFuZ2U6NWZkNGZmYjM0MDAyNGVlYmFiMGE4NzBkMGQ1YWU5MzlfMTQtNS0xLTEtMTQyNjgw_b1c60135-1f54-4209-8777-c4259f77df37"
      unitRef="usd">23000000</us-gaap:RestructuringReserve>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RleHRyZWdpb246MjA2NDhjMjNjYTk1NGFmYjg2ZmMxYzM0Zjc2MjA2YWFfMTQ4_a66041d1-1b20-45d6-be22-5aa962346a94">INVENTORIES, NET&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net, consisted of the following as of:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6/30/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials and packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIFO allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Noncurrent inventories, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Noncurrent inventories, net is recorded in Other assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RleHRyZWdpb246MjA2NDhjMjNjYTk1NGFmYjg2ZmMxYzM0Zjc2MjA2YWFfMTQz_47241666-4b07-45bc-8bc2-6ef83f5752fd">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net, consisted of the following as of:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6/30/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials and packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIFO allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Noncurrent inventories, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Noncurrent inventories, net is recorded in Other assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfMS0xLTEtMS0xNDI2ODA_646f7124-0ecb-440b-bdf0-e45d4620d5ec"
      unitRef="usd">638000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfMS0zLTEtMS0xNDI2ODA_edb78187-5c56-4d4c-8429-ab9d4dc0cc88"
      unitRef="usd">593000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfMi0xLTEtMS0xNDI2ODA_4a31f428-7eac-4e29-bbda-84072d2cd690"
      unitRef="usd">185000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfMi0zLTEtMS0xNDI2ODA_33f7fd44-1398-469f-b8dd-55b6cea31df0"
      unitRef="usd">191000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfMy0xLTEtMS0xNDI2ODA_0617f197-17cf-401b-9e2f-37d260aa6643"
      unitRef="usd">13000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfMy0zLTEtMS0xNDI2ODA_047edb07-4817-4e5a-83c9-10243b3496d1"
      unitRef="usd">16000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryLIFOReserve
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNC0xLTEtMS0xNDI2ODA_51a4ac96-a939-40c0-a51e-12ed697cdc91"
      unitRef="usd">94000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryLIFOReserve
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNC0zLTEtMS0xNDI2ODA_d85ac09e-17aa-4941-90cc-35e7e65ded3e"
      unitRef="usd">40000000</us-gaap:InventoryLIFOReserve>
    <clx:InventoryCurrentAndNoncurrentNet
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNS0xLTEtMS0xNDI2ODA_9d0ad178-6383-4ab7-93f2-0f09c504a022"
      unitRef="usd">742000000</clx:InventoryCurrentAndNoncurrentNet>
    <clx:InventoryCurrentAndNoncurrentNet
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNS0zLTEtMS0xNDI2ODA_6232126e-a9eb-4dd4-8a68-174b5ddcf0e3"
      unitRef="usd">760000000</clx:InventoryCurrentAndNoncurrentNet>
    <us-gaap:InventoryNoncurrent
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNi0xLTEtMS0xNDI2ODA_1fca02fe-6333-4f67-9d61-cd5031f98025"
      unitRef="usd">7000000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNi0zLTEtMS0xNDI2ODA_0c7c95f2-9531-4852-9118-6782ffb932f2"
      unitRef="usd">5000000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNet
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNy0xLTEtMS0xNDI2ODA_f02ea26a-256c-4416-a98f-e9f58c386e40"
      unitRef="usd">735000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yNS9mcmFnOjIwNjQ4YzIzY2E5NTRhZmI4NmZjMWMzNGY3NjIwNmFhL3RhYmxlOmQwYTJiMzFlNjA1MjQ1ZTBhYjkxZjk2OTZhNzU0ZjcwL3RhYmxlcmFuZ2U6ZDBhMmIzMWU2MDUyNDVlMGFiOTFmOTY5NmE3NTRmNzBfNy0zLTEtMS0xNDI2ODA_9de7b607-fd32-4f3a-a9c3-f41e0f46fc57"
      unitRef="usd">755000000</us-gaap:InventoryNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8zMTMzNjA4MTQxMzc2MA_86133c3d-8091-4d10-a13c-7c8b38f30e51">GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of fiscal year 2023, management made a decision to narrow the focus on core brands and streamline investment levels in the Vitamins, Minerals and Supplements (VMS) business. As a result, revisions were made to the internal financial projections and operational plans of the VMS business reflecting the Company&#x2019;s current estimates regarding the future financial performance of these operations and macroeconomic factors. The revised estimated future cash flows reflect lower sales growth expectations and lower investment levels. These revisions were considered a triggering event requiring interim impairment assessments to be performed as part of the preparation of the quar&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;terly financial statements on the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;global indefinite-lived trademarks, other long-term assets and the VMS reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the outcome of these assessments, the following pre-tax, non-cash impairment charges were recorded:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Impairment Charges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;VMS reporting unit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International reporting unit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with recognizing these impairment charges, the Company recognized tax benefits related to the impairments of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$83&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; due to the partial tax deductibility of these charges. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine the estimated fair values of the global indefinite-lived trademarks related to the VMS business, the Company used the DCF method under the relief from royalty income approach. This approach requires significant judgments in determining the royalty rates and the assets&#x2019; estimated cash flows as well as the appropriate discount rates applied to those cash flows to determine fair value. As a result of the interim impairment test, the Company concluded that the carrying value of the global indefinite-lived trademarks exceeded their estimated fair value, and recorded impairment charges of $139. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the useful lives of the impaired trademarks, with a remaining net carrying value of $28 as of&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; March 31, 2023, were changed from indefinite to definite beginning on April 1, 2023, which reflects the remaining expected useful lives of the trademarks based on the most recent financial and operational plans. The weighted-average estimated useful life of these trademarks is 20 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After adjusting the carrying&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;values of the global indefinite-lived trademarks and concluding that the carrying amounts of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the other long-lived assets were recoverable, the Company completed a quantitative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;impairment test for goodwill and recorded a goodwill impairment charge of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $306 i&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;n the VMS reporting unit. To determine the fair value of the VMS reporting unit, the Company used a DCF method under the income approach. In&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;accordance with this approach, the Company estimated the future cash flows of the VMS reporting unit and discounted these cash flows at a rate of return that reflects its relative risk. The other key estimates and factors used in the DCF method include,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;but are not limited to, net sales and expense growth rates and a terminal growth rate. The decrease in projected cash flows due to the revisions adversely impacted key assumptions used&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in determining the fair value of the VMS reporting unit and assets contained therein, primarily projected net sales&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There is no remaining goodwill associated with the impaired reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No triggering events were identified in the fiscal quarter ended March&#160;31, 2023 that would more likely than not reduce the fair value of the International reporting unit below its carrying value through March&#160;31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of Goodwill as of March&#160;31, 2023 from June&#160;30, 2022, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the carrying amount of trademarks and other intangible assets as of March&#160;31, 2023 and as of June&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization / Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization / Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks not subject to amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks subject to amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Amortization expense relating to the Company&#x2019;s intangible assets was $7 and $22 for the three and nine months ended March&#160;31, 2023, respectively, and $8 and $24 for the three and nine months ended March&#160;31, 2022, respectively. Estimated amortization expense for these intangible assets is $8, $29, $28, $28 and $28 for the remainder of fiscal year 2023 and fiscal years 2024, 2025, 2026 and 2027, respectively.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8zMTMzNjA4MTQxMzc2MQ_206736c8-442a-48c1-a128-3606bfdd6db6">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the outcome of these assessments, the following pre-tax, non-cash impairment charges were recorded:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Impairment Charges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;VMS reporting unit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International reporting unit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id94ba9c2186c47749a192c36f50af6e2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl8xLTEtMS0xLTE1NjYwNg_3845dc39-1bfd-48ca-a85d-c2b5d89132ee"
      unitRef="usd">306000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if866eca78fc44cb985650980c0effb9e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl8yLTItMS0xLTE1NzY5OQ_f65cca5a-596d-4a5c-a5b5-1862818785a9"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl8yLTMtMS0xLTE1NzcwNw_508ad3e5-27e0-4a9d-93c3-c77f0f2ec8fc"
      unitRef="usd">306000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="id94ba9c2186c47749a192c36f50af6e2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl8yLTEtMS0xLTE1NjYwNg_454227ff-b504-476f-a3cd-5d381baf4853"
      unitRef="usd">127000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="if866eca78fc44cb985650980c0effb9e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl8zLTItMS0xLTE1NzY5OQ_14b64992-2760-4032-aaa1-833b7c0459f0"
      unitRef="usd">12000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl8zLTMtMS0xLTE1NzcwNw_9ffb9866-4a06-4a3b-9607-7ed49e671c27"
      unitRef="usd">139000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:AssetImpairmentCharges
      contextRef="id94ba9c2186c47749a192c36f50af6e2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl81LTEtMS0xLTE1NjYwNg_6dd17bf2-568e-44fa-b5d4-fda0ca4db47d"
      unitRef="usd">433000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i14a182d0cd5c4d15965a7e7a7bfdc653_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl81LTEtMS0xLTE1NjYwNg_6fd3cc3e-103e-4b62-8c50-8dc7bd860468"
      unitRef="usd">433000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="if866eca78fc44cb985650980c0effb9e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl82LTItMS0xLTE1NzY5OQ_0480a602-616f-4c59-88d9-3d687e0ba797"
      unitRef="usd">12000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i1963ee82a44d46ffa8708d4e456f329c_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl82LTItMS0xLTE1NzY5OQ_437d4512-7080-4ae5-8322-4e1cfeaaea89"
      unitRef="usd">12000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6Y2IwYjcwNzg0NjRkNGVmZGI2MmQzMjEzMjViMTU5ZWYvdGFibGVyYW5nZTpjYjBiNzA3ODQ2NGQ0ZWZkYjYyZDMyMTMyNWIxNTllZl82LTMtMS0xLTE1NzcwNw_81a1d7a9-124b-431c-9584-c244e13453f3"
      unitRef="usd">445000000</us-gaap:AssetImpairmentCharges>
    <clx:ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV81NDk3NTU4MzU3NDg_2ac47263-dbd6-469e-be59-8a28f67eb66f"
      unitRef="usd">-83000000</clx:ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i2f45254db7c44fd7baa3242ec875ed30_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV81NDk3NTU4MzU3ODM_224a14ea-cc36-4c22-b1a2-9c87e1c02e3b"
      unitRef="usd">139000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <clx:IndefiniteLivedIntangibleAssetsRemainingCarryingValue
      contextRef="i30dd390ea6b04c08a6b35540c0fd90d5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV81NDk3NTU4MzU3OTA_62fc8e6d-1ecf-420b-8c87-dfdf2cf4fc9b"
      unitRef="usd">28000000</clx:IndefiniteLivedIntangibleAssetsRemainingCarryingValue>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if51281e120fb4c9aa9d0c0f419704d3e_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV80Mzk4MDQ2NTQyNzQ4_f77cd5d9-7404-4b1f-a385-ef0422543a51">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id94ba9c2186c47749a192c36f50af6e2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV81NDk3NTU4MzU3NzM_cf4f2ffe-c614-4b08-a5fd-f0e30625ad4d"
      unitRef="usd">306000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8zMTMzNjA4MTQxMzc2Mg_1343eab0-3f2e-44ae-8797-ffa0ca17ca20">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of Goodwill as of March&#160;31, 2023 from June&#160;30, 2022, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ifc9854de4e3c4c0985eef6728fd978cf_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18yLTEtMS0xLTE1NjY0Mg_9c216648-7bf2-4816-b518-e1f631f123fb"
      unitRef="usd">629000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia2cff198bfe644e0a8fb1825c00677d3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18yLTMtMS0xLTE1NjY0Mg_f07f9deb-5e6b-4ab9-8d5b-89187c8c3f23"
      unitRef="usd">85000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie62ad774357041f9ae5c145530854b8e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18yLTUtMS0xLTE1NjY0Mg_2dd47839-c530-4d0b-a017-e81d423089f7"
      unitRef="usd">244000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8e18cafffa494d9cb9daca6284175f4f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18yLTctMS0xLTE1NjY0Mg_12a0132b-6ddf-4d13-ac5a-a036111f6951"
      unitRef="usd">600000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18yLTktMS0xLTE1NjY0Mg_f000501e-2301-4fe1-a027-c9ecfb619e91"
      unitRef="usd">1558000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i72eb4644e3f447fe8259fdad6f8dde47_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY180LTEtMS0xLTE1NjY0Mg_edf8bded-71a4-4f46-870d-fc1f4ebe9adc"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i0d6d75e5aa7b47e588ee1b82de531670_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY180LTMtMS0xLTE1NjY0Mg_aa0fd859-0f4b-4bba-a93e-e0149fd5b11f"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i791d5f02e170464bb461195b53387d4d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY180LTUtMS0xLTE1NjY0Mg_563b7f95-33f2-4ae9-914c-7affb3500b9d"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i614e96f28f6b441c978c88983621bfff_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY180LTctMS0xLTE1NjY0Mg_99d775d5-6040-4380-b30f-7705d91b65f4"
      unitRef="usd">-11000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ic42f71e1a2c44eb8bfbfca5078fdca23_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY180LTktMS0xLTE1NjY0Mg_4a61c1b9-c9c9-4902-9323-46340fcbdfbe"
      unitRef="usd">-11000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i0a5483738f5a46b9a4300446be65ea03_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY181LTEtMS0xLTE1NjY0Mg_15071db5-15f5-4ade-b26f-9a54b36696fa"
      unitRef="usd">629000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie8d385e83a0148869431bc29b025489b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY181LTMtMS0xLTE1NjY0Mg_4f874c92-5e8e-4a3a-92cf-74fcda48daf0"
      unitRef="usd">85000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i521e232ee0064169882cd1c6588b7510_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY181LTUtMS0xLTE1NjY0Mg_7a1ca5e4-16af-4891-b26d-2519410b6981"
      unitRef="usd">244000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i85730fdfbb9c48a58317696007eac6f3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY181LTctMS0xLTE1NjY0Mg_71e223c1-7df8-4ed9-875f-6c257f57a0c8"
      unitRef="usd">589000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i660f20ab0c1946359ba21c70908a1443_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY181LTktMS0xLTE1NjY0Mg_6524aba2-f149-47b9-b6ae-c68e0d6a2d5b"
      unitRef="usd">1547000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ibf58e03903bd40ebbfded435df15b857_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY182LTEtMS0xLTE1NjY0Mg_a9f94e56-9b03-4a9d-886c-9614f898207d"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i5ff79fb466cf4f528c2057c39855c6fc_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY182LTMtMS0xLTE1NjY0Mg_67298882-0ed3-4f2a-b145-fa88eb54e5b2"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i61861cccc66e4af39cd5f905d2e6e973_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY182LTUtMS0xLTE1NjY0Mg_eec9ff58-c4b6-4663-9035-d0c79ad060ac"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i2260b79bc57d4a56a8a43db5b050892e_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY182LTctMS0xLTE1NjY0Mg_e79fb0a9-c100-488b-a5f1-61cc451d9049"
      unitRef="usd">6000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ia81dc710789a4279b293057273b0585e_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY182LTktMS0xLTE1NjY0Mg_5df1bea3-1338-4158-a2f5-ccc8e493fbef"
      unitRef="usd">6000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i0ec0696cfea245148b8cb3ed95489d83_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY183LTEtMS0xLTE1NjY0Mg_bd43d1c6-71f4-46c8-bb4b-3d9be9030a6e"
      unitRef="usd">629000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4e028c529aca4fe2a5bc96136e9b1d3d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY183LTMtMS0xLTE1NjY0Mg_c33b273a-a087-48b6-841f-465238eb8975"
      unitRef="usd">85000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3db36ab2a08e4e5e9acec297698a1d58_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY183LTUtMS0xLTE1NjY0Mg_1afbef21-3c20-48cc-aad4-0d93c164ea31"
      unitRef="usd">244000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4c4931a784644dbc9654624dc6378c3d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY183LTctMS0xLTE1NjY0Mg_76a02de0-12b7-4f96-8a6b-3c9dd55d978c"
      unitRef="usd">595000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i058a79b88ddf43df8b916f862dfc5bf7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY183LTktMS0xLTE1NjY0Mg_4cdf971e-acc8-407f-ade7-8989a24f61bd"
      unitRef="usd">1553000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i974dd2e411d44a7387a3a78f3494eff1_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY184LTEtMS0xLTE1NjY0Mg_c75a5e53-0c6e-49bc-bcd5-269e379e30c1"
      unitRef="usd">306000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="iaa6881da3a99458c8448602633dde541_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY184LTMtMS0xLTE1NjY0Mg_6ab8ee50-1f73-47e4-9b16-462994791bf5"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i1a5033b4e8dd41c2a30bdc0f5f38c4d7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY184LTUtMS0xLTE1NjY0Mg_af033dce-5018-4800-a916-1881f18b2dae"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5b73e43b25f6458dbd1f98100fb99374_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY184LTctMS0xLTE1NjY0Mg_5dca7142-f374-4039-af50-46da58b93b36"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY184LTktMS0xLTE1NjY0Mg_dd8f08f3-1cf6-45e5-b7f6-5b711c119ec3"
      unitRef="usd">306000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i974dd2e411d44a7387a3a78f3494eff1_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY185LTEtMS0xLTE1NjY0Mg_7ddec035-9065-4039-9da5-e5188ec687ce"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="iaa6881da3a99458c8448602633dde541_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY185LTMtMS0xLTE1NjY0Mg_ef67ccaf-369a-476d-9f3e-aa9c379e13a9"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i1a5033b4e8dd41c2a30bdc0f5f38c4d7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY185LTUtMS0xLTE1NjY0Mg_45754bcb-a7a0-46fc-a721-5728ecf65849"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i5b73e43b25f6458dbd1f98100fb99374_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY185LTctMS0xLTE1NjY0Mg_aa13974e-e825-43f3-9ede-37c724af0d72"
      unitRef="usd">3000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY185LTktMS0xLTE1NjY0Mg_92c5b84c-c74e-419c-b6ff-79c9e1718856"
      unitRef="usd">3000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i90ccd04fdd2047da9e06c4f3f203df6e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18xMC0xLTEtMS0xNTY2NDI_b58c39c8-42df-44b9-a67c-55efa77c11bc"
      unitRef="usd">323000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i553b47cda5624d2b9e5b9b4464cbf54b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18xMC0zLTEtMS0xNTY2NDI_c4db89fc-ebac-48e0-8f16-0d3bef289d24"
      unitRef="usd">85000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i97da66cd682045d0a6cf64a53511a50f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18xMC01LTEtMS0xNTY2NDI_1d48b947-e0db-4460-8183-1141e6208400"
      unitRef="usd">244000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i491dec08e3a04e15884928a98985d9ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18xMC03LTEtMS0xNTY2NDI_51cec9eb-ca49-49e9-b941-063cf805fcdb"
      unitRef="usd">598000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6YzU1OWRmMjQ3MzU1NDdkNGE2ZGVlYTQxNGMzYTFlYmMvdGFibGVyYW5nZTpjNTU5ZGYyNDczNTU0N2Q0YTZkZWVhNDE0YzNhMWViY18xMC05LTEtMS0xNTY2NDI_aa6f4a67-8553-4b51-8c22-18835d04a300"
      unitRef="usd">1250000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8zMTMzNjA4MTQxMzc2Mw_1a0e711d-e3f5-4b1f-bf01-cfeb934a5b1b">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the carrying amount of trademarks and other intangible assets as of March&#160;31, 2023 and as of June&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization / Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization / Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks not subject to amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks subject to amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <clx:IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment
      contextRef="i152e3a4caade4045835fdf23b4333786_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8yLTEtMS0xLTE1NjgxMg_25758375-3859-4fb9-9ea8-a30c922d873a"
      unitRef="usd">666000000</clx:IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i2f45254db7c44fd7baa3242ec875ed30_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8yLTMtMS0xLTE1NjgxMg_f977cb86-d0c0-4176-a1d9-6eb1f2ed7d45"
      unitRef="usd">139000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i152e3a4caade4045835fdf23b4333786_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8yLTUtMS0xLTE1NjgxMg_dc82f3df-907d-4e99-b5f5-07cc8ec5c8bf"
      unitRef="usd">527000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <clx:IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment
      contextRef="i8437cff6d6ba45528bcf1bb542174783_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8yLTctMS0xLTE1NjgxMg_c8cdbc51-b431-427e-be50-bee4e8a25e65"
      unitRef="usd">668000000</clx:IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ia20a96df8ee1438397ac0e1012769f4a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8yLTktMS0xLTE1NjgxMg_98ad2a09-4a54-4ce4-b197-1ec717d0d2e9"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i8437cff6d6ba45528bcf1bb542174783_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8yLTExLTEtMS0xNTY4MTI_6e104966-3c34-4d73-9f20-3ee3e217247b"
      unitRef="usd">668000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i30dd390ea6b04c08a6b35540c0fd90d5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8zLTEtMS0xLTE1NjgxMg_d31d224e-8ab7-4653-879f-f0ca34b4e172"
      unitRef="usd">56000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i30dd390ea6b04c08a6b35540c0fd90d5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8zLTMtMS0xLTE1NjgxMg_451f4d9d-4624-4d07-b5cf-17d0fda6e56a"
      unitRef="usd">37000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i30dd390ea6b04c08a6b35540c0fd90d5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8zLTUtMS0xLTE1NjgxMg_cb3f227a-7015-42c6-b210-bb60809cf27c"
      unitRef="usd">19000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i88cfb390480c455eb1a2978c32713180_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8zLTctMS0xLTE1NjgxMg_b60682a4-4948-4d66-8677-6ccca3b4def9"
      unitRef="usd">57000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i88cfb390480c455eb1a2978c32713180_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8zLTktMS0xLTE1NjgxMg_37298f28-b67c-47b2-8c28-0b7a07de76b7"
      unitRef="usd">38000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i88cfb390480c455eb1a2978c32713180_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl8zLTExLTEtMS0xNTY4MTI_3c1b48e9-e20f-41ac-8641-3582869f8986"
      unitRef="usd">19000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i38e791e368ab43409f15ba5e5f5cd67b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl80LTEtMS0xLTE1NjgxMg_6ee344ae-d14e-4a66-abb3-0afabf3551d6"
      unitRef="usd">578000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i38e791e368ab43409f15ba5e5f5cd67b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl80LTMtMS0xLTE1NjgxMg_8ca5ac9f-f0cd-4843-8e1a-e77761fd49d0"
      unitRef="usd">402000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i38e791e368ab43409f15ba5e5f5cd67b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl80LTUtMS0xLTE1NjgxMg_5a63e890-6276-4bfc-9259-79ae36b1ba71"
      unitRef="usd">176000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0463f04d5ee3451b946c7af6a61845ef_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl80LTctMS0xLTE1NjgxMg_43a85aee-c454-4e5e-b94e-1fda5e4017cd"
      unitRef="usd">577000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0463f04d5ee3451b946c7af6a61845ef_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl80LTktMS0xLTE1NjgxMg_3f23b6af-0d5e-4ea1-b227-73cb55e2e83b"
      unitRef="usd">380000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0463f04d5ee3451b946c7af6a61845ef_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl80LTExLTEtMS0xNTY4MTI_df632b09-3995-4180-9ee9-d6a9b9f6fd47"
      unitRef="usd">197000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl81LTEtMS0xLTE1NjgxMg_86a9dc1f-2f69-444d-97b5-dd70f5541147"
      unitRef="usd">1300000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl81LTMtMS0xLTE1NjgxMg_d8dc1fc8-2e43-46ca-a680-2297787fc518"
      unitRef="usd">578000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl81LTUtMS0xLTE1NjgxMg_b7c2d69a-ade0-4dd0-9d14-0e23509277d9"
      unitRef="usd">722000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl81LTctMS0xLTE1NjgxMg_b3f4102d-00b9-4efc-b6b6-fe78fe5f8312"
      unitRef="usd">1302000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl81LTktMS0xLTE1NjgxMg_815c8bac-8e84-4f84-9c28-6bde695cd079"
      unitRef="usd">418000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGFibGU6NzNmMDBkOTQ5NjJiNDY0OGI2NTc3M2I3MGM1YmZiMzYvdGFibGVyYW5nZTo3M2YwMGQ5NDk2MmI0NjQ4YjY1NzczYjcwYzViZmIzNl81LTExLTEtMS0xNTY4MTI_9518be1b-b09f-4793-936e-2c32b1c1505b"
      unitRef="usd">884000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5MjY1_50097ed3-ec58-4fc3-b9f2-4c8e4bee3ec2"
      unitRef="usd">7000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5Mjcx_80b8c12e-b4f0-4dba-89fa-c3ca467c02df"
      unitRef="usd">22000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5Mjc2_1832aa02-ae07-409b-884c-a4ca48f7ebc8"
      unitRef="usd">8000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5Mjgy_689f0fb9-ab1d-43dc-82c1-dc2122fcb4e8"
      unitRef="usd">24000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5MzIx_914ad836-1087-42d7-925b-e9b2c22776ee"
      unitRef="usd">8000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5MzI3_1f9a14c3-1459-49a8-b081-6fc8fa1da189"
      unitRef="usd">29000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5MzMz_a2c4d179-cd21-4af1-a298-633d116598e5"
      unitRef="usd">28000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5MzM5_87d2f786-1094-43d6-b2bf-087d851fb26b"
      unitRef="usd">28000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8xMDI2L2ZyYWc6MDdkOTY4NjBiYzUwNGIzM2FjZTVhYzA0OTk5Yzg2NjEvdGV4dHJlZ2lvbjowN2Q5Njg2MGJjNTA0YjMzYWNlNWFjMDQ5OTljODY2MV8yMTk5MDIzMjU5MzQ1_091115b1-2095-4cc2-b3bc-b426e4d0a0ac"
      unitRef="usd">28000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMTg5Mg_4c0db923-5b12-4607-97ed-1f46bcbf18f2">OTHER LIABILITIES&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span id="i5f09d63c9cd64157bb33befdd9640676_1908"/&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Venture Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an agreement with The Procter &amp;amp; Gamble Company (P&amp;amp;G) for the Company&#x2019;s Glad bags and wraps business. In connection with this agreement, P&amp;amp;G provides research and development (R&amp;amp;D) support to the Glad business. As of March&#160;31, 2023 and June&#160;30, 2022, P&amp;amp;G had a 20% interest in the venture. The Company pays a royalty to P&amp;amp;G for its interest in the profits, losses and cash flows, as contractually defined, of the Glad business, which is included in Cost of products sold. In December 2017, the Company and P&amp;amp;G extended the term of the agreement and the related R&amp;amp;D support provided by P&amp;amp;G. The term will expire in January 2026, unless the parties agree, on or prior to January 31, 2025, to further extend the term of the agreement for another seven years or agree to take some other relevant action. The agreement can be terminated earlier under certain circumstances, including at P&amp;amp;G&#x2019;s option upon a change in control of the Company or, at either party&#x2019;s option, upon the sale of the Glad business by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon termination of the agreement, the Company is required to purchase P&amp;amp;G&#x2019;s 20% interest for cash at fair value as established by predetermined valuation procedures. As of March&#160;31, 2023 and June&#160;30, 2022, the estimated fair value of P&amp;amp;G&#x2019;s interest in the venture was $527 and $635, respectively, of which $492 and $468, respectively, has been recognized and is reflected in Other liabilities. The difference between the estimated fair value and the amount recognized, and any future changes in the fair value of P&amp;amp;G&#x2019;s interest, is charged to Cost of products sold in accordance with the effective interest method over the remaining life of the agreement. Following termination, the Glad business will retain the exclusive core intellectual property licenses contributed by P&amp;amp;G on a royalty-free basis for the licensed products marketed.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <clx:PercentageofOwnershipbyVenturePartner
      contextRef="ia26f11b6660a4abcb09094cf9a8a25c1_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMzAy_0bc48b26-0e6d-4246-98c2-a9cc9b4d36e4"
      unitRef="number">0.20</clx:PercentageofOwnershipbyVenturePartner>
    <clx:PercentageofOwnershipbyVenturePartner
      contextRef="icc15044a51144f99b1b95c3d077cfd0a_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMzAy_f4f7e3c6-9a66-4d6a-8f1a-f1483f462d17"
      unitRef="number">0.20</clx:PercentageofOwnershipbyVenturePartner>
    <clx:VentureAgreementOptiontoExtendAgreementTermPeriod
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfNzgz_3c8cbe48-8b03-4acf-a723-5194f2ed1d5c">P7Y</clx:VentureAgreementOptiontoExtendAgreementTermPeriod>
    <clx:PercentageofOwnershipbyVenturePartner
      contextRef="ia26f11b6660a4abcb09094cf9a8a25c1_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMTEyNA_0bc48b26-0e6d-4246-98c2-a9cc9b4d36e4"
      unitRef="number">0.20</clx:PercentageofOwnershipbyVenturePartner>
    <clx:PercentageofOwnershipbyVenturePartner
      contextRef="icc15044a51144f99b1b95c3d077cfd0a_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMTEyNA_f4f7e3c6-9a66-4d6a-8f1a-f1483f462d17"
      unitRef="number">0.20</clx:PercentageofOwnershipbyVenturePartner>
    <clx:VentureAgreement.TerminalObligation
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMTI5Mg_cf9c94ae-8b3e-4b55-b0ad-16cc8e50e331"
      unitRef="usd">527000000</clx:VentureAgreement.TerminalObligation>
    <clx:VentureAgreement.TerminalObligation
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMTI5OQ_0141cce3-3739-46b7-8265-838ad2f6a0d8"
      unitRef="usd">635000000</clx:VentureAgreement.TerminalObligation>
    <clx:VentureAgreementTerminalObligationNet
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMTM0Ng_53142084-1b29-46a6-b035-5b2033fea33b"
      unitRef="usd">492000000</clx:VentureAgreementTerminalObligationNet>
    <clx:VentureAgreementTerminalObligationNet
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8yOC9mcmFnOjVmMDlkNjNjOWNkNjQxNTdiYjMzYmVmZGQ5NjQwNjc2L3RleHRyZWdpb246NWYwOWQ2M2M5Y2Q2NDE1N2JiMzNiZWZkZDk2NDA2NzZfMTM1Mw_2bcf66f4-26d4-4dce-8c95-cdfc130b8caf"
      unitRef="usd">468000000</clx:VentureAgreementTerminalObligationNet>
    <clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfNzgwOQ_b12dbf5c-3deb-41b9-a437-ec196b2ae443">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Risk Management and Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain commodity, foreign currency and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commodity Price Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may use commodity futures, options and swap contracts to limit the impact of price volatility on a portion of its forecasted raw material requirements. These commodity derivatives may be exchange traded or over-the-counter contracts and generally have original contractual maturities of less than two years. Commodity purchase and options contracts are measured at fair value using market quotations obtained from the Chicago Board of Trade commodity futures exchange and commodity derivative dealers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, and June&#160;30, 2022, the notional amount of commodity derivatives was $55 and $27, respectively, which related primarily to exposures in soybean oil used for the Food products business and jet fuel used for the Grilling business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may also enter into certain over-the-counter derivative contracts to manage a portion of the Company&#x2019;s forecasted foreign currency exposure associated with the purchase of inventory. These foreign currency contracts generally have original contractual maturities of less than two years. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of outstanding foreign currency forward contracts used by the Company&#x2019;s subsidiaries to hedge forecasted purchases of inventory were $55 and $31 as of March&#160;31, 2023 and June&#160;30, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may enter into over-the-counter interest rate contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt. These interest rate contracts generally have original contractual maturities of less than three years. The interest rate contracts are measured at fair value using information quoted by bond dealers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held no interest rate contracts as of both March&#160;31, 2023 and June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commodity, Foreign Exchange and Interest Rate Derivatives &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company designates its commodity forward, futures and options contracts for forecasted purchases of raw materials, foreign currency forward contracts for forecasted purchases of inventory and interest rate contracts for forecasted interest payments as cash flow hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings (losses) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (losses) recognized in Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated amount of the existing net gain (loss) in Accumulated other comprehensive net (loss) income as of March&#160;31, 2023 that is expected to be reclassified into Net earnings (losses) within the next twelve months is $9. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Counterparty Risk Management and Derivative Contract Requirements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes a variety of financial institutions as counterparties for over-the-counter derivative instruments. The Company enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually-defined counterparty liability position limits. Of the over-the-counter derivative instruments in liability positions, $1 and $0 contained such terms as of March&#160;31, 2023 and June&#160;30, 2022, respectively. As of both March&#160;31, 2023 and June&#160;30, 2022, neither the Company nor any counterparty was required to post any collateral as no counterparty liability position limits were exceeded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain terms of the agreements governing the Company&#x2019;s over-the-counter derivative instruments require the Company&#x2019;s credit ratings, as assigned by Standard &amp;amp; Poor&#x2019;s and Moody&#x2019;s to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If the Company&#x2019;s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of both March&#160;31, 2023 and June&#160;30, 2022, the Company and each of its counterparties had been assigned investment grade ratings by both Standard &amp;amp; Poor&#x2019;s and Moody&#x2019;s.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s exchange traded futures and options contracts used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account held by the Company&#x2019;s broker for trades conducted on that exchange. As of March&#160;31, 2023 and June&#160;30, 2022, the Company maintained cash margin balances related to exchange traded futures and options contracts of $3 and $1, respectively, which are classified as Prepaid expenses and other current assets on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Trust Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds interests in mutual funds and cash equivalents as part of trust assets related to its nonqualified deferred compensation plans. The participants in the nonqualified deferred compensation plans, who are the Company&#x2019;s current and former employees, may select among certain mutual funds in which their compensation deferrals are invested in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and therefore, trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The interests in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable securities as trading investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3: Unobservable inputs reflecting the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of both March&#160;31, 2023 and June&#160;30, 2022, the Company&#x2019;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#x2019;s nonqualified deferred compensation plans, which were classified as Level 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s derivative instruments qualify for hedge accounting. The following table provides information about the balance sheet classification and the fair values of the Company&#x2019;s derivative instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;6/30/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Hierarchy&lt;br/&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase options contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase swaps contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase futures contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase swaps contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about the balance sheet classification and the fair values of the Company&#x2019;s other assets and liabilities for which disclosure of fair value is required:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;6/30/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Hierarchy&lt;br/&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest-bearing investments, including money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trust assets for nonqualified deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes and loans payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes and loans payable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-term debt and Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;term debt and Long-term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company&#x2019;s credit agreements, all of which are recorded at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furthermore, impairment charges of $445 were recorded during the third quarter of fiscal 2023, of which $306 and $139 related to the goodwill of the VMS reporting unit and certain related indefinite-lived trademarks, respectively. These adjustments were included as Goodwill, trademark and other asset impairments in the condensed consolidated statement of earnings. The non-recurring fair values utilized included unobservable Level 3 inputs based on management&#x2019;s best estimates and assumptions. For additional information, refer to Note 4.&lt;/span&gt;&lt;/div&gt;</clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock>
    <us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1
      contextRef="i48ad1cc1bb794a76b3dd0815532c06b3_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfNjYw_10b2aca2-bf93-48cf-80c0-14ce461ecea6">P2Y</us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id06bee842a75404dac41877bdd92d1ef_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMjE5OTAyMzI2OTQwMg_8a4035da-e836-4b2a-afd7-f95697cc42ac"
      unitRef="usd">55000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia8a40de0484b4eeb80b4fe9c2b92525f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTY0OTI2NzQ0OTU1Nw_2d658edb-b3ad-4057-b6f5-f68b7276109e"
      unitRef="usd">27000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTM4OA_ef74affb-fef8-44fd-9261-1d6fca99e198">P2Y</us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icf2ca00060704f22aa28947a2c33bf44_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMjE5OTAyMzI2OTQwOQ_e2c954fe-d397-4174-816c-6ade7e9ef574"
      unitRef="usd">55000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2159f0fecc5b4470982d356c86f23bf9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTY2NQ_537a9b93-7c69-4756-8238-9230c99a234e"
      unitRef="usd">31000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTk4OQ_52783ffd-e52f-4aad-adfc-d4cb87a9840a">P3Y</us-gaap:MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfNzgxMQ_48f0c984-8a26-4ee1-8f63-de1e48b23437">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings (losses) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (losses) recognized in Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ifd98f18f73954c73b67fcb63121d3a6a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfMy0xLTEtMS0xNDI2ODA_3256dc4f-b134-4366-bfdc-a98e11cb7d1f"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie5e38353ad8c45ebbbeeb1760836023e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfMy0zLTEtMS0xNDI2ODA_513ed888-720a-4d4d-9b4d-88830f3ce00a"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i267e13abd2ac4080863d5a4b5a5a1008_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfMy01LTEtMS0xNDI2ODA_0b93a965-f6eb-4655-a136-707607c429f0"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia50e5e1f44b94908af2b9b0f33a06f5d_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfMy03LTEtMS0xNDI2ODA_ac343129-b340-4123-9731-8ff74b63c6ad"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib90adbece5bb496490f8e0ada42889bf_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNC0xLTEtMS0xNDI2ODA_408736ad-48a8-4224-a7d0-5dfbe453c2fa"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i53d784e371024289a6bb1733a0bfeceb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNC0zLTEtMS0xNDI2ODA_d7c31687-e964-43e0-ba30-78ecaec52481"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i06467bddcdcd40afaf9fc6a5d8f585b6_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNC01LTEtMS0xNDI2ODA_e7d5a2de-7c99-4be8-92e7-2e53996025c7"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i59a5dd038e5d4dc8a7529d286f2503b1_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNC03LTEtMS0xNDI2ODA_e3c89d7e-6353-45bd-8ed1-2f1856ca338e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i84aeaaa8c3d24da2a83bccbe80c40d7c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNS0xLTEtMS0xNDI2ODA_42343933-0533-454b-8229-e041921bcf51"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7569e47c817545e8b392a1799c23bb90_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNS0zLTEtMS0xNDI2ODA_124b791b-bd55-48f1-81e9-708f5188eda0"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i62117e14e9614a8b8aae02999044878f_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNS01LTEtMS0xNDI2ODA_5db56404-8d0d-4088-afab-52ec6660ea80"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i66b892c371534620b3587d9e0450ac51_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNS03LTEtMS0xNDI2ODA_41b95f82-44c4-4653-86e7-4dc67bfc5c01"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNi0xLTEtMS0xNDI2ODA_215cfb2d-ee3f-4530-aca3-65e354d26b44"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNi0zLTEtMS0xNDI2ODA_354a8c5e-b1ff-446a-ae78-f105a8c141e3"
      unitRef="usd">48000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNi01LTEtMS0xNDI2ODA_fb09d6fa-a04a-4eb4-8ee0-8eaa655f7e65"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjMzZjQ5YTYyYWQ5ODQwODJiYmJkZjVlYmQ2OGJkNGZhL3RhYmxlcmFuZ2U6MzNmNDlhNjJhZDk4NDA4MmJiYmRmNWViZDY4YmQ0ZmFfNi03LTEtMS0xNDI2ODA_ed55bdec-814d-4a75-86bf-c3c1f63d397b"
      unitRef="usd">51000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfNzgyMw_1e0fd681-ea4a-4019-b19d-a08135ee90cb">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ifd98f18f73954c73b67fcb63121d3a6a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfMy0yLTEtMS0xNDI2ODA_c170e389-b59e-4a92-90f6-7e3a293008e3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ie5e38353ad8c45ebbbeeb1760836023e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfMy00LTEtMS0xNDI2ODA_2b56ba74-79bb-4633-aceb-02bb3c178ce0"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i267e13abd2ac4080863d5a4b5a5a1008_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfMy02LTEtMS0xNDI2ODA_a0796092-074b-4b7b-bdd6-81db0b7210b5"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ia50e5e1f44b94908af2b9b0f33a06f5d_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfMy04LTEtMS0xNDI2ODA_d6f6884a-4f65-491a-a7f4-2c54e2266037"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ib90adbece5bb496490f8e0ada42889bf_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNC0yLTEtMS0xNDI2ODA_8995c603-e45e-4be5-ad48-f69b93d98365"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i53d784e371024289a6bb1733a0bfeceb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNC00LTEtMS0xNDI2ODA_3a1c4324-9144-4298-a2c3-376f5f3e52b3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i06467bddcdcd40afaf9fc6a5d8f585b6_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNC02LTEtMS0xNDI2ODA_669b473b-89fe-4353-bbf8-58f2d60bd13c"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i59a5dd038e5d4dc8a7529d286f2503b1_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNC04LTEtMS0xNDI2ODA_9335fc38-cad1-409a-9364-a0575009a376"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i84aeaaa8c3d24da2a83bccbe80c40d7c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNS0yLTEtMS0xNDI2ODA_d8029365-d158-4d15-9c2b-95c2ac318a1b"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i7569e47c817545e8b392a1799c23bb90_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNS00LTEtMS0xNDI2ODA_ab68ee66-fc75-42e0-a1d9-60307cea2253"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i62117e14e9614a8b8aae02999044878f_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNS02LTEtMS0xNDI2ODA_7e679ee8-ecf5-4d7d-aae0-15931e669abd"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i66b892c371534620b3587d9e0450ac51_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNS04LTEtMS0xNDI2ODA_7a3b7ec4-64d5-4ef6-a7ce-6369aebfe525"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNi0yLTEtMS0xNDI2ODA_97d85454-9b6a-49bb-b3a7-725adf409fd4"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNi00LTEtMS0xNDI2ODA_0eb862e9-c4fb-4efc-860e-d589ae7b3641"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNi02LTEtMS0xNDI2ODA_a609f8d7-4362-4463-a6e5-95a147f5e7f1"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjliODZlMjNhM2FmMjQzZTE4OTM5ZGU2NmM3MTRiMzNiL3RhYmxlcmFuZ2U6OWI4NmUyM2EzYWYyNDNlMTg5MzlkZTY2YzcxNGIzM2JfNi04LTEtMS0xNDI2ODA_031617f7-7858-42a6-9fa0-7a5d87dddf1e"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMjE5OTAyMzI2OTQxNw_ce1549ab-4f8b-4521-a4f1-0cbc58646e0c"
      unitRef="usd">9000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTY0OTI2NzQ1NTc1NA_cc9f0b3c-6478-4d6f-a954-1866c9e89c12"
      unitRef="usd">1000000</clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount>
    <clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTY0OTI2NzQ1NTc1OQ_6a60a0b8-7a7c-43f7-859d-207ea377ae92"
      unitRef="usd">0</clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount>
    <us-gaap:MarginDepositAssets
      contextRef="i66b2684d698e4766b9ae15f0597d7fdf_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMjE5OTAyMzI2OTQyMg_a68ed9d2-8a95-4baf-9a8a-ca469f07e998"
      unitRef="usd">3000000</us-gaap:MarginDepositAssets>
    <us-gaap:MarginDepositAssets
      contextRef="i8f46aa97434e48e89c802561e09aac43_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfNDgwNw_916b3c34-05eb-4f73-b392-c4fc2c4866e8"
      unitRef="usd">1000000</us-gaap:MarginDepositAssets>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfNzgyMg_36f56dde-b89e-49fc-bb94-2e4e8cb989a6">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3: Unobservable inputs reflecting the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of both March&#160;31, 2023 and June&#160;30, 2022, the Company&#x2019;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#x2019;s nonqualified deferred compensation plans, which were classified as Level 1.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfNzgyOA_2a16e405-2187-45d4-8a5b-e04e67d71dd3">The following table provides information about the balance sheet classification and the fair values of the Company&#x2019;s derivative instruments:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;6/30/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Hierarchy&lt;br/&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase options contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase swaps contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase futures contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase swaps contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about the balance sheet classification and the fair values of the Company&#x2019;s other assets and liabilities for which disclosure of fair value is required:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;6/30/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Hierarchy&lt;br/&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest-bearing investments, including money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trust assets for nonqualified deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes and loans payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes and loans payable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-term debt and Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;term debt and Long-term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company&#x2019;s credit agreements, all of which are recorded at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeAssets
      contextRef="ic9edfde63c0c497e88e10ce6f5c5636f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMy01LTEtMS0xNDI2ODA_e8823ef8-fe6d-443f-bbf4-c28ef9534ac5"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i77a4addd4aa1435083c94a016faebc92_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMy03LTEtMS0xNDI2ODA_20c71aec-25d1-47cb-b3dd-9538073ff2a2"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="icc0a6e589f2b483990fd8b1228aa3c8a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMy05LTEtMS0xNDI2ODA_b1b4b4c3-6375-4670-b9df-e13c983117a8"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="icbea6dcd3f5647a9bf12d9d534a6ca9c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMy0xMS0xLTEtMTQyNjgw_1765ff37-1790-4e0a-9c6e-473d7db0c26c"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i8d413ac1c4d04865a4e5fe3b340023a7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNC01LTEtMS0xNDI2ODA_1a788297-a5a4-4865-a839-bda62e25b45e"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i992290ad5dc147a89b2dc02782ff64ef_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNC03LTEtMS0xNDI2ODA_99d5ec1e-fcd3-4782-b02f-6372202b8d58"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i287e76237d8c427fa8b74226bacd7498_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNC05LTEtMS0xNDI2ODA_73a3aa0b-4840-49c7-b9cb-b0deed932fa9"
      unitRef="usd">6000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iaa9b879156664a4cabe4b0c19b072452_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNC0xMS0xLTEtMTQyNjgw_e72ade8e-f49c-4cdb-bbf9-3af4a14e850f"
      unitRef="usd">6000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="if09b23e716734285ad99334813cdd1c7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNi01LTEtMS0xNDI2ODA_0d4775b2-35d1-4ad2-9dcd-58527f6c41db"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i73735ddebada41feb165c246aab6ce4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNi03LTEtMS0xNDI2ODA_21d57e5d-8429-440c-aee8-770fb0913d52"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i2f6555be7a9e4d239338043a0facd422_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNi05LTEtMS0xNDI2ODA_c42599c5-3d0b-48b0-ba18-a3d7459e4edb"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i6f7ebc1c469348ed885bc1105f8fc3df_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfNi0xMS0xLTEtMTQyNjgw_0429e327-42c2-437a-9a71-10fa45b55b63"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i6a68f814db4a4c5c95ed1bd0205e0034_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfOC01LTEtMS0xNDI2ODA_253314ab-7b00-45e9-af65-debb79573685"
      unitRef="usd">2000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="idb497008d82d4021908269a98083af08_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfOC03LTEtMS0xNDI2ODA_b0eab1f2-93d5-4403-bd1f-788c0143dfdd"
      unitRef="usd">2000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i03ee318c0e494e0981bcc1c4c86ac0c3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfOC05LTEtMS0xNDI2ODA_fb3dbb13-61fe-4179-92e6-c42552d40364"
      unitRef="usd">7000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i5f23483af02142ff962e0bc8a46b198f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfOC0xMS0xLTEtMTQyNjgw_737ba693-f790-42f0-bcb8-790907e92604"
      unitRef="usd">7000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="ic9edfde63c0c497e88e10ce6f5c5636f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTAtNS0xLTEtMTQyNjgw_adcf831d-211d-41a8-86a3-5a4e3b9d19d1"
      unitRef="usd">2000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i77a4addd4aa1435083c94a016faebc92_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTAtNy0xLTEtMTQyNjgw_2cbcc406-4c87-4767-8bec-cac2beb27920"
      unitRef="usd">2000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="icc0a6e589f2b483990fd8b1228aa3c8a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTAtOS0xLTEtMTQyNjgw_ccfd86e8-235e-4641-99ab-82f5cb52107c"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="icbea6dcd3f5647a9bf12d9d534a6ca9c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTAtMTEtMS0xLTE0MjY4MA_d5156565-5ff5-44cc-bd68-37c5de07a07e"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i8d413ac1c4d04865a4e5fe3b340023a7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTEtNS0xLTEtMTQyNjgw_f8cd37fd-73c9-42a9-9b9d-27bce5b34e24"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i992290ad5dc147a89b2dc02782ff64ef_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTEtNy0xLTEtMTQyNjgw_63a5097a-37b1-484a-ad72-ddfc73a186dc"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i287e76237d8c427fa8b74226bacd7498_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTEtOS0xLTEtMTQyNjgw_64a39c8b-c845-450d-9898-49502459a7e4"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="iaa9b879156664a4cabe4b0c19b072452_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTEtMTEtMS0xLTE0MjY4MA_07127be5-2bfb-41aa-acc9-10a5b88d591c"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i6a68f814db4a4c5c95ed1bd0205e0034_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTMtNS0xLTEtMTQyNjgw_cbe2029b-5f1c-434d-847c-351ff9ac334e"
      unitRef="usd">3000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="idb497008d82d4021908269a98083af08_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTMtNy0xLTEtMTQyNjgw_169606bd-f529-4479-a546-2bf5ef1fe6c6"
      unitRef="usd">3000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i03ee318c0e494e0981bcc1c4c86ac0c3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTMtOS0xLTEtMTQyNjgw_d162f3d5-3e98-473e-ae74-dd692782ca69"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i5f23483af02142ff962e0bc8a46b198f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOmJlODMwZjY5Y2E4NTRmNWJiZjQ3YzUwOTUyZDRhMDdlL3RhYmxlcmFuZ2U6YmU4MzBmNjljYTg1NGY1YmJmNDdjNTA5NTJkNGEwN2VfMTMtMTEtMS0xLTE0MjY4MA_d1144346-6f27-4b7c-8e64-f7602d00fa1a"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia680265241d34120bcbc6e5b1c032c3a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMy01LTEtMS0xNDI2ODA_5162c062-6518-4962-ac23-2475944f9c13"
      unitRef="usd">61000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib949b42e3d64447f9f9da32d8fe053fc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMy03LTEtMS0xNDI2ODA_d510ea12-fea4-48c6-bd53-3b7c62d51eb5"
      unitRef="usd">61000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6b1b18d9575c4fe181987e3bdf974c55_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMy05LTEtMS0xNDI2ODA_b16259fa-d5d3-4f06-be30-3a9e3270d585"
      unitRef="usd">86000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib19d64991cb241db9d152df2af96652c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMy0xMS0xLTEtMTQyNjgw_21750e7f-1b1f-4af1-a035-d2f12b5dcb69"
      unitRef="usd">86000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7a98cb40f89c4f6cb3174cc2385cfdc3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNC01LTEtMS0xNDI2ODA_859d6b35-7e44-475d-9d1e-d9b297ae1b56"
      unitRef="usd">7000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iec4aaa03ddf14edab361fbdbd7af4a28_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNC03LTEtMS0xNDI2ODA_65291ab7-2bcb-4e1e-9441-775c57b11e86"
      unitRef="usd">7000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="idd50e0a93db949dc86a0a76dea201d7e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNC05LTEtMS0xNDI2ODA_647acf91-d711-42b7-baac-a66684224545"
      unitRef="usd">4000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="icdc22c41b65b44f5910fb2bd6e7aa7ef_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNC0xMS0xLTEtMTQyNjgw_0dfc3d93-07be-4f0e-966d-710c1189837a"
      unitRef="usd">4000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="id77511cc08ae4fada9800a2edf805e8d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNy01LTEtMS0xNDI2ODA_67a77805-5aaa-4888-9298-a72f5661fb31"
      unitRef="usd">126000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i699f3ca3c5db4d5bba548627af449cf4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNy03LTEtMS0xNDI2ODA_22b7627d-eee5-459c-bc9b-29cfb8d17376"
      unitRef="usd">126000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i80dda40f54024046ade281e97268afde_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNy05LTEtMS0xNDI2ODA_354eddef-f7b1-4b22-9c6c-df4e8d4ca1e8"
      unitRef="usd">119000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="icb50e89eb9054e9497f1a6390acb66df_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfNy0xMS0xLTEtMTQyNjgw_d95d0020-9909-43e7-8195-6b7f84abb487"
      unitRef="usd">119000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:Assets
      contextRef="i6a68f814db4a4c5c95ed1bd0205e0034_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfOC01LTEtMS0xNDI2ODA_d3232fdf-1f70-4d2e-af4d-08ad6ff0352b"
      unitRef="usd">194000000</us-gaap:Assets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idb497008d82d4021908269a98083af08_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfOC03LTEtMS0xNDI2ODA_ab63bb63-aab0-4953-b765-3d5b978bd144"
      unitRef="usd">194000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Assets
      contextRef="i03ee318c0e494e0981bcc1c4c86ac0c3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfOC05LTEtMS0xNDI2ODA_14f293ad-563a-4de6-9aa6-4489fad61964"
      unitRef="usd">209000000</us-gaap:Assets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5f23483af02142ff962e0bc8a46b198f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfOC0xMS0xLTEtMTQyNjgw_4bb6f356-9bba-4b51-a6b5-6ba7b652119d"
      unitRef="usd">209000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CommercialPaper
      contextRef="i9a4b9990a76749d7b5b429e19b132705_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTAtNS0xLTEtMTQyNjgw_30d141df-8448-49db-bd7b-43e7c270f11b"
      unitRef="usd">138000000</us-gaap:CommercialPaper>
    <us-gaap:ShorttermDebtFairValue
      contextRef="i7abd7c745142489ba717edbad8ecc1b6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTAtNy0xLTEtMTQyNjgw_7e079ef5-b08a-46a2-b914-696f53e77c3d"
      unitRef="usd">138000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:CommercialPaper
      contextRef="if177937c7cde476eace985e08c46bb5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTAtOS0xLTEtMTQyNjgw_bb7cff02-e337-409f-b94f-8b53dbf27ea9"
      unitRef="usd">237000000</us-gaap:CommercialPaper>
    <us-gaap:ShorttermDebtFairValue
      contextRef="i86811defe6884c9b8f1c17dcfaada1ff_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTAtMTEtMS0xLTE0MjY4MA_524bc9a2-d912-410d-bbfb-672e0f5b60eb"
      unitRef="usd">237000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:LongTermDebt
      contextRef="i3b50460a1b234ac3b19dc457a1b696e6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTItNS0xLTEtMTQyNjgw_0362abc5-44c4-448f-b7af-a7ea10a8205b"
      unitRef="usd">2476000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i2e23b9c3471546129e5eb560eabed6b9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTItNy0xLTEtMTQyNjgw_3cbf2c02-1307-407c-90ce-e5c750849190"
      unitRef="usd">2376000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="i37e76d4ac9234a0186486ff3b55d6a18_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTItOS0xLTEtMTQyNjgw_0ba88069-1dd8-4cd1-a0c2-a0b3332b2d20"
      unitRef="usd">2474000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iaff929c5c7ef4f728e2ba0db462af797_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTItMTEtMS0xLTE0MjY4MA_f4dd5497-e744-42d3-8492-1fd9541a473b"
      unitRef="usd">2386000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:Liabilities
      contextRef="i6a68f814db4a4c5c95ed1bd0205e0034_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTMtNS0xLTEtMTQyNjgw_138b572f-9c29-4cb6-8897-d36857b64ade"
      unitRef="usd">2614000000</us-gaap:Liabilities>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="idb497008d82d4021908269a98083af08_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTMtNy0xLTEtMTQyNjgw_ff344cc8-6fb4-4fee-9806-7a13ef70bf1e"
      unitRef="usd">2514000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:Liabilities
      contextRef="i03ee318c0e494e0981bcc1c4c86ac0c3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTMtOS0xLTEtMTQyNjgw_b58614f1-eb0b-4aab-bf80-24e3891abc28"
      unitRef="usd">2711000000</us-gaap:Liabilities>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i5f23483af02142ff962e0bc8a46b198f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RhYmxlOjIxMjI1ZmU0OGI2MjRiMzViMmYwNTYxYzU0YTg1Zjc3L3RhYmxlcmFuZ2U6MjEyMjVmZTQ4YjYyNGIzNWIyZjA1NjFjNTRhODVmNzdfMTMtMTEtMS0xLTE0MjY4MA_23f8558f-10d5-45f0-a952-02c901b74be6"
      unitRef="usd">2623000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:AssetImpairmentCharges
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTA5OTUxMTY0MTcwMQ_81a1d7a9-124b-431c-9584-c244e13453f3"
      unitRef="usd">445000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTA5OTUxMTY0MTcwOQ_508ad3e5-27e0-4a9d-93c3-c77f0f2ec8fc"
      unitRef="usd">306000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zMS9mcmFnOjA1OTUwM2MxMGVhZDRlY2ZiOGQ5ZTgzNjVlOWJiMzBmL3RleHRyZWdpb246MDU5NTAzYzEwZWFkNGVjZmI4ZDllODM2NWU5YmIzMGZfMTA5OTUxMTY0MTcxNQ_9ffb9866-4a06-4a3b-9607-7ed49e671c27"
      unitRef="usd">139000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNC9mcmFnOjI3OTFjMjJlYzMyNDQ3Y2I5YTZkYmExZWQ1MjBlN2Q3L3RleHRyZWdpb246Mjc5MWMyMmVjMzI0NDdjYjlhNmRiYTFlZDUyMGU3ZDdfMTEyNA_3382f0d8-939a-4e38-9760-fe2687c39bfa">INCOME TAXESIn determining its quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The effective tax rate on losses was 14.7% and the effective tax rate on earnings was 1,813.5% for the three and nine months ended March&#160;31, 2023, respectively. The effective tax rate on earnings was 23.9% and 23.3% for the three and nine months ended March&#160;31, 2022, respectively. The lower tax rate on losses before income taxes in the current three month period was driven by the partial non-deductibility of impaired VMS goodwill. The substantially higher tax rate on earnings before income taxes in the current nine month period was driven by lower pre-tax income due to the VMS impairment charges and the non-deductibility of a portion of those charges.The Inflation Reduction Act (the &#x201c;Act&#x201d;) was signed into law on August 16, 2022. The Act introduces a new 15% corporate minimum tax for certain large corporations that becomes effective at the beginning of the Company&#x2019;s fiscal 2024 and it imposes a 1% excise tax on the value of share repurchases, net of new share issuances, after December 31, 2022. These provisions, as well as the other corporate tax changes included in the Act, are not expected to have a material impact on the Company&#x2019;s financial statements.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNC9mcmFnOjI3OTFjMjJlYzMyNDQ3Y2I5YTZkYmExZWQ1MjBlN2Q3L3RleHRyZWdpb246Mjc5MWMyMmVjMzI0NDdjYjlhNmRiYTFlZDUyMGU3ZDdfNTI3_922160d9-743f-4679-b80b-21757110570b"
      unitRef="number">0.147</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNC9mcmFnOjI3OTFjMjJlYzMyNDQ3Y2I5YTZkYmExZWQ1MjBlN2Q3L3RleHRyZWdpb246Mjc5MWMyMmVjMzI0NDdjYjlhNmRiYTFlZDUyMGU3ZDdfNTM0_c31ff3d8-2475-4397-b8c6-b97b7f540cf6"
      unitRef="number">18.135</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNC9mcmFnOjI3OTFjMjJlYzMyNDQ3Y2I5YTZkYmExZWQ1MjBlN2Q3L3RleHRyZWdpb246Mjc5MWMyMmVjMzI0NDdjYjlhNmRiYTFlZDUyMGU3ZDdfNTcw_312eeefe-6249-40e4-97f1-5b5dca6064ea"
      unitRef="number">0.239</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNC9mcmFnOjI3OTFjMjJlYzMyNDQ3Y2I5YTZkYmExZWQ1MjBlN2Q3L3RleHRyZWdpb246Mjc5MWMyMmVjMzI0NDdjYjlhNmRiYTFlZDUyMGU3ZDdfNTc3_674f305b-258d-4677-8d3f-32344830a594"
      unitRef="number">0.233</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RleHRyZWdpb246MDUwY2EzYjAyZmUyNGRkY2IxZWNiMTNkMjdmNmMzZjlfMzQ1_1f1a8154-3364-4dd8-9b67-0aff8e159352">NET EARNINGS (LOSSES) PER SHARE (EPS)&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,649&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,177&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,512&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,074&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,649&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,877&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,512&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,943&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Antidilutive stock options and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,953&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net earnings (losses) per share and Diluted net earnings (losses) per share are calculated on Net earnings (losses) attributable to Clorox.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since the Company generated net losses attributable to Clorox for the three and nine months ended March&#160;31, 2023, there was no dilutive effect of stock options and other instruments because their impacts would be antidilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RleHRyZWdpb246MDUwY2EzYjAyZmUyNGRkY2IxZWNiMTNkMjdmNmMzZjlfMzUw_b7b817ad-a137-4a26-8254-24b66e620a8d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,649&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,177&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,512&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,074&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,649&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,877&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,512&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,943&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Antidilutive stock options and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,953&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMi0xLTEtMS0xNDI2ODA_045e08e3-befa-4b7f-b43e-f50fa1131ba3"
      unitRef="shares">123649000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMi0zLTEtMS0xNDI2ODA_29ede725-02b1-4e68-a243-4b24233bf9b5"
      unitRef="shares">123177000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMi01LTEtMS0xNDI2ODA_b20af0c1-e01b-4b33-b418-d8fc9c6e6703"
      unitRef="shares">123512000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMi03LTEtMS0xNDI2ODA_579cf6f6-a9da-413a-bcb7-09b7c8e5afe6"
      unitRef="shares">123074000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMy0xLTEtMS0xNDI2ODA_2e180a21-1627-4c7f-968a-e28d895fc63e"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMy0zLTEtMS0xNDI2ODA_a30b6d2e-5568-412f-9a46-8780753c9ca8"
      unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMy01LTEtMS0xNDI2ODA_ec7183aa-4f19-4b10-81df-4c8184e6f330"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfMy03LTEtMS0xNDI2ODA_5b4b528f-14bc-46b8-b889-d61443b6aa77"
      unitRef="shares">869000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNC0xLTEtMS0xNDI2ODA_d5330061-4b74-4f34-8972-b73ffbe03eb8"
      unitRef="shares">123649000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNC0zLTEtMS0xNDI2ODA_df87c46f-00d8-4d64-b2ef-1f4e0fd78d33"
      unitRef="shares">123877000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNC01LTEtMS0xNDI2ODA_103438e0-3860-4719-996e-34bc85e9f9b8"
      unitRef="shares">123512000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNC03LTEtMS0xNDI2ODA_d107bb45-f50f-4855-bb27-a5843ac136ba"
      unitRef="shares">123943000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNi0xLTEtMS0xNDI2ODA_2a961da7-ff4d-41d2-946c-04076442bd7d"
      unitRef="shares">4953000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNi0zLTEtMS0xNDI2ODA_887d5a7a-8285-4276-9d1d-d6c015eda0ac"
      unitRef="shares">2489000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNi01LTEtMS0xNDI2ODA_32860a61-1cec-4ff2-92ed-e359267ae07f"
      unitRef="shares">4953000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF8zNy9mcmFnOjA1MGNhM2IwMmZlMjRkZGNiMWVjYjEzZDI3ZjZjM2Y5L3RhYmxlOjJlN2MzOTA5ZjdhZTQ1MDg4NTRhYzhhZmY4ZmZmYmMzL3RhYmxlcmFuZ2U6MmU3YzM5MDlmN2FlNDUwODg1NGFjOGFmZjhmZmZiYzNfNi03LTEtMS0xNDI2ODA_af5a4dbe-70a2-4ee2-af8b-1f3783474b26"
      unitRef="shares">2489000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RleHRyZWdpb246YjNmNDFlMWQxMjMxNDBmNjk5NTM1YWIwZDRjMWEzMjJfMTQz_73113bd0-6510-4e7f-ac7e-6561cc6592a4">COMPREHENSIVE INCOME (LOSS)&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of Comprehensive income (loss) for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Total comprehensive income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total comprehensive income (loss) attributable to Clorox&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RleHRyZWdpb246YjNmNDFlMWQxMjMxNDBmNjk5NTM1YWIwZDRjMWEzMjJfMTQ2_8bd3bd8f-6fd4-4d24-b8b4-9e3841580068">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of Comprehensive income (loss) for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Total comprehensive income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total comprehensive income (loss) attributable to Clorox&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMi0xLTEtMS0xNDI2ODA_08e11cf6-c7dc-4e0b-ab8d-af9b87a5a836"
      unitRef="usd">-209000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMi0zLTEtMS0xNDI2ODA_122c3073-d792-4548-8351-05f3a1e5c6c1"
      unitRef="usd">152000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMi01LTEtMS0xNDI2ODA_ab28204e-3b6c-4f29-9f4b-6b1181ed7267"
      unitRef="usd">-20000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMi03LTEtMS0xNDI2ODA_5ce7b781-1753-40da-b61d-ded11c29c64a"
      unitRef="usd">367000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNC0xLTEtMS0xNDI2ODA_7bf735e4-2ea2-4222-8568-ec46e5e267cc"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNC0zLTEtMS0xNDI2ODA_e9bfbeb9-e4cd-4934-ade7-857e72fce19e"
      unitRef="usd">19000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNC01LTEtMS0xNDI2ODA_b1c74843-8a1a-4ed6-bc68-30d9413bbea8"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNC03LTEtMS0xNDI2ODA_61180221-7d27-43d9-8671-038eede7526d"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNS0xLTEtMS0xNDI2ODA_96b3d670-5ee5-4d1f-b12b-8e2997eda1d8"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNS0zLTEtMS0xNDI2ODA_f2cc5f5d-a3bd-4cda-b001-7f0efbaf65da"
      unitRef="usd">34000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNS01LTEtMS0xNDI2ODA_92bad9db-ac2f-46f3-81b4-77514a6dcc0e"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNS03LTEtMS0xNDI2ODA_c274f82a-5e16-4ca8-a490-4ed8c653e53f"
      unitRef="usd">31000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNi0xLTEtMS0xNDI2ODA_eb6ec565-e72b-4de6-94a9-97467f0916a3"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNi0zLTEtMS0xNDI2ODA_0065a0c2-5812-44d6-b6bb-bb58203a5c42"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNi01LTEtMS0xNDI2ODA_c26e69a1-bf53-4bc6-bced-4b846470ec58"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNi03LTEtMS0xNDI2ODA_dc554a50-47d1-4c5f-8790-b29fdf11d423"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNy0xLTEtMS0xNDI2ODA_87fcec40-248a-4eb6-b910-8417953f6a7b"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNy0zLTEtMS0xNDI2ODA_262eef87-d07f-4c3b-a0ff-4f1d392602df"
      unitRef="usd">55000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNy01LTEtMS0xNDI2ODA_ef5c71af-6c00-4dee-938f-f602065c98be"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfNy03LTEtMS0xNDI2ODA_5aa79f24-ebbb-4c0e-9ded-f769f8bc865e"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOC0xLTEtMS0xNDI2ODA_dcbb55cd-8628-471c-b830-c71d4d265f15"
      unitRef="usd">-205000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOC0zLTEtMS0xNDI2ODA_7fa7027d-9c2a-4ee9-a551-4fefc07c8bfc"
      unitRef="usd">207000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOC01LTEtMS0xNDI2ODA_0fc192f2-a342-4c3b-a653-9ef111b1c1db"
      unitRef="usd">-39000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOC03LTEtMS0xNDI2ODA_bd0355e5-1e07-4100-a99b-828aba56be3c"
      unitRef="usd">394000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOS0xLTEtMS0xNDI2ODA_2d072de0-8fe7-43ae-993a-ee321fd3b372"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOS0zLTEtMS0xNDI2ODA_6dbe010f-9cae-4347-a5a5-5d4c4d03b217"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOS01LTEtMS0xNDI2ODA_0361d396-b80d-48fe-8f1c-8433261688ac"
      unitRef="usd">7000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfOS03LTEtMS0xNDI2ODA_b7a7911b-0961-4796-9031-626f4c4ee041"
      unitRef="usd">6000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMTAtMS0xLTEtMTQyNjgw_366d401e-2af2-409d-bd7c-3d47147151d7"
      unitRef="usd">-207000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMTAtMy0xLTEtMTQyNjgw_78b90f18-38dc-42e8-bfae-8254088c3474"
      unitRef="usd">205000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMTAtNS0xLTEtMTQyNjgw_1ea8924e-ca91-43e2-884b-4e92ca194200"
      unitRef="usd">-46000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80MC9mcmFnOmIzZjQxZTFkMTIzMTQwZjY5OTUzNWFiMGQ0YzFhMzIyL3RhYmxlOjE2NDk5ZDRmMjBkNDQ1MTM4MTg5NWJiOGM4NWNhMzE4L3RhYmxlcmFuZ2U6MTY0OTlkNGYyMGQ0NDUxMzgxODk1YmI4Yzg1Y2EzMThfMTAtNy0xLTEtMTQyNjgw_f3223fe7-f5a7-4975-b9a5-4417cd416b77"
      unitRef="usd">388000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RleHRyZWdpb246Y2Q2YmVhMDExYWZmNDg5ZTliYTM3MzQwYWJlMmVjOTJfNjAz_f588a724-db0a-422a-a90e-169d3964bf6f">STOCKHOLDERS&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; EQUITY &lt;/span&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the components of Stockholders&#x2019; equity were as follows for the periods indicated: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%"&gt;(Dollars in millions except per share data; shares in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additional Paid-in Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Net (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders ($1.16 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders ($1.18 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%"&gt;(Dollars in millions except per share data; shares in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additional Paid-in Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Net (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders ($3.48 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Treasury stock purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,589)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders ($4.72 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense), and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense), and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in foreign currency translation adjustments are remeasurement losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future. There were no amounts associated with these loans reclassified from Accumulated other comprehensive net (loss) income for the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RleHRyZWdpb246Y2Q2YmVhMDExYWZmNDg5ZTliYTM3MzQwYWJlMmVjOTJfNjAw_e295a3a7-3210-4f38-8a38-27dcb09b5597">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the components of Stockholders&#x2019; equity were as follows for the periods indicated: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%"&gt;(Dollars in millions except per share data; shares in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additional Paid-in Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Net (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders ($1.16 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders ($1.18 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%"&gt;(Dollars in millions except per share data; shares in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additional Paid-in Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Net (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders ($3.48 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Treasury stock purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,589)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders ($4.72 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i09e3af3669ef426badcf844049084f14_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy0xLTEtMS0xNDI2ODA_83d29086-63cb-4127-9827-05a10bc2599c"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i09e3af3669ef426badcf844049084f14_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy0zLTEtMS0xNDI2ODA_e61a6cae-022b-4b96-a481-5efacbb083fb"
      unitRef="shares">130741000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icd45a75514c24c568a56042ccd0c84da_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy01LTEtMS0xNDI2ODA_5fa8e070-aa2c-475c-b2a1-a8f14b4d9c01"
      unitRef="usd">1180000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i05ffbff4ac6b4a4b91ae2e1f6beaafa4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy03LTEtMS0xNDI2ODA_e90af6c7-ecfd-4fcc-8205-529f9da3f16d"
      unitRef="usd">949000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifae1e2814de34b5eb8043ef76cff06a1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy05LTEtMS0xNDI2ODA_73f4fc30-6ad8-4d31-bad9-8031c3335b15"
      unitRef="usd">-1373000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ifae1e2814de34b5eb8043ef76cff06a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy0xMS0xLTEtMTQyNjgw_96ff53a4-e6cc-4f2d-ab06-bc7780333b76"
      unitRef="shares">7777000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i575dfed5180b41c380550a620ea3e540_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy0xMy0xLTEtMTQyNjgw_fa631860-d8a5-48ff-8a5b-08c48f1e51ee"
      unitRef="usd">-574000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic4e77e9c323c43acad3d23fd72036b5f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy0xNS0xLTEtMTQyNjgw_a4e11ada-d0f2-4cae-ac75-eb183b9729d4"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i565b4c1e42f94eb2b2d7e89045b94abc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMy0xNy0xLTEtMTQyNjgw_47561c80-7a5f-4e79-b9b0-021ee819b430"
      unitRef="usd">491000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i9fb985ea42574447abbdeb651a94e290_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNC03LTEtMS0xNDI2ODA_477a4d7b-a92a-486c-b5e8-913bb2b1d4ca"
      unitRef="usd">150000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1a8f4562f03f485b9222b7cce528e697_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNC0xNS0xLTEtMTQyNjgw_8bdf3fd1-303e-4d7b-8ee3-821cae17d3e5"
      unitRef="usd">2000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNC0xNy0xLTEtMTQyNjgw_74cff457-d49a-4f27-a870-21e9782ce9f9"
      unitRef="usd">152000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0ab076bc30324400b05fae96ad5d777d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNS0xMy0xLTEtMTQyNjgw_eb216888-09db-4dfb-9eb0-771861a6c853"
      unitRef="usd">55000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNS0xNy0xLTEtMTQyNjgw_731be27c-ef10-4132-b0f6-1b12a9b17b38"
      unitRef="usd">55000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNi0wLTEtMS0xNDI2ODAvdGV4dHJlZ2lvbjo4N2ZmOTVkOGRhZjM0YWU4YjdmZTQyMmExOGZjMjVlM18zOA_ab94a41e-cdbb-4f95-96a5-088c1a59acb7"
      unitRef="usdPerShare">1.16</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="i9fb985ea42574447abbdeb651a94e290_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNi03LTEtMS0xNDI2ODA_63e696f8-b49d-4143-b954-a37e85462f4a"
      unitRef="usd">143000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNi0xNy0xLTEtMTQyNjgw_d1a373fd-9a35-4c73-8200-c84206c2f1c2"
      unitRef="usd">143000000</us-gaap:Dividends>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i1a8f4562f03f485b9222b7cce528e697_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNy0xNS0xLTEtMTQyNjgw_b1b1c894-ff5d-4039-ac5e-93837596444d"
      unitRef="usd">4000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNy0xNy0xLTEtMTQyNjgw_876905e4-fe78-4810-b3f5-6ef97c08449e"
      unitRef="usd">4000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i790c9340393b4fb0b02a7296fadf9609_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfOS01LTEtMS0xNDI2ODA_a21971cd-a34b-4ec6-908c-2e08e14804a9"
      unitRef="usd">19000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfOS0xNy0xLTEtMTQyNjgw_cfc75be3-65e2-4990-a395-8fc9c229ae83"
      unitRef="usd">19000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i790c9340393b4fb0b02a7296fadf9609_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTAtNS0xLTEtMTQyNjgw_69647377-b1c5-40c3-b6d1-6a26cbffcbdf"
      unitRef="usd">-4000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i9fb985ea42574447abbdeb651a94e290_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTAtNy0xLTEtMTQyNjgw_ee1df0bf-d0ff-4c51-8735-d5af21a659ad"
      unitRef="usd">-5000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="ifa3654eea4d143be9e65477225892c33_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTAtOS0xLTEtMTQyNjgw_ec71ed9d-9a63-4930-9cb7-aabb6a291fe1"
      unitRef="usd">15000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesShares
      contextRef="ifa3654eea4d143be9e65477225892c33_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTAtMTEtMS0xLTE0MjY4MA_c4218b23-8558-4619-99bb-9e02018bf15b"
      unitRef="shares">107000</clx:OtherEmployeeStockPlanActivitiesShares>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTAtMTctMS0xLTE0MjY4MA_c3cbd414-8a3c-4eed-9b4c-f0f72ecde7ba"
      unitRef="usd">6000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9bca9d2ecd9e481aa1ead4b270214e56_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtMS0xLTEtMTQyNjgw_947516df-16f3-4986-a51e-2090cde8bad8"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9bca9d2ecd9e481aa1ead4b270214e56_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtMy0xLTEtMTQyNjgw_435f6b3b-4b91-496d-aadd-8e9c45c56a4f"
      unitRef="shares">130741000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56725ff0d43240d19e4b0e41d908614a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtNS0xLTEtMTQyNjgw_87e0816d-76eb-4ca8-8fbb-c385a2460a0c"
      unitRef="usd">1195000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95257d576dfd45148c1997c326e7020b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtNy0xLTEtMTQyNjgw_c5469467-cbcf-4eea-b7af-3dcd33beda0d"
      unitRef="usd">951000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i93ed62d82fff40e495d855e264b32bc4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtOS0xLTEtMTQyNjgw_1c6cf3af-e753-4838-8a9d-1f67744938d1"
      unitRef="usd">-1358000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i93ed62d82fff40e495d855e264b32bc4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtMTEtMS0xLTE0MjY4MA_9ca3fd74-1e99-4e8e-af19-8baf8387c048"
      unitRef="shares">7670000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0e4a56d9d98a4157b2c6e3bb88276c9b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtMTMtMS0xLTE0MjY4MA_db0a3323-0887-4b0e-a435-74cae4087c9f"
      unitRef="usd">-519000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1998332848f548599b1f44f8389dcf4c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtMTUtMS0xLTE0MjY4MA_4fe222fa-da2d-4aa2-9553-9a8d627f4f49"
      unitRef="usd">176000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icf74c279d583412eaba0df33f84a8dd7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTMtMTctMS0xLTE0MjY4MA_abcc0c5a-80b6-4ec3-8ca9-4ee3ad6ff9b0"
      unitRef="usd">576000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe250680c3cb4a2d9422e47ecfbb9232_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtMS0xLTEtMTQyNjgw_be896e47-499a-415a-a470-2654b2b813be"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ibe250680c3cb4a2d9422e47ecfbb9232_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtMy0xLTEtMTQyNjgw_6ac35a62-6450-4321-a74a-233788b29812"
      unitRef="shares">130741000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i349984d984ac4a6dbf6cfa7d1779d9c9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtNS0xLTEtMTQyNjgw_a167e340-c596-45f4-9dcd-2bf000225fff"
      unitRef="usd">1207000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0578ecbdca4a4b0683cb8154b35f6aea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtNy0xLTEtMTQyNjgw_02d79927-27bd-4b45-a5cc-99f6e38d2fa7"
      unitRef="usd">782000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i71a1dcd718bb44bfb1a91f3a99cb0ad7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtOS0xLTEtMTQyNjgw_7366c63c-d3e3-4db4-977c-80989438ce0d"
      unitRef="usd">-1297000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i71a1dcd718bb44bfb1a91f3a99cb0ad7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtMTEtMS0xLTE0MjY4MA_e0263219-fd32-4821-9776-1cbdd7d95d48"
      unitRef="shares">7263000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf167b776ade4df7b590155e62a3f0fa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtMTMtMS0xLTE0MjY4MA_51241d58-3376-400e-9bfc-1db25ec4b6c6"
      unitRef="usd">-502000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic441f564bc3e4f1fa09858858b3e6ba6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtMTUtMS0xLTE0MjY4MA_d1cfe363-a377-4ab7-bf31-a46fa344f1fc"
      unitRef="usd">170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i058a79b88ddf43df8b916f862dfc5bf7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTUtMTctMS0xLTE0MjY4MA_fca0f3f5-7fe4-4460-a831-e074800f4df9"
      unitRef="usd">491000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i4e561b7b255d422cbcdac071c1398d6a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTYtNy0xLTEtMTQyNjgw_9b534d52-1d5d-470a-9372-bff6d19342b4"
      unitRef="usd">-211000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6170471920d746bcb25579e59b005902_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTYtMTUtMS0xLTE0MjY4MA_340ce479-3d5a-4efd-b26f-e7ea90428129"
      unitRef="usd">2000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTYtMTctMS0xLTE0MjY4MA_ffe7b573-7793-4e20-98b2-7434d6ddb375"
      unitRef="usd">-209000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia33168f0db0843d685d4b21fe4e5edda_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTctMTMtMS0xLTE0MjY4MA_eb403910-928e-4c7e-a67f-15649f678f4c"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTctMTctMS0xLTE0MjY4MA_5f9fc631-e266-456a-96ef-b959e4800d11"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTgtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246NjYyMGFiMjA3YTY3NDAzYmI5MjM4OGJmMTU2ZTlkYThfMzg_c318fe6a-8e9f-43cd-9d2a-9c3003cbf485"
      unitRef="usdPerShare">1.18</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="i4e561b7b255d422cbcdac071c1398d6a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTgtNy0xLTEtMTQyNjgw_eb207b54-0c06-44e0-8196-44f9eb3d77a3"
      unitRef="usd">147000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTgtMTctMS0xLTE0MjY4MA_6eababe0-3ead-42a4-800e-415e33a30b37"
      unitRef="usd">147000000</us-gaap:Dividends>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i6170471920d746bcb25579e59b005902_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTktMTUtMS0xLTE0MjY4MA_aa52757e-09f5-437e-987d-29b5e31dfe62"
      unitRef="usd">3000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMTktMTctMS0xLTE0MjY4MA_7797ead8-2c84-42e4-bc0c-326e49ecb796"
      unitRef="usd">3000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i428de1acdef7408cacf083e495bd1acc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjEtNS0xLTEtMTQyNjgw_1cca5fa6-ad1a-4f2a-ad56-3bcf6877c283"
      unitRef="usd">29000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjEtMTctMS0xLTE0MjY4MA_bbbfcdec-1057-49a4-8f1c-9f7a2065af83"
      unitRef="usd">29000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i428de1acdef7408cacf083e495bd1acc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjItNS0xLTEtMTQyNjgw_edc3d515-7351-4103-bda7-60017237086f"
      unitRef="usd">-4000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i4e561b7b255d422cbcdac071c1398d6a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjItNy0xLTEtMTQyNjgw_a59b4861-1637-4e11-bfb5-9da061f57026"
      unitRef="usd">-9000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="ib8ebbe87a5b44f8e86adb6c537baa365_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjItOS0xLTEtMTQyNjgw_1dba0711-9bce-47e9-adcb-f1516b636875"
      unitRef="usd">20000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesShares
      contextRef="ib8ebbe87a5b44f8e86adb6c537baa365_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjItMTEtMS0xLTE0MjY4MA_11bedfe9-b88d-4260-ad3e-409ed47da9de"
      unitRef="shares">133000</clx:OtherEmployeeStockPlanActivitiesShares>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjItMTctMS0xLTE0MjY4MA_34ee31ed-c68b-4a59-b1b3-074b38fc8873"
      unitRef="usd">7000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice2dbf9b838649879e0d1331a95d0191_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtMS0xLTEtMTQyNjgw_e0acad6d-b339-40d0-9ad6-0a5f1824ca63"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ice2dbf9b838649879e0d1331a95d0191_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtMy0xLTEtMTQyNjgw_3f14bbfe-4633-48e7-ba3c-091f4cb2e99a"
      unitRef="shares">130741000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i382bd8dd06684d658f4f850a93ab45ab_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtNS0xLTEtMTQyNjgw_08a87075-b94b-4fbf-84cc-c98228af68bf"
      unitRef="usd">1232000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idc1249e856e0404fa74fe81e86ac37b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtNy0xLTEtMTQyNjgw_e8c516f7-b6de-42b2-93da-881d223936ae"
      unitRef="usd">415000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d7a9d9e6abc4064872b7d412c2a4ff8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtOS0xLTEtMTQyNjgw_e900231a-f213-4bed-a8e8-7f18447b0da9"
      unitRef="usd">-1277000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i9d7a9d9e6abc4064872b7d412c2a4ff8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtMTEtMS0xLTE0MjY4MA_5f143ef5-24e5-422a-bc52-5f88795b9fc1"
      unitRef="shares">7130000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if3b6333e92ce42d7ab3cda6056f7c98a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtMTMtMS0xLTE0MjY4MA_76cc7188-290c-47ea-b6c7-fe2d9b26f186"
      unitRef="usd">-498000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i62c0fe22bbdb4fb083de7d9a1d7d1f45_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtMTUtMS0xLTE0MjY4MA_1c21a6d6-15eb-4d1d-9cc5-90bd426ad20a"
      unitRef="usd">169000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMjYtMTctMS0xLTE0MjY4MA_1daacde1-0b7f-4120-aa26-04453d2508fa"
      unitRef="usd">172000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifd6ece4973e949d08182806d9a323160_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtMS0xLTEtMTQyNjgw_4da8bf7b-e309-445e-9deb-f02be3b18f76"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ifd6ece4973e949d08182806d9a323160_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtMy0xLTEtMTQyNjgw_4143f1a4-e84d-481a-a276-3d40d37fe947"
      unitRef="shares">130741000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iacc1e22ac19d48209ceace90c3d5b926_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtNS0xLTEtMTQyNjgw_8c0981f1-6d83-4e1c-aa89-ca6b101ac43f"
      unitRef="usd">1186000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73dbb3c50d1647ceb59c25ac8d3093fb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtNy0xLTEtMTQyNjgw_eb472e9f-9d49-41e8-9322-22666e1705e2"
      unitRef="usd">1036000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6fef3da8c9d340c6996ac9bd4e846ef1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtOS0xLTEtMTQyNjgw_8b833f31-ba43-4511-b381-d079c207e1ad"
      unitRef="usd">-1396000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i6fef3da8c9d340c6996ac9bd4e846ef1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtMTEtMS0xLTE0MjY4MA_2234ad1c-8103-4813-b400-e865518e8e41"
      unitRef="shares">7961000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i38dd7f792041456cbe661ea31eb94219_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtMTMtMS0xLTE0MjY4MA_cb217a81-af41-4e56-8428-6b0872126b7d"
      unitRef="usd">-546000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5409859b1d8845f0aff788c9db7c4c79_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtMTUtMS0xLTE0MjY4MA_c783fe1f-e1ab-49fc-b3a2-7895dfdab6b0"
      unitRef="usd">181000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i38db454957ae42d1a879575c446b836f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzEtMTctMS0xLTE0MjY4MA_48bbcee0-836d-4307-a781-4f0b0b73d359"
      unitRef="usd">592000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="id6228167648a4c80885f8515c358e74c_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzMtNy0xLTEtMTQyNjgw_53df904f-079f-4fe5-bb52-57d0a08a49ff"
      unitRef="usd">361000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5cb19050263443049c6a5d3e0839f6cc_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzMtMTUtMS0xLTE0MjY4MA_7d4fcc50-e6e2-48aa-b553-28aab0eeebb2"
      unitRef="usd">6000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzMtMTctMS0xLTE0MjY4MA_2d5d0988-9bfc-4888-a1b4-2413bef755b4"
      unitRef="usd">367000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if811f809413d4a6bb8691c5fcaa43e23_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzQtMTMtMS0xLTE0MjY4MA_f7b7919d-5eb6-4efa-9be8-6d7c0a7a5c14"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzQtMTctMS0xLTE0MjY4MA_03a3ff13-0d5e-49ec-a793-4d986ef2ad7f"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzUtMC0xLTEtMTQyNjgwL3RleHRyZWdpb246MTczYThhMGQyODczNDM3MjgzZWI3ZjYwZWU3NTExYTZfMzg_bb346733-86bc-492a-a2a4-0494f37e5f6d"
      unitRef="usdPerShare">3.48</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="id6228167648a4c80885f8515c358e74c_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzUtNy0xLTEtMTQyNjgw_e4bfd664-d603-455c-9cd5-2aed73d335e5"
      unitRef="usd">430000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzUtMTctMS0xLTE0MjY4MA_e4e26f4b-8050-4234-8b94-a5f19931436e"
      unitRef="usd">430000000</us-gaap:Dividends>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i5cb19050263443049c6a5d3e0839f6cc_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzYtMTUtMS0xLTE0MjY4MA_5a14ebcf-3c71-41cb-8b21-6f4587788341"
      unitRef="usd">11000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzYtMTctMS0xLTE0MjY4MA_a2fe3bf2-958a-4866-9e1b-452fc67ecb9c"
      unitRef="usd">11000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8d8d459930ee4918898527d3560df45e_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzgtNS0xLTEtMTQyNjgw_d52f7f94-ee14-4ad3-b5df-25bfa0a7d5ae"
      unitRef="usd">44000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzgtMTctMS0xLTE0MjY4MA_727d7d23-e937-4370-a953-0f282f2ac485"
      unitRef="usd">44000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i8d8d459930ee4918898527d3560df45e_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzktNS0xLTEtMTQyNjgw_5e17a829-9a16-4788-b664-4f840f1658cc"
      unitRef="usd">-35000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="id6228167648a4c80885f8515c358e74c_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzktNy0xLTEtMTQyNjgw_c99a2f37-7665-4a91-9f10-6068ea00fcac"
      unitRef="usd">-16000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i0606e8ef65d840a58c50419adf1e8e08_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzktOS0xLTEtMTQyNjgw_7f7a9657-b98e-4783-b552-8614cd4fe530"
      unitRef="usd">63000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesShares
      contextRef="i0606e8ef65d840a58c50419adf1e8e08_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzktMTEtMS0xLTE0MjY4MA_b24c38e0-6e68-41d5-94b2-b2cc3178111b"
      unitRef="shares">443000</clx:OtherEmployeeStockPlanActivitiesShares>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfMzktMTctMS0xLTE0MjY4MA_c14d552a-d129-4958-bf21-ae2a2d13a558"
      unitRef="usd">12000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0606e8ef65d840a58c50419adf1e8e08_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDAtOS0xLTEtMTQyNjgw_5f88e46c-a515-4662-91e8-82ed56c6b276"
      unitRef="usd">25000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0606e8ef65d840a58c50419adf1e8e08_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDAtMTEtMS0xLTE0MjY4MA_f70d5cd4-cec0-4495-9ab7-a6855f28d0b9"
      unitRef="shares">152000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDAtMTctMS0xLTE0MjY4MA_f136e038-2110-497e-9462-d38906593c0e"
      unitRef="usd">25000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9bca9d2ecd9e481aa1ead4b270214e56_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItMS0xLTEtMTQyNjgw_6f9e60de-e5fe-449b-a48d-86d6a8b5dd53"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9bca9d2ecd9e481aa1ead4b270214e56_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItMy0xLTEtMTQyNjgw_642e8f73-d5ce-463e-b8e8-e183bbe00aa3"
      unitRef="shares">130741000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56725ff0d43240d19e4b0e41d908614a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItNS0xLTEtMTQyNjgw_5fdbc46f-3ba8-4256-a1d0-0e4b39429048"
      unitRef="usd">1195000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95257d576dfd45148c1997c326e7020b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItNy0xLTEtMTQyNjgw_fbd7b6b3-47bf-4ed0-9f1e-83280c18d837"
      unitRef="usd">951000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i93ed62d82fff40e495d855e264b32bc4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItOS0xLTEtMTQyNjgw_f25fdda8-a079-42ff-835c-2de946674a0a"
      unitRef="usd">-1358000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i93ed62d82fff40e495d855e264b32bc4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItMTEtMS0xLTE0MjY4MA_366cc1dc-dbb6-40a6-8825-b8ce832769b6"
      unitRef="shares">7670000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0e4a56d9d98a4157b2c6e3bb88276c9b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItMTMtMS0xLTE0MjY4MA_2ad1a22f-d2ad-450d-8e9b-09923c49d8fa"
      unitRef="usd">-519000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1998332848f548599b1f44f8389dcf4c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItMTUtMS0xLTE0MjY4MA_18a7a873-13e0-43f6-8eb9-56bd8e376ff2"
      unitRef="usd">176000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icf74c279d583412eaba0df33f84a8dd7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDItMTctMS0xLTE0MjY4MA_975c7741-eafb-4920-896a-142a61cca814"
      unitRef="usd">576000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2cbd00ee054d4a0ea683f3e69c3f144c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtMS0xLTEtMTQyNjgw_5b785a34-1e58-413b-b71d-f206da537b0d"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2cbd00ee054d4a0ea683f3e69c3f144c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtMy0xLTEtMTQyNjgw_e2d539d9-9c29-404c-9b25-1be3d124ff67"
      unitRef="shares">130741000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i21ccc62d5ccc400ca14bf9ef81476443_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtNS0xLTEtMTQyNjgw_536c1f55-d428-4ca7-aee9-48cdf99361b1"
      unitRef="usd">1202000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i82ec983182ab42d7bee00f12f996858a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtNy0xLTEtMTQyNjgw_3f8c758f-a6a4-41b7-b42e-912ba81adb62"
      unitRef="usd">1048000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie20aff337cf646b68d54fb6090aa44eb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtOS0xLTEtMTQyNjgw_f0e18486-08d5-4b3d-8d63-6f9cdb57193c"
      unitRef="usd">-1346000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ie20aff337cf646b68d54fb6090aa44eb_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtMTEtMS0xLTE0MjY4MA_e1d64800-dec2-4787-ab5a-958f1116038a"
      unitRef="shares">7589000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i789c01c0eea04f1d858ad3fba90164ed_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtMTMtMS0xLTE0MjY4MA_6ec571a2-05f9-497d-8168-425c0b519d95"
      unitRef="usd">-479000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if5da3d885a8845f889db9160bcd4730c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtMTUtMS0xLTE0MjY4MA_b39b5be7-dd1a-4b78-90d3-24b6a8e888d8"
      unitRef="usd">173000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDQtMTctMS0xLTE0MjY4MA_b6fd40c4-6253-461d-837d-2cc5879eab31"
      unitRef="usd">729000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i372b14b520094c4382db02e9bc4689f9_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDUtNy0xLTEtMTQyNjgw_19946cf1-089a-43d6-9a2e-cd606e2b63ea"
      unitRef="usd">-27000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iefab848d9a3b4ce984a98c0628e4cabb_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDUtMTUtMS0xLTE0MjY4MA_7a9088cc-8b17-46c7-a5ec-b7d2eeadce10"
      unitRef="usd">7000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDUtMTctMS0xLTE0MjY4MA_43d9e335-17d7-40d7-90a1-7f520fcc3794"
      unitRef="usd">-20000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia9e6c3f82aac456096e02558c7413ecd_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDYtMTMtMS0xLTE0MjY4MA_2b81ac1d-90ac-495d-88b4-3b52a3bcb5c6"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDYtMTctMS0xLTE0MjY4MA_f6fcf685-23bf-42fb-bb77-d993efd7fd82"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDctMC0xLTEtMTQyNjgwL3RleHRyZWdpb246NjM3M2MxODNmOWJkNDc0NjliNGJiYTViZTZmZjcxZjFfMzg_5e6e25eb-add6-4282-88fc-e6c0acca12dd"
      unitRef="usdPerShare">4.72</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="i372b14b520094c4382db02e9bc4689f9_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDctNy0xLTEtMTQyNjgw_ce5bbbdb-2737-425a-b5e3-864e3bff8e58"
      unitRef="usd">587000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDctMTctMS0xLTE0MjY4MA_13898f01-1e91-496d-b620-e25de36c79e3"
      unitRef="usd">587000000</us-gaap:Dividends>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iefab848d9a3b4ce984a98c0628e4cabb_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDgtMTUtMS0xLTE0MjY4MA_ace301d1-9bbf-4d05-9b5e-4d292927edd9"
      unitRef="usd">11000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNDgtMTctMS0xLTE0MjY4MA_c08dcedc-5ea1-4895-953a-291f59f13869"
      unitRef="usd">11000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7296f62c815b4fb88cc0fabc30e4a5f3_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTAtNS0xLTEtMTQyNjgw_6ba89b49-c8cf-4c74-9dde-3cc59579d385"
      unitRef="usd">60000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTAtMTctMS0xLTE0MjY4MA_2e00f92e-5b92-4e54-a035-7b85407b27dd"
      unitRef="usd">60000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i7296f62c815b4fb88cc0fabc30e4a5f3_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTEtNS0xLTEtMTQyNjgw_a0530be3-120b-470e-8ff2-ea441aa689ac"
      unitRef="usd">-30000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i372b14b520094c4382db02e9bc4689f9_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTEtNy0xLTEtMTQyNjgw_0d008245-d988-4b54-bc04-c52349439d05"
      unitRef="usd">-19000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i2cd390a11523485798e09a245d293c38_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTEtOS0xLTEtMTQyNjgw_4eae1479-b263-4351-a2d2-e8a264ce5387"
      unitRef="usd">69000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesShares
      contextRef="i2cd390a11523485798e09a245d293c38_D20220701-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTEtMTEtMS0xLTE0MjY4MA_134f8e32-d457-4204-b888-bab07e52bae4"
      unitRef="shares">459000</clx:OtherEmployeeStockPlanActivitiesShares>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTEtMTctMS0xLTE0MjY4MA_ce90b77e-6d1b-4afd-8b9e-63b22f01caf8"
      unitRef="usd">20000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice2dbf9b838649879e0d1331a95d0191_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtMS0xLTEtMTQyNjgw_f6c36b8f-b2ab-44b2-bf5e-e1d559586a8e"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ice2dbf9b838649879e0d1331a95d0191_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtMy0xLTEtMTQyNjgw_d84a6bd3-60af-460a-b835-4778e72072e8"
      unitRef="shares">130741000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i382bd8dd06684d658f4f850a93ab45ab_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtNS0xLTEtMTQyNjgw_786bf40a-6ae4-4927-a876-6da7d3b6dc06"
      unitRef="usd">1232000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idc1249e856e0404fa74fe81e86ac37b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtNy0xLTEtMTQyNjgw_80cf93b0-e7b2-43d6-a11c-387d379057ef"
      unitRef="usd">415000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d7a9d9e6abc4064872b7d412c2a4ff8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtOS0xLTEtMTQyNjgw_9ae7434f-aa80-4786-ad8a-bca3d785c3cf"
      unitRef="usd">-1277000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i9d7a9d9e6abc4064872b7d412c2a4ff8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtMTEtMS0xLTE0MjY4MA_788875ac-5af5-48d5-8625-10250d80a4a8"
      unitRef="shares">7130000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if3b6333e92ce42d7ab3cda6056f7c98a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtMTMtMS0xLTE0MjY4MA_4af9a4c9-239f-426d-a53e-f4b0a920a5bb"
      unitRef="usd">-498000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i62c0fe22bbdb4fb083de7d9a1d7d1f45_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtMTUtMS0xLTE0MjY4MA_1b04f5c6-585f-44bc-af51-f250fb4543b3"
      unitRef="usd">169000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmYwNzQ4NjcxN2E4YjQzMzdiM2IxZWI1ZGUyZTk4YWQ3L3RhYmxlcmFuZ2U6ZjA3NDg2NzE3YThiNDMzN2IzYjFlYjVkZTJlOThhZDdfNTUtMTctMS0xLTE0MjY4MA_a688cef4-8113-428c-b4a0-e2fa6657916f"
      unitRef="usd">172000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RleHRyZWdpb246Y2Q2YmVhMDExYWZmNDg5ZTliYTM3MzQwYWJlMmVjOTJfNjAx_26151582-f608-4dcc-93d1-91dc6bd47955">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense), and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense), and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="id54b8127809f4f009450878e1f47eab0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMi0xLTEtMS0xNDI2ODA_180afe4f-a4dd-4cae-a384-28f84e70b9ac"
      unitRef="usd">-431000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iec972b6c609643939ebb658b21202380_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMi0zLTEtMS0xNDI2ODA_6e23c00f-4b63-41fc-9823-783137bc2097"
      unitRef="usd">18000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i10105acceec642bab440c62b4e41da18_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMi01LTEtMS0xNDI2ODA_8563886e-8a96-4959-9c2e-41b4e1de0990"
      unitRef="usd">-161000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i575dfed5180b41c380550a620ea3e540_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMi03LTEtMS0xNDI2ODA_122e3985-861b-4348-867d-058d29c5ca7f"
      unitRef="usd">-574000000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="id7e58ebc3d00448981b37243d360d5b8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMy0xLTEtMS0xNDI2ODA_e6dd6b41-d3d6-45cb-a66d-4e39bbe98479"
      unitRef="usd">19000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i6cd10304fb1c43b798f36d9855e3a674_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMy0zLTEtMS0xNDI2ODA_8bc02dd2-faa9-4bb1-89ef-cf36bd85fdde"
      unitRef="usd">48000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i639e65a448654d5d87000a3caa18af16_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMy01LTEtMS0xNDI2ODA_cb30182d-596a-4b7e-9baa-0b10ab7d7836"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i0ab076bc30324400b05fae96ad5d777d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMy03LTEtMS0xNDI2ODA_a5ecf2ee-b1ca-401a-95d4-624fdf317ccd"
      unitRef="usd">67000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="id7e58ebc3d00448981b37243d360d5b8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNC0xLTEtMS0xNDI2ODA_c510cf4c-c486-4d09-a394-282b305fbdd2"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i6cd10304fb1c43b798f36d9855e3a674_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNC0zLTEtMS0xNDI2ODA_ee921237-53cc-484d-bbc4-a99356cbbae2"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i639e65a448654d5d87000a3caa18af16_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNC01LTEtMS0xNDI2ODA_29d3c992-9681-40a2-9284-31a23a06bd9f"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i0ab076bc30324400b05fae96ad5d777d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNC03LTEtMS0xNDI2ODA_a4501c8a-39c0-441c-b468-8b88aa7c5fe5"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="id7e58ebc3d00448981b37243d360d5b8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNS0xLTEtMS0xNDI2ODA_cf62aaf5-e849-4e51-b401-21b66cf06786"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i6cd10304fb1c43b798f36d9855e3a674_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNS0zLTEtMS0xNDI2ODA_90a6a7e5-3a11-4849-8403-cf60ae600786"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i639e65a448654d5d87000a3caa18af16_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNS01LTEtMS0xNDI2ODA_48703f39-22cf-4d0b-9799-ea50d3b1e4f0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i0ab076bc30324400b05fae96ad5d777d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNS03LTEtMS0xNDI2ODA_18372f1a-1305-4e4f-ae24-a0230899844d"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id7e58ebc3d00448981b37243d360d5b8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNi0xLTEtMS0xNDI2ODA_6c0543a3-2aa5-4a9d-b654-7aaeb52a0a36"
      unitRef="usd">19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6cd10304fb1c43b798f36d9855e3a674_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNi0zLTEtMS0xNDI2ODA_7a8e2327-75e5-46ec-b46d-891c18ddbc67"
      unitRef="usd">34000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i639e65a448654d5d87000a3caa18af16_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNi01LTEtMS0xNDI2ODA_2756f301-83a9-4f19-b76e-039fd1684892"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0ab076bc30324400b05fae96ad5d777d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNi03LTEtMS0xNDI2ODA_d821fbfe-1f35-43c1-9835-bf411333662a"
      unitRef="usd">55000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ie85c1700bb824cf3a99834757ca0345d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNy0xLTEtMS0xNDI2ODA_ab9e3264-14e2-4bd2-a7f3-d24d584aedee"
      unitRef="usd">-412000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8d7840b6eb44467d910474da7f5cf458_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNy0zLTEtMS0xNDI2ODA_f0fb907a-0fc8-488c-ac2f-3c6518e03603"
      unitRef="usd">52000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib7941953b83146c2b4fd8a2efddca131_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNy01LTEtMS0xNDI2ODA_729233ee-a782-4b11-9152-ff4145c57400"
      unitRef="usd">-159000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0e4a56d9d98a4157b2c6e3bb88276c9b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfNy03LTEtMS0xNDI2ODA_b0258d57-7c64-4eb7-9eb3-1ecbe3d68f47"
      unitRef="usd">-519000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifd5d1bb8964841e785fdf870e1cd9c1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfOS0xLTEtMS0xNDI2ODA_bde6996d-9f2e-4878-a056-cf6e653a5096"
      unitRef="usd">-459000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia0ed5f67bc8e489fbf38eea7a87acb42_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfOS0zLTEtMS0xNDI2ODA_f5b62124-3eb0-468b-beca-e42e17952efc"
      unitRef="usd">107000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icb003230a88c4000aac4e5c07d393cd2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfOS01LTEtMS0xNDI2ODA_d8076c9d-8689-43a8-b817-b66e50c67a82"
      unitRef="usd">-150000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibf167b776ade4df7b590155e62a3f0fa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfOS03LTEtMS0xNDI2ODA_6f2ae82a-081f-47f1-8ee4-b58aadfd5f7c"
      unitRef="usd">-502000000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i20cdde6a918646608cafb482b69c1374_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTAtMS0xLTEtMTQyNjgw_7f87bbb3-8a39-4a76-85e2-b1f45ed5cc76"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i5b260ed4689a4167aedbbe4c6e8d5aed_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTAtMy0xLTEtMTQyNjgw_6966176d-862d-4317-909a-557ef5138232"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i7e2a1cf474674d64b709b61efc4388c7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTAtNS0xLTEtMTQyNjgw_61aa8520-5ee5-43ac-89eb-62156fb3cd54"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia33168f0db0843d685d4b21fe4e5edda_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTAtNy0xLTEtMTQyNjgw_5fe9b147-2a16-47f9-96a2-9204cfe0d793"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i20cdde6a918646608cafb482b69c1374_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTEtMS0xLTEtMTQyNjgw_3994b478-9b94-43ae-98e7-32d15149ef9d"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i5b260ed4689a4167aedbbe4c6e8d5aed_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTEtMy0xLTEtMTQyNjgw_b0b44a1a-f317-4ad3-92ea-2509fe53d812"
      unitRef="usd">4000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i7e2a1cf474674d64b709b61efc4388c7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTEtNS0xLTEtMTQyNjgw_f60d94fa-ce2c-44e0-a459-7dbec9223f72"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ia33168f0db0843d685d4b21fe4e5edda_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTEtNy0xLTEtMTQyNjgw_e6483554-0688-4691-8878-ef51dff60cbc"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i20cdde6a918646608cafb482b69c1374_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTItMS0xLTEtMTQyNjgw_e70ac310-5892-4d98-a6b8-d7d47a17cf29"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i5b260ed4689a4167aedbbe4c6e8d5aed_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTItMy0xLTEtMTQyNjgw_b6f058ef-223f-4c4a-95f2-404ad6e7f053"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i7e2a1cf474674d64b709b61efc4388c7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTItNS0xLTEtMTQyNjgw_4e99a536-9c0e-4874-8f27-dc4b5a722f2c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ia33168f0db0843d685d4b21fe4e5edda_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTItNy0xLTEtMTQyNjgw_a0376bdb-0b5e-4dda-808c-735ca2484445"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i20cdde6a918646608cafb482b69c1374_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTMtMS0xLTEtMTQyNjgw_eeba45d6-f328-4a29-8616-95d69ef72775"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5b260ed4689a4167aedbbe4c6e8d5aed_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTMtMy0xLTEtMTQyNjgw_6c7451cf-56ed-4dcf-94c3-5df29724da3b"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7e2a1cf474674d64b709b61efc4388c7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTMtNS0xLTEtMTQyNjgw_cc71f6c0-70a1-4bd7-80a5-bc03861a592d"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia33168f0db0843d685d4b21fe4e5edda_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTMtNy0xLTEtMTQyNjgw_1ac1d290-4a16-4fb2-a008-fdbc878a659c"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i9a904ed9259247ed803bd9c4575c448b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTQtMS0xLTEtMTQyNjgw_eb8896d9-6513-4658-b26e-f4670e11d1c9"
      unitRef="usd">-449000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8624504988204f299f5466845c6db945_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTQtMy0xLTEtMTQyNjgw_4f9c75d5-cd8c-4a88-bcdb-2013ba279ce5"
      unitRef="usd">100000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i991ef5bf9ed442ca8531f36420575a16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTQtNS0xLTEtMTQyNjgw_fb3d3b13-40bf-48c4-8ed1-0d903d5ff690"
      unitRef="usd">-149000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if3b6333e92ce42d7ab3cda6056f7c98a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTQtNy0xLTEtMTQyNjgw_6a71a992-419d-44a6-be96-aa200eb822c4"
      unitRef="usd">-498000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7bb0aa974c214b5e853f0cc3ae70a268_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTgtMS0xLTEtMTQyNjgw_78d2fd1b-c691-4edc-be92-dc02ba64b1b3"
      unitRef="usd">-403000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia520dd3f71774e2b89b0bbe17d6294b9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTgtMy0xLTEtMTQyNjgw_7cbd6fcc-8c4c-48cc-bebc-0f3369cb8e92"
      unitRef="usd">21000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0158083bc55c4728ad23a8bd5fdf8b21_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTgtNS0xLTEtMTQyNjgw_24fd0ccd-b57c-4b69-9565-50aced7ac53d"
      unitRef="usd">-164000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i38dd7f792041456cbe661ea31eb94219_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTgtNy0xLTEtMTQyNjgw_3febde36-bd2c-41a8-8709-6f5acbaf1bb0"
      unitRef="usd">-546000000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia7d813979e3847bf94273f4ad7b0ec5c_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTktMS0xLTEtMTQyNjgw_9a8742cd-0b58-4256-b947-d6a0c732906c"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i3a0052b2ab86487f95d0cc11ca0882df_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTktMy0xLTEtMTQyNjgw_c87b2a75-d9cd-408e-b875-88fec588153e"
      unitRef="usd">51000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="idbbbb87becc84b54bf3ad91efbb9dc00_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTktNS0xLTEtMTQyNjgw_3c4b4cf7-e805-4c43-a2b7-35db6d25d846"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="if811f809413d4a6bb8691c5fcaa43e23_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMTktNy0xLTEtMTQyNjgw_45de7577-381c-4592-9700-a1d16e3d407a"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ia7d813979e3847bf94273f4ad7b0ec5c_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjAtMS0xLTEtMTQyNjgw_b1cc364c-2c7c-4df5-9257-751d6e1b1748"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i3a0052b2ab86487f95d0cc11ca0882df_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjAtMy0xLTEtMTQyNjgw_2c13daa2-d280-48de-9cd1-361245f88f27"
      unitRef="usd">10000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="idbbbb87becc84b54bf3ad91efbb9dc00_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjAtNS0xLTEtMTQyNjgw_4706ff13-e49b-49a9-94ff-a64cbb8ff7a2"
      unitRef="usd">-6000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="if811f809413d4a6bb8691c5fcaa43e23_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjAtNy0xLTEtMTQyNjgw_596034c7-d2c1-497c-af85-a0cb60ffdae4"
      unitRef="usd">4000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ia7d813979e3847bf94273f4ad7b0ec5c_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjEtMS0xLTEtMTQyNjgw_adebd1cc-9b68-4285-bf39-7fa15538d813"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i3a0052b2ab86487f95d0cc11ca0882df_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjEtMy0xLTEtMTQyNjgw_153fc7ea-cdf7-4a86-bfd7-6b1708b23c66"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="idbbbb87becc84b54bf3ad91efbb9dc00_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjEtNS0xLTEtMTQyNjgw_3cee5cbf-0efe-454b-938a-feaec8315137"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="if811f809413d4a6bb8691c5fcaa43e23_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjEtNy0xLTEtMTQyNjgw_834fb3dc-e625-4e5d-8546-ab0c6ef44587"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia7d813979e3847bf94273f4ad7b0ec5c_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjItMS0xLTEtMTQyNjgw_91f548a1-0096-4f45-9707-1f6ae2f31c75"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3a0052b2ab86487f95d0cc11ca0882df_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjItMy0xLTEtMTQyNjgw_f4755fb8-2f37-48df-94c5-b00be80d835a"
      unitRef="usd">31000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idbbbb87becc84b54bf3ad91efbb9dc00_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjItNS0xLTEtMTQyNjgw_b88a424e-b1c5-4e2c-88aa-c9d93631d8ea"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if811f809413d4a6bb8691c5fcaa43e23_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjItNy0xLTEtMTQyNjgw_b18a64ff-f274-4e59-a615-3fedcc2cc67e"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ie85c1700bb824cf3a99834757ca0345d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjMtMS0xLTEtMTQyNjgw_8884c3e1-a413-465d-965d-0be4579567dc"
      unitRef="usd">-412000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8d7840b6eb44467d910474da7f5cf458_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjMtMy0xLTEtMTQyNjgw_c2cdf596-345b-41c0-a023-9b5b4b428bcd"
      unitRef="usd">52000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib7941953b83146c2b4fd8a2efddca131_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjMtNS0xLTEtMTQyNjgw_6ee8a477-284e-4520-9c64-493372a74057"
      unitRef="usd">-159000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0e4a56d9d98a4157b2c6e3bb88276c9b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjMtNy0xLTEtMTQyNjgw_df169f6a-9f6f-4164-8e25-a46fa055e322"
      unitRef="usd">-519000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i70b0eab852154e4abb63bef64c0c9253_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjUtMS0xLTEtMTQyNjgw_a5fe87ad-bc06-4c95-881b-1480ca2ed87d"
      unitRef="usd">-448000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i99ba1c772ca743cab239215ff58256f1_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjUtMy0xLTEtMTQyNjgw_c05030bf-6e7c-44e3-9a66-2c96ada9af55"
      unitRef="usd">121000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic03507f6901a459cbfc9f1686e275800_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjUtNS0xLTEtMTQyNjgw_473767c1-d5d8-4e9d-906a-5aded9e5a2b3"
      unitRef="usd">-152000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i789c01c0eea04f1d858ad3fba90164ed_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjUtNy0xLTEtMTQyNjgw_58afdf61-5094-4a03-9689-f63451ca8399"
      unitRef="usd">-479000000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i74cca342e02946e285f57be15d303376_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjYtMS0xLTEtMTQyNjgw_95c97fcb-ba5f-458b-b92f-ac32eecb469f"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i3b245889d00f4e2eb4062bb56ecd5f01_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjYtMy0xLTEtMTQyNjgw_cf88bd46-afb2-4d83-bf8c-0edc9dac9099"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ib6f7d0c924ce46a4a0fab6f32137e185_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjYtNS0xLTEtMTQyNjgw_83139125-1597-4f41-b04e-39ff7fd57bca"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia9e6c3f82aac456096e02558c7413ecd_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjYtNy0xLTEtMTQyNjgw_3aec182b-93fc-48ae-bfa4-f772a5a3bf03"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i74cca342e02946e285f57be15d303376_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjctMS0xLTEtMTQyNjgw_4bde2dd5-f562-43b3-9b60-7898c986f2f0"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i3b245889d00f4e2eb4062bb56ecd5f01_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjctMy0xLTEtMTQyNjgw_55cf0ed9-f8e0-451d-b86f-150ae600e1ee"
      unitRef="usd">18000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ib6f7d0c924ce46a4a0fab6f32137e185_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjctNS0xLTEtMTQyNjgw_abe8317e-06b2-4bba-9848-ccff6e552ea9"
      unitRef="usd">-4000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ia9e6c3f82aac456096e02558c7413ecd_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjctNy0xLTEtMTQyNjgw_b058bf7c-7949-434b-9ea3-851374d7ec17"
      unitRef="usd">14000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i74cca342e02946e285f57be15d303376_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjgtMS0xLTEtMTQyNjgw_dbbaab1c-8ce5-4790-b1ea-6f251f58fc1a"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i3b245889d00f4e2eb4062bb56ecd5f01_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjgtMy0xLTEtMTQyNjgw_84aa26af-e66c-4ea0-af9f-da88221c82d6"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ib6f7d0c924ce46a4a0fab6f32137e185_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjgtNS0xLTEtMTQyNjgw_3a35899d-b1ce-4c60-9ef1-dc8411527afa"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ia9e6c3f82aac456096e02558c7413ecd_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjgtNy0xLTEtMTQyNjgw_90095090-4bcb-4ae5-bfb1-972ee4fc7b48"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i74cca342e02946e285f57be15d303376_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjktMS0xLTEtMTQyNjgw_ef9d3803-1407-4c94-a141-1ae78ad495a9"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3b245889d00f4e2eb4062bb56ecd5f01_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjktMy0xLTEtMTQyNjgw_e6b54cf1-1e5e-47e6-a922-7d9fbbfa3bfc"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib6f7d0c924ce46a4a0fab6f32137e185_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjktNS0xLTEtMTQyNjgw_80f6f190-8c09-4280-87f8-bad46a908af3"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia9e6c3f82aac456096e02558c7413ecd_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMjktNy0xLTEtMTQyNjgw_bd510f81-8422-4d2d-9f91-3afe53e9d21a"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i9a904ed9259247ed803bd9c4575c448b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMzAtMS0xLTEtMTQyNjgw_2b076786-96d3-4880-a088-71734492c8ee"
      unitRef="usd">-449000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8624504988204f299f5466845c6db945_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMzAtMy0xLTEtMTQyNjgw_063a3dfb-b160-47ee-b796-d3e8bc5c6957"
      unitRef="usd">100000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i991ef5bf9ed442ca8531f36420575a16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMzAtNS0xLTEtMTQyNjgw_bcaa0519-ee85-4e7e-a4b3-03d6f6c8ce3a"
      unitRef="usd">-149000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if3b6333e92ce42d7ab3cda6056f7c98a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RhYmxlOmRhOTM3NzFmY2QwMDRkNjc4MzdkNzUyOTY4YzA5ODBhL3RhYmxlcmFuZ2U6ZGE5Mzc3MWZjZDAwNGQ2NzgzN2Q3NTI5NjhjMDk4MGFfMzAtNy0xLTEtMTQyNjgw_19fdc4b3-1ced-4df2-b631-03c4dda496c1"
      unitRef="usd">-498000000</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i25f320caf7334b4da9436fd1f08de3df_D20220701-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RleHRyZWdpb246Y2Q2YmVhMDExYWZmNDg5ZTliYTM3MzQwYWJlMmVjOTJfNDY4_1e900cce-4b2f-45b6-af5f-e5e56bd9b79b"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i584c8b4ed6394f1d93786bbc0dc674af_D20210701-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RleHRyZWdpb246Y2Q2YmVhMDExYWZmNDg5ZTliYTM3MzQwYWJlMmVjOTJfNDY4_2f201506-2c17-478c-ad11-379b5bf37aba"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ie1af7dfaca4b4bb4939e8512479b3d34_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RleHRyZWdpb246Y2Q2YmVhMDExYWZmNDg5ZTliYTM3MzQwYWJlMmVjOTJfNDY4_5d755a88-89cb-4ea3-aa2e-41e4c60a1da3"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ifa6abb84427f42ceb43e887b2e70e3aa_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80My9mcmFnOmNkNmJlYTAxMWFmZjQ4OWU5YmEzNzM0MGFiZTJlYzkyL3RleHRyZWdpb246Y2Q2YmVhMDExYWZmNDg5ZTliYTM3MzQwYWJlMmVjOTJfNDY4_84d4b27e-a9af-4153-8742-57eb1c4db80b"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTk0OA_e1e09edb-8875-44ff-b587-77a95184d060">EMPLOYEE BENEFIT PLANS&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a domestic qualified pension plan (the Plan). The Plan is frozen for all participants. The Plan generally was frozen effective June 30, 2011 for all employees, except for certain collectively bargained employees, whose Plan freeze was effective January 1, 2019. As a result of the Plan freeze, no employees are eligible to commence participation in the Plan or accrue any additional benefits under the Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 17, 2022, the Company&#x2019;s Board of Directors approved a resolution to terminate the Plan. The amendment will allow the settlement of the pension obligation with either a lump sum payout or a purchased annuity. It is expected to take 18 to 24 months to complete the termination from the date of the approved resolution to terminate the Plan. The completion of the process of offering and accepting lump sum elections are dependent on when certain regulatory approvals are obtained. Currently, there is not enough information available to determine the ultimate charge of the termination. The Plan is fully funded under specified Employee Retirement Income Security Act (ERISA) funding rules as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of net periodic benefit cost for the Company&#x2019;s retirement income plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2023 net periodic benefit cost is 2.7%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net periodic benefit cost for the Company&#x2019;s retirement health care plans was $(1) for both the three and nine months ended March&#160;31, 2023, and $0 for both the three and nine months ended March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During both the three months ended March&#160;31, 2023 and 2022, the Company made $8 in contributions to its domestic retirement income plans. During the nine months ended March&#160;31, 2023 and 2022, the Company made $12 and $13 in contributions to its domestic retirement income plans, respectively.&lt;/span&gt;&lt;/div&gt;Service cost component of the net periodic benefit cost, if any, is reflected in employee benefit costs, all other components are reflected in Other (income) expense, net.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <clx:DefinedBenefitPlanPlanTerminationPeriod
      contextRef="i1b73d8a1cfaf475cb132b48a9922e0b3_D20220517-20220517"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfNjk5_09e61889-e31e-4d59-9561-6266fd8aea48">P18M</clx:DefinedBenefitPlanPlanTerminationPeriod>
    <clx:DefinedBenefitPlanPlanTerminationPeriod
      contextRef="i72e948a45d844caaa808077789bc9946_D20220517-20220517"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfNzA1_b74b3f91-cc57-43fa-80e2-c8187003ddcf">P24M</clx:DefinedBenefitPlanPlanTerminationPeriod>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTk0NQ_18d51198-04e1-464a-992f-c56d3c7aae8b">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of net periodic benefit cost for the Company&#x2019;s retirement income plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2023 net periodic benefit cost is 2.7%.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if97497268cb046da9dca9748a32e4bbb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfMy0xLTEtMS0xNDI2ODA_5e1f6144-5d8a-4a90-b3de-ba257a14bb1a"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i246ce3736a7a4184875d648605151755_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfMy0zLTEtMS0xNDI2ODA_c749890c-254f-4abc-99e6-614f37dbf937"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i69b9322d04104475b3bd0b3239f85400_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfMy01LTEtMS0xNDI2ODA_d2876cd2-c73e-4007-872b-7fafdfce90ee"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i925a3774c2804469a6e6a80652cf53fb_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfMy03LTEtMS0xNDI2ODA_5e904df3-5c71-4b0e-a9c6-f516ac2cd59e"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="if97497268cb046da9dca9748a32e4bbb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNC0xLTEtMS0xNDI2ODA_27d373c4-4c4a-46cd-8b0d-e7fbf381f383"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i246ce3736a7a4184875d648605151755_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNC0zLTEtMS0xNDI2ODA_3aeae124-a277-4326-a51a-0b63ecee09f4"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i69b9322d04104475b3bd0b3239f85400_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNC01LTEtMS0xNDI2ODA_9c431643-2ad3-43dc-8cff-afefb934825e"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i925a3774c2804469a6e6a80652cf53fb_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNC03LTEtMS0xNDI2ODA_d54a34c1-c467-4f52-8ca3-458f0e2f3f9f"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="if97497268cb046da9dca9748a32e4bbb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNS0xLTEtMS0xNDI2ODA_6d0bfc09-125e-445e-b9a8-8e54db133783"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i246ce3736a7a4184875d648605151755_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNS0zLTEtMS0xNDI2ODA_014fcd08-9355-4c30-a884-77e9834b4001"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i69b9322d04104475b3bd0b3239f85400_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNS01LTEtMS0xNDI2ODA_4709b360-2b57-4782-916d-9ee9e0752215"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i925a3774c2804469a6e6a80652cf53fb_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNS03LTEtMS0xNDI2ODA_3cc3d4bf-bb07-40a0-85d5-837f8dd54fbd"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="if97497268cb046da9dca9748a32e4bbb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNi0xLTEtMS0xNDI2ODA_6e5f65f8-c99b-4d71-b04f-619ab4cee395"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i246ce3736a7a4184875d648605151755_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNi0zLTEtMS0xNDI2ODA_536773f9-a071-4ceb-ae56-4b0f745318d4"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i69b9322d04104475b3bd0b3239f85400_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNi01LTEtMS0xNDI2ODA_33e3493c-41b1-4eca-b60c-501158b6f6b3"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i925a3774c2804469a6e6a80652cf53fb_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNi03LTEtMS0xNDI2ODA_ca2b7f01-4fdc-4800-b77d-17284651e744"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if97497268cb046da9dca9748a32e4bbb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNy0xLTEtMS0xNDI2ODA_15d6a0f9-da64-4778-875e-75119978295a"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i246ce3736a7a4184875d648605151755_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNy0zLTEtMS0xNDI2ODA_4603dbfe-f73c-4afa-bc3e-74fef176f8d9"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i69b9322d04104475b3bd0b3239f85400_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNy01LTEtMS0xNDI2ODA_e5b4de16-8a07-46f7-b1a2-ebb587d720a4"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i925a3774c2804469a6e6a80652cf53fb_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RhYmxlOjdiYjMxMWFhZWZjNDQ5ZDA4MGU0NmIxYjI4YTkyNjAyL3RhYmxlcmFuZ2U6N2JiMzExYWFlZmM0NDlkMDgwZTQ2YjFiMjhhOTI2MDJfNy03LTEtMS0xNDI2ODA_a90c3a7c-c957-4557-9191-b6f26bc6e5cb"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTQyNQ_5d20e239-cf0a-47b5-b889-c9bbe3cb76ed"
      unitRef="number">0.027</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTUxMA_3653d1ec-48d5-4795-a4d2-82eb946c8b99"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTUxMA_65dd646e-b8b1-47e2-97fd-314b04a30717"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTA0NDUzNjA0NjYzMzM_a51d63b2-c0d1-4410-96bc-fe764f00f700"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTA0NDUzNjA0NjYzMzM_e36362b4-a4f6-4509-9136-cce43fff983f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i6c9faa6e294049b0b02b4ca616aef8d4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTY0OTI2NzQ0MzYxOQ_7593b000-22c9-48bf-95a5-2345294562d3"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i5018154f07a6473082b19c7019bb5815_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTY0OTI2NzQ0MzYxOQ_b18e9b5c-c2e4-480a-8a98-9f697f9d5c20"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i559a56b3ed7f4dad8b0eb215d3b4d96e_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTY5MA_401fdb89-4ce9-45f0-9078-1f03c8949410"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="icb1bd9ce8db14db8b42305bf898b2988_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80Ni9mcmFnOjFjN2JhYjQzOThjMDQ4NWRhOGIwOTU3ZTJkNThhNGIwL3RleHRyZWdpb246MWM3YmFiNDM5OGMwNDg1ZGE4YjA5NTdlMmQ1OGE0YjBfMTY5Nw_a358944f-209f-4848-950c-dc8a4aa63f31"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfNDg1Mw_da13b9ae-64ca-46b9-9a48-cd48a64c5def">OTHER CONTINGENCIES AND GUARANTEES&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved in certain environmental matters, including response actions at various locations. The Company had recorded liabilities totaling $26 and $28 as of March&#160;31, 2023 and June&#160;30, 2022, respectively, for its share of aggregate future remediation costs related to these matters. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;One matter, which accounted fo&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;r&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $12&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $14 of the recorded liability as of March&#160;31, 2023 and June&#160;30, 2022, respectively, relates to environmental costs associated with one of the Company&#x2019;s former operations at a site located in Alameda County, California. In November 2016, at the request of regulators and with the assistance of environmental consultants, the Company submitted a Feasibility Study that evaluated various options for managing the site and included estimates of the related costs. Following further discussions with the regulators in 2017, the Company recorded an undiscounted liability for costs estimated to be incurred over a 30-year period, based on one of the options in the Feasibility Study. In September 2021, as a result of an additional study and further discussions with regulators, the Company submitted a Soil Vapor Intrusion Report to the regulators, which has not resulted in a change to the recorded liability. While the Company believes its latest estimates of remediation costs are reasonable, the ultimate remediation requirements are not yet finalized and the regulators could require the Company to implement remediation actions for a longer period or take additional actions, which could include estimated undiscounted costs of up to approximately $28 over an estimated 30-year period, or require the Company to take different actions and incur additional costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Another matter in Dickinson County, Michigan, at the site of one of the Company&#x2019;s former operations for which the Company is jointly and severally liable, accounted for $10 and $9 of the recorded liability as of both March&#160;31, 2023 and June&#160;30, 2022, respectively. This amount reflects the Company&#x2019;s agreement to be liable for 24.3% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing agreement with a third party. If the third party is unable to pay its share of the response and remediation obligations, the Company may be responsible for such obligations. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Although it is reasonably possible that the Company&#x2019;s exposure may exceed the amount recorded for the Dickinson County matter, any amount of such additional exposures, or range of exposures, is not estimable at this time. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimated losses related to these matters are sensitive to a variety of uncertain factors, including the efficacy of any remediation efforts, changes in any remediation requirements and the future availability of alternative clean-up technologies. The Company is subject to various legal proceedings, claims and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements (including costs connected to the transition and unwinding of certain supply and manufacturing relationships), product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, either individually or in the aggregate, on the Company&#x2019;s condensed consolidated financial statements taken as a whole.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make, any material payments relating to its indemnifications, and believes that any reasonably possible payments would not have a material adverse effect, either individually or in the aggregate, on the Company&#x2019;s condensed consolidated financial statements taken as a whole.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had not recorded any material liabilities on the aforementioned guarantees as of both March&#160;31, 2023 and June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company was a party to letters of credit of $14 as of March&#160;31, 2023, primarily related to its insurance carriers, of which $0 had been drawn upon.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfMjE2_f178be75-4f16-437e-9661-afcd4580551b"
      unitRef="usd">26000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i39f73c20959b4e5ea5dbe242aa2d3610_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfMjIz_e7b0c983-c14f-4a2c-ad50-b3dba0b4a73a"
      unitRef="usd">28000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i1215ef2fd713408c9543e79c8cf060d0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfMzY4_c8d0234d-5ee3-4863-8a7c-63d651b96ccb"
      unitRef="usd">12000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i7407b536aaac44c9a0ef22436412b35c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfMzc1_f2661df8-4529-402e-bdbe-b53da748bd14"
      unitRef="usd">14000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <clx:RemediationPeriod
      contextRef="iac8c0a67be954e91bf9ca146dc56b8af_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfNDg1Nw_66fab8a3-e412-4207-bb28-ad0d22f34780">P30Y</clx:RemediationPeriod>
    <clx:MaximumExposureUndiscountedCost
      contextRef="i1215ef2fd713408c9543e79c8cf060d0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfMTYwMA_df170f78-af5f-4b19-9487-e52216e76848"
      unitRef="usd">28000000</clx:MaximumExposureUndiscountedCost>
    <clx:RemediationPeriod
      contextRef="iac8c0a67be954e91bf9ca146dc56b8af_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfNDg1MQ_9465b633-6c4e-4a03-a354-7126b22c8551">P30Y</clx:RemediationPeriod>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i5fc0efb36d7e490a8d10a178a4f95683_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfMTg4NA_416db166-4235-48f1-812c-1ded31ba7dbd"
      unitRef="usd">10000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="ic71f7f98850c425cb50e81ac8cee6715_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfNjU5NzA2OTc3MTU3NQ_8e9f306c-277e-43e0-845f-82c4cf595f76"
      unitRef="usd">9000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <clx:SiteContingencyAgreedPercentageOfCostSharing
      contextRef="if9807c06a76d40c0ae21df8a99a25033_D20220701-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfMTk5Nw_46286991-de83-4355-b8c6-4c2f8c427586"
      unitRef="number">0.243</clx:SiteContingencyAgreedPercentageOfCostSharing>
    <clx:RemediationPeriod
      contextRef="if9807c06a76d40c0ae21df8a99a25033_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfNDg1Mg_f7bb2632-59c9-4cc6-9442-a3dbbec0308c">P30Y</clx:RemediationPeriod>
    <clx:LetterOfCreditBorrowingCapacity
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfNDc2MA_04365ad2-f008-4c97-98ff-90f94adc7f90"
      unitRef="usd">14000000</clx:LetterOfCreditBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i85cd7ba9934b45cfb7d15022292a50e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF80OS9mcmFnOmI0NmMzZWJiZTFlZTQzYjE5MTY4ZGI5NDJkNGFiZTlhL3RleHRyZWdpb246YjQ2YzNlYmJlMWVlNDNiMTkxNjhkYjk0MmQ0YWJlOWFfNDgyNw_ded08958-1404-4864-96ac-820edb072cc2"
      unitRef="usd">0</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTgzMA_5748fc24-d740-44f4-984e-eea66c672ac0">SEGMENT RESULTS&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates through strategic business units (SBUs) that are organized into the Company&#x2019;s operating segments. The operating segments are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below present reportable segment information and a reconciliation of the segment information to the Company&#x2019;s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings (losses) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;The earnings (losses) before income taxes for the Health and Wellness segment includes $433 of non-cash impairment charges related to the VMS business for the three and nine months ended March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;The earnings (losses) before income taxes for the International segment include $12 of non-cash impairment charges related to the VMS business for the three and nine months ended March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;The losses before income taxes for Corporate includes restructuring and related implementation costs, net for the streamlined operating model of $21 and $44 for the three and nine months ended March&#160;31, 2023, respectively. While recorded within the Corporate segment, for informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company&#x2019;s reportable segments as a percentage of the total costs: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All intersegment sales are eliminated and are not included in the Company&#x2019;s reportable segments&#x2019; net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales to the Company&#x2019;s largest customer, Walmart Inc. and its affiliates, as a percentage of consolidated net sales, were 26% for the three and nine months ended March&#160;31, 2023 and 25% for the three and nine months ended March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides Net sales as a percentage of the Company&#x2019;s consolidated net sales, disaggregated by operating segment, for the periods indicated:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cleaning&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vitamins, Minerals and Supplements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bags and Wraps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grilling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cat Litter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Food&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natural Personal Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Water Filtration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTgyNw_5e7e9f7c-c7d5-4d19-af31-b0b32927f695">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates through strategic business units (SBUs) that are organized into the Company&#x2019;s operating segments. The operating segments are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTk3_1b6fc735-dee8-49df-b30c-cea373521621"
      unitRef="reportablesegment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTgzOA_92c57a45-9407-4724-928e-7ee9cb8d582f">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below present reportable segment information and a reconciliation of the segment information to the Company&#x2019;s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings (losses) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;The earnings (losses) before income taxes for the Health and Wellness segment includes $433 of non-cash impairment charges related to the VMS business for the three and nine months ended March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;The earnings (losses) before income taxes for the International segment include $12 of non-cash impairment charges related to the VMS business for the three and nine months ended March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;The losses before income taxes for Corporate includes restructuring and related implementation costs, net for the streamlined operating model of $21 and $44 for the three and nine months ended March&#160;31, 2023, respectively. While recorded within the Corporate segment, for informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company&#x2019;s reportable segments as a percentage of the total costs: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides Net sales as a percentage of the Company&#x2019;s consolidated net sales, disaggregated by operating segment, for the periods indicated:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cleaning&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vitamins, Minerals and Supplements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bags and Wraps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grilling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cat Litter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Food&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natural Personal Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Water Filtration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iffcf3e3d97fe478ba53f98097b7768d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMy0yLTEtMS0xNDI2ODA_254e1a74-a0e1-42fc-bdba-0702be3892d0"
      unitRef="usd">707000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3033698cc9d446b98ebb51f2cc6a8fc7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMy00LTEtMS0xNDI2ODA_f5968441-4342-4f00-af68-48b63d98be90"
      unitRef="usd">662000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8b819629ac7412c9fa594839a2ca9ee_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMy02LTEtMS0xNDI2ODA_84635877-56e7-4139-8d27-00f84ed5e17a"
      unitRef="usd">2054000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8d519a96f9042bc8dcb0510d40a1b4e_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMy04LTEtMS0xNDI2ODA_01588b7b-a8a8-475a-afc8-03a5e7d9c16a"
      unitRef="usd">2055000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b20ce7569f946f996cfe02a046120e8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNC0yLTEtMS0xNDI2ODA_0ff02cff-9ba8-4088-bedb-10ff95150e0f"
      unitRef="usd">550000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37775bc712c546ebbc80496c37c9b997_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNC00LTEtMS0xNDI2ODA_64a0c8e9-6c50-456a-9375-6fa300e25bed"
      unitRef="usd">539000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c9d7f9d14d24f99895d7cf206821b4b_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNC02LTEtMS0xNDI2ODA_5b51c882-e7fd-4828-a223-041d1e910262"
      unitRef="usd">1435000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4031a9dd94ae4d12aae506d6f2f1db96_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNC04LTEtMS0xNDI2ODA_6850a4da-5408-4ab0-9981-f5ac001f4f71"
      unitRef="usd">1404000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief9575da4e024669a982592f716c50d9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNS0yLTEtMS0xNDI2ODA_2628c1d5-891a-4746-8bb7-efb0a775c929"
      unitRef="usd">353000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7dc7ce1afe424640808a9e7de9aa36a0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNS00LTEtMS0xNDI2ODA_c4c92d2c-8fba-491f-ba2b-d0597a240101"
      unitRef="usd">306000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie71b9480776e436f9c519240052f7677_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNS02LTEtMS0xNDI2ODA_48c61146-b062-46f2-ac31-1e4cbadb06b2"
      unitRef="usd">1005000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d021f6c3597425098add480ff912297_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNS04LTEtMS0xNDI2ODA_fd1536e5-17e4-4ce4-8be1-8b96cc019f29"
      unitRef="usd">961000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icce3534c232c40299861e02393f34ae2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNi0yLTEtMS0xNDI2ODA_4cf377ea-9dfd-4f20-8594-00ce19cd3a3d"
      unitRef="usd">305000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8021e9a77dd946919cfb390e149fbf16_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNi00LTEtMS0xNDI2ODA_dada02f1-4af4-4f0d-859c-d2c142b350be"
      unitRef="usd">302000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5de8a3a44dc424bbd78630823dbc605_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNi02LTEtMS0xNDI2ODA_f39eaf57-1ead-4f2a-906e-f075d3d4e89d"
      unitRef="usd">876000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifca9fa030b7e4d4d857d843d0538b755_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfNi04LTEtMS0xNDI2ODA_b34187ca-01bf-493b-99f2-0fcb6632a25f"
      unitRef="usd">886000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfOC0yLTEtMS0xNDI2ODA_dadabeba-2001-4e58-b0c4-0c1424f04bac"
      unitRef="usd">1915000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfOC00LTEtMS0xNDI2ODA_23d49e61-c5f7-495c-a374-0522c81d276b"
      unitRef="usd">1809000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfOC02LTEtMS0xNDI2ODA_15c66fa8-2149-4711-ae9d-74076dcbf8ee"
      unitRef="usd">5370000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfOC04LTEtMS0xNDI2ODA_5271d44d-c41b-449b-a937-d1c4a3277643"
      unitRef="usd">5306000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iffcf3e3d97fe478ba53f98097b7768d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTMtMi0xLTEtMTQyNjgw_170a0c28-d231-4d1a-bcf1-1a8798970baf"
      unitRef="usd">-290000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3033698cc9d446b98ebb51f2cc6a8fc7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTMtNC0xLTEtMTQyNjgw_ae4a78fc-531e-4147-9555-cfc56e8966a2"
      unitRef="usd">84000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id8b819629ac7412c9fa594839a2ca9ee_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTMtNi0xLTEtMTQyNjgw_c1f06046-3f75-4faa-855f-d074b16d765a"
      unitRef="usd">-72000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib8d519a96f9042bc8dcb0510d40a1b4e_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTMtOC0xLTEtMTQyNjgw_77f7b125-7c30-43c9-a1ee-66b6bc89d7af"
      unitRef="usd">245000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7b20ce7569f946f996cfe02a046120e8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTQtMi0xLTEtMTQyNjgw_96446760-2f1b-4b9c-9869-af32bcdc1514"
      unitRef="usd">99000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i37775bc712c546ebbc80496c37c9b997_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTQtNC0xLTEtMTQyNjgw_c09f4e04-c631-4c5a-9775-c280f422fa98"
      unitRef="usd">92000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7c9d7f9d14d24f99895d7cf206821b4b_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTQtNi0xLTEtMTQyNjgw_22315567-5224-47d7-835b-210f481076e4"
      unitRef="usd">165000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4031a9dd94ae4d12aae506d6f2f1db96_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTQtOC0xLTEtMTQyNjgw_6d372fe7-e052-41de-8f87-171d46e0095c"
      unitRef="usd">138000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ief9575da4e024669a982592f716c50d9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTUtMi0xLTEtMTQyNjgw_607b3287-d26f-42bc-85f8-8ac87515e965"
      unitRef="usd">83000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7dc7ce1afe424640808a9e7de9aa36a0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTUtNC0xLTEtMTQyNjgw_8e8404da-0ea2-4175-8758-f1db7905fd34"
      unitRef="usd">66000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie71b9480776e436f9c519240052f7677_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTUtNi0xLTEtMTQyNjgw_985a1f7b-5abb-4dd5-b1a9-5540579cf8a2"
      unitRef="usd">217000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5d021f6c3597425098add480ff912297_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTUtOC0xLTEtMTQyNjgw_0694d9e5-2357-4309-9ad9-105e9c7a3817"
      unitRef="usd">239000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icce3534c232c40299861e02393f34ae2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTYtMi0xLTEtMTQyNjgw_cc4bdbeb-cff9-4722-a839-de4cb9c88896"
      unitRef="usd">15000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8021e9a77dd946919cfb390e149fbf16_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTYtNC0xLTEtMTQyNjgw_7498a15d-af07-40b2-a099-b42cd5ed582b"
      unitRef="usd">31000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic5de8a3a44dc424bbd78630823dbc605_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTYtNi0xLTEtMTQyNjgw_20cabbc5-cd2e-4165-a2ab-e631f7fbb558"
      unitRef="usd">62000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifca9fa030b7e4d4d857d843d0538b755_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTYtOC0xLTEtMTQyNjgw_fb3a45ef-4ad4-4a5b-98e9-6982ff8463f7"
      unitRef="usd">80000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icedf8ca64b12469f8b334ea1c52ce44f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTctMi0xLTEtMTQyNjgw_cbb280fc-cd61-4e3b-9854-f1c9624e7d3c"
      unitRef="usd">-152000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic113bbab87514834aeff65f9dcd2d9ea_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTctNC0xLTEtMTQyNjgw_e71758e6-7df5-40c8-9376-dd3dd35275e0"
      unitRef="usd">-73000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib82d343ec2d2457491346026e4a1384b_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTctNi0xLTEtMTQyNjgw_c8fa3f3d-6c08-4a73-84a8-75ef91e57daf"
      unitRef="usd">-371000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i008bd39b3c1441d28f56d156aa4e0e13_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTctOC0xLTEtMTQyNjgw_ff2c22ad-6694-4650-b2d7-7a96651c2377"
      unitRef="usd">-224000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTgtMi0xLTEtMTQyNjgw_5c82bd23-82bb-4d46-aa57-246a2e677999"
      unitRef="usd">-245000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2d1fcb66b2f84117bbfa4e6b0163e2cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTgtNC0xLTEtMTQyNjgw_a47d7d46-c6b2-4e02-b846-54d1ea78df63"
      unitRef="usd">200000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTgtNi0xLTEtMTQyNjgw_58e3b75b-c4e9-44f3-9957-84599af118b1"
      unitRef="usd">1000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if8436d472730424da132f275fca3c42a_D20210701-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjY3MjY1Mjk0YTU0MzQyNTY4OGY5MTdjZWNjNDQ5YzM0L3RhYmxlcmFuZ2U6NjcyNjUyOTRhNTQzNDI1Njg4ZjkxN2NlY2M0NDljMzRfMTgtOC0xLTEtMTQyNjgw_36c0ebde-1ed7-48f9-9e4d-a2c9d509b29b"
      unitRef="usd">478000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:AssetImpairmentCharges
      contextRef="id94ba9c2186c47749a192c36f50af6e2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTA5OTUxMTYzMDgzMg_6dd17bf2-568e-44fa-b5d4-fda0ca4db47d"
      unitRef="usd">433000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i14a182d0cd5c4d15965a7e7a7bfdc653_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTA5OTUxMTYzMDgzMg_6fd3cc3e-103e-4b62-8c50-8dc7bd860468"
      unitRef="usd">433000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="if866eca78fc44cb985650980c0effb9e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTA5OTUxMTYzMDg0OA_0480a602-616f-4c59-88d9-3d687e0ba797"
      unitRef="usd">12000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i1963ee82a44d46ffa8708d4e456f329c_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTA5OTUxMTYzMDg0OA_437d4512-7080-4ae5-8322-4e1cfeaaea89"
      unitRef="usd">12000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i2495ac276b6d484d997eac4fc542962a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTA3Ng_dcc9dc52-31b7-4f54-80fa-c7bf33bc21a5"
      unitRef="usd">21000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTA4Mw_89c59f32-75ca-4079-ba38-598d891611f8"
      unitRef="usd">44000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i06b7961dd4ab4d08b1f59fd5cecff3e8_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfMi0zLTEtMS0xNDI2ODA_bc0b098d-125a-4b89-88ab-59be342f6dbc"
      unitRef="number">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if8cd31d1d39a4a1dad35192d8a05943e_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfMi01LTEtMS0xNDI2ODA_634f4356-8976-4882-b5bb-9b8ca1d22e8a"
      unitRef="number">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iae7e934f7d3345e38420a6419068a3d5_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfMy0zLTEtMS0xNDI2ODA_83a550b6-af80-4548-97eb-d385e9bfa137"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4827a5147dae403184de103cfa7cb609_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfMy01LTEtMS0xNDI2ODA_a49b1ddb-f81d-480f-9fb3-bfbe80b64464"
      unitRef="number">0.02</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iea0e1ddc7df0436291cc964f291d7156_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNC0zLTEtMS0xNDI2ODA_56a21bca-3ee9-461a-9a2a-173c6bdf4af1"
      unitRef="number">0.02</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2c370fc073ec40fc9f41fba7ceb625bf_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNC01LTEtMS0xNDI2ODA_7e275be4-c3c0-4cb9-87fe-60309e3c05fb"
      unitRef="number">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i51a5efc4b1ce48669aeefd4046d6b146_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNS0zLTEtMS0xNDI2ODA_3ccea1ed-63ba-4382-8160-1666d96dece2"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibc836f2559f64ad48298463711e54cef_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNS01LTEtMS0xNDI2ODA_b9f7b675-3a2c-4e4e-9017-d1f6799d10cf"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2d7befdad82d4d418a5d6f0c05a4d46a_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNi0zLTEtMS0xNDI2ODA_b960e75a-bbd3-470e-81a0-a98f0418d7e0"
      unitRef="number">0.66</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5f58e61108af4223b214e3fe0d5d2094_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNi01LTEtMS0xNDI2ODA_84302287-3b86-4ffb-9f17-b0eb75851e30"
      unitRef="number">0.70</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4e525b30dbd84ad096b5a005cb6c06b7_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNy0zLTEtMS0xNDI2ODA_cd714d0d-6041-40ac-8ff6-fe5a1debfffd"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6ed91cca97714a74bfef07a13999207e_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOmZlNTFlYjQ1OTEzMDQ5ODNiZTkzZmI0MTZmN2NkZTBiL3RhYmxlcmFuZ2U6ZmU1MWViNDU5MTMwNDk4M2JlOTNmYjQxNmY3Y2RlMGJfNy01LTEtMS0xNDI2ODA_069ca93f-b31e-47b2-9432-44363e44200f"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i376f067722d54b38b9d07d5df655a930_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTYwOA_3c99f90c-45ea-4936-bdb4-7a9951c0ad35"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie7a17140503d4ae99e2c3110f5493890_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTYwOA_5ae4e646-8a88-47f6-aafc-df6e9b187924"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i534b552133ab458393a04aa68bb98837_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTY1MQ_436e1699-82c4-44d9-8b49-6748249e8dad"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2bcfd545b0374fbdb3542e9d143d4386_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RleHRyZWdpb246N2NhMmNlNjUzODgzNGQ1NWEwOGVlODU5ODc4M2M3YjVfMTY1MQ_70b6d632-f54a-4e7e-bc8b-4798fe5e9de1"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4ff574e3aa2743caabd5efe4f9812b66_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMy0yLTEtMS0xNDI2ODA_3e23cd12-a9cf-4c13-8cc2-bcecfd2359a2"
      unitRef="number">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib002fea2011949d68a0bf85c0cd5f82f_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMy01LTEtMS0xNDI2ODA_8f44c19e-b0dc-4f5e-8814-3fa32ebec85e"
      unitRef="number">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6ca63fe7639d421784a23dec0aad3de2_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMy04LTEtMS0xNDI2ODA_da499b68-53ac-4295-b8a1-00c27656aa18"
      unitRef="number">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5f0cd8998a3d48ed956c2195a10e4a96_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMy0xMS0xLTEtMTQyNjgw_4ed4a0d1-c596-44c4-838e-1f4e43ecb195"
      unitRef="number">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3cdb483b522a49da8b6e69c8bfb68e8b_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNC0yLTEtMS0xNDI2ODA_032707d3-323f-4326-9eb5-cf9092639e7b"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i48472411ffc14234a19c3b450fcd82c8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNC01LTEtMS0xNDI2ODA_cd324069-b704-4366-9f5c-d3b8d5e76ae2"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if3eb238ad2564e2fb6be808234d4fb8a_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNC04LTEtMS0xNDI2ODA_90e22706-6d4f-4a96-927d-f6d2a413689b"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i629e3b1f030e4ce897713db4360a2347_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNC0xMS0xLTEtMTQyNjgw_588bc2e7-75db-48e8-9e87-e4dc7782af45"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9db2e760489b4c11a3d33f81189967c9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNS0yLTEtMS0xNDI2ODA_d2ce016e-5729-4a9e-9fa1-59eeec7f5e01"
      unitRef="number">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i39223577acf644679357f58a1290bd2a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNS01LTEtMS0xNDI2ODA_d9dca5c2-8c11-4448-a00b-7b8e01726653"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie881bce8f5334f7aab4e543c319a5926_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNS04LTEtMS0xNDI2ODA_091859b1-566c-4f8d-b629-0831f20c1923"
      unitRef="number">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idbae45119cfa4a5c8b13e22928f50489_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNS0xMS0xLTEtMTQyNjgw_67a99b80-d594-4d4b-8bb4-771100f2ae3b"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ice64939ca72241c09ec2b7d83c993371_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNi0yLTEtMS0xNDI2ODA_7d5faf6a-611e-41b9-992c-428219172c7f"
      unitRef="number">0.37</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i50673219f145422f8c076edc553d124d_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNi01LTEtMS0xNDI2ODA_9a7972b3-7cd7-402c-8b19-41de46ef7893"
      unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id28fe0fdacae42b3a9ca317dc63e5d74_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNi04LTEtMS0xNDI2ODA_fd205005-2f58-4e2b-877a-f61d7e5f238d"
      unitRef="number">0.38</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1beaeabc59b0460b9b16920dc20b95a4_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNi0xMS0xLTEtMTQyNjgw_b57ee0e9-06b8-47a6-b9ce-542ff99c038c"
      unitRef="number">0.39</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i95fdb90c917e4246b77256a7203284f4_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNy0yLTEtMS0xNDI2ODA_40e2b19e-09e3-4ff0-bce9-0f77c388bcad"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i63cbaccfe8b441e0b139019ea3e13e72_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNy01LTEtMS0xNDI2ODA_98b08317-e45e-4320-a23a-b3efdd260bc9"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i113699d3252e4e2d9ff0cd35976a5b8c_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNy04LTEtMS0xNDI2ODA_f262f1f7-fd51-482a-81de-714315ac9638"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2fbb109938324676a455905b3813090f_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfNy0xMS0xLTEtMTQyNjgw_0f559a78-35f1-40de-a37c-e4537b1e2388"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i57adcb1929154f35951a65c97a1a9eec_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOC0yLTEtMS0xNDI2ODA_7a767fad-0110-4785-a05d-6c89eda1224c"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i787f1a9b3f7a4dc8b0d448fa0c26e975_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOC01LTEtMS0xNDI2ODA_26109a06-773b-4abc-b47a-f3cdafe01dec"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i989a32ba4f8d4a9d8454b53f177bf23d_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOC04LTEtMS0xNDI2ODA_6d66837b-8e4c-4938-a710-b6c0bad6d8e6"
      unitRef="number">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i72213a90a16e4a55bf5162ceee1ad06b_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOC0xMS0xLTEtMTQyNjgw_38d7b416-f0a8-4478-98ed-10359ef13492"
      unitRef="number">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iecbb9ee292dc40f8a27a70a208e98f03_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOS0yLTEtMS0xNDI2ODA_50052fde-cf34-4a3c-99da-3fdd9aa1ba3a"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i503ca72ebec94846ab018289383f13fa_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOS01LTEtMS0xNDI2ODA_d662fdb9-cc79-4450-bd88-1da0d5e97a23"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ieda62ebce8934fb09ef0adb92b5f7803_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOS04LTEtMS0xNDI2ODA_4b9b6735-cb4a-4380-ac7e-b42c7a3d7d62"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i055b0b22709c429cbd64d4daebac1297_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfOS0xMS0xLTEtMTQyNjgw_a8eedd41-efa9-4aab-bbf2-618db01208ff"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8a65275769d74bf48e3a461bc2e6a39d_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTAtMi0xLTEtMTQyNjgw_8627f17e-b58a-42f5-b515-5ac527584e07"
      unitRef="number">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icb5c1ab1b82640178fbbc21e8512a431_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTAtNS0xLTEtMTQyNjgw_afe603f6-b304-44be-b5cc-c8711e70891b"
      unitRef="number">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id2436443839a40d6b25b269f3515ff1c_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTAtOC0xLTEtMTQyNjgw_8b25233b-4714-4006-a1dd-df92f44ce68d"
      unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie58eaa3597cd43668b6d4a0be6618155_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTAtMTEtMS0xLTE0MjY4MA_796f7c42-82c1-4556-9a5c-89678f86c6b5"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iec1abcd1af04423ca693619b5556f630_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTEtMi0xLTEtMTQyNjgw_97244089-0751-4736-9b06-9602e46c133f"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9de0a48a571549d3b006153987874a47_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTEtNS0xLTEtMTQyNjgw_e2f194bd-de39-485a-9ebf-9a882241ed6b"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i63c6253b79704765be3a2886b72dc7ca_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTEtOC0xLTEtMTQyNjgw_593ceca1-ca79-4f27-8970-f7192741fe65"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib18537f4ac7f4342b5c6624f2b7bf768_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTEtMTEtMS0xLTE0MjY4MA_36c7d781-d884-4ab2-8670-4ac0f473b9ea"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4a97ed3b14274b9b830776063e4410c8_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTItMi0xLTEtMTQyNjgw_6d0f5c39-8d55-4211-8c1a-6b75fa5c1982"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if2f5fb7871c7436b900d2cd3d8311c5f_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTItNS0xLTEtMTQyNjgw_2ebfe798-f096-48fe-a6d8-a0b8fa70b0d9"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0f41877e3cc24d2ab82f800b4e54b330_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTItOC0xLTEtMTQyNjgw_c252e3a8-d21c-4978-8fca-4fa095947c3d"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i114f5fcb844c4cd48afc6773bae7de68_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTItMTEtMS0xLTE0MjY4MA_7e32be6b-162a-4e06-9c51-46400c2f01f6"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic47b0bf2f6b74406ae63df384f0f2170_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTMtMi0xLTEtMTQyNjgw_01bed872-8cf8-4652-9da6-b3ccb65cf82c"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8b2275a8baa74a81974673ca3c98e934_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTMtNS0xLTEtMTQyNjgw_e15958d9-946d-4e9a-854b-7394b985d3d6"
      unitRef="number">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i63be3d36820c4c14aeb977054b7bd9ef_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTMtOC0xLTEtMTQyNjgw_46d18a8e-fcf5-435c-ba8f-c20b09ba2460"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic9c4181e447f4561894f05c7189939a9_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTMtMTEtMS0xLTE0MjY4MA_798956c9-15b4-414c-bc78-d012b8459687"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2fcc63cd4e714eeeb040154124f4230f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTQtMi0xLTEtMTQyNjgw_853776a4-7e4a-42d7-8663-68b5cfa487bf"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icaa89fb3550f4a919ddc0549b774313a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTQtNS0xLTEtMTQyNjgw_fd820dc3-834b-47fe-9ac5-2285b737ca24"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i141a04ca2b22429d966e6c25a5ba5b9f_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTQtOC0xLTEtMTQyNjgw_1ffc2527-36ec-4f3a-9f73-e4f56691b94a"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib0aa39c9b9204bc7812195ead8b31158_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTQtMTEtMS0xLTE0MjY4MA_12c0268e-ef45-410e-b919-fb6f7b5c4cc2"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i964cbc2a36904c2c953e83d44d0db963_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTUtMi0xLTEtMTQyNjgw_2485217f-8b5f-4d8a-bc3e-9dcde877170d"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i90c7b45b7f53405ea50b2def6902b7ec_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTUtNS0xLTEtMTQyNjgw_700bc739-6ca0-4d8c-a16d-d44d3e47cbfc"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i80debe7af7c04b0d8001e647ecf24389_D20220701-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTUtOC0xLTEtMTQyNjgw_c575dcda-91ca-4e13-9afc-d85b9fef1c46"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if63670b5302b4743b3c30e0b8aadda12_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTUtMTEtMS0xLTE0MjY4MA_d1b90fc6-dcb1-4c89-93b9-33887761ff70"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i788105bef8f040c3abaaec1851973630_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTYtMi0xLTEtMTQyNjgw_ef141c63-1604-4ea7-8962-73060a43d009"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i119fc41a359743d585ccf388679848e8_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTYtNS0xLTEtMTQyNjgw_f9cc5434-8c14-4387-9758-fbf23d6f4331"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib082af343f52451fb96251c408730857_D20220701-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTYtOC0xLTEtMTQyNjgw_f6e3f0a5-b750-4f29-8d06-c43d388bf3fb"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2d29d27dc57146a59614c80c2341fa42_D20210701-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZjgzMDUzNTg3MTQwNjFhNDY5MzBhODRmMDBhOGQwL3NlYzozNWY4MzA1MzU4NzE0MDYxYTQ2OTMwYTg0ZjAwYThkMF81Mi9mcmFnOjdjYTJjZTY1Mzg4MzRkNTVhMDhlZTg1OTg3ODNjN2I1L3RhYmxlOjBiYzNlZTI0NWRiNjQxYjdhMGYwYWY1MzM1OGZlYzI4L3RhYmxlcmFuZ2U6MGJjM2VlMjQ1ZGI2NDFiN2EwZjBhZjUzMzU4ZmVjMjhfMTYtMTEtMS0xLTE0MjY4MA_44d5c26d-d917-41aa-93d5-b24b386363b2"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>66
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M$A_# K'2 K&#+- DYE%$+K(4;J?V>HOK5,ZR\;BZ?*7S80<YG\M8J)EIF+^
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M>&!S=#$#8F%F "8@,,=QRW'LY?A)-S8J%LLJM2G;:(6ZJC:(@X3';E+MU0I
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MXA(*R*'U'5MX%L$ LFV"@]@-.=E"3KR0OPG-BB>@2^Q7)^%P2%U&9&1,YUN
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M!]H8"@U?(KBRWVA7QXXA.*F4%GD#!@4Y*^I?\K-)Q![ 'ST#P T OQ00-(#
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M(XSWYI?%LWLYOQ2Y3AFG]Q*I/,N(?+ZAJ=A?]<+>RX-O;+W1YD%_?KDE:_I
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MSD6/]!26!8!"CWW#&,I-'03Y@^IS:I/Q>VP@AR"<PAKXL4'?5+!%M<Q_Z3T
MXY>*@(GF#U@%:Z8*5FA;=#4< 1(-6A4^M0KKQCP1Z2W=0*BJVJP\88\B9UO3
MS1>")D:OYM F567>B[(Z.;O"^, 0(609.Y<I3V.G=YOWURYP:LY$,(I-5E(I
M].4).EN\W),O'$)P+HFIB?\30&Z?28!'J>-*O>7XB[RG#UU(CD$Z->4,MVRM
MX=K F;:1AKSU-OY8&)9O2&,L4<O*1!2R]YMEFUE#C:*T*A8WKND\;&00WI8
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MV))?TC%WE,,?27[2-J_;]]='(K.$W@3TI+?MV;J'EHN)E_EI7<(VAH#(A]:
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ML"<SYZ[YY2(_ZHV8$!K,(B,H^K? ,S2&@8C&SQ:SMS;)BMO/'?I[\9U\F:F
M9\[\K?-8'O4.>I!CH1H3K]SR([;^[#)>YDR0O[!,LM-1#[(F1%>URL2@TC;]
M5S=M'+84#AY3&+<*8^&=# G+<Q75\:%W2_ L36C\(*Z*-I'3EI/R-7KZJDDO
M'O_U[>.[*_A\<7)Z\?GBV\6[KX?#2+#\<9BU$*<)8OP(Q&OXXFPL [RS.>:W
M]8=$9\UIW'$Z'3\)^$7Y 4QV^C >C2=/X$W6/DX$;_*8C[%$#Y^UFFFCH\8
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M4?=<"PA/>G:)>N=?)@.9JJ5MVG=K;1^_6=/S?[@W+R>EMR-I('!+T*@[N M
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M5A?Z0HS?0;.?R,C+1*'LDXS=6(HK9K72HFPF8[ODE7NSF\8.<Q.ZWIH)M)E
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M0K'-B+,PEA18W$PJ),$5Z$YMI6!+:-K!0P7A[]#J!JVTL+ /VZCD>P<5?93
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MWWW5(]]<VIN/Z*IT44:2<.U.0U )+5$V8'WF7%Q_B('NE]/17U!+ P04
M" "=A:)6$CEZ5#T)  !8&   &0   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6S-6=MRVS@2_164)CLU4Z5(LNQ<)F.[RG&<C+<J3LK.3!ZV]@$B(1$Q"'
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M/F8@BFN$V8X%RIW0H$<H)'@ !7*U\FHEHQ++.A(WO"I5KAF?R%S 6J\,ON>
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MWUT+7@A#"S"_U-IM'XA ^ZGI[&]02P,$%     @ G86B5N%I*:>7#0  \20
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MRN19WZ>&EW</O&;;RWZ&4BNT[?1C&^;1C0^_2.F?]K_G.0L_8QF6AQ\# :Y
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MS9P>:VAX <TOM';;#AO8/?\&?P%02P,$%     @ G86B5K7:9N_3 @  #08
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MLH70@DC/5(J$9([8/Y"Y&O-:1&J>RW]# /D63@^)%F(#V.P6YM@<&?0&08]
M6O?"UK%SE64JEG;)BE)'";)-TTX12!+6#/O =H:[:(,^=4>N&S*D*22AG(EG
M;,WGK^P-V$ZPB_;C+P=A$'Z"PRU,8BS3L'K[EM72P6&S^Z L3XG_@/@/#ZB[
M3]W]@&T!\'X-X/W_!X )!9<5"MJ0O%6(=B1?JXB[(P6BS5^@)^7&R)F$4#.M
M,C:)HC(K4R>E:D%3#ODV$25SJS;!^Q*B_S$3"I!-J+>'R]\"[W,%.,*XA59Q
M20-&I3& M0+?!S; ,R;4#]Z(^G:2*X*K_[\4%?42\8P2";H,UW3Z+BI6$3*L
M) X.?,QNB8Y1'1VCK=%QC^HL+E-!.DW@*LA#+KV6?"I3::6@#*?99RXU^\K3
M4K +:2)XM=2B+0RV<Z/<[1,F19BE H L^221KH$=7QNZ(FN*PH\!@2B54IY'
M@OG2<@78*G!(5%HT(_&>2#P7YS0$C!0\7SI+CC^95\Z)HP:^1KU!W^/KK.)Y
M[W@V=#_G6B])]$MC9>;"I&6HLF,+2E5!8IN&\[]H47 9KWSOK5^%7JDU9$1.
M<N0"\GGUK &\ZK4P,PM>O(]5^ +0(_Q>! C<M> Z?B>+H/I]0-\_8_<TH=>B
MU:RT@%Y3+R0M55*6+OC2(8J8\BC2)7R1-J@%X.+YOL%:;Z;J*?YH,!^H@]IG
M?R/RO?WY.KC3'X)[D<@H87$=UT1H39=)@PS_O91:Q/_+<%FEP5^G.#U\L?:$
M5Q>F>W3<I&5,PYG*Q1*?+OH;F,W*/ 9,N$F<9A%U2%9([@YN7Z)\8*.Z.1CY
MY@&?A$@*A3+2_HQ""%B.D7V'[$'C4VIE2[)=KO+O)4_]&8JO. &4Q^[41 !X
M5Q6PCJDJP#J6@W#DG^#0/<#(X;!NP_YAU3:CX5;9*J121217R'QM?"?<=7$5
M# [J-AR,J_:\"D@XH=2> ?R>JGS^*QR109FI]6?!YM"6?6SK1CK)$(![P_$(
M[<"UP_&0^LXIX=XH<,KO[5?_XR#PXX ;^>%U+W$MG-&5H<H%<;#AW746DN\'
MV4+:A"DM41SB,*ZT7[*86V^!PS[Z2W0UPV>MZ?Y$6BJ:-!4]'+&-HF*O"D->
M("T\N] PC2CL.F^^YND?U4<*,1;+2)7'[GV7)C.A(PG)"UX(O4HNCE@/(O/,
M9[M8\T5.]6Y;)HF ;0G?SE'+52;C:4H,*]G?I1=@\5XLMC'L^ER[SE^@M+FM
MZ>CH!6<(S*E<H.4H7V)6&EIHP":/N:Y146A)]OM>*DIBTR68ZT*Y,F^*E:
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M(GM^_"\[4K5KWYMR)H;FJYH$A<!T]M/3]-_IA[L3^[UJ1FZ_^H$J0YT,,C:
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MF1%@_-/P[+0B>>%Z>\7]+.@.7:;"R1.C;U7AYX>=<8<*>2>6VE^9^_>RT6?
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MYAQO36F9 /-WQOA5AP6TK]>C?P%02P,$%     @ G86B5FN'^^O+ P  \14
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M92Y9**V!>;X00N\F]@75M2WY!U!+ P04    " "=A:)6 RMZSL4#  "&$
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MQ\[ 01&LR);*!=O] 65"7<T7,BKROVA7QGH."K="LK0$*P5IDA6_Y$M9B#V
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M_"BN+"V/Y?O98?1.^:U[<^?6E$?Z&#\[*=[@\_\ AHC/"14@P3,5RKF\4M.
MY\?J^8UDR^S<^(E)R=+L<H'5V\!U!?5\QIA\N=$!RC\WPE]02P,$%     @
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M&X],QD>;7--<Y2.[RD8&WQB9 ^8T9-L87(<N<<5ZDW=9M I?6[V"2L(YCBZ
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M[)(H ?#OUY2RUX/D L6_/$S^!5!+ P04    " "=A:)6I<:33H0$  "3&0
M&0   'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6RU65MSXC88_2L:=Z>3G<G&
MELTU!69(G.W2AB0#;/>ATP<! MRU+2J)L.VOKWR)K[*Z3I47\.T[1^?(^CC8
MHS.A7]D!8PZ^!7[(QL:!\^.U:;+- 0>(79$C#L69':$!XF*7[DUVI!AMXZ+
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M+A#G=X3PEYV(('L/,_D74$L#!!0    ( )V%HE;0<(X9%@,  .L)   9
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MM<(!4FJ(M(P_&TXGF]( =]M;]F_6N_8R(1('G#Y$H5KTG+8#(<[(DJH;OK[
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M./^Y9A2V+MD+\'PIA'Z[R!Q4AZ]&_P)02P,$%     @ G86B5O)6N."]!
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M#)]^JWQ$OX*YH:-K)F K_'$-06@J22+^U-4_R]#19U 6>R$V."!#"SQ4$/Y
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M@&[:EFN]7YB0Q5*H"W:GM4(+/,7B:?7(Y)F=>?%)B"-.: 08GK>MKGO;\Q)
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M(@P\HR"6Y]*RCQE9(_7.P##B@L6R%P3_"L[Z6" 2R*/?P-.T#\Z^? 5? (G
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MJGB&O!6+E^L?5R^ ZBF9 JO[.XV];.+44" 7*:YV*=]'RQ2M^U)4F-01,U<
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M%5. =JJ@RL0)F,3K-$NM&[(A(8#@/[!#).231RYWEF42YINUF,4_4QS2)95
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MY8K@!>&9@/Q]R>2FH+S)/HZM/H8>_0]02P,$%     @ G86B5@2XH'VE @
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MV$AE/4;JC18KVR?G0F/7M<LE3EZ0!H#?"R'T;F,<M+,\^0U02P,$%     @
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M-[%<ZV7@,5VNI!JPI^,U7I(9D5_7#QS>[)HE27-"1<HHXF0QL:[<4>1ZRJ!
M?$O)3NP](R5ESMAW]7*33"Q'K8AD)):* L//E@0DRQ03K.-'16K5<RK#_><7
M]D^%>! SQX($+/L]3>1J8@TLE) %WF3RD>T^DTI05_'%+!/%7[2KL(Z%XHV0
M+*^,805Y2LM?_%0Y8L\ >,P&7F7@Z0:=(P9^9>"_=X9.9=!Y[PS=RJ"0;I?:
M"\>%6.+IF+,=X@H-;.JA\'YA#?Y*J4J4F>3P-04[.0WN;Q\>H\_1W>SF6X1N
M[N ]0F=?[F>S<W0V@[1,-AE!;($"ED,FKE2*; FZH3'+"4!"(G&:B7-T@;[.
M0G3VX1Q]0"E%MVF602*(L2UAE6HN.ZY6=%VNR#NR(A_=,BI7 D4T(8G!/FRW
M'[;8V^"=VD7>BXNNO5;"6\POD>]^1)[C^8;U!.\W]TQR_M_LT7^>_< 9?ITO
M?L'G'^&;219_7[$L(5S\@J(?FU0^HSLF"?KC:BXDAXW_IRGF)6O'S*JJX4BL
M<4PF%B29('Q+K.G//[D]YU>3PT])%IZ2+#H1V4%H.G5H.FWLTSLX5@CF-*5+
M@<XR)@01YZ98E#2]@D8=)-OIA><,Q_9VW\=-D-OU#C&AD>@0$S4Q?J]?8PZ$
M=FNAW=8<O)<KPE%\4) *O>=0>51=^H@H^ **EL1/(Y,'NJ?,QE.2A:<DBTY$
M=A"D7AVD7FLVPC$.AS2%,XQS0N-G!+6!B@R7[4'R%QQMT&](XP%1,G?W<T]+
MJ\  T3(X;$(N7"TY#9"A.3?[M>S^FYMP0Z%ER]*_28*6T*J];D8$TJ%PIENL
MNB.C]'YS17U->A/B=S3I!A9/UVZ@<<W:![7V0:OVAZI_Q#1!:P:' 9$I)RK*
M:$XH6:3RK< /FE'5Q#<1>E%J(GQ->1/1-0L?UL*'K<)_8Q)GB/V;LF12/VRL
M2XMKT$1TNYK\)N1"WQE1$^,=*<FN\]I'.JT^..P/2\&5?&,/Z!A2U-'$! :4
MYVC[(311^;ID \@?=HZ(WFN>W5;17X@0(U2&/S8Y $O)T_E&XCETT9(ARF"<
M2LZ@.Z9+0$D"I=>\&:JY6W(]>!L2&B!]W3=-2.^(9[Q7SWCOV!)&GU1[0G=-
MD#'.C/NBFDKK,_2R:$ U$BHT475ZNC^:('\PT#QB[]VY<L*7Q657@.(-E64[
M78_6%^JKXAJIC5^[H\ UC(?J E[<\5[IR]L[]/1+=:QD9 %3.9=]B!PO+\3E
MBV3KXL8W9Q+NC\7CBF X>10 OB\8-.S5BYJ@_K?$]!]02P,$%     @ H(6B
M5D(I8M?B"0  .$@  !D   !X;"]W;W)K<VAE971S+W-H965T-#4N>&ULO5QK
M;]LX%OTK@G>PDP!-;#YDV=G$0&-Q,,6VTV[3[F(QV ^JS<1"9<DCR4G[[Y=Z
MU#3)*UI*B?1#8\N'A[J7E[P/4KI^RO*OQ8;STONV3=+B9K0IR]W5>%RL-GP;
M%9?9CJ?BE_LLWT:E^)H_C(M=SJ-UW6B;C/%D,AUOHS@=+:[K:Q_RQ76V+Y,X
MY1]RK]AOMU'^_98GV=/-"(U^7/@8/VS*ZL)X<;V+'O@=+S_O/N3BV_C LHZW
M/"WB+/5R?G\S>HVNF#^K&M2(?\?\J3CZ[%6B?,FRK]67-^N;T:2Z(Y[P55E1
M1.+/(U_R)*F8Q'W\U9*.#GU6#8\__V#_K19>"/,E*O@R2_X3K\O-S6@V\M;\
M/MHGY<?LZ7?>"N17?*LL*>K_O:<6.QEYJWU19MNVL;B#;9PV?Z-OK2*.&@@>
MN %N&V"] >UH0-H&I&\/M&U ^_;@MPUJT<>-[+7BPJB,%M=Y]N3E%5JP51]J
M[=>MA;[BM#*4NS(7O\:B7;FX^_1^^<_?W[\-V<>[7SWVK\]O/OW7.[L3]KC>
M)]S+[CWVUSXNOY][9R$OHS@ISKT+[_-=Z)W]<N[]XHV]8A/EO/#BU/N<QF7Q
M2EP4G]_%22(,H;@>E^(NJ[[&J_:.;IL[PAUW1+QW65IN"H^E:[X&VH?V]G-+
M^['0SD%%^(>*;K&5\%V47WH$O?+P!!/@?I;]FV-(G)_KG3V[=T49Y& OI.8C
M'7S+)"J*RBSNRFSUU?OSK?C=>U/R;?$_:*@;,@J358O@5;&+5OQF)%:Y@N>/
M?+3X^]_0=/(/2,\NR4*79,P1F3(B]# BU,:^"./'>,W3=2'6QU4BYN+:V_&\
MF9;>F9B*ZRP1EPMY]1P:J::3H.ZD\BZ/"W2)9M?CQ^,1 $%3%12:('H98!7$
M3!"YI+([11/^01.^U3;?I"OA*PM>+57-I_-J*:HM=9,E:YX7O[;+F??G1Z$5
M3_B:IRA?@Z;KNS1=EV2A2S+FB$P9L.EAP*96T[WE#W&:QNF#\/5)E*XX- X-
MQ?38G.9(L\L>F-#$!'BN6:6)\><8-LK@(&,P3,97WBK;;D6,5-0K:#5#&Q<*
M3DLK^5 K=$D6-F3^\5J "?(Q(OI<=]2MHO[90?VSH>HOJZ5AGW_O-P!6^J$#
MX)(LG!D#<!'XLSDQK-I1KXK^YP?]SZWZ_T/D.CS*JQ$HO+,D*XH./<]-:?!$
MDV1I@H3!:?-\;LQA0:1IQ.0ATP">YV@B(^F)5=3WY49X6#&YA1HW52KUR!N)
M*R\D+H.K6\MY?"M4$QJ ^+XF-("Y0+H= "#<)?51_H!ZAA]EYBV3+,^^-1.K
M];B@T BX6QKH<H,HHDL.H/Q9H(L.H"B9= B/I?"XO_!I)D8Y+7,16%3K39R6
M7,RG$M8 -N^'Z/(#&*I+#V 0TH6W@U3992* K%'MH@ZK+JHD?5T;O;#XJ,K]
M07&):7GZW 8PN@6' &:JSVT 0VF'L#+&1O8@NYG;?+M+LN^<MYYC)QQ*4^F(
MRYC#XTR-FS',W(3H$34 ,98T (,Z0A<D VID#?\6GU17N=OGJTTUX*"H3@-F
MIVRA4S;6LJF^RN_0M8R%D3T89NGZ1"2,S/ 4Z8G5L@4IWB(P#*H'$SO!I(HI
MPV%DCX=5,8<%PPB,.:<(T>E45X/36+=_Q\Q5QZIZ9;B+[/&NKMYAP2Z"8DJ$
MY_.YK^O7:2C;NU_FJE]5O3*:1?9P=ME8:^W[0 5:FP]>!%VRA4[9F"LVM20K
M@VT\><%:#[9&]D.'S2E;Z)2-N6)3ATUF"]B>+?2J^+0<BG<B>LFG#RCL V(G
M0*JD,C7 ]M3@)^L^V(S9$9D$%$TF$UT3O:%A?RCK!55U(U,';$\=3H<Z+<$)
M$^@!"ON V F0*J9,&K ]:?B94 <#X7S7^/>&AOVAK!=458Q,*[ ]K7B]7L=5
MJA@EWH<H7E\(52RC75Q&":@*IXF%4[;0*1MSQ:8.B\Q \/0E?:HUW1D\;"[9
M0J=LS!6;.FPRH\(#=QC T0C,%0Y/]%H$A$(S8Q4!N?3T$>;JR!^Q3'"P/<$9
M4G;"9EIAE)T C%%V C!&V0G =)6=L$PWL#W=>&[9"0/5=+VLW ,30AAB2 Z!
M.LHA1 ;XQ%Y-/QTC$+.<+9)RO1X"H9">5H:]N-@I+E54&103>U#\L3I8DPI[
M9NU&"2BME6/P40J7;*%3-N:*31T-&;@3_()>D%BSA,'#YI(M=,K&7+&IPW9T
M+LF>4_3R@L3<&PAFQHIA@N94=PD "$WH3%\P(!3I\(%$)A;$GECTWE0E9A!_
M@?7]H26 0K[N]$$J?9L- )%I1QY%9+I [.G"<[88"5"C-[<8892^Q0BAS"U&
M"-6YQ4AD4$[LVP+/#0&(6;V_T&,?"&-X1@!C["R#H"XSEX$M&;)5  IIUN4I
MTDO5 &CNZV6"/DSL!),JIHQHB3VB/6RR=5:5[02#G8C3TKU3-N:*31T*&6^3
M^4OZ?J>; 4[90J=LS!6;>@!6Y@K4GBOT\OTMAW(P".&Y[A) & ETGP##J+X;
M",/F'4LCE2D#'5A''[K31X$#,0&>$K.\""+%/[.Z""+]V=PL+H+(^;2[MDAE
M^$[M=??G^LN6]GBD]#,62P"C^X@0P$QU=PEA2(?@,@"F]@"XC^ GK0*(5PED
M$U!<"UD$<!;'A^P!.K-#NJWAZ&R\/5(><H#%3C5TN7;*%CIE8RV;>D:RHXQ!
M99A.GW=8Z*31.:WO.V4+G;(Q"J4;/NZV<YDET)\]/$3-(S_"_06&^X-@Q)_I
M$[L7&SO)IHHK,P,Z[!#10-]GAO$7 :J6&V.=@Y#3P$2&O3E9'TY5+3*3H/9,
MXO5JM=_NDZ@4DZYQ!TOE-')5-SA[6Y](?M-Y(MG>Q^#IZ#39<,K&7+&IHR63
M#?J2R09UFFPX90N=LC%7;.HS9C+9\!TD&SX0]_OZ%MD21 7Z)@R$HH$>4X)<
MM"/1\&6BX=L3C6<]U.";X;V^^P1 C(<: (Q9>@) 70\U^#*)\.U)Q&EWZD.'
M\^?Z\Y(0RC>V%WMQL5-<JJ@R;?#M:<,? YY:L%,-?B;2Z?.\3MF8*S9U4&3:
MXM,7= V^T\3&*5OHE(VY8E.'[>CY8WL&U,\UF$D "O3 $P3I03@((OJR 8!F
M'35K7^8;OCW?Z+T#Y9L[ X87/ D) 8B>:@"0+N<GTPS?GF8\^_$N'XCQ]<>[
M((SA^@&,\7C7"9 JN\PE_"$/$H!"SLQJF%[J6D(@XW&4/DSL!%,CYOCH32A;
MGC_4KZ I1/RR3\OF)1>'JX?7W+RN7^ZB7;]%5TL$7 _1%6M>8B/IFW?JO(MR
M,?L++^'WHJO)92 &)&]>4]-\*;-=_1Z6+UE99MOZXX9'8BVO .+W^RPK?WRI
M.CB\+&CQ?U!+ P04    " "@A:)648$BH6$'  #!,   &0   'AL+W=O<FMS
M:&5E=',O<VAE970T-BYX;6S-6VMOVS84_2N$5VP)T-06*=E)EAA(+ T-UC19
MDFX8AGU@)-K6JH='T4FZ7S]*<BR+O*+MC07ZI;'EPT/>ARX/'SU[SOGG8LZ8
M0"]IDA7GO;D0B]-^OPCG+*7%NWS!,OG+-.<I%?(KG_6+!6<TJAJE21\/!L-^
M2N.L-SZKGMWR\5F^%$F<L5N.BF6:4O[EDB7Y\WG/Z;T^N(MG<U$^Z(_/%G3&
M[IGXM+CE\EM_S1+%*<N*.,\09]/SWH5S&I#CLD&%^#5FS\7&9U2:\ICGG\LO
M5]%Y;U".B"4L%"4%E7^>V(0E2<DDQ_'WBK2W[K-LN/GYE?VGRGAIS",MV"1/
M?HLC,3_O'?=0Q*9TF8B[_/D]6QGDE7QAGA35O^AYA1WT4+@L1)ZN&LL1I'%6
M_Z4O*T=L-) \< .\:H#5!FY' [)J0';MP5TU<'?MP5LUJ$SOU[97CO.IH.,S
MGC\C7J(E6_FA\G[56OHKSLI$N1=<_AK+=F)\_W S^?G]S0<_N+O_ 06_?+IZ
M^!T=W,M\C)8)0_D43>8TF[$"Q1FZ",-ENDRH8!&Z$7/&T21/97[.R\1Y8NBC
M3.R##WE1L.+P$!WX3- X*0[1$?IT[Z.#-X?H34ES'2>)3)+BK"^D!>4X^N%J
MM)?U:''': FZSC,Q+U"012P"VOOF]B>&]GWIN;7[\*O[+K&1\)KR=X@X;Q$>
M8 *,9[)[<PR9\_]Z#_YS[RUGD'4ND8J/=/!=W$RNT%46)LLHSF;H-N=5+;@0
M@L>/2T$?94*)''W,LU!&@><R"R3L*A.,LT*\K=)')MP#?4%_W,E?D2P%SY1'
M?T*)4@_%A8=2EM?38D%#=MZ3^5DP_L1ZX^^_<X:#'Z$HV23S;9(%ELA:\737
M\71-[.-+FM L9&_1(YO%62:#!07"R+%O(&R2^379L"(K)\RGL><-S_I/F_ZU
MU&'+O][:OY[1OP^YH G*JT(:M@KI02*+Z*&LE?*Q]']6OQB"OD !\#0SW;:1
M$QWA>6V(7T.\#<B1<Z+X2J?!HS6DY8'AV@/#W3*,95%'>@VU@1'%.F,7^^;,
MUNX"2]VU_#5:^VMD]-?F! SE39DHK=R!/&KL8M\7UB:9;Y,LL$36BM/Q.D['
MW\Y,>&PSGC;)?)MD@26R5CQ/UO$\L3 3GN@UU!M@I5I!H)%2L'T Y([4<@PQ
MN4.X(#N#9CTP,)IZLVTZDCZ0ZU,F5XEA0HLBGL8A%9UR?J -4IF!)Q!DI/@#
MP!PIF # N+C#&QNK(\=<<--\F8EBPUA9>:<\3Y&54KSJO667.KU!&$?U#X1Q
M50<!(+?#0;AQ$#8ZZ*K."2E-9%YD;!I+J]G+0CJ!'8(68VT0CFJP#CER-(MU
M$%;M-?.T#6[6.(Y1<ML2;:M>6MFJ^D&':+(-P.BZ#0!U"3>G61LX.RX.NJ7;
MBJ&=<"?'JID RE-M\'?B"K9QM6UM=+IC%NIR]F7Q+$/ADG.6A5^0X#0K$EIO
M=45_+0N1,EDF0"<8J?>=GJVR^5;9 EML[2 U2PEG^.UH+L?FHF-BE<VWRA;8
M8FM'M5GP..85SV[*:T72K@[>B5II(!319A8(Y6J5!D(-2$>E:=8-CE'&VE9?
MQ]H@-9_H$+WVZI@C;;(%,%UUMU'=CEEV?VWUI2OH@>J>K1!_.R0P0MK[SHU.
MQV:=OJ_PPKH\5H47 %&-W<X2&%G:QC8R')MEN"71A74%[*@1AS#J"P%@5$D>
M0)B.%P(W:AN;U?8.H@L#JM=UU=<>1#E8M7,7KF ;5]O61FACL] NY^-EQAE-
MXG_D6SZC<5;4X68RX')FCQB/GVAYS@@6/S/]OE.T53;?*EM@BZT=J&8E@-UO
M1WAAJ\<-5ME\JVR!+;9V5)LU#S:O>7837E@_-W &([78 *!CM=0 &*S55!V$
M.Q;TN%DW8/,9A%W)A?4#!&U'!\"H^M*'>#S5'3K&ZW)'([CQEB.&KZNY,*2;
M5?\ &*+Z!\"H216 H"XQTFAT;-;H>RLO71IKH@-0S]J6%P!253C(TV5P(\.Q
M68;;4E_ AK56*G0,43?'(1Z]5 !$'>\&:30W,6ON'>07 03R0 TW /)4[;4+
M46 F:EO9B&UB%MNWJVM@-(O0(B\$9R+FK-S@6N?[ECTO<P=[7\ZPR>9;90ML
ML;5#U:P'"/YVI!<QKDWVCJI--M\J6V"+K1W5C6M4YI7/;M*+0%O_GE9J(-10
MG5I@+G5V@;DZCI!(LWX@YI,$NP*,Z$< FD^V0OSMD, (:;NB$=W$++J_LO@B
M@,A6?0-(;-4W.D0]:@0@'0?3I-'IQ*S3]Y5=1%?'6B)LA?@ 1-OJ,6/:YC8Z
MG)AUN"71170)K(5<AV@AUR'JM2@ XG7XH%':Q*RT=]%;-<.PY7MMNPM$J><#
M_DY<P3:NVM;^QI7LE/%9=1>^D)&4[W=]HW;]='W?_J*Z9:X\OW1.)P[PW'=.
M@_HV?4-?7^Z_IGQ6[I4E;"J[&KP;R9CP^KY\_47DB^I"^&,N1)Y6'^>,1HR7
M /G[-,_%ZY>R@_7_6AC_"U!+ P04    " "@A:)6>&%_*.<"  "8"0  &0
M 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6RM5FUOVC 0_BM6-FU46AM(@&X,
M(E&2J6AT[4J[:9KVP4T.8BVV,]M ^^]G.R&%*M!JXTOBEWN>\]V3^*Z_XN*W
M3 $4NJ<9DP,G52KON:Z,4Z!8GO <F-Z9<4&QTE,Q=V4N "<61#/7:S:[+L6$
M.4'?KEV)H,\7*B,,K@22"TJQ>#B#C*\&3LM9+UR3>:K,@AOT<SR'*:C;_$KH
MF5NQ)(0"DX0S)& V<(:M7M0Q]M;@&X&5W!@C$\D=Y[_-9)P,G*8Y$&00*\.
M]6L)(\@R0Z2/\:?D="J7!K@Y7K-_LK'K6.ZPA!'/OI-$I0/GO8,2F.%%IJ[Y
MZAS*>.P!8YY)^T2KPO:TZZ!X(16G)5B?@!)6O/%]F8<-@.:I!W@EP'L*:.\
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MS-0 N7])J7AIJ G*CRC^=U!+ P04    " "@A:)6C>$NVAX$  !8$0  &0
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M4:.Z5IR)TG-6ILNUFZYCK5A0@6X#(1@W9@RZ=@=*PZ T D732Z(LH3ON4BU
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M /GW39*(EP]9!]6;Y?/_ %!+ P04    " "@A:)6',4/H!X#  !($0  #0
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M)6$09R@(PV059T2#' &0([N0*:99N@JS54KB&0KB"4IQ%&1X@L*$9E2#_ !
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M<F]P<R]A<' N>&UL4$L! A0#%     @ G86B5N 2'SKO    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ G86B
M5IE<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " "=A:)6OG(_,<<%  "['@  &
M@($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ G86B
M5J]XVAF'!@   Q\  !@              ("!"PX  'AL+W=O<FMS:&5E=',O
M<VAE970R+GAM;%!+ 0(4 Q0    ( )V%HE;I::>^  <   X>   8
M      " @<@4  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M" "=A:)6,:.C&GX#   +#   &               @('^&P  >&PO=V]R:W-H
M965T<R]S:&5E=#0N>&UL4$L! A0#%     @ G86B5G"Q*?2<!@  A!P  !@
M             ("!LA\  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4
M Q0    ( )V%HE9:6H8+#@P  *XA   8              " @80F  !X;"]W
M;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " "=A:)6(5XIOJP&  #$
M$   &               @('(,@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL
M4$L! A0#%     @ G86B5H'';(;# @  "08  !@              ("!JCD
M 'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( )V%HE9QFZN]
MX@@  , 7   8              " @:,\  !X;"]W;W)K<VAE971S+W-H965T
M.2YX;6Q02P$"% ,4    " "=A:)6\/;V:TX%  !D#   &0
M@(&[10  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( )V%
MHE9KCJX68@X  ((O   9              " @4!+  !X;"]W;W)K<VAE971S
M+W-H965T,3$N>&UL4$L! A0#%     @ G86B5O$5&X#1!   %@L  !D
M         ("!V5D  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M    " "=A:)66<0)!GH#   >"   &0              @('A7@  >&PO=V]R
M:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( )V%HE8-".()70,  *<'
M   9              " @9)B  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL
M4$L! A0#%     @ G86B5M0F?T0L!P  5QT  !D              ("!)F8
M 'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " "=A:)6//4?
M'8@%  !%#0  &0              @(&);0  >&PO=V]R:W-H965T<R]S:&5E
M=#$V+GAM;%!+ 0(4 Q0    ( )V%HE82.7I4/0D  %@8   9
M  " @4AS  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @
MG86B5B-N.$/*!@  =A(  !D              ("!O'P  'AL+W=O<FMS:&5E
M=',O<VAE970Q."YX;6Q02P$"% ,4    " "=A:)6X6DIIY<-  #Q)   &0
M            @(&]@P  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4
M Q0    ( )V%HE;J;FV5%@0   H*   9              " @8N1  !X;"]W
M;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ G86B5K7:9N_3 @
M#08  !D              ("!V)4  'AL+W=O<FMS:&5E=',O<VAE970R,2YX
M;6Q02P$"% ,4    " "=A:)6"H*#RH0$  #Q"P  &0              @('B
MF   >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( )V%HE:A
MM^ NC@8  /$3   9              " @9V=  !X;"]W;W)K<VAE971S+W-H
M965T,C,N>&UL4$L! A0#%     @ G86B5C)]4"0, P  S@8  !D
M     ("!8J0  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )V%HE9KA_OKRP,  /$5   9              "
M@:.[  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ G86B
M5K]X^YU5 P  P@T  !D              ("!I;\  'AL+W=O<FMS:&5E=',O
M<VAE970S,"YX;6Q02P$"% ,4    " "=A:)6 RMZSL4#  "&$   &0
M        @($QPP  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0
M   ( )V%HE:?\F'P[P(  +X(   9              " @2W'  !X;"]W;W)K
M<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ G86B5O&E/*,D!   Z!@
M !D              ("!4\H  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q0
M2P$"% ,4    " "=A:)6\3H XN\$  "Q'P  &0              @(&NS@
M>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( )V%HE8EXMP]
M3 4  /X@   9              " @=33  !X;"]W;W)K<VAE971S+W-H965T
M,S4N>&UL4$L! A0#%     @ G86B5J7&DTZ$!   DQD  !D
M ("!5]D  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " "=
MA:)6T'".&18#  #K"0  &0              @($2W@  >&PO=V]R:W-H965T
M<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( )V%HE82MUYQU04  (@E   9
M          " @5_A  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#
M%     @ G86B5O)6N."]!   FAH  !D              ("!:^<  'AL+W=O
M<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " "=A:)6GX8G#]@$  #2
M'@  &0              @(%?[   >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM
M;%!+ 0(4 Q0    ( )V%HE8YS[RF>08  !@M   9              " @6[Q
M  !X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ G86B5@2X
MH'VE @  UP<  !D              ("!'O@  'AL+W=O<FMS:&5E=',O<VAE
M970T,BYX;6Q02P$"% ,4    " "=A:)60E;ET4L#   '"P  &0
M    @('Z^@  >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (
M )V%HE:#2H286@0  *(0   9              " @7S^  !X;"]W;W)K<VAE
M971S+W-H965T-#0N>&UL4$L! A0#%     @ H(6B5D(I8M?B"0  .$@  !D
M             ("!#0,! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"
M% ,4    " "@A:)648$BH6$'  #!,   &0              @($F#0$ >&PO
M=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( *"%HE9X87\HYP(
M )@)   9              " @;X4 0!X;"]W;W)K<VAE971S+W-H965T-#<N
M>&UL4$L! A0#%     @ H(6B5JRDQ&0-!   4!D  !D              ("!
MW!<! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " "@A:)6
MC>$NVAX$  !8$0  &0              @($@' $ >&PO=V]R:W-H965T<R]S
M:&5E=#0Y+GAM;%!+ 0(4 Q0    ( *"%HE9J-2*U\@,  'L0   9
M      " @74@ 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%
M  @ H(6B5EBQ*P<= P  E0P  !D              ("!GB0! 'AL+W=O<FMS
M:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    " "@A:)6]6E7:4T(  "+20
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M+G)E;'-02P$"% ,4    " "@A:)66!FW6(<$  "7(P  #P
M@ &^.P$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ H(6B5GQ^Z1O4 0
MQA\  !H              ( !<D ! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ H(6B5BIDTJ;* 0  FQ\  !,              ( !
M?D(! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #T /0"B$   >40!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>330</ContextCount>
  <ElementCount>239</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>64</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - RESTRUCTURING AND RELATED COSTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS</Role>
      <ShortName>RESTRUCTURING AND RELATED COSTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - INVENTORIES, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INVENTORIESNET</Role>
      <ShortName>INVENTORIES, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTS</Role>
      <ShortName>GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - OTHER LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/OTHERLIABILITIES</Role>
      <ShortName>OTHER LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS</Role>
      <ShortName>NET EARNINGS (LOSSES) PER SHARE (EPS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS</Role>
      <ShortName>COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - EMPLOYEE BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/EMPLOYEEBENEFITPLANS</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES</Role>
      <ShortName>OTHER CONTINGENCIES AND GUARANTEES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - SEGMENT RESULTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SEGMENTRESULTS</Role>
      <ShortName>SEGMENT RESULTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - RESTRUCTURING AND RELATED COSTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables</Role>
      <ShortName>RESTRUCTURING AND RELATED COSTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - INVENTORIES, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INVENTORIESNETTables</Role>
      <ShortName>INVENTORIES, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/INVENTORIESNET</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSTables</Role>
      <ShortName>GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTS</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables</Role>
      <ShortName>NET EARNINGS (LOSSES) PER SHARE (EPS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables</Role>
      <ShortName>COMPREHENSIVE INCOME (LOSS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/EMPLOYEEBENEFITPLANS</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - SEGMENT RESULTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SEGMENTRESULTSTables</Role>
      <ShortName>SEGMENT RESULTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/SEGMENTRESULTS</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - RESTRUCTURING AND RELATED COSTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails</Role>
      <ShortName>RESTRUCTURING AND RELATED COSTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails</Role>
      <ShortName>RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails</Role>
      <ShortName>RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - INVENTORIES, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INVENTORIESNETDetails</Role>
      <ShortName>INVENTORIES, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/INVENTORIESNETTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Schedule of Impairment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails</Role>
      <ShortName>GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Schedule of Impairment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails</Role>
      <ShortName>GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Schedule of Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails</Role>
      <ShortName>GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Schedule of Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - OTHER LIABILITIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails</Role>
      <ShortName>OTHER LIABILITIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/OTHERLIABILITIES</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - INCOME TAXES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/INCOMETAXES</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails</Role>
      <ShortName>NET EARNINGS (LOSSES) PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails</Role>
      <ShortName>COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails</Role>
      <ShortName>OTHER CONTINGENCIES AND GUARANTEES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - SEGMENT RESULTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails</Role>
      <ShortName>SEGMENT RESULTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/SEGMENTRESULTSTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - SEGMENT RESULTS (Reportable Segment Information ) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails</Role>
      <ShortName>SEGMENT RESULTS (Reportable Segment Information ) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/SEGMENTRESULTSTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="clx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - SEGMENT RESULTS (Net Sales Percentages) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails</Role>
      <ShortName>SEGMENT RESULTS (Net Sales Percentages) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/SEGMENTRESULTSTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="clx-20230331.htm">clx-20230331.htm</File>
    <File>clx-20230331.xsd</File>
    <File>clx-20230331_cal.xml</File>
    <File>clx-20230331_def.xml</File>
    <File>clx-20230331_lab.xml</File>
    <File>clx-20230331_pre.xml</File>
    <File>clxq3fy23ex101amendedannua.htm</File>
    <File>clxq3fy23ex311ceocertifica.htm</File>
    <File>clxq3fy23ex312cfocertifica.htm</File>
    <File>clxq3fy23ex32ceocfocertifi.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>clx-20230331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="916">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>71
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "clx-20230331.htm": {
   "axisCustom": 1,
   "axisStandard": 28,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 916,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 330,
   "dts": {
    "calculationLink": {
     "local": [
      "clx-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "clx-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "clx-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "clx-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clx-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "clx-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 425,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 21,
   "keyStandard": 218,
   "memberCustom": 28,
   "memberStandard": 35,
   "nsprefix": "clx",
   "nsuri": "http://www.clorox.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.clorox.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - OTHER LIABILITIES",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.clorox.com/role/OTHERLIABILITIES",
     "shortName": "OTHER LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.clorox.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS)",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS",
     "shortName": "NET EARNINGS (LOSSES) PER SHARE (EPS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - COMPREHENSIVE INCOME (LOSS)",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS",
     "shortName": "COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - STOCKHOLDERS' EQUITY",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - EMPLOYEE BENEFIT PLANS",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANS",
     "shortName": "EMPLOYEE BENEFIT PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES",
     "shortName": "OTHER CONTINGENCIES AND GUARANTEES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - SEGMENT RESULTS",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.clorox.com/role/SEGMENTRESULTS",
     "shortName": "SEGMENT RESULTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "19",
     "role": "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
     "shortName": "Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - RESTRUCTURING AND RELATED COSTS (Tables)",
     "menuCat": "Tables",
     "order": "20",
     "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables",
     "shortName": "RESTRUCTURING AND RELATED COSTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - INVENTORIES, NET (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://www.clorox.com/role/INVENTORIESNETTables",
     "shortName": "INVENTORIES, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSTables",
     "shortName": "GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables",
     "shortName": "NET EARNINGS (LOSSES) PER SHARE (EPS) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables",
     "shortName": "COMPREHENSIVE INCOME (LOSS) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables",
     "shortName": "EMPLOYEE BENEFIT PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - SEGMENT RESULTS (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.clorox.com/role/SEGMENTRESULTSTables",
     "shortName": "SEGMENT RESULTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostIncurredCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - RESTRUCTURING AND RELATED COSTS (Narrative) (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails",
     "shortName": "RESTRUCTURING AND RELATED COSTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i06d000a1aa834bbfac4282e34d583a60_I20230630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostExpectedCost1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i85cd7ba9934b45cfb7d15022292a50e0_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i85cd7ba9934b45cfb7d15022292a50e0_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostIncurredCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails",
     "shortName": "RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i3aa3d22372b64584acb9882537a6dd42_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostIncurredCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i058a79b88ddf43df8b916f862dfc5bf7_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails",
     "shortName": "RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i058a79b88ddf43df8b916f862dfc5bf7_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i85cd7ba9934b45cfb7d15022292a50e0_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - INVENTORIES, NET (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.clorox.com/role/INVENTORIESNETDetails",
     "shortName": "INVENTORIES, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i85cd7ba9934b45cfb7d15022292a50e0_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Schedule of Impairment) (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails",
     "shortName": "GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Schedule of Impairment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "id94ba9c2186c47749a192c36f50af6e2_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "clx:ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Narrative) (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails",
     "shortName": "GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "clx:ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i058a79b88ddf43df8b916f862dfc5bf7_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Schedule of Goodwill) (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails",
     "shortName": "GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Schedule of Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i85cd7ba9934b45cfb7d15022292a50e0_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Intangible Assets) (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails",
     "shortName": "GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS (Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i85cd7ba9934b45cfb7d15022292a50e0_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clx:VentureAgreementOptiontoExtendAgreementTermPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - OTHER LIABILITIES (Narrative) (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails",
     "shortName": "OTHER LIABILITIES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clx:VentureAgreementOptiontoExtendAgreementTermPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i85cd7ba9934b45cfb7d15022292a50e0_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i85cd7ba9934b45cfb7d15022292a50e0_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i6a68f814db4a4c5c95ed1bd0205e0034_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i6a68f814db4a4c5c95ed1bd0205e0034_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i85cd7ba9934b45cfb7d15022292a50e0_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i6a68f814db4a4c5c95ed1bd0205e0034_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - INCOME TAXES (Narrative) (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.clorox.com/role/INCOMETAXESNarrativeDetails",
     "shortName": "INCOME TAXES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails",
     "shortName": "NET EARNINGS (LOSSES) PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
     "shortName": "COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails",
     "shortName": "STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i39f73c20959b4e5ea5dbe242aa2d3610_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses)) (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails",
     "shortName": "STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "ibf167b776ade4df7b590155e62a3f0fa_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
       "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "ie1af7dfaca4b4bb4939e8512479b3d34_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
     "shortName": "STOCKHOLDERS' EQUITY (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
       "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "ie1af7dfaca4b4bb4939e8512479b3d34_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
     "shortName": "EMPLOYEE BENEFIT PLANS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i1b73d8a1cfaf475cb132b48a9922e0b3_D20220517-20220517",
      "decimals": null,
      "lang": "en-US",
      "name": "clx:DefinedBenefitPlanPlanTerminationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income) (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
     "shortName": "EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i85cd7ba9934b45cfb7d15022292a50e0_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccrualForEnvironmentalLossContingencies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails",
     "shortName": "OTHER CONTINGENCIES AND GUARANTEES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i85cd7ba9934b45cfb7d15022292a50e0_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccrualForEnvironmentalLossContingencies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportablesegment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - SEGMENT RESULTS (Narrative) (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
     "shortName": "SEGMENT RESULTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportablesegment",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i2495ac276b6d484d997eac4fc542962a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - SEGMENT RESULTS (Reportable Segment Information ) (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails",
     "shortName": "SEGMENT RESULTS (Reportable Segment Information ) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i4e525b30dbd84ad096b5a005cb6c06b7_D20230101-20230331",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i788105bef8f040c3abaaec1851973630_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - SEGMENT RESULTS (Net Sales Percentages) (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
     "shortName": "SEGMENT RESULTS (Net Sales Percentages) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i788105bef8f040c3abaaec1851973630_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "6",
     "role": "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - RESTRUCTURING AND RELATED COSTS",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS",
     "shortName": "RESTRUCTURING AND RELATED COSTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - INVENTORIES, NET",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.clorox.com/role/INVENTORIESNET",
     "shortName": "INVENTORIES, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTS",
     "shortName": "GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20230331.htm",
      "contextRef": "i27b760ce520c4f69a8133ccc5dd39359_D20220701-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 64,
   "tag": {
    "clx_AlamedaCountyCaliforniaMatterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alameda County, California Matter [Member]",
        "label": "Alameda County, California Matter [Member]",
        "terseLabel": "Alameda County, California Matter"
       }
      }
     },
     "localname": "AlamedaCountyCaliforniaMatterMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_BagsWrapsAndContainersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bags, Wraps, And Containers [Member]",
        "label": "Bags, Wraps, And Containers [Member]",
        "terseLabel": "Bags and Wraps"
       }
      }
     },
     "localname": "BagsWrapsAndContainersMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_CatLitterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cat Litter [Member]",
        "label": "Cat Litter [Member]",
        "terseLabel": "Cat Litter"
       }
      }
     },
     "localname": "CatLitterMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_CleaningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cleaning [Member]",
        "label": "Cleaning [Member]",
        "terseLabel": "Cleaning"
       }
      }
     },
     "localname": "CleaningMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_CommodityPurchaseDerivativeContractsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commodity Purchase Derivative Contracts [Axis]",
        "label": "Commodity Purchase Derivative Contracts [Axis]",
        "terseLabel": "Commodity Purchase Derivative Contracts [Axis]"
       }
      }
     },
     "localname": "CommodityPurchaseDerivativeContractsAxis",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "clx_CommodityPurchaseDerivativeContractsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commodity Purchase Derivative Contracts [Domain]",
        "label": "Commodity Purchase Derivative Contracts [Domain]",
        "terseLabel": "Commodity Purchase Derivative Contracts [Domain]"
       }
      }
     },
     "localname": "CommodityPurchaseDerivativeContractsDomain",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_CostOfGoodsAndServicesSoldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of Goods and Services Sold",
        "label": "Cost of Goods and Services Sold [Member]",
        "terseLabel": "Costs of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_DefinedBenefitPlanPlanTerminationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Termination Period",
        "label": "Defined Benefit Plan, Plan Termination Period",
        "terseLabel": "Plan termination period"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanTerminationPeriod",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instruments subject to contractually defined counterparty liability position limits.",
        "label": "Derivative Instruments Subject To Contractually Defined Counterparty Liability Position Limits, Amount",
        "terseLabel": "Amount of derivative instruments subject to contractually defined counterparty liability position limits"
       }
      }
     },
     "localname": "DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_DickinsonCountyMichiganMatterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dickinson County, Michigan Matter [Member]",
        "label": "Dickinson County, Michigan Matter [Member]",
        "terseLabel": "Dickinson County, Michigan Matter"
       }
      }
     },
     "localname": "DickinsonCountyMichiganMatterMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments and fair value measurements.",
        "label": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "clx_FinancialInstrumentsAndFairValueMeasurementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial Instruments and Fair Value Measurements [Abstract]",
        "label": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]",
        "terseLabel": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]"
       }
      }
     },
     "localname": "FinancialInstrumentsAndFairValueMeasurementsAbstract",
     "nsuri": "http://www.clorox.com/20230331",
     "xbrltype": "stringItemType"
    },
    "clx_FoodProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Food Products [Member]",
        "label": "Food Products [Member]",
        "terseLabel": "Food"
       }
      }
     },
     "localname": "FoodProductsMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_GladBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Glad Business [Member]",
        "label": "Glad Business [Member]",
        "terseLabel": "Glad Business"
       }
      }
     },
     "localname": "GladBusinessMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_GrillingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grilling [Member]",
        "label": "Grilling [Member]",
        "terseLabel": "Grilling"
       }
      }
     },
     "localname": "GrillingMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_HealthAndWellnessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health and Wellness",
        "label": "Health and Wellness [Member]",
        "terseLabel": "Health and Wellness"
       }
      }
     },
     "localname": "HealthAndWellnessMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_HouseholdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Household [Member]",
        "label": "Household [Member]",
        "terseLabel": "Household"
       }
      }
     },
     "localname": "HouseholdMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment of Intangible Assets (Excluding Goodwill), Income Tax Expense (Benefit)",
        "label": "Impairment of Intangible Assets (Excluding Goodwill), Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Impairment, tax benefit"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-lived Intangible Assets (Excluding Goodwill), Before Impairment",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill), Before Impairment",
        "terseLabel": "Not subject to amortization, before impairment"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_IndefiniteLivedIntangibleAssetsRemainingCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-Lived Intangible Assets, Remaining Carrying Value",
        "label": "Indefinite-Lived Intangible Assets, Remaining Carrying Value",
        "verboseLabel": "Remaining net carrying value"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsRemainingCarryingValue",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_InternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International [Member]",
        "label": "International [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_InternationalReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Reporting Unit",
        "label": "International Reporting Unit [Member]",
        "terseLabel": "International reporting unit"
       }
      }
     },
     "localname": "InternationalReportingUnitMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_InventoryCurrentAndNoncurrentNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.clorox.com/role/INVENTORIESNETDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Current And Noncurrent, Net",
        "label": "Inventory, Current And Noncurrent, Net",
        "totalLabel": "Total inventories, net"
       }
      }
     },
     "localname": "InventoryCurrentAndNoncurrentNet",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock options. Also includes the net cash inflow (outflow) from other financing activities.",
        "label": "Issuance Of Common Stock For Employee Stock Plans And Other",
        "terseLabel": "Issuance of common stock for employee stock plans and other"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForEmployeeStockPlansAndOther",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_LetterOfCreditBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding.",
        "label": "Letter of credit",
        "terseLabel": "Letter of credit"
       }
      }
     },
     "localname": "LetterOfCreditBorrowingCapacity",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_LifestyleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lifestyle [Member]",
        "label": "Lifestyle [Member]",
        "terseLabel": "Lifestyle"
       }
      }
     },
     "localname": "LifestyleMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_LongTermInterCompanyLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term inter-company loans included in foreign currency adjustments.",
        "label": "Long-Term Inter-Company Loans [Member]",
        "terseLabel": "Long-Term Inter-Company Loans"
       }
      }
     },
     "localname": "LongTermInterCompanyLoansMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_MaximumExposureUndiscountedCost": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) that the Company could incur over an estimated remediation period.",
        "label": "Maximum Exposure, Undiscounted Cost",
        "terseLabel": "Maximum undiscounted costs"
       }
      }
     },
     "localname": "MaximumExposureUndiscountedCost",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_NaturalPersonalCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Natural Personal Care [Member]",
        "label": "Natural Personal Care [Member]",
        "terseLabel": "Natural Personal Care"
       }
      }
     },
     "localname": "NaturalPersonalCareMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_NotesAndLoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes and Loans Payable [Member]",
        "label": "Notes And Loans Payable [Member]",
        "terseLabel": "Notes and loans payable"
       }
      }
     },
     "localname": "NotesAndLoansPayableMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_OperatingLeaseRightofUseAssetAndLiabilityNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-of-Use Asset And Liability, Net",
        "label": "Operating Lease, Right-of-Use Asset And Liability, Net",
        "terseLabel": "Operating lease right-of-use assets and liabilities, net"
       }
      }
     },
     "localname": "OperatingLeaseRightofUseAssetAndLiabilityNet",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_OtherEmployeeStockPlanActivitiesAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount includes the value of stock granted during the period as a result of exercises of employee stock options or vesting of other share-based awards.",
        "label": "Other Employee Stock Plan Activities, Amount",
        "terseLabel": "Other employee stock plan activities"
       }
      }
     },
     "localname": "OtherEmployeeStockPlanActivitiesAmount",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_OtherEmployeeStockPlanActivitiesShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of exercises of employee stock options or the vesting of other share-based awards.",
        "label": "Other Employee Stock Plan Activities, Shares",
        "terseLabel": "Other employee stock plan activities (in shares)"
       }
      }
     },
     "localname": "OtherEmployeeStockPlanActivitiesShares",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clx_OtherExpenseIncomeNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.",
        "label": "Other Expense (Income), Net",
        "terseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherExpenseIncomeNet",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_OtherIncomeExpenseNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Income (Expense), Net",
        "label": "Other Income (Expense), Net [Member]",
        "terseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherIncomeExpenseNetMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_PercentageofOwnershipbyVenturePartner": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership interest by the venture partner.",
        "label": "Percentage of Ownership by Venture Partner",
        "terseLabel": "Percent ownership by venture partner"
       }
      }
     },
     "localname": "PercentageofOwnershipbyVenturePartner",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clx_ProfessionalProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Professional Products [Member]",
        "label": "Professional Products [Member]",
        "terseLabel": "Professional Products"
       }
      }
     },
     "localname": "ProfessionalProductsMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_PurchasesofInventoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases of Inventory [Member]",
        "label": "Purchases of Inventory [Member]",
        "terseLabel": "Purchases of Inventory"
       }
      }
     },
     "localname": "PurchasesofInventoryMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_RemediationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site.",
        "label": "Remediation period",
        "terseLabel": "Remediation period (in years)"
       }
      }
     },
     "localname": "RemediationPeriod",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "clx_RestructuringAndRelatedCostsBenchmarkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Costs Benchmark",
        "label": "Restructuring and Related Costs Benchmark [Member]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostsBenchmarkMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_RetirementIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirement Income [Member]",
        "label": "Retirement Income Plans [Member]",
        "terseLabel": "Retirement Income Plans"
       }
      }
     },
     "localname": "RetirementIncomeMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_SiteContingencyAgreedPercentageOfCostSharing": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site.",
        "label": "Percentage of liability for aggregate remediation and associated costs, other than legal fees",
        "terseLabel": "Percentage of liability for aggregate remediation and associated costs, other than legal fees"
       }
      }
     },
     "localname": "SiteContingencyAgreedPercentageOfCostSharing",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clx_TotalCommodityPurchaseDerivativeContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Commodity Purchase Derivative Contracts [Member]",
        "label": "Total Commodity Purchase Derivative Contracts [Member]",
        "terseLabel": "Total Commodity Purchase Derivative Contracts"
       }
      }
     },
     "localname": "TotalCommodityPurchaseDerivativeContractsMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_TrademarksNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit.",
        "label": "Trademarks, net",
        "terseLabel": "Trademarks, net"
       }
      }
     },
     "localname": "TrademarksNet",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trust Assets For Nonqualified Deferred Compensation Plans [Member]",
        "label": "Trust Assets for nonqualified deferred compensation plans [Member]",
        "terseLabel": "Trust assets for nonqualified deferred compensation plans"
       }
      }
     },
     "localname": "TrustAssetsForNonqualifiedDeferredCompensationPlansMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_VentureAgreement.TerminalObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Venture Agreement. Terminal Obligation",
        "label": "Venture Agreement. Terminal Obligation",
        "terseLabel": "Venture agreement, terminal obligation"
       }
      }
     },
     "localname": "VentureAgreement.TerminalObligation",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_VentureAgreementOptiontoExtendAgreementTermPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Venture Agreement, Option to Extend Agreement Term Period",
        "label": "Venture Agreement, Option to Extend Agreement Term Period",
        "terseLabel": "Option to extend agreement (in years)"
       }
      }
     },
     "localname": "VentureAgreementOptiontoExtendAgreementTermPeriod",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "clx_VentureAgreementTerminalObligationNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Venture Agreement, Terminal Obligation, Net",
        "label": "Venture Agreement, Terminal Obligation, Net",
        "terseLabel": "Venture agreement terminal obligation, net"
       }
      }
     },
     "localname": "VentureAgreementTerminalObligationNet",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_VitaminsMineralsAndSupplementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vitamins, Minerals and Supplements",
        "label": "Vitamins, Minerals and Supplements [Member]",
        "terseLabel": "Vitamins, Minerals and Supplements"
       }
      }
     },
     "localname": "VitaminsMineralsAndSupplementsMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_VitaminsMineralsAndSupplementsReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vitamins, Minerals And Supplements Reporting Unit",
        "label": "Vitamins, Minerals And Supplements Reporting Unit [Member]",
        "terseLabel": "VMS reporting unit"
       }
      }
     },
     "localname": "VitaminsMineralsAndSupplementsReportingUnitMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_WalmartStoresIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Walmart Stores, Inc. and its affiliates [Member]",
        "label": "Walmart Stores, Inc. [Member]",
        "terseLabel": "Walmart Stores, Inc."
       }
      }
     },
     "localname": "WalmartStoresIncMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_WaterFiltrationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Water Filtration [Member]",
        "label": "Water Filtration [Member]",
        "terseLabel": "Water Filtration"
       }
      }
     },
     "localname": "WaterFiltrationMember",
     "nsuri": "http://www.clorox.com/20230331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r240",
      "r276",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r304",
      "r356",
      "r357",
      "r358",
      "r359",
      "r361",
      "r362",
      "r364",
      "r366",
      "r367",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r240",
      "r276",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r304",
      "r356",
      "r357",
      "r358",
      "r359",
      "r361",
      "r362",
      "r364",
      "r366",
      "r367",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r238",
      "r239",
      "r369",
      "r375",
      "r592",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r309",
      "r608",
      "r683",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r351",
      "r352",
      "r354",
      "r355",
      "r468",
      "r542",
      "r561",
      "r586",
      "r587",
      "r607",
      "r619",
      "r626",
      "r682",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r351",
      "r352",
      "r354",
      "r355",
      "r468",
      "r542",
      "r561",
      "r586",
      "r587",
      "r607",
      "r619",
      "r626",
      "r682",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r309",
      "r608",
      "r683",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r351",
      "r352",
      "r354",
      "r355",
      "r416",
      "r468",
      "r474",
      "r475",
      "r476",
      "r541",
      "r542",
      "r561",
      "r586",
      "r587",
      "r607",
      "r619",
      "r626",
      "r673",
      "r682",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r351",
      "r352",
      "r354",
      "r355",
      "r416",
      "r468",
      "r474",
      "r475",
      "r476",
      "r541",
      "r542",
      "r561",
      "r586",
      "r587",
      "r607",
      "r619",
      "r626",
      "r673",
      "r682",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r238",
      "r239",
      "r369",
      "r375",
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r469",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r254",
      "r469",
      "r636",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r254",
      "r469",
      "r636",
      "r637",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForEnvironmentalLossContingencies": {
     "auth_ref": [
      "r353",
      "r600",
      "r634",
      "r635",
      "r674",
      "r676"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.",
        "label": "Accrual for Environmental Loss Contingencies",
        "terseLabel": "Liability for aggregate future remediation costs"
       }
      }
     },
     "localname": "AccrualForEnvironmentalLossContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r2",
      "r170",
      "r181"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r29",
      "r35",
      "r135",
      "r642",
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Pension and postretirement benefit adjustments"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r85",
      "r200"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment, accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r216",
      "r224",
      "r225",
      "r507",
      "r595",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Net unrealized gains (losses) on derivatives"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r32",
      "r34",
      "r35",
      "r209",
      "r554",
      "r566",
      "r567"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive net (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r223",
      "r224",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r31",
      "r35",
      "r135",
      "r537",
      "r562",
      "r563",
      "r642",
      "r643",
      "r644",
      "r653",
      "r654",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Net (Loss) Income",
        "verboseLabel": "Accumulated other comprehensive net (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r28",
      "r35",
      "r135",
      "r224",
      "r225",
      "r528",
      "r529",
      "r530",
      "r531",
      "r533",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r6"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r477",
      "r478",
      "r479",
      "r653",
      "r654",
      "r655",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r123",
      "r124",
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings (losses) to net cash provided by operations:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r480"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r50",
      "r70",
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive stock options and other (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r50",
      "r84"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Goodwill, trademark and other asset impairments",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r168",
      "r180",
      "r204",
      "r235",
      "r284",
      "r296",
      "r302",
      "r311",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r363",
      "r365",
      "r367",
      "r368",
      "r503",
      "r508",
      "r525",
      "r625",
      "r680",
      "r681",
      "r720"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r197",
      "r211",
      "r235",
      "r311",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r363",
      "r365",
      "r367",
      "r368",
      "r503",
      "r508",
      "r525",
      "r625",
      "r680",
      "r681",
      "r720"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets, estimated fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BankTimeDepositsMember": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest.",
        "label": "Bank Time Deposits [Member]",
        "terseLabel": "Time deposits"
       }
      }
     },
     "localname": "BankTimeDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r159",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Amount"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r52",
      "r199",
      "r588"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents, estimated fair value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r47",
      "r52",
      "r53"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "End of period",
        "periodStartLabel": "Beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Cash, cash equivalents, and restricted cash:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r47",
      "r164"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r155"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "terseLabel": "Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class of Warrant or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r112",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaper": {
     "auth_ref": [
      "r1",
      "r169",
      "r182"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.",
        "label": "Commercial Paper",
        "terseLabel": "Notes and loans payable"
       }
      }
     },
     "localname": "CommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r22",
      "r174",
      "r188"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r95",
      "r348",
      "r349",
      "r585",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "OTHER CONTINGENCIES AND GUARANTEES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommodityContractMember": {
     "auth_ref": [
      "r609",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.",
        "label": "Commodity Contract [Member]",
        "terseLabel": "Commodity purchase derivative contracts",
        "verboseLabel": "Commodity purchase options contracts"
       }
      }
     },
     "localname": "CommodityContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r653",
      "r654",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r5",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance, common stock (in shares)",
        "periodStartLabel": "Beginning balance, common stock (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r5",
      "r625"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of March\u00a031, 2023 and June\u00a030, 2022; and 123,611,466 and 123,152,132 shares outstanding as of March\u00a031, 2023 and June\u00a030, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r36",
      "r220",
      "r222",
      "r230",
      "r550",
      "r558"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income (loss) attributable to Clorox"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r132",
      "r133",
      "r138",
      "r220",
      "r222",
      "r229",
      "r549",
      "r557"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Total comprehensive income attributable to noncontrolling interests",
        "verboseLabel": "Less: Total comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r131",
      "r138",
      "r220",
      "r222",
      "r228",
      "r548",
      "r556"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Comprehensive income (loss)",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r43",
      "r227",
      "r547",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r59",
      "r60",
      "r161",
      "r162",
      "r309",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r59",
      "r60",
      "r161",
      "r162",
      "r309",
      "r568",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r59",
      "r60",
      "r161",
      "r162",
      "r309",
      "r584",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r59",
      "r60",
      "r161",
      "r162",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r56",
      "r59",
      "r60",
      "r61",
      "r161",
      "r163",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r59",
      "r60",
      "r161",
      "r162",
      "r309",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r65",
      "r295",
      "r296",
      "r297",
      "r298",
      "r304",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r41",
      "r543"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r90",
      "r91",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Restructuring Liabilities"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r57",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r371",
      "r524",
      "r605",
      "r606"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Current maturities of long-term debt and Long-term debt, estimated fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.",
        "label": "Deferred Compensation Plan Assets",
        "terseLabel": "Trust assets for nonqualified deferred compensation plans"
       }
      }
     },
     "localname": "DeferredCompensationPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r50",
      "r126",
      "r488",
      "r493",
      "r494",
      "r652"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "verboseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r481",
      "r482"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r393",
      "r432",
      "r457",
      "r611",
      "r612"
     ],
     "calculation": {
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Amortization of unrecognized items"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r440",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "terseLabel": "Weighted average long-term expected rate or return on plan assets (percentage)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r409",
      "r419",
      "r461",
      "r609",
      "r610",
      "r611",
      "r612"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Discretionary contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r393",
      "r431",
      "r456",
      "r611",
      "r612"
     ],
     "calculation": {
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r393",
      "r398",
      "r430",
      "r455",
      "r611",
      "r612"
     ],
     "calculation": {
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r428",
      "r453",
      "r611",
      "r612"
     ],
     "calculation": {
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Total",
        "verboseLabel": "Net periodic benefit cost (benefit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r394",
      "r435",
      "r460"
     ],
     "calculation": {
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedTerseLabel": "Settlement loss recognized"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r50",
      "r279"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r212",
      "r213",
      "r524",
      "r594"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r144",
      "r146",
      "r149",
      "r150",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r142",
      "r144",
      "r149",
      "r150",
      "r153",
      "r154",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r212",
      "r213",
      "r524",
      "r594"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r714",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r147",
      "r149",
      "r151",
      "r152",
      "r154",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r109",
      "r179"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "negatedTerseLabel": "Dividends to Clorox stockholders"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r685",
      "r686",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net earnings (losses) per share attributable to Clorox"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r231",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r255",
      "r257",
      "r262",
      "r263",
      "r264",
      "r268",
      "r518",
      "r519",
      "r551",
      "r559",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net earnings (losses) per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r231",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r257",
      "r262",
      "r263",
      "r264",
      "r268",
      "r518",
      "r519",
      "r551",
      "r559",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net earnings (losses) per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET EARNINGS (LOSSES) PER SHARE (EPS)"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r526"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate on earnings from continuing operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee-Related Costs"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r102",
      "r193",
      "r223",
      "r224",
      "r225",
      "r241",
      "r242",
      "r243",
      "r245",
      "r251",
      "r253",
      "r270",
      "r312",
      "r389",
      "r477",
      "r478",
      "r479",
      "r489",
      "r490",
      "r517",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r533",
      "r537",
      "r562",
      "r563",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r371",
      "r524",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r157",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Assets and Liabilities for Fair Value Disclosure"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r371",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r521",
      "r538",
      "r539",
      "r540",
      "r605",
      "r606",
      "r609",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r157",
      "r158",
      "r371",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r371",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r371",
      "r419",
      "r424",
      "r521",
      "r538",
      "r609",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r371",
      "r419",
      "r424",
      "r521",
      "r539",
      "r605",
      "r606",
      "r609",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r371",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r538",
      "r539",
      "r540",
      "r605",
      "r606",
      "r609",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "totalLabel": "Total liabilities, estimated fair value"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Useful life (in years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r202",
      "r330"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Subject to amortization, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Amortization, year one"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Amortization, remainder of fiscal year"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Amortization, year four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Amortization, year three"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Amortization, year two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r327",
      "r329",
      "r330",
      "r332",
      "r544",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r76",
      "r545"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Subject to amortization, gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r71",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r76",
      "r544"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Subject to amortization, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r594",
      "r609",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign exchange derivative contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign exchange forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r201",
      "r314",
      "r546",
      "r599",
      "r625",
      "r661",
      "r668"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL, TRADEMARK AND OTHER ASSET IMPAIRMENTS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r68",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment Review of Goodwill and Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r50",
      "r315",
      "r320",
      "r326",
      "r599"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Goodwill impairment",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill impairment charge"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r127",
      "r669"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "verboseLabel": "Translation adjustments and other"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r40",
      "r235",
      "r284",
      "r295",
      "r301",
      "r304",
      "r311",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r363",
      "r365",
      "r367",
      "r368",
      "r525",
      "r598",
      "r680"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r50",
      "r80"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Trademarks, net",
        "verboseLabel": "Impairment of intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r649",
      "r672"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "terseLabel": "Intangible asset impairment"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r38",
      "r167",
      "r175",
      "r190",
      "r284",
      "r295",
      "r301",
      "r304",
      "r552",
      "r598"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings (losses) before income taxes",
        "totalLabel": "Earnings (losses) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r333",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r236",
      "r485",
      "r486",
      "r487",
      "r491",
      "r495",
      "r499",
      "r500",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r237",
      "r252",
      "r253",
      "r282",
      "r483",
      "r492",
      "r497",
      "r560"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable": {
     "auth_ref": [
      "r648"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.",
        "label": "Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable",
        "verboseLabel": "Income taxes payable / prepaid"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r264",
      "r473"
     ],
     "calculation": {
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of stock options and other (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r328",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Not subject to amortization"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r72",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r201"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, gross"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r69",
      "r74"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "totalLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of the entity to which the long-term intercompany foreign balances of the entity relate.",
        "label": "Intercompany Foreign Currency Balance by Description [Axis]",
        "terseLabel": "Intercompany Foreign Currency Balance by Description [Axis]"
       }
      }
     },
     "localname": "IntercompanyForeignCurrencyBalanceByDescriptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntercompanyForeignCurrencyBalanceNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name or description of the foreign entity or investment that is of a long-term nature.",
        "label": "Intercompany Foreign Currency Balance, Name [Domain]",
        "terseLabel": "Intercompany Foreign Currency Balance, Name [Domain]"
       }
      }
     },
     "localname": "IntercompanyForeignCurrencyBalanceNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r166",
      "r177",
      "r226",
      "r278",
      "r534"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r594",
      "r609",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "verboseLabel": "Interest rate derivative contracts"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "INVENTORIES, NET"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r67",
      "r590"
     ],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails_1": {
       "order": 1.0,
       "parentTag": "clx_InventoryCurrentAndNoncurrentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLIFOReserve": {
     "auth_ref": [
      "r639"
     ],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails_1": {
       "order": 4.0,
       "parentTag": "clx_InventoryCurrentAndNoncurrentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.",
        "label": "Inventory, LIFO Reserve",
        "negatedLabel": "LIFO allowances"
       }
      }
     },
     "localname": "InventoryLIFOReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r210",
      "r589",
      "r625"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.clorox.com/role/INVENTORIESNETDetails": {
       "order": 2.0,
       "parentTag": "clx_InventoryCurrentAndNoncurrentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "verboseLabel": "Total current inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNoncurrent": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails": {
       "order": 1.0,
       "parentTag": "clx_InventoryCurrentAndNoncurrentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.",
        "label": "Inventory, Noncurrent",
        "terseLabel": "Less: Noncurrent inventories, net"
       }
      }
     },
     "localname": "InventoryNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r67",
      "r640"
     ],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails_1": {
       "order": 2.0,
       "parentTag": "clx_InventoryCurrentAndNoncurrentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw materials and packaging"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r67",
      "r591"
     ],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails_1": {
       "order": 3.0,
       "parentTag": "clx_InventoryCurrentAndNoncurrentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r520"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Trust assets for nonqualified deferred compensation plans, estimated fair value"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letter of credit, amount outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r17",
      "r235",
      "r311",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r363",
      "r365",
      "r367",
      "r368",
      "r504",
      "r508",
      "r509",
      "r525",
      "r597",
      "r680",
      "r720",
      "r721"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r10",
      "r173",
      "r185",
      "r625",
      "r651",
      "r660",
      "r717"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r19",
      "r198",
      "r235",
      "r311",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r363",
      "r365",
      "r367",
      "r368",
      "r504",
      "r508",
      "r509",
      "r525",
      "r625",
      "r680",
      "r720",
      "r721"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r3",
      "r171",
      "r182",
      "r370",
      "r372",
      "r605",
      "r606"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Current maturities of long-term debt and Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-Term Debt [Member]",
        "terseLabel": "Current maturities of long-term debt and Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r205"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r20",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r96",
      "r97",
      "r350",
      "r351",
      "r352",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r96",
      "r97",
      "r350",
      "r351",
      "r352",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r96",
      "r97",
      "r350",
      "r351",
      "r352",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarginDepositAssets": {
     "auth_ref": [
      "r638"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash or securities placed with a broker or counterparty as security for a trading or derivatives securities position which was partially obtained with funds provided by the broker dealer.",
        "label": "Margin Deposit Assets",
        "terseLabel": "Cash margin balances amount"
       }
      }
     },
     "localname": "MarginDepositAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.",
        "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge",
        "terseLabel": "Maximum duration, foreign exchange contracts (in years)"
       }
      }
     },
     "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Length of Time Hedged in Cash Flow Hedge",
        "terseLabel": "Maximum duration, commodity contracts (in years)"
       }
      }
     },
     "localname": "MaximumLengthOfTimeHedgedInCashFlowHedge1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum period the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Length of Time Hedged in Interest Rate Cash Flow Hedge",
        "terseLabel": "Maximum duration, interest rate contracts (in years)"
       }
      }
     },
     "localname": "MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r25",
      "r172",
      "r184",
      "r235",
      "r311",
      "r356",
      "r359",
      "r360",
      "r361",
      "r367",
      "r368",
      "r525"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Dividends to noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Interest-bearing investments, including money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used for financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used for investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r47",
      "r48",
      "r51"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r39",
      "r51",
      "r176",
      "r189",
      "r196",
      "r218",
      "r221",
      "r225",
      "r235",
      "r244",
      "r246",
      "r247",
      "r248",
      "r249",
      "r252",
      "r253",
      "r261",
      "r284",
      "r295",
      "r301",
      "r304",
      "r311",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r363",
      "r365",
      "r367",
      "r368",
      "r519",
      "r525",
      "r598",
      "r680"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings (losses) attributable to Clorox"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r134",
      "r137",
      "r218",
      "r221",
      "r252",
      "r253",
      "r644"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Net earnings attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r129",
      "r389",
      "r653",
      "r654",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r536"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r536"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r203"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r35",
      "r224",
      "r527",
      "r529",
      "r533",
      "r642"
     ],
     "calculation": {
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other comprehensive (loss) income before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r214",
      "r215"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net unrealized gains (losses) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r214",
      "r215",
      "r510",
      "r511",
      "r514"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gains (losses) recognized in Other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r215",
      "r217",
      "r512"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r37",
      "r102",
      "r219",
      "r222",
      "r227",
      "r527",
      "r532",
      "r533",
      "r547",
      "r555",
      "r642",
      "r643"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive (loss) income",
        "totalLabel": "Total other comprehensive (loss) income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r30",
      "r32"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Pension and postretirement benefit adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r33",
      "r223",
      "r227",
      "r483",
      "r496",
      "r498",
      "r527",
      "r530",
      "r533",
      "r547",
      "r555"
     ],
     "calculation": {
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.",
        "label": "Other Intangible Assets, Net",
        "terseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "OtherIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "OTHER LIABILITIES"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERLIABILITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r115",
      "r392",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r440",
      "r441",
      "r443",
      "r446",
      "r449",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r465",
      "r466",
      "r467",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefits Plan"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r601",
      "r602",
      "r603",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r645",
      "r646"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Treasury stock purchased"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r337",
      "r647"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Cash dividends paid to Clorox stockholders"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedTerseLabel": "Cash dividends paid to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r416",
      "r418",
      "r424",
      "r442",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r463",
      "r464",
      "r465",
      "r471",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "EMPLOYEE BENEFIT PLANS"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r4",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r4",
      "r625"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r641"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-Term Debt",
        "terseLabel": "Notes and loans payable, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r196",
      "r218",
      "r221",
      "r232",
      "r235",
      "r244",
      "r252",
      "r253",
      "r284",
      "r295",
      "r301",
      "r304",
      "r311",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r363",
      "r365",
      "r367",
      "r368",
      "r502",
      "r505",
      "r506",
      "r519",
      "r525",
      "r552",
      "r598",
      "r620",
      "r621",
      "r644",
      "r680"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net earnings (losses)",
        "verboseLabel": "Net earnings (losses)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r86",
      "r187",
      "r553",
      "r625"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net of accumulated depreciation and amortization of $2,672 and $2,530, respectively"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r186",
      "r191",
      "r625"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r35",
      "r224",
      "r527",
      "r531",
      "r533",
      "r642"
     ],
     "calculation": {
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "negatedLabel": "Amounts reclassified from Accumulated other comprehensive net (loss) income",
        "terseLabel": "Amounts reclassified from accumulated other comprehensive net (loss) income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Long-term debt repayments"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r325",
      "r326",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [
      "r325",
      "r326",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r125",
      "r192",
      "r728"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r335",
      "r337",
      "r340",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "RESTRUCTURING AND RELATED COSTS"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r336",
      "r339",
      "r343",
      "r345"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Restructuring and related implementation, expected cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r336",
      "r339",
      "r343",
      "r345"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "terseLabel": "Total restructuring and related implementation costs",
        "verboseLabel": "Total, net"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r50",
      "r341",
      "r343",
      "r675"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r336",
      "r337",
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r337",
      "r342"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending accrual balance",
        "periodStartLabel": "Beginning accrual balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r7",
      "r109",
      "r183",
      "r565",
      "r567",
      "r625"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r193",
      "r241",
      "r242",
      "r243",
      "r245",
      "r251",
      "r253",
      "r312",
      "r477",
      "r478",
      "r479",
      "r489",
      "r490",
      "r517",
      "r562",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443",
      "r446",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r685",
      "r686",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443",
      "r446",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r685",
      "r686",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r114",
      "r115",
      "r392",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r440",
      "r441",
      "r443",
      "r446",
      "r449",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r465",
      "r466",
      "r467",
      "r470",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r114",
      "r115",
      "r392",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r440",
      "r441",
      "r443",
      "r446",
      "r449",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r465",
      "r466",
      "r467",
      "r470",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r275",
      "r276",
      "r294",
      "r299",
      "r300",
      "r306",
      "r307",
      "r309",
      "r390",
      "r391",
      "r543"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r309",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue from Contract with Customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r35",
      "r718",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Effects of Derivative Instruments Designated as Hedging Instruments on OCI"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r120",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings"
       }
      }
     },
     "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r71",
      "r75",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r71",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r599",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of impaired intangible assets excluding goodwill. This may include a description of the facts and circumstances leading to the recording of impairment charges of intangible assets in the period, the amount of the impairment charges, the methods of determining fair value of the associated assets, the caption in the income statement in which the impairment losses are aggregated, and the segment in which the impaired intangible assets are reported.",
        "label": "Schedule of Impaired Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Impaired Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfImpairedIntangibleAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r79",
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r0",
      "r11",
      "r12",
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories, Net"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Components of Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r336",
      "r337",
      "r338",
      "r339",
      "r343",
      "r344",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r88",
      "r89",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r87",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r62",
      "r63",
      "r64",
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r62",
      "r63",
      "r64",
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Selected Financial Information Relating to the Company's Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r103",
      "r104",
      "r105",
      "r106",
      "r107",
      "r108",
      "r109",
      "r206",
      "r207",
      "r208",
      "r271",
      "r373",
      "r374",
      "r375",
      "r377",
      "r381",
      "r386",
      "r388",
      "r607",
      "r633",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of Stockholders Equity"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r272",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r309",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r339",
      "r345",
      "r599",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r284",
      "r287",
      "r298",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT RESULTS"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Results"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShorttermDebtFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.",
        "label": "Short-Term Debt, Fair Value",
        "terseLabel": "Notes and loans payable, estimated fair value"
       }
      }
     },
     "localname": "ShorttermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r195",
      "r272",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r309",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r334",
      "r339",
      "r345",
      "r599",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSScheduleofGoodwillDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r24",
      "r102",
      "r193",
      "r223",
      "r224",
      "r225",
      "r241",
      "r242",
      "r243",
      "r245",
      "r251",
      "r253",
      "r270",
      "r312",
      "r389",
      "r477",
      "r478",
      "r479",
      "r489",
      "r490",
      "r517",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r533",
      "r537",
      "r562",
      "r563",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r5",
      "r8",
      "r9",
      "r66",
      "r625",
      "r651",
      "r660",
      "r717"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance, ending",
        "periodStartLabel": "Balance, beginning",
        "totalLabel": "Total Clorox stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r129",
      "r130",
      "r136",
      "r193",
      "r194",
      "r224",
      "r241",
      "r242",
      "r243",
      "r245",
      "r251",
      "r312",
      "r389",
      "r477",
      "r478",
      "r479",
      "r489",
      "r490",
      "r517",
      "r527",
      "r528",
      "r533",
      "r537",
      "r563",
      "r564",
      "r651",
      "r660",
      "r717"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r113",
      "r234",
      "r374",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r387",
      "r389",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSIntangibleAssetsDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETIMPAIRMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction [Domain]",
        "terseLabel": "Transaction [Domain]"
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]",
        "terseLabel": "Transaction Type [Axis]"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "negatedPeriodEndLabel": "Ending balance, treasury stock (in shares)",
        "negatedPeriodStartLabel": "Beginning balance, treasury stock (in shares)",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r5",
      "r102",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Treasury stock purchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r23",
      "r110",
      "r111"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost: 7,129,995 and 7,589,329 shares as of March\u00a031, 2023 and June\u00a030, 2022, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r102",
      "r109",
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Treasury stock purchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r336",
      "r337",
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r256",
      "r264"
     ],
     "calculation": {
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding (in thousands)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r255",
      "r264"
     ],
     "calculation": {
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Subparagraph": "b.",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e526-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q1)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13703-110860",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r627": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r628": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r629": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r631": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r632": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(1)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(3)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>72
<FILENAME>0000021076-23-000015-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000021076-23-000015-xbrl.zip
M4$L#!!0    ( *"%HE8Q*("TR@\" .#*&P 0    8VQX+3(P,C,P,S,Q+FAT
M;>R]:W=31[8N_'W_"KWL\^Z3C!%!76;=Z#1G$ PT?;"<@ G;?,F8537+EI$E
M;TD&S*\_LV0;,)?@@*REM2*Z8UO2TKK4,R_/4Y=9/_^?-T>CWBN:SH:3\3]O
MR)OB1N__W/GY_^OW__N7)X][6Y-T<D3C>>_>E'!.N?=Z.#_H/<\T>]DKT\E1
M[_ED^G+X"OO]Q7?N38Y/I\/]@WE/":4_^G!Z6\3@='2A'T#*/EB%_2# ]Q'
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M1%5='=7E]=XJZTAJC%DQIQ9>>*NS08@&#4HA? NTU-JCNGJ]A$:PNTIF:#%
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MH<TIZV(L. RQ2)5#9MV%-F%(K3+C32AN42A>X@9-&:3&)!-D =X:!#*%=-3
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M@OTZZ469C*(["'13A=16#ZY*N>X>+*51&KQQP9,(J,!D%732OGO@-E)(;?7
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M4QZSTNAC7G2Z1=6=<B=K$2"7Z' N>ZF#"Z0].$YPH)PN@-E%0<ET<%%_PYT
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MBK((W&H1^# C=DD1'CWW",-BCCC%!MG$&)+,>F)-PER$'-Q=#_1<W![BT]U
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MAYB;=>%& 7>.DALD3 2\-"PB'5)$S%(?0_(F";HPX>9I',<I<-$ X:; Q4/
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M:TOC(\/*"G*K%>3#C"@OX0BAD2*<JB@OBI'1)L!R8@*7./$8Z.S B%OO'B[
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M^L!X:I_"A/T1^[T"!+<#@AK!X=)Z+EQ$(G*/N/,*66,QXD(2D[@0)A<KK[(
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M6UL!$A-),RR8T(IP+(GETC!L-4\8?@;\F9B5R9<.^Y,G.+8'$;E^M%^13?"
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MG$[\WW=GGSZ&8P=>'M F_NG+7X= 8;[N;JR?[FQ\I9^.MKYO;QP"%?J'[&Q
MFW]L07M"EA#YSL%G[XRU#@L$;K] /.0T4RZ87.B))"FX2)R,Z&R[>Q+#>H[<
M=RFZ)"2G@@C.'#9.:,I\D)@$Y3'X5!&XYG&>M?V3"*OIA^WM]7?[K=W7K?=;
M;W:V7F^]6M_9:ZV_>K7[86=O:^=-Z^WNWUNOMC;?3YC3>'Y<F=?PWK@AU<B.
MQNO7C;G<>)F\H<8G21(!]YA9Q8S& N,JK1:1Y\S^GN?HE9EX-OKYK&?C]\\A
M)D93UC. 66>*;9$)'",9(V%>,:TTOCJ[?@IW?XY?R23Y\="O&O(L_4X#T\TQ
M^Z$?XGIN<3)9=D<Y'=M'V3K&J[:?7K73^:H]N%BU<SZ (5QE>-@'?IV#6;IP
ME]81W/IPT(IPH=#:MGU_V&)DM97MI_I0MJC5O'KF[_:.V]UL^]"9\$3 _?*E
M5UO]F#KYB)OM=%HV?#D9#,=$(;>J797TSE_IYL-''?BT/^GW1TD)?/\$W.W?
M6]WHXV!@^V=5,VTKV7:_=3PU7OG[N067GA/>/^D,J['MP5I>?1!6]XO'GU#U
MZDFJB)[4Z7VOOE G:]6'VG"Y2?9,N,/@Q W:H6W[L%:U?LL-F'P8FCGZ^N_G
M/3O:6AA,VAW#B];_]KY'\/)6J_<OVC5I>/[F9"PGW\YTI-L;GG<)S"7X3( %
M-+LGDWZ87&%X:(<P%F<M%X'5',<J-&G<AR<P'*F=A8?66;3]W.3JG=SZG"4%
M/C$\Z4_:_>)Z^M-0FW@%[K.%F=GNCHZU308Z]7I#Z$%@=?#PG=X GG$PGGQ5
M7^9HQLJ(9AO*<2[BUQ]] &8H^/E5KK'O[>%AZR!V89[ER\ [0"'A4_9\*8%O
MPL7;QYTXF!C,AVYEKQ5YSL3YQ?L7K3?KZV]_;QU:&$P7(\SLH_8P?PB&YL*>
MCT_Z.>G-,'/S:KQ/.N/ZR?UX<-(93?7)9*@N^SZ;577$NOK8)%8S3]BC]F"0
M.^>W]YNO?G]13?WI/JO:"A )S]WK#X$1]TXZ(4\H\.NJ7H!F?3GICI2VJANF
M#*$ZTZ;^'+36N\ ,.JUWHXO )U_##5H$H_\'W9QMZ?R;T(ISFYF>GR,,^O=)
M-XXD&X97Q_#S_; -N#0>.7B^G/4-NAF&>!"KD[6SAGQU_(4\,K,:/+@@II<&
M<4Q-7UQQ0Z]PH_NE*:]Z@^%@?3#HP>2$N?$1NF[SM#W<[6^T!P!JMG-QH'ZW
M7ZF.)QYL&=H_*%1F]Y_/&AONO9+(:J,0YR$BBR5#WD%O&T,]-FH)J<RED6[]
MW;:NW;F<U&=)H'MO:B4%*P6P&X76GC^;SP8PQAY8"2^@YWNO_Q7 PV=T"B?5
M&X,_IVA!Q14 24<@D+$ALPF?^^GLSQ983LQOYXJM@/T39F%;N8GY-W<R@-\&
M<,GSE)&MD8X\ (@] 12:M*S"HHMLD]-7=+!*I,PD?NO!@P^AXV!5[V<T'JTP
M^=+GG['#8;_M3BJA-Z,]+"+00.C7;VT??U^]VM2*G$"+,M;V7*=],&$]@$:H
MHCAVD$$1T+]_$*<R7P(T]C-)JPZ9Y7; !:IG>;',DP<>"1;HP>QQZ%P8""Q(
M/G/?>%81+'BD0^CIGJMZ/?<1S+[V4?6O5'4_L+9JV3\>IS0!]AUB?^9"$D_'
M''?J6Q4(OVAM_K)9)T,@F.>T[L:7KIXB/SRL83\R"QF.R'V>:_W8B=_RJC;I
ME'-2"<M=#*OP*$ F!M47+C[RO0UTL5KT,ZF*52KY?JP>>CP9X=TS("A@+? H
M[:.3H_Q9F$CYF48<<K2L0SO'M!M8#*Q6HZ5XO(C[?+XQWWG2"P  @^DG 1H/
MPP 4]=NXN\<L==*("5NM$OV-K=&>KY0CD+!7T"0G@<UF#]TYS'^'\2HZE19M
M%;B^S\9380EPZ\I!@:>%"9!BQ9_@\RGF3T[P9'2]J@FK%S,0NK_GJY%>S<,+
M]_:5O4T^F)EC)WLKT-H0@6WFEH]A:V2[;9@$[?X8*V[P:*M79\.8?8X'Y;SO
M:]U>06]_Q#WSF^/;#\8M  _F,4G0FUXOY%FYW@U; %?=@S:8YWINXK,G.9L_
MMG_L?]_=@';MK8O=C7\^BZ@B]+%'6%N*N X).1$YTI[B0 4C@N"K:EPD5!*#
M:13.<ZZDL]HFJP/WEG!![!(RI*USTP%/Y%L;+@K(.IE(E3UO :2!WP=^&?H;
M'.K\PF1NM4:3:YG7PV&LV G\=S!^Z-4,R"%"2[\.1A#2/N\!0(-OESC"Q5NH
M4W5.^Z)S*G#('\Y^7F>DU%P@U01SQ@Y=ZIWTX5;_/;%]6/JF5IQ^K,!JHFAD
M+S:,D,P"+*<$'Z@N-BV*C%0.^/+@O!59\AB[T. +QNL J_F#EUV[#.E9NLE+
M[M2P30WKH1V,!;AJI8#/I79_,*QZ _H5NAD@?200P>(T[/6GUK/\/?#TLS@P
MTK@&P\D2<"XF99\]CT&.HUD=?P/6DN')!37)>V9PJTJ9^V8[)W&T0GM@MF?Y
MJZ/74K]W!",)J]JW=N]D,![ <SXS-5_R3(7OK8YGWN4VM')_9.=\(NS!ZV/)
M:Q78A^_W8-B[/?BM>J(C._W*>0_ PW^/V>P'K2Z,%E"H"?OV[;X_.8*. $8U
M:I4?3G2""REQPJJNM W85>R,9)1S-;#Z3MY*/>SW3@X.H8_SOP^@-1./HOHN
MN 3O__HP^'TTH[,A]/H'=K)HC[6>JR3PH@L&\:!B!2_&,LND22,E<3)U9O3R
M.1.##LG6E[?**S(XF2!7[YGM$WAOY67,N/W6M HY\J"FYV"^Z\3$*[WFN%<1
MQ0H8+J%&]=6K\Z^Z&'S\TM6JN91%JZRK;HW IO:QRU:352+;CV.F6Q'\2AZ=
MFL*S#"";5Z4#7YK:YP]]W85&[LBE"T&CQ[@'P%*_9#Y3.MT9(Y]MPH?[82SE
MYIM.H+%BX</O63>LY/#+UI>G=@7"OWC"Y=-Z]WK E4=.5)SQB%?G4)[6,/35
M_,K]_HN)<C(83Y(L'V8A,$YM%[1^VWCU^O?641P>]J;=0"#/>>6QQ^ A6']8
MP0W<V<5..WZ+@\FB!:,Y^4@>V0I;P1'(;D*[\C?'=@(#/1ZKRX^6FS_!D/%:
M/?M#8S\IVGX^SCFXLN?QHO5AW/*I!DV4U7X^Z)P-95H3_7(21N9^N:\FTW\P
M[9Q=WEN)MKKFY0&!UDQZ=S!>RZ>^E=%PE!81O@]NY4F_.^K \=Y2]95V7B9&
M85JM?GOP=83!4U>I$E^/B0@,VF3,,LZ.MZ*RF8V%Z-[8$;TT"=HC.ZWX1W;X
MLGO5K9:I44\=5(2INE@8+Q,9+L:"S#G6#_M52;:\(]-O9ZL-J^<CYZ#K\TB<
M?WB\5IR=&WNGEY<BF.RC!QPMD%_C=-]7^QRC=>ZZIQY+5*MPH^'YKE*G?53M
M2 Q[J[ F#BM!;'2UW-8N=,E!O_<]4Y)\F]51>960N<(QN'B5\]OK@V%V+R>S
MK#S\U+G8@[$3Q:,S?<$7K5?CI)?0W(J?7#S1Q 4]/NZ,F6%EV)UJ(*HA![)S
M<G0\6IE]M4<!LSB<^#A%',<DX2K U2(;KD0S//L007%]B. C1/O-C#6Y0>Q(
M\]>QV8_V2T=\[?5(6)OX<=,>VU4';::/]Y#NQ'D[LTW/;N7C^!C7.Q5W=!6F
ME\MV]_AD. ;CX<_9RH@]7.Z1VW+J:G$<4<PC0&08Y:\1G/**:6:@G[C,=4WO
M)OSZXR$0S%]];/47=/CBUF,B'G[!K*^,,UQD/.GR9?+<B&&D;<RZY[V1Z5DW
MN^S]G=/'J=7W@B=FHA?3:-;V>V>PHIU=Y8ZY7R:WN8;=S6/\N;73-/3G="^O
MS9/9.YGHDW;WS\G'^=0:C UOJI\N&-DE'WR\O/=[0"7L\()LCX,V9M&*$1T8
M39P18YMB>Y>L;'IL?DDR8,#F(1<SZ,/54,E[E,5A)9H*7^SWNO#K:(=A4((9
MJP@ L?/],TY"R\ <\LHQQ)G32(=D$,?2L.2D%I0LH;[]+F::"$"?BV*!75S,
MA!QDU VV'YJH7U=7? DK"<S,!3UE/B+4VH>%83WT<B!6 Y_ZITQPJ]MZGR/(
MCAP ^2C,*4/3Q8F+F0_]5P_^:OWV>OW]7[_#VG9][WPXSC&2K=_6WW_X';KJ
M174+A/EJ:V4J;J2%6N]/*HCMC^\<6P I!WU[E*7*$P=]!!#&L4 "__ZRM7$>
M7I7Q\[JOMG8O A->Y.6!DC_S@IGE>\"I,%IFQJO05,C6A!ME5S?C^BBR$UA5
M?JI*@)S<,(UO>#QIZ\CGS%&;L)!\SWUT+GQUJC6I=ZE).;RLUJ#L(\<JK6%%
M?*OZ6>?1:0.@"I-,697ST]J 25H-'A&3.+7QN9()SSB_=@Z'FV[;5/3=>7#;
M8)Y[LQ>M]8FJ<JF+.Q6CZ%T*A>QU.V>K4WLQW=Z8U@XN0DBOD:(7$G[[BTWE
MG_KF-S3FZP[FW.RH&Z4K3<21GQSNH?=^N.=2Z%EUU+FRJXLXQ MH: CS.-L^
M/^M\V-G]^(%OO]EFG[X<?MG_\@_?WO-\^\M?7SY]V23;>YVOG]YLBYV/6_@J
M\]A]\T%\VCOXOO\C'.V^V6GO;!R<[OPX.-M^LW.TO??A=/?CNZ_[/[Z2_2_O
MTO:7;;QS\#D10Q4Q!&%+).(B!60T]T@8&:3P1(LHK^[$<X53R,5[2#ZD'KG5
MF&!'(M%.QJCH5:;R;O/]WKL/K_8^O,L'>-9W-EKO-O]>W]O<:+W:?;]WEY,\
MOV[!Y19;KI*7RM)\OCYX:;"@"@>FN!.8.-HP-G7M&CS:L\[BQV2O.H<33T4E
M9X.XK)X &$-3)^$V%]&*DZ4FZ\&CD*.1D][]UNMDU1@,*-JCSLBKRC[=A0QQ
MU NQD[]X%+/'G-]S7T:+086OH0]6!I\;:ZGCN*0J_A&L[VSDCIY?/R]W5R[=
MOHSML7MHQP%Q-8R?J#E5_-?@.$=\50H#K-;^:Z=ZO7+11@_>'>0Y!GUR:+^U
MLQI=G:+H=GO?\LJ3[ "Z]+*WG"4%WSX^WT)HYU#NH\L'/=HC&6;4]DEDVB3H
M>QRZ?VF(@-=4KN^%LW9\:+-;WO.3TR;CK5G@$[-N.PXK6S86>5W'CB*[*L*0
M/>[3RO^%P?O7+3)G!&4)IREJK0,/+FEG@M))!6Z5Y"[<-$W1-4M'CG'?',_)
M_#MI2I*,!U\X=KYL\L^1&>RI9HCQI!"G6")+M$>,."D4U<G;M+*F1"V_13;(
MVPRK]U;YY"-.,+PD1,NY=\9'91F5VI@RK L;UBW\.3AJDJ,,<1PBXM$II$D^
MB6!Y"-J3%*H\H;A>,V 4[3T.@[_D#4P?SN/3RTX%G%GX:U>BUHO6[AA,A[T<
M[FV/LI\X6LP. 41B'\7NA:=4R6Y9%KLS8F 9 .XLL19(A'/)>DXUC8SGY#M6
M3A*;_3*799E:OYI:/S;99P->C*><H)B(0-PRA1S3#A8:F@AXN"1QL;+&9\RL
M6R*&HUXKH*Z82,&YP8XZXK&P*A$<C?!E6!<VK%L_/JM@%/2O1"92C[C2L! H
M;A%3VDJ7)'7.SRPR<I7DN7@1X%UG3"P'D8V08QQ$GX^"]F'PJB.GTQ>Z>M@%
M]2]]L2**E53NQR<R!T.;4B8?5:C<X'SO<.H4@ST;QY9,;1"DT1'(Z>C[WD64
M_XO6J\G1F]$S57K-Y><=Q.$PGS6\>(YQ_:2E(W:7CWJ-#GZ..OT*<1V?*LC!
M'%5LWVT,FW(CK*=*.AFXYL$8%0&SDQ><&CDN0\+ $;QI0:.?6/C6>-CR[\_6
MP+?WUNGN^N?@O0E>_/_LO6E3&TD6+OQ7%,2];\Q$..G<%WN""+JQ/?BV1-O&
M=L 7(E<0UL)(PAA^_7NR)(%0"5L" 0)J.@:#EJJLS#S/><[)L]!,[H#K)<&1
M!CJ6SRH28\Y38@&Y:;GI1[$1%EKA9;>LJE;XMRO,&A\/M/'")$:1$MX"]U,&
M.<LT$D8';8@D)&G0S>5JT//7:1@E28^*-;P:!Y$#[VN=W[L[\+,_ LAOQ9WT
MBPVQ*N5]'L436#\$32YM<M8@F.B N"<8@?ZV"#NK=)!2<E^JD&,\Q1K^"\"R
M>)328HX)P($2R2E/XK0G,#L 4K?5ZIX5/HXBHK1_VL[:[V+D8!F2_]XM%,IT
M\MG,-/I?>)T*)YCMCX,XK\(4KQ49FR@M!M;'V\GXU7RS7CR*G7X^%MDNHB;6
M?^W=O-G%^=NIW?C/:/[&X7Q%B4>?*XB=]./K\2]O<OI@RYZ_;G8*O5U\Z<UU
M'I&CWJ;*.Q:A?L.WKP+BUO$P*&Y4A7UTY]';Z\5;4Q4KA^\)O:XYN?%MO'[S
M>[^Z+-'KAII;7?;7MR1$S/O-&>6!QQ,.BQYO]<GY)T"MRT<<ZF\J\B]04?D7
MM8]'51.GMV?WY!%.L%3AP\R:KCY4<&^S@INC//\"4W'GW?.TI[>1Z<.-L[N\
M'7=C1=Q?U>%>M<EB?S#R1R8]J[\%7]Q\WRNT+JMUX7 J+V/<'])MD.=SZ"+)
M?4Z&QX/]O"^F8J.6WM=[9M'XFR?G,>:E5%U_>0__V[K>C_?4B[2ALI8%2IFB
M3G*AN?7.:$T%4U:&P.G]N8*&H5 PA)^#UZGY,P9T$7O=I^Y &%7,_T(:]%.K
MB$G]ML?V+C[^K!_#/=OP^>.]L_K%?GOO.,#W]H]+%?-WO[#]]_!,6]_A^<)Q
M8^OM.3P?W=O]<MXXWKS(L;-P[>_[[4:Z;$WR&?]L;&W3G:W- \(=,911%%GV
M0/BHD18T(D$X=]HF*G-#JL*,HV^66S1_F47QA\)SS^U'EF5?5%#Z;*%TD>[>
MS@I#J'#>&\ZCM0XDCFOGA0",]5K,X72]H;OW"_&^/C1XDFGPI%%(9@-%06<'
MO0TN%]+1*% < Y9<,P7@>9>FW(^(F _BHG@:=/ES;+7&[E ;<L)3D8R=G8VC
M?.C^;.X\HSG3[=HH/0ER:$(,S$F@@T1S09)6E*C$393!*$-%=4ZX"CAV7B:!
M7J2  \.(6AES+(%"3@F,3#!<!\ QK]G:QH(-ZNX)EA[%G?(BQ%<F203F-'%)
MN!?>4FLE& !&1QI]\-4A\&J(;XF&8):T56"T:0M"RXU.R%(J$:- ,1FEW&H/
M-*3,0QY#?I^0>^XQY'58K_1?P\SO?X_I17'.^OHN[8B7T67SL3W9CSZN>R*U
M4]]'^<.P'1XEJ"SOP;<S _@JAKO69#)BFJP@& N>L'015*:DQ!L7LHZL&.X*
MJ,C+IJ 3*M)%%[6V$E$ILXJT$5F+)4JP:CXJCSEQH"++:1,5Q7U.\FL#,9HH
ML%-IY,([,'"$)EA+'6V*T584=S7DMT1Q'7?!1441)D8@'H5"-L?#,B<LT4P3
MKM/:!BL'2CX[BGL?S.IE?+*:V.=@E#V:$W@WQ\<6AMB=XB06;Q5^NY._RS;A
M#SQ71:#J;0__[CHY\S=/?XQ9J5)NGA=1V?FK;&@D0[&FAN1T'8.XEPE9A3W"
MS&-&@V1$F)DY.W<*I;BCW,S/?2[E9Z7]-!4:5VB\5#2NTN.>!!J7 S2$\ 0[
MBB2L"N+$>:03Q8AAG#3H5*YXG)E?]WS0N+*95O*3Q<3^4>2$;<PJ%/M$\L]G
M'Q5<2ZP?%@6XRNF_RM>?V0P3=K<_'5[+V5PE&][LVU9N^CTL$_#J>N_+<7'Q
MP>F@VSL?EXL<-:"9[/Y7'M-$$8'<L>^J9, XN7;4=:<8H6T!HN=XNV'IJAG5
MJ*YZ$-Z<Z_CJ,IWRI-?U5[TZAA-2:B)X.:2GUXKEKU%GT3R7BR657K8I[(7)
M5-#>2;?H_#%J+S0J%=V/$Y5LAE_-R2O#[MO#7J:Y!D2N+-F][-=>Q'&-6EU,
M-OJ^[.?1CG94!#-=WN]J)4>ES?-NGE&DLFH8,;$+Y.HWC'@6)0HG"[RU[?FK
M81WYHL]K+O@$_[XJ"&D8-@_.;>,!.8%SC*#MFH1>@OFD9$T6*9PH.#5$O&%9
MO%(_E4<I+@!_@&:(?Y[OGI_ >YE'O^0" XV/!S"M1DL?$$[Y\,2YB*QR''D<
MG0W2I&#D2A<YOWG/3]4T&'9QZ/AF:UBTTGK?.QVUDQO\IO;E@DHJETH^[6>"
M8EWW1QP7:+ZFNW(U!!"24>7MW&OL_+*3=#$T^,QDF^=990_^!.Z3:=/GHQ@'
M_==WH0%/IFR!).M*SIU>/_=E"5X7YG:7_?5[FK)JL&:^@A!WS20GXO;9]0_D
M;RKE,&,\LW[!L$!/C9$JU?[FU.]+"W-<ANZO:\%H=WGZAYW"1]U\A2%<3=J"
M$IM/?!>1S6=RTKTY8DUCZF$+._BRF<2HEABMR@6\S!S716J#@S4=K'98>L8=
M#4YR(Z/#BC,?&-%%25A*Z$+G)2,#[YD<CGQM[\/]]]O;%XVMS;/Z\:?6_K</
M1WO'>5S^;'_KS^^-;^]:<%]1.ASYMO^]\3X?GM1A?)OGC?=?6WOM=\WZ^[<P
MYC^_U]]_)'O?OL SMF:F_F-#3$C)YYBZD(L/2F2ED,AG'X@2&N0]9Z^REY3U
M7Z%7A5Y7Z.4TIHDH+:+AS%#KN(C,^T")LE3S"KT>#KTNIM$K"$L\M0S0RQ/$
MF:+(L8!1P"XQZ;5WD:]MT J\*O!ZD>"%A;;*.*U#2)R%W):%R*0E#<D+EU0%
M7@\'7J6XE,23Q%0JI'V,*/>]0!H3C9)C*5$5%55D\72D1T*O%Y(5.3K0KM(@
M 5MLQ($J81F8=6#AZ<"2#=*EQ'GTGMTM.GDTT17(+ (R,ZIZ2*4)33H@39A$
M7#N'+&4&&5@WRZ.)VN"GD_/X(@1+61)4T))1%S@.TA#M!4Y1>\[MN"18)5@/
M*U@ETT,&QF-NH11$!-,#NUQY@S-DG S::A=%BFL;JI*KE9&K^TVGJ>3J5G)5
M9L6")$)\0,KDEE;>&J2Y9"!<WI/L-7:<@4F_H$U_W_QVWD.?H42Q53:J_\K-
MM\<]MVX\+:2+/?I3@))%RG8NG?S^,YKP=]W>-5BI\&0!/&G,R,7S*HEHP<J.
M+O=*%3$@@W% 1*J0,-?,XIB;:MZ]/N>J>  K&;TG'EW)Z')DM,2E:7901L^1
MP(XCSJE#CH+BE\#0""->F:([:26BSTU$ET[)*Q%=CHB6:+D@A!D7',+8^FSN
M>F25$"C!:T&19%4(H$9704:K=,5[\L>O3AC:.&9VV,_RIAWV$K+W7U@2/E->
M!TM=RAE#!@LC+1&.:RF=QEJ147OQQ5PWU8'F+73$C%@R(;1V/&EDK<BQ9%0B
MG2)#8!L':[WSL3C0U L>:#Y"OOSO@BLJ9'EVR"*,\@ =SA.+N<7.&$-((%)H
MBJ-VN$*6AT.6DH&H&4"(("HWJ!*( ^+GRJT<R<2"8S1&S^S:QJ*1$A6P5,!R
M_\"BA0_*66,8=USXY%0@ E-*#;4"QPI8'A!8RF8M]DD*)I$W"<Q:Q16RS&GD
MO;96.BJC<&L;=-'P]WM%ELJ^O9J$J;(:1 QSG)>8-%DNX'2+SMK/Y98O-F^W
MU!B[2MNMTG:KM-W5G;0J;7?27_KA%."+X2IEM\H;F<\90BQAUH3$+>>.*"=3
MY,((FJP/SMAAW@B6#-_&9GG67;P?*')N=[.P8PI[9O?C>>/X\.R 21L$=P8E
M'Q7B7FFD?? (:Z*I]D)1ZE]D&^\*VRILNVK_0X5ARFEJF./<&QU#E"YR+EQR
M@:<*VU8!V\ZGL(T2HJ4F#A&<SY:X3<A8L"QTA)_)D.RMJ;"MPK:7C6W,),4\
MQ488QZ.(5@07*:?6TL DP16VK0"V-:9Y6U3"<T<)2L%@Q)-C2"N"$;.4FR""
M-9(\+6RKLH%?6G*53H9ZKBW55'"5DC$A))V8$T$EFL3=NF-4R56W@9JW91.1
M>NV831090R3B(B3DHA:(*IVXD#(1QE>FA6*5MI@EBX>@L"4B*6NXT\["/T9(
M%E.*26I52=:C2-:T@9++EQ/B*/)<:L1]$L@YBI%A.,)Z46(BFQD@74G6HR4$
MWVM'ITJR;B=9)7JL26!18(4\B!;08\61$TDBE^. -=:6&+NVP1<,*ZTR@JN,
MX&6F,BV= %>I3$L!E.TR"28D!HJE0B[)7+J#PV_8"Q24(Y8IZ0P&$DSD"N0R
M5?F&2Q72I7/I2DB7):0EA[\24A%ID-38(>Z8 RH=';+&6YM<9([KM0U3R>AS
MD]&EL_)*1I<DHR5FKCC6CH(.E4[D@ -&D58V(!X-%9X1045:VZ#EO(PJ*;A*
M"G[4I."7W?*[ZNQ=)16OII+Y6+;6(B=6"1I13!J4C&$&.*")""=B@T]1)I9N
MG56\4EVZYTL.K*"K@JXJ:WDEH6O:A@W"1REL1,YBB[C(QT$.D"SG?I(0/ T.
MWS9MN4*N"KF>,G)5:=$KA%PER]X1+S%A I$D..(4&[#LE4*>4V&24B$Q=>N\
MZ$>"KL+Z_:-H97P9JW6M.?GP[\GF\+?I@#VK\WR^2K$1F4B:8<$$F!4<2V*Y
M- Q;S1.&GP$?4+&V,4=?YT=(Z"S28'=VW];8>NV>F[IO=W[$SJ#;.]]J]GVK
MVS_MQ57IWM[X/);H;;CN1[YWL7VQ1]^*QNZG(Y!4WFCO']>_U2\:[_=8(W^F
M_>YHNGM[_7B3-K:.CNO'C>.]W>^D\?X=2.HAW6_7?^Y=U.%^GN;/['U[EZ63
M'U@I,0=:ATB.*.$B2.0BI4A8:R1E7%K#A_ *&S>&S1RC&V%+$4DPH8GR&*U3
M+O=\<(Y)((;)3?=ZWVY\?=O8W?FT_?;SJUKC[6Y9-B8W])2<#-?DM[?<N.=]
M\]D?Q7#:BCOI<@?]==KKP6^[6>I?\!ZZ.."*<B*E1-SA7 ?9>:2=ITB"6<V2
M  L[A>D]<0OT>TA78$:D\4(W8_]5K1,'K_*FZC?[.=N\FVJ#HUA+W5:K>P;:
M8^@G?#W>R84FF%)-,.R6/>G'U^-?WHS]J,U.<?/B2V^N3X8X*?M&LV8:OOUF
MW!T=K^,A21IY8$=W_GUC=477%;OY[5OW:R?KDLS7KWVQ]\0]#9;.-Z#E%6%X
M6BGO[ ]&_ICE^GY)DR#_8/B/:UGN#YC[_ZBVU[MFI]D'_5<[['9#*4SKX=/$
M5M,*?X!,L9=F@5]RK?$.?)\W8",.=M+('E^=(-A;4J^A0=[^"-?YT*Q?O&LU
MCN%^QQ_)_NZ?8)!__[E__!WNMW_4N/B2J=?9M$$.QOI1'0SY^K<O%)[MO+'U
MM55__ZZYL_NNO;.[)QKMMPS&T ;C/%V>@$QVF^(R*4(YPM$[Q#EVR(6$401C
M@$N*@X@>P(\M>@KR@.EA\_@1GT#V:P5K*PYKR\J!K6!MZ;!6JNL:@U.::(6$
M%V"9!@Y&*:<&66<"#QY[K_7:AC"+^AD?#=:6&V'SJ"+WR9[5VA;X?1,$I&8[
MH78"TVK![CV<(P?@=A&*3P5CEDZ=8++KX[G>[(3/IR<GK6:LT.;V:#.C/CVW
MC"1.-<I-9A"/ #3.!0N0@Q4-U =9],+5#](,]R['JB].WI:NTRMY6[Z\E;0[
M8TFEP#DBS&C$I4G(Z1"0$$[Z",((%@S(FR$/+V\OP2'TK=O[7FMV:B>]KH_]
M1TC<>RKHLG1MGF=^N_//<-XK3+DUILSH9X\E48D8A8CR"7%,'#*1)L14H!);
M*V5N#TR693"LD*NCDM=[8P.5O"Y+7DL< ',%1GX^<=8$?D0!=)MY@PBFG#G&
MC0QD9J[MX\GK,[+A_]Y^MU.S^?@[Y\G,0P&>('(LE*6_;%6?9WC5H@Z? E;,
M:M4MB.76&XEL3O+@V&-D!8F(T BFN?+!&\ *,W^/T<HROW^)6KHRKB3JUA)5
MTKY!"^NQ 1%2UB)N.$$&>X^8B"I*$6)@<6V#XP>5J)=@>Q?M)\#XOAZ<5@5E
M5*>7]TQ0?.OGZ^G@U\U.:'0[?O@'F#<5K"X"JS.B,4S -A"ED62:(6Z=0H8E
MBG#"QHN<B$?IVH;B]*D<6U;1&!6>K::OIL*SY>-9B29*RBBA,H+A%1WB(7"D
MK=3 &KD3(?B$<^U2)<L\<47Q[)Y<.(_1U6OHQXG]_NO:U::_D5DN=7!ZKK'5
M[N7>8IW.<?<W)]U^,V_$U[W<8;#Y([[)FPK1=5W.R7"V'_,%P+XE_[Z>SO2\
MS/?'](==[=$*E1=!Y1GA*B1Y()(I LMDP#*3!)89)$$^",Q(,AKG9%%5!:NL
MF$PMW2-6R=1M9:I\'.65-R+W/Q",(*X%_$8(&')*TY2<8331A2MR5$ZQ19QB
MOZ,P"Y+(Q8L)O"QC<PGS\VR0>?ELIS(^%X/D&1$]"=-HJ;2("ND1YR2?_^F$
MHDE">Z9EY!AH#ENT3-*]R\73<+95^%CAX^,QUPH?%\7'$F4U(2HGL4(I, IF
M(+.Y!CI#B9.($Y?)"P7X*)X-/LZHTW1C'1)YO0Y)_O-Z<T ]AJUF)\">?(W(
M/=0JF<-919?AK'I8[UXQY&N32=8-S[/W"T=DK=FO]:+/>R3DX/.=P5'LU6R_
M'P?]]2FGVP,6WQI=9?1HG*ZK7+2EO""7M5K^[_7J-Z/[XJNO6 <[_W1P\U=*
M=3(>J4*.FIKUB9_SER4CF,K+PF1'O2O+]S BUXOV.[()'O&U;9W9\_[:']?7
M#I9I:N:G)^WFU5OM6FC\WFNAY:SCLV:KM=D)VYV![1PV 1<W"WE:N>IH/^N@
ML_ZF^^=[W[RL;X7OH-]XX_C/YM[%E[/&>]"!]-WQ_N[7H[V+3;RS^UWL71S2
M!HPMO/_*PW\_M/9IZX<[[IXUZ$?1.#ZD]?<?CAN[FWCON'ZQ]ZW1:GQ[=US?
M^BAV=EO'.UM[M/Y57]1W06<?;W)XEI_U"T_KFP=:YFEF 6EL".*!8&0)\TCE
M[I<Z,1P%F:Z7)G02(465F\)PIY76T7 A4A2)"F[Q=&VL]SL[6]^V__[[56WW
MT^;6V_KFI_]7VVQLU79V__OV4VWS\^>WNY]KV_5_-K<_U=\V=C_?HI[:[X=T
M_1%"E"$R)CT.F@./RXW3,IF#*UA%@G\2!;VVBD*>1>&NP5&S%VK_.[4]@)9<
MS2LU,Y>LG4?;*VK\OZK![0""<GL/^#7$FBUX:3]/X: +DM3K=<]&1<#\:;\&
M+X-JBC77LYTP3&KN#P"^VGD<A2[K#XJ+M>*/V.IG!9:__+4Y@$?M@(:KP^=Z
MXWSH(FNPN'F_]J^O]<__KKG3/GR@WU^O;<)'0!'V3UN#5_#OCV),_=I9A+L7
M(X7AY4LWLV;HP$.E9L=V?!-^.^EUCV/!X(:WZ9[ +?.?^;T63.VXL!G<\O*.
M<(_4RM\:S=U?W38LWGG1-%J]Z5]ZW> !FSFK.W_AT/;"^//I=  X,CF*V"OZ
M?>?^"L/[]>/54(8C:UO?ZX*R[W3;@'P):&>W!\^^"]<K'ADHP/A^87P'GYO)
MI5;W['+(-?@#UK</5D*_!I3T;'!4BS]/X)V)6PT_4UJAXF;].#W#10TX8*EP
M6UL; .<\C,6NBIFLP(?_=]HL_BYFO]FN-6&RFKWBNIFJ]/O#184U<G$\$_E:
M_=H);,;Q_)_T(OPY%-C12WFSSF)K9;:=BO^]>2BQ@N=LG4\L;Q\F=[1UN\4F
MOQ>..>?@9AXA/_J4';:ZK@CB#!'FK3F(J 44,<!^ OD%K/P.>- MZ&VK"Q09
M9K@](KK%CAU+*&R2;J^0RVQYKY=P_V'J818;/)8H1$4<)HC#QX/<%1#TIT:<
M4XNX]@2( ]6(22Q="D$&)Y]@D<P_;8;BH9S7NJ<#WVU/@/H$XKV:*I@)"(<&
M]B=8=MT.*I![ BG]L,'M$'''-M_K&VVO6;S]R93@Y&2=<[;\JI9Z'0OZI"X[
MWR3<M0:G>:+E)[>OQ&/4_WF1.I0+5.5<Q NWXG-65I)S%#!]1L^_/30!1@S_
M)<]$$2!PQ\*M*?_WI,(BQAZ>N1WU'N?_7NX!WL+/_VP.Z(+ASAI/B9:>*\6-
M)89Z)I/ -LE("YN 83)W;]3QWKO26W]W^RM3]> .9L&[IGO_1>[1[;.]8W_6
MN#C$C>-/WQOOO[;WWV_3>OOC1?WX+?S_:[.^^T7L?]L;?><KW$MT]G=/CO?@
M/HV+3;:S]9$VWG_$^]_VO^\=[YWO;]7/P70X;WS;_MG8;;7V6_HRI@'^)8WC
MO;/&X0'37 3/#")@.&13PB*K!>QAZD30AC :P7A@^,Z5#Q:5ACN$+52(5"'2
M%"(E+67T5NGD.??.:"$%-AIF(^9XRK@T1"J<D=G+_7/P.C5_QH N8J];(=5B
M2'7^=^ZU/D:JBSVQ\_$@2>&]%18)(P&IK/#("B<0*!F:B[-J8<W:1N%)IF\J
MM*K0ZNFB%>5&6$^5=#)PS8,QN10H3UYP:B2U%7]Z+%2J3Z 2W._L0&!M XL"
M414QH)()R##/D%<JX42C!XWSI/C3,RHKM3MQ C(C<O_%9?PLW2R[@I/<RNSZ
MD<W;G[YUFB=SC#T5VBR,-B5KC8,"H"HEY 3FB"N9D&4^(!&8)LXFKD4N*TD?
M.=ONI0C4TJV*2J#N4: N9A@5A#O)C:&@OB6H;\PHLM82I!ESRF,N3%'[><$*
M*94\K0COK>3I?N6I1(=-QCV=VW=:G'\PATQ."E Q<!.E(K"ZN>ZQ6;G4U?'I
M/8PI_OI,\Z$^^=P&_'R2@Y>9JS)G-_'GYMQ9XLP\&_6W=/NL4'17.G 4ZE'I
MN<7T')EAB,D0B'*)(B%U1)PG"R99X"@%B[WEP7$5%EI[PBW1-& ?A.>!"".%
M55%9N$GP4K"98935VC_*VJ? O&<1$0P_P("@2'N!D0Y>N: EYE*O;7!6;N[P
M *F/<X+F?9Q75,JN4G:/Z#NI &\9@$=G.$DPU]A*3)$D,B'NA4%:!X-8D%I%
M[*PR:C%E9R2+45/+>> R):L5UH%'+F1BU/A*V:W,VG.F A>$(EBA?+X5!=*,
M4L0C\2E:&ZTV,QUDE:ZK=%VEZ^[)KUGAW9+PKN3 U,22H*Q!A'*'.",>&:$Y
M\I0#Y#$N6&) [OE#E#&Y9WR;4<!D.OG[]CECCYX6N9USJ#N=889R[:PY."J2
MOPX[S8M1,G$_SD@3>S69EGSYC9Q.:7_67.S$U!SDE.!6D2P\SHZ^O$R1]/R8
M.:K_YV%AJ0_;"GZ[5@9]D3.7[4Y.\MNU/]_^/(F=?OQS.,// ,ENG?!)&EO?
M66/W"XSQ"VML'1Y06!-%)4/!!9G[TT;D8N;@ENHD5712IK4-/<O=L(+IRK5P
M>EE5(&>IYRSO+%LAAE,8MFNVFH/SJZS/D5BNU^9/V%QQ8-KMPK/F+.Q<RR'/
MPD3M 1"<V@_;.HV7Q1-^G]T]#4:3Y1:NH]EI3J_-+VS]]:[6CH.C;@!X  U3
MO B7:<942[UNN];KGML6+$.S$,^:/3GI=:T_RF4,FOW+/T<5"F"P&0::"30-
M .GQ:3@<0F&S<_FDX_H-XPOWBMH.X_SS83KZJ C$Q'Q,%&&P.8&WU<K_%M_(
M0SCI->%CM=#L>UC/P?BB18_LT71T^]=*.0PFY_YJMJ_5P1C/_(RB"W#YP?4I
M!3S-B%;,JQT4;WG;ZYWGYRTNO< ZQI\^QN&E(HQLUK9X54S95>&J<I8SW&XA
M%9"XH(('ISSG*5<=M8SR'+:H1 P,+VR)_PK]MR\?OGCVYW@ OQS4W]FJ'U#*
M+>'1(N\9H+X'F]L12Y&!I0';&]/(W.R3]/5')2# NS(WS2,9B@J@3CIMU?*2
M7Z):<U3GX5J1BH*C92ELVR%@Y#IM96E:9'LSG*M0X&BEP]QC#?\R(7++QA0,
M#F*^-E7C7?MWWK73F_K3>+A_C4;Z-0^TVLKCK;R;^[8DKZ,,B,3<#)MBAS3L
M8A122-0G()P&MC+5I9V<T;Z;5I/&U&T/-" CKT8EGH8%?8Y@;V3$SDKT"NN'
M>F?TNXM 3HK]#7MW$W18JW9UD:-FH5:+@D/]D5H>B\.PV!!<?99$3>@1-UE&
MH]WMYTI".8MZHJS.S'I-PXI(PZ>. 5DP'NWA)#VYO&^:*,LQ<6.@!K^J%),$
MH9I$F+_DN#?6FI %D1.C, \LSE$IYMV-<OBE&-O?,+1K.5BPO/YU..WE6EPO
M3Q)Q_>([KV='R.['\\;%1WZ0E/)!!(,4SP'$CN0 8BU03)A3( +,"@*BB*<]
M 44QL^G*F$^8A&_F,I"@J(Y/^Y>UR,:JIBHQ-3VJA4V2C"\C:CR<W6EN;-N9
ML=^$[B][MHOJ1U<%NX:3.ZK8=5G$*(,S8-^T-=(^:<5!44[N?Z=@C#4'1;W8
M:HZG1S5EU&6543L<F2'7;2Q[]7K)W'KL[;L(%:YJ,CRPY^ZB?I"Y+4TI(B])
MUK98(RM20+E1(994V,##[.3 6G,EQ:9S4[G 6LFK=>6TF*P#>OUK,]Q3=K9S
MJN2(VNY4H#8]*NLS9A6E4 M;>C#IK+L^UU>D?J*JZH2C[,8E*\!Q['$;?OVZ
MBPTTO2T\<?D:O0@7[@SU_Z55<WF  IJIUFOVOP\-CZ'*^Q[/)XJ_YIN-ZK4.
MM\>HTNW$'FD.'7"OJNTP/2IW"DL!R]KI#L!F:S>'/N)A^?MA%=L\O7%X\#*N
M:'OEF+6UH3@#U9MX;[A6H!=ZT>8#M,ZX#O!U=^V$D_^JYJT-P%KZL75>:-+B
M*WFY@=J<MD^&-73S(E<K66(K94?Z// Z7,8A<<Q<P,*%"XGMQ6;G%2P<2%D/
M1CNQA)=[XS;SD-(]S\-LS^:C+\]NGM'L_>AT)]PU5W2RW^_Z9@&V(UB><(#^
MLNSNZI=L;71+=:M'1DHS]S%IIN85:(_*HH\+I<=.IM>%&VT8.C'VI0W5Q5GW
MM!5J[5P&O=7\GD$#7NX48-;+1X4WL8Q?E2FLN0CH5"B@*;_RX @VT.'1K.%,
M'SW^LO_'2^S<H6_NW/$(+3AFMBCX;<N!J18%5"2?0U&Q]903Y2V/UB5M=9".
MTUS1X\%*8H_-K*H$]D0)[,,#PCB#-<&()9H3<&Q$6AF%4LH).'G):*D7QA/
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M):*P5CFNHM Z1N(T#5$P(A6NI/-)26?I#,%:G((6!N&4ZX Z!Q:L81%%3#C
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M#M+2(%P1:LC54Y'X*GKMJ9\N+  X+@G8J,Q@Y@+'T;D48N!,A$2$ X(Q/%R
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M[Q'DH1UKPY6'_1M_V+RA"\D?[M&K3>*!R[CA#FIVBHT.=V@UX8NGA6GI8V\
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M,WGD8T,IV_'.]F%&QB<%H^^'J_D B_4[<, P9>4N(P_CIK/:T55&-BNGZTK
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M]&)W#0^V3K-2#U?SV;R:SWR)-NBYPWSQ?*UBA)DA#8_:^Z-;KJ*?NKCBZ^8
M5*^?8[O]-9[HVC\@E7%ZTZW@ \Z]L]KV/"_RU5X:T=S^J]')Q' ?],_LR>6Q
M9K'TK28L?D'>FG E/V*S>79^=#-1:N5K%;PO'R:.W/UYF^2MZFT_;\*>/:ME
M)M[+DCQR]A=[J^#OUT9UM0?[Q9A=P4R'!R\PJ'Q,"5PR\V$$8T(^L_A\N',Y
MY/P4A[$#NSN?R1Y9V,S=7O,P6V^3Y[5Y/*>]PHC( QX=8\(:_4IK<VT#\9XX
MIPRW2CH6 M9$"$8]AK_F"("KVY_-]FG[[]@Y'!SMI+S>_XWA,(>?_F7[1^^
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M+[*_O+\PKMGA5!<7H?77-&72AADNCHOA@(]@X70ZU_G8K]DHJ4?NI,+7@QS
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M6Q(UR"HQ15:?KJQZ)W#4)CJ#83D8;E0B5C*#K7=2AKE=P46O+E-6I_V_P8B
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M02PP-6KPPE4*_AKT4WN4#]X6GK4 SVK-J,W-E;(\*(>LH19Q+3UR(FID"'-
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MYB!&%KV3TF$V+N1"B-]()1L=-CI\@'28HI#@R6E#'#ADM)#)B9J)$Y4-NCF
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MWY>]JYP,10)O%7GPB3OAI.,F>512";/<NQ+<*-[VKH:V=_7A:;]( 21T(=O
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M)2AXD,+?FCIJ FA-!NQ5.(A!"HM%\V &P6H+;^9 .F8"=U8*:8(M$DC# Q)
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M[*/52;.87"SRTA4&BRD4]2]40&E]I"YV?.7@<:.Q1F,#I+&U))D7E'7(GA*
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M^$V"O.?!@^4^*,.9#+JKERB9%R8Q3^2)6RVET&T!?P!0WT!8H"W@MXKM7JQ
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M2>9M3DP)"!Q0<2OLJ@SO_NGP#O.%I5XOFPQV78EJI\1)[<ASW+^1NM:"*]H
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MC%653!">XD41KGE$K$,*,_3.?9L[HV$5^H!$(W"DKF@GNUNU\))!XD9&U:J
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M!T"';X5R+*A ;*5R$51B-,0EXRWA,G@AP6]/WPCE^.[7)[^?&V1- L"%FK
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MGV8>0VQW05-+9X<Q/^#1L^HQ^>E2.]Q-"/@\])C/EH5]'O_8OBU#F##\=CD
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ML67C9ON:_A0QW1PQG0MY* [6+A$!V83!&L(.Q!0;@QRG/H@8A*;NT3.V9&/
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M?@]^>6$'<=U;Q/<>.+DU*H(O1SAH<6><9E@IB26+G!/L=0D1K0\XW\R'B&3
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MIW[[.\&N?N?MQ\KI[2BPCK%N$UV%HELSUFVBJU8W&^LU?7ROK2%/Q-RU"QI
M-/IZHUI '-157/?@NJ-A]2H;2S=HQ7-_R;&?G: KJ?&]7+*PT\!2+40VD&3L
M9T9^SB&CF_1PNLFT'R;Y:"'?K5K85"_JV.\J4.M>$JB(9Q'/#1//:]3H_,ZQ
MD_E_&]I::W&GL_T("V>[YX7_KFUVUD[R^SH1;AP=_NONYK\I'1@73YSL&"*6
M['>W+ GNNM_=);F[#%V%E1\**VML[C<K3Y_QK5ZQ*V'KS5M>N7E+NPXRW*X'
M<8'( I$P<;'#%-X\.2JL7%CY%JR,-U E%&V_(F-N\Y9V_=K^8AO?R_OLBS(N
MMF;;FNA=R5:_;4WP+L/L#G;LJ+[=/N"/WUT$$G!NRF/OZK%"_)"M6\JW=*]R
M?NNV.<5630ZPK73O<FO)])_SOJ+M,8&9(SDY1Q#9PWY[)J?L]EY'S2;O$ECM
M\>OGS__S4Y7CW.]RG+MZ/>B?CHZJGZO'+V.3#O_3JO9,MHPT?_2[X^.;[$B6
M#:,Y(C[W_SON-*FPPZKN9%R]S+4_1IV<]CZWFW*_B?%K>\#IU>2 TYLZJ_L.
MB?!--WRM2<A7@/N@X^//>YVO/U=OZ[.P/ZCXQ*+1W++XQ&/RTZ74Y+*L;^L*
M_OYJS5(]WN_W4*V"MF_%J\>T+/E52]XHSVV48[9H41]"KL,W6A^4B-NC9ZI$
MW+Z]O_8 >>(QD7/>46&($MK_+H+69R3ITP(W!6X*9Q3.N!$Q*"M,49BB6*R%
M)XK%>IND@>OWA[;"@[_<&^4;'+^%O$N_B6>K3DS::E(])O0J,;^[!*XEG+DM
M).E-C._"@X5@WY'3QPNMBB[8-EWP$+9&YCH?W<:5V$+6N>W1Q[N3O_M$W>\*
MYVUI'GY9IB()A<0%R@MU"W6W!Q[N48QP8:/!^^7P?/ML7/$-9WU#5<*$)>JU
MYO $^U$\N-5TH@762B1UZU3 _8H.7G&"LS^ZD2FUG2;YXCG+-74V:W7L&AR!
M=5#YNU)7MI"K'A.R=';*O5K6$H6]BF:M75U@I\#.ZF'GR@W2LJK;NZK$%+ H
M;+7R^>K"586KBN6[BF5M@P.304RN%+5=N\IR/71%95F^ZSE;//3M?\Z#K9LU
MUPJI5!<KU<7NF)JENMCUI"G5Q4IUL5)=[ =7%RO%Q>[/JBY37&P;E[P4%RO%
MQ;9QC[P4%RN574K!AA6FQYE2L&'=^^7WC:D*W!2X*9Q1.&.IG-H-[!U9F*+
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MSF>WDZA$9XCUFXML@=0TXO(5#A_='J>?E':&>?/3%&!4)Z'=%&"8N59MKJ8
MPQ1@F (,D^%==O*9#&]3@&'$L[3D,^)I"C!, 8;)95MZX>VS=OG2G4Q2IF'D
ME1FY<7[8C'S,*9G-$F:.[S\GTVA(HR%72EMO-$HH1X:5#2NOG'E[WCQL1C[F
MP[Z$.FK_9[VIOZAP+NOE?!_;I BOVV?.D'4;F=>&K%LA:W-^ZSQ#US7IN@!Y
MP]!US7X#>^@V<(RU%\TSF1U^/@T87:9 8TKR,J#H,PLPEDZMSB<^3\FK5GG'
M4RHEHF0T"L)8K&O(0WL #XHL9)G_[0JX\5]#-V8TROM 37&E].Q*E#=856/A
M:1#_"Y']90^-!;#^.98_*T]UP\;%8SD\_EE\/5'8,+<F8!YC+ELO\(/=+BH*
ML'^'*0@^=7)@GLGQKE[.K,GQ-G.MVEQ-CK?)\38YWB:)M.SD,TFD)L?;B&=I
MR6?$T^1XFQQODRVS0FIL"5,J3-J78>35&;F$V*PF[6M#Z:GEV]K]IWT9!6D4
MY"J)9A<'7@1C&/E(&/GRP!GYF$_ZD^:LS*(C/>5-<G>%\^06U"::],,U?;WY
M_H AZYJZ]ZRUS;3.8R3IN6D#L143</L \,=(UI-6V^1U;STI]D(DQ9ZU5LB*
M;6X24G_GR:Z+(:V19, P<F7VV.+?;;J1LT(6;SY;=L'K8"LL/_!M%@TL=SAB
M;HBYLQ8\$N(CB'L-VR*7_=NG)ZN;1, ;T4ZS:VG(.?GJ54TQKVDD6#7;O(:"
M0@43[0DX_0*X_'H9Y241'?P-,J9-/RFS("TO#'.SV44"OT91.6[$17\! 6P_
M='T8,R14>IC)B/MS*8B[DE%Q9M*ZY3K_]9/;/NM=MAMG[;/+BV:G<=YDG?.K
M=H-==GH-^*_3^+^KJ\N?RBAKTY/<KT&3^;'KLZHIB=M>3\BT]?<$=K19LUJ-
MYB6RCP/\@-L:\C\2-^2BW $V]FO]J6Y]N+Y^K%GIJD6A$(^ =TF7P[\8\92'
M72BP@@JS_T/@9SOP@Z$\G.DIT"J)%].;:&0'D_]#^'CD,9L+E:S>PT&W1($J
M+.HEOBVJ"C)Y@?GA5S<!\*$__LO_NVPU+]Y&5I1T(]=Q0>Y$450Z\3H\"ES]
M1P+_1*W6!UT228&*@-NM7A@,\? ZU2?G<%B$*Y8*.H_'N#0&S\N"$,]E7=<3
M)5@PHQO8RN"[1BT6(EGMH._#3E$_G8<8Q>]$:(O72MB$[E::-H M\46S#Y^B
M<O3^*(8_Z#R%-RGM(_12>HQR_]D- Y^>TE>/(\&?"4P3%%&7XY'L>=SONUF/
M$=Q3MP=&*/P6% ;LI"=[BZ3#I&16VR#T5+;S-;GOKHW+AAG19T)7" H]_';W
M[K1Y)0YA/AR!X@*2"N6-DPS!(:A;U_3P)Q;: ^&PM(E?6VWZW=\3G\N/&_1Q
MJY;J)=H<2S7.J*%>]1*TP*U^$#@OKN?5INX4\O6KCIC7J\Y9_A"L6P_$;I'V
M#M"/9.=TF8>G%Y;"P6:ST0C&!<4?P\^L5ZV.&+!YAKR\XI+R,\A*(8E3)Q8
M<@0_P!0QIS +L)=G2$N.O[*S%@XG"]370! U/>^1O1QX<-8:2%3="+P8:PS\
M*9^>7-D< ^LH6Z9<5+QERJX)]A[8$[UJ>22 \@G"(:D?*_ U$P\%3IP_01*2
M-.$) *I.:(N%2A,EL(=G8V"AQ+0:;S^[T3?K/0P=A!%]U'Q+X\NO/S$?=@G'
M227L'<A#0FJ0'KR&"8\CEU3!>WB%;X-]A2>36 T]\YG.27KD 2QL6ECZ-C@W
M0)V)HV2:1%_[?@(C?N98,XSD &(-K6;C]!\DU4N+Z+K&'/!9NUS6'(VX?!'C
M31#BF11/]M#9_U+F2D4Z<<4CH-YY&(.90U8-'/>!+4RVO+DO'047-2"/8NG'
M:!]($T54SH-A%23 FV3%X+B!8%$JEB4'B%Q/Z4),*V2M3D%HHW[57*\<<G[1
MVME%JS(%=F:N9J[;F>MEJ[V-N2Y9O&H*0DU!J"D(-15GIN*L8N0S!:%&/(UX
MEI9\1UL0^E'<(BR1H6G2[8\CW?ZD.3LML#*I]FNI.,/A1\+A%S/3W@Z;P8^Y
MT*39N"Q?%='^RTV,7C5Z=6-ZM7U1KFHNP^&&PS><,-_J'">''[/IL*"WR)%:
M#H=7W3$[%I(OSGAU<57,+I^LS)C,HY8IS# 4YNE0"L,0\PU$"E":48G)"V&B
M4J=%#4*$N7N![5(BQ(LK4]S<X<BCM!V91#0]6<X'XF39#L/ X5Z:]E9\UG'[
MF'%BV6R4)8@RJD$(G$3 ]H\M[@\P=5 F'J50X_6"E&P=YWLSF]GL7"RL%5A[
M,S=.9)$8M@,>F;^;<R'=%TC_429+7LY.EEP^2^VBD>:H'7F&Y?0DN/=W]]?W
M-W?7'ZW'AZ>[+W</]];U_3OKX]U_?[U[=_?EW^MG!YZ7+#MP+K-]F2+AO31K
MT\YE;7KN'XE+E3<AQSHEGC9SF9GX+7+W>X'G!2]4H2@RXY(A:L@_,7\/\\NS
M)B]O*M=3X:)=;S?/-I[FTVS6VZWU6C7L/G^*)GNUDZ2D*Y.$<RSWK.:6?PNW
M_,=P3XUE1'2N@)'\[#K"=@_2.@-S67V< ;F+5@EO=0S(H6'D51?>.2LAYNVA
M =*EATB"P1\L+!.1%3?7E/(PH>E.FAV#]K5QFIY?;!U Z5@,NU0F9:AB59E<
MBAI58:RSUOG*]XPELEH.?7O:YZMGD&T/4:TTX<CI4=F']&+A>E*>2[>&V0V]
MY[B? H8#G)&%-TDUNBABH;JC>06&G_K1"!X(9P%5I2VQ9_4\9CF8IY<@_$9W
M0VQ$ETT",>9E]I75B+G.PME/PDD5WS-K=O*^[-JV031B>(:-*1I,,#NV'28\
MCTJCP++<(8Z.<$UL+"_ U#)@Y#@(QQF2R3"(XMQ+@Q'^_L_TZBO[C<>?N1<M
MOO?#Z>G+3>>/,#'N,RUA8JH*SV_NII90 FC$Y2$''L6.6%]X.(RLV^\Q\)*Z
M5GA*1B/8BIL!UO&_3P_T$BYZV9L4V$_@3 $$.$"T,;5<Y"O!T$2-F*A!LHT?
M1T@(EX<I/T2(-.18 ^;U\*<ZJD6KT6K@8^31(4NY0U0W?%*8(\(XP]_337Z
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M#X\+T9\\:_3M.J@S>PLUA^HR/H<Q<6AJ6BQI([@\2D@ \%VD/";UA=1>=IS
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M<#I$@JG.F*^,6I'LT%SB"04#!R#.V"+'S>Z'\X(C[V@PI!=R[7F*@J;Y@=*
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M BM'_F(1M-+XE4^V!$[VL  5#@P 3\[#L.3K)KG= B5P9\P$V,3F<P:[T-7
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M_U(?U.WQGCDC<_SEI_\!4$L#!!0    ( *"%HE;$K*MP2Q\  &@G 0 4
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M.$G*HS,@>:*F-EC6H:M/1RE[@DYU<=6[(8<HAI=^5L5X6;K2S&D1H12K:D;
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MS@__[^]'%_^]%.E_*)F8=CA>NL[^<#F0H[(6NQQ@=$#$[HF0KE>F4GYDK0W
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M4S&?+8Z>U)Y)./M(5LWGZIF=MB8PR5NI%,1Z;"E/7SG.,AAAC'-"L*RWZM9
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MQ70N&H6PK6MY][>Z_>>;=5/N.ZH2A\YNVRH48Y>A&*97,P-D;3A1B@=E!*)
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MRQ/R:+:)66SQJ(=!>6N9[J/,_>VS7UX^>_7NS;.WO[]XUV)8R@T?N/O8V &
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M;DY.KB/08./@X>4^PG-X?OB0P]L/[X)^C["SL1_Y?SSH30 _.V#!^(")X03
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M'+HC1QN9)5Q1C==%Q$"K#H_<N[I4%[WN>KOOLH1;[B\=[V-![NZ/:NI,W>D
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M'Z,Z'; UHY2C'_#63P]>C6H=R,7K&Q>\=UV?^A3;,FM<75=KXH^[&R]B,YW
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M=;V8OHMV1S\S+1QN=C.1[+X3]UJ4>?$9:?<&$6''L[H=V&OO#B[<O!@WH?#
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M%_K*#I=7;;-Q]ON#2SG#_N )+(5_L"6'8(X8Q\\;5]3'M:'Y]*_VNX:5M%V
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M$]5N/OS,9H2PL#W/'2M<$^.>Y*"1R&)O&V.C"R@,04R'/OZ_ %!+ P04
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MI##- OU6B#F'-" (2IZA+)$D)@%UB2TX*6EJ<09UL'5;Q]A'0YK3$%M>\?D
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M,_?3+$[#3._P<92F$*4T@CA@' K)1!JKB >4VU[%G!8S-3K8UA2L5+6_0>C
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MC@36_IG+*K<5/+7%OZ-W?2]=-IJ#_/%I+M=O\RL@6S/TN["R=%2<9\6.-H;
M>F V.82Y51H83:_ 2N_ZK_YHQA4I3^QC+7944G(%8Y^KG)_O1V&KDFWO)%M^
MUI:UURPB2HDTE_""!YJPD-Y08D8EI!(% 5&!%-(I5>BXF*G1TZ:4H-!ZNK'.
M"2#M..9R>(;>.JX+5AH5#8.8LHJ&7587@)_HLNV/[H]0NF'Q1!\GA(Q*%MV&
M[E/#F4_W)(+-A>U,)3C3>Q*]*:&FF")2")(0,1C'(@A0I)D@)BYQ.%MC.RWY
MT9KS]+ZMWD;-<JGWPV+H]6T!@/OR/335UYK=&GG<A7IHTL'J//*1OH'*BS_N
M\T?Y3CX55;[.,B<T3=,HQAH63"$2F7XM,Q7 )%$\$!&1,7$J=7I<S-3>S49#
M_5IN5'2-'SZ*H]UZO1R=@9>N41#4Z*Q4'"!!MQL%;R&Z1X6,''S;9>AA6&WG
MI_TGC:VJ*OVK% _R5YHOS"^_2FXZZM21O&;W_$::2M?W],<L0"P(3<8_BTVV
M HTY9($,(<I2$BN",:+85_*8FVI3HQ>C<-6DC<GJ9U"N]3:-^O2WQ 3-/S\^
M-[OHXDC&F4DQV\DZ:X\W>/&PR/^S*4!N0E E+1?:;][(\I>0YOCEL.._UYGR
M@3G3(D%M75(.U-9= 6/?^E_WC;P"K#;3)+2-D\76#_L1LMD<%9M,5EL_0%VR
MVWI*\)IV\6'1]N#=A$>O,U4SH;(@C@1D5&3Z'9&%D,28P#0(19)%&#/N=$KM
MKL+4W@IK5;?Z=CMF$/>8!SMB'A;=@0GX3#+&!O>-%8/D"?<'<=C\C"X%II"G
M80&09;Z&S4CNL5+UL8ZFX<="Y,N76_VU_58G$J_"0=\6BUK$:B^HI)!I%(:0
M$V&:4P<)9!E&,,RR--%_8Y&P<I1[R)X:YS4G8FO]P<H L!6KO#;!/H3(=4:Z
M27!@G(>^[7>!N$?4J2O6]N%; V(^4CB79^R=0JMZHM<1:N4ZXFBA5SU-W0[%
MZCM$W_K2M:C%W;+@?S2E@+:*<\UPQ%(F(_U&($I A&/M)4L:0*YP&F0!BKBP
MJOM@)VYJ[X2V='*C,JAUOCI2PLRUXG0GXMTO /\X#LSYET+8HP:U#3(75*+N
M''[D>M0VIAY6I;9ZRE\;\FK]RW_-9:F'_/;2!C#R(%(98P121"*(E$@AQH3#
M($$"I2C!"#E=Z3A)GQK9;'7.7FM:'Z9^OOY[SY!1M]FPVW\/AO' 1'09O%YZ
MD9^%:<!^Y*=EOWI/\K.PV/0E/S](SS9Z>DID64JQ19<?JNI9BED4*T9"4Z(0
MH00BDP5)<1C!1*1(:7<5$>;6J?RDJ*E1U5I34#4O]*IYH>>UMN"G?-'^QO&6
MIP-L.W+R ^' 3+1!;]<=:A3UV)KO+!B^VO2=%C1NR[ZS!A^T[SO_A/NVZEV[
MH[_7C\XPHD1$"84IQ;%V<8($$ADKR&).4DZ88*'U!FI[X*E1PDHW8)2SWQ#M
M8'5^Z],7@8%7M)WQ3EN98Y;VVK3L##3:]N28^ML;D:/_WN\-_=9H8XY$S &:
M:9[[1B[XMT=:_M'ZM1%3* Z4A$I@4ZDHC2!+I8*9*2,<,QHDB5/MRG,"I[8T
M=_0%1F&PUKCGQN(LYG:O:Y](#KS$+P/1^=UMBXRG-_A9<:.^QVV-WW^;6S_7
M\VPC7^1+^3'_;N[OEOK+D;-Y6V#E$_U'4;XU 0U;7:,S%FN*D0+RF""]/X@X
M)$RE, MI&LHT"(AP:KGM*']J--2H#VO]P<: I@!0=05J&T!MQ"6MNUUGR?+4
M8SCLAS[W\ Z[^UE(/_!\G88X2A_W/*0?- <G(CV'\9#_:[+QZCR]2I;?Y?6/
MO)K). AIP@*(8A1!A"B#&+$8XHR' >=AG(91[[3?0WE3([K=-%3CX8+?C9Z.
M1'8.93OB\HC=P$3E#MMEF;JGP1@B0?>(M-?+RSUM>F<Z;L=C/?MOK?HFOWFN
M\H5IE"H?ZL/<^@N>89YBP12D), 0D5A (B6&(L0XBVD:(+N[9RMI4R.1E6Z]
MJ*,;5SOB\(;6P+1A"U3_[N== /AN?WY4UNOT/^\R^V0#],Z'^D:HW'V3<Q,1
M\T07+S.:1IP&(8:8)]K#")-4[ZJT<Z$HD5330Q+'S"TB97OXJ=% &SY1JPA:
M'5W#37;@.W_&>ADH Z]V)SQZQ(X<,_N"6)&=X4:.#3EFRF$LR-%/]:WMW-RE
M-)D?]_2'*=BQJ.0;N9 J7\Y$*%F*8P[UFYSIO4&J5VX:9U"(6/$@E$B%X>R[
M+%EA7^RY4Z++]W9;[H 7!:N;OS97;DE_N*;>GT/9[NWN$;FA[U96D+6):J9U
M6JLL^*E5]_0U<X_ZT5; >"LGW2UMY.K25J8?%INV>\P]F^%ZKK\7@KXUQ1]?
MWM)YKHIRD=-/U-0J7&4P8)8D"6<P#9C>)$120"S--8\461P$ 6;(NOJKA;RI
M^0>MRJ#1V:1OKK0&C=KVT?,V:'>3RP 8#DPN9^'KD85@@Z-]YH%G/$?*-O"
MJU.&@0-*'5D%-J.,EDG@8-)V]H#+8^Z,_(8^5/]6TJ?J>B%,'@+5F[URE4[#
M,B4BQA2,PTA E%$!&<($T@1)SA&33%K%PYT3-#4.-KK6D:2UPO9$T0GF>:;U
M!=' %&O4O&J@N0):5;#1M0>Y=F)FSZJ^L!NK%O<E&#H1J0TP'0S:^?AHU&EC
MQ#9G6GW>G2QO96G"$>B#+-27/\V0W_(G]O)W_;OG4M[2<KDP7]HPD#3-0AC5
M#9"26$)*X@B*."0I#4@<VS5 LI8X-?ILE0;%2F&3$_^]41D\-3K;$X0=Z.?9
MU3N4 ]/L1E]3=?_+-I:MSN!V&"SM6=<[IF/ESG[37\0=?#??U7RAUXBLE@9H
MTZI@[XOKJ3F!$W(=_&PWSFA$[636-F.[/>@IKO2>LKF<T305+ DR* 6C$*4T
MAC@.3->Z@*4)9YAQIYRUXV*F1M)'PA]_KQ6]-'"T =7NT/)RJ 8FX1XH71X9
MN@/"4/&@C9#7C0+=,?1L[.?NIR\H2;A5V/1=7O%Y85+.UEW"9]PT,4!) A$G
M=<EPTQ!/49C@* AYB!$.G(*=+&1.C1R^W/_KS5?P\</UFP\?/]Q_N+GK4=OO
M#,IV!.$9NX'9HJG&MZ4NV.BK>4-K#&J5/9*' T ^2^:=D3A^+3P["(X6N;-\
M=*0:J$W9O/UB>GH?6Y=!C8(D#!B'D@4Q1)0BB!-3-EG%F8HQ#M(H'K0,:I=V
M4R.QPTJH6Q5,OQRI?+I3]73@:J:=T^S C:\Q>:.PZ 4U3=L*ION&UB>ZKUO6
MU&8&7JNR::=NTRYN:@/KQ?5-K83T>TE\,$<.O G9>:^%Y ^+IAL)?WE#]=K@
M\LW+.UGQ,G^J99J83QP)G)&0P% DIG@^SB".6 2%D'',,A&1Q"D7J8<.4R/\
M;1- :P-8&0%:*\RQSI8=O:)Q^\R7':<// L#,_<0$^!,RA= Z(EZ^V@P*L%>
M -$^C5XRE!M95N72G E4Q3P7-?5^6,K':M5]-* R(HA &O,,HC31/U&L8,#"
M)$-$<90E-FS8)61J=+>C)Z@5=<RP[(2TF[!\ 37\^9T[1M:48P-"%Z?HY[?X
M1/]MPR6=0X]"%C;&K=C ZK/]ZZ[<RC(OQ,U"O*-+.<NP$IB9UL(IDA!AO1,F
M+ R@4 GG49QF4@G7 BP[$J:VT-?%2!HM@583&#W=B[+L MF]PKW ,_#R=D:F
M5\66H]9?5+IE=\31:[@<->A8,9?C'W0/G#"UT1<:Z)>VR:+>-6WZ_7V6RUD4
M1US0 $.">  19Z9N9!A#Q9#,),%9)B.;1GTVPIR6]VB=^_)6ZUQ65Z8'C_VE
M_EEPN]>Y;\@&WV.TJEZM.W::^*F-NE>F.Y%'].RC(7RB.%(@Q(5H.H4\V,+3
M$>UP=HC1 AULC=F.<;!^IF^VUJJ@^(>%R?&NTS77IU<OYC K7SS4[9?U=\K$
M5[QY:<Z\ULF>'XNV=\_+L<$VM_L,\U3%)EM3LLST52401R&&DA#"LB# 4G&7
MPZ?Q5)^<;[<IUK]E^LZ!=K^XC!&_#79'6].<XZ$=5 _3VR/C;6RDO27/C:;X
MR'EX8T_(84K?Z!KT+"#"OTGQ/)=?U%:?RJZ[FEKH)JPD2U,FDXQ#%<011"$G
MD*HL@T$6"\*HWE@DF5.)D<OTF=KK9F6."7E]^TW_BZGQO-CI"7KL^M5T.:O9
MRERD?^AQ/W[IM-J]8D:<K('?&]OS=&YR=N[&V[<)&"38R!.^ODJL7*C-N$58
M_$!W4*;%T[#]R+JI1S=3F. DJVO"&<Z-"((LH1$D2J9U%8@$61W>[ X[S6,:
M6NOF1GXM3'8<YF[\P%1TW6VQ,XGL&NB)"]I!1UW2NX;LK\R]?W4_,WTG5;Z0
MHBVZ<*OGQ/S_7I:/^:)VQ)K#V1G-2"QQIF"JDA2B ".(LT!"JO\A1'J?3C*K
M9K<.,J?FU1@EP7*CI<GMT6K:'P+:8GW^)'4 ! ??HM8:@U9E8/2]JO\$6VJW
M-RS^(;4_7AT VI%.6?U ['38Z@A6QYFK[4BC';TZFK9] NOZ:#^WZ(:6"[V;
MKO1@=0.2=3]L@H(PP0&#2&+]!T<AQ%&JH)1Q0&B*>)0Z;4Y/"9H:/YOMHVQU
MW01D:Y)NF@H!NER6.7M>UCN790'>SHNR.!VGZP:ZG=OE \J!B7JEHN&)IL/0
M()W$SR'AR6,[*694'^Z<L?M>W=G/]PT /GK45@>.)F$42<0II)%IJ1@Q 1G#
M*<0I2R0):(!BIZ9D';*FQAOMR<9:5[!2MF?4[FF0[4C"$W2#WY#W1*U'J.U9
M/+R%U)Z6-'+H[%F3#T-DSS_2NS[GGCM3MY(VKU)SBO_FY>;Q:5Z\F)(.@4KB
M( @A2UD(48P%I"'*($8$R90FD;3;)#I+GAJEF R_4AHE:?D"^+;2SE4[+;&W
MO1X= -'7VSJNFI'L&&%"_U=F>"WPZ8:<OU*?EG+'+OKI!L>1\I^. _1CKT^T
M?,@7[^134>7+]HPTE%@AG'&8R1A!Q#($21!SB)4*D@@CS+'3#NF(C*DQ4IW+
M^%CK"5B3,E$!^FC*_;DQTC$\[;CG0I0&9IE&.]"J!WR?1W<8[XDHCDD8E1(Z
M3-Q?_%T?O?1&?Z?U2-UVI+ZN,DU(FGNIF0JHWL^($,9,!! %DD$:1 +B()0,
M!2P((JLTGAZRIT8+VS? NXUT3!ISJSZH]>\7(.8R+W8T,A#: ].+3Z ON%&W
MALS[[?EYR:]T4VX-R>E;<?LA^I';9[DT[^_;LOB>"^TSO?Q6F;KI[_.%?H\;
MD7R9?Z]+B\RH"#@)1 15D"80)9G>@N$XA@D5/(LHBQ*[% =WT5.[23?'P=QX
M/<]:8Z"*$JB5TH"NM79C,X>)L".S8> =F,L,LK4_N5+;[+A^,IJ#?/$S6"L/
MKL_#[,QE[HAYHC('P:,RF3L@^T368P3W0(.VQN+U0RGK ZKV.FS^A<WSA_JH
MRJ3!X#!&BK$02E,J$251!ID(8RAQ1$A$)$Z1=55;*XE3<\A615?I2NM5Q,$<
M%&N]'5.W[*#O)JQ! !V8IU98KA6^6EV$S\&7+3"=,KGLP+2/-_ .ZDC1!C[
M=8HU< *J(]+ ;IS1X@R<S-J.,G![L&?H)>?FA$B_ VZ+><[U&V!]X<UB0071
MNV9!8^UHTH1#RE4"B0IQRK%*2.I4S_:TJ*E1]$93L%+5YHK<%6 [!](/; ,3
M<4_$W(,^SX+A*Q#TM*!Q@T//&GP0,'K^B;X]>0O^Q[=BKI^H;O[C.5^^?"Z6
MF_@8G"8L2R(%1<H41*EA"BX83(BF"AGP4%#'IKQ=XJ9&&=O:_@_0Z N,PKV)
MXPS<ED=IWD <^O3L$OQZ=/"U@<5;"]].82/W\+4Q_+")K]53OFAEXX%P1*44
M 50XY.88/X4L9 QFF,9!8+)"W#R0TZ*F3"?__9]P%&;_$\A:XTM)Y&("^:]"
M'M=[P:"WM"Y+,0Z=C$8E4Z$1=PKQ1!^WI7RBN6A;BUXOFJRUYL:QK8\QBWF<
MDB!!D% 6F:I #)*8!I!G49!$$B%&G:X#+61.C5!:E8%L=&[:TA5-\>JV8$N?
ME#0;].V(QC.F S/."LY5OV&#9I-3NPY8:G3V1S(. 'EB&QN)H]*. P3[_./R
MZ"6QUR8W]KU6W(0ZY8MGO0O[\B2;WB-MY>=U-V19W?S0#*AEY":(L"YU:.KX
MF""I8JXE/7QH6TC-*$(QSA"' >$F=CN*((TE@K&,]*XJX")6B<N=WX"Z3NV2
M\.8@7Z0MZ]Z_T?J0,YT@E#!D*G%GIH =#@ED!%-(]'XZYB20&7,*7)O*3(_P
MBOLO-M-VK\6)S-_ K]/=TA.&^,'&5+"Q=36C[>=K<Z_ KGE@99_O_(1!)\%K
M?L,PFKY"?L2@D!_/KQA69,\C$OE@[G_:@MJ,H" )S8LAY0(B(CAD6(00JU 0
M+H.$,.5T*K(]^M1(O57.M2+Y<>0LCSSZXC'T*8<U%.X'&,=,]G5FL3/VN,<4
MQ\PZ.)DX^J%+8Y1_+0KQ9SZ?-W&O*4X98DC"M,[:SH(4DI!F, REB",6((2M
M2HV?D3.YQ;L5$KM2]-(@XUU@+5?TY7 -O;;[('5!E/!1'+Q'!.]*>:7HWZ.F
MGH[T/?YQ/P4<-G7H")$RXY1"W/1V9Z;4%0D@"9)8T(C$7%Y4P6&RA0,_W]R#
MF^NOGS]\_O5.^_M?[NYN[GX&MS=?P=V_7G^] 3_=W-[]?%G%!M=J?UZP&Y@?
MCM5L&*0TWUDP!BK;\$KE],Z:>ZYPPZ4E\$S'DT_T'T7Y]KE:ZFU%6=5U!&(A
M4QHR##'1U("2A$&29A0&$44Q)CA#B;3M0W0X_-1(8:6<4SF&$\AUK_G+\1AX
MH=M"X=1;Z+3%%W05.C+H:/V$3ANTW4FHXU.^ZB2L-O@F$6B6!")@88H@$2&&
M2"H.<<ST/IT'"$M.$A8X14!UBYO:(E[I!GC1<?;6!U>[U[@_M 9>XL>K':SA
M>]L%GX>B!L=0&:R2P8ZP5RY?<,SP\S4+CC[5CSZ.E-+]+)=?U#W]H?\V?Q9U
MS&99%W79"EZY+T[=%7&ETAA3R%1F&IA%B:::)(8QYUD6BB",(Z>*3I[UFQI!
M[5:[;B^%FE[=;G3E>QX#S!@66:BW@))"Q&6DYS%FD,8T"24-<)0*E]O=UYS'
M$6YT)SN/=N^I5YR=H7W7KE;K)J6T4.;*SKSK6CM!:^A!L-[@5WH#S8*G%ZEO
M[49]\PX$[?ZK>B@QEY[\O\\7^5)^U$H)/;9>'[F6V@0:[36CX#C#) Z$)GK&
M(!)<0!QF"4P43WB@"*7,Z?W=0X>IO:.WS\$WFI^KU>-M1ERO$P;!><2KAD9_
M6!MPB/=(/4"<0?1^3V&OP2O=83A#=/I^PWVH2PEQT^:IVFH:M:YC6=4ZF3H$
M='XK2U64CZ9VV?5";'YMBDAI'E^5O-Q;M80ED0Q,7@@C"*)8!)!*12')0L8)
MCR@)G(I2CJ?ZU.CW1BG)]<+7U'"\XYS^=94_+.I21K0";;^OG4]H;\[X>JN#
M\KZD/?BWQI7KI_1=&/$5L67VSC1O#&]?)(V-8,OV.BI^ZU]:\Z^V"@F/\H(9
M:^:\OY<&5_R57F=C3<CIM^!H&O1[>;ZG>?EW.G^6;U[>-*4\[[Y)N?RU+)Z?
M-*EN2(QQ*B*FWW418^8($$>0(8Z@0B1628(IBZSN"5T%3^W%M=/GKG%>#?E\
MS"G+YW5AH[H^F#$/U/8!4\!Y7E3/I6,'0NNIL7N_# 'XP&^'#8A7IBQ8JS:H
M]08KQ0>E=E?0/!&SM=A1:=45C'U2='[^TJ[B=15HRI?W>J V,#=+!0\"S"%+
ML?;@,YQ!1I,8\B!%,4Z9H-*)QKJ$38VZMASME;(]@YT[(;:]1/4#W.!7J#TP
MNZ#_]6DPO'>L/B+JE7I,GS;Z=%?HCF?ZT8:FH:JZ+0N5+V=$1*&,N/9S1$),
M.8@0,A9A*)FF""ZBC JG+,BML:=VQU6K!IYJW=Q(8!LPNS7?$X:!EWB#P&TW
M LY+^HBMGE;P]LBC+M@C)NVOSV,?Z=MKX4?^^/SX42X>EM^^J/O\49HS('.6
M: J,OI\7?]9_#V<J#86*(@E%9IKYFF*?+ @C& LF*<,L"C+FUH'!4O+4WN^M
MXD \EVW!1%X\/A;"U"CA+5U6X*=\ 5XD+5WOL.TGQ(X,!H%Y8*I8(=PH7=\R
M:[5!H[=I2U^7,C:J-[_SV?/!$2UOG2!LY8[<'\(1CL.N$:X#N-&8D/GL9K'4
M2^^K?,A-_9G%\K/^9LT(DTKQ6,$L$Z:HNKD]P(F"#(F,\Y RRJVN$$X)F!HI
M-3J"C9+ :&E'/2=![&88'] ,3"2.J%C3Q3G3C[!")?E?'XKOO^A'&T+0/VQX
MX.2 HRSW<^:L5O79S_7S079Z,>B_R/*[_%K,Y^^+\D]:BIE>R2'-J(()Q0HB
MPD)(>"!@(K 2@C A0^SB>9R1-[6EO=M[I-47_&XT!JW*CN<*YP"W\RP\PC@P
M#5R$H+,/88F+)\_AG+11_05+T_>]!-O'>E?$?GY\KMN[W&O&JN9-ETWQC^=J
M:>Z&/LE')LM9RDFF/08,XR0.34TY"EF$$JAB(B,6T22CD6-U; NQ4R,;#;G,
M'Q9M#3G^ I8;W0%=*^\8!6 Y!7:\XQ_8@>EG2V&PPO?M"M^-WB<+7#8&^2VZ
M[8"@OP+<-D+'+L;M ,21PMPN3[LW8-D<PV[?:3^S?TB^O"]61[//=#Y_:?-<
MWII*X;)\HN7R9757^K*^V<X?\V5U77>0G"5$<"'3#&9IA" *H@1BTT*<DDC(
M6(1,"2NZ&UC/J?%CHY4YDA";*XM\*XRF:LPVZY=O&ZX_WV2)\2W3P7QE.WAJ
MC=>_,M;;=S<9\DO23<@3FOKQKJ=V0J;:N;XOP(ZE8)41N&WK.G;A91TX!1IS
MK\"U0U?7H>?<O@_.1.9^I.XY[P9=[W_UTW%GA"GIZ-,SI/31NON, .%V3Z Q
MQ/4]4[T60J^@ZJW^\4MY7_RYF*F *4:2 ,K0;)*2A$*L(@;3$ E%)":QB-V.
M50]D3.V-WYXAMGI> :.IQA$875W/5P\!M3UBO0BF<4Y9W1#J<=9Z$H,+CEL/
MQQSYQ/6D48>'KJ<_VK/2ODFUTQN6MG:VII!E*9=Y64?,MAGSU2:L<BM(5:0\
M"-,8)IS%$"D401:@!*(T3E.A<$((<BJ_WU.1R5'%I]N/7_[]Y@:\N?E\\_[#
M/;C]>/WYSK$ ?]])L3L\&0/JP4]S5_J"E<(#U<ZZ%"Q?9?O[JC%N+?\+P3HH
M\'_I>!>?%O]*\X5)=F^;[:XOJYMSN?;,,B8LD"35+E <IIH!LT1[1*8521R3
M*!6)8IE3SJ^C_*E1H,D4>UZ4DL[S_]2;GP=MPE;]=KW=V1R;]#]#MIH8Y\-D
MWW"/>*IL5-\NS'"U'R%S-<IAL@N"_D^5K:2_UO&R"S0=Y\Q.P[@?.-_J+^<W
MJI=JH3XLONL1B_)E=3TFLI")((6I0LSL_"0D$5$P"Z*0",0SHJS"_[K%3(W.
MUIHV]0M:7>T/ZCH /7^VZ@>F@6GH.$+G><8%*OLC23^0C72BV!<ZIQ/!\XAT
M'.AU/#S:>=QY [:/TRP^W;/\P3.KVGK]=5E2%*11@#(%<<I"B# GD(E80!Q$
M6+&8"!$YM:#;&W]J1+BEGE-1UU/PV7EG%X R,.TYX.&>Z'[<:E_9Z'NCCYLR
M?MRT@[SN$Q_SU9"V7U4_%'"::K\GC6*]TR-1#*D0"&(<RR2,4QJFD4NVDA^U
MG(ABA$2G>R,#5(.UN^TU=7HK+B@*&$RDB2!-5 !)%@4PHCA*<9B0@,O9D]Z9
M%N)N2<OE5"=P7\7AIO&-?,@7IMX+8$T.\>O,&XUB@:F"-%5FWB*]VI)([T&P
MC'B6!DQBW,[;S4),>]96"@YY#R->>\(L7^NC3\'0WL"1?M63J(KI%^G!FEY/
MOP:F7R#/-],>L>)E75D_7Y@\K7:_K;*(B 1SF*I,[VU"@B E,H)!$A/]NA0(
M*ZN$BX.1I[:K:95SZ$^Q@U,WVUUD_<"$U>KE\:SAI+67=*38&6^\9A3'S-CI
M0W'T ST3L/-%4=8+?N7SA(*Q.*(PHRR *$,AQ&&J=QTHP))(I*1(G?*L]P1,
M;0WNO0/S5DW'VZ$#&.T\D4O >06?8GP'XA1 OO*>]X<?-[WYA'$'6<RG/M?W
M/**M2K==E*Z-W[MF51WP-U,A28.88YBD-(:()@FD7 @8LS!AL9)!P)W*+=@(
MG1HUK'7>JTBY"IW]?:6XZV&DS038;F7\PCHXJ5R,:(\]B#U$WG88%B)'WC_8
M@W"X.W!XMF^L[\VC+$WIWU_+XL_E-U.+GRY>9D&&HEBJ$$9Q2#0+"0Q9S&.8
M",5#E$8XR4*W>-^C<J9&/&U$ZTI7T"@+6FU=HWZ/0]O-+QX!&YA2>F+5(_ZW
M$XD+8H"/CSMR''"G<8>QP-T?=X_\^+"H\U5.59*_^=$>1ZRZZ;Z1JBCE!RTV
M+PTUS6)$6!!KIN",8E.S/8.$A"FD$<-()BG&V#H^Y%)EID8GGXOE=IX0?31G
M.O_9%H]BM?(@7VMO'S)Q\:1U<]#84S$P46U,@?,3_3%^6MNS;MK]\Q5H; (?
M7F.&[$-?QIRID0)D1I@QIU@:7Q!W1-Q<+&*TN!Q?8&Q'[W@;LT>N?<[_R!=5
ML:C3ZUX^Y?Q;_D 7G^A2OR':\UY$$DDRFD(5"=.7A&%(N&(P(YD(N)[+@"GK
MG/GS\J;V&ENKW.0UOUR!E=:@4=LA@=D"[?,O)\\8#OS^.0M?CZ!)&QP=$KK]
MXCE68O;EN+KE6-NCU)4K;3'*>#G/]B;MY"X[/-:[P^YCL:B/PF]I^:6LCT)$
M7=W^5I9WWV@I9RI-LCA6"(J,AA"A6$+""(,13P4E-. (.15NLI Y-69N5&ZB
MKJ[ $RW!][HGABE"*XKYG)85>-(+H3+*NS=5/3L%=F>EGH$=F*Y;3.\:3+7"
M)J6Y4;GM.**5!K767KN8VD+DKS/I68EC=QNUA>!(!U'K1_OS4=Y40+M>"%.=
M07NC<L%SN96*Z'B%X#3FQ!9(JW?=FV='\ZUV/(-<*O0"S>.2L9<]^N)QAN78
M,G(?Y-*NDG=-P/=7^61.QTQ44]VER_B.;U[:?ZQ;$,V"@#*2L@ JCF*(HB2%
M)(L55$&4!A@KQ3.GYC(]=)B: [#=+JO5$ZRM %MFU!V>5I]H6CJY7I[VF#'+
MN]1AYV'HJ]5!IN""+HG.('IO=VBOP2OU+72&Z'0#0O>A^A'F?2FIYM^7VLMI
M')YVGZ_W/-34MH>)3#%$-(PAI3C4$X32D&1))H1359:3DJ9&?BM%&U_=C<U.
MPVG'65Y &IB9=O&Y NW.QG\I@+-@>&*8TW)&Y9&SYNZSQ?D'^A;0YW-:5;G*
MF]:E[[6J6T4#ZOHIYHJXE-],4153:HX7C[*I0;R\K=-3/LOE%W5/?ZPW+SP5
M 0U2"87@)MT-!Y#@.#'Q'X3&7" :.=')$$I.C8FNO[S]T#_MHR[=47>[H3\N
MK.\_P/?!C@]?>Y8'IM+Q)[A'^X'A9L!;SX(!5!RYT<%P(!]V1QA05L_*@?2E
M[:K]+O^>"[D0U4$ /HVD(H@@R CBIC2@"0B2$<SB@*B8*DP$GRWD0UT^W:%6
MX'G15GQ!&KXX4&# \S)3DDFLE 9/-!>&*Q9>\A]L9L2.P7T!/%+YF59;PZI?
M2DW*5/NY:\6OAD^0<(#+5SE "XGC5OZSA^"@R)_#H^Z1S?<E-:_INY='5LQG
M2I$@"\,4BC"1$"%$(%:<0D4$"L) !"2PRFH\&'EJ7FBK'&BTLX]6WH6KFRTN
M F'P_:Z5_4X1R$=M[15SO#O2:%'&1PW8CBL^_H&^Z03O\[G\_%P?I- LBE*4
M9# 1YEPJ"#FD5.A]I<)Z#\DCQ"/'FN&;P:>V]-I@>*,@:#1T31;8 N[\"KP$
MCH$7H0,2/5(!#DV^(/Y_:["1@_X/S3B,]#_R&6\GQ_65>#7CF"<H#!2D82(@
M8AG33KM^43(NPUCR2$CE%$%S4M+4ENOZ9+2.G*G#9>H0&=>FS:>A50(E',41
MQ$F@R8^G!+(0I3##+ J3**8A3U>[H%O7 D27X;R[ ]H7/ASH!Z6%KL!R\'D(
M6:I?-UD$&0XSB&B&(<T" @55&0N21.]4Z>X\6!<4\C\+8Y<*&F,">E^GN#/'
MJURG7#6A8*>W[3YN4W:Q&.XVI97SVK<IN^9:W*;L/7!Q!?A39VNF!//'?"$_
M+.5C-6,9PD1*!4,2F'88FF5HDC*(4\TZ(A*QB+.>)>"M%)C:6W6[,GEM -BQ
M #0FM/7*P>_&#E ;XGC-X3Q1=APT)/Q#7T_X1_Z2>O!.\/DO"&\G_K4JPCN!
MTU$2WFV<?I3X_G1.UO56,NO-CR>M@?QW2<OW^CL]DUG$<6PZM8>9)D8F,TA)
MH(E1$!YF(L9Z[^]"C/W4F!P][J3_OF@M@=*#NW%?SQFQ8\#A<1Z8!QL#X,>C
M2:-7P"C.#4?N3H4Q!+SOF@IG,KP,24^4V%.)48GQ,J#VZ?'"T?I&X51Z(/[M
M>B'>R>]R7CR9JXU6QBQ+"8J2+(2QP)DY8\&0X(1"*G" 8BDS%3N=L71*FQKE
MK92M\P3$1EW "^>;SFZ8[0C.&W@#\]@.;EN:@E95GU$C%HAX"__HDC5R'(>%
MV8<!&38/]3VDI8N*<L-.]WJ$NE="1#A7<1K#,*2F(J0,($E8"AFA/*("!31Q
M<J..R)@:86RI"(R.O7I.',/2]ACJ(H2&O]]T J?'R=-)\[V=.1U*&/FTZ:2)
MA^=,IS_:.XMP?[>V#M"RJ;*NPE1BJ1B,$JH@2O6^"J<R@C$2*F:"!Y@X]1R\
M4)^ID<='655_ TTC"KYS_I$WYQ]T+US33PC6I;.:I$$6(^T7QH$)F$-9!ED<
M!:;-FD1AR 7-V.R[+%DQP7G=UNO_G]E>71%&G*V!7U =AX[;(=!7XY<S]H2Q
MOT3BB[09.[78!W1'DHV]#.M>\>GO^9(^Y@L3<"A+.C>YSG?/3T_SNM1JM4[D
M^VV1KUK*ADQ%.!.:G -3DQFI$-(D2*"(D0HBI!"WZXO02_K4WK)__W0'RG5^
MZ[/6T[YLD3OTW10Z.* #$^9*=U.ZJ-$>:/7!EOY;J<3&@AZEHMPQMR\<-2CV
M(Y61<IX#/]6D>D/745O*?<S1*DWU-G>[[E3_0?KMUVZ4DGRY?C_I5]-7NI1-
M88QG+>C+DU;#?#NKF>),!3C(H/;6 XA8RB$+$OU3@JC$04(X(2Y;,WO14WL_
MK#4'2_H#:"6E:?\N:6E"ORI@OA: K^T Q=H0-]_<86[LW/!A$!_X!;(!N_6V
M38:AT5MSEEF5^3QO+[ENI1;IHR!J?[P\><\.@D=UE-T!V?>)>XS0]R!J8;X,
MS6!?\^J/-R]OY()_>Z3E'_5Q:9PRF01"PB#*&$38]#NF.(5AHG]4,48IM:IX
M:BMP:B2VHR\P"H.UOKW.I,\B;GM6X _'P0\#^D/88W]OAXNW#?P9<2/OT.V,
M/]R"6S[7DV1H9:[*S'],%ZOO=&Z\M/<T+^O*?)N28K- QBH.LP0F242TRY3&
MD 0"P9#C,!.,(H2="GM92YX<[9A487/GR\T/<J/[%9#5,G^L _R4MJ.I\^E(
M0=;S8<E%0Z \-"FM *Y_N-D&V"C>%OC<J.Z1H5S1\D55UG+'Y2Q7. [(RWD
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M]K84-E+BG=?(-D"=7SQ;M>9\8?%Y/FN4QKU;KY9J-2C]V@G.PT*R7PZB5&
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M"/&37Y6.&/#]YP>+\CZI9C..^_0#%R<\6LWI/S^\?9SBS7*(A()02!$($:,
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MBORF<^:6M'Y>E1Z]^?&BD^QNMI_O^6J]F-VI=OAJ.<E0F$/,(Q"GN:H<&":
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M5YE'8[G#%GVTA>.H!*1U Q>'8&QC5K_QA;ZG_4GE/5EP-J$HQUPN7T"*H@1
M2D) 0LE:2$B6BE&2"9@YQF*T"AT;0^W"Q%FMH:IY7,5AZ(@,-I_*CY>[3]V#
M,]I[PO!XQS.^?9_N[(5K;#6^4B?Q5?2&RL]3J=U+[,99D/P'<;2+?*]HCK,@
M=(1UG'_WTDK77_FJ<;1=U<+=3>F\H%AP%H(PC#F )$\!0@2"G"/&TXPD(;-*
MFVHH=VP<U:SDK&ZZS6>;M,&M]UI<2V)W]X>AB^4?Y;X=K ; "M(FDIMJV?V4
MIK/$RGL1[6ZI[U10VPB*]N+:9J\[;B65LW+%OY2O*KIE);]#I6R\.DI3A69R
MDF:A8-*C2A$!D',.2!050& 6AC#.8QW=:GY(W2UN;*?6#VOR#U5A;#7?J_6C
MJP-9;B9UPVRXE^0-O)[IIU(4:$V#G:K!YMS;:TD?,U1\;2IU"QMV3\G(\*,M
M);.WW-CDEW(V7^C:W=*-X,N5=*]4\EG^62HOUX2K14G6^F+@X_RK-'(^6TF#
M97O?-R_\I5I)3E36Z2@5,<B** ,PCC% .<4@99%@O!"\*(1=-FI?JAD-LT%S
M6.\E!IOMZ1Z4M?*6EVV\]:,9L0W:-\-0X+Z>P491O4#4M@5J0 =[UJG^:WDO
M^,N9)&_6M.D;<T\$ZTVM0:G8-YB'I.V]_4N7N;?/+[A<'$\ANZ55B.7"-A<Y
MR&,8 YB'!4!Q1$%89"+.$"TL]^(L9(]YN;M1_M@M<EWAGN\*VU6N5X '7.FV
M8SO0DM<8.._+WO.2WVGI:PQ)^_+7O G["U /G*JTC6]13![+U91/J" 0)SP$
M'*E(D+S(  HEBV5A7"!(&<K-BD^>:GQLO*254@,GBG\B/P<;=<TO/QVAU\TT
MEV+2,Y78PF%U\:G-;J=;3T>-#7;EJ<V,YGVGUF<N=3J.0\T:N=ZJ;;$)YQ$/
M\Q2!@J$40"0P(+ (08Y@*J0#4L34*AV;E?2Q#?#FY'@JR+29'G$S1UK>DK+K
M'5M/Q#/F _HBE\-]@1]B 9MW3\1$]COY(A:PM'LC-HVXYN'=W/)6K3^\R&7=
M?/%E7M5T^31_QN5LDF0T%UDJ &.I2AL71P 3G "BBB^2*.<\M$R[>U;FV,BM
M$4^@H]EKI8.-UL%OE=Z6A&:"OAF-><:T9_*Z'$Z'U+G& 'G+E'M>XL")<8TA
M.,Z#:_ZJ<V5H=>@U^_[KK%SI.\]QF!4Y#@G(TIP"2)(4D#!* ,K3/"5%'B>Y
M5;;*(PGC(YE:P4!IZ'2/_!A%4_JX )O>R<(&%I<BSZ=-]U?=^:#]H<LZGS;O
M1#WGE@<=+U&J\G!WXF]XL<"SU=WB7F49JCSS@C+,.2X )30",$T*N6X*<Q#G
M*<Q)".4_=ADP6D6-;8AK397+7NNJ<BII;=T61!T8FXU[/\CU3 #NH-G??SR+
MAZ];C^V"AKWK>-;@HQN.Y]^XB##TW<DO<MESN^+/RPDB!8I03$$B> 8@3" H
MPC@#\DO#(<$XSJ"5%W!2RFAI0JL9_*84#;2F;@1Q@*D5-[@C-10M6(#D2@BG
M0?#+!0<RWH,&3IO9P@ M#SMNO/+O:G6Q=4).Q2@)FB8910*$7,32;>"II(*$
M@S3-.(MA5O \M=IN/2]S;,3P<//G7VZ^/@;W-P^_?K&M[F."L>&FJ5_D^MXJ
MK;0-=@N)_B._S 'RM2EJ(''8K5!S"(XV0"U>=:4;?6/ESWS&%WAZ/6/7[+F<
MJ<LM>%6^<I4E<+;DRSI!"DXY#3,* 6&4 <@)!3A/<E#0L$B++"Y$+.R(QT+Z
MZ"BH4EYGGL-[>NMTL4IQ6UJRZ0M3@NH)X=ZI2NM]%=2::Y3W=0\VRO=04]@)
M-F\$9B-[8"IS@.68U%P:\1YH<=V(+:AE_IWCQ>/O\TF.4)J37( D$@3 ,$L!
MY@4$,4EIDF+(>&IUG.VDQ=CH[GHO%N--*AFL?I]["\CHZ XSINL=Y)X9KS-\
MHY%@>K\?E!W!8T<_^(SL.(]C_P$?'3J,)0[D/$P6X2$&C3D6CRXQ*:>Z=J/D
MX.., M=$,3)=32#B"(8% Q'*I-.7P (4C!&0)RS.4US0@ML5EC84/#8"_')[
M_>'VR^WC[<V#+B_;S$KR7_^!XBC_DU-N$N..,./!/N#MF?H:*FL_K\Y-\MM&
M58^.G2TZOLI9FXH=MM2U)1A'9;!MWW=CJIOEJGS&*WXGMIF9MC_L5L3ULBC'
M&.=%G((T2Q" 45( S%(">,9"3)(LH\SJ2,U&^-@8:Z,["Y3*9Q*@7PZ]&3_U
M!6C/'+516^VS[] ,FOG;_"]#7;#RQ%A6H@=E+1=0#IG+J0W'';8U65;;>,OZ
M(ALO<!K!B #$. <0JN+5C*4@Q#%C,8LRPNR"M XEC(V'&@HZW@\\!M%P^^L2
M:/K>XK)!Q7X'J\UR7[M41^T/NQ/59M[1;E/K@Q=F@:V79S/6\(+JV8#=S>Y5
M.,:BG'V7#WR=SQ:;7W46R>IB"H-)7,"$ 8SDD@JB5.6+93D@RD^!+*,\LSK0
M]Z;9V.CC]'2[O JVINA50],8MUM$_OK6<,OJ/7JL[VVL;6==U#_N:6Y]8>D[
M(>[%>KU/ZEQ?<+8FV?4FP+[HR-T+7^@2:5]46+^^OS47ORXKE1H:O:EL004O
M4A9!#! 1TFOC*0<HY7)UF8@"R[$@<F(4HVHK>&QLO-4]F.J,&@NE/9@+L):_
MU'4PU7"?[KK3(G63=;=T,VV?8/=,I#N<M=Y7U4U/!;34O3H5"*3VP5;][@Q/
MEZ%L7AFE+[0'JI?B&76K6BHNT'546+%J;K"Z*RY&-JNQ.+WOYNIOZ@%?5^6
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MPOIH4:[,4$80!#3&DE;C* 8%% A 3I,",504V.A8MU7"V&A5*QGLM#2GB],
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M>LVY8[R&N;EKX9C%D#YQMI[R.[%WQEC?(/GPIC*KW EU6+F[$1!Q@E,HH*K
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M1! J>!)#BG5DJX,I*!#"9C=MMM.1H!GR:YKA/O6E[:$M<G" $=2X@YP"'C?
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MMK:-L134IAJNCB/:3_FA>-G:O_Q:#UP]64 OUX;;*E-S5^7]MY%B+(+OVU"
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M\-G\[8]?VD_,'S8:^X]?_@]02P,$%     @ H(6B5N)?ACCT>P  >V<% !0
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M<*/RP.[I14KSV5/ZMV]R?/JA7;4OKB"]4F/B/;J.\^?A&!<;NM'7R<WK=O>
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M1J54U%)5V^#<K=V"&U,%&5L)<VL0?$]3/ZG0EUS>1$N7;OJ/$ML-LA)>2,N
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M)$=<.CQ_;':@0R0^F!1S];KCSMMTGRUP??/GPS91RL> P0/01<N3P!UB<PB
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ME^DV*949):7U#X@(&ED, 3QA%!23T5F2F=2UNW6W(/.GB70WA\UF$-U9APW
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MV;HH%!/2DO).+2CB%0@1)=@R\98H017%D(RJVB[A2H+:;/3;2.7/851-_BV
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M]?Z\*:N:$AI U'U(^(P-DRW13CC0(I6'%AU#-H0'G3SSSAJM2>W)WZ^0TDH
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M_S*;TZG[S\MP,2D3S*_7Q-0ASCA=K/A[?Q&FFXR@#0;I[#G(6M%13#7Q[$.
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MVP$\5AGU32;B^N"=2PR<)&(@L*2OVM+)H0_@#&)-KX?4?&/J=DK&M42MP=)
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MUVCZZ6ITW;F4(F<9.0@,>%5.Y:2W4%*IY0DZRMCZM>IXJL=] QT$I\^LR@[
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M*@\3<!?-->^6GW&^Y0!6;DYQ^:Y\#'^3^9W,\LH%)N?V-5[]\UIT,27-4PC
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MX ^5>4=X60=O*BC&A'9@<RQ$?0X0Q*I"*&F9<Q31MK90WU,P+F8.U^0#D#A
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M=IXAB.#!TL^C\UIQU?JY>W?JQD5="RP\!:\VBND.<FNNUFFG*A8C4(,P:.E
MDF,<%*MU!N2-),\T_610C'U'3F>@:H2 1X%VN#I&SMB^N A?,(=7=8C!-_(X
M)V4VGT["[V%)GW\]UXEKF9!\2%8HV(I"0=32@3/&85!.E[MCD+:F;W?XJIZ0
M<X1*9\/)=^PNODGZQV2ZF$VO&/I]0B+]%*;?L:.]42%S#M8(#<H9 4&2T)*4
MUO*$/)I=YJ?M\%7CIC*&@$MK^79W;Y$]O@F?';KD,IK:XD-2,DE 5%)"QJ@I
MH#8ZJM9KR!ZFIB<P#>,*'2;X#B#T(J7Y9;CX938_F?XUF<^F-5 )%_<8/-?6
M%*9C@$+W>"V+$.!1>-"&R8S<E6Q;I_EWI:VGJ^UP+-Q?']!>,:/7L-&%/;G=
M(,VY+XD1\3)1I*NL91"2Y\"3+5YY886Q.UQH]SZX,XMS'"2.%]W(>E\/]3CY
M^^OJL>./:9XL5K.],*]2#AZ5S9%8X9IY4&@,.$;B,=JI@G0I8_0[H.")KQDW
M]ST )EJ*=62$G$V6>#N$_#1'S 3T5%7T:15?+I9GG\.<_L)Y"<YA80)*[5Q6
MJ1@(.AN0A85L8F I[>(%[_.=XZ:G!\#.8 (?>]$65G>>R*>OG2Q?SN;SV7\1
M"Z_"UY#JWE>E9'#%&_!.USF")*]@/(-H- ^:N9+N^L7;%VT]_C7C)I,'@$M+
ML7;@]5ZQL]CP\^YRN5@&,I_33R^^5 -ZKJQ,P5+DI[7-=?BM@:AM!./(255<
MYBA;>[M/T31NTG8@+[>I(OK,M)Z=_/K[R>G'#R=G?[S]V&(QT!,?V&(W\QXD
M-\JHGN&G&N!\P*^U*HK4OTF($;A2C,F"19% 12;!F8#@HZ%/8=&8U'R?^@.T
M'&MUZ/S4ZW6^TL>'R>(?ZX<(BVA"YB!E;==-AM4M- )4#E(487@.K;-8VRD9
MN3V^!0+NVI<&(N_@NKK'Q<MO+\D*?_X2YO]89ULL"W4.!=JD*184 8*OH6&P
M6J H!7G[]5B/TS1VTOUXO3\%I6.4T"6H-MRL']K1UV*F$J'D&CX6%NL*U@0Q
M.:-<$-ZJUF7M3]'4&:B.0L"3\#I"'1W ZP/^A=-+K,LA5P/"R)+_.5E^?G6Y
M6,Z^7"=<B".K8D8PS-3\7' 464J$9*UB*4<M0ONM'#L0UAO0CL'"O0D?K173
M =JV',WK<2B,AQSJNY=U-1$<5U%J%""*#AF#4(*WCN4>(6?<E^GGN1</$GV/
M*+HUWT0YU%(X!\E4VVZT Z>S!R&LQ*RD9[9U&?@CY/1FGPY4^9/>^F'R[P%*
M:W-ZCZ7-9/.2K3%605R-'TA"UJR= DTQ3=T<%UAL'=8^05)GD#I4]7<AU5 /
MHZ\6^(_9?,//8G78D@@B!VZ(^CK(M10*C5E$8-'G')6VR'9"T9/[!>Y^\[BY
MM(:W6 /!C@R+.B+E7?F.A_6YX4X6F86 %"UAVP=-X8C((%P=<2*,\;O-,WL"
M'0\2,-X*DF,U.FLMWI&S8G^&"XH>EF?T-W#Q9IK6QD]E;Y2)"K@ENZ>4PKI5
M5)+/[XN03MLH=AD>M/W3Q]-^(Y7-FLJO!Y_DKMF\R>$49U%C,A"<M* PDNET
M# &=M2$&"C5%ZY&:#U,S;K+].4*DPP3? 81.+ROPWY6K5_HJF/6S/3G^)CCM
M0P;IL7II5D.4Y%@EGEFV3I*-;?T&_3 UG3FS!^I[-HCP.X#1/0'=5)[P\T!F
M6>240-M<%\09#S$+ VB1UZELR.+@[\ZWZ.GLP:8-E)HIX$?(N=\[+V^F93;_
M<K6>ME$:?I?O:)Z9WYNQH9/UJ2@M,],DJ3JYQ*& 0*XUY"QCDISDQUO/]Q@J
M67\S-/#N-]P2\LMOZW]YY2-(FWP21@.3/-6Q  Q\X/4I+&@=,QEBVYS]_<GL
M-,V_#W8>WJHPC+)&#O%?U8W:%Y.\8F-E_%<AK8@\R*AK9H9N <70T^\T@F4Q
M&2Z(F=QBO?#V;^]EE\) "I\UE7YW^%G'P]4]#-H&B)S7:0.Z0-0Z0W:H=5#2
MN#0,@L9^(&JATT<A<H" ._#+WWW%^6HJSB:P6#]TD%"PZ*@!4XD47GA7@U\)
M9*\Q.*==SMCX8GN E)X@<XB.[VX^:"#P#G#S:C8G\QN6>#J;KCG9Y%<2^HR)
M(M&4ZP9?P2'P$,GR!NF0&:/T3AN0]PKF'B!FO,W(@V"GC= [0,\9*>%JZ<?E
M@J+;Q6)S&%8V65D9A(\DF&AKGZZ/X$R.P+- E27W+K=.O#]*4"_;,X9U?-KK
MI@>@7=&^22NCL:HDHA8M!X6ND%B,!Q1&B:"LB*'U.]-W!(SL0;=3[%W('"SE
MD;-DOV&X6'Y^,<U_XL5%%<G:G!HL44AR YDIK*Y+5>"U<4"<I;J10D6_2\_8
M Q_?13A^B+)F;24WMO)GEPO\/+O(:])1LN)=5!!B'042ZAVM ]G0.I^ME.**
M?NJ%<,O'CGQYM%'V$9(:NSMT4G"Q_':Q60+#M1&J9'*NB5=0CM59,AQ!<YFE
M\X6,7]I!R7<^=N1M)TV4?(RD1E;R:AO&="7O<+&9 R64U"EG2)8<'^6C@5#H
M9BM<DB!<+,KS'12]Y:/'35:W4?:Q$NO M7NR-X-ENF^"8B!5'?"?O*[CU3-=
M2D)'B0%9$HV]O28M4L^P%>EY(HFF&NH2<7>:-)37B>RB QLEG49!<O)2!"#?
MIP1?M&:Y_=/'#]T_M1<"]NV?VD<=H\])6BSGEVEY6:=OK+:17X3U4)?%-5MK
M.TU'3Z*R##3&.GE!,@C,5F,ME0XE!VO,#C?;'E_9&XB.T?-L>*%W::IN^C5*
MCI(IG<&S*,AGP+KNSM=Z^.0Y.0&.QV=H'=ZK.VHX;VK\*_$@O?0(L5O]&UB$
MHF"P-@(I44^D H],@4!F,I-UEZL<&F(_0NO47BK?HW5J'_EW *7W\UDF._Q0
MQTYD,:?(."2G69WKF\ 5=(!*:ZU0!LY:._*/4]09H Y5_-U-R>VTT &FK@WY
M']/)\JI7/_J4.8_ !*]C,UT"KQT#(31Q%)1.MG5*^QX1XXX)>^[;[C@=] :B
M]1&S1ENB.8()A8X8DV2N(ZLUN3$F8XV-N75S^18RQC5!1RKV,9@<(.618[=_
MFRS#E\ET\?MDBO-P47>^G%U^_;I>-/D=<YM:#R<<S]R1L&2]]E6 R)@#$Y%)
M%X1U^@Z$MD9P>W]Q1Z Y1,VSYY)Y3\_9VWB1W&59)RZ:5<";;>UQY 7JO/J,
M*CIUMU_BZ;?M0^$R6.JJ)5R:2K2#>^F1Z_OMS3Z]0B#70H-)QI&P5(%0FR!S
MTC9+;HO/K??8[$+7N%,MG[V:IK6F.D#?$_.$3OY.%Y>K@9YUM^T"\\?P][F-
MQC!#XD,,U?PF"U$4DB&7-F?D%)^T]YKV)K.+RHR&6-EO$-31BNL FV^FB5BI
MLVLW7$ZFE\32NNQV-EV\1)(J7OT]8A 7)W^3)$BWDVF8?UL)^91"X"J?V<7%
M2@U$'M;IZBIXH\A[<-I2!&QK?67B'EQ6(9/S&QAKW>PS(#M=%*8,A_5>@-#!
MF7@DST'<7U:*5ML#.)="QJC ,N3K7HBZZ-85DT+10:)O/99V1]*ZJ*\9TBZW
M5U 'N'NTY3@;$8QCB7@A!U[%6D,F0P;,=-WX8J.U@V>A]NWY'KJH9SB$-5-%
M![!:;>1^\^5KF,RKT%Y]#O-/N#A73*NHLX4L:@N$)$'YK T(7H1#YNF$M!XL
MNIV2D=]XAX92 _'_"",$3G%Y%BYP<7-0%LT&^#_\T>U'^>_(QO!S F+122/P
M[$J=+JOJU<7K_ I1F.:*F:$?(\:<$V"],UH4!<4I,K$BT:4M*8K**G+AC"K.
MMZX,^YGF!.R.G19S O915@?WX=-%=DI:C3Z"K;\HZ30$I.A%>Y6T-\%%VV4A
M;%>S!/8"Q=Z%L'MHJ$O$W:G(X[PX:9($XYVJ 7( %[P %E+&5'@J:?#A<C]8
M(>P^"-BW$'8?=70 K]WFU3NNA6?9@$%95R^0(QM8I%]4DEXX:6UN_UKQXR\2
MV L+!RT2V$<Q':#ML?J\NE65\\#!^WHJD6N(64L*CT6=!&J-$*V]UFX7"71P
M:1ZDEQXA=GO4N9!1(9T6J[D$E8N@4%S2/>"8%2$$:=C@/2,_0JGL7BK?9\O
M'O+O $I/%&G*K!C+Q4!RW%4I67#($)CV4F8MN/8[C7?Z%RB5W4OQ^Y7*[J.%
M#C#U^& (;H(.0I#1YMR#4HR#*TD C\$XPS,SK/G0C*.GL7350WG,+=A.-ST
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MUY+'>TM:?3&I>\]E8U7''W)?LAG0V$CJDH0S=01:='O_=,N\6./'Q@VLVC9
MBF5T75 +B_80Z3SAC5 RYAM%T>UJ(WT"V=W-"GY;OYJ['.#W.TQ[X#;?/T#1
M<G4NWKT1Y^_.?OKQXNKF,:20UI'>'5+8&YIB 3\F;EJ^_G]02P,$%     @
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M2XGQ9^TGPG+8\>Y4R!@+;:;7JVSPW>O>M?CZ:;_##GX#4$L! A0#%     @
MH(6B5C$H@+3*#P( X,H; !               ( !     &-L>"TR,#(S,#,S
M,2YH=&U02P$"% ,4    " "@A:)63&VZ>T /  "[G0  $
M@ 'X#P( 8VQX+3(P,C,P,S,Q+GAS9%!+ 0(4 Q0    ( *"%HE;$K*MP2Q\
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M,#(S,#,S,5]L86(N>&UL4$L! A0#%     @ H(6B5N)?ACCT>P  >V<% !0
M             ( !'(@# &-L>"TR,#(S,#,S,5]P<F4N>&UL4$L! A0#%
M  @ H(6B5IQ<\H98%P  A)@  !X              ( !0@0$ &-L>'$S9GDR
M,V5X,3 Q86UE;F1E9&%N;G5A+FAT;5!+ 0(4 Q0    ( *"%HE8U.ZMIE@<
M ,8A   >              "  =8;! !C;'AQ,V9Y,C-E>#,Q,6-E;V-E<G1I
M9FEC82YH=&U02P$"% ,4    " "@A:)6S#9^V;P'  !W(@  '@
M    @ &H(P0 8VQX<3-F>3(S97@S,3)C9F]C97)T:69I8V$N:'1M4$L! A0#
M%     @ H(6B5GBHELOC!   XA4  !X              ( !H"L$ &-L>'$S
M9GDR,V5X,S)C96]C9F]C97)T:69I+FAT;5!+!08     "P + /4"  "_, 0
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
